data_2kr7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kr7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.584 0.231 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.19 99.58 12.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.173 1.389 . . . . 0.0 110.679 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.08 106.04 13.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.546 1.539 . . . . 0.0 111.273 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.63 134.86 35.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 pt -132.46 167.16 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.48 1.512 . . . . 0.0 111.731 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -143.5 136.0 27.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.446 1.899 . . . . 0.0 110.394 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.3 153.04 51.29 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.419 1.488 . . . . 0.0 113.89 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -141.03 121.73 14.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.476 2.31 . . . . 0.0 109.483 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.12 103.46 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.498 1.119 . . . . 0.0 110.186 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -113.92 159.32 20.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.694 1.598 . . . . 0.0 110.623 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.55 147.2 29.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.002 -1.061 . . . . 0.0 111.506 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -64.14 125.57 24.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.389 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.01 -52.91 4.69 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.47 1.51 . . . . 0.0 114.201 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -61.16 143.79 54.87 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.52 1.528 . . . . 0.0 112.818 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -79.27 -13.91 59.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.87 155.98 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.708 1.203 . . . . 0.0 111.362 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.3 144.12 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.407 1.483 . . . . 0.0 110.664 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.58 -52.87 4.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.256 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.9 157.83 36.97 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.626 1.57 . . . . 0.0 111.048 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.3 p -151.05 144.7 25.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.295 1.038 . . . . 0.0 111.828 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.47 -17.85 15.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 167.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -56.49 -46.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.636 1.574 . . . . 0.0 112.019 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 t -68.54 -29.81 68.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -78.09 -72.97 0.34 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.777 1.631 . . . . 0.0 111.748 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -175.48 151.91 1.32 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 128.171 2.588 . . . . 0.0 110.016 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.92 170.86 15.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.66 2.906 . . . . 0.0 113.428 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 tt -124.0 108.55 12.51 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.251 1.42 . . . . 0.0 110.556 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.8 141.65 32.15 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.728 1.211 . . . . 0.0 112.968 170.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -144.12 164.74 29.8 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.256 1.423 . . . . 0.0 111.364 166.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.7 mm -84.1 138.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.702 0.801 . . . . 0.0 110.139 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 mm -47.86 109.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.523 1.529 . . . . 0.0 111.3 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -27.79 6.68 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.244 1.878 . . . . 0.0 114.315 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.6 m -85.25 72.77 10.69 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.922 1.361 . . . . 0.0 111.466 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 72.58 4.83 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.76 -1.213 . . . . 0.0 111.854 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -72.38 -11.84 60.86 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.0 pt -66.76 169.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 127.186 2.194 . . . . 0.0 113.188 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -58.84 147.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.909 1.284 . . . . 0.0 112.46 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.6 74.25 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.53 -36.84 93.66 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 121.194 -0.941 . . . . 0.0 113.109 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 tp -80.87 -28.11 36.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.744 1.218 . . . . 0.0 112.595 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -57.39 -42.78 82.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.431 1.092 . . . . 0.0 112.64 173.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -75.23 -14.93 60.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.67 -47.83 8.36 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.969 1.308 . . . . 0.0 112.645 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.02 -30.71 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.403 1.081 . . . . 0.0 113.615 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.09 -21.98 64.02 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -97.23 -23.04 16.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.811 1.645 . . . . 0.0 113.453 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.38 127.23 32.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.979 1.311 . . . . 0.0 112.28 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -83.62 162.81 20.68 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.925 0.89 . . . . 0.0 111.966 172.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.5 133.19 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.06 1.344 . . . . 0.0 111.692 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.42 13.37 81.71 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.44 1.019 . . . . 0.0 115.307 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -121.48 112.73 18.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.089 1.356 . . . . 0.0 111.832 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -59.92 141.01 56.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.046 0.938 . . . . 0.0 112.029 172.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -141.9 144.03 33.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.95 1.3 . . . . 0.0 111.042 174.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.29 110.96 13.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.672 1.189 . . . . 0.0 110.287 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -113.84 107.97 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.884 1.274 . . . . 0.0 110.839 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.08 126.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.201 1.0 . . . . 0.0 109.657 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.0 mt -124.69 138.56 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.694 1.597 . . . . 0.0 109.065 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 160.32 82.68 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.14 0.976 . . . . 0.0 112.178 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.05 -38.89 14.93 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.5 2.133 . . . . 0.0 111.786 -175.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.46 -12.48 61.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.117 1.767 . . . . 0.0 114.468 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 CA--C 1.545 0.77 0 C-N-CA 125.956 1.702 . . . . 0.0 113.046 179.848 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 . . . . . 0 N--CA 1.469 0.499 0 CA-C-O 120.235 0.065 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.395 -0.816 . . . . 0.0 111.342 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -134.99 125.22 26.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.994 1.718 . . . . 0.0 110.24 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -74.43 119.05 18.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.024 0.93 . . . . 0.0 110.611 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.34 134.52 25.57 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 109.189 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.22 144.11 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.245 1.963 . . . . 0.0 111.582 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -62.07 -14.17 33.61 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.26 -31.34 61.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.58 1.552 . . . . 0.0 113.267 169.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -70.56 -11.58 61.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.415 1.086 . . . . 0.0 113.901 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -132.63 16.88 4.35 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.883 1.673 . . . . 0.0 113.317 -167.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.76 -18.83 14.05 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -172.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.99 6.7 12.09 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.823 1.678 . . . . 0.0 115.426 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.6 pt -137.6 114.86 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.837 1.655 . . . . 0.0 111.31 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -66.39 154.03 41.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.523 1.129 . . . . 0.0 113.39 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.4 mt -132.74 162.85 30.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.823 . . . . 0.0 111.121 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -155.74 162.75 40.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.194 1.398 . . . . 0.0 110.599 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -69.88 129.49 39.67 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.431 -1.418 . . . . 0.0 110.436 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.99 65.47 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.724 1.05 . . . . 0.0 115.724 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp -97.26 150.2 21.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.282 1.541 . . . . 0.0 112.682 171.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 p -72.47 108.44 5.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 111.039 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.73 161.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.717 1.607 . . . . 0.0 110.934 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.52 154.55 40.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.12 1.368 . . . . 0.0 111.484 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.73 108.71 0.47 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.353 0.978 . . . . 0.0 113.084 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -73.33 111.4 8.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 111.575 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.3 t -80.83 158.19 25.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.563 1.145 . . . . 0.0 111.924 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.98 -17.36 63.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.386 1.474 . . . . 0.0 113.682 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.08 20.41 0.14 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.845 1.658 . . . . 0.0 113.911 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 50.22 48.0 22.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.346 2.259 . . . . 0.0 113.073 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -142.36 173.41 11.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.926 1.69 . . . . 0.0 111.736 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.0 m -141.07 107.84 5.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.629 1.171 . . . . 0.0 110.643 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.2 166.44 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.753 -0.592 . . . . 0.0 111.419 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -128.04 137.48 52.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.526 1.53 . . . . 0.0 110.879 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.8 178.98 9.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 113.206 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -126.82 125.65 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.186 0.994 . . . . 0.0 111.394 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.2 mt -72.78 129.02 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.475 1.11 . . . . 0.0 111.128 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -98.06 -35.89 10.28 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.692 1.597 . . . . 0.0 113.305 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -150.7 147.98 28.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.141 1.376 . . . . 0.0 110.164 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -140.01 136.93 34.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.169 0.987 . . . . 0.0 111.704 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.8 t -137.07 168.7 19.09 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.189 1.796 . . . . 0.0 110.154 172.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.33 63.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.099 0.96 . . . . 0.0 113.528 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 p -83.82 -62.05 1.67 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.233 1.813 . . . . 0.0 111.75 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -136.0 165.03 26.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.007 2.123 . . . . 0.0 111.707 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.634 1.573 . . . . 0.0 110.328 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mmm -120.64 105.28 10.64 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.727 2.011 . . . . 0.0 109.332 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 t -112.02 133.76 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 0.0 110.237 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.48 129.99 41.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.722 0.809 . . . . 0.0 111.32 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 CA--C 1.537 0.45 0 C-N-CA 125.656 1.582 . . . . 0.0 111.17 170.258 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 111.331 0.123 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -69.75 141.95 53.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.865 1.266 . . . . 0.0 112.369 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.64 147.97 49.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.534 1.534 . . . . 0.0 110.974 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.77 96.9 9.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.965 1.706 . . . . 0.0 111.074 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -76.86 95.72 4.15 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.799 0.84 . . . . 0.0 109.801 164.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -86.35 143.23 27.96 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.554 -0.716 . . . . 0.0 110.216 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -151.69 170.33 19.99 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -145.92 142.68 28.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.12 1.368 . . . . 0.0 111.306 168.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.25 101.97 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.438 1.095 . . . . 0.0 108.445 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.82 -37.4 86.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.243 1.017 . . . . 0.0 111.574 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 133.78 166.15 11.23 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.049 1.785 . . . . 0.0 113.29 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -98.54 146.92 25.3 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.492 1.117 . . . . 0.0 111.815 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 125.662 1.585 . . . . 0.0 111.31 177.04 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 102.77 10.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.817 1.247 . . . . 0.0 110.618 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.68 118.88 24.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.038 1.335 . . . . 0.0 111.132 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.83 129.46 45.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.775 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.23 165.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.182 . . . . 0.0 111.896 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.46 136.27 34.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.913 1.685 . . . . 0.0 110.121 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.58 154.08 50.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 113.723 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.75 121.11 12.34 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 109.403 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.95 111.47 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 110.472 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -121.27 134.67 55.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.849 1.659 . . . . 0.0 109.229 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -63.67 152.77 38.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.984 -1.072 . . . . 0.0 111.103 165.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -71.46 151.63 43.8 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.394 -0.816 . . . . 0.0 110.832 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.6 -66.29 3.95 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.826 1.203 . . . . 0.0 113.987 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -65.29 141.58 58.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.01 0.905 . . . . 0.0 113.096 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 m -82.06 -15.33 53.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.69 176.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.284 1.033 . . . . 0.0 111.356 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.74 143.22 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.134 1.374 . . . . 0.0 111.274 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 mt -75.84 -57.15 4.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.126 0.971 . . . . 0.0 111.011 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -155.18 157.6 37.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.876 1.27 . . . . 0.0 111.746 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.3 p -155.02 137.06 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.777 1.231 . . . . 0.0 112.179 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.67 -18.06 19.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 166.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -56.94 -43.66 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.643 1.577 . . . . 0.0 112.047 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 t -72.25 -8.82 56.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.088 1.355 . . . . 0.0 113.976 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -107.87 -73.32 0.69 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.364 1.866 . . . . 0.0 110.889 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.52 152.53 6.82 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.966 2.507 . . . . 0.0 110.357 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.79 159.71 52.64 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.78 2.32 . . . . 0.0 112.553 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 tt -104.2 108.93 20.55 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.62 1.568 . . . . 0.0 109.544 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.97 130.76 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.489 1.516 . . . . 0.0 112.158 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.6 162.88 37.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.185 0.994 . . . . 0.0 111.963 167.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.0 mm -81.62 137.91 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.68 0.792 . . . . 0.0 109.033 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.69 104.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.507 1.123 . . . . 0.0 110.879 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.05 39.41 0.23 Allowed Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.508 1.528 . . . . 0.0 116.116 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.6 m -122.79 -31.66 3.65 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.141 1.47 . . . . 0.0 114.256 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 57.59 31.06 19.77 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.668 1.587 . . . . 0.0 114.425 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -69.74 -19.79 63.53 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.6 pt -75.84 168.0 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.298 1.439 . . . . 0.0 112.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.7 pt -59.16 148.14 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.556 1.143 . . . . 0.0 111.96 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.04 84.2 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.94 0.896 . . . . 0.0 113.298 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.88 68.84 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.051 0.834 . . . . 0.0 114.656 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.12 -36.62 11.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.382 1.473 . . . . 0.0 111.555 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -56.17 -44.25 79.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.401 1.081 . . . . 0.0 111.921 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -76.67 12.31 1.35 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.886 1.274 . . . . 0.0 113.802 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.52 -45.24 2.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.973 1.709 . . . . 0.0 113.121 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.5 m -55.5 -28.19 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -62.76 -16.45 57.9 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -110.92 -5.35 14.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.142 1.377 . . . . 0.0 113.627 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.95 114.02 18.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.012 1.325 . . . . 0.0 112.331 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -71.57 157.18 38.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.833 0.825 . . . . 0.0 112.369 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.18 135.65 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.53 1.532 . . . . 0.0 112.027 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.71 16.34 74.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.63 1.11 . . . . 0.0 115.094 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -122.19 111.7 17.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.318 1.447 . . . . 0.0 111.178 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -58.5 142.77 47.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.78 0.832 . . . . 0.0 112.163 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -142.46 141.21 32.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.777 1.231 . . . . 0.0 111.19 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -125.79 105.23 8.81 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.272 1.429 . . . . 0.0 110.329 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.67 106.8 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.865 1.266 . . . . 0.0 111.109 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.58 128.99 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.371 1.069 . . . . 0.0 109.783 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.96 145.79 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.939 1.696 . . . . 0.0 109.664 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.63 156.96 81.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.364 1.466 . . . . 0.0 113.283 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.15 -3.14 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.036 3.157 . . . . 0.0 116.634 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.83 -4.06 12.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.602 1.161 . . . . 0.0 113.502 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 N--CA 1.478 0.933 0 C-N-CA 125.503 1.521 . . . . 0.0 113.637 -177.755 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 . . . . . 0 N--CA 1.474 0.772 0 CA-C-O 121.264 0.554 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.53 138.78 45.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.132 1.773 . . . . 0.0 110.456 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -134.02 113.35 12.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 111.238 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -79.17 96.42 5.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.931 1.292 . . . . 0.0 111.33 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -94.74 137.33 22.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.319 1.847 . . . . 0.0 109.799 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.7 158.51 50.38 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.901 2.401 . . . . 0.0 112.13 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -76.27 65.24 2.18 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.371 1.068 . . . . 0.0 111.813 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -133.3 -36.43 0.99 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.421 1.889 . . . . 0.0 112.599 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -74.02 -12.37 60.61 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 171.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.14 28.54 6.04 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.977 1.711 . . . . 0.0 112.631 -171.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -11.94 60.77 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.95 5.42 6.46 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.772 1.653 . . . . 0.0 115.33 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 pt -138.21 122.29 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.509 1.924 . . . . 0.0 110.463 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -68.33 154.87 40.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.1 0.96 . . . . 0.0 113.34 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -133.16 159.4 40.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.482 1.913 . . . . 0.0 110.832 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -155.53 164.36 38.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 110.574 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -67.12 132.39 47.73 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.626 -1.296 . . . . 0.0 110.599 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.85 43.59 65.68 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.188 0.899 . . . . 0.0 114.655 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.38 145.3 47.31 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.55 1.14 . . . . 0.0 111.952 170.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -68.96 123.93 22.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.656 1.182 . . . . 0.0 110.679 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.33 155.58 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.514 1.526 . . . . 0.0 111.398 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -90.37 144.72 25.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.455 1.102 . . . . 0.0 111.608 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.03 96.94 0.49 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -65.31 144.31 57.21 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.267 1.034 . . . . 0.0 111.261 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.1 t -125.27 154.61 41.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.244 1.418 . . . . 0.0 112.151 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.4 -15.65 60.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.618 1.967 . . . . 0.0 113.65 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.38 15.71 0.43 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.44 1.896 . . . . 0.0 113.777 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.53 48.53 20.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 112.564 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -142.7 179.96 6.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.764 1.626 . . . . 0.0 112.202 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.6 m -145.73 127.91 15.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.563 1.145 . . . . 0.0 111.766 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -98.52 172.8 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.998 1.319 . . . . 0.0 112.104 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -121.19 119.98 33.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.183 1.793 . . . . 0.0 109.924 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -136.25 177.99 7.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.262 1.825 . . . . 0.0 112.415 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.23 131.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.165 1.386 . . . . 0.0 110.001 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -72.47 129.02 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.199 1.0 . . . . 0.0 110.663 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -93.98 -43.33 8.59 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.83 1.252 . . . . 0.0 112.359 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -144.45 152.74 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.004 1.322 . . . . 0.0 111.1 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.97 148.65 34.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.805 1.242 . . . . 0.0 112.431 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.7 t -152.34 171.51 17.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.724 2.01 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.28 -24.5 64.88 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.562 1.145 . . . . 0.0 113.352 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.2 p -84.31 -61.43 1.81 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.456 1.903 . . . . 0.0 112.571 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.27 166.02 24.78 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.277 2.231 . . . . 0.0 111.764 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.21 137.23 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 110.562 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 26.3 mmm -109.85 99.44 8.58 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.737 2.015 . . . . 0.0 109.601 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -98.2 149.89 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.346 1.059 . . . . 0.0 111.328 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.97 141.76 45.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 111.694 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 125.264 1.425 . . . . 0.0 111.697 170.147 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.4 p -63.97 137.21 57.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.99 1.316 . . . . 0.0 113.227 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 mt -123.12 125.51 45.3 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.339 1.456 . . . . 0.0 111.842 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.97 96.39 6.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.177 1.391 . . . . 0.0 111.157 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.79 97.47 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.636 0.774 . . . . 0.0 109.233 162.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.34 142.75 27.65 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.111 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -150.97 170.75 18.58 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -148.72 137.8 21.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.167 1.387 . . . . 0.0 111.183 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.6 t -80.95 103.02 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.46 1.104 . . . . 0.0 108.341 166.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.9 mt -66.89 -28.3 68.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.906 0.482 . . . . 0.0 112.139 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.13 -179.01 16.6 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.612 2.053 . . . . 0.0 112.254 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -115.49 154.76 28.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.049 0.94 . . . . 0.0 112.03 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 125.691 1.596 . . . . 0.0 111.108 178.358 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 120.537 0.208 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.88 104.16 7.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.923 . . . . 0.0 110.136 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.63 143.12 29.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.772 1.229 . . . . 0.0 111.123 172.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.92 139.48 53.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.511 1.524 . . . . 0.0 110.767 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.82 159.32 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.488 1.115 . . . . 0.0 111.386 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -133.28 134.42 43.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.902 1.681 . . . . 0.0 109.133 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -138.43 152.09 48.04 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -134.67 128.11 32.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.702 2.801 . . . . 0.0 108.828 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.19 119.28 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.294 1.038 . . . . 0.0 111.004 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -132.22 147.45 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.788 1.635 . . . . 0.0 112.166 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -66.71 136.5 55.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.628 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -72.85 78.26 1.14 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.23 1.014 . . . . 0.0 113.313 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.66 -53.29 0.52 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.966 1.746 . . . . 0.0 112.33 172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -68.55 147.43 51.97 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.924 1.29 . . . . 0.0 112.261 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.0 p -79.05 -6.77 57.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.43 162.35 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.186 1.394 . . . . 0.0 112.086 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.17 108.42 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.851 1.26 . . . . 0.0 109.272 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.44 -46.25 77.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.537 1.135 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.38 168.58 26.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.006 1.322 . . . . 0.0 111.233 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -155.55 157.51 36.95 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 112.902 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.45 -16.08 8.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.064 1.346 . . . . 0.0 112.782 168.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -55.39 -60.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 126.155 1.782 . . . . 0.0 111.912 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -69.03 -22.4 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.485 1.114 . . . . 0.0 113.035 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.48 -74.02 0.31 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.744 1.617 . . . . 0.0 111.711 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -168.64 125.98 0.86 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.174 1.79 . . . . 0.0 110.64 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.29 142.36 85.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.65 2.233 . . . . 0.0 112.027 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.01 101.56 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 0.0 110.387 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 130.3 34.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.202 1.401 . . . . 0.0 112.035 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.41 169.46 23.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.085 1.354 . . . . 0.0 112.47 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -94.49 139.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.334 1.053 . . . . 0.0 108.706 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.4 111.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.814 1.646 . . . . 0.0 112.14 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.38 74.31 0.69 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.962 1.744 . . . . 0.0 113.708 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.4 m -131.05 -37.79 1.26 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.039 1.336 . . . . 0.0 113.569 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.98 35.3 26.22 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 125.66 1.584 . . . . 0.0 114.523 172.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -99.58 -13.48 19.41 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 pt -68.92 167.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.614 1.166 . . . . 0.0 111.706 171.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 pt -55.71 142.34 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.619 -0.676 . . . . 0.0 110.893 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.17 72.68 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.292 -0.88 . . . . 0.0 112.868 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -45.07 87.02 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.142 0.877 . . . . 0.0 113.207 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.85 -31.1 59.17 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.355 1.062 . . . . 0.0 112.339 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.46 -48.31 82.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.616 1.166 . . . . 0.0 111.829 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -68.86 -5.44 21.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.63 -51.43 3.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.705 1.602 . . . . 0.0 112.852 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 p -54.95 -31.95 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.959 1.303 . . . . 0.0 114.079 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.99 -17.49 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -106.02 -7.95 17.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.736 2.014 . . . . 0.0 114.11 175.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.51 118.84 25.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.083 1.353 . . . . 0.0 112.337 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -77.33 160.21 28.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.914 0.886 . . . . 0.0 112.202 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -53.59 129.34 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.506 1.522 . . . . 0.0 111.647 170.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.95 -0.19 67.22 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.787 1.184 . . . . 0.0 115.866 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -97.04 113.07 24.58 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.411 1.606 . . . . 0.0 112.087 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -55.99 135.12 52.66 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.52 0.728 . . . . 0.0 111.103 164.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -137.79 113.18 9.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 0.0 110.93 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.83 98.45 11.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 110.242 172.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.27 153.11 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.824 0.85 . . . . 0.0 110.237 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.37 124.68 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.987 1.315 . . . . 0.0 109.988 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.94 134.12 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.115 1.766 . . . . 0.0 110.244 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.64 159.12 70.7 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.203 1.401 . . . . 0.0 112.936 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.83 50.56 2.5 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.682 3.588 . . . . 0.0 113.839 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.99 1.53 2.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.777 2.031 . . . . 0.0 113.15 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 125.447 1.499 . . . . 0.0 111.761 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.14 146.1 47.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.074 1.35 . . . . 0.0 110.216 169.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -134.97 107.37 7.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.823 1.249 . . . . 0.0 110.121 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.4 121.47 18.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.049 0.54 . . . . 0.0 110.102 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.5 m -135.42 159.24 72.41 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.176 1.79 . . . . 0.0 110.724 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.21 165.21 31.46 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.325 2.016 . . . . 0.0 111.819 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -69.73 10.76 0.34 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.68 -43.48 97.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.451 1.5 . . . . 0.0 113.429 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -69.26 -21.92 63.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.049 0.94 . . . . 0.0 113.379 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -132.58 50.02 2.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.957 1.703 . . . . 0.0 111.391 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.07 -27.21 67.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.779 1.232 . . . . 0.0 113.0 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.43 34.02 1.64 Allowed Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.993 1.759 . . . . 0.0 114.094 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.64 128.82 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 126.643 1.977 . . . . 0.0 108.794 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -64.99 142.07 58.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.029 0.932 . . . . 0.0 111.762 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.41 146.02 51.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.736 1.614 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.45 145.06 20.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.622 1.169 . . . . 0.0 111.547 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.99 90.48 0.18 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.994 1.717 . . . . 0.0 110.579 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.51 -4.37 8.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.869 1.7 . . . . 0.0 116.58 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.5 159.41 32.27 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.482 2.141 . . . . 0.0 113.023 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -84.62 126.03 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 0.0 110.846 165.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.2 149.46 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.644 1.977 . . . . 0.0 110.723 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -97.78 155.72 16.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.74 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.82 95.52 0.19 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.17 1.367 . . . . 0.0 112.686 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.19 105.79 2.21 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.769 -0.842 . . . . 0.0 111.234 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -75.65 154.4 36.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.691 1.197 . . . . 0.0 112.169 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -65.11 -19.32 65.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.609 1.563 . . . . 0.0 112.661 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.3 13.21 0.13 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.663 1.985 . . . . 0.0 114.601 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 58.66 48.95 10.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.039 2.136 . . . . 0.0 112.597 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -146.57 176.82 9.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.533 1.933 . . . . 0.0 110.929 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 m -140.28 107.08 5.38 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 111.581 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.89 167.22 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.605 0.762 . . . . 0.0 111.8 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -128.34 132.3 48.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.977 1.711 . . . . 0.0 110.129 172.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.28 177.11 8.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.842 1.657 . . . . 0.0 112.509 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.75 137.99 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.46 1.504 . . . . 0.0 110.337 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.57 114.9 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.981 -1.074 . . . . 0.0 109.524 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -84.46 -33.18 23.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.195 1.398 . . . . 0.0 112.888 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -156.69 159.78 38.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.11 1.364 . . . . 0.0 111.445 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -149.06 151.06 33.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.956 1.302 . . . . 0.0 112.669 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -154.95 -176.55 5.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.737 1.615 . . . . 0.0 111.657 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.09 -27.95 54.34 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.301 1.441 . . . . 0.0 113.251 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.0 p -83.1 -65.3 1.03 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.904 1.682 . . . . 0.0 111.843 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -132.38 173.18 11.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.099 2.16 . . . . 0.0 111.71 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -143.51 148.83 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 127.148 2.179 . . . . 0.0 109.399 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.1 mtp -122.42 100.04 6.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.574 1.549 . . . . 0.0 110.263 -174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.23 140.44 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.926 1.29 . . . . 0.0 111.67 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.81 151.06 46.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.719 0.808 . . . . 0.0 111.347 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 125.252 1.421 . . . . 0.0 111.684 170.132 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.9 pttt . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.97 145.0 55.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.853 1.661 . . . . 0.0 112.558 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.17 124.98 44.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.574 1.55 . . . . 0.0 111.446 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.38 139.53 32.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.655 0.782 . . . . 0.0 111.444 169.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.83 95.21 4.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.523 1.929 . . . . 0.0 108.78 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -81.83 112.32 18.85 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.437 1.095 . . . . 0.0 108.572 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.17 169.4 16.92 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -147.25 139.11 24.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.319 1.448 . . . . 0.0 110.579 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.59 100.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.23 -17.53 64.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.259 1.023 . . . . 0.0 112.568 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.57 -171.1 13.55 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.786 1.66 . . . . 0.0 112.735 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -125.93 151.44 46.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.128 0.971 . . . . 0.0 112.48 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 . . . . . 0 N--CA 1.472 0.641 0 C-N-CA 126.17 1.788 . . . . 0.0 111.04 -177.108 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 110.469 -0.196 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.41 112.23 17.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.332 0.653 . . . . 0.0 109.293 164.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.56 141.26 42.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.035 166.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.99 130.4 55.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.0 2.12 . . . . 0.0 109.991 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.3 pt -132.63 159.41 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.247 1.019 . . . . 0.0 112.392 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -138.47 134.75 34.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.192 1.797 . . . . 0.0 109.817 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -136.88 152.03 49.76 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.111 1.364 . . . . 0.0 114.027 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.42 115.99 9.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.614 2.365 . . . . 0.0 109.606 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.24 103.65 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 122.27 1.033 . . . . 0.0 110.634 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -102.77 152.15 21.58 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.593 2.357 . . . . 0.0 110.212 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -77.69 150.78 34.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.903 -1.123 . . . . 0.0 111.332 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -70.54 85.83 0.63 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.86 -1.15 . . . . 0.0 111.88 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.5 -44.78 1.26 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.467 1.984 . . . . 0.0 114.39 170.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -70.64 151.44 44.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.18 0.99 . . . . 0.0 112.971 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.4 m -79.87 -15.85 56.55 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.975 1.31 . . . . 0.0 114.072 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.83 159.57 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.777 0.831 . . . . 0.0 111.944 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.41 128.78 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.159 1.383 . . . . 0.0 109.517 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.43 -51.58 10.54 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.936 0.495 . . . . 0.0 111.423 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -159.89 163.84 34.0 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.393 1.877 . . . . 0.0 111.112 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.8 p -154.35 159.93 41.43 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.882 -1.136 . . . . 0.0 112.482 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -114.38 -12.52 12.37 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 165.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.19 -48.36 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.784 1.633 . . . . 0.0 111.826 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -76.0 -6.89 53.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.716 1.206 . . . . 0.0 113.984 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -107.47 -73.58 0.68 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.943 1.697 . . . . 0.0 111.354 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -163.54 131.68 2.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.301 1.84 . . . . 0.0 109.774 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.5 160.06 37.52 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.173 2.582 . . . . 0.0 112.891 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 tt -95.11 126.28 40.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 109.863 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -106.27 127.44 53.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.102 1.761 . . . . 0.0 111.558 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -147.57 162.98 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.508 1.123 . . . . 0.0 111.966 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.2 mm -88.38 149.48 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.717 -1.24 . . . . 0.0 109.366 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -50.7 106.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 110.971 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.03 59.63 1.75 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.547 1.546 . . . . 0.0 114.492 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -113.5 -28.68 7.44 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.966 1.306 . . . . 0.0 113.243 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.67 32.9 18.19 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.74 2.016 . . . . 0.0 114.711 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -83.5 -17.94 40.19 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -76.75 171.05 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.974 1.31 . . . . 0.0 112.791 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.4 pt -57.18 142.48 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.966 0.906 . . . . 0.0 111.46 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.78 77.57 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.48 -21.8 65.03 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.086 0.85 . . . . 0.0 114.518 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -96.52 -35.49 11.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.466 1.507 . . . . 0.0 111.804 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -56.77 -45.75 81.9 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.887 1.675 . . . . 0.0 112.188 174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -75.69 -2.0 27.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.917 0.887 . . . . 0.0 113.393 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.5 -42.27 4.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.601 1.56 . . . . 0.0 113.18 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.02 -25.73 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.522 1.129 . . . . 0.0 113.893 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.3 -24.96 67.84 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -37.24 15.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.133 1.373 . . . . 0.0 112.498 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.91 131.3 46.77 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.63 1.572 . . . . 0.0 113.377 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -92.51 151.51 20.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.2 1.0 . . . . 0.0 111.833 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.16 125.06 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.904 0.882 . . . . 0.0 110.061 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.19 86.19 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.454 1.026 . . . . 0.0 115.454 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -122.58 116.38 23.76 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.992 1.396 . . . . 0.0 111.259 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -58.26 143.07 45.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.157 0.983 . . . . 0.0 112.008 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.49 142.5 41.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.633 1.573 . . . . 0.0 110.173 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -129.99 81.8 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.181 0.993 . . . . 0.0 110.583 -167.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -88.06 117.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.921 1.289 . . . . 0.0 111.554 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.44 118.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.889 0.876 . . . . 0.0 109.465 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -115.62 138.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 126.604 1.961 . . . . 0.0 108.812 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.08 155.52 90.15 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.475 1.11 . . . . 0.0 112.042 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.7 -46.28 5.38 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.601 2.201 . . . . 0.0 112.473 -172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -64.69 -23.17 67.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.536 1.534 . . . . 0.0 113.309 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 125.229 1.412 . . . . 0.0 113.502 176.54 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 p90 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.03 132.98 41.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 111.386 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.7 120.09 28.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.74 1.216 . . . . 0.0 110.847 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.12 101.47 5.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.345 1.458 . . . . 0.0 111.453 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 t -99.72 136.88 20.16 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.32 1.848 . . . . 0.0 109.476 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.87 152.58 68.78 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.502 2.134 . . . . 0.0 111.676 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -76.88 57.45 1.32 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.127 1.371 . . . . 0.0 111.447 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.63 -50.52 1.06 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.205 1.802 . . . . 0.0 112.812 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -66.43 -15.01 63.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -98.45 17.83 18.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.717 2.007 . . . . 0.0 113.484 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 112.3 1.47 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.717 -1.239 . . . . 0.0 111.341 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.22 2.43 59.13 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.869 1.223 . . . . 0.0 115.446 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.68 130.48 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.919 1.36 . . . . 0.0 111.368 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.76 147.64 39.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.532 1.133 . . . . 0.0 111.173 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.09 152.4 47.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.98 1.712 . . . . 0.0 109.689 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -155.8 162.05 40.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 111.604 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.25 123.6 20.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.829 -1.169 . . . . 0.0 110.92 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.96 30.68 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.167 0.889 . . . . 0.0 114.786 173.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.4 ptp -109.1 144.96 36.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.195 0.997 . . . . 0.0 111.421 165.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.1 p -70.26 136.67 50.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.883 0.873 . . . . 0.0 110.812 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.9 p -140.66 164.61 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.573 1.549 . . . . 0.0 111.046 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.21 148.39 34.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.212 1.405 . . . . 0.0 111.858 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.85 94.72 0.31 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.463 1.506 . . . . 0.0 111.936 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -68.66 104.96 2.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.855 0.862 . . . . 0.0 111.063 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -77.93 158.38 29.38 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.678 1.191 . . . . 0.0 112.21 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -66.48 -16.95 64.51 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.443 1.497 . . . . 0.0 113.264 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -72.16 13.86 0.28 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.575 1.95 . . . . 0.0 114.212 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 57.13 47.23 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.883 2.073 . . . . 0.0 112.301 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.06 170.43 15.95 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.037 2.135 . . . . 0.0 109.637 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 34.6 m -136.95 115.51 11.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.56 1.144 . . . . 0.0 111.585 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.64 164.5 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 111.406 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -121.23 133.14 55.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.677 1.591 . . . . 0.0 110.624 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 177.15 9.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.683 1.593 . . . . 0.0 112.474 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.94 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.428 1.491 . . . . 0.0 109.362 173.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.9 mt -74.93 116.42 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.706 1.202 . . . . 0.0 109.629 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -92.98 -33.12 14.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.131 0.972 . . . . 0.0 112.611 -175.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -148.41 148.09 29.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.946 1.698 . . . . 0.0 110.78 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -142.58 157.93 44.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.221 1.008 . . . . 0.0 112.51 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 t -157.01 176.21 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.861 1.664 . . . . 0.0 111.167 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.17 -25.85 62.72 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.531 1.132 . . . . 0.0 113.184 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.6 p -82.74 -64.18 1.22 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.747 1.619 . . . . 0.0 112.044 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -135.08 168.47 19.07 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.592 2.357 . . . . 0.0 111.159 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -137.58 150.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.498 1.519 . . . . 0.0 110.617 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.2 mmm -127.76 103.08 7.09 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.798 2.039 . . . . 0.0 110.288 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.76 143.47 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.398 1.479 . . . . 0.0 110.246 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.23 96.8 2.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.206 1.002 . . . . 0.0 111.861 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 CA--C 1.54 0.562 0 C-N-CA 125.063 1.345 . . . . 0.0 112.392 173.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.3 p -91.24 150.31 21.39 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.957 1.303 . . . . 0.0 113.208 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.3 120.94 32.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.742 2.017 . . . . 0.0 110.911 -170.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 101.08 10.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -79.59 92.43 5.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.633 0.773 . . . . 0.0 110.08 167.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -73.12 124.03 24.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 165.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -144.18 169.39 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -148.4 147.97 29.8 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.789 1.236 . . . . 0.0 111.511 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.95 108.0 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.614 1.166 . . . . 0.0 108.444 167.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.7 -12.76 60.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.007 1.323 . . . . 0.0 112.768 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.57 -150.51 18.66 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 126.009 1.766 . . . . 0.0 111.475 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.77 163.7 31.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.492 1.117 . . . . 0.0 112.681 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 125.397 1.479 . . . . 0.0 113.125 176.087 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 120.477 0.18 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.31 8.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.39 123.63 23.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.065 1.346 . . . . 0.0 110.566 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.72 117.44 34.08 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.6 1.96 . . . . 0.0 109.707 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.34 160.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.363 1.065 . . . . 0.0 111.524 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.13 165.36 28.05 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.076 -1.015 . . . . 0.0 112.445 169.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -147.69 157.8 43.72 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.7 1.6 . . . . 0.0 113.858 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -134.01 123.79 25.17 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.873 3.269 . . . . 0.0 108.148 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.21 112.58 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.263 1.025 . . . . 0.0 109.372 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -115.84 143.72 45.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.753 1.621 . . . . 0.0 110.172 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -70.04 132.92 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.516 -0.74 . . . . 0.0 110.4 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -59.16 123.84 18.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.305 0.642 . . . . 0.0 111.943 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.82 -45.86 2.31 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.019 1.771 . . . . 0.0 114.306 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -74.72 154.7 38.3 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.664 1.186 . . . . 0.0 113.514 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 m -83.8 -14.94 50.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.18 163.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.049 0.94 . . . . 0.0 111.983 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.66 122.74 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.367 1.467 . . . . 0.0 109.299 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.69 -51.09 24.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.102 0.961 . . . . 0.0 111.058 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.52 156.54 28.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.006 1.323 . . . . 0.0 112.554 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 57.5 m -149.84 151.97 34.37 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.679 1.591 . . . . 0.0 111.76 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.49 -6.13 11.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.3 mt -50.88 -58.14 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.908 1.683 . . . . 0.0 112.196 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -75.1 -19.83 59.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.504 1.121 . . . . 0.0 113.389 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -78.59 -72.47 0.38 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.048 1.739 . . . . 0.0 111.109 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -168.34 125.87 0.9 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 127.074 2.15 . . . . 0.0 109.392 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.29 147.05 87.43 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.444 2.096 . . . . 0.0 111.403 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.5 tp -72.83 142.89 48.0 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.316 1.047 . . . . 0.0 110.172 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -120.68 111.79 18.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 0.0 109.685 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -131.77 169.54 16.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.078 0.951 . . . . 0.0 112.262 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.2 mm -105.94 137.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.234 1.014 . . . . 0.0 108.9 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -46.37 106.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.634 1.574 . . . . 0.0 111.345 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.88 15.03 17.63 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.25 1.405 . . . . 0.0 116.397 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.6 m -73.8 -43.54 58.55 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.859 1.829 . . . . 0.0 113.001 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m120 57.17 21.52 6.61 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.161 2.185 . . . . 0.0 116.538 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -74.61 -16.0 60.81 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.4 pt -66.6 168.86 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.434 1.494 . . . . 0.0 112.96 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 pt -56.1 144.43 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.228 1.011 . . . . 0.0 111.775 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -38.41 75.23 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -171.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.81 -33.16 86.17 Favored Glycine 0 CA--C 1.539 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 113.962 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.52 -29.64 22.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.251 1.42 . . . . 0.0 112.144 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -59.65 -43.29 93.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.738 1.615 . . . . 0.0 112.091 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -70.47 -13.91 62.31 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.38 -46.81 7.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.817 1.247 . . . . 0.0 112.723 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.33 -27.77 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.8 -24.47 66.93 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.94 -36.65 10.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.107 1.763 . . . . 0.0 112.684 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.96 112.15 0.89 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.963 1.705 . . . . 0.0 113.142 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.08 151.4 41.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.448 0.699 . . . . 0.0 112.053 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 tt -57.33 127.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.426 1.09 . . . . 0.0 111.494 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.96 9.23 85.28 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.094 1.33 . . . . 0.0 115.3 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.1 119.07 30.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.088 1.444 . . . . 0.0 111.763 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -59.25 142.36 52.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.059 0.944 . . . . 0.0 112.082 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -136.51 138.82 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.598 1.159 . . . . 0.0 110.481 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -130.02 89.3 2.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.433 1.093 . . . . 0.0 110.534 -167.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -101.09 118.15 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.879 1.272 . . . . 0.0 111.507 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.9 t -78.82 111.18 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.434 1.094 . . . . 0.0 109.536 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.17 133.81 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.3 1.44 . . . . 0.0 109.53 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.51 153.45 93.1 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.09 0.956 . . . . 0.0 111.743 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.04 -43.53 35.69 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.563 2.175 . . . . 0.0 112.521 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.92 -15.6 63.53 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.833 1.653 . . . . 0.0 114.838 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 124.769 1.227 . . . . 0.0 113.035 176.488 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 120.688 0.28 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.36 147.85 44.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.199 1.4 . . . . 0.0 110.316 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -129.51 115.92 18.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.191 1.396 . . . . 0.0 110.653 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.8 115.43 6.58 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.498 0.719 . . . . 0.0 110.121 164.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.32 133.93 25.49 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 126.633 1.973 . . . . 0.0 109.463 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.2 155.96 60.08 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.201 1.934 . . . . 0.0 111.673 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -64.06 -17.62 63.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.91 -38.89 58.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.332 2.653 . . . . 0.0 114.316 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -71.58 -15.95 62.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.27 -45.41 3.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.635 1.174 . . . . 0.0 112.947 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 21.28 66.97 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 129.611 3.164 . . . . 0.0 115.043 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.41 -22.42 3.94 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.041 1.305 . . . . 0.0 115.601 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.55 132.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.247 1.523 . . . . 0.0 109.621 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.24 67.76 3.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.777 1.631 . . . . 0.0 112.613 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.66 148.05 17.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.713 1.605 . . . . 0.0 112.131 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -151.34 155.75 39.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.198 1.399 . . . . 0.0 111.189 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -71.81 21.94 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 54.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 120.95 -1.094 . . . . 0.0 113.578 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.8 ptm -132.29 151.58 51.77 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.991 1.317 . . . . 0.0 111.874 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 p -70.25 133.05 46.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.354 1.061 . . . . 0.0 111.245 167.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -135.72 156.95 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.149 1.78 . . . . 0.0 110.689 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -95.66 145.82 24.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.446 1.098 . . . . 0.0 111.902 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.18 95.44 0.37 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.692 1.615 . . . . 0.0 111.855 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -65.68 137.96 57.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 117.85 0.825 . . . . 0.0 111.123 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 t -116.93 155.15 29.6 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.942 1.697 . . . . 0.0 111.75 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.85 -15.44 58.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.177 1.791 . . . . 0.0 113.345 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.23 15.17 0.35 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.419 1.888 . . . . 0.0 113.769 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 55.54 46.74 22.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.368 2.267 . . . . 0.0 112.543 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -144.74 177.45 8.7 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.174 1.79 . . . . 0.0 112.218 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.7 m -145.37 120.32 10.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.667 1.187 . . . . 0.0 111.796 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -88.9 173.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.584 1.153 . . . . 0.0 112.053 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.7 133.97 46.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.219 1.408 . . . . 0.0 111.441 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.81 11.22 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.464 1.506 . . . . 0.0 112.052 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.95 131.95 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.639 1.176 . . . . 0.0 110.618 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.7 mt -70.55 134.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 120.821 -1.174 . . . . 0.0 111.059 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -94.73 -46.38 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.825 1.25 . . . . 0.0 112.065 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -146.81 156.87 43.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.284 1.434 . . . . 0.0 111.258 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.26 146.84 29.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.727 1.211 . . . . 0.0 112.331 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.3 t -152.97 169.41 22.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.272 1.829 . . . . 0.0 110.547 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.93 -27.26 67.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.192 0.997 . . . . 0.0 113.493 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -80.67 -66.42 0.89 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.789 2.036 . . . . 0.0 111.714 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -132.3 157.49 44.29 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.619 1.968 . . . . 0.0 111.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.41 150.32 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.95 2.1 . . . . 0.0 108.233 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.6 mtp -126.18 100.56 6.37 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.822 1.249 . . . . 0.0 109.992 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.3 m -99.29 151.72 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.287 1.035 . . . . 0.0 111.075 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.68 148.79 46.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.339 0.656 . . . . 0.0 111.187 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 N--CA 1.47 0.572 0 C-N-CA 125.264 1.426 . . . . 0.0 112.326 172.873 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.2 p -73.06 136.88 45.03 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 112.47 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.81 136.48 53.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.618 1.967 . . . . 0.0 110.736 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.31 105.25 17.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.685 1.194 . . . . 0.0 111.345 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.88 92.09 8.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 109.913 167.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -74.84 122.5 23.46 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 163.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -143.24 166.35 24.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.454 0.702 . . . . 0.0 112.03 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -151.2 145.67 25.56 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.462 0.705 . . . . 0.0 112.503 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.1 t -91.25 102.87 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.475 1.51 . . . . 0.0 108.715 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.17 -27.36 69.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.85 0.86 . . . . 0.0 111.6 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.41 -133.04 7.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 125.992 1.758 . . . . 0.0 110.899 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -150.37 162.89 39.67 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.842 1.257 . . . . 0.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 . . . . . 0 N--CA 1.472 0.641 0 C-N-CA 125.201 1.4 . . . . 0.0 111.269 171.021 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 111.628 0.232 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.96 113.31 21.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.383 1.073 . . . . 0.0 111.573 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.2 101.43 7.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 110.483 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.53 111.19 11.75 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.01 1.724 . . . . 0.0 110.043 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 pp -133.6 158.3 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.944 0.897 . . . . 0.0 111.968 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -137.65 138.34 39.36 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.501 1.521 . . . . 0.0 109.852 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -136.4 162.19 33.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.854 1.262 . . . . 0.0 113.796 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -144.83 160.24 41.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.074 2.149 . . . . 0.0 111.678 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.47 112.59 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.36 1.464 . . . . 0.0 110.451 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -114.62 154.52 28.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.995 2.118 . . . . 0.0 110.054 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.91 148.28 26.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.323 1.449 . . . . 0.0 111.567 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -70.68 94.03 0.98 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.831 -1.168 . . . . 0.0 111.253 166.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 -39.22 2.97 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.233 1.873 . . . . 0.0 114.894 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -73.44 149.84 42.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.502 1.151 . . . . 0.0 112.046 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m -69.37 -23.06 63.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.923 1.289 . . . . 0.0 113.776 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.65 153.47 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 113.296 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.94 128.14 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.838 1.655 . . . . 0.0 108.982 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.24 -51.95 7.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.144 0.578 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.09 160.07 43.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.185 1.794 . . . . 0.0 111.488 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -162.38 167.14 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.923 1.289 . . . . 0.0 113.138 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -130.72 13.77 5.37 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 164.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.0 mm -53.15 -59.99 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.578 1.551 . . . . 0.0 112.358 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -78.68 -16.17 57.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -172.6 3.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.063 2.145 . . . . 0.0 111.722 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.94 126.36 83.24 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.208 1.003 . . . . 0.0 110.97 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.31 162.75 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.135 2.557 . . . . 0.0 112.335 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.95 149.1 37.73 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.823 168.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -130.81 48.26 2.44 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.297 1.439 . . . . 0.0 110.939 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -69.33 163.11 25.84 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.357 -0.84 . . . . 0.0 113.14 -175.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 mm -116.61 137.34 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.672 1.589 . . . . 0.0 109.244 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.73 107.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.799 1.64 . . . . 0.0 111.908 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.63 -28.03 8.43 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.24 1.876 . . . . 0.0 114.311 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -58.35 -24.52 60.06 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.593 1.697 . . . . 0.0 113.735 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 40.55 60.43 1.88 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.422 2.689 . . . . 0.0 114.137 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -89.41 -17.44 28.79 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.72 170.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.933 1.293 . . . . 0.0 112.218 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 pt -63.26 147.1 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.459 -0.776 . . . . 0.0 111.863 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.93 -25.92 68.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.26 -40.69 98.16 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.859 -1.151 . . . . 0.0 112.991 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 tp -81.63 -25.45 35.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.717 1.607 . . . . 0.0 112.804 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -51.25 -49.39 61.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.779 1.632 . . . . 0.0 112.476 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -13.89 62.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.256 1.022 . . . . 0.0 113.708 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.54 -43.36 7.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.793 1.237 . . . . 0.0 112.968 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.46 -27.25 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.34 -17.43 63.7 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -103.79 -40.44 6.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.907 1.683 . . . . 0.0 113.328 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.58 134.36 56.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.183 0.993 . . . . 0.0 112.5 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.7 161.6 13.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.05 0.94 . . . . 0.0 112.282 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -54.49 124.49 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.394 1.078 . . . . 0.0 111.575 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.63 -0.28 77.2 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.234 1.397 . . . . 0.0 115.604 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -105.96 112.6 25.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.415 1.607 . . . . 0.0 111.551 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -57.49 144.73 35.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.54 0.736 . . . . 0.0 111.824 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -138.12 139.81 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.155 1.782 . . . . 0.0 109.96 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -130.45 110.39 11.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.208 1.403 . . . . 0.0 110.571 -173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -118.17 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.611 1.564 . . . . 0.0 110.778 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.81 123.05 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.898 0.879 . . . . 0.0 109.118 173.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.3 mt -127.87 130.4 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 109.294 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.2 145.3 97.47 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.785 0.834 . . . . 0.0 110.984 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.09 -32.55 91.71 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.884 1.722 . . . . 0.0 112.971 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -63.08 -20.7 65.59 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 CA--C 1.549 0.914 0 C-N-CA 125.206 1.402 . . . . 0.0 113.163 175.343 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.01 129.11 38.15 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 111.481 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -120.74 118.11 29.21 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.222 1.409 . . . . 0.0 110.153 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.95 130.27 42.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.163 0.985 . . . . 0.0 110.746 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.1 t -135.75 136.66 23.91 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.034 1.733 . . . . 0.0 109.15 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.63 157.83 54.93 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.637 2.225 . . . . 0.0 112.211 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -75.94 66.18 2.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.31 1.444 . . . . 0.0 111.876 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.38 -50.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.151 1.781 . . . . 0.0 112.245 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.84 -11.68 48.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -120.1 10.48 11.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.43 1.892 . . . . 0.0 113.718 -171.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -56.16 -27.99 56.4 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.371 1.468 . . . . 0.0 114.145 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.42 10.21 22.03 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.676 1.608 . . . . 0.0 116.367 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.8 pt -134.91 131.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.555 1.678 . . . . 0.0 112.893 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -75.92 137.64 40.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.168 1.387 . . . . 0.0 112.256 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.72 165.17 15.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.829 1.651 . . . . 0.0 112.655 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.21 155.5 30.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.017 1.727 . . . . 0.0 110.764 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -73.38 107.54 5.73 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.464 -1.397 . . . . 0.0 111.05 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.88 26.94 11.79 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.501 0.961 . . . . 0.0 115.501 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.1 ptm -99.73 153.26 19.25 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.883 1.342 . . . . 0.0 112.263 168.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 p -70.46 113.96 8.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.249 1.42 . . . . 0.0 111.157 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.15 161.19 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.896 1.678 . . . . 0.0 111.035 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -123.25 155.44 37.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.813 1.645 . . . . 0.0 111.878 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.58 105.51 0.29 Allowed Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.361 0.982 . . . . 0.0 113.341 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.0 111.57 7.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.926 1.29 . . . . 0.0 111.894 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.9 t -80.55 159.7 25.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.102 1.361 . . . . 0.0 111.897 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.04 -15.52 62.43 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.048 1.339 . . . . 0.0 113.366 173.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.44 18.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.757 1.623 . . . . 0.0 113.966 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 51.83 44.01 29.68 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.474 2.31 . . . . 0.0 113.077 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -140.98 172.33 12.83 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.286 1.834 . . . . 0.0 111.533 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.0 m -141.53 107.62 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.04 1.336 . . . . 0.0 110.521 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.59 167.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.972 -0.455 . . . . 0.0 111.41 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -132.41 136.22 46.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.082 1.353 . . . . 0.0 111.284 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.4 -179.53 8.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.816 1.246 . . . . 0.0 112.798 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.81 132.72 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.204 1.401 . . . . 0.0 110.61 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.63 122.46 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.9 1.28 . . . . 0.0 110.571 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -90.27 -38.02 13.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.705 1.202 . . . . 0.0 113.08 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -153.35 154.67 34.98 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.337 1.455 . . . . 0.0 111.571 170.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.07 145.83 30.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 113.388 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.4 m -148.3 173.68 12.79 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.771 2.028 . . . . 0.0 111.379 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.82 -21.99 61.62 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.9 p -83.52 -61.62 1.79 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.075 1.75 . . . . 0.0 111.924 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -136.62 169.31 17.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.628 2.371 . . . . 0.0 111.056 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.76 154.91 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.148 1.779 . . . . 0.0 109.888 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.0 mtp -130.22 101.27 5.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.518 1.527 . . . . 0.0 109.969 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.9 t -109.66 147.78 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.209 1.404 . . . . 0.0 109.371 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.89 134.01 54.36 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.758 -0.589 . . . . 0.0 111.158 168.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 125.365 1.466 . . . . 0.0 111.754 178.477 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 147.09 53.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.363 1.865 . . . . 0.0 113.597 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.8 mp -122.56 160.84 24.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.59 103.36 13.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.999 1.72 . . . . 0.0 111.161 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -82.41 109.99 17.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.601 0.76 . . . . 0.0 109.576 166.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -110.49 138.9 46.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.216 1.006 . . . . 0.0 110.129 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.94 170.0 20.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.417 0.687 . . . . 0.0 112.756 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -146.04 146.65 31.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 111.237 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.5 105.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.696 1.198 . . . . 0.0 108.742 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.17 -26.41 56.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.487 1.115 . . . . 0.0 112.453 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.89 -168.0 33.84 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -132.8 130.5 39.96 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.762 1.625 . . . . 0.0 110.225 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 124.938 1.295 . . . . 0.0 110.149 -177.331 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.09 98.72 9.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.019 1.328 . . . . 0.0 110.859 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.68 128.59 34.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.3 1.44 . . . . 0.0 111.327 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.72 134.7 43.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.166 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 pt -127.98 162.6 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.887 1.275 . . . . 0.0 112.247 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -138.64 131.45 29.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.509 1.924 . . . . 0.0 109.458 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -137.05 153.94 50.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.728 1.211 . . . . 0.0 113.784 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -143.68 133.93 24.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.907 2.483 . . . . 0.0 110.144 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.2 103.14 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -110.53 147.32 34.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.961 2.104 . . . . 0.0 110.906 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -76.68 141.64 40.87 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.409 -0.807 . . . . 0.0 111.872 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.6 93.45 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.779 0.832 . . . . 0.0 111.549 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.06 -54.65 0.7 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.247 1.88 . . . . 0.0 113.713 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 t -68.48 154.68 41.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -79.06 -20.67 48.27 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.258 1.423 . . . . 0.0 113.308 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.98 155.72 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.439 -0.788 . . . . 0.0 111.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.52 131.13 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.498 1.519 . . . . 0.0 110.082 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.8 mt -73.18 -55.1 6.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.503 0.721 . . . . 0.0 111.409 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.28 155.87 34.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.319 1.448 . . . . 0.0 110.922 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.4 p -148.26 126.03 11.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.266 1.026 . . . . 0.0 111.926 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -88.09 -29.65 20.47 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.199 0.6 . . . . 0.0 112.363 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -51.8 -51.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.013 1.725 . . . . 0.0 112.296 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -69.7 -14.99 63.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.497 1.119 . . . . 0.0 113.754 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -92.01 -72.17 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.812 1.645 . . . . 0.0 110.6 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -167.1 154.43 8.43 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.679 1.992 . . . . 0.0 111.623 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.31 146.38 69.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.439 2.092 . . . . 0.0 111.478 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 tp -87.52 130.55 34.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.857 1.263 . . . . 0.0 109.723 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.02 138.18 49.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.922 0.889 . . . . 0.0 112.649 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -153.04 163.02 40.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.189 1.396 . . . . 0.0 111.86 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.24 141.2 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -47.57 109.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.549 1.54 . . . . 0.0 111.163 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.4 -5.02 31.4 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.698 1.618 . . . . 0.0 115.916 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.9 m -57.04 -32.17 65.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.122 1.961 . . . . 0.0 113.665 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 47.31 62.5 2.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.589 1.956 . . . . 0.0 113.55 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.07 -20.83 13.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 pt -74.53 170.79 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.177 1.791 . . . . 0.0 112.611 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.9 pt -59.73 145.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.966 0.906 . . . . 0.0 111.781 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.69 75.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.6 98.75 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 121.552 -0.718 . . . . 0.0 113.029 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.5 tp -77.33 -34.19 55.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.616 1.166 . . . . 0.0 112.24 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.0 tp10 -56.74 -38.67 72.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.452 1.101 . . . . 0.0 112.668 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -78.82 -14.27 59.35 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.26 9.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.171 . . . . 0.0 112.501 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -59.3 -27.53 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.87 -20.41 66.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.63 -13.27 16.02 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.74 . . . . 0.0 113.121 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.44 132.58 50.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.598 1.159 . . . . 0.0 112.76 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -91.85 130.47 37.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 111.195 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.76 126.74 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.8 1.24 . . . . 0.0 111.674 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.64 9.03 87.26 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.13 119.03 29.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.383 1.591 . . . . 0.0 111.773 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -62.72 139.64 58.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.572 0.749 . . . . 0.0 111.465 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -141.93 160.49 40.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.457 1.103 . . . . 0.0 112.282 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.1 107.91 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 109.951 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -110.69 116.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.83 1.252 . . . . 0.0 110.097 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.8 110.77 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.449 -0.782 . . . . 0.0 109.376 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.9 139.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.089 1.756 . . . . 0.0 109.47 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.63 151.24 88.83 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.859 0.864 . . . . 0.0 112.244 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.73 -39.22 75.23 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.357 2.704 . . . . 0.0 112.472 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.64 -9.16 40.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.425 1.89 . . . . 0.0 114.205 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 125.828 1.651 . . . . 0.0 113.191 -179.09 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.549 0.923 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.3 mt -145.7 137.91 25.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.63 1.972 . . . . 0.0 110.991 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -144.2 127.99 17.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.15 0.58 . . . . 0.0 111.872 169.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -76.37 98.34 4.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.74 1.216 . . . . 0.0 110.425 167.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.31 156.6 38.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.424 1.889 . . . . 0.0 110.849 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 152.12 59.88 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.177 1.918 . . . . 0.0 111.771 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.4 -23.39 65.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.972 . . . . 0.0 113.15 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -51.01 -36.42 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.376 1.87 . . . . 0.0 113.789 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -66.49 -19.47 65.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.5 1.12 . . . . 0.0 113.564 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -133.28 17.84 4.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.307 1.843 . . . . 0.0 113.008 -172.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -57.43 -24.9 58.38 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.889 1.676 . . . . 0.0 114.438 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -113.57 17.43 20.94 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 126.24 1.876 . . . . 0.0 115.342 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.6 mt -123.49 123.55 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.316 1.558 . . . . 0.0 111.242 -170.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.74 77.34 2.06 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.055 1.742 . . . . 0.0 113.182 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.91 153.51 40.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.232 1.013 . . . . 0.0 112.759 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.99 137.29 18.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.105 1.362 . . . . 0.0 111.11 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -58.27 114.52 2.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.158 0.983 . . . . 0.0 110.93 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.54 20.94 11.05 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -108.93 161.3 15.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.277 1.538 . . . . 0.0 112.149 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.6 t -88.97 116.14 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.399 1.08 . . . . 0.0 110.967 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.0 160.92 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.896 1.678 . . . . 0.0 110.936 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -115.75 140.73 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.85 1.26 . . . . 0.0 111.823 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.75 93.34 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.575 1.559 . . . . 0.0 112.164 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -65.95 147.1 53.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.793 -0.828 . . . . 0.0 111.506 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -130.69 157.48 42.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.819 1.648 . . . . 0.0 112.302 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.35 -15.83 61.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.402 1.881 . . . . 0.0 113.689 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.38 14.75 0.41 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.162 1.785 . . . . 0.0 113.825 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 54.62 46.91 23.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.164 2.186 . . . . 0.0 112.556 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -140.94 173.21 11.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.987 1.715 . . . . 0.0 112.192 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 m -145.03 112.98 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 111.273 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -76.57 165.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.15 0.58 . . . . 0.0 111.482 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -123.18 139.96 53.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.274 1.43 . . . . 0.0 110.396 170.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.55 173.57 15.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.313 1.045 . . . . 0.0 113.144 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.81 135.97 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.076 1.351 . . . . 0.0 110.166 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 mm -67.06 117.96 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.974 1.309 . . . . 0.0 109.585 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -101.01 -36.11 9.13 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.699 1.2 . . . . 0.0 112.222 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.14 163.61 39.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.756 1.622 . . . . 0.0 111.8 166.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.08 158.46 43.59 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.329 1.052 . . . . 0.0 111.928 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 t -144.26 175.4 10.12 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.413 1.885 . . . . 0.0 111.202 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.61 69.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.144 1.377 . . . . 0.0 113.893 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -130.57 -9.69 4.06 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.184 1.394 . . . . 0.0 114.748 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -143.92 164.71 29.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.134 1.774 . . . . 0.0 111.821 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.4 t -140.24 141.96 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.657 1.583 . . . . 0.0 109.893 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.7 mtp -113.43 114.12 26.14 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.232 1.413 . . . . 0.0 111.104 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 t -121.46 153.05 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 109.964 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.73 107.25 0.67 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.824 1.249 . . . . 0.0 112.071 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.47 0.539 0 C-N-CA 124.863 1.265 . . . . 0.0 111.323 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.98 141.95 45.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.26 1.424 . . . . 0.0 112.628 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.14 146.57 49.89 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.182 1.393 . . . . 0.0 111.886 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.01 103.68 16.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.512 1.525 . . . . 0.0 111.506 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.42 98.41 9.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.998 0.904 . . . . 0.0 109.851 167.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.51 123.5 32.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.461 1.504 . . . . 0.0 109.483 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.45 171.81 14.92 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -152.11 150.32 29.77 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.015 1.726 . . . . 0.0 111.576 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.9 112.54 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.357 1.463 . . . . 0.0 108.506 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.34 -33.58 76.06 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.133 0.973 . . . . 0.0 111.514 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 132.38 -168.79 22.51 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 126.358 1.933 . . . . 0.0 111.09 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -136.05 153.62 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.678 1.191 . . . . 0.0 111.982 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 125.096 1.358 . . . . 0.0 110.682 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.623 0 CA-C-O 120.297 0.094 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.24 118.99 38.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.122 0.969 . . . . 0.0 110.902 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.7 118.92 23.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.881 1.672 . . . . 0.0 110.902 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.44 131.3 37.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.072 0.949 . . . . 0.0 111.32 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -130.52 167.91 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.695 1.198 . . . . 0.0 112.303 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.35 133.5 33.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.43 1.892 . . . . 0.0 110.52 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -139.16 150.3 45.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 123.002 1.382 . . . . 0.0 113.934 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.32 136.96 26.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.927 2.091 . . . . 0.0 109.708 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.24 105.15 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.09 1.356 . . . . 0.0 110.397 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -113.23 147.47 37.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.342 1.857 . . . . 0.0 110.533 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.84 140.57 53.26 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.65 -0.656 . . . . 0.0 111.293 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.71 -34.87 78.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.864 -1.148 . . . . 0.0 113.846 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.85 55.72 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.992 1.282 . . . . 0.0 115.426 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.4 t -145.91 144.53 30.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.783 1.233 . . . . 0.0 111.283 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -73.38 -11.83 60.61 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.69 159.46 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.139 0.976 . . . . 0.0 111.991 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.1 p -108.79 145.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.185 1.394 . . . . 0.0 110.898 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.88 -44.11 7.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.325 1.05 . . . . 0.0 111.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.5 157.57 38.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 112.423 170.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -161.21 128.21 4.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.882 1.273 . . . . 0.0 111.341 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -16.44 40.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 167.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.07 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.897 1.279 . . . . 0.0 111.827 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -70.98 -9.64 58.34 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.81 1.244 . . . . 0.0 113.606 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -104.27 -75.8 0.61 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.409 1.883 . . . . 0.0 110.909 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -168.1 148.98 4.63 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.637 2.375 . . . . 0.0 110.579 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.47 149.28 74.52 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.892 2.394 . . . . 0.0 112.9 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.9 tp -80.52 123.97 28.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.162 0.985 . . . . 0.0 109.806 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.99 131.69 56.02 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.696 1.198 . . . . 0.0 112.253 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.93 165.12 35.58 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.435 1.094 . . . . 0.0 112.657 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -96.42 143.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.125 1.37 . . . . 0.0 109.12 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.05 113.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.643 1.577 . . . . 0.0 111.608 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 62.91 0.63 Allowed Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.788 1.661 . . . . 0.0 113.114 -174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.9 m -134.27 -49.61 0.79 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.691 1.596 . . . . 0.0 111.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.5 m120 58.89 29.37 18.77 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.232 1.813 . . . . 0.0 115.287 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -70.79 -19.88 62.65 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.25 166.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 112.751 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 pt -62.48 157.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.075 0.95 . . . . 0.0 113.389 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.22 80.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.655 1.182 . . . . 0.0 113.716 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.33 -46.59 93.57 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.033 0.825 . . . . 0.0 112.841 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -69.04 -34.91 75.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 111.772 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -56.02 -35.38 66.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.105 1.362 . . . . 0.0 113.449 171.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -80.37 3.24 21.84 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.1 -33.69 3.87 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.348 1.459 . . . . 0.0 113.392 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -58.47 -28.63 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.872 -1.143 . . . . 0.0 113.929 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -71.11 -23.06 62.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -94.84 -27.58 15.67 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.344 1.858 . . . . 0.0 112.478 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.25 118.9 4.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.717 2.007 . . . . 0.0 113.474 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -80.11 145.62 32.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 111.483 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.24 132.4 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.879 0.872 . . . . 0.0 111.195 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.53 6.49 86.74 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.194 1.237 . . . . 0.0 116.194 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -118.62 114.26 22.5 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.881 1.672 . . . . 0.0 111.403 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -62.4 140.67 58.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.076 0.551 . . . . 0.0 111.305 169.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -142.42 162.11 36.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.49 1.116 . . . . 0.0 112.447 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -130.46 112.78 13.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.778 1.631 . . . . 0.0 109.844 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.92 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.341 1.456 . . . . 0.0 109.82 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 t -73.9 120.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.055 0.942 . . . . 0.0 110.046 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.3 mm -105.15 142.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.401 1.481 . . . . 0.0 110.061 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.87 156.94 85.93 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.693 1.197 . . . . 0.0 112.789 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.27 -11.92 27.77 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.461 2.774 . . . . 0.0 114.97 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -106.58 -9.35 16.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.094 1.358 . . . . 0.0 113.809 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 . . . . . 0 N--CA 1.479 0.986 0 C-N-CA 124.983 1.313 . . . . 0.0 113.081 -176.633 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 p90 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.06 107.08 9.16 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.849 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -85.12 131.99 34.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.838 1.255 . . . . 0.0 111.014 171.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -84.76 100.51 11.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.504 1.522 . . . . 0.0 110.238 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.1 137.3 20.83 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 124.932 1.293 . . . . 0.0 109.569 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.79 157.73 51.4 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 0.0 112.638 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.69 72.99 2.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.338 1.055 . . . . 0.0 111.454 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.42 -50.14 0.92 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.434 1.894 . . . . 0.0 111.452 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -65.26 -13.7 58.99 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.75 19.7 5.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.405 1.482 . . . . 0.0 114.461 -166.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.82 -25.48 63.78 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.86 9.04 37.02 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.126 1.346 . . . . 0.0 115.613 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.67 129.67 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.156 1.783 . . . . 0.0 111.04 -173.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -77.03 58.03 1.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.573 1.949 . . . . 0.0 112.556 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -61.29 157.21 16.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.991 1.317 . . . . 0.0 113.098 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -153.25 155.28 36.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.761 0.824 . . . . 0.0 112.524 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -60.05 113.56 2.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.937 1.295 . . . . 0.0 111.037 174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.74 4.8 24.47 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.921 1.528 . . . . 0.0 116.921 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.4 ptm -101.63 154.26 19.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.97 1.885 . . . . 0.0 113.034 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 p -72.17 94.86 1.59 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.15 1.78 . . . . 0.0 111.657 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -82.2 156.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.443 1.497 . . . . 0.0 111.618 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.86 143.38 49.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.585 1.554 . . . . 0.0 110.694 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.05 99.14 0.36 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.772 1.177 . . . . 0.0 112.17 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -67.52 143.54 56.1 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.114 -0.639 . . . . 0.0 111.195 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -123.1 154.35 38.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.867 1.667 . . . . 0.0 111.457 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.44 -20.83 65.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.552 1.541 . . . . 0.0 113.164 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.67 19.88 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.097 2.159 . . . . 0.0 114.22 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.7 m120 52.52 47.97 23.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.391 2.276 . . . . 0.0 113.04 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -140.6 172.28 12.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.959 1.703 . . . . 0.0 112.108 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.4 m -143.48 118.47 10.02 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.94 1.296 . . . . 0.0 111.012 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.82 162.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.727 0.811 . . . . 0.0 111.259 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -134.06 128.36 34.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.572 1.549 . . . . 0.0 111.147 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.28 -175.65 5.54 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.34 1.456 . . . . 0.0 112.564 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.15 136.84 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 110.034 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.1 mt -68.11 133.08 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.396 1.478 . . . . 0.0 111.005 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -108.22 -37.99 5.87 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.146 1.379 . . . . 0.0 112.886 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.55 157.89 42.83 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.399 1.08 . . . . 0.0 111.482 166.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.24 143.44 28.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.241 -0.912 . . . . 0.0 113.204 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 70.3 m -141.04 168.69 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.876 2.07 . . . . 0.0 110.584 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.15 -25.87 67.17 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 121.203 -0.935 . . . . 0.0 113.211 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -81.18 -60.18 2.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.952 2.101 . . . . 0.0 112.988 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -140.65 168.88 18.75 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.288 2.235 . . . . 0.0 111.781 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.69 132.96 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.54 1.536 . . . . 0.0 111.553 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.7 mtp -101.82 115.25 30.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.185 1.794 . . . . 0.0 110.803 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.57 136.41 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.738 1.615 . . . . 0.0 110.872 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.94 111.81 5.91 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.344 0.658 . . . . 0.0 111.484 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 126.778 2.031 . . . . 0.0 111.467 -174.61 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.2 p -65.27 146.64 54.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.124 1.369 . . . . 0.0 113.039 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.17 131.57 44.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.687 -170.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.42 98.97 12.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.149 0.98 . . . . 0.0 111.652 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.23 103.14 10.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.758 0.79 . . . . 0.0 110.328 166.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -94.68 124.18 38.56 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.445 1.898 . . . . 0.0 109.336 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -148.82 170.65 17.78 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -154.33 147.43 24.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.98 1.712 . . . . 0.0 112.14 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 9.8 t -83.79 108.09 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.819 1.248 . . . . 0.0 108.727 163.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.1 mt -65.67 -39.48 91.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.888 -0.508 . . . . 0.0 111.492 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.76 -179.22 18.45 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.579 1.561 . . . . 0.0 113.496 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -96.57 147.68 23.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.968 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 . . . . . 0 N--CA 1.477 0.925 0 C-N-CA 124.979 1.312 . . . . 0.0 112.438 172.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.177 0.037 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 103.94 11.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.917 0.887 . . . . 0.0 110.893 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.53 120.81 18.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.539 1.536 . . . . 0.0 110.573 168.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.18 124.2 47.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.2 pt -131.35 163.62 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.661 1.184 . . . . 0.0 112.289 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -136.79 138.66 41.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.601 1.96 . . . . 0.0 109.831 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.77 151.93 44.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.066 1.346 . . . . 0.0 114.272 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -146.87 120.65 9.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.615 2.366 . . . . 0.0 110.315 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -99.94 110.28 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.858 1.663 . . . . 0.0 110.429 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 ttm105 -113.78 144.84 42.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.297 1.839 . . . . 0.0 110.694 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.79 117.33 11.25 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.84 105.33 0.55 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.571 0.748 . . . . 0.0 110.667 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.01 23.64 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 126.173 1.844 . . . . 0.0 115.169 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -137.05 165.84 25.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.332 1.566 . . . . 0.0 113.271 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.1 p -89.5 -13.47 37.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.737 2.015 . . . . 0.0 114.755 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.23 177.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 113.661 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.85 145.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.209 1.404 . . . . 0.0 110.121 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mp -106.57 -53.45 2.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.649 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.29 150.22 35.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.406 1.483 . . . . 0.0 110.381 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.6 p -163.01 169.61 19.31 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.158 -0.964 . . . . 0.0 111.694 173.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -122.72 -12.74 8.04 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -36.8 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 124.281 1.032 . . . . 0.0 112.217 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -73.1 -5.7 40.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.591 1.156 . . . . 0.0 113.601 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -117.59 -87.97 0.61 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.902 2.081 . . . . 0.0 110.367 -171.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -153.38 154.09 30.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 127.419 2.288 . . . . 0.0 111.272 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.35 150.69 86.89 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.596 2.864 . . . . 0.0 113.269 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -87.6 123.7 32.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.432 1.493 . . . . 0.0 109.774 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.15 134.58 50.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 111.533 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -150.12 172.58 15.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.499 1.119 . . . . 0.0 112.918 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.21 151.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.339 1.455 . . . . 0.0 109.195 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.85 109.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.509 1.124 . . . . 0.0 111.009 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.08 27.06 6.38 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.526 1.37 . . . . 0.0 116.526 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.3 m -97.06 -24.1 15.94 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 119.39 1.595 . . . . 0.0 114.355 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.3 t30 45.73 43.13 9.37 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.915 2.086 . . . . 0.0 115.092 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -71.77 -31.14 66.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.4 1.88 . . . . 0.0 114.155 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -72.41 166.87 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.866 1.267 . . . . 0.0 111.517 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 pt -63.15 146.36 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 0.0 111.413 172.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.9 75.76 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.07 -31.06 67.94 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.005 0.812 . . . . 0.0 113.913 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.25 -29.66 24.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.836 1.255 . . . . 0.0 112.307 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.09 -38.23 82.32 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.01 -1.056 . . . . 0.0 112.021 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -68.03 0.24 3.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.835 1.254 . . . . 0.0 114.312 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.39 -41.82 3.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.617 1.567 . . . . 0.0 113.167 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.71 -29.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.64 -10.39 55.85 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -118.96 -17.95 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.925 1.69 . . . . 0.0 114.549 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.95 141.62 49.43 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.309 0.959 . . . . 0.0 112.345 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -90.28 158.22 17.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.719 1.207 . . . . 0.0 111.779 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.03 129.75 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.179 0.992 . . . . 0.0 111.307 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.68 3.88 74.21 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.831 1.205 . . . . 0.0 115.692 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.63 111.95 24.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.181 1.491 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -55.93 139.66 45.48 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.766 0.826 . . . . 0.0 111.723 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -137.11 149.15 47.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.57 1.548 . . . . 0.0 110.275 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -134.71 104.74 6.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.449 1.099 . . . . 0.0 110.348 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.19 118.66 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.083 1.353 . . . . 0.0 110.359 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.0 t -75.83 121.32 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 109.59 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.55 144.46 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.953 1.701 . . . . 0.0 109.822 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.02 92.83 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.814 1.246 . . . . 0.0 112.55 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.81 -33.9 41.92 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.538 2.159 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -31.64 72.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.923 0.889 . . . . 0.0 113.265 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 125.322 1.449 . . . . 0.0 113.177 177.559 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.66 147.23 30.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.149 2.58 . . . . 0.0 109.563 166.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -145.53 117.45 8.24 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.172 1.389 . . . . 0.0 110.416 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.11 118.45 15.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.955 0.902 . . . . 0.0 111.133 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.56 158.73 69.02 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 127.243 2.217 . . . . 0.0 110.978 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 149.3 64.43 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.154 1.902 . . . . 0.0 110.958 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -62.26 -20.31 64.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.533 0.733 . . . . 0.0 112.958 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -52.07 -32.19 33.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.997 1.719 . . . . 0.0 113.72 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -64.76 -18.16 64.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.517 1.127 . . . . 0.0 113.344 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.88 18.32 6.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.045 2.138 . . . . 0.0 112.915 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -53.34 108.61 0.35 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.61 1.564 . . . . 0.0 112.164 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.66 -5.11 34.82 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.826 1.679 . . . . 0.0 115.434 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mt -101.5 130.98 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.44 1.496 . . . . 0.0 110.375 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.76 89.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.489 1.116 . . . . 0.0 111.468 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.5 158.28 36.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.279 1.032 . . . . 0.0 111.777 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -155.33 145.81 22.05 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.732 1.213 . . . . 0.0 111.288 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -73.21 83.02 1.35 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.165 0.986 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.77 46.25 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.362 1.458 . . . . 0.0 113.87 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ppp? -129.01 148.7 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.199 1.4 . . . . 0.0 111.109 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 p -76.68 108.35 9.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.872 1.669 . . . . 0.0 111.479 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.1 156.79 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.668 1.587 . . . . 0.0 110.679 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -121.24 154.63 36.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.662 1.185 . . . . 0.0 111.068 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.68 106.23 0.41 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.344 0.973 . . . . 0.0 113.217 -173.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -74.55 114.05 12.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.462 1.105 . . . . 0.0 111.932 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -84.95 159.2 20.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.166 1.386 . . . . 0.0 112.122 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.46 -18.46 63.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.225 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.19 10.71 0.28 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 113.897 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 55.41 46.35 23.47 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.155 2.182 . . . . 0.0 111.956 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -141.22 171.13 14.48 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.795 2.038 . . . . 0.0 111.167 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 m -140.74 108.06 5.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.497 1.119 . . . . 0.0 110.697 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.42 165.88 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.832 -0.543 . . . . 0.0 111.29 176.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -129.16 131.11 47.11 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.971 1.308 . . . . 0.0 110.592 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.36 177.91 9.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.803 1.241 . . . . 0.0 113.59 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.89 135.59 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.628 1.571 . . . . 0.0 109.903 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.93 120.94 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.313 1.045 . . . . 0.0 110.22 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -87.69 -38.07 16.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.878 1.271 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.54 152.74 37.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.932 1.293 . . . . 0.0 111.63 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -146.78 142.56 27.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.094 0.957 . . . . 0.0 112.601 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.0 t -153.51 169.42 23.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.137 2.175 . . . . 0.0 110.125 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.71 -28.29 68.32 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.123 0.969 . . . . 0.0 113.408 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.6 p -79.56 -60.66 2.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.135 1.774 . . . . 0.0 111.852 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -134.16 156.94 47.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.371 1.868 . . . . 0.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.6 142.0 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.622 1.969 . . . . 0.0 108.566 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.9 mtp -121.94 98.87 6.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.997 1.319 . . . . 0.0 110.161 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.62 148.0 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.642 1.177 . . . . 0.0 109.849 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -62.99 110.4 1.78 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.36 0.664 . . . . 0.0 111.669 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.181 1.393 . . . . 0.0 109.422 171.222 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.162 0.506 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.01 146.6 37.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.39 1.876 . . . . 0.0 113.13 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.9 mt -128.36 140.32 51.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.685 1.594 . . . . 0.0 110.941 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.88 94.31 5.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.023 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.48 92.68 3.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.503 1.121 . . . . 0.0 109.697 167.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 -75.48 139.46 42.24 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.86 171.06 17.82 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -150.23 146.2 26.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.028 1.331 . . . . 0.0 111.36 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.21 104.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.536 1.134 . . . . 0.0 109.119 167.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.71 -24.52 58.77 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 112.338 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.29 -167.43 25.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.047 1.308 . . . . 0.0 113.907 171.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.43 145.96 49.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 110.626 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 113.132 175.825 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.3 104.89 7.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.253 1.021 . . . . 0.0 109.63 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.08 141.21 37.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.657 1.183 . . . . 0.0 110.671 169.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.25 133.49 47.54 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.391 1.476 . . . . 0.0 110.599 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 pt -134.35 163.98 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.869 1.268 . . . . 0.0 111.544 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -137.84 135.81 36.57 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.168 1.387 . . . . 0.0 109.699 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -134.09 158.99 42.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 123.067 1.413 . . . . 0.0 114.368 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -141.04 120.83 13.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.961 2.904 . . . . 0.0 108.259 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -100.71 105.69 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.446 1.117 . . . . 0.0 109.93 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 ttp85 -118.57 153.16 34.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.202 2.201 . . . . 0.0 109.717 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.5 146.33 50.32 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.316 -0.865 . . . . 0.0 110.836 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -70.52 -33.11 70.81 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.881 -1.137 . . . . 0.0 112.434 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.45 -35.67 7.84 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.352 0.977 . . . . 0.0 115.017 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -116.92 151.07 37.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.319 1.448 . . . . 0.0 112.604 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 t -73.1 -7.52 51.71 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.95 151.11 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 120.892 -1.13 . . . . 0.0 112.372 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.43 126.97 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.226 1.41 . . . . 0.0 109.843 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -84.58 -42.89 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.777 0.831 . . . . 0.0 110.818 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -158.49 163.4 37.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.3 1.84 . . . . 0.0 110.767 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -166.65 150.57 7.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.071 1.348 . . . . 0.0 112.131 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -124.55 4.26 8.29 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -47.98 -64.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.234 1.414 . . . . 0.0 112.079 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 t -79.9 -23.67 41.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.256 1.023 . . . . 0.0 113.368 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -69.64 -71.61 0.22 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.884 1.674 . . . . 0.0 112.056 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -165.63 140.0 3.88 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.099 1.759 . . . . 0.0 110.876 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.41 152.48 75.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.666 2.244 . . . . 0.0 112.698 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.8 tp -83.07 97.68 8.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.222 1.809 . . . . 0.0 110.294 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -74.08 129.85 38.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.368 1.467 . . . . 0.0 111.923 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -149.43 176.49 10.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.967 1.307 . . . . 0.0 112.846 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.0 mm -112.43 134.87 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.469 1.508 . . . . 0.0 109.385 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.0 mm -50.09 117.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.332 1.453 . . . . 0.0 110.956 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.26 71.6 1.12 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.014 1.293 . . . . 0.0 112.044 -169.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -134.6 -43.9 0.75 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.049 1.34 . . . . 0.0 113.344 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 54.09 21.14 2.82 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 126.721 2.008 . . . . 0.0 115.097 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 pt -71.66 165.75 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 112.469 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.29 142.65 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.729 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.8 82.4 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.4 -28.72 69.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.48 -0.763 . . . . 0.0 113.992 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 tp -87.15 -35.39 18.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.044 1.338 . . . . 0.0 111.898 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.36 -46.42 69.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.718 1.207 . . . . 0.0 111.415 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -77.91 13.63 1.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.011 1.324 . . . . 0.0 114.143 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.59 -39.92 2.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.714 1.606 . . . . 0.0 113.616 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.22 -29.1 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -67.26 -14.32 62.81 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -118.69 -9.5 10.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.416 1.486 . . . . 0.0 114.112 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.85 8.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.212 1.405 . . . . 0.0 111.61 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -62.47 145.73 53.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.705 0.802 . . . . 0.0 112.117 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.75 133.41 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.664 0.786 . . . . 0.0 110.691 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 10.39 56.55 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 115.709 1.044 . . . . 0.0 115.709 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.91 128.13 54.13 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.448 1.499 . . . . 0.0 111.281 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -57.93 140.91 51.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.021 0.928 . . . . 0.0 112.243 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -134.12 141.51 47.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.795 2.038 . . . . 0.0 109.864 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.17 106.75 6.9 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.55 113.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.757 1.223 . . . . 0.0 111.711 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.96 123.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 109.554 173.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.4 mt -128.73 135.71 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.92 1.288 . . . . 0.0 109.489 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.6 161.46 59.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 125.703 1.601 . . . . 0.0 112.623 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 42.41 0.76 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 125.18 3.92 . . . . 0.0 113.872 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.42 -35.77 1.94 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.877 2.071 . . . . 0.0 113.057 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 . . . . . 0 N--CA 1.477 0.89 0 C-N-CA 124.317 1.047 . . . . 0.0 113.617 174.658 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.345 0.593 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.53 166.75 24.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.674 1.589 . . . . 0.0 111.903 172.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -144.86 131.14 19.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.502 1.121 . . . . 0.0 110.983 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -70.04 128.57 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.794 0.838 . . . . 0.0 110.923 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.05 137.73 18.55 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.299 1.84 . . . . 0.0 109.903 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.73 172.66 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.017 2.478 . . . . 0.0 113.122 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -69.5 70.26 0.28 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.471 1.908 . . . . 0.0 111.901 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -129.19 -64.39 0.91 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.591 1.956 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -64.12 -16.39 61.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.906 1.283 . . . . 0.0 113.653 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -131.69 13.88 4.9 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.968 1.707 . . . . 0.0 113.422 -172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.61 -28.59 65.76 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.699 -1.251 . . . . 0.0 113.435 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.89 12.55 56.21 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.844 1.688 . . . . 0.0 115.047 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.75 115.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.509 1.524 . . . . 0.0 110.257 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.3 108.48 4.22 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.297 -0.877 . . . . 0.0 111.629 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.0 mt -101.63 156.99 17.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.368 1.467 . . . . 0.0 111.814 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.17 145.23 17.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.019 1.728 . . . . 0.0 109.863 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -51.87 128.35 23.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.772 0.829 . . . . 0.0 111.943 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 56.12 3.47 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.27 0.938 . . . . 0.0 114.327 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.1 ptp -132.27 172.45 12.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.116 1.766 . . . . 0.0 110.931 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 t -101.94 103.91 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.022 0.929 . . . . 0.0 110.452 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.28 154.44 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.153 1.381 . . . . 0.0 110.331 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -120.27 153.58 36.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.49 1.116 . . . . 0.0 111.944 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 97.52 0.23 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.73 1.157 . . . . 0.0 112.742 -175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.71 142.67 58.35 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.874 -0.78 . . . . 0.0 111.38 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.0 t -126.09 157.12 38.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.909 1.683 . . . . 0.0 111.607 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.95 -15.15 61.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.071 1.748 . . . . 0.0 113.509 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -76.41 15.63 0.58 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.609 1.963 . . . . 0.0 113.721 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.6 m120 56.73 39.95 29.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.878 2.071 . . . . 0.0 113.136 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -133.67 172.56 12.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.686 1.995 . . . . 0.0 111.409 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.6 m -142.44 114.73 8.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.351 1.46 . . . . 0.0 110.427 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -72.57 163.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.015 0.526 . . . . 0.0 111.166 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -133.49 132.95 41.62 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.046 1.338 . . . . 0.0 110.901 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.96 175.33 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.613 1.565 . . . . 0.0 112.814 -166.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.427 ' H ' ' HB3' ' A' ' 125' ' ' ASP . 4.8 mp -121.46 142.76 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.705 1.602 . . . . 0.0 110.625 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.76 113.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.575 1.15 . . . . 0.0 109.856 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.96 -30.41 15.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.915 1.286 . . . . 0.0 113.429 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -155.38 155.55 33.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.947 1.699 . . . . 0.0 110.581 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -147.26 147.72 30.71 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.21 0.914 . . . . 0.0 113.253 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.0 t -153.17 171.91 17.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.737 2.015 . . . . 0.0 110.975 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.31 -21.98 61.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.63 1.172 . . . . 0.0 113.558 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.4 p -82.55 -63.6 1.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 111.724 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -135.22 165.17 26.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.325 2.25 . . . . 0.0 111.339 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.48 154.13 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.179 1.792 . . . . 0.0 109.798 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 80.2 mtp -125.77 103.98 8.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.159 1.384 . . . . 0.0 110.421 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -99.54 141.62 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.134 1.373 . . . . 0.0 109.627 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 113' ' ' ILE . 13.9 t70 -62.08 140.04 58.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.946 1.298 . . . . 0.0 111.436 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 124.686 1.194 . . . . 0.0 111.946 175.536 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -63.34 139.47 58.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.489 1.516 . . . . 0.0 112.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.4 148.04 46.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.279 1.432 . . . . 0.0 111.15 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -98.49 102.6 14.39 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.991 2.117 . . . . 0.0 110.262 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -80.12 95.29 6.18 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.607 0.717 . . . . 0.0 109.734 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -86.55 112.7 21.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.689 1.596 . . . . 0.0 108.776 171.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -136.12 170.31 16.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.833 0.853 . . . . 0.0 112.865 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -147.36 137.61 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.639 1.176 . . . . 0.0 111.005 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.7 t -87.45 94.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.03 -28.63 69.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.779 1.231 . . . . 0.0 112.686 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.68 177.87 15.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.968 1.746 . . . . 0.0 112.582 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -112.29 156.06 23.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.779 0.832 . . . . 0.0 111.688 169.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 125.637 1.575 . . . . 0.0 111.332 178.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 111.152 0.056 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.94 115.03 22.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.824 0.85 . . . . 0.0 110.127 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.11 114.68 11.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.999 1.32 . . . . 0.0 109.908 162.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.48 119.84 33.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.798 1.239 . . . . 0.0 109.111 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.94 163.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.207 1.003 . . . . 0.0 111.859 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -143.1 140.22 30.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.565 1.546 . . . . 0.0 110.635 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -136.74 158.08 45.27 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.385 1.474 . . . . 0.0 114.055 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -144.16 107.92 4.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.643 1.977 . . . . 0.0 110.614 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.68 117.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 0.0 111.076 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -131.31 156.48 45.4 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.899 1.68 . . . . 0.0 111.104 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.3 146.46 40.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.297 -0.877 . . . . 0.0 111.055 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.16 133.51 48.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.075 0.95 . . . . 0.0 110.927 169.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.49 -57.13 3.76 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.991 1.281 . . . . 0.0 114.177 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -62.87 147.55 49.87 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.497 1.119 . . . . 0.0 112.598 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.5 m -83.44 -7.74 59.5 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.25 161.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.0 0.818 . . . . 0.0 111.876 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.71 124.75 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.351 1.46 . . . . 0.0 109.504 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 mt -71.7 -53.57 13.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.012 0.525 . . . . 0.0 112.016 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -157.88 162.09 38.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.761 1.224 . . . . 0.0 111.686 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 p -154.63 130.25 9.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.945 1.298 . . . . 0.0 112.466 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.64 -2.02 19.06 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.7 mm -51.67 -52.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.987 1.715 . . . . 0.0 111.884 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 m -82.6 -6.27 59.26 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 mmpp? -92.17 -172.07 3.02 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.56 1.944 . . . . 0.0 110.657 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.5 137.2 97.06 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 121.469 -0.77 . . . . 0.0 110.799 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.81 163.52 35.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.221 2.614 . . . . 0.0 113.204 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -92.91 110.24 21.7 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.76 1.224 . . . . 0.0 110.754 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.85 131.16 35.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.766 1.626 . . . . 0.0 111.499 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -143.06 157.04 44.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.256 1.022 . . . . 0.0 111.722 164.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.59 148.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.024 -1.047 . . . . 0.0 109.711 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.0 mm -48.19 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.316 1.446 . . . . 0.0 111.335 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.03 11.48 49.33 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -69.44 -35.0 75.25 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.926 1.863 . . . . 0.0 113.557 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.3 m120 57.72 37.74 27.33 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.527 1.931 . . . . 0.0 115.281 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -79.25 -23.65 43.52 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -72.76 167.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.367 1.067 . . . . 0.0 112.84 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.3 pt -59.11 136.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.95 0.9 . . . . 0.0 111.202 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.24 70.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.287 -0.883 . . . . 0.0 112.606 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.94 -13.97 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.111 173.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.94 -36.68 6.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.349 1.86 . . . . 0.0 111.595 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.28 -32.79 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -4.01 0.86 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 174.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.79 -29.9 4.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.387 1.875 . . . . 0.0 113.965 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.41 -24.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.849 1.204 . . . . 0.0 113.373 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -66.4 -13.85 61.29 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.34 -21.24 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.755 1.622 . . . . 0.0 113.859 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.29 111.58 2.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.662 1.185 . . . . 0.0 112.15 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.67 159.69 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.116 0.96 . . . . 0.0 113.2 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -56.64 131.99 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.194 1.398 . . . . 0.0 111.617 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.93 8.53 68.95 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.967 1.27 . . . . 0.0 115.064 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.53 112.7 24.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.032 1.333 . . . . 0.0 111.471 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -59.0 134.52 57.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.428 0.691 . . . . 0.0 111.363 171.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.61 112.97 12.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.121 1.768 . . . . 0.0 110.032 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.94 92.73 4.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.927 1.291 . . . . 0.0 110.508 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.06 165.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.592 0.757 . . . . 0.0 111.485 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.86 130.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.331 1.452 . . . . 0.0 108.461 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.4 mt -127.78 130.42 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 126.615 1.966 . . . . 0.0 109.135 -165.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.32 147.25 82.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.608 0.763 . . . . 0.0 111.264 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.22 -43.16 9.05 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -166.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.28 -21.86 66.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.822 1.649 . . . . 0.0 114.068 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.698 1.199 . . . . 0.0 112.508 175.572 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.34 143.96 50.72 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.069 -1.02 . . . . 0.0 110.635 174.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -126.39 124.65 40.68 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.666 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -83.89 78.34 9.74 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.366 1.079 . . . . 0.0 111.186 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.54 136.49 59.73 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.097 1.759 . . . . 0.0 109.903 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 159.44 52.91 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.71 2.273 . . . . 0.0 112.701 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -17.8 47.7 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.25 -31.26 63.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.902 1.681 . . . . 0.0 113.575 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -81.09 -6.16 58.49 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.155 0.982 . . . . 0.0 113.636 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -133.41 45.74 2.66 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.009 2.124 . . . . 0.0 110.996 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.66 111.82 19.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.54 1.136 . . . . 0.0 111.6 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.85 55.46 4.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.457 1.027 . . . . 0.0 114.319 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.46 -179.6 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.731 2.412 . . . . 0.0 111.786 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -131.99 88.3 2.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.588 1.555 . . . . 0.0 110.601 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.24 151.69 38.38 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.454 0.702 . . . . 0.0 111.398 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.84 135.09 19.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.217 1.007 . . . . 0.0 111.388 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.56 102.74 0.35 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.481 1.513 . . . . 0.0 110.563 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.97 21.15 5.75 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.994 1.283 . . . . 0.0 115.797 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -112.92 158.01 20.74 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.26 1.53 . . . . 0.0 112.555 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 p -82.46 97.8 8.58 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.113 1.365 . . . . 0.0 111.771 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 p -83.7 162.2 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.962 0.905 . . . . 0.0 111.015 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -123.32 152.89 40.98 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.276 1.431 . . . . 0.0 111.37 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.42 108.08 0.47 Allowed Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.369 0.985 . . . . 0.0 112.692 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -66.71 145.46 55.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.157 -0.614 . . . . 0.0 111.359 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -125.14 156.45 38.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.109 1.764 . . . . 0.0 111.533 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.16 -16.02 49.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.202 1.801 . . . . 0.0 114.294 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -74.68 12.82 0.73 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.428 1.891 . . . . 0.0 113.89 173.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 m120 54.27 48.66 20.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.942 2.097 . . . . 0.0 112.221 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -140.12 173.81 11.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.191 1.797 . . . . 0.0 111.792 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.4 m -145.67 110.96 5.32 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.05 1.34 . . . . 0.0 110.529 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.07 167.36 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.74 -0.6 . . . . 0.0 111.43 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -121.54 139.45 53.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.641 1.576 . . . . 0.0 110.725 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.8 173.96 14.65 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.465 1.106 . . . . 0.0 112.65 -168.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.85 128.53 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.0 mm -63.22 125.48 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.413 1.485 . . . . 0.0 110.279 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -111.84 -34.93 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.647 1.179 . . . . 0.0 113.041 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -157.62 167.5 29.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.491 1.116 . . . . 0.0 112.039 165.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.72 140.38 33.12 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.201 1.001 . . . . 0.0 112.168 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.9 m -111.76 174.07 6.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.152 2.181 . . . . 0.0 110.739 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.02 68.58 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 70.9 p -130.19 -7.57 4.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.788 1.635 . . . . 0.0 114.809 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -145.0 165.37 28.36 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.256 1.822 . . . . 0.0 111.278 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.69 144.42 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.706 1.603 . . . . 0.0 109.712 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 37.7 mmm -116.14 109.5 17.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 110.051 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.31 148.1 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.35 1.46 . . . . 0.0 109.933 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 120.52 13.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.241 1.417 . . . . 0.0 111.867 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 125.886 1.674 . . . . 0.0 111.873 -179.746 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.87 144.21 43.49 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.185 1.394 . . . . 0.0 111.3 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.2 143.95 46.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.065 1.346 . . . . 0.0 111.262 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.75 144.38 37.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.659 0.784 . . . . 0.0 111.357 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -128.79 92.13 3.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.074 1.75 . . . . 0.0 108.652 170.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -79.01 110.37 14.17 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.901 1.28 . . . . 0.0 108.802 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -131.88 166.97 20.42 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.349 0.66 . . . . 0.0 112.773 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -149.92 142.74 24.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.658 1.183 . . . . 0.0 111.673 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.14 106.69 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.997 1.319 . . . . 0.0 108.826 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.61 -38.19 77.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 111.63 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.55 158.88 7.73 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.296 1.427 . . . . 0.0 114.749 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -82.9 125.38 31.3 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.803 1.641 . . . . 0.0 111.506 -176.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 . . . . . 0 N--CA 1.476 0.84 0 C-N-CA 125.276 1.43 . . . . 0.0 111.225 179.888 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.19 108.44 6.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.093 0.557 . . . . 0.0 110.602 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.27 120.05 14.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.265 1.826 . . . . 0.0 110.456 165.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.28 113.86 27.69 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.244 2.218 . . . . 0.0 108.952 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 159.35 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 112.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -135.09 129.67 34.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.885 1.274 . . . . 0.0 110.38 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -135.68 155.0 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.607 1.163 . . . . 0.0 113.034 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -140.17 166.09 25.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.097 1.759 . . . . 0.0 111.424 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.37 101.2 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.84 1.256 . . . . 0.0 111.194 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -90.51 154.03 19.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 110.219 170.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -61.54 135.4 57.64 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.894 161.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -71.21 91.72 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.23 -0.919 . . . . 0.0 110.776 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.93 -68.91 0.54 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.185 1.85 . . . . 0.0 112.302 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -67.11 158.67 30.58 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.7 m -79.02 -13.09 59.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.46 151.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.074 0.852 . . . . 0.0 112.063 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.6 114.91 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.364 1.466 . . . . 0.0 109.182 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.0 mt -68.29 -48.57 64.62 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.619 1.168 . . . . 0.0 111.66 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -154.02 158.19 40.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.638 1.575 . . . . 0.0 110.362 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 p -151.2 125.68 9.49 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.472 1.109 . . . . 0.0 111.52 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -90.13 -30.89 17.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.29 0.636 . . . . 0.0 111.912 170.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.85 -50.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.613 1.565 . . . . 0.0 111.815 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -70.53 -5.54 29.72 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.21 1.404 . . . . 0.0 114.548 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -100.85 -83.61 0.44 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.772 1.629 . . . . 0.0 109.702 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.71 156.78 31.09 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 127.45 2.3 . . . . 0.0 110.451 171.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.82 141.35 78.01 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.679 2.253 . . . . 0.0 111.733 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.82 136.83 43.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.959 1.303 . . . . 0.0 109.971 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.64 119.71 34.52 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.05 1.34 . . . . 0.0 111.208 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -148.49 172.68 14.1 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -109.99 142.85 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.302 1.441 . . . . 0.0 109.839 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mm -47.32 115.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 111.864 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.52 64.76 1.49 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.171 1.367 . . . . 0.0 113.425 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -115.67 -22.37 9.21 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.044 1.338 . . . . 0.0 114.529 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m120 52.05 28.57 5.45 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 127.489 2.316 . . . . 0.0 116.107 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -86.75 -32.14 20.56 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 pt -81.26 170.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.975 1.31 . . . . 0.0 112.168 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.1 pt -59.57 140.01 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.189 0.996 . . . . 0.0 111.723 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.39 78.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -28.75 70.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.115 0.864 . . . . 0.0 114.295 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.19 -38.7 14.08 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.676 1.19 . . . . 0.0 111.588 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -53.42 -46.28 69.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.229 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.04 1.72 3.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.948 1.699 . . . . 0.0 114.667 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.55 -35.72 5.15 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.72 1.608 . . . . 0.0 113.498 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.74 -41.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.339 1.427 . . . . 0.0 112.253 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.29 -10.46 32.62 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -112.33 -9.43 13.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.205 1.802 . . . . 0.0 113.927 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.86 145.87 28.4 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.818 1.247 . . . . 0.0 111.842 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -98.37 157.01 16.46 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.925 1.29 . . . . 0.0 111.566 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 tt -57.39 129.36 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 111.829 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.14 78.88 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.035 1.302 . . . . 0.0 115.368 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.28 114.13 20.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.09 1.445 . . . . 0.0 111.65 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -56.0 142.06 37.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.536 1.135 . . . . 0.0 112.717 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -137.44 116.46 12.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.015 1.726 . . . . 0.0 110.728 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -101.4 107.05 18.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.012 1.325 . . . . 0.0 110.73 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -115.9 110.3 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.564 1.146 . . . . 0.0 110.907 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 t -73.89 130.19 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.73 141.64 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.157 1.383 . . . . 0.0 109.764 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.68 155.08 87.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.905 1.282 . . . . 0.0 112.789 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.62 -18.6 64.67 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.362 2.708 . . . . 0.0 114.457 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.49 -6.56 20.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.366 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 . . . . . 0 N--CA 1.477 0.91 0 C-N-CA 125.19 1.396 . . . . 0.0 113.224 179.225 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.546 0.806 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.7 mt -142.16 160.67 39.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.566 1.946 . . . . 0.0 112.974 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.39 133.23 11.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.297 1.439 . . . . 0.0 111.427 162.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -78.29 99.51 6.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.443 1.097 . . . . 0.0 110.407 167.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.67 137.1 21.46 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.714 1.606 . . . . 0.0 109.425 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.44 155.92 50.37 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 112.922 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -75.71 60.75 1.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.171 1.788 . . . . 0.0 112.24 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -122.38 -54.11 1.89 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.302 1.841 . . . . 0.0 111.038 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -63.78 -17.18 62.81 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.464 1.105 . . . . 0.0 113.453 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -126.59 12.05 7.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.822 1.649 . . . . 0.0 113.875 -170.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.417 1.087 . . . . 0.0 113.542 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.4 12.87 47.78 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.19 1.852 . . . . 0.0 115.355 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.6 mt -122.1 126.66 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.251 1.525 . . . . 0.0 110.725 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.93 78.38 0.64 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.22 1.408 . . . . 0.0 112.649 173.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.7 156.2 24.3 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.74 162.77 40.48 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.256 1.822 . . . . 0.0 110.028 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -71.32 136.05 47.66 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.698 -1.251 . . . . 0.0 110.816 166.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.68 18.15 76.05 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.5 ptm -100.53 148.64 24.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.944 1.372 . . . . 0.0 111.776 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -68.49 143.43 54.99 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.059 0.944 . . . . 0.0 111.765 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.37 163.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.757 1.623 . . . . 0.0 111.278 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.25 158.0 35.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.399 1.88 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.88 103.7 0.25 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 123.774 0.702 . . . . 0.0 113.229 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.38 111.03 8.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.323 1.049 . . . . 0.0 111.5 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 t -81.2 154.44 26.66 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.6 1.16 . . . . 0.0 111.744 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.86 -13.57 59.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.774 1.229 . . . . 0.0 113.515 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.06 18.85 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.165 1.786 . . . . 0.0 113.841 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 55.3 42.94 29.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.386 2.274 . . . . 0.0 113.037 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -143.02 169.75 16.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.794 1.638 . . . . 0.0 112.043 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.8 m -141.41 107.11 5.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 110.592 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.79 167.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.992 -0.442 . . . . 0.0 111.18 174.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.08 135.88 37.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.721 1.208 . . . . 0.0 111.587 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.41 -167.97 1.89 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.816 1.246 . . . . 0.0 112.732 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.55 140.29 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.296 1.838 . . . . 0.0 110.528 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.98 124.61 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.418 1.087 . . . . 0.0 111.317 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -91.57 -35.96 13.96 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.722 1.609 . . . . 0.0 113.352 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -154.8 160.21 41.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.223 1.409 . . . . 0.0 110.879 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -148.35 150.08 32.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.171 0.988 . . . . 0.0 113.038 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -143.95 175.69 9.84 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.179 1.791 . . . . 0.0 110.91 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.31 -20.77 58.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.51 1.124 . . . . 0.0 113.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -86.75 -57.49 2.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.68 1.592 . . . . 0.0 111.967 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -138.17 169.95 16.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.4 2.28 . . . . 0.0 111.308 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.45 148.28 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.496 1.518 . . . . 0.0 110.934 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.5 mtp -112.57 92.38 4.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.708 1.603 . . . . 0.0 110.436 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.7 143.37 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.526 1.53 . . . . 0.0 109.808 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -63.87 125.3 23.94 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.876 170.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 124.378 1.071 . . . . 0.0 110.132 173.097 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 p -65.6 144.54 56.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.198 1.399 . . . . 0.0 112.533 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.8 mt -126.84 142.76 51.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.125 1.37 . . . . 0.0 111.809 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.97 95.11 9.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.537 1.135 . . . . 0.0 111.292 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.76 88.82 5.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.261 1.029 . . . . 0.0 110.796 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.77 124.23 28.88 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.016 1.326 . . . . 0.0 109.45 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.57 171.76 13.73 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -150.94 144.86 25.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.405 1.482 . . . . 0.0 111.237 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.9 101.06 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.426 1.09 . . . . 0.0 108.233 165.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.71 -28.5 66.89 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.539 0.736 . . . . 0.0 112.258 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.74 -160.77 28.62 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.497 1.046 . . . . 0.0 113.539 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.73 149.42 51.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.49 1.116 . . . . 0.0 110.872 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 124.868 1.267 . . . . 0.0 112.048 174.956 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 120.408 0.147 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.57 105.22 9.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.807 0.843 . . . . 0.0 110.678 174.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 129.99 41.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.295 1.038 . . . . 0.0 110.348 165.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -116.47 130.03 56.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.191 1.396 . . . . 0.0 110.39 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.91 163.64 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.511 1.124 . . . . 0.0 112.192 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.88 135.01 34.03 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.58 1.952 . . . . 0.0 110.453 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -139.06 149.61 44.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.111 1.434 . . . . 0.0 114.429 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.27 114.5 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.802 2.441 . . . . 0.0 109.253 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -92.87 96.59 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.409 1.084 . . . . 0.0 110.191 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -95.66 158.11 15.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.157 1.783 . . . . 0.0 110.362 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -72.35 156.8 38.71 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.125 -0.985 . . . . 0.0 110.98 166.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -65.65 -64.62 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 113.104 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.07 -47.76 5.4 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.018 0.818 . . . . 0.0 113.566 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -72.04 150.71 43.73 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 112.367 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 m -74.71 -12.39 60.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.813 1.245 . . . . 0.0 114.184 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 156.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.757 0.823 . . . . 0.0 113.091 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.39 128.13 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.886 1.674 . . . . 0.0 109.304 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -81.06 -49.35 11.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.178 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -154.87 160.51 41.25 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.171 1.388 . . . . 0.0 111.748 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.2 p -158.51 126.58 5.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.739 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.95 -17.15 31.94 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 170.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.12 -36.74 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.055 1.342 . . . . 0.0 112.553 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.1 p -75.57 -6.9 52.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.1 1.36 . . . . 0.0 114.64 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -107.93 -88.07 0.48 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.597 1.959 . . . . 0.0 110.133 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -151.44 152.71 31.24 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.937 2.095 . . . . 0.0 110.858 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.75 158.62 56.43 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.734 2.956 . . . . 0.0 113.526 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.38 112.61 23.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.657 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.97 129.49 40.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.716 1.607 . . . . 0.0 111.605 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -147.66 176.93 9.7 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 112.474 171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.96 150.64 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.626 1.57 . . . . 0.0 108.856 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.6 mm -49.41 106.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.509 1.124 . . . . 0.0 111.892 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.73 80.21 1.5 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 125.887 1.708 . . . . 0.0 113.476 -171.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.3 m -132.61 -49.1 0.9 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.056 1.343 . . . . 0.0 112.897 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.25 32.84 22.3 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.596 1.558 . . . . 0.0 114.365 175.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -27.67 34.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.29 171.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.801 1.241 . . . . 0.0 112.317 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -56.25 144.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.533 1.133 . . . . 0.0 112.179 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.086 0.954 . . . . 0.0 113.216 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.37 93.85 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.45 1.024 . . . . 0.0 113.317 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.03 -42.38 38.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.626 0.77 . . . . 0.0 112.121 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -53.08 -48.19 67.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.756 1.162 . . . . 0.0 112.79 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.31 -21.59 66.73 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.98 27.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.114 0.966 . . . . 0.0 112.291 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -53.42 -44.31 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.749 1.159 . . . . 0.0 112.541 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.17 -18.25 65.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -102.84 -20.66 14.22 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.983 1.713 . . . . 0.0 113.971 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.63 134.19 48.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.917 1.287 . . . . 0.0 112.058 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.45 150.34 34.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.922 0.889 . . . . 0.0 111.665 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -56.61 129.62 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.689 1.196 . . . . 0.0 111.161 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.37 76.85 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -122.83 117.82 26.53 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.956 1.378 . . . . 0.0 111.429 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -60.65 141.2 57.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.007 0.923 . . . . 0.0 111.982 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -138.54 120.34 15.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.898 1.279 . . . . 0.0 111.019 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.58 101.51 11.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 110.376 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.26 116.72 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.101 1.36 . . . . 0.0 111.403 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 t -80.21 109.88 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.227 1.011 . . . . 0.0 109.7 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.8 mm -98.52 136.42 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.903 1.281 . . . . 0.0 109.808 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 152.35 89.41 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.336 1.055 . . . . 0.0 111.966 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.72 -46.05 22.16 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.682 2.255 . . . . 0.0 111.867 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 -14.09 46.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 0.0 114.976 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.572 1.549 . . . . 0.0 112.714 -178.239 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.997 0.427 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.04 143.26 33.13 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.976 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -116.37 117.5 30.14 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.925 1.29 . . . . 0.0 110.074 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -74.27 106.75 6.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.088 0.955 . . . . 0.0 110.18 171.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -121.44 131.58 24.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 126.8 2.04 . . . . 0.0 109.293 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.18 155.5 64.4 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.084 1.856 . . . . 0.0 112.557 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -58.72 -19.95 44.68 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 172.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.11 -30.97 62.84 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.936 1.294 . . . . 0.0 113.174 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -81.35 -3.32 52.3 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.204 1.002 . . . . 0.0 113.416 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.22 20.22 7.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.231 2.212 . . . . 0.0 112.432 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.94 104.28 0.28 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.461 1.505 . . . . 0.0 111.875 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.82 3.15 52.41 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.373 1.463 . . . . 0.0 115.68 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 pt -129.63 98.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.865 1.666 . . . . 0.0 111.209 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.28 144.34 54.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.698 1.199 . . . . 0.0 111.665 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -125.7 159.72 31.55 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.396 1.478 . . . . 0.0 111.1 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -150.86 145.19 25.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.244 1.418 . . . . 0.0 110.325 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -58.51 128.62 38.08 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.674 0.79 . . . . 0.0 111.349 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 43.08 12.93 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 123.741 0.686 . . . . 0.0 114.445 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.73 153.89 47.73 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.57 1.148 . . . . 0.0 111.705 168.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.9 t -82.83 98.75 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.233 1.413 . . . . 0.0 112.034 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.63 156.97 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 110.914 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -113.0 149.09 33.8 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.466 1.106 . . . . 0.0 111.353 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.42 97.58 0.22 Allowed Glycine 0 N--CA 1.469 0.862 0 C-N-CA 124.44 1.019 . . . . 0.0 112.516 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.1 110.79 4.69 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.999 0.919 . . . . 0.0 111.101 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -78.39 153.18 31.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.239 1.016 . . . . 0.0 111.659 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -66.21 -12.95 59.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.467 1.507 . . . . 0.0 113.245 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.98 16.39 0.16 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 126.339 1.855 . . . . 0.0 114.01 168.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.59 45.63 15.88 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.227 2.211 . . . . 0.0 112.649 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -145.29 170.03 17.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.358 1.863 . . . . 0.0 111.163 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.1 m -142.44 120.61 12.2 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.753 1.221 . . . . 0.0 110.82 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.57 167.14 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.104 0.561 . . . . 0.0 111.752 174.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -117.0 127.61 54.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.279 1.431 . . . . 0.0 109.052 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.5 171.84 13.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.975 1.31 . . . . 0.0 112.446 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.28 130.06 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.104 0.961 . . . . 0.0 110.57 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.4 mm -62.47 103.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 109.533 170.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -84.13 -38.29 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.061 0.945 . . . . 0.0 111.667 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -149.46 165.4 32.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.461 1.104 . . . . 0.0 112.373 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.01 159.0 44.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.765 1.226 . . . . 0.0 111.921 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.2 m -134.59 174.76 10.19 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.207 1.803 . . . . 0.0 110.835 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.24 -15.56 63.29 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.6 t -140.25 -17.93 0.91 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.92 1.688 . . . . 0.0 114.489 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -133.46 168.03 19.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.662 1.585 . . . . 0.0 112.282 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -136.48 148.65 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.817 2.047 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.0 mtp -129.82 99.57 5.17 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.978 1.311 . . . . 0.0 110.801 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.14 147.32 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 110.005 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.46 128.69 36.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.113 0.565 . . . . 0.0 111.143 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.552 . . . . 0.0 110.779 172.324 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.85 140.66 58.89 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.963 1.705 . . . . 0.0 112.423 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -129.59 138.42 51.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.929 1.292 . . . . 0.0 112.009 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.41 96.68 10.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.486 1.514 . . . . 0.0 111.046 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -76.72 92.6 3.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.345 0.658 . . . . 0.0 109.585 166.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -77.09 119.5 20.88 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 164.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -138.25 169.83 17.09 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.378 0.671 . . . . 0.0 112.48 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -149.22 143.35 25.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.834 1.254 . . . . 0.0 111.584 171.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.5 t -82.24 104.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.772 1.229 . . . . 0.0 108.45 165.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.33 -35.49 75.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.366 0.666 . . . . 0.0 111.703 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.66 -149.95 18.86 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.449 1.499 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -129.29 151.16 50.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.262 1.025 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 . . . . . 0 N--CA 1.475 0.778 0 C-N-CA 125.382 1.473 . . . . 0.0 111.264 175.348 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.01 118.1 18.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.101 0.96 . . . . 0.0 111.45 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.5 106.7 8.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.696 1.599 . . . . 0.0 110.001 164.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.66 115.46 24.13 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.392 1.877 . . . . 0.0 109.501 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -131.78 158.57 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.078 0.951 . . . . 0.0 111.892 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -138.87 134.6 33.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.901 1.28 . . . . 0.0 110.281 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -131.9 162.11 31.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.145 1.378 . . . . 0.0 112.803 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.17 171.03 15.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 111.357 166.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.77 106.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.454 1.102 . . . . 0.0 110.981 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -116.65 154.86 29.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.634 1.574 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.92 148.4 40.11 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.552 -0.717 . . . . 0.0 111.042 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -66.59 -25.84 66.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 -72.94 0.95 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.226 1.393 . . . . 0.0 112.647 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -59.89 140.18 56.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.221 1.408 . . . . 0.0 113.576 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -70.9 -21.28 62.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.812 1.245 . . . . 0.0 113.892 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.37 158.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.952 1.301 . . . . 0.0 112.562 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.0 129.04 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.478 1.511 . . . . 0.0 109.75 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mp -79.69 -45.67 18.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.392 0.677 . . . . 0.0 111.312 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.71 158.27 40.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.163 1.385 . . . . 0.0 111.383 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.3 t -156.93 141.63 16.86 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.278 -0.889 . . . . 0.0 112.666 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.17 3.7 15.29 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.398 1.879 . . . . 0.0 112.752 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.55 -55.9 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.469 1.107 . . . . 0.0 111.214 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 t -72.21 -21.64 61.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.458 1.103 . . . . 0.0 113.034 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -80.81 -178.18 6.69 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.954 2.102 . . . . 0.0 111.841 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.39 128.11 92.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.873 0.869 . . . . 0.0 111.069 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.48 151.85 83.91 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.851 2.367 . . . . 0.0 112.427 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 tt -81.9 134.87 35.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.318 1.047 . . . . 0.0 109.981 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -119.43 114.46 22.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.78 1.632 . . . . 0.0 110.564 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -130.13 172.71 11.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.255 1.022 . . . . 0.0 112.26 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.3 mm -115.8 150.73 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.263 1.425 . . . . 0.0 109.023 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.57 106.16 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.72 29.9 7.1 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.405 1.479 . . . . 0.0 116.369 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 m -98.23 -38.56 9.24 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.53 1.665 . . . . 0.0 113.795 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 55.28 33.02 19.8 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.114 1.766 . . . . 0.0 115.198 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -68.03 -21.42 65.02 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.8 pt -74.26 168.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.964 1.706 . . . . 0.0 113.082 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 pt -60.86 152.79 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.29 1.036 . . . . 0.0 112.518 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.64 -43.13 79.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.11 73.06 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 114.105 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -88.88 -30.5 18.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.999 1.32 . . . . 0.0 112.223 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.6 -44.27 72.92 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.777 1.631 . . . . 0.0 111.639 171.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.79 8.46 6.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.379 1.471 . . . . 0.0 113.817 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.41 -39.58 2.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.499 1.519 . . . . 0.0 113.671 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.27 -30.07 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.323 1.049 . . . . 0.0 113.572 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.17 -14.24 62.21 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.16 -34.46 7.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.511 1.525 . . . . 0.0 112.782 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.91 149.82 26.0 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.551 0.74 . . . . 0.0 111.808 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.07 161.06 22.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 111.409 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.52 125.49 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.81 0.844 . . . . 0.0 111.759 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.78 76.64 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.778 1.18 . . . . 0.0 115.038 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.08 108.76 17.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.957 1.378 . . . . 0.0 111.334 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -57.78 141.2 49.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.982 0.913 . . . . 0.0 112.223 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.33 116.98 12.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.179 1.791 . . . . 0.0 110.716 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.0 112.19 23.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.924 1.29 . . . . 0.0 110.871 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -123.05 112.51 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.132 0.973 . . . . 0.0 111.256 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.7 127.83 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 121.197 -0.939 . . . . 0.0 109.303 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.4 mt -120.56 135.95 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.699 1.6 . . . . 0.0 108.703 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.64 148.69 96.61 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.652 0.781 . . . . 0.0 111.494 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.56 -44.58 13.69 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.02 2.48 . . . . 0.0 112.405 -170.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.14 -30.69 71.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.229 1.811 . . . . 0.0 113.695 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.758 -176.297 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.44 115.38 11.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.852 2.061 . . . . 0.0 111.349 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -116.98 119.22 34.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.259 1.423 . . . . 0.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.09 105.7 11.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.042 1.337 . . . . 0.0 111.06 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.85 131.56 21.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.673 1.989 . . . . 0.0 109.296 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.33 162.21 41.46 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.441 2.094 . . . . 0.0 112.52 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.95 -22.45 49.12 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.013 0.925 . . . . 0.0 113.417 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.42 -39.56 57.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.026 2.13 . . . . 0.0 114.031 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -69.77 -17.84 63.45 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -131.7 15.35 4.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.934 1.693 . . . . 0.0 114.161 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -57.33 -27.94 62.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.343 1.457 . . . . 0.0 114.143 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.76 6.69 33.29 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.823 1.678 . . . . 0.0 116.061 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.26 113.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.33 1.565 . . . . 0.0 111.881 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.92 139.65 58.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.102 0.961 . . . . 0.0 112.012 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -121.02 172.27 8.06 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.092 1.757 . . . . 0.0 111.609 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -148.29 161.15 42.1 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.222 1.009 . . . . 0.0 112.039 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -73.37 95.47 2.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.396 1.078 . . . . 0.0 111.026 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.41 64.24 0.73 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.9 ptp -133.95 152.0 51.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.129 1.372 . . . . 0.0 111.527 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.7 m -77.23 98.77 5.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.531 1.532 . . . . 0.0 110.652 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.09 154.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.366 1.466 . . . . 0.0 111.321 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.35 147.49 29.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.744 1.218 . . . . 0.0 111.589 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.99 96.98 0.28 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.949 1.261 . . . . 0.0 112.423 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -72.15 114.84 10.69 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.874 0.87 . . . . 0.0 111.13 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -82.42 154.84 24.97 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.507 1.123 . . . . 0.0 111.574 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.54 -13.21 39.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.024 1.329 . . . . 0.0 113.545 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -73.75 19.38 0.11 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.464 1.505 . . . . 0.0 113.781 171.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 58.4 33.85 23.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.346 2.259 . . . . 0.0 113.738 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -135.84 169.75 17.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.813 2.045 . . . . 0.0 111.493 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.1 m -137.68 138.28 39.24 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.543 1.537 . . . . 0.0 110.184 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.02 170.64 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.228 1.011 . . . . 0.0 111.372 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.23 133.74 55.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.919 1.688 . . . . 0.0 110.717 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.93 171.06 14.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.095 1.758 . . . . 0.0 111.228 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.7 126.97 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.862 0.865 . . . . 0.0 110.019 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.49 129.49 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 110.567 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -91.5 -49.27 6.41 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.061 1.344 . . . . 0.0 111.504 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -151.87 170.73 19.1 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.813 1.245 . . . . 0.0 112.208 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.72 155.61 45.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.432 1.093 . . . . 0.0 113.019 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.42 169.11 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.038 2.535 . . . . 0.0 110.049 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.41 67.96 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.129 -0.982 . . . . 0.0 113.167 171.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 63.9 p -131.22 -8.47 3.8 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.311 1.444 . . . . 0.0 114.811 -173.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -141.81 171.19 14.4 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.776 1.63 . . . . 0.0 111.047 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -138.65 150.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.514 1.926 . . . . 0.0 108.738 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 62.2 mtp -125.54 114.6 18.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.508 1.123 . . . . 0.0 111.035 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.2 163.83 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.811 1.244 . . . . 0.0 112.163 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -102.13 88.49 3.34 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.86 1.264 . . . . 0.0 112.182 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.475 0.801 0 C-N-CA 124.647 1.179 . . . . 0.0 112.268 171.863 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.9 p -64.66 144.85 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.36 1.464 . . . . 0.0 113.14 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -130.31 136.42 49.12 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.275 . . . . 0.0 111.706 -173.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.68 97.41 7.9 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.73 1.612 . . . . 0.0 111.324 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.65 83.59 6.4 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.415 1.102 . . . . 0.0 110.613 166.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -76.58 131.67 39.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.14 169.89 19.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -145.41 145.63 31.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.971 1.309 . . . . 0.0 111.656 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 t -84.49 100.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.863 1.265 . . . . 0.0 108.693 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.23 -31.96 71.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.38 0.672 . . . . 0.0 111.837 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.88 -170.05 31.28 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.196 0.903 . . . . 0.0 114.883 170.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.55 118.93 27.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.616 1.567 . . . . 0.0 110.219 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 . . . . . 0 N--CA 1.48 1.045 0 C-N-CA 124.985 1.314 . . . . 0.0 112.558 -177.037 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 . . . . . 0 N--CA 1.473 0.682 0 CA-C-O 120.47 0.176 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 107.51 17.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.184 0.994 . . . . 0.0 110.435 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.02 128.7 37.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.382 165.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.23 124.81 53.4 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.592 1.557 . . . . 0.0 109.619 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -128.5 163.68 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.82 136.72 40.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 109.745 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.07 157.95 45.58 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.069 1.414 . . . . 0.0 114.783 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -139.13 141.25 38.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.462 3.105 . . . . 0.0 108.878 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.22 110.06 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.873 1.269 . . . . 0.0 110.429 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -123.69 168.85 12.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.539 1.536 . . . . 0.0 112.685 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -62.57 151.97 36.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.505 1.122 . . . . 0.0 111.147 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -20.28 63.24 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.42 25.35 1.53 Allowed Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.123 1.344 . . . . 0.0 114.959 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -141.16 161.41 37.93 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.917 1.358 . . . . 0.0 112.52 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -75.71 -17.72 59.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.783 1.633 . . . . 0.0 113.762 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -64.04 151.69 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.799 0.84 . . . . 0.0 112.456 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.46 117.25 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.787 1.635 . . . . 0.0 108.943 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.87 -44.05 56.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.721 0.808 . . . . 0.0 111.77 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.67 164.09 39.06 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.648 1.179 . . . . 0.0 111.581 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 m -165.87 159.6 16.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.384 1.874 . . . . 0.0 111.844 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -126.08 2.75 7.22 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 164.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.9 mm -47.46 -46.2 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.01 1.724 . . . . 0.0 113.965 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -93.42 -2.62 54.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.955 1.302 . . . . 0.0 113.581 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -98.05 -166.52 1.39 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.875 2.47 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.91 134.26 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.473 1.109 . . . . 0.0 111.775 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.55 159.01 55.18 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.27 2.647 . . . . 0.0 113.314 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.88 95.06 5.96 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.435 1.094 . . . . 0.0 110.268 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.34 125.46 31.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.159 1.783 . . . . 0.0 111.578 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.48 172.6 14.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.168 0.987 . . . . 0.0 113.399 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 142.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.601 1.56 . . . . 0.0 109.507 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mm -47.93 121.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.971 1.708 . . . . 0.0 112.462 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.41 76.85 1.09 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.995 1.283 . . . . 0.0 112.806 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -130.79 -26.69 2.18 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 53.48 21.96 2.7 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.518 1.927 . . . . 0.0 115.683 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -78.25 -28.6 47.82 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -170.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 pt -82.07 171.18 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.86 1.664 . . . . 0.0 112.196 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 pt -55.34 140.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.818 0.847 . . . . 0.0 111.169 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.67 78.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.543 0.737 . . . . 0.0 112.915 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.88 -30.41 72.98 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.327 0.965 . . . . 0.0 114.303 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.67 -43.9 13.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.337 1.055 . . . . 0.0 111.404 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -53.25 -48.02 68.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.595 1.158 . . . . 0.0 112.309 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.05 0.3 2.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.984 1.314 . . . . 0.0 114.468 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.54 -25.42 7.9 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.968 1.707 . . . . 0.0 114.04 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.3 t -58.31 -42.02 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.736 1.607 . . . . 0.0 112.114 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.92 -12.62 61.06 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.95 -36.9 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.995 1.718 . . . . 0.0 112.18 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 140.74 58.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.085 1.354 . . . . 0.0 112.385 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -86.28 154.28 21.37 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.009 0.924 . . . . 0.0 111.964 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.71 131.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.287 1.035 . . . . 0.0 111.346 171.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.25 12.63 76.43 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.289 0.947 . . . . 0.0 115.157 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.31 115.49 19.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.322 1.449 . . . . 0.0 111.246 -175.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -59.41 141.32 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.866 0.866 . . . . 0.0 112.151 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.17 142.68 42.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.147 1.379 . . . . 0.0 111.054 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.79 128.54 52.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.14 1.376 . . . . 0.0 110.156 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.55 110.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.706 2.002 . . . . 0.0 110.166 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.1 t -69.49 125.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.769 0.828 . . . . 0.0 109.94 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.29 140.1 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.308 1.443 . . . . 0.0 109.826 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.45 154.74 87.23 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.241 1.016 . . . . 0.0 111.731 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.18 -40.67 67.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.627 2.218 . . . . 0.0 113.462 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.28 -18.35 59.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.475 0.793 0 C-N-CA 124.737 1.215 . . . . 0.0 114.017 -178.841 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 p90 . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.8 103.59 10.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.252 1.021 . . . . 0.0 110.629 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -88.91 116.75 27.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.59 0.756 . . . . 0.0 110.35 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.11 112.22 7.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.25 1.02 . . . . 0.0 110.221 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 156.3 54.45 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 126.071 1.749 . . . . 0.0 110.812 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.08 149.64 46.8 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.047 1.831 . . . . 0.0 112.005 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -61.45 -17.31 53.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.04 1.336 . . . . 0.0 113.171 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.35 -33.9 22.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.184 2.194 . . . . 0.0 113.624 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -71.38 -10.8 60.35 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -135.19 14.48 3.53 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.612 1.565 . . . . 0.0 114.194 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.86 112.56 0.96 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.43 1.092 . . . . 0.0 112.441 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.11 3.86 58.81 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.21 1.386 . . . . 0.0 115.374 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mt -108.22 139.56 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.284 1.434 . . . . 0.0 110.378 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.0 55.87 1.86 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.378 1.871 . . . . 0.0 113.588 -173.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -55.04 130.04 40.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.283 1.833 . . . . 0.0 113.303 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.23 148.47 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.752 2.021 . . . . 0.0 110.345 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.36 135.76 57.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.489 1.116 . . . . 0.0 112.25 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 -9.37 75.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.136 1.35 . . . . 0.0 116.371 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 ptp -70.16 152.28 44.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.169 1.984 . . . . 0.0 112.416 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 p -78.38 102.01 7.53 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.606 1.163 . . . . 0.0 110.311 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.3 160.86 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.419 1.088 . . . . 0.0 110.551 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.32 162.21 30.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.06 1.344 . . . . 0.0 112.002 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.69 108.82 0.38 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.275 0.94 . . . . 0.0 112.891 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -66.4 147.13 53.74 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 122.05 -0.677 . . . . 0.0 111.299 174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -128.88 157.39 41.7 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.729 1.612 . . . . 0.0 111.737 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -14.08 60.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.215 1.806 . . . . 0.0 113.736 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.35 13.13 0.62 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.285 1.834 . . . . 0.0 113.912 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.1 m120 57.25 40.14 28.12 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.13 2.172 . . . . 0.0 113.171 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -131.9 171.01 14.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.872 2.069 . . . . 0.0 111.253 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.6 m -141.93 111.75 6.73 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.683 1.593 . . . . 0.0 109.634 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.62 166.94 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 118.497 0.59 . . . . 0.0 111.067 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.33 154.77 34.55 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.623 1.169 . . . . 0.0 111.17 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.8 176.7 12.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.629 1.572 . . . . 0.0 110.966 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.37 128.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.385 1.074 . . . . 0.0 110.476 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.0 mm -68.65 125.97 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.062 0.945 . . . . 0.0 110.693 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.08 -38.68 5.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.773 1.229 . . . . 0.0 113.381 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -151.93 156.17 39.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.468 1.107 . . . . 0.0 111.243 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -147.19 149.85 33.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.186 -0.946 . . . . 0.0 113.395 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -143.2 170.17 16.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.841 2.057 . . . . 0.0 110.804 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.264 -0.897 . . . . 0.0 113.251 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.3 p -78.92 -66.71 0.83 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.676 1.99 . . . . 0.0 112.021 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -135.73 171.0 15.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.098 2.159 . . . . 0.0 111.367 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.21 144.03 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.567 1.547 . . . . 0.0 110.429 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.6 mtp -116.41 113.66 23.19 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.781 1.632 . . . . 0.0 110.651 -170.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.48 135.43 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.187 1.395 . . . . 0.0 110.264 -166.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.32 83.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.287 1.435 . . . . 0.0 112.17 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 126.035 1.734 . . . . 0.0 112.29 173.335 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.3 p -64.72 147.63 52.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.879 0.872 . . . . 0.0 112.125 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.58 154.21 51.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.81 1.244 . . . . 0.0 111.425 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.23 104.43 14.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 110.728 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -80.07 109.83 14.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.639 0.776 . . . . 0.0 109.726 167.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.24 120.64 43.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.858 1.663 . . . . 0.0 108.941 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -143.4 169.78 17.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 113.087 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.85 144.97 28.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.634 1.174 . . . . 0.0 111.899 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -83.18 102.9 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.918 1.287 . . . . 0.0 109.003 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.35 -36.03 78.63 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.201 0.6 . . . . 0.0 111.698 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.68 -165.93 27.47 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.367 0.984 . . . . 0.0 114.211 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.21 133.2 54.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.818 1.647 . . . . 0.0 110.223 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.062 1.345 . . . . 0.0 112.015 175.933 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.43 105.7 8.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.708 1.203 . . . . 0.0 111.172 172.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.58 125.51 28.16 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.046 1.339 . . . . 0.0 110.227 163.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.37 123.88 50.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.34 1.456 . . . . 0.0 110.083 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 pt -131.22 161.3 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.219 1.007 . . . . 0.0 112.129 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -135.89 146.94 47.93 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.841 1.656 . . . . 0.0 110.397 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.51 154.31 43.5 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -146.03 129.06 16.51 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.766 2.426 . . . . 0.0 110.571 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.88 110.39 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.969 1.708 . . . . 0.0 110.062 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -116.5 151.74 35.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.855 1.662 . . . . 0.0 111.259 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.42 126.34 29.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.931 0.893 . . . . 0.0 109.79 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.73 75.65 1.12 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.316 -0.865 . . . . 0.0 111.352 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 -5.28 2.64 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.117 1.818 . . . . 0.0 116.135 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.0 t -133.45 144.29 49.39 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.981 1.891 . . . . 0.0 112.776 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 p -76.59 31.55 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.616 2.766 . . . . 0.0 115.599 -171.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.35 176.57 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.184 1.394 . . . . 0.0 112.216 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.45 117.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.434 1.494 . . . . 0.0 108.987 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.47 -53.3 6.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.912 0.885 . . . . 0.0 111.494 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -144.42 150.64 38.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.557 1.943 . . . . 0.0 109.865 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 p -157.64 151.58 24.29 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.295 -0.878 . . . . 0.0 112.703 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.3 -6.58 8.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.217 1.407 . . . . 0.0 113.135 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -62.5 -37.5 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.287 1.435 . . . . 0.0 112.094 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -73.38 -10.62 59.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.7 1.2 . . . . 0.0 113.506 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -114.7 -170.43 1.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 127.504 2.321 . . . . 0.0 111.164 -171.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.69 125.75 83.51 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 124.378 1.071 . . . . 0.0 111.835 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.68 152.21 82.34 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.029 2.486 . . . . 0.0 112.554 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.0 tp -75.91 108.91 9.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.119 1.368 . . . . 0.0 110.897 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -93.71 131.9 38.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.532 1.533 . . . . 0.0 111.78 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -146.78 167.86 22.81 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.478 1.111 . . . . 0.0 112.88 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.0 mm -101.48 146.88 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 109.715 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.3 mm -46.46 118.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.362 1.865 . . . . 0.0 111.792 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.19 77.5 1.05 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.993 1.282 . . . . 0.0 112.886 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -123.13 -36.84 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.002 1.321 . . . . 0.0 114.426 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.47 23.27 2.45 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 126.846 2.058 . . . . 0.0 115.175 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -80.15 -24.79 40.18 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.2 pt -78.42 167.07 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.989 1.316 . . . . 0.0 112.475 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.9 pt -59.53 141.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.242 1.017 . . . . 0.0 111.692 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.34 73.43 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.91 68.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.347 0.975 . . . . 0.0 114.296 176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.58 -35.17 13.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.307 1.443 . . . . 0.0 111.844 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -59.4 -40.74 87.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.223 1.409 . . . . 0.0 112.678 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -73.69 -8.34 55.6 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.47 -47.89 5.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.978 1.311 . . . . 0.0 112.631 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.95 -28.54 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.996 1.318 . . . . 0.0 114.134 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 -19.71 63.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -108.46 -11.48 15.15 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.722 1.609 . . . . 0.0 113.843 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.94 113.09 4.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.35 1.46 . . . . 0.0 112.138 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.97 147.14 50.54 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.763 0.825 . . . . 0.0 111.891 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.49 131.65 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.432 1.093 . . . . 0.0 111.429 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.91 12.88 79.04 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.61 1.1 . . . . 0.0 115.334 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -116.65 118.53 32.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.229 1.412 . . . . 0.0 111.678 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -61.09 133.65 56.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.223 1.009 . . . . 0.0 111.947 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -136.97 136.45 38.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 110.956 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -126.63 105.93 9.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.678 1.191 . . . . 0.0 110.526 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 m -109.8 114.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.554 1.542 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.7 t -73.81 126.91 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.74 130.98 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.718 1.607 . . . . 0.0 108.989 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 154.45 87.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.65 1.18 . . . . 0.0 111.675 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.48 -45.06 15.64 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.201 1.934 . . . . 0.0 111.646 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -62.11 -21.07 64.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.116 178.435 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.2 p90 . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.55 137.82 31.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 112.002 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -126.8 124.29 39.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -88.04 82.5 7.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.9 1.68 . . . . 0.0 110.255 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.69 136.04 45.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.144 1.378 . . . . 0.0 109.722 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.77 156.01 57.63 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.475 2.117 . . . . 0.0 112.24 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -65.85 -9.28 27.54 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -56.31 -31.5 63.74 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.327 1.051 . . . . 0.0 113.582 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -82.17 -6.61 59.33 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -130.04 15.58 5.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.44 1.896 . . . . 0.0 113.403 -169.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.62 107.93 0.34 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.996 1.718 . . . . 0.0 112.289 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.84 11.05 57.13 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.88 1.229 . . . . 0.0 115.784 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.42 132.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.368 1.584 . . . . 0.0 110.557 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.67 79.45 9.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.915 1.686 . . . . 0.0 112.696 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.01 155.76 35.68 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.59 1.156 . . . . 0.0 112.819 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.91 157.64 45.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -73.96 25.69 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.113 1.765 . . . . 0.0 114.999 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.4 56.22 0.06 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.988 1.28 . . . . 0.0 112.663 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.4 ptp -132.18 149.25 52.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.699 1.2 . . . . 0.0 112.208 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -67.49 125.35 25.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.363 1.465 . . . . 0.0 110.629 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.14 160.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.627 1.571 . . . . 0.0 111.146 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -119.5 149.84 41.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.498 1.519 . . . . 0.0 111.578 -177.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.89 108.53 0.64 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.651 1.119 . . . . 0.0 113.047 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -71.82 112.63 8.09 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.817 -0.814 . . . . 0.0 111.464 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 t -89.03 159.93 17.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.618 1.167 . . . . 0.0 111.967 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -13.56 60.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.623 1.569 . . . . 0.0 113.959 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.65 11.15 0.68 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.754 1.622 . . . . 0.0 113.941 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 53.41 47.86 23.17 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.844 2.058 . . . . 0.0 111.908 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.49 168.17 20.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.776 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 m -140.78 105.56 4.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.138 -0.976 . . . . 0.0 111.045 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.35 170.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.941 -0.474 . . . . 0.0 111.494 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 139.06 54.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.088 1.755 . . . . 0.0 111.564 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.06 179.48 7.71 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.419 1.888 . . . . 0.0 111.872 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.67 128.65 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.729 1.212 . . . . 0.0 110.722 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -72.7 131.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.865 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -95.38 -42.31 8.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.988 1.715 . . . . 0.0 112.0 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -155.09 167.36 30.63 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.625 1.17 . . . . 0.0 112.006 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -140.29 144.84 36.61 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.096 1.358 . . . . 0.0 111.536 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.4 m -117.94 174.08 6.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.776 2.03 . . . . 0.0 110.613 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.05 -19.79 63.27 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.1 p -133.45 -18.31 2.22 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.846 1.658 . . . . 0.0 115.173 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -143.03 172.06 13.22 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.045 1.738 . . . . 0.0 112.145 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.2 t -137.85 126.33 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 127.13 2.172 . . . . 0.0 110.591 -172.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 76.9 mmm -94.15 111.57 23.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.695 1.598 . . . . 0.0 111.078 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.13 151.27 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.131 1.772 . . . . 0.0 112.249 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -91.71 115.57 28.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.105 1.362 . . . . 0.0 111.166 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.344 1.858 . . . . 0.0 111.234 -179.419 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.1 p -64.48 137.78 58.05 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.923 1.689 . . . . 0.0 112.351 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.25 144.78 51.56 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.795 1.238 . . . . 0.0 112.001 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.09 99.1 10.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.676 1.59 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.39 93.37 5.96 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.704 1.202 . . . . 0.0 109.837 168.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 -76.93 141.37 40.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.928 -1.108 . . . . 0.0 109.784 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -152.72 170.48 20.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.905 0.882 . . . . 0.0 113.0 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -149.55 142.28 24.6 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.14 1.376 . . . . 0.0 111.132 169.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.29 107.8 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.154 1.382 . . . . 0.0 109.025 169.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.7 mp -69.95 -33.9 72.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 111.184 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.62 -175.13 22.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.438 1.494 . . . . 0.0 114.008 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.15 139.38 42.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.0 110.455 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 124.354 1.062 . . . . 0.0 113.28 177.004 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 120.65 0.262 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.89 106.37 8.53 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.354 1.062 . . . . 0.0 110.323 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 125.17 29.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.067 1.347 . . . . 0.0 110.63 169.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.88 125.63 51.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.475 1.51 . . . . 0.0 110.388 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 pt -133.61 163.26 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.314 1.046 . . . . 0.0 112.042 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -140.59 138.05 34.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.056 1.342 . . . . 0.0 110.559 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.47 160.56 38.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.141 1.376 . . . . 0.0 113.728 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -143.33 161.39 38.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.001 1.72 . . . . 0.0 111.396 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.03 107.41 11.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.735 1.614 . . . . 0.0 110.038 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -113.92 157.41 22.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.908 1.683 . . . . 0.0 110.31 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -63.81 152.18 40.24 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.689 -0.632 . . . . 0.0 110.933 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -25.79 60.11 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.38 57.38 0.3 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.47 1.033 . . . . 0.0 113.743 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 t -144.57 163.7 33.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.604 1.162 . . . . 0.0 112.441 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -80.36 -21.96 41.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 113.466 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 pp -69.35 157.06 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.811 0.732 . . . . 0.0 111.36 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.36 144.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.508 1.523 . . . . 0.0 110.697 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.91 -48.08 6.43 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.544 0.738 . . . . 0.0 111.038 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 157.21 36.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.704 1.602 . . . . 0.0 111.735 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.5 p -162.98 163.79 25.96 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.532 1.133 . . . . 0.0 113.615 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.86 8.28 4.11 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 167.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.43 -53.58 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 p -76.32 -18.92 58.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 0.0 113.892 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.02 -171.35 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.006 2.123 . . . . 0.0 111.035 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -64.17 142.59 98.28 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 121.147 -0.97 . . . . 0.0 111.77 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.14 159.43 53.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.374 2.716 . . . . 0.0 112.597 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.86 109.06 15.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 110.363 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.59 127.14 32.12 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.438 1.895 . . . . 0.0 111.452 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.14 175.1 10.74 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.7 137.77 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.051 1.74 . . . . 0.0 109.078 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 mm -48.14 109.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.27 1.828 . . . . 0.0 111.804 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.05 87.27 1.24 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.415 1.483 . . . . 0.0 112.936 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.1 t -146.35 -33.47 0.31 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.2 m120 53.45 60.64 3.58 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.852 2.061 . . . . 0.0 113.789 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -111.04 -26.28 9.33 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.8 pt -81.04 174.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.436 1.495 . . . . 0.0 112.177 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.8 pt -58.2 141.18 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.797 0.839 . . . . 0.0 111.469 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.08 91.75 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.81 -33.45 73.28 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.052 0.834 . . . . 0.0 113.95 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 tp -81.73 -45.38 15.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.436 1.094 . . . . 0.0 111.342 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -49.36 -47.7 47.26 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.71 1.604 . . . . 0.0 113.287 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.43 -18.22 63.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 113.276 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.05 -43.92 10.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.914 1.286 . . . . 0.0 112.69 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.62 -43.06 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 119.941 1.246 . . . . 0.0 112.525 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.58 -20.79 65.94 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -102.69 -11.34 18.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.399 1.88 . . . . 0.0 113.801 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.03 126.63 31.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.408 1.483 . . . . 0.0 112.392 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -77.8 155.04 31.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.754 0.822 . . . . 0.0 112.01 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.62 134.29 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.897 1.279 . . . . 0.0 111.473 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.54 13.83 74.58 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.75 100.23 7.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.964 1.306 . . . . 0.0 111.63 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -58.18 131.86 51.83 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.287 1.035 . . . . 0.0 111.469 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.41 157.84 44.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.907 0.883 . . . . 0.0 112.79 171.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -128.79 96.78 4.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.994 1.318 . . . . 0.0 110.91 -170.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -97.94 106.23 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.394 1.478 . . . . 0.0 110.119 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 t -74.26 123.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.351 -0.843 . . . . 0.0 109.807 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.41 140.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.451 1.9 . . . . 0.0 109.383 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.15 158.91 69.34 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.416 1.087 . . . . 0.0 112.214 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.93 -46.79 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.32 2.013 . . . . 0.0 112.082 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.89 -14.42 61.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.198 1.399 . . . . 0.0 114.656 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.38 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.221 0.534 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.7 mt -121.16 146.78 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.729 1.611 . . . . 0.0 111.69 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -131.54 111.45 11.77 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.685 1.594 . . . . 0.0 111.253 167.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -69.58 115.17 8.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.715 0.806 . . . . 0.0 110.087 160.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.36 156.85 69.53 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 125.942 1.697 . . . . 0.0 109.898 176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.34 153.52 61.4 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.025 1.817 . . . . 0.0 111.881 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -61.26 -19.37 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 0.0 113.245 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -53.95 -30.51 47.06 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.49 1.516 . . . . 0.0 114.589 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -19.73 65.05 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 175.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -137.68 20.98 2.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.032 1.733 . . . . 0.0 112.556 -168.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.93 -24.8 55.26 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.168 1.787 . . . . 0.0 114.168 -171.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.18 16.07 46.29 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.059 1.79 . . . . 0.0 115.338 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.32 132.62 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.281 1.54 . . . . 0.0 111.023 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -81.34 89.2 6.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.685 1.194 . . . . 0.0 111.108 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.2 160.28 32.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 112.326 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.1 152.29 27.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.019 1.328 . . . . 0.0 111.81 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -72.88 84.25 1.23 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.685 1.194 . . . . 0.0 110.878 168.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.69 43.71 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.765 1.174 . . . . 0.0 114.699 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.4 ptm -129.38 150.69 50.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.149 1.38 . . . . 0.0 111.149 170.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 p -67.99 133.83 49.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.041 0.937 . . . . 0.0 110.955 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.24 152.82 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.35 1.86 . . . . 0.0 110.166 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.59 143.95 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.572 1.149 . . . . 0.0 110.958 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.12 99.92 0.44 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 124.802 1.191 . . . . 0.0 112.109 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -66.87 140.31 57.79 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 117.604 0.702 . . . . 0.0 111.203 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -119.07 154.54 33.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.036 1.735 . . . . 0.0 111.656 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -62.0 -17.66 57.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.988 1.715 . . . . 0.0 113.439 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.99 15.46 0.16 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 127.23 2.212 . . . . 0.0 113.999 173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.6 m120 52.66 48.12 23.21 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.134 2.174 . . . . 0.0 112.617 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -144.77 177.36 8.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.798 1.639 . . . . 0.0 111.969 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.0 m -145.2 128.94 17.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.905 1.282 . . . . 0.0 110.538 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -84.66 165.72 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.73 0.812 . . . . 0.0 111.81 172.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -133.36 126.57 31.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.465 1.506 . . . . 0.0 110.209 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.77 -172.88 4.37 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.677 1.191 . . . . 0.0 112.486 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mp -113.67 140.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.629 1.572 . . . . 0.0 109.804 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.43 134.57 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.797 1.239 . . . . 0.0 110.831 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -107.96 -32.96 7.36 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.42 1.088 . . . . 0.0 113.57 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -152.83 153.92 34.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.231 1.412 . . . . 0.0 111.173 164.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -142.63 134.12 26.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 111.715 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 160.74 39.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.567 1.547 . . . . 0.0 110.517 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.24 -23.26 67.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.1 p -77.28 -62.59 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.021 1.728 . . . . 0.0 111.68 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -138.87 160.95 38.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.007 2.123 . . . . 0.0 112.109 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.41 147.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.703 1.601 . . . . 0.0 110.396 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -121.84 105.69 10.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.69 1.596 . . . . 0.0 110.288 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -106.31 146.59 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.555 1.542 . . . . 0.0 111.072 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 141.94 49.84 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.841 -0.537 . . . . 0.0 111.112 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 125.389 1.476 . . . . 0.0 111.474 176.797 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.19 142.85 57.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.738 1.615 . . . . 0.0 111.764 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.3 mt -126.71 143.1 51.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 112.002 -174.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.85 98.53 11.83 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.949 1.3 . . . . 0.0 111.457 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -79.62 92.57 5.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.848 0.832 . . . . 0.0 110.77 168.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.12 128.77 34.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.256 1.422 . . . . 0.0 109.417 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.47 169.39 21.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -149.55 147.96 28.79 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 112.055 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.9 108.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.42 1.488 . . . . 0.0 109.167 166.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.84 -29.43 68.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.51 0.724 . . . . 0.0 111.302 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.67 172.07 14.22 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.534 2.016 . . . . 0.0 112.422 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.15 156.34 17.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.451 0.7 . . . . 0.0 112.717 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 178.652 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.19 96.95 5.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.487 1.115 . . . . 0.0 111.176 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.83 118.99 22.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.752 2.021 . . . . 0.0 111.734 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.88 130.5 48.37 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.185 1.394 . . . . 0.0 111.313 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.52 158.74 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.173 1.389 . . . . 0.0 111.734 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -138.94 141.24 38.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 110.972 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.44 154.2 49.98 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 123.123 1.44 . . . . 0.0 114.069 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -142.56 113.03 7.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.18 2.592 . . . . 0.0 109.068 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.29 115.73 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.69 1.196 . . . . 0.0 109.602 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -124.54 151.87 44.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.132 1.773 . . . . 0.0 110.547 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.66 146.76 48.06 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.606 -0.683 . . . . 0.0 111.251 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.84 -33.35 61.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -170.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.2 45.33 0.84 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.368 0.985 . . . . 0.0 114.141 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 t -142.28 156.48 45.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 112.579 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.2 p -82.52 -11.9 58.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.97 1.708 . . . . 0.0 114.331 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.03 178.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.966 1.306 . . . . 0.0 112.196 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 p -133.77 137.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.736 1.215 . . . . 0.0 110.197 168.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.7 mt -81.27 -51.39 8.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.635 0.774 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.31 163.33 30.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.925 1.29 . . . . 0.0 112.544 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.9 p -157.11 165.27 36.51 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.003 -1.061 . . . . 0.0 112.812 171.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.68 -4.29 10.27 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 164.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.62 -48.57 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.762 1.625 . . . . 0.0 112.215 -171.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -75.93 -17.24 59.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -86.93 -73.93 0.45 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.061 1.745 . . . . 0.0 111.715 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -166.93 134.18 1.99 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.665 1.986 . . . . 0.0 110.335 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.95 154.33 74.98 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.11 2.54 . . . . 0.0 112.882 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tt -95.0 111.89 23.65 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 109.796 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -93.27 131.89 37.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.868 1.267 . . . . 0.0 111.519 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -145.6 179.38 7.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 112.097 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.81 135.5 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.758 1.223 . . . . 0.0 109.251 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.8 mm -49.8 109.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.14 1.376 . . . . 0.0 111.038 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.71 53.31 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.617 1.58 . . . . 0.0 114.634 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 m -122.79 -32.23 3.57 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.591 1.156 . . . . 0.0 113.296 175.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 54.3 33.45 18.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.327 1.851 . . . . 0.0 114.888 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -79.45 -24.1 42.66 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.0 pt -69.56 166.95 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.636 1.174 . . . . 0.0 112.589 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.6 pt -57.58 141.76 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.019 0.927 . . . . 0.0 111.428 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.18 76.81 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -173.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.11 68.53 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.002 0.81 . . . . 0.0 114.17 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -90.19 -29.72 18.05 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.177 1.391 . . . . 0.0 112.213 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -60.47 -42.88 97.16 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.844 -1.16 . . . . 0.0 112.504 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.53 -10.14 53.73 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.08 -49.94 4.56 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.625 1.57 . . . . 0.0 112.821 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.87 -31.71 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.565 1.146 . . . . 0.0 114.038 -174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.64 -21.04 66.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.74 -13.78 16.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.678 1.991 . . . . 0.0 113.536 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.5 116.84 16.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.492 1.517 . . . . 0.0 112.07 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -73.7 157.48 36.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.813 0.816 . . . . 0.0 112.46 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.14 133.96 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.086 1.355 . . . . 0.0 111.639 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.47 72.52 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.758 1.171 . . . . 0.0 114.938 176.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -120.14 108.34 14.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.173 1.389 . . . . 0.0 111.201 -170.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -54.93 129.94 39.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.993 0.917 . . . . 0.0 111.456 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.84 141.26 51.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.072 1.349 . . . . 0.0 111.169 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -127.11 112.71 15.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.415 1.486 . . . . 0.0 109.572 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.81 124.03 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.627 1.171 . . . . 0.0 111.556 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.08 127.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.726 0.811 . . . . 0.0 109.646 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.34 135.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.251 1.82 . . . . 0.0 108.964 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.2 155.02 67.79 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.921 0.888 . . . . 0.0 112.329 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.15 -41.76 15.67 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.109 1.873 . . . . 0.0 111.379 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.71 -23.67 64.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.911 1.684 . . . . 0.0 114.51 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 N--CA 1.474 0.757 0 O-C-N 121.429 -0.794 . . . . 0.0 112.561 172.592 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.1 mt -153.46 132.57 12.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 129.32 3.048 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -139.93 117.01 11.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.09 1.356 . . . . 0.0 110.159 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.16 112.65 6.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 110.547 168.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.5 m -119.59 157.42 51.92 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.729 1.612 . . . . 0.0 110.634 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.43 163.04 40.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.008 1.805 . . . . 0.0 111.38 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -67.21 0.53 2.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.234 1.814 . . . . 0.0 114.667 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.31 -38.04 81.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.547 1.939 . . . . 0.0 113.907 -175.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -67.48 -15.89 63.91 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -127.38 21.18 6.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.514 1.526 . . . . 0.0 113.005 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.49 99.06 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.761 1.624 . . . . 0.0 112.171 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.95 56.93 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.599 1.571 . . . . 0.0 115.596 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.77 127.56 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.567 1.547 . . . . 0.0 109.763 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.87 124.13 21.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.828 0.851 . . . . 0.0 111.529 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.1 mt -115.11 139.27 50.03 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.335 1.454 . . . . 0.0 110.589 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -150.35 150.68 31.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.887 1.275 . . . . 0.0 111.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -76.66 89.59 3.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.83 -1.169 . . . . 0.0 111.052 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.72 43.11 0.27 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.482 1.515 . . . . 0.0 114.6 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 ptm -133.13 152.1 51.96 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.196 1.398 . . . . 0.0 111.365 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p -68.57 133.53 48.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.88 1.272 . . . . 0.0 111.32 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.73 156.94 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.481 1.913 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.86 139.54 53.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.634 1.174 . . . . 0.0 111.037 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.02 100.2 0.55 Allowed Glycine 0 N--CA 1.469 0.879 0 C-N-CA 124.878 1.228 . . . . 0.0 112.282 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -64.15 144.79 56.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.72 0.76 . . . . 0.0 111.383 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -128.93 155.44 45.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.576 1.55 . . . . 0.0 111.578 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -65.46 -14.95 62.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.836 1.654 . . . . 0.0 113.221 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -73.46 17.29 0.15 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.457 1.903 . . . . 0.0 113.934 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 54.15 44.72 28.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.144 2.178 . . . . 0.0 112.425 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.26 173.49 11.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.966 2.107 . . . . 0.0 111.48 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.4 m -146.14 118.33 8.35 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.66 1.184 . . . . 0.0 110.179 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -73.66 162.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.312 0.506 . . . . 0.0 110.976 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -137.26 119.76 15.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.348 1.459 . . . . 0.0 110.652 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.04 -170.75 3.59 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.456 1.103 . . . . 0.0 112.543 -172.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.71 142.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.393 1.477 . . . . 0.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.3 mt -73.46 126.3 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.066 -1.021 . . . . 0.0 110.303 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -101.41 -33.82 9.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.357 1.063 . . . . 0.0 113.174 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.41 154.93 36.55 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.372 1.469 . . . . 0.0 111.31 170.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -144.98 146.86 32.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.273 1.029 . . . . 0.0 112.078 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.3 t -146.47 170.46 16.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.438 1.895 . . . . 0.0 110.471 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.11 61.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.021 0.929 . . . . 0.0 113.463 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -79.91 -61.77 1.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.641 1.576 . . . . 0.0 111.706 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -138.45 166.92 23.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.029 2.132 . . . . 0.0 111.517 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.36 144.16 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.576 1.551 . . . . 0.0 110.6 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.8 mtp -118.42 93.36 4.09 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.018 1.727 . . . . 0.0 110.883 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.59 149.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.555 1.542 . . . . 0.0 109.904 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.8 114.25 4.92 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.363 -0.836 . . . . 0.0 111.508 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 125.668 1.587 . . . . 0.0 109.146 172.065 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 111.204 0.076 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.39 140.41 56.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.315 1.046 . . . . 0.0 111.701 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.62 134.15 55.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.819 2.047 . . . . 0.0 110.915 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.95 101.86 14.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.041 1.336 . . . . 0.0 111.347 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -81.68 96.96 7.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.893 0.877 . . . . 0.0 110.169 167.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -84.0 120.1 25.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.274 1.43 . . . . 0.0 108.87 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.72 168.84 18.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.69 0.677 . . . . 0.0 112.825 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -147.83 137.33 22.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.054 0.942 . . . . 0.0 111.699 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.8 t -80.63 102.77 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.211 1.004 . . . . 0.0 108.386 166.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.5 mt -65.52 -31.99 73.35 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.026 0.53 . . . . 0.0 111.549 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.31 174.32 13.45 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 126.928 2.204 . . . . 0.0 112.333 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -108.03 140.82 40.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.057 0.943 . . . . 0.0 111.113 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 125.533 1.533 . . . . 0.0 109.659 173.348 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 120.356 0.122 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.56 99.81 3.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.225 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.46 41.09 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.786 0.834 . . . . 0.0 111.051 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.62 131.55 49.89 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.721 1.608 . . . . 0.0 110.262 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -127.7 161.85 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.435 1.094 . . . . 0.0 111.791 171.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -137.27 127.12 25.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.605 1.562 . . . . 0.0 110.162 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -131.48 149.13 52.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.951 1.3 . . . . 0.0 112.888 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -137.89 148.66 45.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.631 2.372 . . . . 0.0 109.934 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.97 121.37 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.066 0.946 . . . . 0.0 112.054 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -124.26 142.82 50.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.336 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -66.29 128.64 36.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.106 0.962 . . . . 0.0 111.001 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.53 106.27 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.474 -0.767 . . . . 0.0 112.407 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.39 -13.97 47.43 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 126.445 1.974 . . . . 0.0 115.327 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -119.78 125.19 47.99 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.259 1.53 . . . . 0.0 111.582 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 m -66.43 18.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.812 2.445 . . . . 0.0 116.088 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -82.68 172.58 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.3 1.84 . . . . 0.0 112.44 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.84 89.02 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.044 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.55 -23.72 61.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.27 156.86 31.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.86 1.664 . . . . 0.0 110.389 165.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.7 p -155.66 159.68 39.78 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.435 -0.791 . . . . 0.0 111.986 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -114.33 -27.4 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.71 1.204 . . . . 0.0 112.08 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -55.43 -49.67 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.889 1.675 . . . . 0.0 112.252 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -65.47 -26.2 67.83 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.928 0.891 . . . . 0.0 113.122 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -85.81 -74.4 0.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.658 1.583 . . . . 0.0 111.351 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -169.35 149.56 3.87 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.915 2.086 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.49 144.69 74.16 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.528 2.152 . . . . 0.0 111.872 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.57 112.17 19.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 110.221 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -100.05 124.94 45.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.927 0.891 . . . . 0.0 112.199 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.04 168.86 23.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.313 1.045 . . . . 0.0 113.425 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.07 126.72 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.692 1.197 . . . . 0.0 109.137 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.0 mm -49.41 113.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.527 1.531 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.16 69.09 0.66 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.668 1.604 . . . . 0.0 112.368 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -140.04 -33.76 0.57 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.158 1.383 . . . . 0.0 113.616 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.98 28.46 14.8 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.433 1.893 . . . . 0.0 114.821 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -81.36 -21.62 38.97 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.8 pt -73.8 169.22 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.853 1.661 . . . . 0.0 112.923 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -56.63 144.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.15 0.98 . . . . 0.0 112.083 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.06 73.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.007 0.923 . . . . 0.0 113.262 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.82 70.02 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 123.731 0.681 . . . . 0.0 114.349 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -93.22 -30.43 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.773 1.229 . . . . 0.0 112.353 173.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.23 -43.14 82.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 112.321 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.92 -41.96 9.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.155 1.382 . . . . 0.0 113.024 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.05 -23.81 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.708 -1.245 . . . . 0.0 113.633 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.81 -26.86 62.57 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -83.65 -44.2 14.79 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.216 1.806 . . . . 0.0 111.394 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 122.28 13.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.846 1.258 . . . . 0.0 111.987 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 159.46 15.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.452 1.501 . . . . 0.0 111.916 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -55.67 129.95 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.128 1.371 . . . . 0.0 112.464 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.9 13.68 82.29 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.43 1.014 . . . . 0.0 115.21 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -126.26 115.77 20.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.05 1.34 . . . . 0.0 111.814 -172.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -60.2 141.16 56.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.717 0.807 . . . . 0.0 112.309 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -136.98 115.1 11.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.256 1.422 . . . . 0.0 111.382 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -90.18 114.29 26.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.227 1.411 . . . . 0.0 110.594 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.39 106.56 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.249 1.42 . . . . 0.0 110.593 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.26 131.87 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.235 -0.916 . . . . 0.0 109.593 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.6 mt -121.81 139.62 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.691 1.596 . . . . 0.0 109.228 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.6 155.46 81.46 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.226 1.01 . . . . 0.0 111.969 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.65 -29.96 84.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.604 2.203 . . . . 0.0 113.308 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.66 -23.86 45.47 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 . . . . . 0 N--CA 1.477 0.877 0 C-N-CA 125.093 1.357 . . . . 0.0 113.758 -172.61 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.27 148.97 27.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.027 0.931 . . . . 0.0 110.853 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -140.07 108.52 5.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.656 1.182 . . . . 0.0 110.838 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.35 122.92 18.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.351 1.061 . . . . 0.0 111.148 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 p -136.05 137.96 26.32 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.492 1.917 . . . . 0.0 109.949 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.3 168.32 25.09 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.739 2.292 . . . . 0.0 112.428 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -69.46 21.19 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.412 2.285 . . . . 0.0 115.003 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.89 -19.91 19.19 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.429 1.891 . . . . 0.0 113.888 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -98.61 -9.65 24.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.818 1.247 . . . . 0.0 113.814 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.24 26.62 6.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.299 1.84 . . . . 0.0 112.647 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.29 105.43 0.23 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 111.174 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.78 -0.02 39.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.647 1.594 . . . . 0.0 115.75 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.8 mt -100.51 136.85 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.321 1.56 . . . . 0.0 110.387 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.06 76.61 10.05 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.08 1.752 . . . . 0.0 112.971 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 140.52 57.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.137 -0.977 . . . . 0.0 112.334 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.38 152.95 32.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.397 1.879 . . . . 0.0 110.869 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -72.83 108.41 5.78 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.461 170.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.19 57.56 1.29 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.492 1.044 . . . . 0.0 113.54 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.7 ptm -135.05 154.72 51.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.768 1.627 . . . . 0.0 111.319 167.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 p -79.74 119.03 22.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.148 0.979 . . . . 0.0 110.64 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.95 158.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.823 1.649 . . . . 0.0 110.34 173.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -125.82 153.84 43.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.168 1.387 . . . . 0.0 111.465 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.49 101.47 0.28 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.382 0.991 . . . . 0.0 112.608 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -65.14 128.54 36.2 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.939 -0.742 . . . . 0.0 110.985 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -105.78 155.67 19.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.453 1.501 . . . . 0.0 111.399 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.03 -20.07 65.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.301 1.44 . . . . 0.0 113.126 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -71.65 19.83 0.06 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.983 2.113 . . . . 0.0 114.192 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.5 m120 52.02 47.63 24.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.316 2.246 . . . . 0.0 112.915 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -142.12 177.78 7.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.719 1.607 . . . . 0.0 112.109 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.8 m -145.99 113.85 6.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.361 1.064 . . . . 0.0 111.373 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.41 164.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.338 0.655 . . . . 0.0 111.406 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -136.57 136.8 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.358 1.463 . . . . 0.0 111.346 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.11 -178.99 7.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.455 1.102 . . . . 0.0 113.361 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.08 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.411 1.484 . . . . 0.0 110.538 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.2 mt -76.99 120.2 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.13 0.972 . . . . 0.0 110.661 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.96 -31.06 16.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.169 1.388 . . . . 0.0 113.531 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -153.7 150.0 28.1 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.878 1.671 . . . . 0.0 110.673 171.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -141.18 155.01 46.12 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.926 0.89 . . . . 0.0 112.661 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -153.34 174.26 14.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.172 1.789 . . . . 0.0 111.135 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 -29.44 66.88 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.47 1.108 . . . . 0.0 113.187 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.1 p -80.57 -62.76 1.58 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.017 1.727 . . . . 0.0 111.944 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -135.53 166.64 22.73 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.226 2.21 . . . . 0.0 111.405 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.83 147.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.915 1.686 . . . . 0.0 109.319 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 28.4 mtm -121.11 101.57 7.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.177 1.391 . . . . 0.0 110.15 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.3 t -97.17 150.12 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.394 1.077 . . . . 0.0 110.131 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.35 130.68 47.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.653 0.781 . . . . 0.0 111.033 166.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 CA--C 1.539 0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 111.571 176.65 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 120.432 0.158 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -65.72 143.75 57.34 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.766 1.226 . . . . 0.0 112.808 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.9 mt -125.01 123.06 39.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.13 1.372 . . . . 0.0 111.356 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.74 99.51 5.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.967 1.307 . . . . 0.0 111.159 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -79.68 99.46 7.41 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.757 0.789 . . . . 0.0 110.186 165.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -91.74 120.55 32.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.114 1.365 . . . . 0.0 109.034 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -140.94 168.7 19.15 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -148.33 140.49 24.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.079 1.351 . . . . 0.0 111.43 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.09 102.4 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 163.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.29 -33.73 71.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 111.701 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.76 -139.07 10.63 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.265 1.888 . . . . 0.0 110.675 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -150.31 165.2 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.461 1.105 . . . . 0.0 112.374 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.468 0.458 0 C-N-CA 126.221 1.809 . . . . 0.0 110.813 171.678 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.767 0.317 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.22 101.16 7.83 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 109.593 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.28 144.13 31.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.096 1.358 . . . . 0.0 111.033 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.74 126.53 47.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.503 1.521 . . . . 0.0 109.932 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.15 156.83 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.323 1.049 . . . . 0.0 110.969 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -139.16 135.68 34.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.68 1.192 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -138.3 157.2 46.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.781 1.232 . . . . 0.0 113.574 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -139.62 152.85 47.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.439 1.896 . . . . 0.0 110.763 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.85 119.13 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.583 1.553 . . . . 0.0 109.693 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -139.13 145.66 39.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.764 1.625 . . . . 0.0 111.176 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.22 133.18 45.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.454 0.702 . . . . 0.0 111.215 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -57.74 111.33 1.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.155 0.982 . . . . 0.0 111.752 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 23.24 33.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.64 1.114 . . . . 0.0 115.634 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -128.21 165.48 20.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.119 1.46 . . . . 0.0 113.579 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.2 m -99.15 -8.35 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.428 1.891 . . . . 0.0 113.865 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 166.98 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.643 0.777 . . . . 0.0 111.704 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.35 116.04 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.404 1.482 . . . . 0.0 108.751 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.58 -48.73 37.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.588 0.755 . . . . 0.0 111.026 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.27 162.04 36.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.16 1.384 . . . . 0.0 112.025 170.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -161.52 168.4 23.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.141 . . . . 0.0 112.494 168.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -123.82 -1.71 8.37 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 164.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.54 -60.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.733 1.613 . . . . 0.0 112.156 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -73.67 -22.98 59.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -74.5 -72.94 0.26 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.934 1.693 . . . . 0.0 112.067 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -169.7 118.65 0.55 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.083 2.153 . . . . 0.0 109.846 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -62.76 152.04 80.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.862 2.374 . . . . 0.0 112.706 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.8 tp -83.6 98.56 9.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.629 1.572 . . . . 0.0 110.873 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -71.11 117.51 12.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.357 1.463 . . . . 0.0 110.98 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -144.76 175.43 10.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.441 1.096 . . . . 0.0 113.129 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -113.48 137.52 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.456 1.502 . . . . 0.0 110.138 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -51.65 110.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.166 1.386 . . . . 0.0 111.086 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.94 -1.61 24.31 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.723 1.63 . . . . 0.0 115.677 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 m -70.69 -44.88 66.04 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.338 1.569 . . . . 0.0 112.531 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.3 m120 50.59 31.5 5.76 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.16 2.184 . . . . 0.0 116.013 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -13.81 61.19 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -69.63 168.31 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.843 1.657 . . . . 0.0 113.363 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -58.73 144.62 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.403 1.081 . . . . 0.0 111.953 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.7 -37.01 77.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.39 -29.11 73.56 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.672 -0.643 . . . . 0.0 113.82 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.03 -32.47 17.57 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 111.963 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -54.56 -47.31 73.41 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.061 1.344 . . . . 0.0 111.992 172.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -71.43 -10.81 60.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.67 -50.99 5.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.104 1.362 . . . . 0.0 112.485 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.04 -24.89 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -66.09 -19.99 66.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -106.0 -17.89 14.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.128 1.371 . . . . 0.0 114.187 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.97 118.65 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.667 1.187 . . . . 0.0 112.554 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -83.96 158.62 21.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 112.4 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -56.89 130.17 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.079 1.352 . . . . 0.0 111.595 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.97 11.81 78.88 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.977 1.275 . . . . 0.0 115.271 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -116.43 112.37 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.901 1.351 . . . . 0.0 111.763 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -60.33 143.21 53.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.189 0.995 . . . . 0.0 112.165 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -142.23 145.27 33.91 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.768 1.227 . . . . 0.0 111.476 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -126.08 113.16 16.72 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.869 1.668 . . . . 0.0 109.864 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -118.69 111.34 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.678 1.191 . . . . 0.0 110.533 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 t -76.45 128.39 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.919 0.888 . . . . 0.0 109.512 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 mt -124.83 139.4 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.461 1.505 . . . . 0.0 109.822 -174.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.09 151.66 97.03 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 112.133 173.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.6 -36.24 43.44 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.587 2.191 . . . . 0.0 112.508 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -67.31 -21.08 65.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.869 1.268 . . . . 0.0 114.166 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.761 1.224 . . . . 0.0 113.216 177.877 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.9 p90 . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.26 115.05 21.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.078 -1.014 . . . . 0.0 110.533 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -102.44 118.85 37.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.664 1.186 . . . . 0.0 110.814 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.47 128.83 36.79 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.82 0.848 . . . . 0.0 110.676 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 139.86 17.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.31 1.844 . . . . 0.0 109.613 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.09 154.95 62.17 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.458 2.105 . . . . 0.0 112.684 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -68.95 -4.56 17.16 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.39 -35.18 37.73 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 112.963 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -88.48 -2.97 58.89 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.323 1.449 . . . . 0.0 113.797 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -131.79 25.52 4.68 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.314 2.246 . . . . 0.0 112.326 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.64 105.49 1.24 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.793 1.637 . . . . 0.0 111.426 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.72 -9.14 56.83 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.725 1.631 . . . . 0.0 115.048 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.5 mt -88.38 126.13 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 109.634 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.36 130.92 45.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.609 0.763 . . . . 0.0 112.058 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.2 mt -124.77 138.57 54.27 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.723 1.609 . . . . 0.0 110.521 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -154.15 158.04 39.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.202 1.401 . . . . 0.0 111.01 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.13 119.32 10.61 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.949 -1.095 . . . . 0.0 111.16 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.94 43.11 5.16 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.09 0.852 . . . . 0.0 115.2 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 ptm -132.89 152.13 51.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.84 1.256 . . . . 0.0 111.889 168.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -74.03 134.09 42.98 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.351 1.06 . . . . 0.0 111.327 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.62 146.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.003 2.121 . . . . 0.0 110.592 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 133.89 41.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.94 1.296 . . . . 0.0 111.425 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.17 93.34 0.55 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.216 1.388 . . . . 0.0 112.196 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -63.74 144.46 57.01 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.961 0.88 . . . . 0.0 111.237 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 t -129.26 156.52 43.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.063 1.345 . . . . 0.0 112.435 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.14 -17.16 64.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.503 1.921 . . . . 0.0 113.474 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -74.81 16.63 0.27 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.34 1.856 . . . . 0.0 113.714 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.86 48.75 17.42 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.108 2.163 . . . . 0.0 112.511 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -143.36 176.32 9.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.96 1.704 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -146.62 113.53 6.12 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.674 1.189 . . . . 0.0 111.642 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.0 169.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.403 0.681 . . . . 0.0 111.717 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -135.72 124.83 24.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.426 1.49 . . . . 0.0 110.595 172.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.25 175.42 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.669 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -110.84 131.98 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 111.534 -171.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 56.7 mt -67.81 134.27 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.854 1.662 . . . . 0.0 111.304 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -112.39 -34.35 5.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.393 1.877 . . . . 0.0 113.299 -174.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -151.82 162.49 40.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.147 1.379 . . . . 0.0 110.855 169.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.81 158.36 43.74 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.9 m -140.0 176.6 8.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.159 2.184 . . . . 0.0 111.081 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.94 76.09 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 67.4 p -128.73 -3.57 5.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.842 1.657 . . . . 0.0 114.419 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -140.98 166.38 24.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.974 1.709 . . . . 0.0 111.679 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.71 157.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.602 1.561 . . . . 0.0 110.419 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.1 mtp -120.22 123.02 42.22 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.79 1.636 . . . . 0.0 109.771 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.69 143.46 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.35 1.46 . . . . 0.0 109.357 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -69.84 110.89 5.21 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.75 -0.594 . . . . 0.0 111.366 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 126.733 2.013 . . . . 0.0 111.779 178.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -66.6 145.33 55.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.89 1.676 . . . . 0.0 112.43 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.9 mt -133.92 147.75 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.294 1.437 . . . . 0.0 111.728 -174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.47 103.25 15.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 111.196 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -79.81 97.6 6.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.288 0.635 . . . . 0.0 109.405 161.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -89.63 140.42 29.57 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 170.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -150.34 169.39 21.51 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -146.25 150.5 35.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.391 1.476 . . . . 0.0 111.237 169.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.54 109.2 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 108.548 167.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.72 -36.85 84.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.184 0.593 . . . . 0.0 111.114 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.2 -164.07 25.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.114 1.816 . . . . 0.0 111.963 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.31 157.7 45.43 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.663 1.585 . . . . 0.0 111.291 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 C-N-CA 124.971 1.309 . . . . 0.0 111.269 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.051 0.453 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -144.32 129.11 18.31 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.101 0.961 . . . . 0.0 111.011 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -88.37 76.97 8.24 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.079 1.351 . . . . 0.0 111.247 175.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -137.72 171.26 14.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.264 1.825 . . . . 0.0 111.876 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -63.99 162.94 13.06 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.199 1.399 . . . . 0.0 113.433 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.77 94.55 3.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.968 1.307 . . . . 0.0 110.968 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -70.51 13.62 0.17 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.893 1.677 . . . . 0.0 114.52 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.9 m -71.25 -18.02 62.46 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.984 1.714 . . . . 0.0 114.494 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -86.12 131.02 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.686 1.195 . . . . 0.0 110.212 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -61.38 152.04 30.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.315 1.846 . . . . 0.0 113.689 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -139.85 152.72 46.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.61 1.564 . . . . 0.0 111.331 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.19 99.58 12.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.173 1.389 . . . . 0.0 110.679 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.08 106.04 13.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.546 1.539 . . . . 0.0 111.273 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.63 134.86 35.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 pt -132.46 167.16 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.48 1.512 . . . . 0.0 111.731 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -143.5 136.0 27.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.446 1.899 . . . . 0.0 110.394 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.3 153.04 51.29 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.419 1.488 . . . . 0.0 113.89 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -141.03 121.73 14.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.476 2.31 . . . . 0.0 109.483 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.12 103.46 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.498 1.119 . . . . 0.0 110.186 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -113.92 159.32 20.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.694 1.598 . . . . 0.0 110.623 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.55 147.2 29.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.002 -1.061 . . . . 0.0 111.506 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -64.14 125.57 24.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.389 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.01 -52.91 4.69 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.47 1.51 . . . . 0.0 114.201 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -61.16 143.79 54.87 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.52 1.528 . . . . 0.0 112.818 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -79.27 -13.91 59.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.87 155.98 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.708 1.203 . . . . 0.0 111.362 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.3 144.12 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.407 1.483 . . . . 0.0 110.664 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.58 -52.87 4.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.256 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.9 157.83 36.97 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.626 1.57 . . . . 0.0 111.048 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.3 p -151.05 144.7 25.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.295 1.038 . . . . 0.0 111.828 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.47 -17.85 15.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 167.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -56.49 -46.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.636 1.574 . . . . 0.0 112.019 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 t -68.54 -29.81 68.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -78.09 -72.97 0.34 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.777 1.631 . . . . 0.0 111.748 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -175.48 151.91 1.32 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 128.171 2.588 . . . . 0.0 110.016 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.92 170.86 15.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.66 2.906 . . . . 0.0 113.428 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 tt -124.0 108.55 12.51 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.251 1.42 . . . . 0.0 110.556 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.8 141.65 32.15 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.728 1.211 . . . . 0.0 112.968 170.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -144.12 164.74 29.8 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.256 1.423 . . . . 0.0 111.364 166.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.7 mm -84.1 138.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.702 0.801 . . . . 0.0 110.139 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 mm -47.86 109.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.523 1.529 . . . . 0.0 111.3 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -27.79 6.68 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.244 1.878 . . . . 0.0 114.315 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.6 m -85.25 72.77 10.69 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.922 1.361 . . . . 0.0 111.466 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 72.58 4.83 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.76 -1.213 . . . . 0.0 111.854 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -72.38 -11.84 60.86 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.0 pt -66.76 169.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 127.186 2.194 . . . . 0.0 113.188 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -58.84 147.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.909 1.284 . . . . 0.0 112.46 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.6 74.25 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.53 -36.84 93.66 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 121.194 -0.941 . . . . 0.0 113.109 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 tp -80.87 -28.11 36.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.744 1.218 . . . . 0.0 112.595 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -57.39 -42.78 82.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.431 1.092 . . . . 0.0 112.64 173.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -75.23 -14.93 60.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.67 -47.83 8.36 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.969 1.308 . . . . 0.0 112.645 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.02 -30.71 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.403 1.081 . . . . 0.0 113.615 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.09 -21.98 64.02 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -97.23 -23.04 16.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.811 1.645 . . . . 0.0 113.453 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.38 127.23 32.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.979 1.311 . . . . 0.0 112.28 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -83.62 162.81 20.68 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.925 0.89 . . . . 0.0 111.966 172.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.5 133.19 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.06 1.344 . . . . 0.0 111.692 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.42 13.37 81.71 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.44 1.019 . . . . 0.0 115.307 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -121.48 112.73 18.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.089 1.356 . . . . 0.0 111.832 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -59.92 141.01 56.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.046 0.938 . . . . 0.0 112.029 172.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -141.9 144.03 33.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.95 1.3 . . . . 0.0 111.042 174.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.29 110.96 13.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.672 1.189 . . . . 0.0 110.287 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -113.84 107.97 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.884 1.274 . . . . 0.0 110.839 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.08 126.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.201 1.0 . . . . 0.0 109.657 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.0 mt -124.69 138.56 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.694 1.597 . . . . 0.0 109.065 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 160.32 82.68 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.14 0.976 . . . . 0.0 112.178 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.05 -38.89 14.93 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.5 2.133 . . . . 0.0 111.786 -175.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.46 -12.48 61.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.117 1.767 . . . . 0.0 114.468 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.65 -1.02 26.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.956 1.702 . . . . 0.0 113.046 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.34 -65.28 1.21 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.525 1.53 . . . . 0.0 112.09 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -127.91 -20.33 3.87 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.2 25.18 68.0 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 t -64.22 -41.94 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.445 1.098 . . . . 0.0 112.38 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.97 92.04 2.69 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.478 1.111 . . . . 0.0 110.837 -172.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.89 163.45 7.61 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.385 1.474 . . . . 0.0 113.379 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.9 p -113.77 34.92 4.31 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.641 1.976 . . . . 0.0 112.782 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 t -123.48 106.42 10.6 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.283 1.833 . . . . 0.0 110.715 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -137.04 139.43 41.35 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.243 1.817 . . . . 0.0 110.863 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.395 -0.816 . . . . 0.0 111.342 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -134.99 125.22 26.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.994 1.718 . . . . 0.0 110.24 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -74.43 119.05 18.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.024 0.93 . . . . 0.0 110.611 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.34 134.52 25.57 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 109.189 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.22 144.11 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.245 1.963 . . . . 0.0 111.582 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -62.07 -14.17 33.61 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.26 -31.34 61.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.58 1.552 . . . . 0.0 113.267 169.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -70.56 -11.58 61.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.415 1.086 . . . . 0.0 113.901 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -132.63 16.88 4.35 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.883 1.673 . . . . 0.0 113.317 -167.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.76 -18.83 14.05 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -172.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.99 6.7 12.09 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.823 1.678 . . . . 0.0 115.426 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.6 pt -137.6 114.86 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.837 1.655 . . . . 0.0 111.31 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -66.39 154.03 41.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.523 1.129 . . . . 0.0 113.39 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.4 mt -132.74 162.85 30.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.823 . . . . 0.0 111.121 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -155.74 162.75 40.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.194 1.398 . . . . 0.0 110.599 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -69.88 129.49 39.67 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.431 -1.418 . . . . 0.0 110.436 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.99 65.47 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.724 1.05 . . . . 0.0 115.724 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp -97.26 150.2 21.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.282 1.541 . . . . 0.0 112.682 171.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 p -72.47 108.44 5.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 111.039 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.73 161.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.717 1.607 . . . . 0.0 110.934 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.52 154.55 40.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.12 1.368 . . . . 0.0 111.484 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.73 108.71 0.47 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.353 0.978 . . . . 0.0 113.084 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -73.33 111.4 8.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 111.575 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.3 t -80.83 158.19 25.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.563 1.145 . . . . 0.0 111.924 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.98 -17.36 63.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.386 1.474 . . . . 0.0 113.682 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.08 20.41 0.14 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.845 1.658 . . . . 0.0 113.911 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 50.22 48.0 22.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.346 2.259 . . . . 0.0 113.073 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -142.36 173.41 11.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.926 1.69 . . . . 0.0 111.736 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.0 m -141.07 107.84 5.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.629 1.171 . . . . 0.0 110.643 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.2 166.44 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.753 -0.592 . . . . 0.0 111.419 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -128.04 137.48 52.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.526 1.53 . . . . 0.0 110.879 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.8 178.98 9.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 113.206 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -126.82 125.65 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.186 0.994 . . . . 0.0 111.394 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.2 mt -72.78 129.02 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.475 1.11 . . . . 0.0 111.128 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -98.06 -35.89 10.28 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.692 1.597 . . . . 0.0 113.305 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -150.7 147.98 28.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.141 1.376 . . . . 0.0 110.164 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -140.01 136.93 34.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.169 0.987 . . . . 0.0 111.704 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.8 t -137.07 168.7 19.09 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.189 1.796 . . . . 0.0 110.154 172.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.33 63.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.099 0.96 . . . . 0.0 113.528 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 p -83.82 -62.05 1.67 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.233 1.813 . . . . 0.0 111.75 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -136.0 165.03 26.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.007 2.123 . . . . 0.0 111.707 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.634 1.573 . . . . 0.0 110.328 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mmm -120.64 105.28 10.64 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.727 2.011 . . . . 0.0 109.332 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 t -112.02 133.76 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 0.0 110.237 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.48 129.99 41.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.722 0.809 . . . . 0.0 111.32 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -136.34 163.81 29.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.656 1.582 . . . . 0.0 111.17 170.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -79.98 169.55 17.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.324 1.05 . . . . 0.0 112.701 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 144.6 17.51 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.571 1.148 . . . . 0.0 110.497 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.38 -9.19 24.84 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.147 2.565 . . . . 0.0 114.195 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.6 -17.93 62.89 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.53 1.532 . . . . 0.0 112.967 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.76 -176.33 0.64 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.483 1.513 . . . . 0.0 113.429 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.1 176.75 9.34 Favored Glycine 0 CA--C 1.543 1.81 0 O-C-N 121.334 -0.854 . . . . 0.0 114.184 166.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 168.65 19.12 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.158 2.183 . . . . 0.0 111.331 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -69.75 141.95 53.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.865 1.266 . . . . 0.0 112.369 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.64 147.97 49.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.534 1.534 . . . . 0.0 110.974 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.77 96.9 9.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.965 1.706 . . . . 0.0 111.074 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -76.86 95.72 4.15 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.799 0.84 . . . . 0.0 109.801 164.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -86.35 143.23 27.96 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.554 -0.716 . . . . 0.0 110.216 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -151.69 170.33 19.99 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -145.92 142.68 28.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.12 1.368 . . . . 0.0 111.306 168.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.25 101.97 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.438 1.095 . . . . 0.0 108.445 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.82 -37.4 86.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.243 1.017 . . . . 0.0 111.574 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 133.78 166.15 11.23 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.049 1.785 . . . . 0.0 113.29 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -98.54 146.92 25.3 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.492 1.117 . . . . 0.0 111.815 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -142.08 147.85 37.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.662 1.585 . . . . 0.0 111.31 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -74.51 136.58 42.2 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.983 0.513 . . . . 0.0 110.379 170.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.8 m -133.89 160.3 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.777 1.631 . . . . 0.0 111.062 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.6 m -135.86 156.66 48.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.995 1.318 . . . . 0.0 112.087 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -90.94 55.48 2.93 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.16 1.384 . . . . 0.0 111.567 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -138.19 -73.19 0.41 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.77 1.228 . . . . 0.0 111.43 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.187 1.395 . . . . 0.0 113.399 173.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 44.15 47.43 7.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.031 2.132 . . . . 0.0 113.98 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -126.92 22.37 6.75 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.403 1.881 . . . . 0.0 113.724 -169.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -98.16 70.3 2.05 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.771 1.628 . . . . 0.0 110.978 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.29 150.27 36.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.549 1.14 . . . . 0.0 111.985 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -120.39 148.18 44.11 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.954 1.702 . . . . 0.0 111.551 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -77.67 5.35 9.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.719 1.608 . . . . 0.0 114.083 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.1 m -69.36 8.27 0.64 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.473 1.909 . . . . 0.0 114.741 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.2 mm -55.4 144.34 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.561 1.944 . . . . 0.0 111.261 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -111.65 167.32 10.43 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.117 1.767 . . . . 0.0 111.812 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -146.03 153.04 40.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.062 1.345 . . . . 0.0 111.863 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 102.77 10.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.817 1.247 . . . . 0.0 110.618 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.68 118.88 24.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.038 1.335 . . . . 0.0 111.132 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.83 129.46 45.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.775 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.23 165.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.182 . . . . 0.0 111.896 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.46 136.27 34.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.913 1.685 . . . . 0.0 110.121 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.58 154.08 50.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 113.723 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.75 121.11 12.34 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 109.403 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.95 111.47 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 110.472 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -121.27 134.67 55.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.849 1.659 . . . . 0.0 109.229 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -63.67 152.77 38.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.984 -1.072 . . . . 0.0 111.103 165.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -71.46 151.63 43.8 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.394 -0.816 . . . . 0.0 110.832 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.6 -66.29 3.95 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.826 1.203 . . . . 0.0 113.987 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -65.29 141.58 58.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.01 0.905 . . . . 0.0 113.096 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 m -82.06 -15.33 53.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.69 176.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.284 1.033 . . . . 0.0 111.356 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.74 143.22 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.134 1.374 . . . . 0.0 111.274 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 mt -75.84 -57.15 4.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.126 0.971 . . . . 0.0 111.011 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -155.18 157.6 37.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.876 1.27 . . . . 0.0 111.746 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.3 p -155.02 137.06 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.777 1.231 . . . . 0.0 112.179 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.67 -18.06 19.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 166.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -56.94 -43.66 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.643 1.577 . . . . 0.0 112.047 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 t -72.25 -8.82 56.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.088 1.355 . . . . 0.0 113.976 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -107.87 -73.32 0.69 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.364 1.866 . . . . 0.0 110.889 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.52 152.53 6.82 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.966 2.507 . . . . 0.0 110.357 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.79 159.71 52.64 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.78 2.32 . . . . 0.0 112.553 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 tt -104.2 108.93 20.55 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.62 1.568 . . . . 0.0 109.544 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.97 130.76 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.489 1.516 . . . . 0.0 112.158 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.6 162.88 37.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.185 0.994 . . . . 0.0 111.963 167.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.0 mm -81.62 137.91 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.68 0.792 . . . . 0.0 109.033 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.69 104.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.507 1.123 . . . . 0.0 110.879 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.05 39.41 0.23 Allowed Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.508 1.528 . . . . 0.0 116.116 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.6 m -122.79 -31.66 3.65 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.141 1.47 . . . . 0.0 114.256 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 57.59 31.06 19.77 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.668 1.587 . . . . 0.0 114.425 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -69.74 -19.79 63.53 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.6 pt -75.84 168.0 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.298 1.439 . . . . 0.0 112.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.7 pt -59.16 148.14 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.556 1.143 . . . . 0.0 111.96 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.04 84.2 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.94 0.896 . . . . 0.0 113.298 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.88 68.84 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.051 0.834 . . . . 0.0 114.656 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.12 -36.62 11.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.382 1.473 . . . . 0.0 111.555 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -56.17 -44.25 79.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.401 1.081 . . . . 0.0 111.921 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -76.67 12.31 1.35 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.886 1.274 . . . . 0.0 113.802 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.52 -45.24 2.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.973 1.709 . . . . 0.0 113.121 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.5 m -55.5 -28.19 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -62.76 -16.45 57.9 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -110.92 -5.35 14.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.142 1.377 . . . . 0.0 113.627 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.95 114.02 18.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.012 1.325 . . . . 0.0 112.331 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -71.57 157.18 38.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.833 0.825 . . . . 0.0 112.369 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.18 135.65 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.53 1.532 . . . . 0.0 112.027 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.71 16.34 74.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.63 1.11 . . . . 0.0 115.094 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -122.19 111.7 17.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.318 1.447 . . . . 0.0 111.178 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -58.5 142.77 47.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.78 0.832 . . . . 0.0 112.163 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -142.46 141.21 32.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.777 1.231 . . . . 0.0 111.19 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -125.79 105.23 8.81 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.272 1.429 . . . . 0.0 110.329 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.67 106.8 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.865 1.266 . . . . 0.0 111.109 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.58 128.99 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.371 1.069 . . . . 0.0 109.783 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.96 145.79 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.939 1.696 . . . . 0.0 109.664 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.63 156.96 81.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.364 1.466 . . . . 0.0 113.283 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.15 -3.14 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.036 3.157 . . . . 0.0 116.634 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.83 -4.06 12.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.602 1.161 . . . . 0.0 113.502 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -111.49 -6.45 14.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.503 1.521 . . . . 0.0 113.637 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.04 91.06 2.54 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.87 1.668 . . . . 0.0 111.352 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 40.21 67.46 0.49 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.716 2.006 . . . . 0.0 112.547 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.71 100.99 0.48 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.742 1.163 . . . . 0.0 114.172 -170.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.3 m -126.06 139.6 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.83 1.652 . . . . 0.0 111.181 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -71.09 154.44 41.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.18 1.392 . . . . 0.0 111.363 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.93 131.25 47.11 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.176 -0.952 . . . . 0.0 110.343 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -61.61 -20.81 63.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 73.9 m -144.97 82.14 1.66 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.826 2.05 . . . . 0.0 111.22 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -76.78 156.42 32.36 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.11 -0.994 . . . . 0.0 111.991 171.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.53 138.78 45.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.132 1.773 . . . . 0.0 110.456 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -134.02 113.35 12.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 111.238 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -79.17 96.42 5.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.931 1.292 . . . . 0.0 111.33 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -94.74 137.33 22.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.319 1.847 . . . . 0.0 109.799 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.7 158.51 50.38 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.901 2.401 . . . . 0.0 112.13 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -76.27 65.24 2.18 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.371 1.068 . . . . 0.0 111.813 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -133.3 -36.43 0.99 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.421 1.889 . . . . 0.0 112.599 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -74.02 -12.37 60.61 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 171.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.14 28.54 6.04 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.977 1.711 . . . . 0.0 112.631 -171.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -11.94 60.77 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.95 5.42 6.46 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.772 1.653 . . . . 0.0 115.33 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 pt -138.21 122.29 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.509 1.924 . . . . 0.0 110.463 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -68.33 154.87 40.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.1 0.96 . . . . 0.0 113.34 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -133.16 159.4 40.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.482 1.913 . . . . 0.0 110.832 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -155.53 164.36 38.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 110.574 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -67.12 132.39 47.73 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.626 -1.296 . . . . 0.0 110.599 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.85 43.59 65.68 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.188 0.899 . . . . 0.0 114.655 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.38 145.3 47.31 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.55 1.14 . . . . 0.0 111.952 170.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -68.96 123.93 22.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.656 1.182 . . . . 0.0 110.679 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.33 155.58 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.514 1.526 . . . . 0.0 111.398 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -90.37 144.72 25.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.455 1.102 . . . . 0.0 111.608 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.03 96.94 0.49 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -65.31 144.31 57.21 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.267 1.034 . . . . 0.0 111.261 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.1 t -125.27 154.61 41.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.244 1.418 . . . . 0.0 112.151 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.4 -15.65 60.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.618 1.967 . . . . 0.0 113.65 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.38 15.71 0.43 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.44 1.896 . . . . 0.0 113.777 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.53 48.53 20.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 112.564 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -142.7 179.96 6.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.764 1.626 . . . . 0.0 112.202 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.6 m -145.73 127.91 15.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.563 1.145 . . . . 0.0 111.766 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -98.52 172.8 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.998 1.319 . . . . 0.0 112.104 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -121.19 119.98 33.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.183 1.793 . . . . 0.0 109.924 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -136.25 177.99 7.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.262 1.825 . . . . 0.0 112.415 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.23 131.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.165 1.386 . . . . 0.0 110.001 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -72.47 129.02 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.199 1.0 . . . . 0.0 110.663 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -93.98 -43.33 8.59 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.83 1.252 . . . . 0.0 112.359 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -144.45 152.74 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.004 1.322 . . . . 0.0 111.1 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.97 148.65 34.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.805 1.242 . . . . 0.0 112.431 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.7 t -152.34 171.51 17.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.724 2.01 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.28 -24.5 64.88 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.562 1.145 . . . . 0.0 113.352 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.2 p -84.31 -61.43 1.81 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.456 1.903 . . . . 0.0 112.571 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.27 166.02 24.78 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.277 2.231 . . . . 0.0 111.764 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.21 137.23 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 110.562 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 26.3 mmm -109.85 99.44 8.58 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.737 2.015 . . . . 0.0 109.601 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -98.2 149.89 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.346 1.059 . . . . 0.0 111.328 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.97 141.76 45.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 111.694 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -137.78 165.54 26.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.264 1.425 . . . . 0.0 111.697 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -147.19 92.43 2.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.278 1.431 . . . . 0.0 110.521 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -86.26 131.1 47.33 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.478 0.711 . . . . 0.0 110.565 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.07 -16.99 32.05 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.855 2.37 . . . . 0.0 114.084 -174.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.5 mt -111.31 77.07 1.01 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.995 1.718 . . . . 0.0 109.968 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.96 173.46 16.76 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.606 1.163 . . . . 0.0 113.34 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.06 -179.45 31.08 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.857 2.17 . . . . 0.0 113.321 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -139.36 165.98 25.78 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.032 1.733 . . . . 0.0 112.868 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.4 p -63.97 137.21 57.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.99 1.316 . . . . 0.0 113.227 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 mt -123.12 125.51 45.3 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.339 1.456 . . . . 0.0 111.842 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.97 96.39 6.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.177 1.391 . . . . 0.0 111.157 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.79 97.47 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.636 0.774 . . . . 0.0 109.233 162.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.34 142.75 27.65 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.111 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -150.97 170.75 18.58 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -148.72 137.8 21.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.167 1.387 . . . . 0.0 111.183 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.6 t -80.95 103.02 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.46 1.104 . . . . 0.0 108.341 166.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.9 mt -66.89 -28.3 68.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.906 0.482 . . . . 0.0 112.139 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.13 -179.01 16.6 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.612 2.053 . . . . 0.0 112.254 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -115.49 154.76 28.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.049 0.94 . . . . 0.0 112.03 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -132.71 124.79 28.84 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.691 1.596 . . . . 0.0 111.108 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -70.72 127.07 31.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.72 1.208 . . . . 0.0 110.337 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.88 130.77 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.597 1.159 . . . . 0.0 111.342 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.2 m -146.23 157.38 43.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.296 1.439 . . . . 0.0 111.966 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -88.17 -9.55 52.76 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.671 1.188 . . . . 0.0 113.601 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.79 -46.49 65.63 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.062 1.345 . . . . 0.0 112.753 -174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 125.721 1.608 . . . . 0.0 113.179 172.326 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtm . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -154.45 175.38 13.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.12 1.768 . . . . 0.0 110.954 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -60.53 147.79 40.16 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.795 0.838 . . . . 0.0 112.141 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -74.26 -83.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.468 1.107 . . . . 0.0 111.458 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -160.04 165.33 32.09 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.263 1.425 . . . . 0.0 111.24 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 mt -76.52 152.33 36.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.881 0.872 . . . . 0.0 111.925 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -140.69 109.55 6.04 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.831 1.652 . . . . 0.0 110.034 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 m -68.65 -27.65 66.19 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.1 mm -73.76 145.18 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.467 1.507 . . . . 0.0 109.621 172.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.29 160.91 14.84 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.492 -0.755 . . . . 0.0 112.745 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -146.76 145.0 29.8 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.013 1.325 . . . . 0.0 110.483 168.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.88 104.16 7.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.923 . . . . 0.0 110.136 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.63 143.12 29.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.772 1.229 . . . . 0.0 111.123 172.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.92 139.48 53.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.511 1.524 . . . . 0.0 110.767 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.82 159.32 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.488 1.115 . . . . 0.0 111.386 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -133.28 134.42 43.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.902 1.681 . . . . 0.0 109.133 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -138.43 152.09 48.04 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -134.67 128.11 32.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.702 2.801 . . . . 0.0 108.828 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.19 119.28 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.294 1.038 . . . . 0.0 111.004 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -132.22 147.45 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.788 1.635 . . . . 0.0 112.166 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -66.71 136.5 55.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.628 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -72.85 78.26 1.14 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.23 1.014 . . . . 0.0 113.313 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.66 -53.29 0.52 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.966 1.746 . . . . 0.0 112.33 172.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -68.55 147.43 51.97 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.924 1.29 . . . . 0.0 112.261 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.0 p -79.05 -6.77 57.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.43 162.35 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.186 1.394 . . . . 0.0 112.086 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.17 108.42 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.851 1.26 . . . . 0.0 109.272 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.44 -46.25 77.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.537 1.135 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.38 168.58 26.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.006 1.322 . . . . 0.0 111.233 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -155.55 157.51 36.95 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 112.902 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.45 -16.08 8.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.064 1.346 . . . . 0.0 112.782 168.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -55.39 -60.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 126.155 1.782 . . . . 0.0 111.912 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -69.03 -22.4 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.485 1.114 . . . . 0.0 113.035 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.48 -74.02 0.31 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.744 1.617 . . . . 0.0 111.711 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -168.64 125.98 0.86 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.174 1.79 . . . . 0.0 110.64 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.29 142.36 85.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.65 2.233 . . . . 0.0 112.027 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.01 101.56 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 0.0 110.387 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 130.3 34.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.202 1.401 . . . . 0.0 112.035 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.41 169.46 23.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.085 1.354 . . . . 0.0 112.47 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -94.49 139.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.334 1.053 . . . . 0.0 108.706 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.4 111.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.814 1.646 . . . . 0.0 112.14 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.38 74.31 0.69 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.962 1.744 . . . . 0.0 113.708 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.4 m -131.05 -37.79 1.26 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.039 1.336 . . . . 0.0 113.569 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.98 35.3 26.22 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 125.66 1.584 . . . . 0.0 114.523 172.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -99.58 -13.48 19.41 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 pt -68.92 167.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.614 1.166 . . . . 0.0 111.706 171.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 pt -55.71 142.34 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.619 -0.676 . . . . 0.0 110.893 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.17 72.68 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.292 -0.88 . . . . 0.0 112.868 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -45.07 87.02 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.142 0.877 . . . . 0.0 113.207 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.85 -31.1 59.17 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.355 1.062 . . . . 0.0 112.339 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.46 -48.31 82.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.616 1.166 . . . . 0.0 111.829 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -68.86 -5.44 21.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.63 -51.43 3.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.705 1.602 . . . . 0.0 112.852 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 p -54.95 -31.95 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.959 1.303 . . . . 0.0 114.079 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.99 -17.49 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -106.02 -7.95 17.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.736 2.014 . . . . 0.0 114.11 175.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.51 118.84 25.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.083 1.353 . . . . 0.0 112.337 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -77.33 160.21 28.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.914 0.886 . . . . 0.0 112.202 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -53.59 129.34 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.506 1.522 . . . . 0.0 111.647 170.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.95 -0.19 67.22 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.787 1.184 . . . . 0.0 115.866 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -97.04 113.07 24.58 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.411 1.606 . . . . 0.0 112.087 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -55.99 135.12 52.66 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.52 0.728 . . . . 0.0 111.103 164.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -137.79 113.18 9.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 0.0 110.93 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.83 98.45 11.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 110.242 172.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.27 153.11 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.824 0.85 . . . . 0.0 110.237 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.37 124.68 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.987 1.315 . . . . 0.0 109.988 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.94 134.12 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.115 1.766 . . . . 0.0 110.244 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.64 159.12 70.7 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.203 1.401 . . . . 0.0 112.936 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.83 50.56 2.5 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.682 3.588 . . . . 0.0 113.839 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.99 1.53 2.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.777 2.031 . . . . 0.0 113.15 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -147.04 -56.66 0.25 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.447 1.499 . . . . 0.0 111.761 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.64 74.51 1.08 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.502 1.121 . . . . 0.0 111.544 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 42.51 70.85 0.25 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.613 2.365 . . . . 0.0 112.989 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.08 78.19 0.29 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.01 1.766 . . . . 0.0 113.808 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.79 130.36 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.884 2.073 . . . . 0.0 109.504 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -65.61 166.92 9.82 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.685 1.194 . . . . 0.0 112.654 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -112.27 142.7 44.45 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.147 -0.971 . . . . 0.0 112.075 171.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -73.62 1.84 9.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.217 1.407 . . . . 0.0 113.846 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.8 p -145.14 52.51 1.21 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.776 2.031 . . . . 0.0 112.291 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -60.7 163.19 5.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.229 1.012 . . . . 0.0 112.173 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.14 146.1 47.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.074 1.35 . . . . 0.0 110.216 169.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -134.97 107.37 7.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.823 1.249 . . . . 0.0 110.121 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.4 121.47 18.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.049 0.54 . . . . 0.0 110.102 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.5 m -135.42 159.24 72.41 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.176 1.79 . . . . 0.0 110.724 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.21 165.21 31.46 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.325 2.016 . . . . 0.0 111.819 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -69.73 10.76 0.34 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.68 -43.48 97.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.451 1.5 . . . . 0.0 113.429 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -69.26 -21.92 63.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.049 0.94 . . . . 0.0 113.379 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -132.58 50.02 2.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.957 1.703 . . . . 0.0 111.391 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.07 -27.21 67.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.779 1.232 . . . . 0.0 113.0 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.43 34.02 1.64 Allowed Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.993 1.759 . . . . 0.0 114.094 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.64 128.82 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 126.643 1.977 . . . . 0.0 108.794 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -64.99 142.07 58.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.029 0.932 . . . . 0.0 111.762 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.41 146.02 51.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.736 1.614 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.45 145.06 20.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.622 1.169 . . . . 0.0 111.547 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.99 90.48 0.18 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.994 1.717 . . . . 0.0 110.579 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.51 -4.37 8.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.869 1.7 . . . . 0.0 116.58 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.5 159.41 32.27 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.482 2.141 . . . . 0.0 113.023 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -84.62 126.03 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 0.0 110.846 165.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.2 149.46 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.644 1.977 . . . . 0.0 110.723 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -97.78 155.72 16.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.74 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.82 95.52 0.19 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.17 1.367 . . . . 0.0 112.686 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.19 105.79 2.21 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.769 -0.842 . . . . 0.0 111.234 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -75.65 154.4 36.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.691 1.197 . . . . 0.0 112.169 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -65.11 -19.32 65.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.609 1.563 . . . . 0.0 112.661 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.3 13.21 0.13 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.663 1.985 . . . . 0.0 114.601 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 58.66 48.95 10.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.039 2.136 . . . . 0.0 112.597 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -146.57 176.82 9.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.533 1.933 . . . . 0.0 110.929 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 m -140.28 107.08 5.38 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 111.581 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.89 167.22 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.605 0.762 . . . . 0.0 111.8 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -128.34 132.3 48.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.977 1.711 . . . . 0.0 110.129 172.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.28 177.11 8.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.842 1.657 . . . . 0.0 112.509 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.75 137.99 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.46 1.504 . . . . 0.0 110.337 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.57 114.9 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.981 -1.074 . . . . 0.0 109.524 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -84.46 -33.18 23.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.195 1.398 . . . . 0.0 112.888 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -156.69 159.78 38.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.11 1.364 . . . . 0.0 111.445 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -149.06 151.06 33.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.956 1.302 . . . . 0.0 112.669 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -154.95 -176.55 5.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.737 1.615 . . . . 0.0 111.657 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.09 -27.95 54.34 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.301 1.441 . . . . 0.0 113.251 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.0 p -83.1 -65.3 1.03 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.904 1.682 . . . . 0.0 111.843 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -132.38 173.18 11.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.099 2.16 . . . . 0.0 111.71 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -143.51 148.83 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 127.148 2.179 . . . . 0.0 109.399 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.1 mtp -122.42 100.04 6.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.574 1.549 . . . . 0.0 110.263 -174.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.23 140.44 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.926 1.29 . . . . 0.0 111.67 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -64.81 151.06 46.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.719 0.808 . . . . 0.0 111.347 168.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -146.95 169.88 18.25 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.252 1.421 . . . . 0.0 111.684 170.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -144.21 140.65 29.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.701 1.6 . . . . 0.0 110.209 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -152.06 129.78 5.9 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.934 0.894 . . . . 0.0 110.861 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.36 -19.81 21.74 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.726 2.284 . . . . 0.0 113.847 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 65.8 mt -104.4 76.78 1.34 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.529 1.532 . . . . 0.0 109.122 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -159.23 178.52 9.9 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.435 1.894 . . . . 0.0 112.043 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.39 166.77 36.92 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.061 1.791 . . . . 0.0 112.582 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -129.12 145.62 51.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.889 1.276 . . . . 0.0 112.582 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.97 145.0 55.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.853 1.661 . . . . 0.0 112.558 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.17 124.98 44.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.574 1.55 . . . . 0.0 111.446 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.38 139.53 32.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.655 0.782 . . . . 0.0 111.444 169.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.83 95.21 4.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.523 1.929 . . . . 0.0 108.78 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -81.83 112.32 18.85 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.437 1.095 . . . . 0.0 108.572 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.17 169.4 16.92 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -147.25 139.11 24.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.319 1.448 . . . . 0.0 110.579 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.59 100.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.23 -17.53 64.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.259 1.023 . . . . 0.0 112.568 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.57 -171.1 13.55 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.786 1.66 . . . . 0.0 112.735 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -125.93 151.44 46.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.128 0.971 . . . . 0.0 112.48 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -128.6 114.72 17.04 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.17 1.788 . . . . 0.0 111.04 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -77.22 92.66 3.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.857 1.663 . . . . 0.0 110.316 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.68 163.97 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.165 1.386 . . . . 0.0 112.672 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.2 t -60.31 156.3 15.96 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.23 1.012 . . . . 0.0 112.537 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.25 -16.24 43.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.371 1.469 . . . . 0.0 113.913 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -69.89 -16.15 63.19 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.721 1.608 . . . . 0.0 113.828 174.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 125.95 1.7 . . . . 0.0 114.19 -172.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 111.29 0.107 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -137.96 164.61 28.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.587 1.955 . . . . 0.0 110.592 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -145.54 174.48 11.13 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.748 1.619 . . . . 0.0 111.644 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -139.85 156.39 46.74 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.981 1.312 . . . . 0.0 111.403 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -149.13 165.79 30.73 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.986 1.715 . . . . 0.0 111.318 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.3 108.36 11.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.619 1.567 . . . . 0.0 111.03 -173.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -116.92 82.59 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.475 1.51 . . . . 0.0 110.559 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 p -67.54 -61.54 1.85 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.657 1.583 . . . . 0.0 112.414 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.0 mm -74.1 154.0 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 126.195 1.798 . . . . 0.0 110.181 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -95.15 160.5 14.53 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.391 1.476 . . . . 0.0 112.807 173.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.94 156.04 49.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.127 1.371 . . . . 0.0 110.469 165.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.41 112.23 17.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.332 0.653 . . . . 0.0 109.293 164.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.56 141.26 42.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.035 166.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.99 130.4 55.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.0 2.12 . . . . 0.0 109.991 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.3 pt -132.63 159.41 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.247 1.019 . . . . 0.0 112.392 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -138.47 134.75 34.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.192 1.797 . . . . 0.0 109.817 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -136.88 152.03 49.76 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.111 1.364 . . . . 0.0 114.027 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.42 115.99 9.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.614 2.365 . . . . 0.0 109.606 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.24 103.65 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 122.27 1.033 . . . . 0.0 110.634 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -102.77 152.15 21.58 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.593 2.357 . . . . 0.0 110.212 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -77.69 150.78 34.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.903 -1.123 . . . . 0.0 111.332 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -70.54 85.83 0.63 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.86 -1.15 . . . . 0.0 111.88 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.5 -44.78 1.26 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.467 1.984 . . . . 0.0 114.39 170.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -70.64 151.44 44.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.18 0.99 . . . . 0.0 112.971 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.4 m -79.87 -15.85 56.55 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.975 1.31 . . . . 0.0 114.072 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.83 159.57 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.777 0.831 . . . . 0.0 111.944 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.41 128.78 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.159 1.383 . . . . 0.0 109.517 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.43 -51.58 10.54 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.936 0.495 . . . . 0.0 111.423 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -159.89 163.84 34.0 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.393 1.877 . . . . 0.0 111.112 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.8 p -154.35 159.93 41.43 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.882 -1.136 . . . . 0.0 112.482 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -114.38 -12.52 12.37 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 165.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.19 -48.36 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.784 1.633 . . . . 0.0 111.826 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -76.0 -6.89 53.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.716 1.206 . . . . 0.0 113.984 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -107.47 -73.58 0.68 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.943 1.697 . . . . 0.0 111.354 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -163.54 131.68 2.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.301 1.84 . . . . 0.0 109.774 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.5 160.06 37.52 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.173 2.582 . . . . 0.0 112.891 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 tt -95.11 126.28 40.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 109.863 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -106.27 127.44 53.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.102 1.761 . . . . 0.0 111.558 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -147.57 162.98 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.508 1.123 . . . . 0.0 111.966 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.2 mm -88.38 149.48 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.717 -1.24 . . . . 0.0 109.366 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -50.7 106.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 110.971 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.03 59.63 1.75 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.547 1.546 . . . . 0.0 114.492 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -113.5 -28.68 7.44 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.966 1.306 . . . . 0.0 113.243 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.67 32.9 18.19 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.74 2.016 . . . . 0.0 114.711 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -83.5 -17.94 40.19 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -76.75 171.05 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.974 1.31 . . . . 0.0 112.791 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.4 pt -57.18 142.48 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.966 0.906 . . . . 0.0 111.46 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.78 77.57 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.48 -21.8 65.03 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.086 0.85 . . . . 0.0 114.518 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -96.52 -35.49 11.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.466 1.507 . . . . 0.0 111.804 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -56.77 -45.75 81.9 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.887 1.675 . . . . 0.0 112.188 174.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -75.69 -2.0 27.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.917 0.887 . . . . 0.0 113.393 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.5 -42.27 4.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.601 1.56 . . . . 0.0 113.18 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.02 -25.73 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.522 1.129 . . . . 0.0 113.893 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.3 -24.96 67.84 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -37.24 15.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.133 1.373 . . . . 0.0 112.498 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.91 131.3 46.77 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.63 1.572 . . . . 0.0 113.377 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -92.51 151.51 20.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.2 1.0 . . . . 0.0 111.833 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.16 125.06 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.904 0.882 . . . . 0.0 110.061 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.19 86.19 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.454 1.026 . . . . 0.0 115.454 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -122.58 116.38 23.76 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.992 1.396 . . . . 0.0 111.259 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -58.26 143.07 45.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.157 0.983 . . . . 0.0 112.008 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.49 142.5 41.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.633 1.573 . . . . 0.0 110.173 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -129.99 81.8 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.181 0.993 . . . . 0.0 110.583 -167.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -88.06 117.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.921 1.289 . . . . 0.0 111.554 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.44 118.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.889 0.876 . . . . 0.0 109.465 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -115.62 138.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 126.604 1.961 . . . . 0.0 108.812 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.08 155.52 90.15 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.475 1.11 . . . . 0.0 112.042 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.7 -46.28 5.38 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.601 2.201 . . . . 0.0 112.473 -172.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -64.69 -23.17 67.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.536 1.534 . . . . 0.0 113.309 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.45 -8.18 59.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.229 1.412 . . . . 0.0 113.502 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.62 -67.44 0.99 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.204 1.401 . . . . 0.0 111.733 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -139.39 -22.62 0.9 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.46 92.19 0.19 Allowed Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.337 1.446 . . . . 0.0 114.232 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.74 160.3 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.806 1.643 . . . . 0.0 112.515 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -142.4 175.66 9.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.195 1.798 . . . . 0.0 112.211 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -133.77 170.4 15.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.864 1.666 . . . . 0.0 112.229 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 t -111.28 11.53 21.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.798 1.639 . . . . 0.0 113.162 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.0 p -158.83 114.69 2.62 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.731 1.612 . . . . 0.0 111.384 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -149.66 157.34 43.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.53 1.132 . . . . 0.0 113.275 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.03 132.98 41.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 111.386 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.7 120.09 28.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.74 1.216 . . . . 0.0 110.847 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.12 101.47 5.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.345 1.458 . . . . 0.0 111.453 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 t -99.72 136.88 20.16 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.32 1.848 . . . . 0.0 109.476 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.87 152.58 68.78 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.502 2.134 . . . . 0.0 111.676 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -76.88 57.45 1.32 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.127 1.371 . . . . 0.0 111.447 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.63 -50.52 1.06 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.205 1.802 . . . . 0.0 112.812 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -66.43 -15.01 63.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -98.45 17.83 18.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.717 2.007 . . . . 0.0 113.484 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 112.3 1.47 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.717 -1.239 . . . . 0.0 111.341 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.22 2.43 59.13 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.869 1.223 . . . . 0.0 115.446 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.68 130.48 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.919 1.36 . . . . 0.0 111.368 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.76 147.64 39.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.532 1.133 . . . . 0.0 111.173 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.09 152.4 47.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.98 1.712 . . . . 0.0 109.689 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -155.8 162.05 40.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 111.604 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.25 123.6 20.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.829 -1.169 . . . . 0.0 110.92 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.96 30.68 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.167 0.889 . . . . 0.0 114.786 173.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.4 ptp -109.1 144.96 36.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.195 0.997 . . . . 0.0 111.421 165.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.1 p -70.26 136.67 50.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.883 0.873 . . . . 0.0 110.812 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.9 p -140.66 164.61 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.573 1.549 . . . . 0.0 111.046 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.21 148.39 34.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.212 1.405 . . . . 0.0 111.858 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.85 94.72 0.31 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.463 1.506 . . . . 0.0 111.936 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -68.66 104.96 2.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.855 0.862 . . . . 0.0 111.063 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -77.93 158.38 29.38 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.678 1.191 . . . . 0.0 112.21 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -66.48 -16.95 64.51 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.443 1.497 . . . . 0.0 113.264 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -72.16 13.86 0.28 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.575 1.95 . . . . 0.0 114.212 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 57.13 47.23 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.883 2.073 . . . . 0.0 112.301 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.06 170.43 15.95 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.037 2.135 . . . . 0.0 109.637 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 34.6 m -136.95 115.51 11.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.56 1.144 . . . . 0.0 111.585 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.64 164.5 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 111.406 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -121.23 133.14 55.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.677 1.591 . . . . 0.0 110.624 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 177.15 9.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.683 1.593 . . . . 0.0 112.474 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.94 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.428 1.491 . . . . 0.0 109.362 173.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.9 mt -74.93 116.42 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.706 1.202 . . . . 0.0 109.629 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -92.98 -33.12 14.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.131 0.972 . . . . 0.0 112.611 -175.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -148.41 148.09 29.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.946 1.698 . . . . 0.0 110.78 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -142.58 157.93 44.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.221 1.008 . . . . 0.0 112.51 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 t -157.01 176.21 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.861 1.664 . . . . 0.0 111.167 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.17 -25.85 62.72 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.531 1.132 . . . . 0.0 113.184 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.6 p -82.74 -64.18 1.22 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.747 1.619 . . . . 0.0 112.044 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -135.08 168.47 19.07 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.592 2.357 . . . . 0.0 111.159 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -137.58 150.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.498 1.519 . . . . 0.0 110.617 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.2 mmm -127.76 103.08 7.09 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.798 2.039 . . . . 0.0 110.288 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.76 143.47 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.398 1.479 . . . . 0.0 110.246 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.23 96.8 2.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.206 1.002 . . . . 0.0 111.861 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -94.56 168.92 10.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.063 1.345 . . . . 0.0 112.392 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -135.04 115.17 13.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.529 1.932 . . . . 0.0 110.263 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.87 135.94 10.68 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.634 0.774 . . . . 0.0 111.204 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -72.49 4.13 3.69 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.858 3.038 . . . . 0.0 114.941 -173.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.8 mt -112.79 12.44 19.57 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.602 1.961 . . . . 0.0 112.952 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -44.75 -62.13 1.32 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.278 2.231 . . . . 0.0 115.514 -167.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 58.5 81.06 0.08 OUTLIER Glycine 0 CA--C 1.542 1.75 0 C-N-CA 126.272 1.891 . . . . 0.0 116.999 169.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -74.43 154.61 38.69 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.787 1.235 . . . . 0.0 112.912 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.3 p -91.24 150.31 21.39 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.957 1.303 . . . . 0.0 113.208 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.3 120.94 32.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.742 2.017 . . . . 0.0 110.911 -170.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 101.08 10.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -79.59 92.43 5.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.633 0.773 . . . . 0.0 110.08 167.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -73.12 124.03 24.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 165.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -144.18 169.39 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -148.4 147.97 29.8 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.789 1.236 . . . . 0.0 111.511 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.95 108.0 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.614 1.166 . . . . 0.0 108.444 167.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.7 -12.76 60.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.007 1.323 . . . . 0.0 112.768 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.57 -150.51 18.66 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 126.009 1.766 . . . . 0.0 111.475 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.77 163.7 31.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.492 1.117 . . . . 0.0 112.681 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -144.91 155.26 43.34 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.397 1.479 . . . . 0.0 113.125 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.39 87.72 7.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.505 1.522 . . . . 0.0 111.187 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.7 160.87 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.368 1.067 . . . . 0.0 112.713 175.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 74.6 m -140.86 161.54 37.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.282 1.833 . . . . 0.0 111.787 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -84.49 -71.75 0.5 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.34 1.056 . . . . 0.0 112.395 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.64 -0.44 6.13 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -175.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 128.083 2.553 . . . . 0.0 114.919 -179.686 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -60.55 150.06 32.71 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.812 1.245 . . . . 0.0 111.411 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -129.02 94.82 3.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.722 1.209 . . . . 0.0 111.229 -173.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -119.33 144.12 47.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.087 1.355 . . . . 0.0 111.667 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -140.71 -171.69 3.29 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.534 2.333 . . . . 0.0 110.376 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.45 106.03 0.86 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.992 1.317 . . . . 0.0 110.968 172.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -120.03 54.16 1.04 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.283 1.833 . . . . 0.0 111.307 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 t -85.33 -25.98 26.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.55 1.14 . . . . 0.0 113.655 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.45 133.21 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.669 1.588 . . . . 0.0 109.723 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -61.09 146.39 47.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.926 0.89 . . . . 0.0 112.67 175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -145.94 149.05 33.48 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.111 1.364 . . . . 0.0 111.151 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.31 8.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.39 123.63 23.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.065 1.346 . . . . 0.0 110.566 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.72 117.44 34.08 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.6 1.96 . . . . 0.0 109.707 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.34 160.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.363 1.065 . . . . 0.0 111.524 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.13 165.36 28.05 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.076 -1.015 . . . . 0.0 112.445 169.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -147.69 157.8 43.72 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.7 1.6 . . . . 0.0 113.858 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -134.01 123.79 25.17 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.873 3.269 . . . . 0.0 108.148 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.21 112.58 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.263 1.025 . . . . 0.0 109.372 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -115.84 143.72 45.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.753 1.621 . . . . 0.0 110.172 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -70.04 132.92 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.516 -0.74 . . . . 0.0 110.4 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -59.16 123.84 18.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.305 0.642 . . . . 0.0 111.943 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.82 -45.86 2.31 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.019 1.771 . . . . 0.0 114.306 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -74.72 154.7 38.3 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.664 1.186 . . . . 0.0 113.514 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 m -83.8 -14.94 50.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.18 163.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.049 0.94 . . . . 0.0 111.983 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.66 122.74 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.367 1.467 . . . . 0.0 109.299 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.69 -51.09 24.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.102 0.961 . . . . 0.0 111.058 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.52 156.54 28.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.006 1.323 . . . . 0.0 112.554 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 57.5 m -149.84 151.97 34.37 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.679 1.591 . . . . 0.0 111.76 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.49 -6.13 11.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.3 mt -50.88 -58.14 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.908 1.683 . . . . 0.0 112.196 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -75.1 -19.83 59.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.504 1.121 . . . . 0.0 113.389 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -78.59 -72.47 0.38 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.048 1.739 . . . . 0.0 111.109 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -168.34 125.87 0.9 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 127.074 2.15 . . . . 0.0 109.392 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.29 147.05 87.43 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.444 2.096 . . . . 0.0 111.403 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.5 tp -72.83 142.89 48.0 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.316 1.047 . . . . 0.0 110.172 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -120.68 111.79 18.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 0.0 109.685 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -131.77 169.54 16.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.078 0.951 . . . . 0.0 112.262 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.2 mm -105.94 137.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.234 1.014 . . . . 0.0 108.9 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -46.37 106.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.634 1.574 . . . . 0.0 111.345 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.88 15.03 17.63 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.25 1.405 . . . . 0.0 116.397 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.6 m -73.8 -43.54 58.55 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.859 1.829 . . . . 0.0 113.001 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m120 57.17 21.52 6.61 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.161 2.185 . . . . 0.0 116.538 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -74.61 -16.0 60.81 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.4 pt -66.6 168.86 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.434 1.494 . . . . 0.0 112.96 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 pt -56.1 144.43 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.228 1.011 . . . . 0.0 111.775 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -38.41 75.23 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -171.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.81 -33.16 86.17 Favored Glycine 0 CA--C 1.539 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 113.962 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.52 -29.64 22.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.251 1.42 . . . . 0.0 112.144 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -59.65 -43.29 93.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.738 1.615 . . . . 0.0 112.091 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -70.47 -13.91 62.31 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.38 -46.81 7.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.817 1.247 . . . . 0.0 112.723 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.33 -27.77 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.8 -24.47 66.93 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.94 -36.65 10.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.107 1.763 . . . . 0.0 112.684 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.96 112.15 0.89 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.963 1.705 . . . . 0.0 113.142 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.08 151.4 41.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.448 0.699 . . . . 0.0 112.053 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 tt -57.33 127.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.426 1.09 . . . . 0.0 111.494 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.96 9.23 85.28 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.094 1.33 . . . . 0.0 115.3 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.1 119.07 30.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.088 1.444 . . . . 0.0 111.763 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -59.25 142.36 52.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.059 0.944 . . . . 0.0 112.082 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -136.51 138.82 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.598 1.159 . . . . 0.0 110.481 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -130.02 89.3 2.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.433 1.093 . . . . 0.0 110.534 -167.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -101.09 118.15 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.879 1.272 . . . . 0.0 111.507 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.9 t -78.82 111.18 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.434 1.094 . . . . 0.0 109.536 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.17 133.81 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.3 1.44 . . . . 0.0 109.53 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.51 153.45 93.1 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.09 0.956 . . . . 0.0 111.743 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.04 -43.53 35.69 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.563 2.175 . . . . 0.0 112.521 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.92 -15.6 63.53 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.833 1.653 . . . . 0.0 114.838 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -99.74 -26.88 13.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.769 1.227 . . . . 0.0 113.035 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.33 -70.57 0.33 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.852 1.261 . . . . 0.0 111.331 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -138.61 -18.36 1.09 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.67 7.69 58.91 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.795 1.188 . . . . 0.0 115.494 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.68 150.23 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 127.182 2.193 . . . . 0.0 109.584 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -135.59 166.16 23.85 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.657 1.583 . . . . 0.0 111.452 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -65.34 151.26 46.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.49 1.116 . . . . 0.0 113.474 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.7 p -83.02 15.13 2.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.334 1.854 . . . . 0.0 114.793 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m -108.41 79.26 1.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.178 1.391 . . . . 0.0 112.946 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -118.39 166.2 12.95 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.58 1.552 . . . . 0.0 110.936 166.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.36 147.85 44.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.199 1.4 . . . . 0.0 110.316 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -129.51 115.92 18.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.191 1.396 . . . . 0.0 110.653 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.8 115.43 6.58 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.498 0.719 . . . . 0.0 110.121 164.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.32 133.93 25.49 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 126.633 1.973 . . . . 0.0 109.463 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.2 155.96 60.08 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.201 1.934 . . . . 0.0 111.673 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -64.06 -17.62 63.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.91 -38.89 58.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.332 2.653 . . . . 0.0 114.316 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -71.58 -15.95 62.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.27 -45.41 3.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.635 1.174 . . . . 0.0 112.947 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 21.28 66.97 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 129.611 3.164 . . . . 0.0 115.043 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.41 -22.42 3.94 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.041 1.305 . . . . 0.0 115.601 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.55 132.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.247 1.523 . . . . 0.0 109.621 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.24 67.76 3.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.777 1.631 . . . . 0.0 112.613 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.66 148.05 17.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.713 1.605 . . . . 0.0 112.131 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -151.34 155.75 39.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.198 1.399 . . . . 0.0 111.189 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -71.81 21.94 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 54.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 120.95 -1.094 . . . . 0.0 113.578 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.8 ptm -132.29 151.58 51.77 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.991 1.317 . . . . 0.0 111.874 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 p -70.25 133.05 46.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.354 1.061 . . . . 0.0 111.245 167.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -135.72 156.95 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.149 1.78 . . . . 0.0 110.689 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -95.66 145.82 24.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.446 1.098 . . . . 0.0 111.902 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.18 95.44 0.37 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.692 1.615 . . . . 0.0 111.855 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -65.68 137.96 57.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 117.85 0.825 . . . . 0.0 111.123 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 t -116.93 155.15 29.6 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.942 1.697 . . . . 0.0 111.75 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.85 -15.44 58.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.177 1.791 . . . . 0.0 113.345 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.23 15.17 0.35 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.419 1.888 . . . . 0.0 113.769 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 55.54 46.74 22.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.368 2.267 . . . . 0.0 112.543 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -144.74 177.45 8.7 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.174 1.79 . . . . 0.0 112.218 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.7 m -145.37 120.32 10.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.667 1.187 . . . . 0.0 111.796 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -88.9 173.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.584 1.153 . . . . 0.0 112.053 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.7 133.97 46.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.219 1.408 . . . . 0.0 111.441 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.81 11.22 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.464 1.506 . . . . 0.0 112.052 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.95 131.95 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.639 1.176 . . . . 0.0 110.618 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.7 mt -70.55 134.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 120.821 -1.174 . . . . 0.0 111.059 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -94.73 -46.38 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.825 1.25 . . . . 0.0 112.065 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -146.81 156.87 43.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.284 1.434 . . . . 0.0 111.258 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.26 146.84 29.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.727 1.211 . . . . 0.0 112.331 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.3 t -152.97 169.41 22.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.272 1.829 . . . . 0.0 110.547 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.93 -27.26 67.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.192 0.997 . . . . 0.0 113.493 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -80.67 -66.42 0.89 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.789 2.036 . . . . 0.0 111.714 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -132.3 157.49 44.29 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.619 1.968 . . . . 0.0 111.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.41 150.32 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.95 2.1 . . . . 0.0 108.233 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.6 mtp -126.18 100.56 6.37 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.822 1.249 . . . . 0.0 109.992 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.3 m -99.29 151.72 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.287 1.035 . . . . 0.0 111.075 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.68 148.79 46.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.339 0.656 . . . . 0.0 111.187 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -145.05 152.82 40.7 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.264 1.426 . . . . 0.0 112.326 172.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -69.14 -28.63 66.62 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.614 1.166 . . . . 0.0 113.504 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 48.46 83.77 0.21 Allowed Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 127.609 2.364 . . . . 0.0 113.378 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -65.48 -13.71 41.18 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.021 2.48 . . . . 0.0 115.333 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.4 mp -85.0 6.24 25.97 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 125.894 1.678 . . . . 0.0 113.099 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.68 167.3 2.78 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.883 1.673 . . . . 0.0 115.119 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.17 128.0 3.25 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 126.635 2.065 . . . . 0.0 112.002 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -139.74 167.53 21.89 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.57 1.548 . . . . 0.0 112.756 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.2 p -73.06 136.88 45.03 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 112.47 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.81 136.48 53.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.618 1.967 . . . . 0.0 110.736 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.31 105.25 17.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.685 1.194 . . . . 0.0 111.345 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.88 92.09 8.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 109.913 167.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -74.84 122.5 23.46 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 163.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -143.24 166.35 24.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.454 0.702 . . . . 0.0 112.03 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -151.2 145.67 25.56 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.462 0.705 . . . . 0.0 112.503 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.1 t -91.25 102.87 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.475 1.51 . . . . 0.0 108.715 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.17 -27.36 69.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.85 0.86 . . . . 0.0 111.6 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.41 -133.04 7.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 125.992 1.758 . . . . 0.0 110.899 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -150.37 162.89 39.67 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.842 1.257 . . . . 0.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -130.71 132.38 45.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.201 1.4 . . . . 0.0 111.269 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.11 130.96 42.85 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.998 0.919 . . . . 0.0 110.127 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.4 m -131.98 171.13 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.407 1.883 . . . . 0.0 110.581 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.9 p -60.16 145.47 46.87 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.646 0.736 . . . . 0.0 112.429 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.72 -0.3 10.78 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.201 1.4 . . . . 0.0 113.794 -175.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.97 -35.39 74.4 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.192 1.397 . . . . 0.0 112.715 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 128.65 2.78 . . . . 0.0 114.729 -178.138 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -141.02 97.39 3.17 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.274 1.43 . . . . 0.0 110.701 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -137.85 147.61 44.66 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.337 1.455 . . . . 0.0 111.805 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -142.69 130.58 21.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.409 1.884 . . . . 0.0 110.442 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -73.06 167.18 21.65 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.331 1.052 . . . . 0.0 112.262 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.05 101.28 1.38 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.774 1.23 . . . . 0.0 111.984 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.6 9.96 3.61 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 99.6 p -64.76 -22.58 67.02 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.9 mp -73.5 152.53 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.483 1.513 . . . . 0.0 110.928 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -55.14 156.45 4.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.642 1.977 . . . . 0.0 112.775 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -140.98 151.74 44.38 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.171 1.389 . . . . 0.0 111.628 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.96 113.31 21.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.383 1.073 . . . . 0.0 111.573 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.2 101.43 7.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 110.483 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.53 111.19 11.75 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.01 1.724 . . . . 0.0 110.043 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 pp -133.6 158.3 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.944 0.897 . . . . 0.0 111.968 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -137.65 138.34 39.36 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.501 1.521 . . . . 0.0 109.852 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -136.4 162.19 33.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.854 1.262 . . . . 0.0 113.796 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -144.83 160.24 41.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.074 2.149 . . . . 0.0 111.678 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.47 112.59 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.36 1.464 . . . . 0.0 110.451 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -114.62 154.52 28.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.995 2.118 . . . . 0.0 110.054 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.91 148.28 26.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.323 1.449 . . . . 0.0 111.567 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -70.68 94.03 0.98 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.831 -1.168 . . . . 0.0 111.253 166.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 -39.22 2.97 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.233 1.873 . . . . 0.0 114.894 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -73.44 149.84 42.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.502 1.151 . . . . 0.0 112.046 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m -69.37 -23.06 63.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.923 1.289 . . . . 0.0 113.776 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.65 153.47 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 113.296 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.94 128.14 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.838 1.655 . . . . 0.0 108.982 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.24 -51.95 7.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.144 0.578 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.09 160.07 43.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.185 1.794 . . . . 0.0 111.488 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -162.38 167.14 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.923 1.289 . . . . 0.0 113.138 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -130.72 13.77 5.37 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 164.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.0 mm -53.15 -59.99 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.578 1.551 . . . . 0.0 112.358 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -78.68 -16.17 57.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -172.6 3.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.063 2.145 . . . . 0.0 111.722 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.94 126.36 83.24 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.208 1.003 . . . . 0.0 110.97 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.31 162.75 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.135 2.557 . . . . 0.0 112.335 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.95 149.1 37.73 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.823 168.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -130.81 48.26 2.44 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.297 1.439 . . . . 0.0 110.939 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -69.33 163.11 25.84 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.357 -0.84 . . . . 0.0 113.14 -175.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 mm -116.61 137.34 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.672 1.589 . . . . 0.0 109.244 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.73 107.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.799 1.64 . . . . 0.0 111.908 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.63 -28.03 8.43 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.24 1.876 . . . . 0.0 114.311 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -58.35 -24.52 60.06 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.593 1.697 . . . . 0.0 113.735 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 40.55 60.43 1.88 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.422 2.689 . . . . 0.0 114.137 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -89.41 -17.44 28.79 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.72 170.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.933 1.293 . . . . 0.0 112.218 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 pt -63.26 147.1 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.459 -0.776 . . . . 0.0 111.863 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.93 -25.92 68.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.26 -40.69 98.16 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.859 -1.151 . . . . 0.0 112.991 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 tp -81.63 -25.45 35.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.717 1.607 . . . . 0.0 112.804 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -51.25 -49.39 61.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.779 1.632 . . . . 0.0 112.476 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -13.89 62.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.256 1.022 . . . . 0.0 113.708 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.54 -43.36 7.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.793 1.237 . . . . 0.0 112.968 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.46 -27.25 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.34 -17.43 63.7 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -103.79 -40.44 6.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.907 1.683 . . . . 0.0 113.328 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.58 134.36 56.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.183 0.993 . . . . 0.0 112.5 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.7 161.6 13.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.05 0.94 . . . . 0.0 112.282 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -54.49 124.49 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.394 1.078 . . . . 0.0 111.575 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.63 -0.28 77.2 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.234 1.397 . . . . 0.0 115.604 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -105.96 112.6 25.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.415 1.607 . . . . 0.0 111.551 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -57.49 144.73 35.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.54 0.736 . . . . 0.0 111.824 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -138.12 139.81 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.155 1.782 . . . . 0.0 109.96 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -130.45 110.39 11.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.208 1.403 . . . . 0.0 110.571 -173.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -118.17 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.611 1.564 . . . . 0.0 110.778 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.81 123.05 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.898 0.879 . . . . 0.0 109.118 173.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.3 mt -127.87 130.4 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 109.294 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.2 145.3 97.47 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.785 0.834 . . . . 0.0 110.984 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.09 -32.55 91.71 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.884 1.722 . . . . 0.0 112.971 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -63.08 -20.7 65.59 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -87.74 -0.04 56.37 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.206 1.402 . . . . 0.0 113.163 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.35 -67.53 0.65 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.606 1.562 . . . . 0.0 112.395 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -142.23 88.47 2.09 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.499 2.32 . . . . 0.0 110.1 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.34 91.71 0.65 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.044 1.307 . . . . 0.0 113.255 -175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.53 148.55 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.836 1.654 . . . . 0.0 111.262 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -149.57 165.79 31.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.109 1.764 . . . . 0.0 111.691 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.3 138.36 32.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.431 1.092 . . . . 0.0 111.896 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.3 p -84.96 3.58 37.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.116 1.766 . . . . 0.0 114.24 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.8 t -154.72 100.48 2.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.624 1.569 . . . . 0.0 110.711 -170.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -148.82 161.44 41.82 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.166 0.987 . . . . 0.0 113.595 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.01 129.11 38.15 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 111.481 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -120.74 118.11 29.21 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.222 1.409 . . . . 0.0 110.153 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.95 130.27 42.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.163 0.985 . . . . 0.0 110.746 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.1 t -135.75 136.66 23.91 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.034 1.733 . . . . 0.0 109.15 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.63 157.83 54.93 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.637 2.225 . . . . 0.0 112.211 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -75.94 66.18 2.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.31 1.444 . . . . 0.0 111.876 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.38 -50.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.151 1.781 . . . . 0.0 112.245 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.84 -11.68 48.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -120.1 10.48 11.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.43 1.892 . . . . 0.0 113.718 -171.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -56.16 -27.99 56.4 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.371 1.468 . . . . 0.0 114.145 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.42 10.21 22.03 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.676 1.608 . . . . 0.0 116.367 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.8 pt -134.91 131.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.555 1.678 . . . . 0.0 112.893 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -75.92 137.64 40.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.168 1.387 . . . . 0.0 112.256 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.72 165.17 15.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.829 1.651 . . . . 0.0 112.655 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.21 155.5 30.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.017 1.727 . . . . 0.0 110.764 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -73.38 107.54 5.73 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.464 -1.397 . . . . 0.0 111.05 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.88 26.94 11.79 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.501 0.961 . . . . 0.0 115.501 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.1 ptm -99.73 153.26 19.25 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.883 1.342 . . . . 0.0 112.263 168.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 p -70.46 113.96 8.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.249 1.42 . . . . 0.0 111.157 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.15 161.19 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.896 1.678 . . . . 0.0 111.035 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -123.25 155.44 37.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.813 1.645 . . . . 0.0 111.878 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.58 105.51 0.29 Allowed Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.361 0.982 . . . . 0.0 113.341 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.0 111.57 7.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.926 1.29 . . . . 0.0 111.894 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.9 t -80.55 159.7 25.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.102 1.361 . . . . 0.0 111.897 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.04 -15.52 62.43 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.048 1.339 . . . . 0.0 113.366 173.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.44 18.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.757 1.623 . . . . 0.0 113.966 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 51.83 44.01 29.68 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.474 2.31 . . . . 0.0 113.077 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -140.98 172.33 12.83 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.286 1.834 . . . . 0.0 111.533 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.0 m -141.53 107.62 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.04 1.336 . . . . 0.0 110.521 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.59 167.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.972 -0.455 . . . . 0.0 111.41 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -132.41 136.22 46.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.082 1.353 . . . . 0.0 111.284 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.4 -179.53 8.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.816 1.246 . . . . 0.0 112.798 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.81 132.72 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.204 1.401 . . . . 0.0 110.61 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.63 122.46 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.9 1.28 . . . . 0.0 110.571 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -90.27 -38.02 13.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.705 1.202 . . . . 0.0 113.08 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -153.35 154.67 34.98 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.337 1.455 . . . . 0.0 111.571 170.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.07 145.83 30.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 113.388 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.4 m -148.3 173.68 12.79 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.771 2.028 . . . . 0.0 111.379 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.82 -21.99 61.62 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.9 p -83.52 -61.62 1.79 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.075 1.75 . . . . 0.0 111.924 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -136.62 169.31 17.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.628 2.371 . . . . 0.0 111.056 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.76 154.91 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.148 1.779 . . . . 0.0 109.888 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.0 mtp -130.22 101.27 5.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.518 1.527 . . . . 0.0 109.969 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.9 t -109.66 147.78 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.209 1.404 . . . . 0.0 109.371 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.89 134.01 54.36 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.758 -0.589 . . . . 0.0 111.158 168.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -143.71 173.76 11.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.365 1.466 . . . . 0.0 111.754 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -128.45 133.74 48.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.241 1.816 . . . . 0.0 110.143 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -156.63 128.45 3.91 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.79 0.836 . . . . 0.0 111.321 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.4 -15.9 34.79 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.771 2.314 . . . . 0.0 114.965 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.27 12.68 15.36 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.072 1.349 . . . . 0.0 113.506 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.1 -16.17 4.71 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.24 96.93 2.21 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 126.348 1.928 . . . . 0.0 113.328 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -64.85 166.98 8.18 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.887 1.275 . . . . 0.0 113.046 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 147.09 53.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.363 1.865 . . . . 0.0 113.597 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.8 mp -122.56 160.84 24.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.59 103.36 13.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.999 1.72 . . . . 0.0 111.161 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -82.41 109.99 17.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.601 0.76 . . . . 0.0 109.576 166.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -110.49 138.9 46.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.216 1.006 . . . . 0.0 110.129 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.94 170.0 20.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.417 0.687 . . . . 0.0 112.756 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -146.04 146.65 31.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 111.237 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.5 105.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.696 1.198 . . . . 0.0 108.742 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.17 -26.41 56.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.487 1.115 . . . . 0.0 112.453 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.89 -168.0 33.84 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -132.8 130.5 39.96 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.762 1.625 . . . . 0.0 110.225 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -117.18 93.89 4.35 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.938 1.295 . . . . 0.0 110.149 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.34 122.99 17.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.961 1.704 . . . . 0.0 111.134 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.27 164.41 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.652 1.581 . . . . 0.0 111.802 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 73.7 m -77.72 166.9 22.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.95 0.9 . . . . 0.0 111.79 168.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.93 -3.85 12.11 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.796 1.239 . . . . 0.0 114.046 174.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.28 -61.39 1.91 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.251 1.42 . . . . 0.0 111.939 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.962 1.705 . . . . 0.0 113.482 178.109 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.51 165.68 32.49 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.785 1.634 . . . . 0.0 112.474 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -149.38 175.65 11.27 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.779 2.031 . . . . 0.0 111.297 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -132.5 149.69 52.28 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.088 1.355 . . . . 0.0 112.378 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.41 167.9 17.07 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.761 2.024 . . . . 0.0 113.277 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.41 160.34 14.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.571 1.549 . . . . 0.0 111.426 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.97 20.84 0.18 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.257 1.823 . . . . 0.0 113.811 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t 65.94 21.56 11.35 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.03 2.132 . . . . 0.0 114.467 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mm -88.97 123.74 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.846 1.658 . . . . 0.0 111.305 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -73.44 131.03 41.35 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.217 1.407 . . . . 0.0 111.326 173.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -160.03 151.47 19.71 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.48 1.512 . . . . 0.0 111.654 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.09 98.72 9.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.019 1.328 . . . . 0.0 110.859 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.68 128.59 34.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.3 1.44 . . . . 0.0 111.327 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.72 134.7 43.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.166 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 pt -127.98 162.6 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.887 1.275 . . . . 0.0 112.247 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -138.64 131.45 29.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.509 1.924 . . . . 0.0 109.458 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -137.05 153.94 50.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.728 1.211 . . . . 0.0 113.784 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -143.68 133.93 24.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.907 2.483 . . . . 0.0 110.144 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.2 103.14 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -110.53 147.32 34.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.961 2.104 . . . . 0.0 110.906 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -76.68 141.64 40.87 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.409 -0.807 . . . . 0.0 111.872 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.6 93.45 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.779 0.832 . . . . 0.0 111.549 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.06 -54.65 0.7 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.247 1.88 . . . . 0.0 113.713 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 t -68.48 154.68 41.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -79.06 -20.67 48.27 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.258 1.423 . . . . 0.0 113.308 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.98 155.72 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.439 -0.788 . . . . 0.0 111.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.52 131.13 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.498 1.519 . . . . 0.0 110.082 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.8 mt -73.18 -55.1 6.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.503 0.721 . . . . 0.0 111.409 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.28 155.87 34.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.319 1.448 . . . . 0.0 110.922 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.4 p -148.26 126.03 11.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.266 1.026 . . . . 0.0 111.926 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -88.09 -29.65 20.47 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.199 0.6 . . . . 0.0 112.363 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -51.8 -51.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.013 1.725 . . . . 0.0 112.296 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -69.7 -14.99 63.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.497 1.119 . . . . 0.0 113.754 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -92.01 -72.17 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.812 1.645 . . . . 0.0 110.6 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -167.1 154.43 8.43 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.679 1.992 . . . . 0.0 111.623 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.31 146.38 69.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.439 2.092 . . . . 0.0 111.478 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 tp -87.52 130.55 34.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.857 1.263 . . . . 0.0 109.723 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.02 138.18 49.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.922 0.889 . . . . 0.0 112.649 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -153.04 163.02 40.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.189 1.396 . . . . 0.0 111.86 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.24 141.2 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -47.57 109.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.549 1.54 . . . . 0.0 111.163 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.4 -5.02 31.4 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.698 1.618 . . . . 0.0 115.916 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.9 m -57.04 -32.17 65.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.122 1.961 . . . . 0.0 113.665 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 47.31 62.5 2.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.589 1.956 . . . . 0.0 113.55 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.07 -20.83 13.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 pt -74.53 170.79 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.177 1.791 . . . . 0.0 112.611 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.9 pt -59.73 145.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.966 0.906 . . . . 0.0 111.781 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.69 75.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.6 98.75 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 121.552 -0.718 . . . . 0.0 113.029 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.5 tp -77.33 -34.19 55.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.616 1.166 . . . . 0.0 112.24 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.0 tp10 -56.74 -38.67 72.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.452 1.101 . . . . 0.0 112.668 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -78.82 -14.27 59.35 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.26 9.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.171 . . . . 0.0 112.501 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -59.3 -27.53 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.87 -20.41 66.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.63 -13.27 16.02 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.74 . . . . 0.0 113.121 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.44 132.58 50.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.598 1.159 . . . . 0.0 112.76 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -91.85 130.47 37.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 111.195 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.76 126.74 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.8 1.24 . . . . 0.0 111.674 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.64 9.03 87.26 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.13 119.03 29.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.383 1.591 . . . . 0.0 111.773 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -62.72 139.64 58.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.572 0.749 . . . . 0.0 111.465 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -141.93 160.49 40.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.457 1.103 . . . . 0.0 112.282 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.1 107.91 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 109.951 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -110.69 116.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.83 1.252 . . . . 0.0 110.097 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.8 110.77 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.449 -0.782 . . . . 0.0 109.376 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.9 139.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.089 1.756 . . . . 0.0 109.47 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.63 151.24 88.83 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.859 0.864 . . . . 0.0 112.244 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.73 -39.22 75.23 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.357 2.704 . . . . 0.0 112.472 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.64 -9.16 40.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.425 1.89 . . . . 0.0 114.205 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -113.07 5.07 16.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.828 1.651 . . . . 0.0 113.191 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.51 -67.45 0.89 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.541 1.536 . . . . 0.0 112.635 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -124.46 -12.18 7.28 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.02 29.9 72.28 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.057 -1.027 . . . . 0.0 115.374 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.0 p -65.01 151.25 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.861 1.264 . . . . 0.0 111.905 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -147.34 172.23 14.21 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.627 1.571 . . . . 0.0 112.427 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -118.06 142.07 47.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.713 1.605 . . . . 0.0 111.83 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.3 p -89.49 16.48 7.58 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.037 2.135 . . . . 0.0 114.49 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.3 t -41.88 -60.7 1.3 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.563 2.345 . . . . 0.0 114.806 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 56.55 8.03 0.41 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.3 mt -145.7 137.91 25.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.63 1.972 . . . . 0.0 110.991 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -144.2 127.99 17.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.15 0.58 . . . . 0.0 111.872 169.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -76.37 98.34 4.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.74 1.216 . . . . 0.0 110.425 167.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.31 156.6 38.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.424 1.889 . . . . 0.0 110.849 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 152.12 59.88 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.177 1.918 . . . . 0.0 111.771 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.4 -23.39 65.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.972 . . . . 0.0 113.15 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -51.01 -36.42 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.376 1.87 . . . . 0.0 113.789 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -66.49 -19.47 65.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.5 1.12 . . . . 0.0 113.564 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -133.28 17.84 4.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.307 1.843 . . . . 0.0 113.008 -172.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -57.43 -24.9 58.38 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.889 1.676 . . . . 0.0 114.438 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -113.57 17.43 20.94 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 126.24 1.876 . . . . 0.0 115.342 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.6 mt -123.49 123.55 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.316 1.558 . . . . 0.0 111.242 -170.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.74 77.34 2.06 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.055 1.742 . . . . 0.0 113.182 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.91 153.51 40.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.232 1.013 . . . . 0.0 112.759 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.99 137.29 18.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.105 1.362 . . . . 0.0 111.11 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -58.27 114.52 2.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.158 0.983 . . . . 0.0 110.93 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.54 20.94 11.05 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -108.93 161.3 15.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.277 1.538 . . . . 0.0 112.149 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.6 t -88.97 116.14 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.399 1.08 . . . . 0.0 110.967 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.0 160.92 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.896 1.678 . . . . 0.0 110.936 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -115.75 140.73 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.85 1.26 . . . . 0.0 111.823 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.75 93.34 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.575 1.559 . . . . 0.0 112.164 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -65.95 147.1 53.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.793 -0.828 . . . . 0.0 111.506 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -130.69 157.48 42.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.819 1.648 . . . . 0.0 112.302 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.35 -15.83 61.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.402 1.881 . . . . 0.0 113.689 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.38 14.75 0.41 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.162 1.785 . . . . 0.0 113.825 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 54.62 46.91 23.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.164 2.186 . . . . 0.0 112.556 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -140.94 173.21 11.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.987 1.715 . . . . 0.0 112.192 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 m -145.03 112.98 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 111.273 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -76.57 165.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.15 0.58 . . . . 0.0 111.482 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -123.18 139.96 53.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.274 1.43 . . . . 0.0 110.396 170.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.55 173.57 15.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.313 1.045 . . . . 0.0 113.144 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.81 135.97 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.076 1.351 . . . . 0.0 110.166 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 mm -67.06 117.96 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.974 1.309 . . . . 0.0 109.585 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -101.01 -36.11 9.13 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.699 1.2 . . . . 0.0 112.222 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.14 163.61 39.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.756 1.622 . . . . 0.0 111.8 166.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.08 158.46 43.59 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.329 1.052 . . . . 0.0 111.928 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 t -144.26 175.4 10.12 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.413 1.885 . . . . 0.0 111.202 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.61 69.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.144 1.377 . . . . 0.0 113.893 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -130.57 -9.69 4.06 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.184 1.394 . . . . 0.0 114.748 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -143.92 164.71 29.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.134 1.774 . . . . 0.0 111.821 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.4 t -140.24 141.96 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.657 1.583 . . . . 0.0 109.893 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.7 mtp -113.43 114.12 26.14 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.232 1.413 . . . . 0.0 111.104 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 t -121.46 153.05 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 109.964 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.73 107.25 0.67 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.824 1.249 . . . . 0.0 112.071 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -134.76 105.02 6.25 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.863 1.265 . . . . 0.0 111.323 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -59.88 144.35 49.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.568 0.747 . . . . 0.0 110.646 164.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -67.72 108.87 3.01 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.554 1.142 . . . . 0.0 111.074 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.46 -42.78 2.44 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.569 2.18 . . . . 0.0 112.872 -165.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.06 94.53 7.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.054 1.342 . . . . 0.0 108.179 168.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.5 96.49 0.52 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.287 1.035 . . . . 0.0 111.419 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.07 -166.55 33.75 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.374 0.988 . . . . 0.0 114.271 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -123.91 159.88 28.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.272 1.829 . . . . 0.0 111.98 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.98 141.95 45.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.26 1.424 . . . . 0.0 112.628 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.14 146.57 49.89 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.182 1.393 . . . . 0.0 111.886 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.01 103.68 16.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.512 1.525 . . . . 0.0 111.506 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.42 98.41 9.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.998 0.904 . . . . 0.0 109.851 167.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.51 123.5 32.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.461 1.504 . . . . 0.0 109.483 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.45 171.81 14.92 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -152.11 150.32 29.77 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.015 1.726 . . . . 0.0 111.576 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.9 112.54 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.357 1.463 . . . . 0.0 108.506 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.34 -33.58 76.06 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.133 0.973 . . . . 0.0 111.514 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 132.38 -168.79 22.51 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 126.358 1.933 . . . . 0.0 111.09 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -136.05 153.62 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.678 1.191 . . . . 0.0 111.982 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.49 129.87 51.42 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.096 1.358 . . . . 0.0 110.682 175.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.09 96.48 2.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.977 0.911 . . . . 0.0 109.978 172.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.97 164.18 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.821 1.648 . . . . 0.0 111.759 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 42.6 m -140.07 160.2 40.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.296 1.438 . . . . 0.0 111.58 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.57 25.91 8.56 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.957 1.703 . . . . 0.0 111.651 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 60.36 24.48 13.98 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 127.273 2.229 . . . . 0.0 114.268 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.926 2.09 . . . . 0.0 114.025 178.445 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.8 mmt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.133 0.492 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -88.51 164.53 15.39 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.759 -1.213 . . . . 0.0 112.074 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -126.83 128.49 46.63 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.942 1.697 . . . . 0.0 110.145 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -145.06 156.67 44.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.253 1.421 . . . . 0.0 110.457 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -66.63 155.0 39.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.604 0.762 . . . . 0.0 111.751 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.53 168.27 19.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.179 1.392 . . . . 0.0 112.935 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.08 52.72 0.81 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.648 1.579 . . . . 0.0 112.555 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 p -69.7 2.46 3.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.339 1.856 . . . . 0.0 114.974 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.6 mm -56.74 140.36 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 127.254 2.221 . . . . 0.0 111.589 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -65.77 138.32 57.85 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.997 1.319 . . . . 0.0 111.473 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.73 170.45 16.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.911 2.084 . . . . 0.0 111.031 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.24 118.99 38.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.122 0.969 . . . . 0.0 110.902 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.7 118.92 23.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.881 1.672 . . . . 0.0 110.902 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.44 131.3 37.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.072 0.949 . . . . 0.0 111.32 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -130.52 167.91 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.695 1.198 . . . . 0.0 112.303 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.35 133.5 33.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.43 1.892 . . . . 0.0 110.52 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -139.16 150.3 45.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 123.002 1.382 . . . . 0.0 113.934 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.32 136.96 26.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.927 2.091 . . . . 0.0 109.708 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.24 105.15 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.09 1.356 . . . . 0.0 110.397 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -113.23 147.47 37.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.342 1.857 . . . . 0.0 110.533 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.84 140.57 53.26 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.65 -0.656 . . . . 0.0 111.293 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.71 -34.87 78.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.864 -1.148 . . . . 0.0 113.846 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.85 55.72 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.992 1.282 . . . . 0.0 115.426 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.4 t -145.91 144.53 30.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.783 1.233 . . . . 0.0 111.283 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -73.38 -11.83 60.61 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.69 159.46 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.139 0.976 . . . . 0.0 111.991 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.1 p -108.79 145.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.185 1.394 . . . . 0.0 110.898 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.88 -44.11 7.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.325 1.05 . . . . 0.0 111.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.5 157.57 38.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 112.423 170.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -161.21 128.21 4.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.882 1.273 . . . . 0.0 111.341 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -16.44 40.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 167.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.07 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.897 1.279 . . . . 0.0 111.827 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -70.98 -9.64 58.34 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.81 1.244 . . . . 0.0 113.606 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -104.27 -75.8 0.61 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.409 1.883 . . . . 0.0 110.909 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -168.1 148.98 4.63 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.637 2.375 . . . . 0.0 110.579 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.47 149.28 74.52 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.892 2.394 . . . . 0.0 112.9 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.9 tp -80.52 123.97 28.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.162 0.985 . . . . 0.0 109.806 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.99 131.69 56.02 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.696 1.198 . . . . 0.0 112.253 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.93 165.12 35.58 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.435 1.094 . . . . 0.0 112.657 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -96.42 143.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.125 1.37 . . . . 0.0 109.12 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.05 113.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.643 1.577 . . . . 0.0 111.608 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 62.91 0.63 Allowed Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.788 1.661 . . . . 0.0 113.114 -174.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.9 m -134.27 -49.61 0.79 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.691 1.596 . . . . 0.0 111.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.5 m120 58.89 29.37 18.77 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.232 1.813 . . . . 0.0 115.287 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -70.79 -19.88 62.65 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.25 166.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 112.751 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 pt -62.48 157.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.075 0.95 . . . . 0.0 113.389 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.22 80.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.655 1.182 . . . . 0.0 113.716 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.33 -46.59 93.57 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.033 0.825 . . . . 0.0 112.841 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -69.04 -34.91 75.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 111.772 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -56.02 -35.38 66.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.105 1.362 . . . . 0.0 113.449 171.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -80.37 3.24 21.84 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.1 -33.69 3.87 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.348 1.459 . . . . 0.0 113.392 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -58.47 -28.63 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.872 -1.143 . . . . 0.0 113.929 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -71.11 -23.06 62.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -94.84 -27.58 15.67 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.344 1.858 . . . . 0.0 112.478 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.25 118.9 4.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.717 2.007 . . . . 0.0 113.474 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -80.11 145.62 32.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 111.483 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.24 132.4 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.879 0.872 . . . . 0.0 111.195 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.53 6.49 86.74 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.194 1.237 . . . . 0.0 116.194 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -118.62 114.26 22.5 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.881 1.672 . . . . 0.0 111.403 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -62.4 140.67 58.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.076 0.551 . . . . 0.0 111.305 169.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -142.42 162.11 36.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.49 1.116 . . . . 0.0 112.447 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -130.46 112.78 13.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.778 1.631 . . . . 0.0 109.844 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.92 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.341 1.456 . . . . 0.0 109.82 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 t -73.9 120.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.055 0.942 . . . . 0.0 110.046 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.3 mm -105.15 142.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.401 1.481 . . . . 0.0 110.061 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.87 156.94 85.93 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.693 1.197 . . . . 0.0 112.789 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.27 -11.92 27.77 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.461 2.774 . . . . 0.0 114.97 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -106.58 -9.35 16.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.094 1.358 . . . . 0.0 113.809 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -108.58 -18.9 13.61 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.983 1.313 . . . . 0.0 113.081 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.12 -167.95 1.63 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.532 1.933 . . . . 0.0 111.968 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -56.7 -22.13 32.75 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 169.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.74 72.77 1.23 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.411 1.481 . . . . 0.0 114.142 168.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.57 64.84 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.222 1.409 . . . . 0.0 112.785 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -69.73 169.27 13.24 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 121.221 -0.924 . . . . 0.0 112.481 170.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -139.33 154.15 47.84 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.186 1.394 . . . . 0.0 112.661 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -84.94 -6.18 59.34 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -172.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.0 p -153.65 123.47 6.81 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.384 1.473 . . . . 0.0 112.064 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.34 158.07 43.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.947 1.299 . . . . 0.0 112.379 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.06 107.08 9.16 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.849 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -85.12 131.99 34.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.838 1.255 . . . . 0.0 111.014 171.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -84.76 100.51 11.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.504 1.522 . . . . 0.0 110.238 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.1 137.3 20.83 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 124.932 1.293 . . . . 0.0 109.569 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.79 157.73 51.4 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 0.0 112.638 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.69 72.99 2.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.338 1.055 . . . . 0.0 111.454 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.42 -50.14 0.92 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.434 1.894 . . . . 0.0 111.452 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -65.26 -13.7 58.99 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.75 19.7 5.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.405 1.482 . . . . 0.0 114.461 -166.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.82 -25.48 63.78 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.86 9.04 37.02 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.126 1.346 . . . . 0.0 115.613 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.67 129.67 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.156 1.783 . . . . 0.0 111.04 -173.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -77.03 58.03 1.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.573 1.949 . . . . 0.0 112.556 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -61.29 157.21 16.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.991 1.317 . . . . 0.0 113.098 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -153.25 155.28 36.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.761 0.824 . . . . 0.0 112.524 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -60.05 113.56 2.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.937 1.295 . . . . 0.0 111.037 174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.74 4.8 24.47 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.921 1.528 . . . . 0.0 116.921 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.4 ptm -101.63 154.26 19.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.97 1.885 . . . . 0.0 113.034 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 p -72.17 94.86 1.59 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.15 1.78 . . . . 0.0 111.657 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -82.2 156.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.443 1.497 . . . . 0.0 111.618 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.86 143.38 49.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.585 1.554 . . . . 0.0 110.694 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.05 99.14 0.36 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.772 1.177 . . . . 0.0 112.17 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -67.52 143.54 56.1 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.114 -0.639 . . . . 0.0 111.195 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -123.1 154.35 38.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.867 1.667 . . . . 0.0 111.457 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.44 -20.83 65.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.552 1.541 . . . . 0.0 113.164 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.67 19.88 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.097 2.159 . . . . 0.0 114.22 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.7 m120 52.52 47.97 23.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.391 2.276 . . . . 0.0 113.04 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -140.6 172.28 12.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.959 1.703 . . . . 0.0 112.108 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.4 m -143.48 118.47 10.02 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.94 1.296 . . . . 0.0 111.012 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.82 162.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.727 0.811 . . . . 0.0 111.259 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -134.06 128.36 34.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.572 1.549 . . . . 0.0 111.147 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.28 -175.65 5.54 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.34 1.456 . . . . 0.0 112.564 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.15 136.84 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 110.034 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.1 mt -68.11 133.08 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.396 1.478 . . . . 0.0 111.005 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -108.22 -37.99 5.87 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.146 1.379 . . . . 0.0 112.886 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.55 157.89 42.83 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.399 1.08 . . . . 0.0 111.482 166.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.24 143.44 28.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.241 -0.912 . . . . 0.0 113.204 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 70.3 m -141.04 168.69 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.876 2.07 . . . . 0.0 110.584 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.15 -25.87 67.17 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 121.203 -0.935 . . . . 0.0 113.211 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -81.18 -60.18 2.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.952 2.101 . . . . 0.0 112.988 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -140.65 168.88 18.75 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.288 2.235 . . . . 0.0 111.781 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.69 132.96 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.54 1.536 . . . . 0.0 111.553 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.7 mtp -101.82 115.25 30.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.185 1.794 . . . . 0.0 110.803 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.57 136.41 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.738 1.615 . . . . 0.0 110.872 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.94 111.81 5.91 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.344 0.658 . . . . 0.0 111.484 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -123.62 172.43 8.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.778 2.031 . . . . 0.0 111.467 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -132.61 127.55 35.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.827 1.651 . . . . 0.0 110.203 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.96 144.51 19.09 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.859 1.264 . . . . 0.0 110.395 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.83 -13.97 29.55 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.945 2.43 . . . . 0.0 113.491 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.22 14.37 9.49 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.47 1.908 . . . . 0.0 113.436 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.61 178.08 7.57 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.621 1.568 . . . . 0.0 113.465 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.93 -178.28 18.67 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.073 1.796 . . . . 0.0 113.347 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -139.3 169.41 17.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.538 1.535 . . . . 0.0 113.307 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.2 p -65.27 146.64 54.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.124 1.369 . . . . 0.0 113.039 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.17 131.57 44.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.687 -170.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.42 98.97 12.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.149 0.98 . . . . 0.0 111.652 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.23 103.14 10.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.758 0.79 . . . . 0.0 110.328 166.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -94.68 124.18 38.56 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.445 1.898 . . . . 0.0 109.336 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -148.82 170.65 17.78 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -154.33 147.43 24.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.98 1.712 . . . . 0.0 112.14 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 9.8 t -83.79 108.09 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.819 1.248 . . . . 0.0 108.727 163.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.1 mt -65.67 -39.48 91.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.888 -0.508 . . . . 0.0 111.492 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.76 -179.22 18.45 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.579 1.561 . . . . 0.0 113.496 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -96.57 147.68 23.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.968 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -128.65 144.66 51.2 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.979 1.312 . . . . 0.0 112.438 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -92.5 92.52 8.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.055 1.342 . . . . 0.0 110.427 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.51 156.08 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.879 0.872 . . . . 0.0 111.842 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.3 p -70.77 158.85 35.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.665 0.786 . . . . 0.0 112.323 172.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -125.29 25.94 7.0 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.714 1.605 . . . . 0.0 112.046 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 63.32 24.12 14.09 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.614 1.966 . . . . 0.0 113.911 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.465 1.906 . . . . 0.0 114.115 177.266 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -141.81 162.76 34.69 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.771 1.629 . . . . 0.0 110.85 -176.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -91.17 -2.97 57.42 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.306 1.442 . . . . 0.0 114.481 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -74.98 174.79 8.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.674 1.59 . . . . 0.0 113.437 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -133.03 172.72 12.26 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.557 1.943 . . . . 0.0 112.581 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.71 43.76 1.96 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.371 1.468 . . . . 0.0 111.668 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -128.92 60.95 1.53 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.895 1.278 . . . . 0.0 113.505 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -67.46 -8.73 35.72 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.641 1.576 . . . . 0.0 114.803 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mp -66.26 121.51 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.827 2.051 . . . . 0.0 110.514 -177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 152.94 40.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.453 1.101 . . . . 0.0 112.286 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -152.73 155.56 37.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.205 1.802 . . . . 0.0 111.094 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 103.94 11.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.917 0.887 . . . . 0.0 110.893 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.53 120.81 18.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.539 1.536 . . . . 0.0 110.573 168.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.18 124.2 47.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.2 pt -131.35 163.62 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.661 1.184 . . . . 0.0 112.289 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -136.79 138.66 41.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.601 1.96 . . . . 0.0 109.831 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.77 151.93 44.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.066 1.346 . . . . 0.0 114.272 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -146.87 120.65 9.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.615 2.366 . . . . 0.0 110.315 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -99.94 110.28 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.858 1.663 . . . . 0.0 110.429 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 ttm105 -113.78 144.84 42.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.297 1.839 . . . . 0.0 110.694 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.79 117.33 11.25 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.84 105.33 0.55 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.571 0.748 . . . . 0.0 110.667 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.01 23.64 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 126.173 1.844 . . . . 0.0 115.169 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -137.05 165.84 25.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.332 1.566 . . . . 0.0 113.271 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.1 p -89.5 -13.47 37.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.737 2.015 . . . . 0.0 114.755 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.23 177.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 113.661 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.85 145.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.209 1.404 . . . . 0.0 110.121 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mp -106.57 -53.45 2.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.649 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.29 150.22 35.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.406 1.483 . . . . 0.0 110.381 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.6 p -163.01 169.61 19.31 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.158 -0.964 . . . . 0.0 111.694 173.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -122.72 -12.74 8.04 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -36.8 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 124.281 1.032 . . . . 0.0 112.217 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -73.1 -5.7 40.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.591 1.156 . . . . 0.0 113.601 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -117.59 -87.97 0.61 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.902 2.081 . . . . 0.0 110.367 -171.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -153.38 154.09 30.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 127.419 2.288 . . . . 0.0 111.272 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.35 150.69 86.89 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.596 2.864 . . . . 0.0 113.269 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -87.6 123.7 32.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.432 1.493 . . . . 0.0 109.774 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.15 134.58 50.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 111.533 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -150.12 172.58 15.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.499 1.119 . . . . 0.0 112.918 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.21 151.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.339 1.455 . . . . 0.0 109.195 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.85 109.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.509 1.124 . . . . 0.0 111.009 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.08 27.06 6.38 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.526 1.37 . . . . 0.0 116.526 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.3 m -97.06 -24.1 15.94 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 119.39 1.595 . . . . 0.0 114.355 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.3 t30 45.73 43.13 9.37 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.915 2.086 . . . . 0.0 115.092 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -71.77 -31.14 66.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.4 1.88 . . . . 0.0 114.155 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -72.41 166.87 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.866 1.267 . . . . 0.0 111.517 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 pt -63.15 146.36 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 0.0 111.413 172.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.9 75.76 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.07 -31.06 67.94 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.005 0.812 . . . . 0.0 113.913 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.25 -29.66 24.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.836 1.255 . . . . 0.0 112.307 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.09 -38.23 82.32 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.01 -1.056 . . . . 0.0 112.021 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -68.03 0.24 3.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.835 1.254 . . . . 0.0 114.312 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.39 -41.82 3.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.617 1.567 . . . . 0.0 113.167 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.71 -29.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.64 -10.39 55.85 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -118.96 -17.95 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.925 1.69 . . . . 0.0 114.549 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.95 141.62 49.43 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.309 0.959 . . . . 0.0 112.345 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -90.28 158.22 17.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.719 1.207 . . . . 0.0 111.779 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.03 129.75 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.179 0.992 . . . . 0.0 111.307 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.68 3.88 74.21 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.831 1.205 . . . . 0.0 115.692 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.63 111.95 24.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.181 1.491 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -55.93 139.66 45.48 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.766 0.826 . . . . 0.0 111.723 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -137.11 149.15 47.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.57 1.548 . . . . 0.0 110.275 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -134.71 104.74 6.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.449 1.099 . . . . 0.0 110.348 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.19 118.66 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.083 1.353 . . . . 0.0 110.359 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.0 t -75.83 121.32 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 109.59 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.55 144.46 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.953 1.701 . . . . 0.0 109.822 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.02 92.83 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.814 1.246 . . . . 0.0 112.55 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.81 -33.9 41.92 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.538 2.159 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -31.64 72.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.923 0.889 . . . . 0.0 113.265 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.67 -18.46 44.43 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.322 1.449 . . . . 0.0 113.177 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.92 -42.12 5.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.988 1.315 . . . . 0.0 113.767 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -134.79 -27.1 1.31 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.632 1.573 . . . . 0.0 114.83 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.2 -144.96 19.52 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 119.27 0.941 . . . . 0.0 112.273 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.5 m -50.97 96.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 127.158 2.183 . . . . 0.0 113.778 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -71.55 163.33 27.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.998 1.319 . . . . 0.0 112.466 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.9 -21.2 65.85 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.6 -1.313 . . . . 0.0 114.232 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 m -75.42 -0.36 19.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.265 1.826 . . . . 0.0 114.194 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t -69.15 -173.6 0.54 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 112.424 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 69.05 14.6 8.8 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.723 2.009 . . . . 0.0 113.458 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.66 147.23 30.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.149 2.58 . . . . 0.0 109.563 166.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -145.53 117.45 8.24 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.172 1.389 . . . . 0.0 110.416 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.11 118.45 15.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.955 0.902 . . . . 0.0 111.133 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.56 158.73 69.02 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 127.243 2.217 . . . . 0.0 110.978 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 149.3 64.43 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.154 1.902 . . . . 0.0 110.958 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -62.26 -20.31 64.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.533 0.733 . . . . 0.0 112.958 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -52.07 -32.19 33.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.997 1.719 . . . . 0.0 113.72 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -64.76 -18.16 64.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.517 1.127 . . . . 0.0 113.344 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.88 18.32 6.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.045 2.138 . . . . 0.0 112.915 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -53.34 108.61 0.35 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.61 1.564 . . . . 0.0 112.164 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.66 -5.11 34.82 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.826 1.679 . . . . 0.0 115.434 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mt -101.5 130.98 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.44 1.496 . . . . 0.0 110.375 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.76 89.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.489 1.116 . . . . 0.0 111.468 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.5 158.28 36.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.279 1.032 . . . . 0.0 111.777 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -155.33 145.81 22.05 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.732 1.213 . . . . 0.0 111.288 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -73.21 83.02 1.35 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.165 0.986 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.77 46.25 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.362 1.458 . . . . 0.0 113.87 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ppp? -129.01 148.7 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.199 1.4 . . . . 0.0 111.109 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 p -76.68 108.35 9.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.872 1.669 . . . . 0.0 111.479 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.1 156.79 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.668 1.587 . . . . 0.0 110.679 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -121.24 154.63 36.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.662 1.185 . . . . 0.0 111.068 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.68 106.23 0.41 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.344 0.973 . . . . 0.0 113.217 -173.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -74.55 114.05 12.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.462 1.105 . . . . 0.0 111.932 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -84.95 159.2 20.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.166 1.386 . . . . 0.0 112.122 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.46 -18.46 63.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.225 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.19 10.71 0.28 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 113.897 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 55.41 46.35 23.47 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.155 2.182 . . . . 0.0 111.956 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -141.22 171.13 14.48 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.795 2.038 . . . . 0.0 111.167 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 m -140.74 108.06 5.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.497 1.119 . . . . 0.0 110.697 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.42 165.88 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.832 -0.543 . . . . 0.0 111.29 176.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -129.16 131.11 47.11 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.971 1.308 . . . . 0.0 110.592 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.36 177.91 9.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.803 1.241 . . . . 0.0 113.59 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.89 135.59 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.628 1.571 . . . . 0.0 109.903 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.93 120.94 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.313 1.045 . . . . 0.0 110.22 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -87.69 -38.07 16.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.878 1.271 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.54 152.74 37.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.932 1.293 . . . . 0.0 111.63 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -146.78 142.56 27.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.094 0.957 . . . . 0.0 112.601 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.0 t -153.51 169.42 23.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.137 2.175 . . . . 0.0 110.125 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.71 -28.29 68.32 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.123 0.969 . . . . 0.0 113.408 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.6 p -79.56 -60.66 2.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.135 1.774 . . . . 0.0 111.852 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -134.16 156.94 47.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.371 1.868 . . . . 0.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.6 142.0 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.622 1.969 . . . . 0.0 108.566 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.9 mtp -121.94 98.87 6.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.997 1.319 . . . . 0.0 110.161 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.62 148.0 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.642 1.177 . . . . 0.0 109.849 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -62.99 110.4 1.78 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.36 0.664 . . . . 0.0 111.669 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -130.94 119.09 21.61 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.181 1.393 . . . . 0.0 109.422 171.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -71.75 37.34 0.06 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 126.75 2.02 . . . . 0.0 113.186 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.52 140.97 96.8 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.197 1.399 . . . . 0.0 111.991 -172.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.05 -29.16 12.14 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.832 2.355 . . . . 0.0 114.097 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.99 46.0 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.46 1.504 . . . . 0.0 111.632 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.99 -41.49 42.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.603 1.561 . . . . 0.0 114.095 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.44 -164.92 33.78 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.079 1.324 . . . . 0.0 113.11 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.87 168.31 9.58 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.703 1.201 . . . . 0.0 112.037 167.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.01 146.6 37.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.39 1.876 . . . . 0.0 113.13 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.9 mt -128.36 140.32 51.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.685 1.594 . . . . 0.0 110.941 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.88 94.31 5.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.023 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.48 92.68 3.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.503 1.121 . . . . 0.0 109.697 167.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 -75.48 139.46 42.24 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.86 171.06 17.82 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -150.23 146.2 26.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.028 1.331 . . . . 0.0 111.36 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.21 104.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.536 1.134 . . . . 0.0 109.119 167.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.71 -24.52 58.77 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 112.338 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.29 -167.43 25.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.047 1.308 . . . . 0.0 113.907 171.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.43 145.96 49.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 110.626 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -134.85 151.63 51.08 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 113.132 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.93 109.85 13.6 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.059 1.344 . . . . 0.0 110.586 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.3 m -66.53 153.6 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.578 0.751 . . . . 0.0 111.778 170.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.6 p -78.77 170.28 16.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.798 0.839 . . . . 0.0 111.635 164.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.36 8.24 7.13 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.702 1.601 . . . . 0.0 113.146 175.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.28 -51.53 36.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.797 1.639 . . . . 0.0 112.872 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 127.066 2.147 . . . . 0.0 112.32 178.439 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.96 166.51 19.91 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.912 1.285 . . . . 0.0 111.831 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -66.72 172.37 4.34 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.484 1.514 . . . . 0.0 112.697 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -121.92 153.55 38.32 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.244 1.418 . . . . 0.0 111.333 170.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -154.51 170.49 21.31 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.511 1.924 . . . . 0.0 110.368 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.81 98.73 1.26 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.375 1.47 . . . . 0.0 112.19 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -105.63 81.83 1.73 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.581 1.552 . . . . 0.0 110.749 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.4 t -70.12 -46.71 64.22 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.029 0.931 . . . . 0.0 112.346 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.7 mm -113.85 141.58 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.44 1.896 . . . . 0.0 109.235 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.51 173.09 11.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.168 1.787 . . . . 0.0 111.193 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 -132.6 143.71 49.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.585 1.554 . . . . 0.0 111.269 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.3 104.89 7.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.253 1.021 . . . . 0.0 109.63 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.08 141.21 37.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.657 1.183 . . . . 0.0 110.671 169.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.25 133.49 47.54 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.391 1.476 . . . . 0.0 110.599 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 pt -134.35 163.98 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.869 1.268 . . . . 0.0 111.544 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -137.84 135.81 36.57 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.168 1.387 . . . . 0.0 109.699 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -134.09 158.99 42.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 123.067 1.413 . . . . 0.0 114.368 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -141.04 120.83 13.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.961 2.904 . . . . 0.0 108.259 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -100.71 105.69 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.446 1.117 . . . . 0.0 109.93 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 ttp85 -118.57 153.16 34.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.202 2.201 . . . . 0.0 109.717 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.5 146.33 50.32 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.316 -0.865 . . . . 0.0 110.836 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -70.52 -33.11 70.81 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.881 -1.137 . . . . 0.0 112.434 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.45 -35.67 7.84 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.352 0.977 . . . . 0.0 115.017 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -116.92 151.07 37.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.319 1.448 . . . . 0.0 112.604 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 t -73.1 -7.52 51.71 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.95 151.11 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 120.892 -1.13 . . . . 0.0 112.372 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.43 126.97 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.226 1.41 . . . . 0.0 109.843 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -84.58 -42.89 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.777 0.831 . . . . 0.0 110.818 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -158.49 163.4 37.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.3 1.84 . . . . 0.0 110.767 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -166.65 150.57 7.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.071 1.348 . . . . 0.0 112.131 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -124.55 4.26 8.29 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -47.98 -64.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.234 1.414 . . . . 0.0 112.079 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 t -79.9 -23.67 41.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.256 1.023 . . . . 0.0 113.368 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -69.64 -71.61 0.22 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.884 1.674 . . . . 0.0 112.056 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -165.63 140.0 3.88 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.099 1.759 . . . . 0.0 110.876 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.41 152.48 75.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.666 2.244 . . . . 0.0 112.698 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.8 tp -83.07 97.68 8.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.222 1.809 . . . . 0.0 110.294 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -74.08 129.85 38.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.368 1.467 . . . . 0.0 111.923 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -149.43 176.49 10.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.967 1.307 . . . . 0.0 112.846 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.0 mm -112.43 134.87 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.469 1.508 . . . . 0.0 109.385 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.0 mm -50.09 117.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.332 1.453 . . . . 0.0 110.956 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.26 71.6 1.12 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.014 1.293 . . . . 0.0 112.044 -169.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -134.6 -43.9 0.75 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.049 1.34 . . . . 0.0 113.344 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 54.09 21.14 2.82 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 126.721 2.008 . . . . 0.0 115.097 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 pt -71.66 165.75 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 112.469 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.29 142.65 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.729 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.8 82.4 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.4 -28.72 69.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.48 -0.763 . . . . 0.0 113.992 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 tp -87.15 -35.39 18.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.044 1.338 . . . . 0.0 111.898 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.36 -46.42 69.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.718 1.207 . . . . 0.0 111.415 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -77.91 13.63 1.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.011 1.324 . . . . 0.0 114.143 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.59 -39.92 2.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.714 1.606 . . . . 0.0 113.616 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.22 -29.1 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -67.26 -14.32 62.81 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -118.69 -9.5 10.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.416 1.486 . . . . 0.0 114.112 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.85 8.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.212 1.405 . . . . 0.0 111.61 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -62.47 145.73 53.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.705 0.802 . . . . 0.0 112.117 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.75 133.41 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.664 0.786 . . . . 0.0 110.691 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 10.39 56.55 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 115.709 1.044 . . . . 0.0 115.709 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.91 128.13 54.13 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.448 1.499 . . . . 0.0 111.281 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -57.93 140.91 51.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.021 0.928 . . . . 0.0 112.243 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -134.12 141.51 47.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.795 2.038 . . . . 0.0 109.864 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.17 106.75 6.9 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.55 113.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.757 1.223 . . . . 0.0 111.711 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.96 123.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 109.554 173.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.4 mt -128.73 135.71 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.92 1.288 . . . . 0.0 109.489 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.6 161.46 59.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 125.703 1.601 . . . . 0.0 112.623 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 42.41 0.76 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 125.18 3.92 . . . . 0.0 113.872 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.42 -35.77 1.94 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.877 2.071 . . . . 0.0 113.057 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -110.93 -15.59 13.73 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.317 1.047 . . . . 0.0 113.617 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.83 99.92 5.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.403 1.481 . . . . 0.0 111.125 -171.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 43.19 47.97 5.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.684 1.594 . . . . 0.0 112.512 -163.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.27 -160.27 30.98 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.808 1.671 . . . . 0.0 114.139 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 t 61.7 34.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.146 1.378 . . . . 0.0 110.909 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -64.2 149.99 46.74 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.837 1.655 . . . . 0.0 112.342 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.05 107.26 8.13 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.799 1.24 . . . . 0.0 113.866 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.9 m -94.68 21.47 7.34 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.67 1.588 . . . . 0.0 113.102 171.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.4 m 55.76 63.34 2.08 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.119 2.167 . . . . 0.0 113.989 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -85.97 177.54 7.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.863 1.265 . . . . 0.0 112.135 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.53 166.75 24.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.674 1.589 . . . . 0.0 111.903 172.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -144.86 131.14 19.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.502 1.121 . . . . 0.0 110.983 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -70.04 128.57 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.794 0.838 . . . . 0.0 110.923 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.05 137.73 18.55 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.299 1.84 . . . . 0.0 109.903 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.73 172.66 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.017 2.478 . . . . 0.0 113.122 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -69.5 70.26 0.28 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.471 1.908 . . . . 0.0 111.901 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -129.19 -64.39 0.91 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.591 1.956 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -64.12 -16.39 61.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.906 1.283 . . . . 0.0 113.653 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -131.69 13.88 4.9 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.968 1.707 . . . . 0.0 113.422 -172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.61 -28.59 65.76 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.699 -1.251 . . . . 0.0 113.435 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.89 12.55 56.21 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.844 1.688 . . . . 0.0 115.047 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.75 115.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.509 1.524 . . . . 0.0 110.257 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.3 108.48 4.22 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.297 -0.877 . . . . 0.0 111.629 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.0 mt -101.63 156.99 17.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.368 1.467 . . . . 0.0 111.814 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.17 145.23 17.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.019 1.728 . . . . 0.0 109.863 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -51.87 128.35 23.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.772 0.829 . . . . 0.0 111.943 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 56.12 3.47 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.27 0.938 . . . . 0.0 114.327 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.1 ptp -132.27 172.45 12.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.116 1.766 . . . . 0.0 110.931 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 t -101.94 103.91 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.022 0.929 . . . . 0.0 110.452 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.28 154.44 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.153 1.381 . . . . 0.0 110.331 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -120.27 153.58 36.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.49 1.116 . . . . 0.0 111.944 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 97.52 0.23 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.73 1.157 . . . . 0.0 112.742 -175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.71 142.67 58.35 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.874 -0.78 . . . . 0.0 111.38 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.0 t -126.09 157.12 38.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.909 1.683 . . . . 0.0 111.607 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.95 -15.15 61.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.071 1.748 . . . . 0.0 113.509 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -76.41 15.63 0.58 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.609 1.963 . . . . 0.0 113.721 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.6 m120 56.73 39.95 29.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.878 2.071 . . . . 0.0 113.136 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -133.67 172.56 12.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.686 1.995 . . . . 0.0 111.409 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.6 m -142.44 114.73 8.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.351 1.46 . . . . 0.0 110.427 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -72.57 163.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.015 0.526 . . . . 0.0 111.166 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -133.49 132.95 41.62 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.046 1.338 . . . . 0.0 110.901 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.96 175.33 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.613 1.565 . . . . 0.0 112.814 -166.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.427 ' H ' ' HB3' ' A' ' 125' ' ' ASP . 4.8 mp -121.46 142.76 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.705 1.602 . . . . 0.0 110.625 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.76 113.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.575 1.15 . . . . 0.0 109.856 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.96 -30.41 15.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.915 1.286 . . . . 0.0 113.429 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -155.38 155.55 33.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.947 1.699 . . . . 0.0 110.581 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -147.26 147.72 30.71 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.21 0.914 . . . . 0.0 113.253 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.0 t -153.17 171.91 17.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.737 2.015 . . . . 0.0 110.975 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.31 -21.98 61.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.63 1.172 . . . . 0.0 113.558 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.4 p -82.55 -63.6 1.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 111.724 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -135.22 165.17 26.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.325 2.25 . . . . 0.0 111.339 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.48 154.13 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.179 1.792 . . . . 0.0 109.798 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 80.2 mtp -125.77 103.98 8.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.159 1.384 . . . . 0.0 110.421 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -99.54 141.62 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.134 1.373 . . . . 0.0 109.627 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.427 ' HB3' ' H ' ' A' ' 113' ' ' ILE . 13.9 t70 -62.08 140.04 58.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.946 1.298 . . . . 0.0 111.436 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -143.43 173.74 11.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.686 1.194 . . . . 0.0 111.946 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -121.5 176.0 5.9 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.211 1.804 . . . . 0.0 111.578 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.77 133.59 10.48 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.556 1.142 . . . . 0.0 110.367 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.38 -35.22 51.34 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.214 1.943 . . . . 0.0 112.3 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.94 3.8 9.5 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.53 -26.79 65.61 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.46 -160.38 31.49 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.41 1.481 . . . . 0.0 113.588 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -132.73 165.55 24.26 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.232 1.413 . . . . 0.0 112.618 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -63.34 139.47 58.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.489 1.516 . . . . 0.0 112.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.4 148.04 46.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.279 1.432 . . . . 0.0 111.15 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -98.49 102.6 14.39 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.991 2.117 . . . . 0.0 110.262 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -80.12 95.29 6.18 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.607 0.717 . . . . 0.0 109.734 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -86.55 112.7 21.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.689 1.596 . . . . 0.0 108.776 171.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -136.12 170.31 16.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.833 0.853 . . . . 0.0 112.865 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -147.36 137.61 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.639 1.176 . . . . 0.0 111.005 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.7 t -87.45 94.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.03 -28.63 69.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.779 1.231 . . . . 0.0 112.686 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.68 177.87 15.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.968 1.746 . . . . 0.0 112.582 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -112.29 156.06 23.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.779 0.832 . . . . 0.0 111.688 169.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -135.19 130.62 35.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.637 1.575 . . . . 0.0 111.332 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -73.03 117.69 15.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.907 0.883 . . . . 0.0 109.513 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.8 m -110.17 170.56 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.37 1.468 . . . . 0.0 110.746 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 88.1 p -130.93 156.82 44.44 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.259 1.024 . . . . 0.0 112.315 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.82 9.04 3.57 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.947 1.699 . . . . 0.0 112.92 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -73.06 -44.61 60.39 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.585 1.554 . . . . 0.0 112.871 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.008 1.723 . . . . 0.0 114.475 -178.694 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -61.98 156.0 22.25 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.753 1.221 . . . . 0.0 112.401 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -84.02 175.46 9.52 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.972 1.309 . . . . 0.0 112.815 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -132.15 142.75 49.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.706 1.602 . . . . 0.0 111.589 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -85.53 168.66 14.31 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.295 1.438 . . . . 0.0 112.461 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.14 112.62 9.36 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.455 1.102 . . . . 0.0 110.588 166.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -129.43 27.57 5.29 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.696 1.598 . . . . 0.0 113.319 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -66.81 -35.03 79.13 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.298 1.439 . . . . 0.0 113.992 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -74.16 132.58 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.307 1.443 . . . . 0.0 110.546 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -61.36 159.18 12.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.15 1.38 . . . . 0.0 113.6 176.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -137.14 156.23 48.61 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.193 1.397 . . . . 0.0 111.152 170.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.94 115.03 22.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.824 0.85 . . . . 0.0 110.127 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.11 114.68 11.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.999 1.32 . . . . 0.0 109.908 162.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.48 119.84 33.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.798 1.239 . . . . 0.0 109.111 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.94 163.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.207 1.003 . . . . 0.0 111.859 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -143.1 140.22 30.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.565 1.546 . . . . 0.0 110.635 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -136.74 158.08 45.27 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.385 1.474 . . . . 0.0 114.055 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -144.16 107.92 4.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.643 1.977 . . . . 0.0 110.614 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.68 117.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 0.0 111.076 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -131.31 156.48 45.4 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.899 1.68 . . . . 0.0 111.104 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.3 146.46 40.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.297 -0.877 . . . . 0.0 111.055 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.16 133.51 48.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.075 0.95 . . . . 0.0 110.927 169.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.49 -57.13 3.76 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.991 1.281 . . . . 0.0 114.177 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -62.87 147.55 49.87 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.497 1.119 . . . . 0.0 112.598 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.5 m -83.44 -7.74 59.5 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.25 161.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.0 0.818 . . . . 0.0 111.876 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.71 124.75 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.351 1.46 . . . . 0.0 109.504 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 mt -71.7 -53.57 13.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.012 0.525 . . . . 0.0 112.016 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -157.88 162.09 38.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.761 1.224 . . . . 0.0 111.686 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 p -154.63 130.25 9.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.945 1.298 . . . . 0.0 112.466 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.64 -2.02 19.06 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.7 mm -51.67 -52.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.987 1.715 . . . . 0.0 111.884 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 m -82.6 -6.27 59.26 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 mmpp? -92.17 -172.07 3.02 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.56 1.944 . . . . 0.0 110.657 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.5 137.2 97.06 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 121.469 -0.77 . . . . 0.0 110.799 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.81 163.52 35.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.221 2.614 . . . . 0.0 113.204 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -92.91 110.24 21.7 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.76 1.224 . . . . 0.0 110.754 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.85 131.16 35.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.766 1.626 . . . . 0.0 111.499 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -143.06 157.04 44.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.256 1.022 . . . . 0.0 111.722 164.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.59 148.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.024 -1.047 . . . . 0.0 109.711 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.0 mm -48.19 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.316 1.446 . . . . 0.0 111.335 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.03 11.48 49.33 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -69.44 -35.0 75.25 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.926 1.863 . . . . 0.0 113.557 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.3 m120 57.72 37.74 27.33 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.527 1.931 . . . . 0.0 115.281 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -79.25 -23.65 43.52 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -72.76 167.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.367 1.067 . . . . 0.0 112.84 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.3 pt -59.11 136.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.95 0.9 . . . . 0.0 111.202 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.24 70.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.287 -0.883 . . . . 0.0 112.606 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.94 -13.97 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.111 173.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.94 -36.68 6.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.349 1.86 . . . . 0.0 111.595 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.28 -32.79 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -4.01 0.86 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 174.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.79 -29.9 4.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.387 1.875 . . . . 0.0 113.965 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.41 -24.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.849 1.204 . . . . 0.0 113.373 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -66.4 -13.85 61.29 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.34 -21.24 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.755 1.622 . . . . 0.0 113.859 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.29 111.58 2.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.662 1.185 . . . . 0.0 112.15 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.67 159.69 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.116 0.96 . . . . 0.0 113.2 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -56.64 131.99 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.194 1.398 . . . . 0.0 111.617 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.93 8.53 68.95 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.967 1.27 . . . . 0.0 115.064 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.53 112.7 24.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.032 1.333 . . . . 0.0 111.471 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -59.0 134.52 57.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.428 0.691 . . . . 0.0 111.363 171.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.61 112.97 12.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.121 1.768 . . . . 0.0 110.032 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.94 92.73 4.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.927 1.291 . . . . 0.0 110.508 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.06 165.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.592 0.757 . . . . 0.0 111.485 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.86 130.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.331 1.452 . . . . 0.0 108.461 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.4 mt -127.78 130.42 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 126.615 1.966 . . . . 0.0 109.135 -165.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.32 147.25 82.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.608 0.763 . . . . 0.0 111.264 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.22 -43.16 9.05 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -166.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.28 -21.86 66.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.822 1.649 . . . . 0.0 114.068 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -81.75 -13.53 57.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.698 1.199 . . . . 0.0 112.508 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.31 -73.39 0.64 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.126 1.77 . . . . 0.0 111.586 173.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -141.94 -12.32 0.86 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.66 78.15 0.84 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.406 1.003 . . . . 0.0 113.267 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.3 m -126.03 132.63 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.798 1.639 . . . . 0.0 110.767 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -134.21 172.51 12.76 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.893 1.277 . . . . 0.0 111.583 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -137.46 165.85 25.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.128 1.371 . . . . 0.0 111.868 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -122.68 8.46 9.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.129 1.772 . . . . 0.0 113.429 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.7 p -124.93 96.13 4.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.933 2.093 . . . . 0.0 111.786 -170.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -121.47 178.51 4.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.506 2.322 . . . . 0.0 109.848 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.34 143.96 50.72 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.069 -1.02 . . . . 0.0 110.635 174.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -126.39 124.65 40.68 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.666 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -83.89 78.34 9.74 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.366 1.079 . . . . 0.0 111.186 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.54 136.49 59.73 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.097 1.759 . . . . 0.0 109.903 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 159.44 52.91 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.71 2.273 . . . . 0.0 112.701 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -17.8 47.7 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.25 -31.26 63.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.902 1.681 . . . . 0.0 113.575 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -81.09 -6.16 58.49 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.155 0.982 . . . . 0.0 113.636 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -133.41 45.74 2.66 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.009 2.124 . . . . 0.0 110.996 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.66 111.82 19.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.54 1.136 . . . . 0.0 111.6 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.85 55.46 4.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.457 1.027 . . . . 0.0 114.319 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.46 -179.6 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.731 2.412 . . . . 0.0 111.786 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -131.99 88.3 2.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.588 1.555 . . . . 0.0 110.601 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 26.0 mt -75.24 151.69 38.38 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.454 0.702 . . . . 0.0 111.398 176.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.84 135.09 19.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.217 1.007 . . . . 0.0 111.388 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.56 102.74 0.35 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.481 1.513 . . . . 0.0 110.563 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.97 21.15 5.75 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.994 1.283 . . . . 0.0 115.797 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -112.92 158.01 20.74 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.26 1.53 . . . . 0.0 112.555 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 p -82.46 97.8 8.58 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.113 1.365 . . . . 0.0 111.771 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 p -83.7 162.2 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.962 0.905 . . . . 0.0 111.015 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -123.32 152.89 40.98 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.276 1.431 . . . . 0.0 111.37 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.42 108.08 0.47 Allowed Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.369 0.985 . . . . 0.0 112.692 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -66.71 145.46 55.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.157 -0.614 . . . . 0.0 111.359 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -125.14 156.45 38.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.109 1.764 . . . . 0.0 111.533 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.16 -16.02 49.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.202 1.801 . . . . 0.0 114.294 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -74.68 12.82 0.73 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.428 1.891 . . . . 0.0 113.89 173.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 m120 54.27 48.66 20.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.942 2.097 . . . . 0.0 112.221 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -140.12 173.81 11.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.191 1.797 . . . . 0.0 111.792 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.4 m -145.67 110.96 5.32 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.05 1.34 . . . . 0.0 110.529 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.07 167.36 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.74 -0.6 . . . . 0.0 111.43 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -121.54 139.45 53.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.641 1.576 . . . . 0.0 110.725 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.8 173.96 14.65 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.465 1.106 . . . . 0.0 112.65 -168.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.85 128.53 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.0 mm -63.22 125.48 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.413 1.485 . . . . 0.0 110.279 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -111.84 -34.93 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.647 1.179 . . . . 0.0 113.041 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -157.62 167.5 29.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.491 1.116 . . . . 0.0 112.039 165.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.72 140.38 33.12 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.201 1.001 . . . . 0.0 112.168 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.9 m -111.76 174.07 6.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.152 2.181 . . . . 0.0 110.739 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.02 68.58 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 70.9 p -130.19 -7.57 4.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.788 1.635 . . . . 0.0 114.809 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -145.0 165.37 28.36 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.256 1.822 . . . . 0.0 111.278 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.69 144.42 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.706 1.603 . . . . 0.0 109.712 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 37.7 mmm -116.14 109.5 17.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 110.051 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.31 148.1 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.35 1.46 . . . . 0.0 109.933 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 120.52 13.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.241 1.417 . . . . 0.0 111.867 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -134.59 164.45 27.45 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.886 1.674 . . . . 0.0 111.873 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -83.03 171.09 14.16 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.518 1.127 . . . . 0.0 112.102 167.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -145.69 131.82 9.61 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.619 1.167 . . . . 0.0 110.769 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.52 -39.76 3.42 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.811 2.341 . . . . 0.0 112.968 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.67 78.75 7.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.444 1.098 . . . . 0.0 108.595 169.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.37 162.72 22.09 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.419 1.088 . . . . 0.0 112.692 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.12 102.21 2.34 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.71 1.148 . . . . 0.0 113.859 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -77.67 155.26 31.45 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.231 1.812 . . . . 0.0 112.693 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.87 144.21 43.49 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.185 1.394 . . . . 0.0 111.3 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.2 143.95 46.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.065 1.346 . . . . 0.0 111.262 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.75 144.38 37.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.659 0.784 . . . . 0.0 111.357 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -128.79 92.13 3.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.074 1.75 . . . . 0.0 108.652 170.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -79.01 110.37 14.17 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.901 1.28 . . . . 0.0 108.802 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -131.88 166.97 20.42 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.349 0.66 . . . . 0.0 112.773 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -149.92 142.74 24.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.658 1.183 . . . . 0.0 111.673 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.14 106.69 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.997 1.319 . . . . 0.0 108.826 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.61 -38.19 77.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 111.63 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.55 158.88 7.73 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.296 1.427 . . . . 0.0 114.749 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -82.9 125.38 31.3 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.803 1.641 . . . . 0.0 111.506 -176.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -142.83 120.42 11.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.276 1.43 . . . . 0.0 111.225 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.38 145.86 47.43 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.988 -1.07 . . . . 0.0 111.526 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.76 146.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.55 1.54 . . . . 0.0 110.85 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.4 m -70.13 126.88 30.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.218 1.007 . . . . 0.0 111.61 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -103.71 1.64 32.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.421 1.489 . . . . 0.0 113.656 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.44 -58.67 2.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.979 1.712 . . . . 0.0 113.166 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.744 1.618 . . . . 0.0 113.925 -177.817 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -129.38 125.55 36.84 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.125 1.37 . . . . 0.0 111.052 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -137.79 171.01 15.07 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.671 1.988 . . . . 0.0 110.945 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -145.18 172.91 12.44 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.643 1.177 . . . . 0.0 111.93 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -126.0 170.69 11.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.167 1.787 . . . . 0.0 112.022 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tt -118.99 107.23 13.28 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.625 1.57 . . . . 0.0 110.576 -173.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -132.87 85.29 2.21 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.552 1.541 . . . . 0.0 111.261 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 m -74.39 -12.13 60.43 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.8 mm -78.83 170.03 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 126.799 2.04 . . . . 0.0 110.538 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.55 145.62 47.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.407 1.083 . . . . 0.0 112.39 164.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -159.48 160.1 34.3 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.899 2.079 . . . . 0.0 109.621 167.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.19 108.44 6.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.093 0.557 . . . . 0.0 110.602 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.27 120.05 14.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.265 1.826 . . . . 0.0 110.456 165.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.28 113.86 27.69 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.244 2.218 . . . . 0.0 108.952 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 159.35 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 112.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -135.09 129.67 34.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.885 1.274 . . . . 0.0 110.38 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -135.68 155.0 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.607 1.163 . . . . 0.0 113.034 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -140.17 166.09 25.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.097 1.759 . . . . 0.0 111.424 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.37 101.2 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.84 1.256 . . . . 0.0 111.194 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -90.51 154.03 19.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 110.219 170.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -61.54 135.4 57.64 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.894 161.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -71.21 91.72 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.23 -0.919 . . . . 0.0 110.776 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.93 -68.91 0.54 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.185 1.85 . . . . 0.0 112.302 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -67.11 158.67 30.58 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.7 m -79.02 -13.09 59.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.46 151.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.074 0.852 . . . . 0.0 112.063 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.6 114.91 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.364 1.466 . . . . 0.0 109.182 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.0 mt -68.29 -48.57 64.62 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.619 1.168 . . . . 0.0 111.66 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -154.02 158.19 40.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.638 1.575 . . . . 0.0 110.362 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 p -151.2 125.68 9.49 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.472 1.109 . . . . 0.0 111.52 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -90.13 -30.89 17.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.29 0.636 . . . . 0.0 111.912 170.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.85 -50.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.613 1.565 . . . . 0.0 111.815 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -70.53 -5.54 29.72 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.21 1.404 . . . . 0.0 114.548 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -100.85 -83.61 0.44 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.772 1.629 . . . . 0.0 109.702 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.71 156.78 31.09 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 127.45 2.3 . . . . 0.0 110.451 171.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.82 141.35 78.01 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.679 2.253 . . . . 0.0 111.733 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.82 136.83 43.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.959 1.303 . . . . 0.0 109.971 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.64 119.71 34.52 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.05 1.34 . . . . 0.0 111.208 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -148.49 172.68 14.1 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -109.99 142.85 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.302 1.441 . . . . 0.0 109.839 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mm -47.32 115.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 111.864 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.52 64.76 1.49 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.171 1.367 . . . . 0.0 113.425 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -115.67 -22.37 9.21 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.044 1.338 . . . . 0.0 114.529 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m120 52.05 28.57 5.45 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 127.489 2.316 . . . . 0.0 116.107 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -86.75 -32.14 20.56 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 pt -81.26 170.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.975 1.31 . . . . 0.0 112.168 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.1 pt -59.57 140.01 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.189 0.996 . . . . 0.0 111.723 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.39 78.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -28.75 70.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.115 0.864 . . . . 0.0 114.295 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.19 -38.7 14.08 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.676 1.19 . . . . 0.0 111.588 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -53.42 -46.28 69.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.229 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.04 1.72 3.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.948 1.699 . . . . 0.0 114.667 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.55 -35.72 5.15 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.72 1.608 . . . . 0.0 113.498 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.74 -41.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.339 1.427 . . . . 0.0 112.253 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.29 -10.46 32.62 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -112.33 -9.43 13.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.205 1.802 . . . . 0.0 113.927 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.86 145.87 28.4 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.818 1.247 . . . . 0.0 111.842 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -98.37 157.01 16.46 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.925 1.29 . . . . 0.0 111.566 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 tt -57.39 129.36 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 111.829 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.14 78.88 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.035 1.302 . . . . 0.0 115.368 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.28 114.13 20.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.09 1.445 . . . . 0.0 111.65 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -56.0 142.06 37.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.536 1.135 . . . . 0.0 112.717 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -137.44 116.46 12.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.015 1.726 . . . . 0.0 110.728 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -101.4 107.05 18.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.012 1.325 . . . . 0.0 110.73 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -115.9 110.3 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.564 1.146 . . . . 0.0 110.907 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 t -73.89 130.19 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.73 141.64 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.157 1.383 . . . . 0.0 109.764 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.68 155.08 87.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.905 1.282 . . . . 0.0 112.789 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.62 -18.6 64.67 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.362 2.708 . . . . 0.0 114.457 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.49 -6.56 20.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.366 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -106.65 -21.41 13.06 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.19 1.396 . . . . 0.0 113.224 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.67 -168.3 1.36 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.899 1.68 . . . . 0.0 112.897 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -54.48 -21.36 9.75 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 164.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.84 72.16 1.1 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.307 1.432 . . . . 0.0 113.546 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.39 154.91 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.036 1.734 . . . . 0.0 110.876 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -137.72 144.83 41.91 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.769 1.227 . . . . 0.0 110.597 169.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -140.32 82.26 1.85 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.092 1.357 . . . . 0.0 109.771 167.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 p -62.11 -37.84 86.62 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.331 1.052 . . . . 0.0 111.952 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.1 m 47.39 48.46 16.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.366 1.466 . . . . 0.0 112.382 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 71.99 15.1 5.69 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.242 2.217 . . . . 0.0 114.402 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.7 mt -142.16 160.67 39.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.566 1.946 . . . . 0.0 112.974 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.39 133.23 11.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.297 1.439 . . . . 0.0 111.427 162.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -78.29 99.51 6.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.443 1.097 . . . . 0.0 110.407 167.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.67 137.1 21.46 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.714 1.606 . . . . 0.0 109.425 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.44 155.92 50.37 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 112.922 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -75.71 60.75 1.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.171 1.788 . . . . 0.0 112.24 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -122.38 -54.11 1.89 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.302 1.841 . . . . 0.0 111.038 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -63.78 -17.18 62.81 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.464 1.105 . . . . 0.0 113.453 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -126.59 12.05 7.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.822 1.649 . . . . 0.0 113.875 -170.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.417 1.087 . . . . 0.0 113.542 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.4 12.87 47.78 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.19 1.852 . . . . 0.0 115.355 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.6 mt -122.1 126.66 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.251 1.525 . . . . 0.0 110.725 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.93 78.38 0.64 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.22 1.408 . . . . 0.0 112.649 173.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.7 156.2 24.3 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.74 162.77 40.48 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.256 1.822 . . . . 0.0 110.028 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -71.32 136.05 47.66 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.698 -1.251 . . . . 0.0 110.816 166.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.68 18.15 76.05 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.5 ptm -100.53 148.64 24.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.944 1.372 . . . . 0.0 111.776 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -68.49 143.43 54.99 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.059 0.944 . . . . 0.0 111.765 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.37 163.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.757 1.623 . . . . 0.0 111.278 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.25 158.0 35.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.399 1.88 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.88 103.7 0.25 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 123.774 0.702 . . . . 0.0 113.229 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.38 111.03 8.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.323 1.049 . . . . 0.0 111.5 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 t -81.2 154.44 26.66 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.6 1.16 . . . . 0.0 111.744 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.86 -13.57 59.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.774 1.229 . . . . 0.0 113.515 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.06 18.85 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.165 1.786 . . . . 0.0 113.841 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 55.3 42.94 29.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.386 2.274 . . . . 0.0 113.037 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -143.02 169.75 16.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.794 1.638 . . . . 0.0 112.043 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.8 m -141.41 107.11 5.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 110.592 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.79 167.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.992 -0.442 . . . . 0.0 111.18 174.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.08 135.88 37.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.721 1.208 . . . . 0.0 111.587 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.41 -167.97 1.89 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.816 1.246 . . . . 0.0 112.732 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.55 140.29 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.296 1.838 . . . . 0.0 110.528 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.98 124.61 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.418 1.087 . . . . 0.0 111.317 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -91.57 -35.96 13.96 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.722 1.609 . . . . 0.0 113.352 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -154.8 160.21 41.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.223 1.409 . . . . 0.0 110.879 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -148.35 150.08 32.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.171 0.988 . . . . 0.0 113.038 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -143.95 175.69 9.84 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.179 1.791 . . . . 0.0 110.91 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.31 -20.77 58.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.51 1.124 . . . . 0.0 113.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -86.75 -57.49 2.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.68 1.592 . . . . 0.0 111.967 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -138.17 169.95 16.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.4 2.28 . . . . 0.0 111.308 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.45 148.28 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.496 1.518 . . . . 0.0 110.934 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.5 mtp -112.57 92.38 4.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.708 1.603 . . . . 0.0 110.436 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.7 143.37 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.526 1.53 . . . . 0.0 109.808 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -63.87 125.3 23.94 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.876 170.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -128.91 112.06 13.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.378 1.071 . . . . 0.0 110.132 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -125.11 24.71 7.42 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.912 1.685 . . . . 0.0 112.063 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.72 143.98 97.13 Favored Pre-proline 0 CA--C 1.549 0.939 0 O-C-N 120.997 -1.064 . . . . 0.0 111.357 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.31 -4.21 15.03 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.737 2.958 . . . . 0.0 114.207 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.15 92.26 1.69 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.44 2.296 . . . . 0.0 110.081 173.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.01 -64.32 1.21 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.636 0.774 . . . . 0.0 112.048 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.21 92.51 0.06 OUTLIER Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.767 1.651 . . . . 0.0 114.567 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -130.73 160.08 35.38 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.061 1.345 . . . . 0.0 113.507 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 p -65.6 144.54 56.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.198 1.399 . . . . 0.0 112.533 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.8 mt -126.84 142.76 51.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.125 1.37 . . . . 0.0 111.809 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.97 95.11 9.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.537 1.135 . . . . 0.0 111.292 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.76 88.82 5.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.261 1.029 . . . . 0.0 110.796 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.77 124.23 28.88 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.016 1.326 . . . . 0.0 109.45 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.57 171.76 13.73 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -150.94 144.86 25.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.405 1.482 . . . . 0.0 111.237 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.9 101.06 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.426 1.09 . . . . 0.0 108.233 165.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.71 -28.5 66.89 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.539 0.736 . . . . 0.0 112.258 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.74 -160.77 28.62 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.497 1.046 . . . . 0.0 113.539 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.73 149.42 51.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.49 1.116 . . . . 0.0 110.872 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -137.58 142.36 41.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.868 1.267 . . . . 0.0 112.048 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -71.86 131.86 43.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.537 0.735 . . . . 0.0 110.361 169.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.4 172.4 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.878 1.671 . . . . 0.0 111.561 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.6 t -126.76 167.39 15.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.844 1.658 . . . . 0.0 111.287 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.4 -0.68 8.71 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.899 1.68 . . . . 0.0 112.918 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -83.88 -55.18 4.38 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.175 1.39 . . . . 0.0 112.721 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 127.285 2.234 . . . . 0.0 112.414 -175.271 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.823 0.344 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -111.85 -12.16 13.83 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.592 1.157 . . . . 0.0 112.968 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -70.59 99.87 1.73 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.816 1.647 . . . . 0.0 111.174 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -61.57 119.76 9.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.193 1.397 . . . . 0.0 111.496 172.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -75.09 158.28 33.37 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.803 0.841 . . . . 0.0 112.451 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.06 19.25 15.87 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.36 1.864 . . . . 0.0 112.263 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 56.53 19.25 4.05 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.702 2.001 . . . . 0.0 114.812 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.0 m -77.3 12.74 1.38 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.465 1.906 . . . . 0.0 114.748 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.2 mm -60.98 139.94 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.994 1.718 . . . . 0.0 111.295 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -107.26 150.46 26.64 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.092 1.757 . . . . 0.0 111.06 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.55 153.88 34.3 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.658 1.583 . . . . 0.0 111.381 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.57 105.22 9.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.807 0.843 . . . . 0.0 110.678 174.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 129.99 41.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.295 1.038 . . . . 0.0 110.348 165.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -116.47 130.03 56.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.191 1.396 . . . . 0.0 110.39 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.91 163.64 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.511 1.124 . . . . 0.0 112.192 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.88 135.01 34.03 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.58 1.952 . . . . 0.0 110.453 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -139.06 149.61 44.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.111 1.434 . . . . 0.0 114.429 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.27 114.5 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.802 2.441 . . . . 0.0 109.253 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -92.87 96.59 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.409 1.084 . . . . 0.0 110.191 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -95.66 158.11 15.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.157 1.783 . . . . 0.0 110.362 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -72.35 156.8 38.71 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.125 -0.985 . . . . 0.0 110.98 166.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -65.65 -64.62 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 113.104 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.07 -47.76 5.4 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.018 0.818 . . . . 0.0 113.566 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -72.04 150.71 43.73 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 112.367 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 m -74.71 -12.39 60.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.813 1.245 . . . . 0.0 114.184 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 156.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.757 0.823 . . . . 0.0 113.091 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.39 128.13 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.886 1.674 . . . . 0.0 109.304 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -81.06 -49.35 11.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.178 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -154.87 160.51 41.25 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.171 1.388 . . . . 0.0 111.748 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.2 p -158.51 126.58 5.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.739 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.95 -17.15 31.94 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 170.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.12 -36.74 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.055 1.342 . . . . 0.0 112.553 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.1 p -75.57 -6.9 52.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.1 1.36 . . . . 0.0 114.64 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -107.93 -88.07 0.48 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.597 1.959 . . . . 0.0 110.133 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -151.44 152.71 31.24 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.937 2.095 . . . . 0.0 110.858 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.75 158.62 56.43 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.734 2.956 . . . . 0.0 113.526 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.38 112.61 23.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.657 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.97 129.49 40.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.716 1.607 . . . . 0.0 111.605 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -147.66 176.93 9.7 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 112.474 171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.96 150.64 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.626 1.57 . . . . 0.0 108.856 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.6 mm -49.41 106.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.509 1.124 . . . . 0.0 111.892 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.73 80.21 1.5 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 125.887 1.708 . . . . 0.0 113.476 -171.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.3 m -132.61 -49.1 0.9 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.056 1.343 . . . . 0.0 112.897 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.25 32.84 22.3 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.596 1.558 . . . . 0.0 114.365 175.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -27.67 34.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.29 171.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.801 1.241 . . . . 0.0 112.317 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -56.25 144.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.533 1.133 . . . . 0.0 112.179 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.086 0.954 . . . . 0.0 113.216 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.37 93.85 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.45 1.024 . . . . 0.0 113.317 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.03 -42.38 38.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.626 0.77 . . . . 0.0 112.121 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -53.08 -48.19 67.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.756 1.162 . . . . 0.0 112.79 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.31 -21.59 66.73 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.98 27.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.114 0.966 . . . . 0.0 112.291 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -53.42 -44.31 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.749 1.159 . . . . 0.0 112.541 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.17 -18.25 65.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -102.84 -20.66 14.22 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.983 1.713 . . . . 0.0 113.971 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.63 134.19 48.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.917 1.287 . . . . 0.0 112.058 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.45 150.34 34.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.922 0.889 . . . . 0.0 111.665 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -56.61 129.62 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.689 1.196 . . . . 0.0 111.161 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.37 76.85 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -122.83 117.82 26.53 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.956 1.378 . . . . 0.0 111.429 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -60.65 141.2 57.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.007 0.923 . . . . 0.0 111.982 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -138.54 120.34 15.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.898 1.279 . . . . 0.0 111.019 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.58 101.51 11.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 110.376 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.26 116.72 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.101 1.36 . . . . 0.0 111.403 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 t -80.21 109.88 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.227 1.011 . . . . 0.0 109.7 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.8 mm -98.52 136.42 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.903 1.281 . . . . 0.0 109.808 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 152.35 89.41 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.336 1.055 . . . . 0.0 111.966 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.72 -46.05 22.16 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.682 2.255 . . . . 0.0 111.867 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 -14.09 46.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 0.0 114.976 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.36 -27.13 9.66 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.572 1.549 . . . . 0.0 112.714 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.08 -69.73 0.62 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.043 1.337 . . . . 0.0 112.151 171.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -101.08 -17.9 16.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.02 1.328 . . . . 0.0 113.694 -173.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.36 -174.42 41.71 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.725 1.155 . . . . 0.0 112.925 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -56.33 110.47 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.199 1.4 . . . . 0.0 112.014 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.63 155.4 39.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.022 0.929 . . . . 0.0 112.907 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.76 60.52 5.97 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.088 1.355 . . . . 0.0 113.016 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 81.6 p -74.18 5.52 4.36 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 71.0 m -63.32 109.28 1.53 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.832 1.253 . . . . 0.0 112.109 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -131.47 176.43 8.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.983 2.113 . . . . 0.0 111.329 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.04 143.26 33.13 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.976 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -116.37 117.5 30.14 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.925 1.29 . . . . 0.0 110.074 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -74.27 106.75 6.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.088 0.955 . . . . 0.0 110.18 171.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -121.44 131.58 24.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 126.8 2.04 . . . . 0.0 109.293 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.18 155.5 64.4 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.084 1.856 . . . . 0.0 112.557 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -58.72 -19.95 44.68 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 172.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.11 -30.97 62.84 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.936 1.294 . . . . 0.0 113.174 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -81.35 -3.32 52.3 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.204 1.002 . . . . 0.0 113.416 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.22 20.22 7.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.231 2.212 . . . . 0.0 112.432 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.94 104.28 0.28 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.461 1.505 . . . . 0.0 111.875 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.82 3.15 52.41 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.373 1.463 . . . . 0.0 115.68 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 pt -129.63 98.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.865 1.666 . . . . 0.0 111.209 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.28 144.34 54.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.698 1.199 . . . . 0.0 111.665 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -125.7 159.72 31.55 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.396 1.478 . . . . 0.0 111.1 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -150.86 145.19 25.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.244 1.418 . . . . 0.0 110.325 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -58.51 128.62 38.08 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.674 0.79 . . . . 0.0 111.349 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 43.08 12.93 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 123.741 0.686 . . . . 0.0 114.445 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.73 153.89 47.73 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.57 1.148 . . . . 0.0 111.705 168.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.9 t -82.83 98.75 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.233 1.413 . . . . 0.0 112.034 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.63 156.97 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 110.914 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -113.0 149.09 33.8 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.466 1.106 . . . . 0.0 111.353 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.42 97.58 0.22 Allowed Glycine 0 N--CA 1.469 0.862 0 C-N-CA 124.44 1.019 . . . . 0.0 112.516 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.1 110.79 4.69 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.999 0.919 . . . . 0.0 111.101 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -78.39 153.18 31.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.239 1.016 . . . . 0.0 111.659 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -66.21 -12.95 59.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.467 1.507 . . . . 0.0 113.245 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.98 16.39 0.16 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 126.339 1.855 . . . . 0.0 114.01 168.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.59 45.63 15.88 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.227 2.211 . . . . 0.0 112.649 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -145.29 170.03 17.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.358 1.863 . . . . 0.0 111.163 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.1 m -142.44 120.61 12.2 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.753 1.221 . . . . 0.0 110.82 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.57 167.14 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.104 0.561 . . . . 0.0 111.752 174.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -117.0 127.61 54.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.279 1.431 . . . . 0.0 109.052 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.5 171.84 13.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.975 1.31 . . . . 0.0 112.446 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.28 130.06 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.104 0.961 . . . . 0.0 110.57 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.4 mm -62.47 103.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 109.533 170.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -84.13 -38.29 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.061 0.945 . . . . 0.0 111.667 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -149.46 165.4 32.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.461 1.104 . . . . 0.0 112.373 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.01 159.0 44.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.765 1.226 . . . . 0.0 111.921 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.2 m -134.59 174.76 10.19 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.207 1.803 . . . . 0.0 110.835 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.24 -15.56 63.29 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.6 t -140.25 -17.93 0.91 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.92 1.688 . . . . 0.0 114.489 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -133.46 168.03 19.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.662 1.585 . . . . 0.0 112.282 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -136.48 148.65 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.817 2.047 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.0 mtp -129.82 99.57 5.17 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.978 1.311 . . . . 0.0 110.801 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.14 147.32 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 110.005 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.46 128.69 36.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.113 0.565 . . . . 0.0 111.143 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -134.07 162.78 31.15 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.552 . . . . 0.0 110.779 172.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -149.98 173.14 14.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.504 1.522 . . . . 0.0 110.61 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -108.22 129.81 23.59 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.545 0.738 . . . . 0.0 110.589 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.37 -34.16 35.76 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.582 2.188 . . . . 0.0 112.7 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.05 78.75 8.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.794 1.237 . . . . 0.0 108.596 167.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.34 98.83 6.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.524 1.53 . . . . 0.0 111.52 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.65 178.57 35.19 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.397 1.475 . . . . 0.0 113.595 -177.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -138.61 161.52 36.9 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.261 1.425 . . . . 0.0 113.393 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.85 140.66 58.89 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.963 1.705 . . . . 0.0 112.423 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -129.59 138.42 51.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.929 1.292 . . . . 0.0 112.009 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.41 96.68 10.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.486 1.514 . . . . 0.0 111.046 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -76.72 92.6 3.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.345 0.658 . . . . 0.0 109.585 166.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -77.09 119.5 20.88 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 164.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -138.25 169.83 17.09 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.378 0.671 . . . . 0.0 112.48 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -149.22 143.35 25.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.834 1.254 . . . . 0.0 111.584 171.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.5 t -82.24 104.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.772 1.229 . . . . 0.0 108.45 165.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.33 -35.49 75.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.366 0.666 . . . . 0.0 111.703 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.66 -149.95 18.86 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.449 1.499 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -129.29 151.16 50.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.262 1.025 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -129.07 136.2 49.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.382 1.473 . . . . 0.0 111.264 175.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.78 102.94 9.34 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.88 1.272 . . . . 0.0 110.264 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 30.5 m -133.06 169.48 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.573 1.549 . . . . 0.0 111.555 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.4 p -140.77 162.42 35.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.273 1.429 . . . . 0.0 111.966 174.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -124.84 18.71 8.58 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.792 1.637 . . . . 0.0 112.081 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 66.1 0.78 1.73 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.936 2.495 . . . . 0.0 114.653 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 128.726 2.81 . . . . 0.0 112.791 167.821 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -77.2 -64.66 1.09 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.31 1.044 . . . . 0.0 111.19 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -83.01 163.69 20.82 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.517 1.127 . . . . 0.0 111.376 174.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -83.78 -8.54 59.21 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -146.07 150.86 36.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.711 1.205 . . . . 0.0 112.6 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.0 130.98 35.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.691 2.396 . . . . 0.0 110.699 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 57.85 22.35 8.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.564 1.546 . . . . 0.0 114.314 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 t -71.08 -0.09 8.79 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.359 1.864 . . . . 0.0 114.899 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.6 mp -58.54 149.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 126.481 1.912 . . . . 0.0 110.313 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -89.89 135.76 33.44 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.329 1.452 . . . . 0.0 111.09 173.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -157.84 166.53 32.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.698 1.599 . . . . 0.0 111.844 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.01 118.1 18.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.101 0.96 . . . . 0.0 111.45 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.5 106.7 8.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.696 1.599 . . . . 0.0 110.001 164.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.66 115.46 24.13 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.392 1.877 . . . . 0.0 109.501 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -131.78 158.57 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.078 0.951 . . . . 0.0 111.892 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -138.87 134.6 33.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.901 1.28 . . . . 0.0 110.281 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -131.9 162.11 31.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.145 1.378 . . . . 0.0 112.803 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.17 171.03 15.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 111.357 166.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.77 106.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.454 1.102 . . . . 0.0 110.981 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -116.65 154.86 29.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.634 1.574 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.92 148.4 40.11 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.552 -0.717 . . . . 0.0 111.042 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -66.59 -25.84 66.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 -72.94 0.95 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.226 1.393 . . . . 0.0 112.647 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -59.89 140.18 56.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.221 1.408 . . . . 0.0 113.576 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -70.9 -21.28 62.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.812 1.245 . . . . 0.0 113.892 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.37 158.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.952 1.301 . . . . 0.0 112.562 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.0 129.04 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.478 1.511 . . . . 0.0 109.75 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mp -79.69 -45.67 18.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.392 0.677 . . . . 0.0 111.312 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.71 158.27 40.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.163 1.385 . . . . 0.0 111.383 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.3 t -156.93 141.63 16.86 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.278 -0.889 . . . . 0.0 112.666 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.17 3.7 15.29 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.398 1.879 . . . . 0.0 112.752 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.55 -55.9 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.469 1.107 . . . . 0.0 111.214 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 t -72.21 -21.64 61.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.458 1.103 . . . . 0.0 113.034 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -80.81 -178.18 6.69 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.954 2.102 . . . . 0.0 111.841 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.39 128.11 92.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.873 0.869 . . . . 0.0 111.069 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.48 151.85 83.91 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.851 2.367 . . . . 0.0 112.427 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 tt -81.9 134.87 35.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.318 1.047 . . . . 0.0 109.981 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -119.43 114.46 22.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.78 1.632 . . . . 0.0 110.564 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -130.13 172.71 11.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.255 1.022 . . . . 0.0 112.26 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.3 mm -115.8 150.73 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.263 1.425 . . . . 0.0 109.023 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.57 106.16 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.72 29.9 7.1 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.405 1.479 . . . . 0.0 116.369 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 m -98.23 -38.56 9.24 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.53 1.665 . . . . 0.0 113.795 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 55.28 33.02 19.8 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.114 1.766 . . . . 0.0 115.198 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -68.03 -21.42 65.02 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.8 pt -74.26 168.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.964 1.706 . . . . 0.0 113.082 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 pt -60.86 152.79 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.29 1.036 . . . . 0.0 112.518 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.64 -43.13 79.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.11 73.06 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 114.105 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -88.88 -30.5 18.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.999 1.32 . . . . 0.0 112.223 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.6 -44.27 72.92 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.777 1.631 . . . . 0.0 111.639 171.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.79 8.46 6.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.379 1.471 . . . . 0.0 113.817 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.41 -39.58 2.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.499 1.519 . . . . 0.0 113.671 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.27 -30.07 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.323 1.049 . . . . 0.0 113.572 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.17 -14.24 62.21 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.16 -34.46 7.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.511 1.525 . . . . 0.0 112.782 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.91 149.82 26.0 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.551 0.74 . . . . 0.0 111.808 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.07 161.06 22.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 111.409 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.52 125.49 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.81 0.844 . . . . 0.0 111.759 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.78 76.64 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.778 1.18 . . . . 0.0 115.038 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.08 108.76 17.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.957 1.378 . . . . 0.0 111.334 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -57.78 141.2 49.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.982 0.913 . . . . 0.0 112.223 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.33 116.98 12.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.179 1.791 . . . . 0.0 110.716 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.0 112.19 23.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.924 1.29 . . . . 0.0 110.871 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -123.05 112.51 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.132 0.973 . . . . 0.0 111.256 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.7 127.83 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 121.197 -0.939 . . . . 0.0 109.303 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.4 mt -120.56 135.95 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.699 1.6 . . . . 0.0 108.703 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.64 148.69 96.61 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.652 0.781 . . . . 0.0 111.494 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.56 -44.58 13.69 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.02 2.48 . . . . 0.0 112.405 -170.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.14 -30.69 71.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.229 1.811 . . . . 0.0 113.695 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -80.69 -29.31 36.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.758 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.53 -66.44 0.81 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.9 1.28 . . . . 0.0 111.791 168.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -143.51 -37.55 0.34 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.82 72.18 0.66 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.626 1.584 . . . . 0.0 115.667 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.17 -1.56 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -70.71 155.96 40.1 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.522 1.129 . . . . 0.0 113.425 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -87.78 89.92 8.18 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.476 1.91 . . . . 0.0 113.199 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 m -113.13 35.49 3.93 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.838 1.655 . . . . 0.0 113.839 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 p -55.0 112.18 1.0 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.996 1.718 . . . . 0.0 111.334 163.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -134.58 150.24 50.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.44 115.38 11.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.852 2.061 . . . . 0.0 111.349 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -116.98 119.22 34.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.259 1.423 . . . . 0.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.09 105.7 11.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.042 1.337 . . . . 0.0 111.06 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.85 131.56 21.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.673 1.989 . . . . 0.0 109.296 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.33 162.21 41.46 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.441 2.094 . . . . 0.0 112.52 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.95 -22.45 49.12 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.013 0.925 . . . . 0.0 113.417 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.42 -39.56 57.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.026 2.13 . . . . 0.0 114.031 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -69.77 -17.84 63.45 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -131.7 15.35 4.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.934 1.693 . . . . 0.0 114.161 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -57.33 -27.94 62.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.343 1.457 . . . . 0.0 114.143 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.76 6.69 33.29 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.823 1.678 . . . . 0.0 116.061 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.26 113.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.33 1.565 . . . . 0.0 111.881 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.92 139.65 58.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.102 0.961 . . . . 0.0 112.012 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -121.02 172.27 8.06 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.092 1.757 . . . . 0.0 111.609 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -148.29 161.15 42.1 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.222 1.009 . . . . 0.0 112.039 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -73.37 95.47 2.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.396 1.078 . . . . 0.0 111.026 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.41 64.24 0.73 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.9 ptp -133.95 152.0 51.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.129 1.372 . . . . 0.0 111.527 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.7 m -77.23 98.77 5.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.531 1.532 . . . . 0.0 110.652 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.09 154.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.366 1.466 . . . . 0.0 111.321 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.35 147.49 29.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.744 1.218 . . . . 0.0 111.589 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.99 96.98 0.28 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.949 1.261 . . . . 0.0 112.423 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -72.15 114.84 10.69 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.874 0.87 . . . . 0.0 111.13 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -82.42 154.84 24.97 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.507 1.123 . . . . 0.0 111.574 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.54 -13.21 39.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.024 1.329 . . . . 0.0 113.545 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -73.75 19.38 0.11 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.464 1.505 . . . . 0.0 113.781 171.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 58.4 33.85 23.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.346 2.259 . . . . 0.0 113.738 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -135.84 169.75 17.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.813 2.045 . . . . 0.0 111.493 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.1 m -137.68 138.28 39.24 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.543 1.537 . . . . 0.0 110.184 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.02 170.64 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.228 1.011 . . . . 0.0 111.372 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.23 133.74 55.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.919 1.688 . . . . 0.0 110.717 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.93 171.06 14.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.095 1.758 . . . . 0.0 111.228 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.7 126.97 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.862 0.865 . . . . 0.0 110.019 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.49 129.49 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 110.567 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -91.5 -49.27 6.41 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.061 1.344 . . . . 0.0 111.504 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -151.87 170.73 19.1 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.813 1.245 . . . . 0.0 112.208 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.72 155.61 45.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.432 1.093 . . . . 0.0 113.019 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.42 169.11 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.038 2.535 . . . . 0.0 110.049 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.41 67.96 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.129 -0.982 . . . . 0.0 113.167 171.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 63.9 p -131.22 -8.47 3.8 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.311 1.444 . . . . 0.0 114.811 -173.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -141.81 171.19 14.4 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.776 1.63 . . . . 0.0 111.047 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -138.65 150.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.514 1.926 . . . . 0.0 108.738 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 62.2 mtp -125.54 114.6 18.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.508 1.123 . . . . 0.0 111.035 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.2 163.83 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.811 1.244 . . . . 0.0 112.163 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -102.13 88.49 3.34 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.86 1.264 . . . . 0.0 112.182 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -81.28 171.97 14.18 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.647 1.179 . . . . 0.0 112.268 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -108.46 110.1 21.53 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.84 1.656 . . . . 0.0 110.148 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -66.35 134.62 94.64 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.554 0.742 . . . . 0.0 111.139 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.98 -31.85 23.14 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.54 2.16 . . . . 0.0 114.183 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.1 56.32 0.77 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.822 1.649 . . . . 0.0 111.022 175.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.5 103.49 14.41 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.747 1.619 . . . . 0.0 112.56 -173.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.25 -159.41 13.91 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.291 1.424 . . . . 0.0 113.495 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 159.71 35.91 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.378 1.871 . . . . 0.0 111.912 173.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.9 p -64.66 144.85 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.36 1.464 . . . . 0.0 113.14 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -130.31 136.42 49.12 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.275 . . . . 0.0 111.706 -173.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.68 97.41 7.9 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.73 1.612 . . . . 0.0 111.324 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.65 83.59 6.4 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.415 1.102 . . . . 0.0 110.613 166.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -76.58 131.67 39.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.14 169.89 19.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -145.41 145.63 31.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.971 1.309 . . . . 0.0 111.656 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 t -84.49 100.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.863 1.265 . . . . 0.0 108.693 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.23 -31.96 71.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.38 0.672 . . . . 0.0 111.837 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.88 -170.05 31.28 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.196 0.903 . . . . 0.0 114.883 170.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.55 118.93 27.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.616 1.567 . . . . 0.0 110.219 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -138.4 128.34 25.39 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.985 1.314 . . . . 0.0 112.558 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -75.45 115.69 15.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.407 0.683 . . . . 0.0 110.759 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.06 164.14 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.358 1.863 . . . . 0.0 111.094 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.1 m -135.06 146.89 49.38 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.623 1.169 . . . . 0.0 111.803 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -89.05 22.39 2.78 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.832 1.653 . . . . 0.0 112.973 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.16 13.96 6.24 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.666 1.986 . . . . 0.0 114.228 -172.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.985 2.114 . . . . 0.0 114.832 177.776 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -141.59 -63.49 0.45 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.836 -1.165 . . . . 0.0 111.751 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -75.85 171.92 13.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.409 1.084 . . . . 0.0 111.662 170.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -125.59 92.34 3.59 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.531 1.533 . . . . 0.0 111.618 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -78.02 170.46 16.57 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.149 1.38 . . . . 0.0 112.779 173.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.18 110.68 17.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.023 1.729 . . . . 0.0 110.163 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -134.42 75.93 1.61 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.777 1.631 . . . . 0.0 112.534 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 p -69.73 -20.92 63.51 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.6 mm -131.76 131.93 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.608 1.963 . . . . 0.0 110.665 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -73.93 137.48 43.65 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.3 1.44 . . . . 0.0 111.843 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -136.69 155.03 50.42 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.277 1.831 . . . . 0.0 110.656 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 107.51 17.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.184 0.994 . . . . 0.0 110.435 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.02 128.7 37.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.382 165.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.23 124.81 53.4 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.592 1.557 . . . . 0.0 109.619 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.5 pt -128.5 163.68 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 171.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.82 136.72 40.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 109.745 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.07 157.95 45.58 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.069 1.414 . . . . 0.0 114.783 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -139.13 141.25 38.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.462 3.105 . . . . 0.0 108.878 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.22 110.06 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.873 1.269 . . . . 0.0 110.429 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -123.69 168.85 12.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.539 1.536 . . . . 0.0 112.685 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -62.57 151.97 36.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.505 1.122 . . . . 0.0 111.147 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -20.28 63.24 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.42 25.35 1.53 Allowed Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.123 1.344 . . . . 0.0 114.959 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -141.16 161.41 37.93 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.917 1.358 . . . . 0.0 112.52 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -75.71 -17.72 59.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.783 1.633 . . . . 0.0 113.762 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -64.04 151.69 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.799 0.84 . . . . 0.0 112.456 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.46 117.25 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.787 1.635 . . . . 0.0 108.943 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.87 -44.05 56.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.721 0.808 . . . . 0.0 111.77 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.67 164.09 39.06 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.648 1.179 . . . . 0.0 111.581 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 m -165.87 159.6 16.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.384 1.874 . . . . 0.0 111.844 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -126.08 2.75 7.22 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 164.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.9 mm -47.46 -46.2 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.01 1.724 . . . . 0.0 113.965 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -93.42 -2.62 54.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.955 1.302 . . . . 0.0 113.581 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -98.05 -166.52 1.39 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.875 2.47 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.91 134.26 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.473 1.109 . . . . 0.0 111.775 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.55 159.01 55.18 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.27 2.647 . . . . 0.0 113.314 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.88 95.06 5.96 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.435 1.094 . . . . 0.0 110.268 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.34 125.46 31.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.159 1.783 . . . . 0.0 111.578 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.48 172.6 14.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.168 0.987 . . . . 0.0 113.399 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 142.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.601 1.56 . . . . 0.0 109.507 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mm -47.93 121.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.971 1.708 . . . . 0.0 112.462 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.41 76.85 1.09 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.995 1.283 . . . . 0.0 112.806 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -130.79 -26.69 2.18 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 53.48 21.96 2.7 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.518 1.927 . . . . 0.0 115.683 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -78.25 -28.6 47.82 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -170.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 pt -82.07 171.18 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.86 1.664 . . . . 0.0 112.196 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 pt -55.34 140.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.818 0.847 . . . . 0.0 111.169 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.67 78.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.543 0.737 . . . . 0.0 112.915 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.88 -30.41 72.98 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.327 0.965 . . . . 0.0 114.303 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.67 -43.9 13.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.337 1.055 . . . . 0.0 111.404 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -53.25 -48.02 68.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.595 1.158 . . . . 0.0 112.309 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.05 0.3 2.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.984 1.314 . . . . 0.0 114.468 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.54 -25.42 7.9 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.968 1.707 . . . . 0.0 114.04 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.3 t -58.31 -42.02 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.736 1.607 . . . . 0.0 112.114 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.92 -12.62 61.06 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.95 -36.9 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.995 1.718 . . . . 0.0 112.18 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 140.74 58.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.085 1.354 . . . . 0.0 112.385 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -86.28 154.28 21.37 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.009 0.924 . . . . 0.0 111.964 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.71 131.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.287 1.035 . . . . 0.0 111.346 171.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.25 12.63 76.43 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.289 0.947 . . . . 0.0 115.157 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.31 115.49 19.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.322 1.449 . . . . 0.0 111.246 -175.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -59.41 141.32 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.866 0.866 . . . . 0.0 112.151 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.17 142.68 42.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.147 1.379 . . . . 0.0 111.054 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.79 128.54 52.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.14 1.376 . . . . 0.0 110.156 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.55 110.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.706 2.002 . . . . 0.0 110.166 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.1 t -69.49 125.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.769 0.828 . . . . 0.0 109.94 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.29 140.1 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.308 1.443 . . . . 0.0 109.826 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.45 154.74 87.23 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.241 1.016 . . . . 0.0 111.731 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.18 -40.67 67.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.627 2.218 . . . . 0.0 113.462 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.28 -18.35 59.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -90.31 -9.73 46.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.737 1.215 . . . . 0.0 114.017 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.46 78.32 1.84 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.346 1.458 . . . . 0.0 111.528 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 39.9 74.01 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.894 2.077 . . . . 0.0 113.335 -175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.53 101.35 0.33 Allowed Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.03 1.3 . . . . 0.0 113.641 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.53 61.35 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.223 1.809 . . . . 0.0 111.646 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -64.37 164.73 10.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.838 1.255 . . . . 0.0 113.155 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -123.06 8.39 9.25 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.047 1.739 . . . . 0.0 113.262 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.6 t -76.01 14.92 0.61 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.666 1.986 . . . . 0.0 114.071 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.91 114.4 2.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.252 2.221 . . . . 0.0 112.493 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -137.9 149.94 46.67 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.556 1.542 . . . . 0.0 113.039 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.8 103.59 10.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.252 1.021 . . . . 0.0 110.629 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -88.91 116.75 27.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.59 0.756 . . . . 0.0 110.35 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.11 112.22 7.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.25 1.02 . . . . 0.0 110.221 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 156.3 54.45 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 126.071 1.749 . . . . 0.0 110.812 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.08 149.64 46.8 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.047 1.831 . . . . 0.0 112.005 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -61.45 -17.31 53.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.04 1.336 . . . . 0.0 113.171 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.35 -33.9 22.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.184 2.194 . . . . 0.0 113.624 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -71.38 -10.8 60.35 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -135.19 14.48 3.53 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.612 1.565 . . . . 0.0 114.194 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.86 112.56 0.96 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.43 1.092 . . . . 0.0 112.441 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.11 3.86 58.81 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.21 1.386 . . . . 0.0 115.374 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mt -108.22 139.56 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.284 1.434 . . . . 0.0 110.378 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.0 55.87 1.86 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.378 1.871 . . . . 0.0 113.588 -173.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -55.04 130.04 40.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.283 1.833 . . . . 0.0 113.303 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.23 148.47 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.752 2.021 . . . . 0.0 110.345 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.36 135.76 57.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.489 1.116 . . . . 0.0 112.25 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 -9.37 75.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.136 1.35 . . . . 0.0 116.371 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 ptp -70.16 152.28 44.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.169 1.984 . . . . 0.0 112.416 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 p -78.38 102.01 7.53 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.606 1.163 . . . . 0.0 110.311 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.3 160.86 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.419 1.088 . . . . 0.0 110.551 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.32 162.21 30.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.06 1.344 . . . . 0.0 112.002 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.69 108.82 0.38 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.275 0.94 . . . . 0.0 112.891 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -66.4 147.13 53.74 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 122.05 -0.677 . . . . 0.0 111.299 174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -128.88 157.39 41.7 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.729 1.612 . . . . 0.0 111.737 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -14.08 60.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.215 1.806 . . . . 0.0 113.736 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.35 13.13 0.62 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.285 1.834 . . . . 0.0 113.912 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.1 m120 57.25 40.14 28.12 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.13 2.172 . . . . 0.0 113.171 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -131.9 171.01 14.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.872 2.069 . . . . 0.0 111.253 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.6 m -141.93 111.75 6.73 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.683 1.593 . . . . 0.0 109.634 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.62 166.94 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 118.497 0.59 . . . . 0.0 111.067 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.33 154.77 34.55 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.623 1.169 . . . . 0.0 111.17 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.8 176.7 12.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.629 1.572 . . . . 0.0 110.966 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.37 128.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.385 1.074 . . . . 0.0 110.476 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.0 mm -68.65 125.97 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.062 0.945 . . . . 0.0 110.693 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.08 -38.68 5.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.773 1.229 . . . . 0.0 113.381 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -151.93 156.17 39.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.468 1.107 . . . . 0.0 111.243 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -147.19 149.85 33.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.186 -0.946 . . . . 0.0 113.395 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -143.2 170.17 16.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.841 2.057 . . . . 0.0 110.804 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.264 -0.897 . . . . 0.0 113.251 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.3 p -78.92 -66.71 0.83 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.676 1.99 . . . . 0.0 112.021 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -135.73 171.0 15.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.098 2.159 . . . . 0.0 111.367 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.21 144.03 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.567 1.547 . . . . 0.0 110.429 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.6 mtp -116.41 113.66 23.19 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.781 1.632 . . . . 0.0 110.651 -170.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.48 135.43 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.187 1.395 . . . . 0.0 110.264 -166.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.32 83.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.287 1.435 . . . . 0.0 112.17 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.14 170.28 11.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.035 1.734 . . . . 0.0 112.29 173.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -154.35 169.98 22.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.657 1.983 . . . . 0.0 110.676 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.92 138.22 95.07 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.586 172.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.97 -9.42 20.81 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.186 2.59 . . . . 0.0 114.456 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.91 32.79 4.02 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.861 2.065 . . . . 0.0 112.396 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.02 159.12 3.47 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.929 1.292 . . . . 0.0 113.766 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.84 -171.54 53.89 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.256 0.931 . . . . 0.0 113.45 -172.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.44 158.5 44.27 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.107 1.763 . . . . 0.0 112.152 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.3 p -64.72 147.63 52.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.879 0.872 . . . . 0.0 112.125 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.58 154.21 51.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.81 1.244 . . . . 0.0 111.425 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.23 104.43 14.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 110.728 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -80.07 109.83 14.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.639 0.776 . . . . 0.0 109.726 167.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.24 120.64 43.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.858 1.663 . . . . 0.0 108.941 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -143.4 169.78 17.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 113.087 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.85 144.97 28.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.634 1.174 . . . . 0.0 111.899 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.3 t -83.18 102.9 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.918 1.287 . . . . 0.0 109.003 165.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.35 -36.03 78.63 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.201 0.6 . . . . 0.0 111.698 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.68 -165.93 27.47 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.367 0.984 . . . . 0.0 114.211 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.21 133.2 54.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.818 1.647 . . . . 0.0 110.223 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -124.31 159.11 31.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.062 1.345 . . . . 0.0 112.015 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.77 129.85 39.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.905 0.882 . . . . 0.0 111.385 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.01 170.18 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.202 1.401 . . . . 0.0 113.334 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 25.6 m 67.87 98.34 0.06 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.644 2.377 . . . . 0.0 113.904 173.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.4 53.36 0.4 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.646 1.978 . . . . 0.0 113.043 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 58.95 13.61 2.91 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.791 2.436 . . . . 0.0 115.258 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? . . . . . 0 C--O 1.253 1.245 0 C-N-CA 127.113 2.165 . . . . 0.0 115.167 -178.907 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.462 0.173 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -119.65 12.83 12.35 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.958 1.703 . . . . 0.0 113.229 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -63.73 148.03 50.19 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.961 -1.087 . . . . 0.0 112.353 173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -154.5 167.96 28.31 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.746 1.618 . . . . 0.0 111.194 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -138.95 177.66 7.73 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.39 1.876 . . . . 0.0 111.482 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.87 101.07 3.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.851 1.261 . . . . 0.0 110.703 173.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -128.74 61.45 1.5 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.284 1.833 . . . . 0.0 111.856 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.6 t -58.53 -41.88 86.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.409 1.083 . . . . 0.0 113.424 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.1 mm -128.95 144.87 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.409 1.883 . . . . 0.0 109.87 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -65.31 141.11 58.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.365 1.466 . . . . 0.0 111.9 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -137.08 119.96 16.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.883 1.673 . . . . 0.0 110.492 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.43 105.7 8.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.708 1.203 . . . . 0.0 111.172 172.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.58 125.51 28.16 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.046 1.339 . . . . 0.0 110.227 163.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.37 123.88 50.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.34 1.456 . . . . 0.0 110.083 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 pt -131.22 161.3 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.219 1.007 . . . . 0.0 112.129 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -135.89 146.94 47.93 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.841 1.656 . . . . 0.0 110.397 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.51 154.31 43.5 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -146.03 129.06 16.51 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.766 2.426 . . . . 0.0 110.571 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.88 110.39 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.969 1.708 . . . . 0.0 110.062 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -116.5 151.74 35.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.855 1.662 . . . . 0.0 111.259 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.42 126.34 29.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.931 0.893 . . . . 0.0 109.79 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.73 75.65 1.12 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.316 -0.865 . . . . 0.0 111.352 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 -5.28 2.64 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.117 1.818 . . . . 0.0 116.135 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.0 t -133.45 144.29 49.39 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.981 1.891 . . . . 0.0 112.776 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 p -76.59 31.55 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.616 2.766 . . . . 0.0 115.599 -171.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.35 176.57 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.184 1.394 . . . . 0.0 112.216 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.45 117.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.434 1.494 . . . . 0.0 108.987 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.47 -53.3 6.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.912 0.885 . . . . 0.0 111.494 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -144.42 150.64 38.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.557 1.943 . . . . 0.0 109.865 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 p -157.64 151.58 24.29 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.295 -0.878 . . . . 0.0 112.703 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.3 -6.58 8.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.217 1.407 . . . . 0.0 113.135 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -62.5 -37.5 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.287 1.435 . . . . 0.0 112.094 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -73.38 -10.62 59.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.7 1.2 . . . . 0.0 113.506 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -114.7 -170.43 1.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 127.504 2.321 . . . . 0.0 111.164 -171.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.69 125.75 83.51 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 124.378 1.071 . . . . 0.0 111.835 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.68 152.21 82.34 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.029 2.486 . . . . 0.0 112.554 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.0 tp -75.91 108.91 9.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.119 1.368 . . . . 0.0 110.897 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -93.71 131.9 38.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.532 1.533 . . . . 0.0 111.78 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -146.78 167.86 22.81 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.478 1.111 . . . . 0.0 112.88 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.0 mm -101.48 146.88 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 109.715 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.3 mm -46.46 118.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.362 1.865 . . . . 0.0 111.792 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.19 77.5 1.05 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.993 1.282 . . . . 0.0 112.886 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -123.13 -36.84 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.002 1.321 . . . . 0.0 114.426 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.47 23.27 2.45 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 126.846 2.058 . . . . 0.0 115.175 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -80.15 -24.79 40.18 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.2 pt -78.42 167.07 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.989 1.316 . . . . 0.0 112.475 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.9 pt -59.53 141.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.242 1.017 . . . . 0.0 111.692 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.34 73.43 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.91 68.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.347 0.975 . . . . 0.0 114.296 176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.58 -35.17 13.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.307 1.443 . . . . 0.0 111.844 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -59.4 -40.74 87.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.223 1.409 . . . . 0.0 112.678 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -73.69 -8.34 55.6 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.47 -47.89 5.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.978 1.311 . . . . 0.0 112.631 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.95 -28.54 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.996 1.318 . . . . 0.0 114.134 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 -19.71 63.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -108.46 -11.48 15.15 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.722 1.609 . . . . 0.0 113.843 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.94 113.09 4.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.35 1.46 . . . . 0.0 112.138 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.97 147.14 50.54 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.763 0.825 . . . . 0.0 111.891 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.49 131.65 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.432 1.093 . . . . 0.0 111.429 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.91 12.88 79.04 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.61 1.1 . . . . 0.0 115.334 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -116.65 118.53 32.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.229 1.412 . . . . 0.0 111.678 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -61.09 133.65 56.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.223 1.009 . . . . 0.0 111.947 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -136.97 136.45 38.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 110.956 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -126.63 105.93 9.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.678 1.191 . . . . 0.0 110.526 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 m -109.8 114.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.554 1.542 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.7 t -73.81 126.91 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.74 130.98 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.718 1.607 . . . . 0.0 108.989 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 154.45 87.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.65 1.18 . . . . 0.0 111.675 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.48 -45.06 15.64 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.201 1.934 . . . . 0.0 111.646 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -62.11 -21.07 64.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -85.79 -1.76 57.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.116 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.3 -67.8 0.6 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.497 1.519 . . . . 0.0 112.113 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -143.59 91.83 2.29 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.209 2.204 . . . . 0.0 109.826 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.85 -94.6 0.36 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.19 0.9 . . . . 0.0 112.357 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.8 m 42.42 42.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 127.578 2.351 . . . . 0.0 115.154 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -112.17 175.79 5.29 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.639 1.976 . . . . 0.0 113.596 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -106.42 47.01 0.89 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.02 1.728 . . . . 0.0 113.384 -171.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -66.38 -21.02 66.22 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.724 -1.235 . . . . 0.0 113.298 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.8 t -144.45 108.87 4.84 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.094 2.158 . . . . 0.0 109.164 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -141.39 160.22 40.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.829 1.252 . . . . 0.0 112.909 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.55 137.82 31.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 112.002 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -126.8 124.29 39.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -88.04 82.5 7.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.9 1.68 . . . . 0.0 110.255 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.69 136.04 45.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.144 1.378 . . . . 0.0 109.722 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.77 156.01 57.63 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.475 2.117 . . . . 0.0 112.24 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -65.85 -9.28 27.54 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -56.31 -31.5 63.74 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.327 1.051 . . . . 0.0 113.582 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -82.17 -6.61 59.33 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -130.04 15.58 5.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.44 1.896 . . . . 0.0 113.403 -169.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.62 107.93 0.34 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.996 1.718 . . . . 0.0 112.289 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.84 11.05 57.13 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.88 1.229 . . . . 0.0 115.784 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.42 132.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.368 1.584 . . . . 0.0 110.557 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.67 79.45 9.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.915 1.686 . . . . 0.0 112.696 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.01 155.76 35.68 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.59 1.156 . . . . 0.0 112.819 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.91 157.64 45.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -73.96 25.69 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.113 1.765 . . . . 0.0 114.999 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.4 56.22 0.06 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.988 1.28 . . . . 0.0 112.663 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.4 ptp -132.18 149.25 52.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.699 1.2 . . . . 0.0 112.208 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -67.49 125.35 25.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.363 1.465 . . . . 0.0 110.629 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.14 160.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.627 1.571 . . . . 0.0 111.146 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -119.5 149.84 41.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.498 1.519 . . . . 0.0 111.578 -177.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.89 108.53 0.64 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.651 1.119 . . . . 0.0 113.047 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -71.82 112.63 8.09 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.817 -0.814 . . . . 0.0 111.464 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 t -89.03 159.93 17.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.618 1.167 . . . . 0.0 111.967 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -13.56 60.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.623 1.569 . . . . 0.0 113.959 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.65 11.15 0.68 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.754 1.622 . . . . 0.0 113.941 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 53.41 47.86 23.17 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.844 2.058 . . . . 0.0 111.908 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.49 168.17 20.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.776 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 m -140.78 105.56 4.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.138 -0.976 . . . . 0.0 111.045 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.35 170.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.941 -0.474 . . . . 0.0 111.494 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 139.06 54.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.088 1.755 . . . . 0.0 111.564 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.06 179.48 7.71 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.419 1.888 . . . . 0.0 111.872 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.67 128.65 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.729 1.212 . . . . 0.0 110.722 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -72.7 131.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.865 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -95.38 -42.31 8.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.988 1.715 . . . . 0.0 112.0 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -155.09 167.36 30.63 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.625 1.17 . . . . 0.0 112.006 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -140.29 144.84 36.61 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.096 1.358 . . . . 0.0 111.536 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.4 m -117.94 174.08 6.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.776 2.03 . . . . 0.0 110.613 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.05 -19.79 63.27 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.1 p -133.45 -18.31 2.22 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.846 1.658 . . . . 0.0 115.173 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -143.03 172.06 13.22 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.045 1.738 . . . . 0.0 112.145 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.2 t -137.85 126.33 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 127.13 2.172 . . . . 0.0 110.591 -172.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 76.9 mmm -94.15 111.57 23.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.695 1.598 . . . . 0.0 111.078 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.13 151.27 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.131 1.772 . . . . 0.0 112.249 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -91.71 115.57 28.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.105 1.362 . . . . 0.0 111.166 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -123.47 170.09 10.73 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.344 1.858 . . . . 0.0 111.234 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -112.17 142.63 44.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.595 1.558 . . . . 0.0 110.925 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -104.5 127.14 29.62 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.962 0.905 . . . . 0.0 110.956 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.2 -16.94 35.85 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.848 2.365 . . . . 0.0 114.849 -172.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.87 22.23 0.78 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.703 1.601 . . . . 0.0 112.982 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.07 174.93 6.43 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.955 1.702 . . . . 0.0 113.382 173.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.51 171.34 49.65 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 124.637 1.113 . . . . 0.0 114.367 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.25 168.17 22.39 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.923 1.689 . . . . 0.0 113.123 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.1 p -64.48 137.78 58.05 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.923 1.689 . . . . 0.0 112.351 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.25 144.78 51.56 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.795 1.238 . . . . 0.0 112.001 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.09 99.1 10.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.676 1.59 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.39 93.37 5.96 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.704 1.202 . . . . 0.0 109.837 168.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 -76.93 141.37 40.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.928 -1.108 . . . . 0.0 109.784 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -152.72 170.48 20.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.905 0.882 . . . . 0.0 113.0 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -149.55 142.28 24.6 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.14 1.376 . . . . 0.0 111.132 169.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.29 107.8 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.154 1.382 . . . . 0.0 109.025 169.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.7 mp -69.95 -33.9 72.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 111.184 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.62 -175.13 22.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.438 1.494 . . . . 0.0 114.008 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.15 139.38 42.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.0 110.455 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -138.97 157.36 46.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.354 1.062 . . . . 0.0 113.28 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.58 107.32 18.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.151 1.38 . . . . 0.0 110.808 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.61 159.36 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.108 0.963 . . . . 0.0 112.578 171.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.4 m -131.75 158.44 41.2 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.864 1.666 . . . . 0.0 111.027 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -122.02 60.28 0.98 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.151 1.38 . . . . 0.0 110.041 -176.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.59 14.56 5.02 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.412 2.285 . . . . 0.0 115.45 -174.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--O 1.255 1.347 0 C-N-CA 127.856 2.462 . . . . 0.0 114.131 175.886 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.7 tpp . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.68 168.39 21.43 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.166 1.386 . . . . 0.0 112.415 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -100.87 -63.57 1.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.881 1.272 . . . . 0.0 112.098 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.1 m170 45.05 44.12 7.99 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.156 1.782 . . . . 0.0 113.455 -171.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -68.92 156.21 38.93 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.682 1.593 . . . . 0.0 113.267 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt -107.83 93.99 4.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.382 1.473 . . . . 0.0 110.781 -168.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.08 63.85 0.66 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.775 1.63 . . . . 0.0 111.276 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.7 m -70.21 -27.82 64.8 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.373 -0.829 . . . . 0.0 113.196 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.7 mm -75.7 146.08 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.715 1.206 . . . . 0.0 110.051 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -102.2 147.75 26.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.029 1.732 . . . . 0.0 111.79 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.72 157.07 43.19 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.611 1.564 . . . . 0.0 111.023 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.89 106.37 8.53 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.354 1.062 . . . . 0.0 110.323 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 125.17 29.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.067 1.347 . . . . 0.0 110.63 169.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.88 125.63 51.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.475 1.51 . . . . 0.0 110.388 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 pt -133.61 163.26 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.314 1.046 . . . . 0.0 112.042 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -140.59 138.05 34.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.056 1.342 . . . . 0.0 110.559 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.47 160.56 38.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.141 1.376 . . . . 0.0 113.728 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -143.33 161.39 38.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.001 1.72 . . . . 0.0 111.396 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.03 107.41 11.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.735 1.614 . . . . 0.0 110.038 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -113.92 157.41 22.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.908 1.683 . . . . 0.0 110.31 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -63.81 152.18 40.24 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.689 -0.632 . . . . 0.0 110.933 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -25.79 60.11 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.38 57.38 0.3 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.47 1.033 . . . . 0.0 113.743 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 t -144.57 163.7 33.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.604 1.162 . . . . 0.0 112.441 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -80.36 -21.96 41.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 113.466 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 pp -69.35 157.06 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.811 0.732 . . . . 0.0 111.36 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.36 144.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.508 1.523 . . . . 0.0 110.697 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.91 -48.08 6.43 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.544 0.738 . . . . 0.0 111.038 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 157.21 36.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.704 1.602 . . . . 0.0 111.735 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.5 p -162.98 163.79 25.96 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.532 1.133 . . . . 0.0 113.615 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.86 8.28 4.11 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 167.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.43 -53.58 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 p -76.32 -18.92 58.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 0.0 113.892 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.02 -171.35 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.006 2.123 . . . . 0.0 111.035 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -64.17 142.59 98.28 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 121.147 -0.97 . . . . 0.0 111.77 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.14 159.43 53.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.374 2.716 . . . . 0.0 112.597 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.86 109.06 15.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 110.363 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.59 127.14 32.12 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.438 1.895 . . . . 0.0 111.452 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.14 175.1 10.74 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.7 137.77 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.051 1.74 . . . . 0.0 109.078 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 mm -48.14 109.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.27 1.828 . . . . 0.0 111.804 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.05 87.27 1.24 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.415 1.483 . . . . 0.0 112.936 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.1 t -146.35 -33.47 0.31 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.2 m120 53.45 60.64 3.58 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.852 2.061 . . . . 0.0 113.789 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -111.04 -26.28 9.33 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.8 pt -81.04 174.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.436 1.495 . . . . 0.0 112.177 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.8 pt -58.2 141.18 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.797 0.839 . . . . 0.0 111.469 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.08 91.75 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.81 -33.45 73.28 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.052 0.834 . . . . 0.0 113.95 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 tp -81.73 -45.38 15.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.436 1.094 . . . . 0.0 111.342 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -49.36 -47.7 47.26 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.71 1.604 . . . . 0.0 113.287 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.43 -18.22 63.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 113.276 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.05 -43.92 10.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.914 1.286 . . . . 0.0 112.69 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.62 -43.06 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 119.941 1.246 . . . . 0.0 112.525 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.58 -20.79 65.94 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -102.69 -11.34 18.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.399 1.88 . . . . 0.0 113.801 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.03 126.63 31.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.408 1.483 . . . . 0.0 112.392 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -77.8 155.04 31.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.754 0.822 . . . . 0.0 112.01 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.62 134.29 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.897 1.279 . . . . 0.0 111.473 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.54 13.83 74.58 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.75 100.23 7.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.964 1.306 . . . . 0.0 111.63 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -58.18 131.86 51.83 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.287 1.035 . . . . 0.0 111.469 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.41 157.84 44.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.907 0.883 . . . . 0.0 112.79 171.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -128.79 96.78 4.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.994 1.318 . . . . 0.0 110.91 -170.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -97.94 106.23 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.394 1.478 . . . . 0.0 110.119 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 t -74.26 123.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.351 -0.843 . . . . 0.0 109.807 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.41 140.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.451 1.9 . . . . 0.0 109.383 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.15 158.91 69.34 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.416 1.087 . . . . 0.0 112.214 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.93 -46.79 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.32 2.013 . . . . 0.0 112.082 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.89 -14.42 61.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.198 1.399 . . . . 0.0 114.656 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -79.43 -7.74 58.62 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.3 -82.59 0.52 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.051 1.34 . . . . 0.0 111.368 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -138.44 92.53 2.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.503 1.921 . . . . 0.0 109.574 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.03 81.08 1.71 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.754 1.168 . . . . 0.0 112.541 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.2 75.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.487 1.515 . . . . 0.0 111.832 -174.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -133.76 156.09 48.61 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.216 1.406 . . . . 0.0 111.738 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -138.34 110.24 7.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.447 1.899 . . . . 0.0 110.521 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 t -93.45 -8.03 42.76 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.72 56.59 7.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.328 1.851 . . . . 0.0 113.128 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -74.83 175.45 8.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.097 1.359 . . . . 0.0 112.39 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.7 mt -121.16 146.78 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.729 1.611 . . . . 0.0 111.69 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -131.54 111.45 11.77 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.685 1.594 . . . . 0.0 111.253 167.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -69.58 115.17 8.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.715 0.806 . . . . 0.0 110.087 160.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.36 156.85 69.53 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 125.942 1.697 . . . . 0.0 109.898 176.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.34 153.52 61.4 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.025 1.817 . . . . 0.0 111.881 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -61.26 -19.37 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 0.0 113.245 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -53.95 -30.51 47.06 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.49 1.516 . . . . 0.0 114.589 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -19.73 65.05 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 175.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -137.68 20.98 2.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.032 1.733 . . . . 0.0 112.556 -168.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.93 -24.8 55.26 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.168 1.787 . . . . 0.0 114.168 -171.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.18 16.07 46.29 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.059 1.79 . . . . 0.0 115.338 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.32 132.62 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.281 1.54 . . . . 0.0 111.023 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -81.34 89.2 6.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.685 1.194 . . . . 0.0 111.108 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.2 160.28 32.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 112.326 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.1 152.29 27.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.019 1.328 . . . . 0.0 111.81 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -72.88 84.25 1.23 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.685 1.194 . . . . 0.0 110.878 168.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.69 43.71 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.765 1.174 . . . . 0.0 114.699 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.4 ptm -129.38 150.69 50.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.149 1.38 . . . . 0.0 111.149 170.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 p -67.99 133.83 49.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.041 0.937 . . . . 0.0 110.955 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.24 152.82 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.35 1.86 . . . . 0.0 110.166 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.59 143.95 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.572 1.149 . . . . 0.0 110.958 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.12 99.92 0.44 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 124.802 1.191 . . . . 0.0 112.109 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -66.87 140.31 57.79 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 117.604 0.702 . . . . 0.0 111.203 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -119.07 154.54 33.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.036 1.735 . . . . 0.0 111.656 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -62.0 -17.66 57.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.988 1.715 . . . . 0.0 113.439 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.99 15.46 0.16 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 127.23 2.212 . . . . 0.0 113.999 173.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.6 m120 52.66 48.12 23.21 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.134 2.174 . . . . 0.0 112.617 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -144.77 177.36 8.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.798 1.639 . . . . 0.0 111.969 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.0 m -145.2 128.94 17.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.905 1.282 . . . . 0.0 110.538 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -84.66 165.72 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.73 0.812 . . . . 0.0 111.81 172.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -133.36 126.57 31.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.465 1.506 . . . . 0.0 110.209 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.77 -172.88 4.37 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.677 1.191 . . . . 0.0 112.486 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mp -113.67 140.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.629 1.572 . . . . 0.0 109.804 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.43 134.57 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.797 1.239 . . . . 0.0 110.831 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -107.96 -32.96 7.36 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.42 1.088 . . . . 0.0 113.57 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -152.83 153.92 34.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.231 1.412 . . . . 0.0 111.173 164.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -142.63 134.12 26.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 111.715 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 160.74 39.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.567 1.547 . . . . 0.0 110.517 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.24 -23.26 67.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.1 p -77.28 -62.59 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.021 1.728 . . . . 0.0 111.68 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -138.87 160.95 38.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.007 2.123 . . . . 0.0 112.109 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.41 147.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.703 1.601 . . . . 0.0 110.396 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -121.84 105.69 10.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.69 1.596 . . . . 0.0 110.288 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -106.31 146.59 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.555 1.542 . . . . 0.0 111.072 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 141.94 49.84 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.841 -0.537 . . . . 0.0 111.112 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -136.05 156.95 47.97 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.389 1.476 . . . . 0.0 111.474 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -126.04 109.23 12.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.675 1.59 . . . . 0.0 110.382 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -67.99 134.15 91.86 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.268 1.427 . . . . 0.0 110.755 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.52 -25.17 35.3 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.386 2.057 . . . . 0.0 113.447 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.1 mt -83.29 5.81 21.91 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.908 1.283 . . . . 0.0 113.591 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.67 169.48 3.95 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.729 1.612 . . . . 0.0 114.316 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.22 -173.87 29.3 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.411 1.481 . . . . 0.0 113.326 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -135.17 161.64 34.77 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.064 1.745 . . . . 0.0 112.043 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.19 142.85 57.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.738 1.615 . . . . 0.0 111.764 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.3 mt -126.71 143.1 51.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 112.002 -174.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.85 98.53 11.83 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.949 1.3 . . . . 0.0 111.457 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -79.62 92.57 5.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.848 0.832 . . . . 0.0 110.77 168.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.12 128.77 34.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.256 1.422 . . . . 0.0 109.417 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.47 169.39 21.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -149.55 147.96 28.79 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 112.055 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.9 108.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.42 1.488 . . . . 0.0 109.167 166.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.84 -29.43 68.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.51 0.724 . . . . 0.0 111.302 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.67 172.07 14.22 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.534 2.016 . . . . 0.0 112.422 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.15 156.34 17.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.451 0.7 . . . . 0.0 112.717 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -147.33 143.66 28.2 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -69.21 126.06 28.6 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.396 0.678 . . . . 0.0 110.428 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.6 m -122.0 162.9 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.84 1.656 . . . . 0.0 110.936 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.8 m -121.83 172.78 7.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.71 1.604 . . . . 0.0 112.002 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -96.77 -9.94 27.8 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.548 1.139 . . . . 0.0 113.61 171.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -77.65 -32.79 53.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.192 1.397 . . . . 0.0 113.144 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.335 1.854 . . . . 0.0 115.051 -178.461 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 mtt . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -138.5 146.59 42.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.703 1.601 . . . . 0.0 110.938 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.4 173.27 12.6 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.169 1.388 . . . . 0.0 111.769 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -70.48 81.53 0.57 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.288 1.035 . . . . 0.0 111.565 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -129.92 164.7 23.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.976 2.11 . . . . 0.0 110.809 172.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.88 -7.98 51.66 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.822 1.249 . . . . 0.0 113.382 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.13 32.06 2.03 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.723 2.009 . . . . 0.0 114.187 -177.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 t -54.52 -43.7 72.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.56 1.144 . . . . 0.0 113.355 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.2 mm -71.45 143.84 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.311 -0.868 . . . . 0.0 111.618 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -52.77 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 128.53 2.732 . . . . 0.0 113.071 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -72.7 122.63 21.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.017 1.327 . . . . 0.0 112.189 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.19 96.95 5.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.487 1.115 . . . . 0.0 111.176 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.83 118.99 22.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.752 2.021 . . . . 0.0 111.734 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.88 130.5 48.37 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.185 1.394 . . . . 0.0 111.313 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.52 158.74 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.173 1.389 . . . . 0.0 111.734 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -138.94 141.24 38.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 110.972 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.44 154.2 49.98 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 123.123 1.44 . . . . 0.0 114.069 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -142.56 113.03 7.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.18 2.592 . . . . 0.0 109.068 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.29 115.73 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.69 1.196 . . . . 0.0 109.602 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -124.54 151.87 44.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.132 1.773 . . . . 0.0 110.547 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.66 146.76 48.06 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.606 -0.683 . . . . 0.0 111.251 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.84 -33.35 61.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -170.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.2 45.33 0.84 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.368 0.985 . . . . 0.0 114.141 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 t -142.28 156.48 45.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 112.579 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.2 p -82.52 -11.9 58.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.97 1.708 . . . . 0.0 114.331 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.03 178.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.966 1.306 . . . . 0.0 112.196 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 p -133.77 137.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.736 1.215 . . . . 0.0 110.197 168.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.7 mt -81.27 -51.39 8.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.635 0.774 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.31 163.33 30.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.925 1.29 . . . . 0.0 112.544 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.9 p -157.11 165.27 36.51 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.003 -1.061 . . . . 0.0 112.812 171.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.68 -4.29 10.27 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 164.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.62 -48.57 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.762 1.625 . . . . 0.0 112.215 -171.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -75.93 -17.24 59.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -86.93 -73.93 0.45 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.061 1.745 . . . . 0.0 111.715 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -166.93 134.18 1.99 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.665 1.986 . . . . 0.0 110.335 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.95 154.33 74.98 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.11 2.54 . . . . 0.0 112.882 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tt -95.0 111.89 23.65 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 109.796 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -93.27 131.89 37.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.868 1.267 . . . . 0.0 111.519 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -145.6 179.38 7.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 112.097 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.81 135.5 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.758 1.223 . . . . 0.0 109.251 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.8 mm -49.8 109.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.14 1.376 . . . . 0.0 111.038 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.71 53.31 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.617 1.58 . . . . 0.0 114.634 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 m -122.79 -32.23 3.57 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.591 1.156 . . . . 0.0 113.296 175.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 54.3 33.45 18.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.327 1.851 . . . . 0.0 114.888 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -79.45 -24.1 42.66 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.0 pt -69.56 166.95 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.636 1.174 . . . . 0.0 112.589 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.6 pt -57.58 141.76 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.019 0.927 . . . . 0.0 111.428 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.18 76.81 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -173.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.11 68.53 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.002 0.81 . . . . 0.0 114.17 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -90.19 -29.72 18.05 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.177 1.391 . . . . 0.0 112.213 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -60.47 -42.88 97.16 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.844 -1.16 . . . . 0.0 112.504 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.53 -10.14 53.73 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.08 -49.94 4.56 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.625 1.57 . . . . 0.0 112.821 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.87 -31.71 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.565 1.146 . . . . 0.0 114.038 -174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.64 -21.04 66.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.74 -13.78 16.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.678 1.991 . . . . 0.0 113.536 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.5 116.84 16.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.492 1.517 . . . . 0.0 112.07 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -73.7 157.48 36.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.813 0.816 . . . . 0.0 112.46 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.14 133.96 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.086 1.355 . . . . 0.0 111.639 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.47 72.52 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.758 1.171 . . . . 0.0 114.938 176.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -120.14 108.34 14.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.173 1.389 . . . . 0.0 111.201 -170.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -54.93 129.94 39.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.993 0.917 . . . . 0.0 111.456 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.84 141.26 51.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.072 1.349 . . . . 0.0 111.169 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -127.11 112.71 15.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.415 1.486 . . . . 0.0 109.572 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.81 124.03 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.627 1.171 . . . . 0.0 111.556 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.08 127.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.726 0.811 . . . . 0.0 109.646 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.34 135.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.251 1.82 . . . . 0.0 108.964 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.2 155.02 67.79 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.921 0.888 . . . . 0.0 112.329 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.15 -41.76 15.67 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.109 1.873 . . . . 0.0 111.379 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.71 -23.67 64.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.911 1.684 . . . . 0.0 114.51 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.24 -23.46 51.31 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.429 -0.794 . . . . 0.0 112.561 172.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.33 -72.6 0.49 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.645 1.178 . . . . 0.0 111.774 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -142.28 -22.21 0.69 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -173.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.37 80.43 0.5 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.314 1.435 . . . . 0.0 114.296 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.9 m -103.58 8.57 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.28 1.432 . . . . 0.0 113.749 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -63.82 170.96 3.02 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.074 1.35 . . . . 0.0 113.355 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.25 171.94 13.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.866 1.667 . . . . 0.0 112.073 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 m -70.11 29.84 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.479 2.312 . . . . 0.0 115.554 -173.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.7 m -64.74 -166.58 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.232 2.213 . . . . 0.0 112.063 164.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 68.15 16.35 9.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.893 1.677 . . . . 0.0 112.636 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.1 mt -153.46 132.57 12.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 129.32 3.048 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -139.93 117.01 11.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.09 1.356 . . . . 0.0 110.159 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.16 112.65 6.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 110.547 168.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.5 m -119.59 157.42 51.92 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.729 1.612 . . . . 0.0 110.634 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.43 163.04 40.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.008 1.805 . . . . 0.0 111.38 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -67.21 0.53 2.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.234 1.814 . . . . 0.0 114.667 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.31 -38.04 81.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.547 1.939 . . . . 0.0 113.907 -175.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -67.48 -15.89 63.91 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -127.38 21.18 6.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.514 1.526 . . . . 0.0 113.005 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.49 99.06 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.761 1.624 . . . . 0.0 112.171 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.95 56.93 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.599 1.571 . . . . 0.0 115.596 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.77 127.56 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.567 1.547 . . . . 0.0 109.763 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.87 124.13 21.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.828 0.851 . . . . 0.0 111.529 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.1 mt -115.11 139.27 50.03 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.335 1.454 . . . . 0.0 110.589 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -150.35 150.68 31.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.887 1.275 . . . . 0.0 111.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -76.66 89.59 3.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.83 -1.169 . . . . 0.0 111.052 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.72 43.11 0.27 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.482 1.515 . . . . 0.0 114.6 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 ptm -133.13 152.1 51.96 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.196 1.398 . . . . 0.0 111.365 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p -68.57 133.53 48.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.88 1.272 . . . . 0.0 111.32 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.73 156.94 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.481 1.913 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.86 139.54 53.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.634 1.174 . . . . 0.0 111.037 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.02 100.2 0.55 Allowed Glycine 0 N--CA 1.469 0.879 0 C-N-CA 124.878 1.228 . . . . 0.0 112.282 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -64.15 144.79 56.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.72 0.76 . . . . 0.0 111.383 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -128.93 155.44 45.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.576 1.55 . . . . 0.0 111.578 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -65.46 -14.95 62.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.836 1.654 . . . . 0.0 113.221 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -73.46 17.29 0.15 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.457 1.903 . . . . 0.0 113.934 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 54.15 44.72 28.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.144 2.178 . . . . 0.0 112.425 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.26 173.49 11.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.966 2.107 . . . . 0.0 111.48 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.4 m -146.14 118.33 8.35 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.66 1.184 . . . . 0.0 110.179 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -73.66 162.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.312 0.506 . . . . 0.0 110.976 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -137.26 119.76 15.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.348 1.459 . . . . 0.0 110.652 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.04 -170.75 3.59 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.456 1.103 . . . . 0.0 112.543 -172.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.71 142.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.393 1.477 . . . . 0.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.3 mt -73.46 126.3 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.066 -1.021 . . . . 0.0 110.303 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -101.41 -33.82 9.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.357 1.063 . . . . 0.0 113.174 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.41 154.93 36.55 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.372 1.469 . . . . 0.0 111.31 170.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -144.98 146.86 32.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.273 1.029 . . . . 0.0 112.078 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.3 t -146.47 170.46 16.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.438 1.895 . . . . 0.0 110.471 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.11 61.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.021 0.929 . . . . 0.0 113.463 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -79.91 -61.77 1.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.641 1.576 . . . . 0.0 111.706 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -138.45 166.92 23.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.029 2.132 . . . . 0.0 111.517 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.36 144.16 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.576 1.551 . . . . 0.0 110.6 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.8 mtp -118.42 93.36 4.09 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.018 1.727 . . . . 0.0 110.883 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.59 149.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.555 1.542 . . . . 0.0 109.904 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.8 114.25 4.92 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.363 -0.836 . . . . 0.0 111.508 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -124.85 99.21 6.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.668 1.587 . . . . 0.0 109.146 172.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -62.16 164.6 6.67 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.325 0.65 . . . . 0.0 111.527 170.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.05 140.47 17.06 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.154 0.582 . . . . 0.0 111.433 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.56 -12.65 24.8 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.144 2.563 . . . . 0.0 113.781 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.6 mt -73.0 -27.14 61.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.846 1.259 . . . . 0.0 113.155 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.55 161.54 27.71 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.24 1.016 . . . . 0.0 112.414 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.64 160.2 44.59 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 121.685 -0.635 . . . . 0.0 113.304 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -141.14 178.76 7.16 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.58 1.952 . . . . 0.0 111.204 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.39 140.41 56.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.315 1.046 . . . . 0.0 111.701 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.62 134.15 55.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.819 2.047 . . . . 0.0 110.915 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.95 101.86 14.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.041 1.336 . . . . 0.0 111.347 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -81.68 96.96 7.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.893 0.877 . . . . 0.0 110.169 167.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -84.0 120.1 25.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.274 1.43 . . . . 0.0 108.87 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.72 168.84 18.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.69 0.677 . . . . 0.0 112.825 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -147.83 137.33 22.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.054 0.942 . . . . 0.0 111.699 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.8 t -80.63 102.77 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.211 1.004 . . . . 0.0 108.386 166.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.5 mt -65.52 -31.99 73.35 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.026 0.53 . . . . 0.0 111.549 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.31 174.32 13.45 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 126.928 2.204 . . . . 0.0 112.333 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -108.03 140.82 40.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.057 0.943 . . . . 0.0 111.113 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -110.55 107.76 17.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.533 1.533 . . . . 0.0 109.659 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.85 128.44 36.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.85 0.86 . . . . 0.0 109.962 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.31 157.63 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.763 1.225 . . . . 0.0 110.998 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 65.6 m -145.25 153.38 41.24 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.42 1.488 . . . . 0.0 110.909 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -134.82 15.19 3.61 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.499 1.52 . . . . 0.0 113.083 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -130.0 -61.08 1.0 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.28 1.832 . . . . 0.0 111.468 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.718 1.607 . . . . 0.0 113.487 173.659 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -147.87 155.0 41.14 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.056 1.342 . . . . 0.0 112.237 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -157.19 -179.0 7.78 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.037 2.135 . . . . 0.0 111.188 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -136.66 107.99 6.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.805 1.242 . . . . 0.0 111.243 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -78.9 168.45 19.68 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.128 0.971 . . . . 0.0 112.447 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -81.16 -2.87 50.21 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.185 1.394 . . . . 0.0 114.484 171.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -113.26 65.43 0.65 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.571 1.948 . . . . 0.0 112.31 -172.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.5 m -73.63 -5.13 38.47 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.3 mp -65.56 146.75 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 126.387 1.875 . . . . 0.0 110.382 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -59.26 159.39 7.78 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.373 1.469 . . . . 0.0 112.489 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -148.9 149.36 31.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.062 1.345 . . . . 0.0 111.188 170.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.56 99.81 3.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.225 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.46 41.09 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.786 0.834 . . . . 0.0 111.051 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.62 131.55 49.89 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.721 1.608 . . . . 0.0 110.262 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -127.7 161.85 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.435 1.094 . . . . 0.0 111.791 171.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -137.27 127.12 25.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.605 1.562 . . . . 0.0 110.162 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -131.48 149.13 52.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.951 1.3 . . . . 0.0 112.888 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -137.89 148.66 45.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.631 2.372 . . . . 0.0 109.934 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.97 121.37 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.066 0.946 . . . . 0.0 112.054 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -124.26 142.82 50.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.336 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -66.29 128.64 36.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.106 0.962 . . . . 0.0 111.001 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.53 106.27 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.474 -0.767 . . . . 0.0 112.407 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.39 -13.97 47.43 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 126.445 1.974 . . . . 0.0 115.327 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -119.78 125.19 47.99 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.259 1.53 . . . . 0.0 111.582 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 m -66.43 18.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.812 2.445 . . . . 0.0 116.088 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -82.68 172.58 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.3 1.84 . . . . 0.0 112.44 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.84 89.02 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.044 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.55 -23.72 61.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.27 156.86 31.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.86 1.664 . . . . 0.0 110.389 165.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.7 p -155.66 159.68 39.78 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.435 -0.791 . . . . 0.0 111.986 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -114.33 -27.4 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.71 1.204 . . . . 0.0 112.08 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -55.43 -49.67 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.889 1.675 . . . . 0.0 112.252 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -65.47 -26.2 67.83 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.928 0.891 . . . . 0.0 113.122 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -85.81 -74.4 0.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.658 1.583 . . . . 0.0 111.351 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -169.35 149.56 3.87 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.915 2.086 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.49 144.69 74.16 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.528 2.152 . . . . 0.0 111.872 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.57 112.17 19.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 110.221 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -100.05 124.94 45.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.927 0.891 . . . . 0.0 112.199 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.04 168.86 23.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.313 1.045 . . . . 0.0 113.425 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.07 126.72 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.692 1.197 . . . . 0.0 109.137 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.0 mm -49.41 113.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.527 1.531 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.16 69.09 0.66 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.668 1.604 . . . . 0.0 112.368 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -140.04 -33.76 0.57 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.158 1.383 . . . . 0.0 113.616 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.98 28.46 14.8 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.433 1.893 . . . . 0.0 114.821 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -81.36 -21.62 38.97 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.8 pt -73.8 169.22 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.853 1.661 . . . . 0.0 112.923 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -56.63 144.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.15 0.98 . . . . 0.0 112.083 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.06 73.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.007 0.923 . . . . 0.0 113.262 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.82 70.02 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 123.731 0.681 . . . . 0.0 114.349 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -93.22 -30.43 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.773 1.229 . . . . 0.0 112.353 173.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.23 -43.14 82.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 112.321 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.92 -41.96 9.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.155 1.382 . . . . 0.0 113.024 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.05 -23.81 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.708 -1.245 . . . . 0.0 113.633 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.81 -26.86 62.57 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -83.65 -44.2 14.79 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.216 1.806 . . . . 0.0 111.394 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 122.28 13.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.846 1.258 . . . . 0.0 111.987 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 159.46 15.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.452 1.501 . . . . 0.0 111.916 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -55.67 129.95 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.128 1.371 . . . . 0.0 112.464 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.9 13.68 82.29 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.43 1.014 . . . . 0.0 115.21 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -126.26 115.77 20.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.05 1.34 . . . . 0.0 111.814 -172.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -60.2 141.16 56.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.717 0.807 . . . . 0.0 112.309 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -136.98 115.1 11.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.256 1.422 . . . . 0.0 111.382 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -90.18 114.29 26.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.227 1.411 . . . . 0.0 110.594 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.39 106.56 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.249 1.42 . . . . 0.0 110.593 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.26 131.87 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.235 -0.916 . . . . 0.0 109.593 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.6 mt -121.81 139.62 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.691 1.596 . . . . 0.0 109.228 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.6 155.46 81.46 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.226 1.01 . . . . 0.0 111.969 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.65 -29.96 84.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.604 2.203 . . . . 0.0 113.308 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.66 -23.86 45.47 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.69 -9.22 52.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.093 1.357 . . . . 0.0 113.758 -172.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.54 78.49 1.85 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.109 1.764 . . . . 0.0 110.597 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 43.02 76.06 0.08 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.393 2.277 . . . . 0.0 113.895 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 87.85 0.12 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.605 1.574 . . . . 0.0 113.951 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.35 19.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 127.059 2.143 . . . . 0.0 113.251 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -60.95 170.83 1.4 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.34 1.856 . . . . 0.0 114.346 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -73.1 179.27 3.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.871 1.668 . . . . 0.0 113.796 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 76.1 p -110.86 7.5 21.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.642 1.577 . . . . 0.0 113.604 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 p -153.52 137.57 16.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.742 1.617 . . . . 0.0 112.824 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -141.67 169.34 17.78 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.834 2.054 . . . . 0.0 110.67 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.27 148.97 27.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.027 0.931 . . . . 0.0 110.853 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -140.07 108.52 5.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.656 1.182 . . . . 0.0 110.838 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.35 122.92 18.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.351 1.061 . . . . 0.0 111.148 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 p -136.05 137.96 26.32 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.492 1.917 . . . . 0.0 109.949 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.3 168.32 25.09 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.739 2.292 . . . . 0.0 112.428 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -69.46 21.19 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.412 2.285 . . . . 0.0 115.003 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.89 -19.91 19.19 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.429 1.891 . . . . 0.0 113.888 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -98.61 -9.65 24.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.818 1.247 . . . . 0.0 113.814 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.24 26.62 6.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.299 1.84 . . . . 0.0 112.647 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.29 105.43 0.23 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 111.174 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.78 -0.02 39.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.647 1.594 . . . . 0.0 115.75 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.8 mt -100.51 136.85 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.321 1.56 . . . . 0.0 110.387 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.06 76.61 10.05 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.08 1.752 . . . . 0.0 112.971 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 140.52 57.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.137 -0.977 . . . . 0.0 112.334 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.38 152.95 32.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.397 1.879 . . . . 0.0 110.869 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -72.83 108.41 5.78 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.461 170.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.19 57.56 1.29 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.492 1.044 . . . . 0.0 113.54 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.7 ptm -135.05 154.72 51.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.768 1.627 . . . . 0.0 111.319 167.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 p -79.74 119.03 22.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.148 0.979 . . . . 0.0 110.64 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.95 158.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.823 1.649 . . . . 0.0 110.34 173.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -125.82 153.84 43.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.168 1.387 . . . . 0.0 111.465 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.49 101.47 0.28 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.382 0.991 . . . . 0.0 112.608 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -65.14 128.54 36.2 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.939 -0.742 . . . . 0.0 110.985 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -105.78 155.67 19.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.453 1.501 . . . . 0.0 111.399 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.03 -20.07 65.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.301 1.44 . . . . 0.0 113.126 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -71.65 19.83 0.06 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.983 2.113 . . . . 0.0 114.192 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.5 m120 52.02 47.63 24.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.316 2.246 . . . . 0.0 112.915 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -142.12 177.78 7.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.719 1.607 . . . . 0.0 112.109 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.8 m -145.99 113.85 6.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.361 1.064 . . . . 0.0 111.373 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.41 164.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.338 0.655 . . . . 0.0 111.406 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -136.57 136.8 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.358 1.463 . . . . 0.0 111.346 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.11 -178.99 7.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.455 1.102 . . . . 0.0 113.361 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.08 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.411 1.484 . . . . 0.0 110.538 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.2 mt -76.99 120.2 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.13 0.972 . . . . 0.0 110.661 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.96 -31.06 16.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.169 1.388 . . . . 0.0 113.531 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -153.7 150.0 28.1 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.878 1.671 . . . . 0.0 110.673 171.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -141.18 155.01 46.12 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.926 0.89 . . . . 0.0 112.661 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -153.34 174.26 14.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.172 1.789 . . . . 0.0 111.135 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 -29.44 66.88 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.47 1.108 . . . . 0.0 113.187 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.1 p -80.57 -62.76 1.58 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.017 1.727 . . . . 0.0 111.944 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -135.53 166.64 22.73 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.226 2.21 . . . . 0.0 111.405 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.83 147.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.915 1.686 . . . . 0.0 109.319 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 28.4 mtm -121.11 101.57 7.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.177 1.391 . . . . 0.0 110.15 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.3 t -97.17 150.12 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.394 1.077 . . . . 0.0 110.131 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.35 130.68 47.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.653 0.781 . . . . 0.0 111.033 166.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -142.38 169.75 17.0 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 111.571 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -117.6 133.97 55.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.063 1.745 . . . . 0.0 109.813 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -145.42 132.47 10.08 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.128 0.971 . . . . 0.0 111.312 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.28 -38.06 5.17 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.917 2.411 . . . . 0.0 112.831 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.43 80.06 6.93 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.212 1.005 . . . . 0.0 108.882 170.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -98.69 -42.12 7.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.924 1.69 . . . . 0.0 112.63 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.82 -161.07 33.19 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.874 1.702 . . . . 0.0 113.61 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.82 151.54 38.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.48 1.912 . . . . 0.0 111.098 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -65.72 143.75 57.34 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.766 1.226 . . . . 0.0 112.808 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.9 mt -125.01 123.06 39.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.13 1.372 . . . . 0.0 111.356 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.74 99.51 5.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.967 1.307 . . . . 0.0 111.159 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -79.68 99.46 7.41 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.757 0.789 . . . . 0.0 110.186 165.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -91.74 120.55 32.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.114 1.365 . . . . 0.0 109.034 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -140.94 168.7 19.15 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -148.33 140.49 24.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.079 1.351 . . . . 0.0 111.43 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.09 102.4 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 163.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.29 -33.73 71.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 111.701 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.76 -139.07 10.63 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.265 1.888 . . . . 0.0 110.675 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -150.31 165.2 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.461 1.105 . . . . 0.0 112.374 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -132.6 140.72 48.36 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.221 1.809 . . . . 0.0 110.813 171.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.72 141.08 49.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.419 0.688 . . . . 0.0 110.463 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 30.8 m -137.37 170.7 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.055 1.742 . . . . 0.0 111.277 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.2 p -59.84 148.14 35.76 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.669 1.188 . . . . 0.0 112.958 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -103.49 -0.71 29.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.003 1.321 . . . . 0.0 113.993 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -139.82 -58.52 0.56 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.642 1.577 . . . . 0.0 111.207 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.706 1.602 . . . . 0.0 113.318 170.875 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.405 0.621 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -69.36 143.66 53.66 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.484 -1.385 . . . . 0.0 110.976 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -124.81 170.13 11.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.787 1.635 . . . . 0.0 111.306 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -134.82 169.52 17.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.698 1.599 . . . . 0.0 112.072 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -71.97 90.24 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.234 1.413 . . . . 0.0 112.073 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.17 130.26 45.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.314 1.446 . . . . 0.0 111.113 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 52.98 33.61 15.09 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.781 1.632 . . . . 0.0 113.858 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.8 t -56.23 -47.55 78.23 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.828 1.251 . . . . 0.0 112.786 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.0 mm -93.71 147.71 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.288 1.435 . . . . 0.0 109.574 174.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -54.64 155.7 3.98 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.806 1.642 . . . . 0.0 113.031 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -119.28 134.44 55.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.723 1.209 . . . . 0.0 110.989 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.22 101.16 7.83 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 109.593 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.28 144.13 31.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.096 1.358 . . . . 0.0 111.033 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.74 126.53 47.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.503 1.521 . . . . 0.0 109.932 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.15 156.83 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.323 1.049 . . . . 0.0 110.969 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -139.16 135.68 34.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.68 1.192 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -138.3 157.2 46.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.781 1.232 . . . . 0.0 113.574 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -139.62 152.85 47.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.439 1.896 . . . . 0.0 110.763 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.85 119.13 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.583 1.553 . . . . 0.0 109.693 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -139.13 145.66 39.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.764 1.625 . . . . 0.0 111.176 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.22 133.18 45.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.454 0.702 . . . . 0.0 111.215 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -57.74 111.33 1.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.155 0.982 . . . . 0.0 111.752 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 23.24 33.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.64 1.114 . . . . 0.0 115.634 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -128.21 165.48 20.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.119 1.46 . . . . 0.0 113.579 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.2 m -99.15 -8.35 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.428 1.891 . . . . 0.0 113.865 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 166.98 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.643 0.777 . . . . 0.0 111.704 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.35 116.04 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.404 1.482 . . . . 0.0 108.751 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.58 -48.73 37.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.588 0.755 . . . . 0.0 111.026 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.27 162.04 36.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.16 1.384 . . . . 0.0 112.025 170.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -161.52 168.4 23.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.141 . . . . 0.0 112.494 168.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -123.82 -1.71 8.37 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 164.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.54 -60.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.733 1.613 . . . . 0.0 112.156 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -73.67 -22.98 59.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -74.5 -72.94 0.26 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.934 1.693 . . . . 0.0 112.067 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -169.7 118.65 0.55 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.083 2.153 . . . . 0.0 109.846 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -62.76 152.04 80.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.862 2.374 . . . . 0.0 112.706 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.8 tp -83.6 98.56 9.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.629 1.572 . . . . 0.0 110.873 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -71.11 117.51 12.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.357 1.463 . . . . 0.0 110.98 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -144.76 175.43 10.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.441 1.096 . . . . 0.0 113.129 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -113.48 137.52 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.456 1.502 . . . . 0.0 110.138 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -51.65 110.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.166 1.386 . . . . 0.0 111.086 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.94 -1.61 24.31 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.723 1.63 . . . . 0.0 115.677 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 m -70.69 -44.88 66.04 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.338 1.569 . . . . 0.0 112.531 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.3 m120 50.59 31.5 5.76 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.16 2.184 . . . . 0.0 116.013 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -13.81 61.19 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -69.63 168.31 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.843 1.657 . . . . 0.0 113.363 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -58.73 144.62 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.403 1.081 . . . . 0.0 111.953 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.7 -37.01 77.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.39 -29.11 73.56 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.672 -0.643 . . . . 0.0 113.82 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.03 -32.47 17.57 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 111.963 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -54.56 -47.31 73.41 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.061 1.344 . . . . 0.0 111.992 172.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -71.43 -10.81 60.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.67 -50.99 5.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.104 1.362 . . . . 0.0 112.485 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.04 -24.89 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -66.09 -19.99 66.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -106.0 -17.89 14.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.128 1.371 . . . . 0.0 114.187 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.97 118.65 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.667 1.187 . . . . 0.0 112.554 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -83.96 158.62 21.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 112.4 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -56.89 130.17 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.079 1.352 . . . . 0.0 111.595 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.97 11.81 78.88 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.977 1.275 . . . . 0.0 115.271 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -116.43 112.37 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.901 1.351 . . . . 0.0 111.763 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -60.33 143.21 53.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.189 0.995 . . . . 0.0 112.165 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -142.23 145.27 33.91 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.768 1.227 . . . . 0.0 111.476 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -126.08 113.16 16.72 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.869 1.668 . . . . 0.0 109.864 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -118.69 111.34 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.678 1.191 . . . . 0.0 110.533 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 t -76.45 128.39 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.919 0.888 . . . . 0.0 109.512 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 mt -124.83 139.4 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.461 1.505 . . . . 0.0 109.822 -174.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.09 151.66 97.03 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 112.133 173.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.6 -36.24 43.44 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.587 2.191 . . . . 0.0 112.508 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -67.31 -21.08 65.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.869 1.268 . . . . 0.0 114.166 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -93.73 -17.66 22.94 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.761 1.224 . . . . 0.0 113.216 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.34 -59.19 2.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.585 1.154 . . . . 0.0 112.408 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -128.35 -20.66 3.65 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.76 26.34 68.55 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-N 119.776 1.171 . . . . 0.0 115.352 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.56 29.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.335 1.854 . . . . 0.0 112.548 -168.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -60.23 155.43 17.56 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.406 1.482 . . . . 0.0 113.883 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.59 101.48 13.65 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.199 1.4 . . . . 0.0 111.663 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 t -71.74 18.7 0.07 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.701 1.6 . . . . 0.0 114.318 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 p -154.6 108.96 2.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.514 1.925 . . . . 0.0 111.2 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -146.76 157.37 43.66 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.046 1.338 . . . . 0.0 112.236 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.26 115.05 21.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.078 -1.014 . . . . 0.0 110.533 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -102.44 118.85 37.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.664 1.186 . . . . 0.0 110.814 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.47 128.83 36.79 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.82 0.848 . . . . 0.0 110.676 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 139.86 17.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.31 1.844 . . . . 0.0 109.613 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.09 154.95 62.17 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.458 2.105 . . . . 0.0 112.684 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -68.95 -4.56 17.16 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.39 -35.18 37.73 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 112.963 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -88.48 -2.97 58.89 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.323 1.449 . . . . 0.0 113.797 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -131.79 25.52 4.68 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.314 2.246 . . . . 0.0 112.326 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.64 105.49 1.24 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.793 1.637 . . . . 0.0 111.426 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.72 -9.14 56.83 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.725 1.631 . . . . 0.0 115.048 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.5 mt -88.38 126.13 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 109.634 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.36 130.92 45.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.609 0.763 . . . . 0.0 112.058 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.2 mt -124.77 138.57 54.27 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.723 1.609 . . . . 0.0 110.521 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -154.15 158.04 39.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.202 1.401 . . . . 0.0 111.01 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.13 119.32 10.61 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.949 -1.095 . . . . 0.0 111.16 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.94 43.11 5.16 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.09 0.852 . . . . 0.0 115.2 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 ptm -132.89 152.13 51.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.84 1.256 . . . . 0.0 111.889 168.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -74.03 134.09 42.98 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.351 1.06 . . . . 0.0 111.327 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.62 146.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.003 2.121 . . . . 0.0 110.592 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 133.89 41.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.94 1.296 . . . . 0.0 111.425 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.17 93.34 0.55 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.216 1.388 . . . . 0.0 112.196 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -63.74 144.46 57.01 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.961 0.88 . . . . 0.0 111.237 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 t -129.26 156.52 43.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.063 1.345 . . . . 0.0 112.435 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.14 -17.16 64.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.503 1.921 . . . . 0.0 113.474 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -74.81 16.63 0.27 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.34 1.856 . . . . 0.0 113.714 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.86 48.75 17.42 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.108 2.163 . . . . 0.0 112.511 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -143.36 176.32 9.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.96 1.704 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -146.62 113.53 6.12 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.674 1.189 . . . . 0.0 111.642 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.0 169.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.403 0.681 . . . . 0.0 111.717 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -135.72 124.83 24.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.426 1.49 . . . . 0.0 110.595 172.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.25 175.42 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.669 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -110.84 131.98 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 111.534 -171.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 56.7 mt -67.81 134.27 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.854 1.662 . . . . 0.0 111.304 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -112.39 -34.35 5.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.393 1.877 . . . . 0.0 113.299 -174.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -151.82 162.49 40.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.147 1.379 . . . . 0.0 110.855 169.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.81 158.36 43.74 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.9 m -140.0 176.6 8.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.159 2.184 . . . . 0.0 111.081 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.94 76.09 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 67.4 p -128.73 -3.57 5.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.842 1.657 . . . . 0.0 114.419 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -140.98 166.38 24.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.974 1.709 . . . . 0.0 111.679 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.71 157.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.602 1.561 . . . . 0.0 110.419 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.1 mtp -120.22 123.02 42.22 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.79 1.636 . . . . 0.0 109.771 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.69 143.46 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.35 1.46 . . . . 0.0 109.357 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -69.84 110.89 5.21 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.75 -0.594 . . . . 0.0 111.366 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -116.85 172.79 7.02 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.733 2.013 . . . . 0.0 111.779 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -129.86 137.91 50.68 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.911 1.684 . . . . 0.0 110.896 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -151.9 134.09 8.51 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.076 0.95 . . . . 0.0 110.889 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.92 -31.94 18.84 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.544 2.163 . . . . 0.0 112.716 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.09 75.35 8.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.963 0.905 . . . . 0.0 109.172 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.35 -26.84 26.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.483 1.113 . . . . 0.0 112.611 169.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.41 -168.16 37.06 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.406 1.955 . . . . 0.0 113.601 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.63 160.38 35.54 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.253 1.821 . . . . 0.0 112.199 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -66.6 145.33 55.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.89 1.676 . . . . 0.0 112.43 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.9 mt -133.92 147.75 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.294 1.437 . . . . 0.0 111.728 -174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.47 103.25 15.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 111.196 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -79.81 97.6 6.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.288 0.635 . . . . 0.0 109.405 161.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -89.63 140.42 29.57 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 170.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -150.34 169.39 21.51 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -146.25 150.5 35.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.391 1.476 . . . . 0.0 111.237 169.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.54 109.2 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 108.548 167.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.72 -36.85 84.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.184 0.593 . . . . 0.0 111.114 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.2 -164.07 25.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.114 1.816 . . . . 0.0 111.963 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.31 157.7 45.43 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.663 1.585 . . . . 0.0 111.291 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.7 121.32 31.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.971 1.309 . . . . 0.0 111.269 172.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.23 105.83 8.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.813 1.245 . . . . 0.0 109.776 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.3 m -63.29 161.85 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.601 0.76 . . . . 0.0 112.032 172.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.3 p -138.26 155.53 48.54 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.97 1.308 . . . . 0.0 112.195 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -136.6 49.83 2.06 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.628 1.571 . . . . 0.0 110.855 -173.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 61.0 9.16 2.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.655 1.982 . . . . 0.0 115.61 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 C--O 1.253 1.256 0 C-N-CA 127.005 2.122 . . . . 0.0 113.774 172.367 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.584 0.231 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.19 99.58 12.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.173 1.389 . . . . 0.0 110.679 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.08 106.04 13.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.546 1.539 . . . . 0.0 111.273 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.63 134.86 35.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 pt -132.46 167.16 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.48 1.512 . . . . 0.0 111.731 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -143.5 136.0 27.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.446 1.899 . . . . 0.0 110.394 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.3 153.04 51.29 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.419 1.488 . . . . 0.0 113.89 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -141.03 121.73 14.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.476 2.31 . . . . 0.0 109.483 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.12 103.46 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.498 1.119 . . . . 0.0 110.186 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -113.92 159.32 20.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.694 1.598 . . . . 0.0 110.623 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.55 147.2 29.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.002 -1.061 . . . . 0.0 111.506 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -64.14 125.57 24.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.389 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.01 -52.91 4.69 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.47 1.51 . . . . 0.0 114.201 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -61.16 143.79 54.87 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.52 1.528 . . . . 0.0 112.818 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -79.27 -13.91 59.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.87 155.98 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.708 1.203 . . . . 0.0 111.362 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.3 144.12 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.407 1.483 . . . . 0.0 110.664 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.58 -52.87 4.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.256 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.9 157.83 36.97 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.626 1.57 . . . . 0.0 111.048 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.3 p -151.05 144.7 25.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.295 1.038 . . . . 0.0 111.828 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.47 -17.85 15.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 167.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -56.49 -46.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.636 1.574 . . . . 0.0 112.019 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 t -68.54 -29.81 68.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -78.09 -72.97 0.34 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.777 1.631 . . . . 0.0 111.748 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -175.48 151.91 1.32 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 128.171 2.588 . . . . 0.0 110.016 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.92 170.86 15.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.66 2.906 . . . . 0.0 113.428 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 tt -124.0 108.55 12.51 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.251 1.42 . . . . 0.0 110.556 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.8 141.65 32.15 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.728 1.211 . . . . 0.0 112.968 170.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -144.12 164.74 29.8 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.256 1.423 . . . . 0.0 111.364 166.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.7 mm -84.1 138.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.702 0.801 . . . . 0.0 110.139 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 mm -47.86 109.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.523 1.529 . . . . 0.0 111.3 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -27.79 6.68 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.244 1.878 . . . . 0.0 114.315 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.6 m -85.25 72.77 10.69 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.922 1.361 . . . . 0.0 111.466 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 72.58 4.83 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.76 -1.213 . . . . 0.0 111.854 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -72.38 -11.84 60.86 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.0 pt -66.76 169.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 127.186 2.194 . . . . 0.0 113.188 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -58.84 147.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.909 1.284 . . . . 0.0 112.46 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.6 74.25 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.53 -36.84 93.66 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 121.194 -0.941 . . . . 0.0 113.109 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 tp -80.87 -28.11 36.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.744 1.218 . . . . 0.0 112.595 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -57.39 -42.78 82.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.431 1.092 . . . . 0.0 112.64 173.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -75.23 -14.93 60.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.67 -47.83 8.36 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.969 1.308 . . . . 0.0 112.645 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.02 -30.71 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.403 1.081 . . . . 0.0 113.615 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.09 -21.98 64.02 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -97.23 -23.04 16.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.811 1.645 . . . . 0.0 113.453 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.38 127.23 32.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.979 1.311 . . . . 0.0 112.28 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -83.62 162.81 20.68 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.925 0.89 . . . . 0.0 111.966 172.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.5 133.19 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.06 1.344 . . . . 0.0 111.692 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.42 13.37 81.71 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.44 1.019 . . . . 0.0 115.307 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -121.48 112.73 18.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.089 1.356 . . . . 0.0 111.832 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -59.92 141.01 56.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.046 0.938 . . . . 0.0 112.029 172.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -141.9 144.03 33.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.95 1.3 . . . . 0.0 111.042 174.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.29 110.96 13.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.672 1.189 . . . . 0.0 110.287 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -113.84 107.97 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.884 1.274 . . . . 0.0 110.839 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.08 126.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.201 1.0 . . . . 0.0 109.657 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.0 mt -124.69 138.56 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.694 1.597 . . . . 0.0 109.065 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 160.32 82.68 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.14 0.976 . . . . 0.0 112.178 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.05 -38.89 14.93 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.5 2.133 . . . . 0.0 111.786 -175.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.46 -12.48 61.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.117 1.767 . . . . 0.0 114.468 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 CA--C 1.545 0.77 0 C-N-CA 125.956 1.702 . . . . 0.0 113.046 179.848 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 . . . . . 0 N--CA 1.469 0.499 0 CA-C-O 120.235 0.065 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.395 -0.816 . . . . 0.0 111.342 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -134.99 125.22 26.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.994 1.718 . . . . 0.0 110.24 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -74.43 119.05 18.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.024 0.93 . . . . 0.0 110.611 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.34 134.52 25.57 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 109.189 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.22 144.11 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.245 1.963 . . . . 0.0 111.582 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -62.07 -14.17 33.61 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.26 -31.34 61.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.58 1.552 . . . . 0.0 113.267 169.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -70.56 -11.58 61.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.415 1.086 . . . . 0.0 113.901 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -132.63 16.88 4.35 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.883 1.673 . . . . 0.0 113.317 -167.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.76 -18.83 14.05 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -172.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.99 6.7 12.09 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.823 1.678 . . . . 0.0 115.426 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.6 pt -137.6 114.86 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.837 1.655 . . . . 0.0 111.31 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -66.39 154.03 41.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.523 1.129 . . . . 0.0 113.39 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.4 mt -132.74 162.85 30.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.823 . . . . 0.0 111.121 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -155.74 162.75 40.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.194 1.398 . . . . 0.0 110.599 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -69.88 129.49 39.67 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.431 -1.418 . . . . 0.0 110.436 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.99 65.47 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.724 1.05 . . . . 0.0 115.724 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp -97.26 150.2 21.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.282 1.541 . . . . 0.0 112.682 171.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 p -72.47 108.44 5.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 111.039 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.73 161.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.717 1.607 . . . . 0.0 110.934 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.52 154.55 40.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.12 1.368 . . . . 0.0 111.484 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.73 108.71 0.47 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.353 0.978 . . . . 0.0 113.084 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -73.33 111.4 8.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 111.575 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.3 t -80.83 158.19 25.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.563 1.145 . . . . 0.0 111.924 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.98 -17.36 63.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.386 1.474 . . . . 0.0 113.682 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.08 20.41 0.14 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.845 1.658 . . . . 0.0 113.911 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 50.22 48.0 22.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.346 2.259 . . . . 0.0 113.073 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -142.36 173.41 11.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.926 1.69 . . . . 0.0 111.736 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.0 m -141.07 107.84 5.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.629 1.171 . . . . 0.0 110.643 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.2 166.44 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.753 -0.592 . . . . 0.0 111.419 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -128.04 137.48 52.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.526 1.53 . . . . 0.0 110.879 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.8 178.98 9.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 113.206 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -126.82 125.65 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.186 0.994 . . . . 0.0 111.394 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.2 mt -72.78 129.02 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.475 1.11 . . . . 0.0 111.128 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -98.06 -35.89 10.28 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.692 1.597 . . . . 0.0 113.305 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -150.7 147.98 28.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.141 1.376 . . . . 0.0 110.164 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -140.01 136.93 34.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.169 0.987 . . . . 0.0 111.704 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.8 t -137.07 168.7 19.09 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.189 1.796 . . . . 0.0 110.154 172.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.33 63.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.099 0.96 . . . . 0.0 113.528 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 p -83.82 -62.05 1.67 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.233 1.813 . . . . 0.0 111.75 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -136.0 165.03 26.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.007 2.123 . . . . 0.0 111.707 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.634 1.573 . . . . 0.0 110.328 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mmm -120.64 105.28 10.64 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.727 2.011 . . . . 0.0 109.332 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 t -112.02 133.76 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 0.0 110.237 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.48 129.99 41.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.722 0.809 . . . . 0.0 111.32 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 CA--C 1.537 0.45 0 C-N-CA 125.656 1.582 . . . . 0.0 111.17 170.258 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 111.331 0.123 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -69.75 141.95 53.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.865 1.266 . . . . 0.0 112.369 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.64 147.97 49.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.534 1.534 . . . . 0.0 110.974 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.77 96.9 9.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.965 1.706 . . . . 0.0 111.074 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -76.86 95.72 4.15 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.799 0.84 . . . . 0.0 109.801 164.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -86.35 143.23 27.96 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.554 -0.716 . . . . 0.0 110.216 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -151.69 170.33 19.99 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -145.92 142.68 28.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.12 1.368 . . . . 0.0 111.306 168.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.25 101.97 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.438 1.095 . . . . 0.0 108.445 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.82 -37.4 86.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.243 1.017 . . . . 0.0 111.574 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 133.78 166.15 11.23 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.049 1.785 . . . . 0.0 113.29 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -98.54 146.92 25.3 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.492 1.117 . . . . 0.0 111.815 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 125.662 1.585 . . . . 0.0 111.31 177.04 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 102.77 10.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.817 1.247 . . . . 0.0 110.618 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.68 118.88 24.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.038 1.335 . . . . 0.0 111.132 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.83 129.46 45.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.775 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.23 165.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.182 . . . . 0.0 111.896 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.46 136.27 34.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.913 1.685 . . . . 0.0 110.121 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.58 154.08 50.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 113.723 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.75 121.11 12.34 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 109.403 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.95 111.47 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 110.472 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -121.27 134.67 55.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.849 1.659 . . . . 0.0 109.229 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -63.67 152.77 38.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.984 -1.072 . . . . 0.0 111.103 165.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -71.46 151.63 43.8 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.394 -0.816 . . . . 0.0 110.832 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.6 -66.29 3.95 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.826 1.203 . . . . 0.0 113.987 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -65.29 141.58 58.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.01 0.905 . . . . 0.0 113.096 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 m -82.06 -15.33 53.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.69 176.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.284 1.033 . . . . 0.0 111.356 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.74 143.22 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.134 1.374 . . . . 0.0 111.274 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 mt -75.84 -57.15 4.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.126 0.971 . . . . 0.0 111.011 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -155.18 157.6 37.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.876 1.27 . . . . 0.0 111.746 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.3 p -155.02 137.06 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.777 1.231 . . . . 0.0 112.179 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.67 -18.06 19.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 166.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -56.94 -43.66 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.643 1.577 . . . . 0.0 112.047 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 t -72.25 -8.82 56.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.088 1.355 . . . . 0.0 113.976 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -107.87 -73.32 0.69 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.364 1.866 . . . . 0.0 110.889 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.52 152.53 6.82 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.966 2.507 . . . . 0.0 110.357 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.79 159.71 52.64 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.78 2.32 . . . . 0.0 112.553 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 tt -104.2 108.93 20.55 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.62 1.568 . . . . 0.0 109.544 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.97 130.76 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.489 1.516 . . . . 0.0 112.158 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.6 162.88 37.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.185 0.994 . . . . 0.0 111.963 167.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.0 mm -81.62 137.91 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.68 0.792 . . . . 0.0 109.033 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.69 104.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.507 1.123 . . . . 0.0 110.879 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.05 39.41 0.23 Allowed Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.508 1.528 . . . . 0.0 116.116 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.6 m -122.79 -31.66 3.65 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.141 1.47 . . . . 0.0 114.256 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 57.59 31.06 19.77 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.668 1.587 . . . . 0.0 114.425 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -69.74 -19.79 63.53 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.6 pt -75.84 168.0 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.298 1.439 . . . . 0.0 112.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.7 pt -59.16 148.14 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.556 1.143 . . . . 0.0 111.96 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.04 84.2 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.94 0.896 . . . . 0.0 113.298 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.88 68.84 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.051 0.834 . . . . 0.0 114.656 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.12 -36.62 11.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.382 1.473 . . . . 0.0 111.555 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -56.17 -44.25 79.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.401 1.081 . . . . 0.0 111.921 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -76.67 12.31 1.35 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.886 1.274 . . . . 0.0 113.802 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.52 -45.24 2.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.973 1.709 . . . . 0.0 113.121 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.5 m -55.5 -28.19 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -62.76 -16.45 57.9 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -110.92 -5.35 14.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.142 1.377 . . . . 0.0 113.627 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.95 114.02 18.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.012 1.325 . . . . 0.0 112.331 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -71.57 157.18 38.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.833 0.825 . . . . 0.0 112.369 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.18 135.65 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.53 1.532 . . . . 0.0 112.027 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.71 16.34 74.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.63 1.11 . . . . 0.0 115.094 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -122.19 111.7 17.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.318 1.447 . . . . 0.0 111.178 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -58.5 142.77 47.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.78 0.832 . . . . 0.0 112.163 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -142.46 141.21 32.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.777 1.231 . . . . 0.0 111.19 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -125.79 105.23 8.81 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.272 1.429 . . . . 0.0 110.329 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.67 106.8 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.865 1.266 . . . . 0.0 111.109 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.58 128.99 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.371 1.069 . . . . 0.0 109.783 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.96 145.79 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.939 1.696 . . . . 0.0 109.664 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.63 156.96 81.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.364 1.466 . . . . 0.0 113.283 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.15 -3.14 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.036 3.157 . . . . 0.0 116.634 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.83 -4.06 12.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.602 1.161 . . . . 0.0 113.502 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 N--CA 1.478 0.933 0 C-N-CA 125.503 1.521 . . . . 0.0 113.637 -177.755 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 . . . . . 0 N--CA 1.474 0.772 0 CA-C-O 121.264 0.554 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.53 138.78 45.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.132 1.773 . . . . 0.0 110.456 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -134.02 113.35 12.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 111.238 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -79.17 96.42 5.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.931 1.292 . . . . 0.0 111.33 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -94.74 137.33 22.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.319 1.847 . . . . 0.0 109.799 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.7 158.51 50.38 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.901 2.401 . . . . 0.0 112.13 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -76.27 65.24 2.18 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.371 1.068 . . . . 0.0 111.813 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -133.3 -36.43 0.99 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.421 1.889 . . . . 0.0 112.599 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.02 -12.37 60.61 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 171.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.14 28.54 6.04 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.977 1.711 . . . . 0.0 112.631 -171.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -11.94 60.77 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.95 5.42 6.46 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.772 1.653 . . . . 0.0 115.33 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 pt -138.21 122.29 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.509 1.924 . . . . 0.0 110.463 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -68.33 154.87 40.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.1 0.96 . . . . 0.0 113.34 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -133.16 159.4 40.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.482 1.913 . . . . 0.0 110.832 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -155.53 164.36 38.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 110.574 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -67.12 132.39 47.73 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.626 -1.296 . . . . 0.0 110.599 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.85 43.59 65.68 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.188 0.899 . . . . 0.0 114.655 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.38 145.3 47.31 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.55 1.14 . . . . 0.0 111.952 170.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -68.96 123.93 22.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.656 1.182 . . . . 0.0 110.679 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.33 155.58 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.514 1.526 . . . . 0.0 111.398 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -90.37 144.72 25.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.455 1.102 . . . . 0.0 111.608 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.03 96.94 0.49 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -65.31 144.31 57.21 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.267 1.034 . . . . 0.0 111.261 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.1 t -125.27 154.61 41.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.244 1.418 . . . . 0.0 112.151 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.4 -15.65 60.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.618 1.967 . . . . 0.0 113.65 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.38 15.71 0.43 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.44 1.896 . . . . 0.0 113.777 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.53 48.53 20.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 112.564 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -142.7 179.96 6.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.764 1.626 . . . . 0.0 112.202 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.6 m -145.73 127.91 15.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.563 1.145 . . . . 0.0 111.766 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -98.52 172.8 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.998 1.319 . . . . 0.0 112.104 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -121.19 119.98 33.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.183 1.793 . . . . 0.0 109.924 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -136.25 177.99 7.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.262 1.825 . . . . 0.0 112.415 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.23 131.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.165 1.386 . . . . 0.0 110.001 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -72.47 129.02 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.199 1.0 . . . . 0.0 110.663 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -93.98 -43.33 8.59 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.83 1.252 . . . . 0.0 112.359 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -144.45 152.74 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.004 1.322 . . . . 0.0 111.1 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.97 148.65 34.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.805 1.242 . . . . 0.0 112.431 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.7 t -152.34 171.51 17.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.724 2.01 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.28 -24.5 64.88 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.562 1.145 . . . . 0.0 113.352 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.2 p -84.31 -61.43 1.81 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.456 1.903 . . . . 0.0 112.571 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.27 166.02 24.78 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.277 2.231 . . . . 0.0 111.764 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.21 137.23 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 110.562 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 26.3 mmm -109.85 99.44 8.58 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.737 2.015 . . . . 0.0 109.601 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -98.2 149.89 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.346 1.059 . . . . 0.0 111.328 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.97 141.76 45.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 111.694 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 125.264 1.425 . . . . 0.0 111.697 170.147 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.4 p -63.97 137.21 57.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.99 1.316 . . . . 0.0 113.227 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 mt -123.12 125.51 45.3 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.339 1.456 . . . . 0.0 111.842 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.97 96.39 6.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.177 1.391 . . . . 0.0 111.157 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.79 97.47 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.636 0.774 . . . . 0.0 109.233 162.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.34 142.75 27.65 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.111 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -150.97 170.75 18.58 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -148.72 137.8 21.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.167 1.387 . . . . 0.0 111.183 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.6 t -80.95 103.02 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.46 1.104 . . . . 0.0 108.341 166.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.9 mt -66.89 -28.3 68.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.906 0.482 . . . . 0.0 112.139 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.13 -179.01 16.6 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.612 2.053 . . . . 0.0 112.254 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -115.49 154.76 28.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.049 0.94 . . . . 0.0 112.03 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 125.691 1.596 . . . . 0.0 111.108 178.358 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 120.537 0.208 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.88 104.16 7.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.923 . . . . 0.0 110.136 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.63 143.12 29.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.772 1.229 . . . . 0.0 111.123 172.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.92 139.48 53.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.511 1.524 . . . . 0.0 110.767 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.82 159.32 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.488 1.115 . . . . 0.0 111.386 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -133.28 134.42 43.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.902 1.681 . . . . 0.0 109.133 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -138.43 152.09 48.04 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -134.67 128.11 32.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.702 2.801 . . . . 0.0 108.828 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.19 119.28 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.294 1.038 . . . . 0.0 111.004 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -132.22 147.45 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.788 1.635 . . . . 0.0 112.166 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -66.71 136.5 55.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.628 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -72.85 78.26 1.14 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.23 1.014 . . . . 0.0 113.313 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.66 -53.29 0.52 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.966 1.746 . . . . 0.0 112.33 172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -68.55 147.43 51.97 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.924 1.29 . . . . 0.0 112.261 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.0 p -79.05 -6.77 57.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.43 162.35 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.186 1.394 . . . . 0.0 112.086 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.17 108.42 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.851 1.26 . . . . 0.0 109.272 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.44 -46.25 77.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.537 1.135 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.38 168.58 26.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.006 1.322 . . . . 0.0 111.233 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -155.55 157.51 36.95 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 112.902 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.45 -16.08 8.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.064 1.346 . . . . 0.0 112.782 168.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -55.39 -60.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 126.155 1.782 . . . . 0.0 111.912 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -69.03 -22.4 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.485 1.114 . . . . 0.0 113.035 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.48 -74.02 0.31 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.744 1.617 . . . . 0.0 111.711 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -168.64 125.98 0.86 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.174 1.79 . . . . 0.0 110.64 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.29 142.36 85.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.65 2.233 . . . . 0.0 112.027 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.01 101.56 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 0.0 110.387 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 130.3 34.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.202 1.401 . . . . 0.0 112.035 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.41 169.46 23.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.085 1.354 . . . . 0.0 112.47 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -94.49 139.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.334 1.053 . . . . 0.0 108.706 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.4 111.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.814 1.646 . . . . 0.0 112.14 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.38 74.31 0.69 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.962 1.744 . . . . 0.0 113.708 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.4 m -131.05 -37.79 1.26 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.039 1.336 . . . . 0.0 113.569 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.98 35.3 26.22 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 125.66 1.584 . . . . 0.0 114.523 172.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -99.58 -13.48 19.41 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 pt -68.92 167.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.614 1.166 . . . . 0.0 111.706 171.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 pt -55.71 142.34 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.619 -0.676 . . . . 0.0 110.893 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.17 72.68 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.292 -0.88 . . . . 0.0 112.868 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -45.07 87.02 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.142 0.877 . . . . 0.0 113.207 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.85 -31.1 59.17 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.355 1.062 . . . . 0.0 112.339 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.46 -48.31 82.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.616 1.166 . . . . 0.0 111.829 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -68.86 -5.44 21.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.63 -51.43 3.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.705 1.602 . . . . 0.0 112.852 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 p -54.95 -31.95 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.959 1.303 . . . . 0.0 114.079 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.99 -17.49 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -106.02 -7.95 17.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.736 2.014 . . . . 0.0 114.11 175.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.51 118.84 25.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.083 1.353 . . . . 0.0 112.337 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -77.33 160.21 28.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.914 0.886 . . . . 0.0 112.202 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -53.59 129.34 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.506 1.522 . . . . 0.0 111.647 170.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.95 -0.19 67.22 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.787 1.184 . . . . 0.0 115.866 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -97.04 113.07 24.58 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.411 1.606 . . . . 0.0 112.087 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -55.99 135.12 52.66 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.52 0.728 . . . . 0.0 111.103 164.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -137.79 113.18 9.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 0.0 110.93 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.83 98.45 11.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 110.242 172.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.27 153.11 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.824 0.85 . . . . 0.0 110.237 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.37 124.68 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.987 1.315 . . . . 0.0 109.988 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.94 134.12 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.115 1.766 . . . . 0.0 110.244 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.64 159.12 70.7 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.203 1.401 . . . . 0.0 112.936 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.83 50.56 2.5 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.682 3.588 . . . . 0.0 113.839 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.99 1.53 2.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.777 2.031 . . . . 0.0 113.15 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 125.447 1.499 . . . . 0.0 111.761 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.14 146.1 47.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.074 1.35 . . . . 0.0 110.216 169.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -134.97 107.37 7.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.823 1.249 . . . . 0.0 110.121 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.4 121.47 18.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.049 0.54 . . . . 0.0 110.102 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.5 m -135.42 159.24 72.41 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.176 1.79 . . . . 0.0 110.724 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.21 165.21 31.46 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.325 2.016 . . . . 0.0 111.819 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -69.73 10.76 0.34 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.68 -43.48 97.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.451 1.5 . . . . 0.0 113.429 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -69.26 -21.92 63.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.049 0.94 . . . . 0.0 113.379 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -132.58 50.02 2.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.957 1.703 . . . . 0.0 111.391 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.07 -27.21 67.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.779 1.232 . . . . 0.0 113.0 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.43 34.02 1.64 Allowed Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.993 1.759 . . . . 0.0 114.094 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.64 128.82 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 126.643 1.977 . . . . 0.0 108.794 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -64.99 142.07 58.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.029 0.932 . . . . 0.0 111.762 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.41 146.02 51.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.736 1.614 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.45 145.06 20.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.622 1.169 . . . . 0.0 111.547 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.99 90.48 0.18 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.994 1.717 . . . . 0.0 110.579 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.51 -4.37 8.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.869 1.7 . . . . 0.0 116.58 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.5 159.41 32.27 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.482 2.141 . . . . 0.0 113.023 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -84.62 126.03 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 0.0 110.846 165.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.2 149.46 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.644 1.977 . . . . 0.0 110.723 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -97.78 155.72 16.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.74 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.82 95.52 0.19 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.17 1.367 . . . . 0.0 112.686 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.19 105.79 2.21 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.769 -0.842 . . . . 0.0 111.234 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -75.65 154.4 36.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.691 1.197 . . . . 0.0 112.169 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -65.11 -19.32 65.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.609 1.563 . . . . 0.0 112.661 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.3 13.21 0.13 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.663 1.985 . . . . 0.0 114.601 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 58.66 48.95 10.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.039 2.136 . . . . 0.0 112.597 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -146.57 176.82 9.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.533 1.933 . . . . 0.0 110.929 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 m -140.28 107.08 5.38 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 111.581 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.89 167.22 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.605 0.762 . . . . 0.0 111.8 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -128.34 132.3 48.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.977 1.711 . . . . 0.0 110.129 172.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.28 177.11 8.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.842 1.657 . . . . 0.0 112.509 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.413 ' H ' ' HB3' ' A' ' 125' ' ' ASP . 4.7 mp -115.75 137.99 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.46 1.504 . . . . 0.0 110.337 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.57 114.9 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.981 -1.074 . . . . 0.0 109.524 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -84.46 -33.18 23.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.195 1.398 . . . . 0.0 112.888 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -156.69 159.78 38.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.11 1.364 . . . . 0.0 111.445 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -149.06 151.06 33.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.956 1.302 . . . . 0.0 112.669 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -154.95 -176.55 5.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.737 1.615 . . . . 0.0 111.657 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.09 -27.95 54.34 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.301 1.441 . . . . 0.0 113.251 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.0 p -83.1 -65.3 1.03 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.904 1.682 . . . . 0.0 111.843 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -132.38 173.18 11.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.099 2.16 . . . . 0.0 111.71 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -143.51 148.83 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 127.148 2.179 . . . . 0.0 109.399 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.1 mtp -122.42 100.04 6.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.574 1.549 . . . . 0.0 110.263 -174.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.23 140.44 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.926 1.29 . . . . 0.0 111.67 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 113' ' ' ILE . 16.8 t70 -64.81 151.06 46.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.719 0.808 . . . . 0.0 111.347 168.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 125.252 1.421 . . . . 0.0 111.684 170.132 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.9 pttt . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.97 145.0 55.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.853 1.661 . . . . 0.0 112.558 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.17 124.98 44.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.574 1.55 . . . . 0.0 111.446 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.38 139.53 32.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.655 0.782 . . . . 0.0 111.444 169.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.83 95.21 4.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.523 1.929 . . . . 0.0 108.78 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -81.83 112.32 18.85 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.437 1.095 . . . . 0.0 108.572 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.17 169.4 16.92 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -147.25 139.11 24.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.319 1.448 . . . . 0.0 110.579 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.59 100.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.23 -17.53 64.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.259 1.023 . . . . 0.0 112.568 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.57 -171.1 13.55 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.786 1.66 . . . . 0.0 112.735 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -125.93 151.44 46.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.128 0.971 . . . . 0.0 112.48 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 . . . . . 0 N--CA 1.472 0.641 0 C-N-CA 126.17 1.788 . . . . 0.0 111.04 -177.108 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 110.469 -0.196 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.41 112.23 17.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.332 0.653 . . . . 0.0 109.293 164.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.56 141.26 42.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.035 166.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.99 130.4 55.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.0 2.12 . . . . 0.0 109.991 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.3 pt -132.63 159.41 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.247 1.019 . . . . 0.0 112.392 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -138.47 134.75 34.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.192 1.797 . . . . 0.0 109.817 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -136.88 152.03 49.76 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.111 1.364 . . . . 0.0 114.027 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.42 115.99 9.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.614 2.365 . . . . 0.0 109.606 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.24 103.65 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 122.27 1.033 . . . . 0.0 110.634 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -102.77 152.15 21.58 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.593 2.357 . . . . 0.0 110.212 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -77.69 150.78 34.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.903 -1.123 . . . . 0.0 111.332 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -70.54 85.83 0.63 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.86 -1.15 . . . . 0.0 111.88 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.5 -44.78 1.26 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.467 1.984 . . . . 0.0 114.39 170.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -70.64 151.44 44.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.18 0.99 . . . . 0.0 112.971 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.4 m -79.87 -15.85 56.55 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.975 1.31 . . . . 0.0 114.072 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.83 159.57 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.777 0.831 . . . . 0.0 111.944 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.41 128.78 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.159 1.383 . . . . 0.0 109.517 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.43 -51.58 10.54 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.936 0.495 . . . . 0.0 111.423 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -159.89 163.84 34.0 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.393 1.877 . . . . 0.0 111.112 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.8 p -154.35 159.93 41.43 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.882 -1.136 . . . . 0.0 112.482 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -114.38 -12.52 12.37 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 165.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.19 -48.36 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.784 1.633 . . . . 0.0 111.826 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -76.0 -6.89 53.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.716 1.206 . . . . 0.0 113.984 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -107.47 -73.58 0.68 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.943 1.697 . . . . 0.0 111.354 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -163.54 131.68 2.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.301 1.84 . . . . 0.0 109.774 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.5 160.06 37.52 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.173 2.582 . . . . 0.0 112.891 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 tt -95.11 126.28 40.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 109.863 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -106.27 127.44 53.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.102 1.761 . . . . 0.0 111.558 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -147.57 162.98 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.508 1.123 . . . . 0.0 111.966 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.2 mm -88.38 149.48 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.717 -1.24 . . . . 0.0 109.366 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -50.7 106.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 110.971 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.03 59.63 1.75 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.547 1.546 . . . . 0.0 114.492 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -113.5 -28.68 7.44 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.966 1.306 . . . . 0.0 113.243 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.67 32.9 18.19 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.74 2.016 . . . . 0.0 114.711 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -83.5 -17.94 40.19 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -76.75 171.05 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.974 1.31 . . . . 0.0 112.791 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.4 pt -57.18 142.48 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.966 0.906 . . . . 0.0 111.46 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.78 77.57 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.48 -21.8 65.03 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.086 0.85 . . . . 0.0 114.518 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -96.52 -35.49 11.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.466 1.507 . . . . 0.0 111.804 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -56.77 -45.75 81.9 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.887 1.675 . . . . 0.0 112.188 174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -75.69 -2.0 27.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.917 0.887 . . . . 0.0 113.393 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.5 -42.27 4.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.601 1.56 . . . . 0.0 113.18 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.02 -25.73 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.522 1.129 . . . . 0.0 113.893 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.3 -24.96 67.84 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -37.24 15.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.133 1.373 . . . . 0.0 112.498 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.91 131.3 46.77 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.63 1.572 . . . . 0.0 113.377 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -92.51 151.51 20.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.2 1.0 . . . . 0.0 111.833 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.16 125.06 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.904 0.882 . . . . 0.0 110.061 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.19 86.19 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.454 1.026 . . . . 0.0 115.454 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -122.58 116.38 23.76 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.992 1.396 . . . . 0.0 111.259 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -58.26 143.07 45.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.157 0.983 . . . . 0.0 112.008 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.49 142.5 41.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.633 1.573 . . . . 0.0 110.173 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -129.99 81.8 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.181 0.993 . . . . 0.0 110.583 -167.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -88.06 117.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.921 1.289 . . . . 0.0 111.554 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.44 118.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.889 0.876 . . . . 0.0 109.465 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -115.62 138.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 126.604 1.961 . . . . 0.0 108.812 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.08 155.52 90.15 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.475 1.11 . . . . 0.0 112.042 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.7 -46.28 5.38 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.601 2.201 . . . . 0.0 112.473 -172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -64.69 -23.17 67.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.536 1.534 . . . . 0.0 113.309 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 125.229 1.412 . . . . 0.0 113.502 176.54 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 p90 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.03 132.98 41.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 111.386 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.7 120.09 28.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.74 1.216 . . . . 0.0 110.847 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.12 101.47 5.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.345 1.458 . . . . 0.0 111.453 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 t -99.72 136.88 20.16 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.32 1.848 . . . . 0.0 109.476 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.87 152.58 68.78 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.502 2.134 . . . . 0.0 111.676 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -76.88 57.45 1.32 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.127 1.371 . . . . 0.0 111.447 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.63 -50.52 1.06 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.205 1.802 . . . . 0.0 112.812 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -66.43 -15.01 63.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -98.45 17.83 18.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.717 2.007 . . . . 0.0 113.484 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 112.3 1.47 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.717 -1.239 . . . . 0.0 111.341 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.22 2.43 59.13 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.869 1.223 . . . . 0.0 115.446 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.68 130.48 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.919 1.36 . . . . 0.0 111.368 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.76 147.64 39.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.532 1.133 . . . . 0.0 111.173 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.09 152.4 47.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.98 1.712 . . . . 0.0 109.689 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -155.8 162.05 40.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 111.604 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.25 123.6 20.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.829 -1.169 . . . . 0.0 110.92 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.96 30.68 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.167 0.889 . . . . 0.0 114.786 173.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.4 ptp -109.1 144.96 36.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.195 0.997 . . . . 0.0 111.421 165.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.1 p -70.26 136.67 50.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.883 0.873 . . . . 0.0 110.812 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.9 p -140.66 164.61 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.573 1.549 . . . . 0.0 111.046 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.21 148.39 34.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.212 1.405 . . . . 0.0 111.858 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.85 94.72 0.31 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.463 1.506 . . . . 0.0 111.936 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -68.66 104.96 2.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.855 0.862 . . . . 0.0 111.063 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -77.93 158.38 29.38 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.678 1.191 . . . . 0.0 112.21 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -66.48 -16.95 64.51 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.443 1.497 . . . . 0.0 113.264 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -72.16 13.86 0.28 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.575 1.95 . . . . 0.0 114.212 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 57.13 47.23 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.883 2.073 . . . . 0.0 112.301 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.06 170.43 15.95 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.037 2.135 . . . . 0.0 109.637 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 34.6 m -136.95 115.51 11.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.56 1.144 . . . . 0.0 111.585 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.64 164.5 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 111.406 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -121.23 133.14 55.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.677 1.591 . . . . 0.0 110.624 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 177.15 9.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.683 1.593 . . . . 0.0 112.474 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.94 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.428 1.491 . . . . 0.0 109.362 173.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.9 mt -74.93 116.42 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.706 1.202 . . . . 0.0 109.629 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -92.98 -33.12 14.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.131 0.972 . . . . 0.0 112.611 -175.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -148.41 148.09 29.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.946 1.698 . . . . 0.0 110.78 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -142.58 157.93 44.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.221 1.008 . . . . 0.0 112.51 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 t -157.01 176.21 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.861 1.664 . . . . 0.0 111.167 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.17 -25.85 62.72 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.531 1.132 . . . . 0.0 113.184 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.6 p -82.74 -64.18 1.22 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.747 1.619 . . . . 0.0 112.044 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -135.08 168.47 19.07 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.592 2.357 . . . . 0.0 111.159 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -137.58 150.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.498 1.519 . . . . 0.0 110.617 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.2 mmm -127.76 103.08 7.09 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.798 2.039 . . . . 0.0 110.288 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.76 143.47 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.398 1.479 . . . . 0.0 110.246 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.23 96.8 2.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.206 1.002 . . . . 0.0 111.861 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 CA--C 1.54 0.562 0 C-N-CA 125.063 1.345 . . . . 0.0 112.392 173.924 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.3 p -91.24 150.31 21.39 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.957 1.303 . . . . 0.0 113.208 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.3 120.94 32.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.742 2.017 . . . . 0.0 110.911 -170.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 101.08 10.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -79.59 92.43 5.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.633 0.773 . . . . 0.0 110.08 167.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -73.12 124.03 24.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 165.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -144.18 169.39 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -148.4 147.97 29.8 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.789 1.236 . . . . 0.0 111.511 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.95 108.0 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.614 1.166 . . . . 0.0 108.444 167.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.7 -12.76 60.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.007 1.323 . . . . 0.0 112.768 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.57 -150.51 18.66 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 126.009 1.766 . . . . 0.0 111.475 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.77 163.7 31.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.492 1.117 . . . . 0.0 112.681 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 125.397 1.479 . . . . 0.0 113.125 176.087 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 120.477 0.18 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.31 8.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.39 123.63 23.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.065 1.346 . . . . 0.0 110.566 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.72 117.44 34.08 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.6 1.96 . . . . 0.0 109.707 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.34 160.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.363 1.065 . . . . 0.0 111.524 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.13 165.36 28.05 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.076 -1.015 . . . . 0.0 112.445 169.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -147.69 157.8 43.72 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.7 1.6 . . . . 0.0 113.858 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -134.01 123.79 25.17 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.873 3.269 . . . . 0.0 108.148 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.21 112.58 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.263 1.025 . . . . 0.0 109.372 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -115.84 143.72 45.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.753 1.621 . . . . 0.0 110.172 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -70.04 132.92 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.516 -0.74 . . . . 0.0 110.4 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -59.16 123.84 18.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.305 0.642 . . . . 0.0 111.943 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.82 -45.86 2.31 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.019 1.771 . . . . 0.0 114.306 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -74.72 154.7 38.3 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.664 1.186 . . . . 0.0 113.514 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 m -83.8 -14.94 50.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.18 163.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.049 0.94 . . . . 0.0 111.983 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.66 122.74 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.367 1.467 . . . . 0.0 109.299 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.69 -51.09 24.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.102 0.961 . . . . 0.0 111.058 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.52 156.54 28.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.006 1.323 . . . . 0.0 112.554 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 57.5 m -149.84 151.97 34.37 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.679 1.591 . . . . 0.0 111.76 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.49 -6.13 11.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.3 mt -50.88 -58.14 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.908 1.683 . . . . 0.0 112.196 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -75.1 -19.83 59.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.504 1.121 . . . . 0.0 113.389 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -78.59 -72.47 0.38 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.048 1.739 . . . . 0.0 111.109 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -168.34 125.87 0.9 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 127.074 2.15 . . . . 0.0 109.392 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.29 147.05 87.43 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.444 2.096 . . . . 0.0 111.403 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.5 tp -72.83 142.89 48.0 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.316 1.047 . . . . 0.0 110.172 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -120.68 111.79 18.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 0.0 109.685 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -131.77 169.54 16.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.078 0.951 . . . . 0.0 112.262 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.2 mm -105.94 137.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.234 1.014 . . . . 0.0 108.9 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -46.37 106.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.634 1.574 . . . . 0.0 111.345 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.88 15.03 17.63 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.25 1.405 . . . . 0.0 116.397 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.6 m -73.8 -43.54 58.55 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.859 1.829 . . . . 0.0 113.001 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m120 57.17 21.52 6.61 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.161 2.185 . . . . 0.0 116.538 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -74.61 -16.0 60.81 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.4 pt -66.6 168.86 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.434 1.494 . . . . 0.0 112.96 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 pt -56.1 144.43 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.228 1.011 . . . . 0.0 111.775 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -38.41 75.23 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -171.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.81 -33.16 86.17 Favored Glycine 0 CA--C 1.539 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 113.962 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.52 -29.64 22.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.251 1.42 . . . . 0.0 112.144 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -59.65 -43.29 93.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.738 1.615 . . . . 0.0 112.091 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -70.47 -13.91 62.31 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.38 -46.81 7.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.817 1.247 . . . . 0.0 112.723 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.33 -27.77 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.8 -24.47 66.93 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.94 -36.65 10.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.107 1.763 . . . . 0.0 112.684 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.96 112.15 0.89 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.963 1.705 . . . . 0.0 113.142 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.08 151.4 41.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.448 0.699 . . . . 0.0 112.053 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 tt -57.33 127.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.426 1.09 . . . . 0.0 111.494 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.96 9.23 85.28 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.094 1.33 . . . . 0.0 115.3 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.1 119.07 30.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.088 1.444 . . . . 0.0 111.763 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -59.25 142.36 52.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.059 0.944 . . . . 0.0 112.082 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -136.51 138.82 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.598 1.159 . . . . 0.0 110.481 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -130.02 89.3 2.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.433 1.093 . . . . 0.0 110.534 -167.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -101.09 118.15 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.879 1.272 . . . . 0.0 111.507 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.9 t -78.82 111.18 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.434 1.094 . . . . 0.0 109.536 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.17 133.81 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.3 1.44 . . . . 0.0 109.53 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.51 153.45 93.1 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.09 0.956 . . . . 0.0 111.743 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.04 -43.53 35.69 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.563 2.175 . . . . 0.0 112.521 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.92 -15.6 63.53 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.833 1.653 . . . . 0.0 114.838 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 124.769 1.227 . . . . 0.0 113.035 176.488 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 120.688 0.28 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.36 147.85 44.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.199 1.4 . . . . 0.0 110.316 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -129.51 115.92 18.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.191 1.396 . . . . 0.0 110.653 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.8 115.43 6.58 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.498 0.719 . . . . 0.0 110.121 164.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.32 133.93 25.49 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 126.633 1.973 . . . . 0.0 109.463 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.2 155.96 60.08 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.201 1.934 . . . . 0.0 111.673 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -64.06 -17.62 63.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.91 -38.89 58.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.332 2.653 . . . . 0.0 114.316 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -71.58 -15.95 62.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.27 -45.41 3.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.635 1.174 . . . . 0.0 112.947 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 21.28 66.97 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 129.611 3.164 . . . . 0.0 115.043 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.41 -22.42 3.94 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.041 1.305 . . . . 0.0 115.601 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.55 132.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.247 1.523 . . . . 0.0 109.621 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.24 67.76 3.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.777 1.631 . . . . 0.0 112.613 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.66 148.05 17.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.713 1.605 . . . . 0.0 112.131 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -151.34 155.75 39.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.198 1.399 . . . . 0.0 111.189 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -71.81 21.94 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 54.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 120.95 -1.094 . . . . 0.0 113.578 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.8 ptm -132.29 151.58 51.77 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.991 1.317 . . . . 0.0 111.874 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 p -70.25 133.05 46.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.354 1.061 . . . . 0.0 111.245 167.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -135.72 156.95 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.149 1.78 . . . . 0.0 110.689 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -95.66 145.82 24.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.446 1.098 . . . . 0.0 111.902 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.18 95.44 0.37 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.692 1.615 . . . . 0.0 111.855 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -65.68 137.96 57.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 117.85 0.825 . . . . 0.0 111.123 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 t -116.93 155.15 29.6 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.942 1.697 . . . . 0.0 111.75 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.85 -15.44 58.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.177 1.791 . . . . 0.0 113.345 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.23 15.17 0.35 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.419 1.888 . . . . 0.0 113.769 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 55.54 46.74 22.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.368 2.267 . . . . 0.0 112.543 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -144.74 177.45 8.7 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.174 1.79 . . . . 0.0 112.218 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.7 m -145.37 120.32 10.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.667 1.187 . . . . 0.0 111.796 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -88.9 173.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.584 1.153 . . . . 0.0 112.053 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.7 133.97 46.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.219 1.408 . . . . 0.0 111.441 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.81 11.22 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.464 1.506 . . . . 0.0 112.052 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.95 131.95 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.639 1.176 . . . . 0.0 110.618 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.7 mt -70.55 134.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 120.821 -1.174 . . . . 0.0 111.059 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -94.73 -46.38 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.825 1.25 . . . . 0.0 112.065 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -146.81 156.87 43.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.284 1.434 . . . . 0.0 111.258 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.26 146.84 29.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.727 1.211 . . . . 0.0 112.331 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.3 t -152.97 169.41 22.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.272 1.829 . . . . 0.0 110.547 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.93 -27.26 67.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.192 0.997 . . . . 0.0 113.493 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -80.67 -66.42 0.89 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.789 2.036 . . . . 0.0 111.714 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -132.3 157.49 44.29 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.619 1.968 . . . . 0.0 111.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.41 150.32 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.95 2.1 . . . . 0.0 108.233 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.6 mtp -126.18 100.56 6.37 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.822 1.249 . . . . 0.0 109.992 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.3 m -99.29 151.72 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.287 1.035 . . . . 0.0 111.075 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.68 148.79 46.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.339 0.656 . . . . 0.0 111.187 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 N--CA 1.47 0.572 0 C-N-CA 125.264 1.426 . . . . 0.0 112.326 172.873 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.2 p -73.06 136.88 45.03 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 112.47 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.81 136.48 53.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.618 1.967 . . . . 0.0 110.736 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.31 105.25 17.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.685 1.194 . . . . 0.0 111.345 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.88 92.09 8.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 109.913 167.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -74.84 122.5 23.46 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 163.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -143.24 166.35 24.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.454 0.702 . . . . 0.0 112.03 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -151.2 145.67 25.56 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.462 0.705 . . . . 0.0 112.503 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.1 t -91.25 102.87 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.475 1.51 . . . . 0.0 108.715 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.17 -27.36 69.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.85 0.86 . . . . 0.0 111.6 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.41 -133.04 7.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 125.992 1.758 . . . . 0.0 110.899 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -150.37 162.89 39.67 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.842 1.257 . . . . 0.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 . . . . . 0 N--CA 1.472 0.641 0 C-N-CA 125.201 1.4 . . . . 0.0 111.269 171.021 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 111.628 0.232 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.96 113.31 21.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.383 1.073 . . . . 0.0 111.573 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.2 101.43 7.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 110.483 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.53 111.19 11.75 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.01 1.724 . . . . 0.0 110.043 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 pp -133.6 158.3 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.944 0.897 . . . . 0.0 111.968 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -137.65 138.34 39.36 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.501 1.521 . . . . 0.0 109.852 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -136.4 162.19 33.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.854 1.262 . . . . 0.0 113.796 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -144.83 160.24 41.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.074 2.149 . . . . 0.0 111.678 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.47 112.59 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.36 1.464 . . . . 0.0 110.451 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -114.62 154.52 28.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.995 2.118 . . . . 0.0 110.054 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.91 148.28 26.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.323 1.449 . . . . 0.0 111.567 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -70.68 94.03 0.98 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.831 -1.168 . . . . 0.0 111.253 166.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 -39.22 2.97 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.233 1.873 . . . . 0.0 114.894 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -73.44 149.84 42.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.502 1.151 . . . . 0.0 112.046 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m -69.37 -23.06 63.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.923 1.289 . . . . 0.0 113.776 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.65 153.47 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 113.296 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.94 128.14 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.838 1.655 . . . . 0.0 108.982 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.24 -51.95 7.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.144 0.578 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.09 160.07 43.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.185 1.794 . . . . 0.0 111.488 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -162.38 167.14 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.923 1.289 . . . . 0.0 113.138 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -130.72 13.77 5.37 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 164.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.0 mm -53.15 -59.99 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.578 1.551 . . . . 0.0 112.358 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -78.68 -16.17 57.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -172.6 3.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.063 2.145 . . . . 0.0 111.722 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.94 126.36 83.24 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.208 1.003 . . . . 0.0 110.97 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.31 162.75 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.135 2.557 . . . . 0.0 112.335 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.95 149.1 37.73 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.823 168.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -130.81 48.26 2.44 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.297 1.439 . . . . 0.0 110.939 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -69.33 163.11 25.84 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.357 -0.84 . . . . 0.0 113.14 -175.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 mm -116.61 137.34 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.672 1.589 . . . . 0.0 109.244 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.73 107.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.799 1.64 . . . . 0.0 111.908 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.63 -28.03 8.43 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.24 1.876 . . . . 0.0 114.311 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -58.35 -24.52 60.06 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.593 1.697 . . . . 0.0 113.735 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 40.55 60.43 1.88 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.422 2.689 . . . . 0.0 114.137 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -89.41 -17.44 28.79 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.72 170.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.933 1.293 . . . . 0.0 112.218 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 pt -63.26 147.1 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.459 -0.776 . . . . 0.0 111.863 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.93 -25.92 68.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.26 -40.69 98.16 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.859 -1.151 . . . . 0.0 112.991 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 tp -81.63 -25.45 35.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.717 1.607 . . . . 0.0 112.804 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -51.25 -49.39 61.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.779 1.632 . . . . 0.0 112.476 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -13.89 62.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.256 1.022 . . . . 0.0 113.708 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.54 -43.36 7.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.793 1.237 . . . . 0.0 112.968 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.46 -27.25 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.34 -17.43 63.7 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -103.79 -40.44 6.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.907 1.683 . . . . 0.0 113.328 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.58 134.36 56.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.183 0.993 . . . . 0.0 112.5 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.7 161.6 13.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.05 0.94 . . . . 0.0 112.282 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -54.49 124.49 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.394 1.078 . . . . 0.0 111.575 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.63 -0.28 77.2 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.234 1.397 . . . . 0.0 115.604 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -105.96 112.6 25.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.415 1.607 . . . . 0.0 111.551 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -57.49 144.73 35.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.54 0.736 . . . . 0.0 111.824 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -138.12 139.81 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.155 1.782 . . . . 0.0 109.96 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -130.45 110.39 11.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.208 1.403 . . . . 0.0 110.571 -173.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -118.17 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.611 1.564 . . . . 0.0 110.778 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.81 123.05 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.898 0.879 . . . . 0.0 109.118 173.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.3 mt -127.87 130.4 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 109.294 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.2 145.3 97.47 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.785 0.834 . . . . 0.0 110.984 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.09 -32.55 91.71 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.884 1.722 . . . . 0.0 112.971 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -63.08 -20.7 65.59 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 CA--C 1.549 0.914 0 C-N-CA 125.206 1.402 . . . . 0.0 113.163 175.343 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.01 129.11 38.15 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 111.481 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -120.74 118.11 29.21 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.222 1.409 . . . . 0.0 110.153 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.95 130.27 42.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.163 0.985 . . . . 0.0 110.746 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.1 t -135.75 136.66 23.91 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.034 1.733 . . . . 0.0 109.15 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.63 157.83 54.93 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.637 2.225 . . . . 0.0 112.211 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -75.94 66.18 2.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.31 1.444 . . . . 0.0 111.876 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.38 -50.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.151 1.781 . . . . 0.0 112.245 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.84 -11.68 48.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -120.1 10.48 11.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.43 1.892 . . . . 0.0 113.718 -171.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -56.16 -27.99 56.4 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.371 1.468 . . . . 0.0 114.145 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.42 10.21 22.03 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.676 1.608 . . . . 0.0 116.367 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.8 pt -134.91 131.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.555 1.678 . . . . 0.0 112.893 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -75.92 137.64 40.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.168 1.387 . . . . 0.0 112.256 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.72 165.17 15.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.829 1.651 . . . . 0.0 112.655 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.21 155.5 30.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.017 1.727 . . . . 0.0 110.764 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -73.38 107.54 5.73 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.464 -1.397 . . . . 0.0 111.05 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.88 26.94 11.79 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.501 0.961 . . . . 0.0 115.501 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.1 ptm -99.73 153.26 19.25 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.883 1.342 . . . . 0.0 112.263 168.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 p -70.46 113.96 8.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.249 1.42 . . . . 0.0 111.157 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.15 161.19 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.896 1.678 . . . . 0.0 111.035 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -123.25 155.44 37.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.813 1.645 . . . . 0.0 111.878 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.58 105.51 0.29 Allowed Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.361 0.982 . . . . 0.0 113.341 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.0 111.57 7.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.926 1.29 . . . . 0.0 111.894 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.9 t -80.55 159.7 25.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.102 1.361 . . . . 0.0 111.897 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.04 -15.52 62.43 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.048 1.339 . . . . 0.0 113.366 173.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.44 18.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.757 1.623 . . . . 0.0 113.966 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 51.83 44.01 29.68 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.474 2.31 . . . . 0.0 113.077 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -140.98 172.33 12.83 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.286 1.834 . . . . 0.0 111.533 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.0 m -141.53 107.62 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.04 1.336 . . . . 0.0 110.521 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.59 167.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.972 -0.455 . . . . 0.0 111.41 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -132.41 136.22 46.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.082 1.353 . . . . 0.0 111.284 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.4 -179.53 8.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.816 1.246 . . . . 0.0 112.798 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.81 132.72 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.204 1.401 . . . . 0.0 110.61 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.63 122.46 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.9 1.28 . . . . 0.0 110.571 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -90.27 -38.02 13.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.705 1.202 . . . . 0.0 113.08 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -153.35 154.67 34.98 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.337 1.455 . . . . 0.0 111.571 170.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.07 145.83 30.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 113.388 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.4 m -148.3 173.68 12.79 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.771 2.028 . . . . 0.0 111.379 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.82 -21.99 61.62 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.9 p -83.52 -61.62 1.79 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.075 1.75 . . . . 0.0 111.924 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -136.62 169.31 17.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.628 2.371 . . . . 0.0 111.056 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.76 154.91 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.148 1.779 . . . . 0.0 109.888 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.0 mtp -130.22 101.27 5.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.518 1.527 . . . . 0.0 109.969 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.9 t -109.66 147.78 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.209 1.404 . . . . 0.0 109.371 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.89 134.01 54.36 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.758 -0.589 . . . . 0.0 111.158 168.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 125.365 1.466 . . . . 0.0 111.754 178.477 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 147.09 53.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.363 1.865 . . . . 0.0 113.597 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.8 mp -122.56 160.84 24.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.59 103.36 13.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.999 1.72 . . . . 0.0 111.161 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -82.41 109.99 17.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.601 0.76 . . . . 0.0 109.576 166.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -110.49 138.9 46.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.216 1.006 . . . . 0.0 110.129 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.94 170.0 20.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.417 0.687 . . . . 0.0 112.756 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -146.04 146.65 31.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 111.237 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.5 105.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.696 1.198 . . . . 0.0 108.742 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.17 -26.41 56.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.487 1.115 . . . . 0.0 112.453 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.89 -168.0 33.84 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -132.8 130.5 39.96 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.762 1.625 . . . . 0.0 110.225 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 124.938 1.295 . . . . 0.0 110.149 -177.331 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.09 98.72 9.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.019 1.328 . . . . 0.0 110.859 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.68 128.59 34.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.3 1.44 . . . . 0.0 111.327 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.72 134.7 43.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.166 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 pt -127.98 162.6 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.887 1.275 . . . . 0.0 112.247 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -138.64 131.45 29.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.509 1.924 . . . . 0.0 109.458 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -137.05 153.94 50.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.728 1.211 . . . . 0.0 113.784 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -143.68 133.93 24.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.907 2.483 . . . . 0.0 110.144 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.2 103.14 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -110.53 147.32 34.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.961 2.104 . . . . 0.0 110.906 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -76.68 141.64 40.87 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.409 -0.807 . . . . 0.0 111.872 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.6 93.45 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.779 0.832 . . . . 0.0 111.549 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.06 -54.65 0.7 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.247 1.88 . . . . 0.0 113.713 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 t -68.48 154.68 41.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -79.06 -20.67 48.27 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.258 1.423 . . . . 0.0 113.308 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.98 155.72 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.439 -0.788 . . . . 0.0 111.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.52 131.13 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.498 1.519 . . . . 0.0 110.082 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.8 mt -73.18 -55.1 6.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.503 0.721 . . . . 0.0 111.409 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.28 155.87 34.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.319 1.448 . . . . 0.0 110.922 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.4 p -148.26 126.03 11.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.266 1.026 . . . . 0.0 111.926 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -88.09 -29.65 20.47 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.199 0.6 . . . . 0.0 112.363 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -51.8 -51.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.013 1.725 . . . . 0.0 112.296 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -69.7 -14.99 63.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.497 1.119 . . . . 0.0 113.754 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -92.01 -72.17 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.812 1.645 . . . . 0.0 110.6 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -167.1 154.43 8.43 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.679 1.992 . . . . 0.0 111.623 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.31 146.38 69.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.439 2.092 . . . . 0.0 111.478 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 tp -87.52 130.55 34.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.857 1.263 . . . . 0.0 109.723 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.02 138.18 49.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.922 0.889 . . . . 0.0 112.649 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -153.04 163.02 40.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.189 1.396 . . . . 0.0 111.86 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.24 141.2 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -47.57 109.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.549 1.54 . . . . 0.0 111.163 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.4 -5.02 31.4 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.698 1.618 . . . . 0.0 115.916 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.9 m -57.04 -32.17 65.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.122 1.961 . . . . 0.0 113.665 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 47.31 62.5 2.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.589 1.956 . . . . 0.0 113.55 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.07 -20.83 13.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 pt -74.53 170.79 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.177 1.791 . . . . 0.0 112.611 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.9 pt -59.73 145.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.966 0.906 . . . . 0.0 111.781 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.69 75.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.6 98.75 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 121.552 -0.718 . . . . 0.0 113.029 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.5 tp -77.33 -34.19 55.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.616 1.166 . . . . 0.0 112.24 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.0 tp10 -56.74 -38.67 72.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.452 1.101 . . . . 0.0 112.668 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -78.82 -14.27 59.35 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.26 9.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.171 . . . . 0.0 112.501 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -59.3 -27.53 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.87 -20.41 66.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.63 -13.27 16.02 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.74 . . . . 0.0 113.121 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.44 132.58 50.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.598 1.159 . . . . 0.0 112.76 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -91.85 130.47 37.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 111.195 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.76 126.74 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.8 1.24 . . . . 0.0 111.674 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.64 9.03 87.26 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.13 119.03 29.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.383 1.591 . . . . 0.0 111.773 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -62.72 139.64 58.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.572 0.749 . . . . 0.0 111.465 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -141.93 160.49 40.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.457 1.103 . . . . 0.0 112.282 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.1 107.91 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 109.951 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -110.69 116.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.83 1.252 . . . . 0.0 110.097 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.8 110.77 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.449 -0.782 . . . . 0.0 109.376 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.9 139.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.089 1.756 . . . . 0.0 109.47 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.63 151.24 88.83 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.859 0.864 . . . . 0.0 112.244 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.73 -39.22 75.23 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.357 2.704 . . . . 0.0 112.472 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.64 -9.16 40.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.425 1.89 . . . . 0.0 114.205 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 125.828 1.651 . . . . 0.0 113.191 -179.09 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.549 0.923 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.3 mt -145.7 137.91 25.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.63 1.972 . . . . 0.0 110.991 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -144.2 127.99 17.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.15 0.58 . . . . 0.0 111.872 169.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -76.37 98.34 4.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.74 1.216 . . . . 0.0 110.425 167.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.31 156.6 38.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.424 1.889 . . . . 0.0 110.849 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 152.12 59.88 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.177 1.918 . . . . 0.0 111.771 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.4 -23.39 65.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.972 . . . . 0.0 113.15 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -51.01 -36.42 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.376 1.87 . . . . 0.0 113.789 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -66.49 -19.47 65.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.5 1.12 . . . . 0.0 113.564 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -133.28 17.84 4.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.307 1.843 . . . . 0.0 113.008 -172.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -57.43 -24.9 58.38 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.889 1.676 . . . . 0.0 114.438 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -113.57 17.43 20.94 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 126.24 1.876 . . . . 0.0 115.342 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.6 mt -123.49 123.55 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.316 1.558 . . . . 0.0 111.242 -170.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.74 77.34 2.06 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.055 1.742 . . . . 0.0 113.182 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.91 153.51 40.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.232 1.013 . . . . 0.0 112.759 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.99 137.29 18.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.105 1.362 . . . . 0.0 111.11 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -58.27 114.52 2.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.158 0.983 . . . . 0.0 110.93 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.54 20.94 11.05 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -108.93 161.3 15.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.277 1.538 . . . . 0.0 112.149 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.6 t -88.97 116.14 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.399 1.08 . . . . 0.0 110.967 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.0 160.92 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.896 1.678 . . . . 0.0 110.936 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -115.75 140.73 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.85 1.26 . . . . 0.0 111.823 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.75 93.34 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.575 1.559 . . . . 0.0 112.164 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -65.95 147.1 53.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.793 -0.828 . . . . 0.0 111.506 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -130.69 157.48 42.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.819 1.648 . . . . 0.0 112.302 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.35 -15.83 61.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.402 1.881 . . . . 0.0 113.689 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.38 14.75 0.41 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.162 1.785 . . . . 0.0 113.825 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 54.62 46.91 23.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.164 2.186 . . . . 0.0 112.556 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -140.94 173.21 11.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.987 1.715 . . . . 0.0 112.192 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 m -145.03 112.98 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 111.273 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -76.57 165.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.15 0.58 . . . . 0.0 111.482 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -123.18 139.96 53.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.274 1.43 . . . . 0.0 110.396 170.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.55 173.57 15.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.313 1.045 . . . . 0.0 113.144 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.81 135.97 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.076 1.351 . . . . 0.0 110.166 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 mm -67.06 117.96 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.974 1.309 . . . . 0.0 109.585 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -101.01 -36.11 9.13 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.699 1.2 . . . . 0.0 112.222 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.14 163.61 39.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.756 1.622 . . . . 0.0 111.8 166.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.08 158.46 43.59 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.329 1.052 . . . . 0.0 111.928 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 t -144.26 175.4 10.12 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.413 1.885 . . . . 0.0 111.202 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.61 69.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.144 1.377 . . . . 0.0 113.893 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -130.57 -9.69 4.06 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.184 1.394 . . . . 0.0 114.748 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -143.92 164.71 29.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.134 1.774 . . . . 0.0 111.821 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.4 t -140.24 141.96 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.657 1.583 . . . . 0.0 109.893 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.7 mtp -113.43 114.12 26.14 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.232 1.413 . . . . 0.0 111.104 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 t -121.46 153.05 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 109.964 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.73 107.25 0.67 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.824 1.249 . . . . 0.0 112.071 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.47 0.539 0 C-N-CA 124.863 1.265 . . . . 0.0 111.323 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.98 141.95 45.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.26 1.424 . . . . 0.0 112.628 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.14 146.57 49.89 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.182 1.393 . . . . 0.0 111.886 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.01 103.68 16.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.512 1.525 . . . . 0.0 111.506 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.42 98.41 9.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.998 0.904 . . . . 0.0 109.851 167.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.51 123.5 32.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.461 1.504 . . . . 0.0 109.483 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.45 171.81 14.92 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -152.11 150.32 29.77 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.015 1.726 . . . . 0.0 111.576 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.9 112.54 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.357 1.463 . . . . 0.0 108.506 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.34 -33.58 76.06 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.133 0.973 . . . . 0.0 111.514 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 132.38 -168.79 22.51 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 126.358 1.933 . . . . 0.0 111.09 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -136.05 153.62 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.678 1.191 . . . . 0.0 111.982 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 125.096 1.358 . . . . 0.0 110.682 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.623 0 CA-C-O 120.297 0.094 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.24 118.99 38.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.122 0.969 . . . . 0.0 110.902 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.7 118.92 23.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.881 1.672 . . . . 0.0 110.902 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.44 131.3 37.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.072 0.949 . . . . 0.0 111.32 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -130.52 167.91 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.695 1.198 . . . . 0.0 112.303 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.35 133.5 33.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.43 1.892 . . . . 0.0 110.52 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -139.16 150.3 45.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 123.002 1.382 . . . . 0.0 113.934 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.32 136.96 26.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.927 2.091 . . . . 0.0 109.708 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.24 105.15 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.09 1.356 . . . . 0.0 110.397 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -113.23 147.47 37.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.342 1.857 . . . . 0.0 110.533 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.84 140.57 53.26 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.65 -0.656 . . . . 0.0 111.293 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.71 -34.87 78.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.864 -1.148 . . . . 0.0 113.846 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.85 55.72 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.992 1.282 . . . . 0.0 115.426 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.4 t -145.91 144.53 30.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.783 1.233 . . . . 0.0 111.283 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -73.38 -11.83 60.61 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.69 159.46 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.139 0.976 . . . . 0.0 111.991 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.1 p -108.79 145.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.185 1.394 . . . . 0.0 110.898 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.88 -44.11 7.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.325 1.05 . . . . 0.0 111.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.5 157.57 38.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 112.423 170.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -161.21 128.21 4.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.882 1.273 . . . . 0.0 111.341 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -16.44 40.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 167.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.07 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.897 1.279 . . . . 0.0 111.827 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -70.98 -9.64 58.34 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.81 1.244 . . . . 0.0 113.606 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -104.27 -75.8 0.61 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.409 1.883 . . . . 0.0 110.909 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -168.1 148.98 4.63 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.637 2.375 . . . . 0.0 110.579 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.47 149.28 74.52 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.892 2.394 . . . . 0.0 112.9 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.9 tp -80.52 123.97 28.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.162 0.985 . . . . 0.0 109.806 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.99 131.69 56.02 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.696 1.198 . . . . 0.0 112.253 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.93 165.12 35.58 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.435 1.094 . . . . 0.0 112.657 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -96.42 143.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.125 1.37 . . . . 0.0 109.12 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.05 113.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.643 1.577 . . . . 0.0 111.608 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 62.91 0.63 Allowed Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.788 1.661 . . . . 0.0 113.114 -174.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.9 m -134.27 -49.61 0.79 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.691 1.596 . . . . 0.0 111.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.5 m120 58.89 29.37 18.77 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.232 1.813 . . . . 0.0 115.287 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -70.79 -19.88 62.65 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.25 166.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 112.751 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 pt -62.48 157.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.075 0.95 . . . . 0.0 113.389 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.22 80.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.655 1.182 . . . . 0.0 113.716 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.33 -46.59 93.57 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.033 0.825 . . . . 0.0 112.841 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -69.04 -34.91 75.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 111.772 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -56.02 -35.38 66.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.105 1.362 . . . . 0.0 113.449 171.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -80.37 3.24 21.84 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.1 -33.69 3.87 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.348 1.459 . . . . 0.0 113.392 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -58.47 -28.63 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.872 -1.143 . . . . 0.0 113.929 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -71.11 -23.06 62.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -94.84 -27.58 15.67 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.344 1.858 . . . . 0.0 112.478 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.25 118.9 4.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.717 2.007 . . . . 0.0 113.474 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -80.11 145.62 32.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 111.483 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.24 132.4 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.879 0.872 . . . . 0.0 111.195 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.53 6.49 86.74 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.194 1.237 . . . . 0.0 116.194 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -118.62 114.26 22.5 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.881 1.672 . . . . 0.0 111.403 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -62.4 140.67 58.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.076 0.551 . . . . 0.0 111.305 169.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -142.42 162.11 36.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.49 1.116 . . . . 0.0 112.447 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -130.46 112.78 13.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.778 1.631 . . . . 0.0 109.844 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.92 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.341 1.456 . . . . 0.0 109.82 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 t -73.9 120.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.055 0.942 . . . . 0.0 110.046 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.3 mm -105.15 142.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.401 1.481 . . . . 0.0 110.061 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.87 156.94 85.93 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.693 1.197 . . . . 0.0 112.789 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.27 -11.92 27.77 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.461 2.774 . . . . 0.0 114.97 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -106.58 -9.35 16.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.094 1.358 . . . . 0.0 113.809 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 . . . . . 0 N--CA 1.479 0.986 0 C-N-CA 124.983 1.313 . . . . 0.0 113.081 -176.633 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 p90 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.06 107.08 9.16 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.849 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -85.12 131.99 34.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.838 1.255 . . . . 0.0 111.014 171.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -84.76 100.51 11.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.504 1.522 . . . . 0.0 110.238 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.1 137.3 20.83 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 124.932 1.293 . . . . 0.0 109.569 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.79 157.73 51.4 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 0.0 112.638 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.69 72.99 2.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.338 1.055 . . . . 0.0 111.454 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.42 -50.14 0.92 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.434 1.894 . . . . 0.0 111.452 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -65.26 -13.7 58.99 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.75 19.7 5.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.405 1.482 . . . . 0.0 114.461 -166.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.82 -25.48 63.78 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.86 9.04 37.02 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.126 1.346 . . . . 0.0 115.613 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.67 129.67 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.156 1.783 . . . . 0.0 111.04 -173.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -77.03 58.03 1.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.573 1.949 . . . . 0.0 112.556 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -61.29 157.21 16.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.991 1.317 . . . . 0.0 113.098 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -153.25 155.28 36.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.761 0.824 . . . . 0.0 112.524 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -60.05 113.56 2.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.937 1.295 . . . . 0.0 111.037 174.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.74 4.8 24.47 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.921 1.528 . . . . 0.0 116.921 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.4 ptm -101.63 154.26 19.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.97 1.885 . . . . 0.0 113.034 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 p -72.17 94.86 1.59 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.15 1.78 . . . . 0.0 111.657 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -82.2 156.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.443 1.497 . . . . 0.0 111.618 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.86 143.38 49.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.585 1.554 . . . . 0.0 110.694 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.05 99.14 0.36 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.772 1.177 . . . . 0.0 112.17 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -67.52 143.54 56.1 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.114 -0.639 . . . . 0.0 111.195 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -123.1 154.35 38.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.867 1.667 . . . . 0.0 111.457 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.44 -20.83 65.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.552 1.541 . . . . 0.0 113.164 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.67 19.88 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.097 2.159 . . . . 0.0 114.22 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.7 m120 52.52 47.97 23.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.391 2.276 . . . . 0.0 113.04 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -140.6 172.28 12.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.959 1.703 . . . . 0.0 112.108 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.4 m -143.48 118.47 10.02 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.94 1.296 . . . . 0.0 111.012 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.82 162.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.727 0.811 . . . . 0.0 111.259 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -134.06 128.36 34.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.572 1.549 . . . . 0.0 111.147 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.28 -175.65 5.54 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.34 1.456 . . . . 0.0 112.564 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.15 136.84 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 110.034 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.1 mt -68.11 133.08 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.396 1.478 . . . . 0.0 111.005 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -108.22 -37.99 5.87 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.146 1.379 . . . . 0.0 112.886 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.55 157.89 42.83 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.399 1.08 . . . . 0.0 111.482 166.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.24 143.44 28.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.241 -0.912 . . . . 0.0 113.204 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 70.3 m -141.04 168.69 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.876 2.07 . . . . 0.0 110.584 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.15 -25.87 67.17 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 121.203 -0.935 . . . . 0.0 113.211 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -81.18 -60.18 2.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.952 2.101 . . . . 0.0 112.988 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -140.65 168.88 18.75 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.288 2.235 . . . . 0.0 111.781 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.69 132.96 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.54 1.536 . . . . 0.0 111.553 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.7 mtp -101.82 115.25 30.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.185 1.794 . . . . 0.0 110.803 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.57 136.41 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.738 1.615 . . . . 0.0 110.872 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.94 111.81 5.91 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.344 0.658 . . . . 0.0 111.484 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 126.778 2.031 . . . . 0.0 111.467 -174.61 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.2 p -65.27 146.64 54.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.124 1.369 . . . . 0.0 113.039 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.17 131.57 44.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.687 -170.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.42 98.97 12.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.149 0.98 . . . . 0.0 111.652 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.23 103.14 10.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.758 0.79 . . . . 0.0 110.328 166.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -94.68 124.18 38.56 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.445 1.898 . . . . 0.0 109.336 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -148.82 170.65 17.78 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -154.33 147.43 24.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.98 1.712 . . . . 0.0 112.14 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 9.8 t -83.79 108.09 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.819 1.248 . . . . 0.0 108.727 163.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.1 mt -65.67 -39.48 91.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.888 -0.508 . . . . 0.0 111.492 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.76 -179.22 18.45 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.579 1.561 . . . . 0.0 113.496 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -96.57 147.68 23.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.968 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 . . . . . 0 N--CA 1.477 0.925 0 C-N-CA 124.979 1.312 . . . . 0.0 112.438 172.993 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.177 0.037 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 103.94 11.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.917 0.887 . . . . 0.0 110.893 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.53 120.81 18.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.539 1.536 . . . . 0.0 110.573 168.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.18 124.2 47.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.2 pt -131.35 163.62 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.661 1.184 . . . . 0.0 112.289 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -136.79 138.66 41.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.601 1.96 . . . . 0.0 109.831 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.77 151.93 44.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.066 1.346 . . . . 0.0 114.272 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -146.87 120.65 9.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.615 2.366 . . . . 0.0 110.315 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -99.94 110.28 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.858 1.663 . . . . 0.0 110.429 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 ttm105 -113.78 144.84 42.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.297 1.839 . . . . 0.0 110.694 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.79 117.33 11.25 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -61.84 105.33 0.55 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.571 0.748 . . . . 0.0 110.667 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.01 23.64 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 126.173 1.844 . . . . 0.0 115.169 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -137.05 165.84 25.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.332 1.566 . . . . 0.0 113.271 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.1 p -89.5 -13.47 37.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.737 2.015 . . . . 0.0 114.755 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.23 177.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 113.661 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.85 145.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.209 1.404 . . . . 0.0 110.121 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mp -106.57 -53.45 2.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.649 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.29 150.22 35.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.406 1.483 . . . . 0.0 110.381 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.6 p -163.01 169.61 19.31 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.158 -0.964 . . . . 0.0 111.694 173.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -122.72 -12.74 8.04 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -36.8 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 124.281 1.032 . . . . 0.0 112.217 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -73.1 -5.7 40.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.591 1.156 . . . . 0.0 113.601 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -117.59 -87.97 0.61 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.902 2.081 . . . . 0.0 110.367 -171.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -153.38 154.09 30.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 127.419 2.288 . . . . 0.0 111.272 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.35 150.69 86.89 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.596 2.864 . . . . 0.0 113.269 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -87.6 123.7 32.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.432 1.493 . . . . 0.0 109.774 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.15 134.58 50.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 111.533 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -150.12 172.58 15.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.499 1.119 . . . . 0.0 112.918 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.21 151.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.339 1.455 . . . . 0.0 109.195 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.85 109.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.509 1.124 . . . . 0.0 111.009 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.08 27.06 6.38 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.526 1.37 . . . . 0.0 116.526 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.3 m -97.06 -24.1 15.94 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 119.39 1.595 . . . . 0.0 114.355 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.3 t30 45.73 43.13 9.37 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.915 2.086 . . . . 0.0 115.092 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -71.77 -31.14 66.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.4 1.88 . . . . 0.0 114.155 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -72.41 166.87 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.866 1.267 . . . . 0.0 111.517 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 pt -63.15 146.36 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 0.0 111.413 172.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.9 75.76 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.07 -31.06 67.94 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.005 0.812 . . . . 0.0 113.913 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.25 -29.66 24.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.836 1.255 . . . . 0.0 112.307 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.09 -38.23 82.32 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.01 -1.056 . . . . 0.0 112.021 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -68.03 0.24 3.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.835 1.254 . . . . 0.0 114.312 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.39 -41.82 3.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.617 1.567 . . . . 0.0 113.167 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.71 -29.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.64 -10.39 55.85 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -118.96 -17.95 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.925 1.69 . . . . 0.0 114.549 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.95 141.62 49.43 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.309 0.959 . . . . 0.0 112.345 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -90.28 158.22 17.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.719 1.207 . . . . 0.0 111.779 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.03 129.75 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.179 0.992 . . . . 0.0 111.307 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.68 3.88 74.21 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.831 1.205 . . . . 0.0 115.692 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.63 111.95 24.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.181 1.491 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -55.93 139.66 45.48 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.766 0.826 . . . . 0.0 111.723 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -137.11 149.15 47.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.57 1.548 . . . . 0.0 110.275 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -134.71 104.74 6.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.449 1.099 . . . . 0.0 110.348 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.19 118.66 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.083 1.353 . . . . 0.0 110.359 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.0 t -75.83 121.32 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 109.59 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.55 144.46 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.953 1.701 . . . . 0.0 109.822 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.02 92.83 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.814 1.246 . . . . 0.0 112.55 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.81 -33.9 41.92 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.538 2.159 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -31.64 72.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.923 0.889 . . . . 0.0 113.265 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 125.322 1.449 . . . . 0.0 113.177 177.559 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.66 147.23 30.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.149 2.58 . . . . 0.0 109.563 166.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -145.53 117.45 8.24 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.172 1.389 . . . . 0.0 110.416 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.11 118.45 15.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.955 0.902 . . . . 0.0 111.133 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.56 158.73 69.02 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 127.243 2.217 . . . . 0.0 110.978 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 149.3 64.43 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.154 1.902 . . . . 0.0 110.958 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -62.26 -20.31 64.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.533 0.733 . . . . 0.0 112.958 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -52.07 -32.19 33.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.997 1.719 . . . . 0.0 113.72 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -64.76 -18.16 64.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.517 1.127 . . . . 0.0 113.344 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.88 18.32 6.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.045 2.138 . . . . 0.0 112.915 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -53.34 108.61 0.35 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.61 1.564 . . . . 0.0 112.164 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.66 -5.11 34.82 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.826 1.679 . . . . 0.0 115.434 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mt -101.5 130.98 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.44 1.496 . . . . 0.0 110.375 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.76 89.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.489 1.116 . . . . 0.0 111.468 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.5 158.28 36.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.279 1.032 . . . . 0.0 111.777 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -155.33 145.81 22.05 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.732 1.213 . . . . 0.0 111.288 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -73.21 83.02 1.35 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.165 0.986 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.77 46.25 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.362 1.458 . . . . 0.0 113.87 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ppp? -129.01 148.7 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.199 1.4 . . . . 0.0 111.109 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 p -76.68 108.35 9.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.872 1.669 . . . . 0.0 111.479 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.1 156.79 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.668 1.587 . . . . 0.0 110.679 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -121.24 154.63 36.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.662 1.185 . . . . 0.0 111.068 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.68 106.23 0.41 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.344 0.973 . . . . 0.0 113.217 -173.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -74.55 114.05 12.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.462 1.105 . . . . 0.0 111.932 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -84.95 159.2 20.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.166 1.386 . . . . 0.0 112.122 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.46 -18.46 63.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.225 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.19 10.71 0.28 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 113.897 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 55.41 46.35 23.47 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.155 2.182 . . . . 0.0 111.956 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -141.22 171.13 14.48 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.795 2.038 . . . . 0.0 111.167 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 m -140.74 108.06 5.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.497 1.119 . . . . 0.0 110.697 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.42 165.88 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.832 -0.543 . . . . 0.0 111.29 176.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -129.16 131.11 47.11 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.971 1.308 . . . . 0.0 110.592 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.36 177.91 9.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.803 1.241 . . . . 0.0 113.59 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.89 135.59 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.628 1.571 . . . . 0.0 109.903 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.93 120.94 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.313 1.045 . . . . 0.0 110.22 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -87.69 -38.07 16.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.878 1.271 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.54 152.74 37.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.932 1.293 . . . . 0.0 111.63 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -146.78 142.56 27.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.094 0.957 . . . . 0.0 112.601 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.0 t -153.51 169.42 23.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.137 2.175 . . . . 0.0 110.125 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.71 -28.29 68.32 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.123 0.969 . . . . 0.0 113.408 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.6 p -79.56 -60.66 2.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.135 1.774 . . . . 0.0 111.852 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -134.16 156.94 47.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.371 1.868 . . . . 0.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.6 142.0 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.622 1.969 . . . . 0.0 108.566 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.9 mtp -121.94 98.87 6.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.997 1.319 . . . . 0.0 110.161 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.62 148.0 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.642 1.177 . . . . 0.0 109.849 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -62.99 110.4 1.78 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.36 0.664 . . . . 0.0 111.669 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.181 1.393 . . . . 0.0 109.422 171.222 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.162 0.506 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.01 146.6 37.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.39 1.876 . . . . 0.0 113.13 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.9 mt -128.36 140.32 51.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.685 1.594 . . . . 0.0 110.941 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.88 94.31 5.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.023 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.48 92.68 3.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.503 1.121 . . . . 0.0 109.697 167.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 -75.48 139.46 42.24 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.86 171.06 17.82 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -150.23 146.2 26.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.028 1.331 . . . . 0.0 111.36 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.21 104.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.536 1.134 . . . . 0.0 109.119 167.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.71 -24.52 58.77 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 112.338 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.29 -167.43 25.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.047 1.308 . . . . 0.0 113.907 171.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.43 145.96 49.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 110.626 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 113.132 175.825 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.3 104.89 7.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.253 1.021 . . . . 0.0 109.63 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.08 141.21 37.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.657 1.183 . . . . 0.0 110.671 169.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.25 133.49 47.54 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.391 1.476 . . . . 0.0 110.599 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 pt -134.35 163.98 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.869 1.268 . . . . 0.0 111.544 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -137.84 135.81 36.57 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.168 1.387 . . . . 0.0 109.699 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -134.09 158.99 42.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 123.067 1.413 . . . . 0.0 114.368 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -141.04 120.83 13.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.961 2.904 . . . . 0.0 108.259 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -100.71 105.69 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.446 1.117 . . . . 0.0 109.93 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 ttp85 -118.57 153.16 34.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.202 2.201 . . . . 0.0 109.717 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.5 146.33 50.32 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.316 -0.865 . . . . 0.0 110.836 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -70.52 -33.11 70.81 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.881 -1.137 . . . . 0.0 112.434 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.45 -35.67 7.84 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.352 0.977 . . . . 0.0 115.017 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -116.92 151.07 37.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.319 1.448 . . . . 0.0 112.604 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 t -73.1 -7.52 51.71 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.95 151.11 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 120.892 -1.13 . . . . 0.0 112.372 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.43 126.97 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.226 1.41 . . . . 0.0 109.843 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -84.58 -42.89 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.777 0.831 . . . . 0.0 110.818 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -158.49 163.4 37.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.3 1.84 . . . . 0.0 110.767 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -166.65 150.57 7.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.071 1.348 . . . . 0.0 112.131 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -124.55 4.26 8.29 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -47.98 -64.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.234 1.414 . . . . 0.0 112.079 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 t -79.9 -23.67 41.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.256 1.023 . . . . 0.0 113.368 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -69.64 -71.61 0.22 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.884 1.674 . . . . 0.0 112.056 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -165.63 140.0 3.88 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.099 1.759 . . . . 0.0 110.876 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.41 152.48 75.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.666 2.244 . . . . 0.0 112.698 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.8 tp -83.07 97.68 8.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.222 1.809 . . . . 0.0 110.294 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -74.08 129.85 38.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.368 1.467 . . . . 0.0 111.923 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -149.43 176.49 10.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.967 1.307 . . . . 0.0 112.846 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.0 mm -112.43 134.87 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.469 1.508 . . . . 0.0 109.385 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.0 mm -50.09 117.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.332 1.453 . . . . 0.0 110.956 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.26 71.6 1.12 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.014 1.293 . . . . 0.0 112.044 -169.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -134.6 -43.9 0.75 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.049 1.34 . . . . 0.0 113.344 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 54.09 21.14 2.82 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 126.721 2.008 . . . . 0.0 115.097 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 pt -71.66 165.75 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 112.469 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.29 142.65 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.729 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.8 82.4 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.4 -28.72 69.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.48 -0.763 . . . . 0.0 113.992 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 tp -87.15 -35.39 18.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.044 1.338 . . . . 0.0 111.898 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.36 -46.42 69.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.718 1.207 . . . . 0.0 111.415 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -77.91 13.63 1.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.011 1.324 . . . . 0.0 114.143 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.59 -39.92 2.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.714 1.606 . . . . 0.0 113.616 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.22 -29.1 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -67.26 -14.32 62.81 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -118.69 -9.5 10.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.416 1.486 . . . . 0.0 114.112 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.85 8.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.212 1.405 . . . . 0.0 111.61 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -62.47 145.73 53.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.705 0.802 . . . . 0.0 112.117 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.75 133.41 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.664 0.786 . . . . 0.0 110.691 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 10.39 56.55 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 115.709 1.044 . . . . 0.0 115.709 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.91 128.13 54.13 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.448 1.499 . . . . 0.0 111.281 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -57.93 140.91 51.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.021 0.928 . . . . 0.0 112.243 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -134.12 141.51 47.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.795 2.038 . . . . 0.0 109.864 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.17 106.75 6.9 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.55 113.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.757 1.223 . . . . 0.0 111.711 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.96 123.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 109.554 173.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.4 mt -128.73 135.71 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.92 1.288 . . . . 0.0 109.489 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.6 161.46 59.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 125.703 1.601 . . . . 0.0 112.623 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 42.41 0.76 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 125.18 3.92 . . . . 0.0 113.872 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.42 -35.77 1.94 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.877 2.071 . . . . 0.0 113.057 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 . . . . . 0 N--CA 1.477 0.89 0 C-N-CA 124.317 1.047 . . . . 0.0 113.617 174.658 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.345 0.593 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.53 166.75 24.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.674 1.589 . . . . 0.0 111.903 172.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -144.86 131.14 19.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.502 1.121 . . . . 0.0 110.983 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -70.04 128.57 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.794 0.838 . . . . 0.0 110.923 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.05 137.73 18.55 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.299 1.84 . . . . 0.0 109.903 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.73 172.66 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.017 2.478 . . . . 0.0 113.122 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -69.5 70.26 0.28 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.471 1.908 . . . . 0.0 111.901 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -129.19 -64.39 0.91 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.591 1.956 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -64.12 -16.39 61.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.906 1.283 . . . . 0.0 113.653 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.407 ' CG ' HD11 ' A' ' 94' ' ' LEU . 42.5 m-85 -131.69 13.88 4.9 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.968 1.707 . . . . 0.0 113.422 -172.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.61 -28.59 65.76 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.699 -1.251 . . . . 0.0 113.435 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.89 12.55 56.21 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.844 1.688 . . . . 0.0 115.047 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.75 115.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.509 1.524 . . . . 0.0 110.257 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.3 108.48 4.22 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.297 -0.877 . . . . 0.0 111.629 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.407 HD11 ' CG ' ' A' ' 89' ' ' PHE . 80.0 mt -101.63 156.99 17.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.368 1.467 . . . . 0.0 111.814 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.17 145.23 17.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.019 1.728 . . . . 0.0 109.863 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -51.87 128.35 23.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.772 0.829 . . . . 0.0 111.943 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 56.12 3.47 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.27 0.938 . . . . 0.0 114.327 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.1 ptp -132.27 172.45 12.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.116 1.766 . . . . 0.0 110.931 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 t -101.94 103.91 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.022 0.929 . . . . 0.0 110.452 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.28 154.44 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.153 1.381 . . . . 0.0 110.331 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -120.27 153.58 36.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.49 1.116 . . . . 0.0 111.944 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 97.52 0.23 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.73 1.157 . . . . 0.0 112.742 -175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.71 142.67 58.35 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.874 -0.78 . . . . 0.0 111.38 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.0 t -126.09 157.12 38.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.909 1.683 . . . . 0.0 111.607 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.95 -15.15 61.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.071 1.748 . . . . 0.0 113.509 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -76.41 15.63 0.58 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.609 1.963 . . . . 0.0 113.721 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.6 m120 56.73 39.95 29.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.878 2.071 . . . . 0.0 113.136 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -133.67 172.56 12.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.686 1.995 . . . . 0.0 111.409 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.6 m -142.44 114.73 8.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.351 1.46 . . . . 0.0 110.427 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -72.57 163.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.015 0.526 . . . . 0.0 111.166 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -133.49 132.95 41.62 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.046 1.338 . . . . 0.0 110.901 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.96 175.33 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.613 1.565 . . . . 0.0 112.814 -166.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.438 ' H ' ' HB3' ' A' ' 125' ' ' ASP . 4.8 mp -121.46 142.76 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.705 1.602 . . . . 0.0 110.625 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.76 113.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.575 1.15 . . . . 0.0 109.856 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.96 -30.41 15.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.915 1.286 . . . . 0.0 113.429 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -155.38 155.55 33.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.947 1.699 . . . . 0.0 110.581 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -147.26 147.72 30.71 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.21 0.914 . . . . 0.0 113.253 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.0 t -153.17 171.91 17.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.737 2.015 . . . . 0.0 110.975 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.31 -21.98 61.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.63 1.172 . . . . 0.0 113.558 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.4 p -82.55 -63.6 1.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 111.724 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -135.22 165.17 26.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.325 2.25 . . . . 0.0 111.339 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.48 154.13 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.179 1.792 . . . . 0.0 109.798 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 80.2 mtp -125.77 103.98 8.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.159 1.384 . . . . 0.0 110.421 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -99.54 141.62 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.134 1.373 . . . . 0.0 109.627 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 113' ' ' ILE . 13.9 t70 -62.08 140.04 58.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.946 1.298 . . . . 0.0 111.436 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 124.686 1.194 . . . . 0.0 111.946 175.536 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -63.34 139.47 58.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.489 1.516 . . . . 0.0 112.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.4 148.04 46.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.279 1.432 . . . . 0.0 111.15 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -98.49 102.6 14.39 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.991 2.117 . . . . 0.0 110.262 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -80.12 95.29 6.18 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.607 0.717 . . . . 0.0 109.734 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -86.55 112.7 21.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.689 1.596 . . . . 0.0 108.776 171.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -136.12 170.31 16.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.833 0.853 . . . . 0.0 112.865 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -147.36 137.61 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.639 1.176 . . . . 0.0 111.005 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.7 t -87.45 94.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.03 -28.63 69.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.779 1.231 . . . . 0.0 112.686 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.68 177.87 15.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.968 1.746 . . . . 0.0 112.582 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -112.29 156.06 23.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.779 0.832 . . . . 0.0 111.688 169.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 125.637 1.575 . . . . 0.0 111.332 178.957 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.46 ' N ' HE21 ' A' ' 11' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 111.152 0.056 . . . . 0.0 111.152 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.94 115.03 22.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.824 0.85 . . . . 0.0 110.127 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.11 114.68 11.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.999 1.32 . . . . 0.0 109.908 162.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.48 119.84 33.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.798 1.239 . . . . 0.0 109.111 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.94 163.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.207 1.003 . . . . 0.0 111.859 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -143.1 140.22 30.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.565 1.546 . . . . 0.0 110.635 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -136.74 158.08 45.27 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.385 1.474 . . . . 0.0 114.055 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -144.16 107.92 4.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.643 1.977 . . . . 0.0 110.614 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.68 117.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 0.0 111.076 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -131.31 156.48 45.4 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.899 1.68 . . . . 0.0 111.104 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.3 146.46 40.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.297 -0.877 . . . . 0.0 111.055 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.16 133.51 48.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.075 0.95 . . . . 0.0 110.927 169.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.49 -57.13 3.76 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.991 1.281 . . . . 0.0 114.177 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -62.87 147.55 49.87 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.497 1.119 . . . . 0.0 112.598 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.5 m -83.44 -7.74 59.5 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.25 161.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.0 0.818 . . . . 0.0 111.876 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.71 124.75 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.351 1.46 . . . . 0.0 109.504 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 mt -71.7 -53.57 13.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.012 0.525 . . . . 0.0 112.016 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -157.88 162.09 38.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.761 1.224 . . . . 0.0 111.686 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 p -154.63 130.25 9.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.945 1.298 . . . . 0.0 112.466 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.64 -2.02 19.06 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.7 mm -51.67 -52.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.987 1.715 . . . . 0.0 111.884 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 m -82.6 -6.27 59.26 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 mmpp? -92.17 -172.07 3.02 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.56 1.944 . . . . 0.0 110.657 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.5 137.2 97.06 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 121.469 -0.77 . . . . 0.0 110.799 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.81 163.52 35.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.221 2.614 . . . . 0.0 113.204 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -92.91 110.24 21.7 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.76 1.224 . . . . 0.0 110.754 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.85 131.16 35.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.766 1.626 . . . . 0.0 111.499 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -143.06 157.04 44.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.256 1.022 . . . . 0.0 111.722 164.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.59 148.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.024 -1.047 . . . . 0.0 109.711 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.0 mm -48.19 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.316 1.446 . . . . 0.0 111.335 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.03 11.48 49.33 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -69.44 -35.0 75.25 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.926 1.863 . . . . 0.0 113.557 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.3 m120 57.72 37.74 27.33 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.527 1.931 . . . . 0.0 115.281 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -79.25 -23.65 43.52 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -72.76 167.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.367 1.067 . . . . 0.0 112.84 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.3 pt -59.11 136.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.95 0.9 . . . . 0.0 111.202 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.24 70.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.287 -0.883 . . . . 0.0 112.606 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.94 -13.97 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.111 173.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.94 -36.68 6.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.349 1.86 . . . . 0.0 111.595 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.28 -32.79 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -4.01 0.86 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 174.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.79 -29.9 4.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.387 1.875 . . . . 0.0 113.965 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.41 -24.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.849 1.204 . . . . 0.0 113.373 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -66.4 -13.85 61.29 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.34 -21.24 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.755 1.622 . . . . 0.0 113.859 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.29 111.58 2.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.662 1.185 . . . . 0.0 112.15 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.67 159.69 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.116 0.96 . . . . 0.0 113.2 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -56.64 131.99 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.194 1.398 . . . . 0.0 111.617 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.93 8.53 68.95 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.967 1.27 . . . . 0.0 115.064 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.53 112.7 24.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.032 1.333 . . . . 0.0 111.471 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -59.0 134.52 57.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.428 0.691 . . . . 0.0 111.363 171.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.61 112.97 12.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.121 1.768 . . . . 0.0 110.032 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.94 92.73 4.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.927 1.291 . . . . 0.0 110.508 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.06 165.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.592 0.757 . . . . 0.0 111.485 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.86 130.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.331 1.452 . . . . 0.0 108.461 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.4 mt -127.78 130.42 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 126.615 1.966 . . . . 0.0 109.135 -165.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.32 147.25 82.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.608 0.763 . . . . 0.0 111.264 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.22 -43.16 9.05 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -166.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.28 -21.86 66.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.822 1.649 . . . . 0.0 114.068 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.698 1.199 . . . . 0.0 112.508 175.572 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.34 143.96 50.72 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.069 -1.02 . . . . 0.0 110.635 174.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -126.39 124.65 40.68 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.666 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -83.89 78.34 9.74 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.366 1.079 . . . . 0.0 111.186 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.54 136.49 59.73 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.097 1.759 . . . . 0.0 109.903 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 159.44 52.91 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.71 2.273 . . . . 0.0 112.701 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -17.8 47.7 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.25 -31.26 63.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.902 1.681 . . . . 0.0 113.575 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -81.09 -6.16 58.49 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.155 0.982 . . . . 0.0 113.636 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -133.41 45.74 2.66 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.009 2.124 . . . . 0.0 110.996 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.66 111.82 19.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.54 1.136 . . . . 0.0 111.6 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.85 55.46 4.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.457 1.027 . . . . 0.0 114.319 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.428 HD13 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -137.46 -179.6 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.731 2.412 . . . . 0.0 111.786 -178.076 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -131.99 88.3 2.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.588 1.555 . . . . 0.0 110.601 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.428 ' HG ' HD13 ' A' ' 92' ' ' ILE . 26.0 mt -75.24 151.69 38.38 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.454 0.702 . . . . 0.0 111.398 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.84 135.09 19.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.217 1.007 . . . . 0.0 111.388 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.56 102.74 0.35 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.481 1.513 . . . . 0.0 110.563 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.97 21.15 5.75 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.994 1.283 . . . . 0.0 115.797 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -112.92 158.01 20.74 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.26 1.53 . . . . 0.0 112.555 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 p -82.46 97.8 8.58 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.113 1.365 . . . . 0.0 111.771 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 p -83.7 162.2 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.962 0.905 . . . . 0.0 111.015 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -123.32 152.89 40.98 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.276 1.431 . . . . 0.0 111.37 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.42 108.08 0.47 Allowed Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.369 0.985 . . . . 0.0 112.692 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -66.71 145.46 55.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.157 -0.614 . . . . 0.0 111.359 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -125.14 156.45 38.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.109 1.764 . . . . 0.0 111.533 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.16 -16.02 49.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.202 1.801 . . . . 0.0 114.294 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -74.68 12.82 0.73 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.428 1.891 . . . . 0.0 113.89 173.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 m120 54.27 48.66 20.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.942 2.097 . . . . 0.0 112.221 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -140.12 173.81 11.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.191 1.797 . . . . 0.0 111.792 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.4 m -145.67 110.96 5.32 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.05 1.34 . . . . 0.0 110.529 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.07 167.36 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.74 -0.6 . . . . 0.0 111.43 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -121.54 139.45 53.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.641 1.576 . . . . 0.0 110.725 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.8 173.96 14.65 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.465 1.106 . . . . 0.0 112.65 -168.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.85 128.53 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.0 mm -63.22 125.48 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.413 1.485 . . . . 0.0 110.279 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -111.84 -34.93 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.647 1.179 . . . . 0.0 113.041 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -157.62 167.5 29.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.491 1.116 . . . . 0.0 112.039 165.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.72 140.38 33.12 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.201 1.001 . . . . 0.0 112.168 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.9 m -111.76 174.07 6.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.152 2.181 . . . . 0.0 110.739 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.02 68.58 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 70.9 p -130.19 -7.57 4.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.788 1.635 . . . . 0.0 114.809 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -145.0 165.37 28.36 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.256 1.822 . . . . 0.0 111.278 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.69 144.42 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.706 1.603 . . . . 0.0 109.712 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 37.7 mmm -116.14 109.5 17.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 110.051 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.31 148.1 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.35 1.46 . . . . 0.0 109.933 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 120.52 13.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.241 1.417 . . . . 0.0 111.867 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 125.886 1.674 . . . . 0.0 111.873 -179.746 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.87 144.21 43.49 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.185 1.394 . . . . 0.0 111.3 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.2 143.95 46.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.065 1.346 . . . . 0.0 111.262 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.75 144.38 37.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.659 0.784 . . . . 0.0 111.357 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -128.79 92.13 3.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.074 1.75 . . . . 0.0 108.652 170.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -79.01 110.37 14.17 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.901 1.28 . . . . 0.0 108.802 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -131.88 166.97 20.42 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.349 0.66 . . . . 0.0 112.773 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -149.92 142.74 24.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.658 1.183 . . . . 0.0 111.673 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.14 106.69 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.997 1.319 . . . . 0.0 108.826 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.61 -38.19 77.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 111.63 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.55 158.88 7.73 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.296 1.427 . . . . 0.0 114.749 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -82.9 125.38 31.3 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.803 1.641 . . . . 0.0 111.506 -176.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 . . . . . 0 N--CA 1.476 0.84 0 C-N-CA 125.276 1.43 . . . . 0.0 111.225 179.888 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.19 108.44 6.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.093 0.557 . . . . 0.0 110.602 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.27 120.05 14.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.265 1.826 . . . . 0.0 110.456 165.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.28 113.86 27.69 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.244 2.218 . . . . 0.0 108.952 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 159.35 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 112.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -135.09 129.67 34.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.885 1.274 . . . . 0.0 110.38 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -135.68 155.0 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.607 1.163 . . . . 0.0 113.034 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -140.17 166.09 25.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.097 1.759 . . . . 0.0 111.424 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.37 101.2 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.84 1.256 . . . . 0.0 111.194 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -90.51 154.03 19.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 110.219 170.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -61.54 135.4 57.64 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.894 161.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -71.21 91.72 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.23 -0.919 . . . . 0.0 110.776 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.93 -68.91 0.54 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.185 1.85 . . . . 0.0 112.302 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -67.11 158.67 30.58 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.7 m -79.02 -13.09 59.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.46 151.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.074 0.852 . . . . 0.0 112.063 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.6 114.91 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.364 1.466 . . . . 0.0 109.182 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.0 mt -68.29 -48.57 64.62 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.619 1.168 . . . . 0.0 111.66 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -154.02 158.19 40.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.638 1.575 . . . . 0.0 110.362 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 p -151.2 125.68 9.49 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.472 1.109 . . . . 0.0 111.52 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -90.13 -30.89 17.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.29 0.636 . . . . 0.0 111.912 170.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.85 -50.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.613 1.565 . . . . 0.0 111.815 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -70.53 -5.54 29.72 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.21 1.404 . . . . 0.0 114.548 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -100.85 -83.61 0.44 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.772 1.629 . . . . 0.0 109.702 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.71 156.78 31.09 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 127.45 2.3 . . . . 0.0 110.451 171.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.82 141.35 78.01 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.679 2.253 . . . . 0.0 111.733 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.82 136.83 43.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.959 1.303 . . . . 0.0 109.971 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.64 119.71 34.52 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.05 1.34 . . . . 0.0 111.208 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -148.49 172.68 14.1 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -109.99 142.85 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.302 1.441 . . . . 0.0 109.839 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mm -47.32 115.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 111.864 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.52 64.76 1.49 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.171 1.367 . . . . 0.0 113.425 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -115.67 -22.37 9.21 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.044 1.338 . . . . 0.0 114.529 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m120 52.05 28.57 5.45 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 127.489 2.316 . . . . 0.0 116.107 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -86.75 -32.14 20.56 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 pt -81.26 170.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.975 1.31 . . . . 0.0 112.168 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.1 pt -59.57 140.01 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.189 0.996 . . . . 0.0 111.723 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.39 78.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -28.75 70.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.115 0.864 . . . . 0.0 114.295 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.19 -38.7 14.08 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.676 1.19 . . . . 0.0 111.588 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -53.42 -46.28 69.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.229 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.04 1.72 3.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.948 1.699 . . . . 0.0 114.667 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.55 -35.72 5.15 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.72 1.608 . . . . 0.0 113.498 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.74 -41.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.339 1.427 . . . . 0.0 112.253 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.29 -10.46 32.62 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -112.33 -9.43 13.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.205 1.802 . . . . 0.0 113.927 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.86 145.87 28.4 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.818 1.247 . . . . 0.0 111.842 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -98.37 157.01 16.46 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.925 1.29 . . . . 0.0 111.566 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 tt -57.39 129.36 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 111.829 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.14 78.88 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.035 1.302 . . . . 0.0 115.368 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.28 114.13 20.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.09 1.445 . . . . 0.0 111.65 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -56.0 142.06 37.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.536 1.135 . . . . 0.0 112.717 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -137.44 116.46 12.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.015 1.726 . . . . 0.0 110.728 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -101.4 107.05 18.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.012 1.325 . . . . 0.0 110.73 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -115.9 110.3 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.564 1.146 . . . . 0.0 110.907 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 t -73.89 130.19 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.73 141.64 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.157 1.383 . . . . 0.0 109.764 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.68 155.08 87.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.905 1.282 . . . . 0.0 112.789 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.62 -18.6 64.67 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.362 2.708 . . . . 0.0 114.457 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.49 -6.56 20.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.366 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 . . . . . 0 N--CA 1.477 0.91 0 C-N-CA 125.19 1.396 . . . . 0.0 113.224 179.225 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.546 0.806 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.7 mt -142.16 160.67 39.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.566 1.946 . . . . 0.0 112.974 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.39 133.23 11.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.297 1.439 . . . . 0.0 111.427 162.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -78.29 99.51 6.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.443 1.097 . . . . 0.0 110.407 167.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.67 137.1 21.46 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.714 1.606 . . . . 0.0 109.425 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.44 155.92 50.37 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 112.922 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -75.71 60.75 1.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.171 1.788 . . . . 0.0 112.24 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -122.38 -54.11 1.89 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.302 1.841 . . . . 0.0 111.038 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -63.78 -17.18 62.81 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.464 1.105 . . . . 0.0 113.453 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -126.59 12.05 7.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.822 1.649 . . . . 0.0 113.875 -170.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.417 1.087 . . . . 0.0 113.542 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.4 12.87 47.78 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.19 1.852 . . . . 0.0 115.355 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.6 mt -122.1 126.66 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.251 1.525 . . . . 0.0 110.725 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.93 78.38 0.64 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.22 1.408 . . . . 0.0 112.649 173.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.7 156.2 24.3 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.74 162.77 40.48 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.256 1.822 . . . . 0.0 110.028 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -71.32 136.05 47.66 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.698 -1.251 . . . . 0.0 110.816 166.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.68 18.15 76.05 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.5 ptm -100.53 148.64 24.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.944 1.372 . . . . 0.0 111.776 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -68.49 143.43 54.99 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.059 0.944 . . . . 0.0 111.765 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.37 163.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.757 1.623 . . . . 0.0 111.278 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.25 158.0 35.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.399 1.88 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.88 103.7 0.25 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 123.774 0.702 . . . . 0.0 113.229 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.38 111.03 8.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.323 1.049 . . . . 0.0 111.5 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 t -81.2 154.44 26.66 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.6 1.16 . . . . 0.0 111.744 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.86 -13.57 59.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.774 1.229 . . . . 0.0 113.515 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.06 18.85 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.165 1.786 . . . . 0.0 113.841 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 55.3 42.94 29.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.386 2.274 . . . . 0.0 113.037 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -143.02 169.75 16.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.794 1.638 . . . . 0.0 112.043 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.8 m -141.41 107.11 5.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 110.592 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.79 167.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.992 -0.442 . . . . 0.0 111.18 174.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.08 135.88 37.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.721 1.208 . . . . 0.0 111.587 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.41 -167.97 1.89 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.816 1.246 . . . . 0.0 112.732 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.55 140.29 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.296 1.838 . . . . 0.0 110.528 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.98 124.61 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.418 1.087 . . . . 0.0 111.317 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -91.57 -35.96 13.96 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.722 1.609 . . . . 0.0 113.352 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -154.8 160.21 41.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.223 1.409 . . . . 0.0 110.879 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -148.35 150.08 32.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.171 0.988 . . . . 0.0 113.038 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -143.95 175.69 9.84 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.179 1.791 . . . . 0.0 110.91 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.31 -20.77 58.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.51 1.124 . . . . 0.0 113.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -86.75 -57.49 2.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.68 1.592 . . . . 0.0 111.967 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -138.17 169.95 16.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.4 2.28 . . . . 0.0 111.308 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.45 148.28 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.496 1.518 . . . . 0.0 110.934 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.5 mtp -112.57 92.38 4.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.708 1.603 . . . . 0.0 110.436 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.7 143.37 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.526 1.53 . . . . 0.0 109.808 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -63.87 125.3 23.94 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.876 170.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 124.378 1.071 . . . . 0.0 110.132 173.097 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 p -65.6 144.54 56.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.198 1.399 . . . . 0.0 112.533 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.8 mt -126.84 142.76 51.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.125 1.37 . . . . 0.0 111.809 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.97 95.11 9.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.537 1.135 . . . . 0.0 111.292 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.76 88.82 5.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.261 1.029 . . . . 0.0 110.796 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.77 124.23 28.88 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.016 1.326 . . . . 0.0 109.45 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.57 171.76 13.73 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -150.94 144.86 25.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.405 1.482 . . . . 0.0 111.237 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.9 101.06 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.426 1.09 . . . . 0.0 108.233 165.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.71 -28.5 66.89 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.539 0.736 . . . . 0.0 112.258 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.74 -160.77 28.62 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.497 1.046 . . . . 0.0 113.539 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.73 149.42 51.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.49 1.116 . . . . 0.0 110.872 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 124.868 1.267 . . . . 0.0 112.048 174.956 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 120.408 0.147 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.57 105.22 9.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.807 0.843 . . . . 0.0 110.678 174.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 129.99 41.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.295 1.038 . . . . 0.0 110.348 165.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -116.47 130.03 56.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.191 1.396 . . . . 0.0 110.39 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.91 163.64 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.511 1.124 . . . . 0.0 112.192 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.88 135.01 34.03 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.58 1.952 . . . . 0.0 110.453 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -139.06 149.61 44.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.111 1.434 . . . . 0.0 114.429 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.27 114.5 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.802 2.441 . . . . 0.0 109.253 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -92.87 96.59 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.409 1.084 . . . . 0.0 110.191 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -95.66 158.11 15.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.157 1.783 . . . . 0.0 110.362 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -72.35 156.8 38.71 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.125 -0.985 . . . . 0.0 110.98 166.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -65.65 -64.62 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 113.104 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.07 -47.76 5.4 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.018 0.818 . . . . 0.0 113.566 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -72.04 150.71 43.73 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 112.367 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 m -74.71 -12.39 60.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.813 1.245 . . . . 0.0 114.184 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 156.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.757 0.823 . . . . 0.0 113.091 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.39 128.13 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.886 1.674 . . . . 0.0 109.304 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -81.06 -49.35 11.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.178 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -154.87 160.51 41.25 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.171 1.388 . . . . 0.0 111.748 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.2 p -158.51 126.58 5.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.739 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.95 -17.15 31.94 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 170.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.12 -36.74 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.055 1.342 . . . . 0.0 112.553 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.1 p -75.57 -6.9 52.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.1 1.36 . . . . 0.0 114.64 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -107.93 -88.07 0.48 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.597 1.959 . . . . 0.0 110.133 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -151.44 152.71 31.24 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.937 2.095 . . . . 0.0 110.858 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.75 158.62 56.43 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.734 2.956 . . . . 0.0 113.526 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.38 112.61 23.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.657 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.97 129.49 40.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.716 1.607 . . . . 0.0 111.605 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -147.66 176.93 9.7 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 112.474 171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.96 150.64 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.626 1.57 . . . . 0.0 108.856 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.6 mm -49.41 106.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.509 1.124 . . . . 0.0 111.892 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.73 80.21 1.5 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 125.887 1.708 . . . . 0.0 113.476 -171.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.3 m -132.61 -49.1 0.9 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.056 1.343 . . . . 0.0 112.897 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.25 32.84 22.3 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.596 1.558 . . . . 0.0 114.365 175.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -27.67 34.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.29 171.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.801 1.241 . . . . 0.0 112.317 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -56.25 144.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.533 1.133 . . . . 0.0 112.179 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.086 0.954 . . . . 0.0 113.216 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.37 93.85 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.45 1.024 . . . . 0.0 113.317 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.03 -42.38 38.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.626 0.77 . . . . 0.0 112.121 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -53.08 -48.19 67.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.756 1.162 . . . . 0.0 112.79 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.31 -21.59 66.73 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.98 27.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.114 0.966 . . . . 0.0 112.291 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -53.42 -44.31 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.749 1.159 . . . . 0.0 112.541 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.17 -18.25 65.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -102.84 -20.66 14.22 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.983 1.713 . . . . 0.0 113.971 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.63 134.19 48.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.917 1.287 . . . . 0.0 112.058 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.45 150.34 34.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.922 0.889 . . . . 0.0 111.665 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -56.61 129.62 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.689 1.196 . . . . 0.0 111.161 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.37 76.85 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -122.83 117.82 26.53 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.956 1.378 . . . . 0.0 111.429 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -60.65 141.2 57.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.007 0.923 . . . . 0.0 111.982 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -138.54 120.34 15.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.898 1.279 . . . . 0.0 111.019 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.58 101.51 11.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 110.376 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.26 116.72 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.101 1.36 . . . . 0.0 111.403 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 t -80.21 109.88 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.227 1.011 . . . . 0.0 109.7 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.8 mm -98.52 136.42 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.903 1.281 . . . . 0.0 109.808 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 152.35 89.41 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.336 1.055 . . . . 0.0 111.966 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.72 -46.05 22.16 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.682 2.255 . . . . 0.0 111.867 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 -14.09 46.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 0.0 114.976 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.572 1.549 . . . . 0.0 112.714 -178.239 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.997 0.427 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.04 143.26 33.13 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.976 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -116.37 117.5 30.14 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.925 1.29 . . . . 0.0 110.074 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -74.27 106.75 6.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.088 0.955 . . . . 0.0 110.18 171.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -121.44 131.58 24.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 126.8 2.04 . . . . 0.0 109.293 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.18 155.5 64.4 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.084 1.856 . . . . 0.0 112.557 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -58.72 -19.95 44.68 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 172.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.11 -30.97 62.84 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.936 1.294 . . . . 0.0 113.174 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -81.35 -3.32 52.3 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.204 1.002 . . . . 0.0 113.416 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.22 20.22 7.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.231 2.212 . . . . 0.0 112.432 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.94 104.28 0.28 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.461 1.505 . . . . 0.0 111.875 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.82 3.15 52.41 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.373 1.463 . . . . 0.0 115.68 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 pt -129.63 98.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.865 1.666 . . . . 0.0 111.209 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.28 144.34 54.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.698 1.199 . . . . 0.0 111.665 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -125.7 159.72 31.55 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.396 1.478 . . . . 0.0 111.1 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -150.86 145.19 25.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.244 1.418 . . . . 0.0 110.325 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -58.51 128.62 38.08 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.674 0.79 . . . . 0.0 111.349 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 43.08 12.93 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 123.741 0.686 . . . . 0.0 114.445 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.73 153.89 47.73 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.57 1.148 . . . . 0.0 111.705 168.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.9 t -82.83 98.75 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.233 1.413 . . . . 0.0 112.034 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.63 156.97 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 110.914 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -113.0 149.09 33.8 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.466 1.106 . . . . 0.0 111.353 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.42 97.58 0.22 Allowed Glycine 0 N--CA 1.469 0.862 0 C-N-CA 124.44 1.019 . . . . 0.0 112.516 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.1 110.79 4.69 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.999 0.919 . . . . 0.0 111.101 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -78.39 153.18 31.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.239 1.016 . . . . 0.0 111.659 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -66.21 -12.95 59.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.467 1.507 . . . . 0.0 113.245 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.98 16.39 0.16 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 126.339 1.855 . . . . 0.0 114.01 168.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.59 45.63 15.88 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.227 2.211 . . . . 0.0 112.649 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -145.29 170.03 17.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.358 1.863 . . . . 0.0 111.163 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.1 m -142.44 120.61 12.2 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.753 1.221 . . . . 0.0 110.82 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.57 167.14 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.104 0.561 . . . . 0.0 111.752 174.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -117.0 127.61 54.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.279 1.431 . . . . 0.0 109.052 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.5 171.84 13.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.975 1.31 . . . . 0.0 112.446 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.28 130.06 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.104 0.961 . . . . 0.0 110.57 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.4 mm -62.47 103.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 109.533 170.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -84.13 -38.29 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.061 0.945 . . . . 0.0 111.667 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -149.46 165.4 32.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.461 1.104 . . . . 0.0 112.373 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.01 159.0 44.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.765 1.226 . . . . 0.0 111.921 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.2 m -134.59 174.76 10.19 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.207 1.803 . . . . 0.0 110.835 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.24 -15.56 63.29 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.6 t -140.25 -17.93 0.91 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.92 1.688 . . . . 0.0 114.489 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -133.46 168.03 19.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.662 1.585 . . . . 0.0 112.282 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -136.48 148.65 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.817 2.047 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.0 mtp -129.82 99.57 5.17 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.978 1.311 . . . . 0.0 110.801 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.14 147.32 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 110.005 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.46 128.69 36.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.113 0.565 . . . . 0.0 111.143 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.552 . . . . 0.0 110.779 172.324 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.85 140.66 58.89 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.963 1.705 . . . . 0.0 112.423 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -129.59 138.42 51.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.929 1.292 . . . . 0.0 112.009 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.41 96.68 10.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.486 1.514 . . . . 0.0 111.046 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -76.72 92.6 3.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.345 0.658 . . . . 0.0 109.585 166.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -77.09 119.5 20.88 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 164.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -138.25 169.83 17.09 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.378 0.671 . . . . 0.0 112.48 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -149.22 143.35 25.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.834 1.254 . . . . 0.0 111.584 171.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.5 t -82.24 104.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.772 1.229 . . . . 0.0 108.45 165.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.33 -35.49 75.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.366 0.666 . . . . 0.0 111.703 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.66 -149.95 18.86 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.449 1.499 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -129.29 151.16 50.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.262 1.025 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 . . . . . 0 N--CA 1.475 0.778 0 C-N-CA 125.382 1.473 . . . . 0.0 111.264 175.348 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.01 118.1 18.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.101 0.96 . . . . 0.0 111.45 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.5 106.7 8.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.696 1.599 . . . . 0.0 110.001 164.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.66 115.46 24.13 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.392 1.877 . . . . 0.0 109.501 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -131.78 158.57 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.078 0.951 . . . . 0.0 111.892 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -138.87 134.6 33.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.901 1.28 . . . . 0.0 110.281 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -131.9 162.11 31.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.145 1.378 . . . . 0.0 112.803 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.17 171.03 15.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 111.357 166.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.77 106.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.454 1.102 . . . . 0.0 110.981 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -116.65 154.86 29.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.634 1.574 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.92 148.4 40.11 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.552 -0.717 . . . . 0.0 111.042 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -66.59 -25.84 66.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 -72.94 0.95 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.226 1.393 . . . . 0.0 112.647 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -59.89 140.18 56.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.221 1.408 . . . . 0.0 113.576 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -70.9 -21.28 62.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.812 1.245 . . . . 0.0 113.892 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.37 158.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.952 1.301 . . . . 0.0 112.562 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.0 129.04 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.478 1.511 . . . . 0.0 109.75 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mp -79.69 -45.67 18.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.392 0.677 . . . . 0.0 111.312 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.71 158.27 40.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.163 1.385 . . . . 0.0 111.383 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.3 t -156.93 141.63 16.86 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.278 -0.889 . . . . 0.0 112.666 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.17 3.7 15.29 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.398 1.879 . . . . 0.0 112.752 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.55 -55.9 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.469 1.107 . . . . 0.0 111.214 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 t -72.21 -21.64 61.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.458 1.103 . . . . 0.0 113.034 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -80.81 -178.18 6.69 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.954 2.102 . . . . 0.0 111.841 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.39 128.11 92.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.873 0.869 . . . . 0.0 111.069 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.48 151.85 83.91 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.851 2.367 . . . . 0.0 112.427 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 tt -81.9 134.87 35.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.318 1.047 . . . . 0.0 109.981 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -119.43 114.46 22.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.78 1.632 . . . . 0.0 110.564 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -130.13 172.71 11.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.255 1.022 . . . . 0.0 112.26 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.3 mm -115.8 150.73 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.263 1.425 . . . . 0.0 109.023 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.57 106.16 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.72 29.9 7.1 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.405 1.479 . . . . 0.0 116.369 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 m -98.23 -38.56 9.24 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.53 1.665 . . . . 0.0 113.795 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 55.28 33.02 19.8 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.114 1.766 . . . . 0.0 115.198 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -68.03 -21.42 65.02 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.8 pt -74.26 168.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.964 1.706 . . . . 0.0 113.082 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 pt -60.86 152.79 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.29 1.036 . . . . 0.0 112.518 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.64 -43.13 79.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.11 73.06 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 114.105 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -88.88 -30.5 18.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.999 1.32 . . . . 0.0 112.223 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.6 -44.27 72.92 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.777 1.631 . . . . 0.0 111.639 171.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.79 8.46 6.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.379 1.471 . . . . 0.0 113.817 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.41 -39.58 2.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.499 1.519 . . . . 0.0 113.671 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.27 -30.07 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.323 1.049 . . . . 0.0 113.572 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.17 -14.24 62.21 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.16 -34.46 7.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.511 1.525 . . . . 0.0 112.782 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.91 149.82 26.0 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.551 0.74 . . . . 0.0 111.808 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.07 161.06 22.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 111.409 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.52 125.49 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.81 0.844 . . . . 0.0 111.759 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.78 76.64 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.778 1.18 . . . . 0.0 115.038 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.08 108.76 17.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.957 1.378 . . . . 0.0 111.334 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -57.78 141.2 49.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.982 0.913 . . . . 0.0 112.223 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.33 116.98 12.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.179 1.791 . . . . 0.0 110.716 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.0 112.19 23.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.924 1.29 . . . . 0.0 110.871 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -123.05 112.51 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.132 0.973 . . . . 0.0 111.256 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.7 127.83 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 121.197 -0.939 . . . . 0.0 109.303 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.4 mt -120.56 135.95 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.699 1.6 . . . . 0.0 108.703 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.64 148.69 96.61 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.652 0.781 . . . . 0.0 111.494 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.56 -44.58 13.69 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.02 2.48 . . . . 0.0 112.405 -170.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.14 -30.69 71.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.229 1.811 . . . . 0.0 113.695 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.758 -176.297 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.44 115.38 11.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.852 2.061 . . . . 0.0 111.349 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -116.98 119.22 34.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.259 1.423 . . . . 0.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.09 105.7 11.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.042 1.337 . . . . 0.0 111.06 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.85 131.56 21.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.673 1.989 . . . . 0.0 109.296 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.33 162.21 41.46 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.441 2.094 . . . . 0.0 112.52 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.95 -22.45 49.12 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.013 0.925 . . . . 0.0 113.417 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.42 -39.56 57.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.026 2.13 . . . . 0.0 114.031 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -69.77 -17.84 63.45 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -131.7 15.35 4.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.934 1.693 . . . . 0.0 114.161 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -57.33 -27.94 62.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.343 1.457 . . . . 0.0 114.143 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.76 6.69 33.29 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.823 1.678 . . . . 0.0 116.061 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.26 113.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.33 1.565 . . . . 0.0 111.881 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.92 139.65 58.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.102 0.961 . . . . 0.0 112.012 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -121.02 172.27 8.06 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.092 1.757 . . . . 0.0 111.609 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -148.29 161.15 42.1 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.222 1.009 . . . . 0.0 112.039 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -73.37 95.47 2.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.396 1.078 . . . . 0.0 111.026 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.41 64.24 0.73 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.9 ptp -133.95 152.0 51.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.129 1.372 . . . . 0.0 111.527 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.7 m -77.23 98.77 5.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.531 1.532 . . . . 0.0 110.652 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.09 154.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.366 1.466 . . . . 0.0 111.321 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.35 147.49 29.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.744 1.218 . . . . 0.0 111.589 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.99 96.98 0.28 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.949 1.261 . . . . 0.0 112.423 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -72.15 114.84 10.69 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.874 0.87 . . . . 0.0 111.13 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -82.42 154.84 24.97 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.507 1.123 . . . . 0.0 111.574 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.54 -13.21 39.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.024 1.329 . . . . 0.0 113.545 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -73.75 19.38 0.11 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.464 1.505 . . . . 0.0 113.781 171.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 58.4 33.85 23.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.346 2.259 . . . . 0.0 113.738 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -135.84 169.75 17.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.813 2.045 . . . . 0.0 111.493 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.1 m -137.68 138.28 39.24 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.543 1.537 . . . . 0.0 110.184 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.02 170.64 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.228 1.011 . . . . 0.0 111.372 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.23 133.74 55.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.919 1.688 . . . . 0.0 110.717 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.93 171.06 14.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.095 1.758 . . . . 0.0 111.228 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.7 126.97 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.862 0.865 . . . . 0.0 110.019 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.49 129.49 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 110.567 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -91.5 -49.27 6.41 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.061 1.344 . . . . 0.0 111.504 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -151.87 170.73 19.1 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.813 1.245 . . . . 0.0 112.208 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.72 155.61 45.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.432 1.093 . . . . 0.0 113.019 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.42 169.11 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.038 2.535 . . . . 0.0 110.049 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.41 67.96 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.129 -0.982 . . . . 0.0 113.167 171.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 63.9 p -131.22 -8.47 3.8 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.311 1.444 . . . . 0.0 114.811 -173.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -141.81 171.19 14.4 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.776 1.63 . . . . 0.0 111.047 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -138.65 150.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.514 1.926 . . . . 0.0 108.738 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 62.2 mtp -125.54 114.6 18.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.508 1.123 . . . . 0.0 111.035 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.2 163.83 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.811 1.244 . . . . 0.0 112.163 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -102.13 88.49 3.34 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.86 1.264 . . . . 0.0 112.182 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.475 0.801 0 C-N-CA 124.647 1.179 . . . . 0.0 112.268 171.863 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.9 p -64.66 144.85 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.36 1.464 . . . . 0.0 113.14 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -130.31 136.42 49.12 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.275 . . . . 0.0 111.706 -173.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.68 97.41 7.9 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.73 1.612 . . . . 0.0 111.324 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.65 83.59 6.4 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.415 1.102 . . . . 0.0 110.613 166.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -76.58 131.67 39.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.14 169.89 19.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -145.41 145.63 31.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.971 1.309 . . . . 0.0 111.656 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 t -84.49 100.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.863 1.265 . . . . 0.0 108.693 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.23 -31.96 71.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.38 0.672 . . . . 0.0 111.837 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.88 -170.05 31.28 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.196 0.903 . . . . 0.0 114.883 170.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.55 118.93 27.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.616 1.567 . . . . 0.0 110.219 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 . . . . . 0 N--CA 1.48 1.045 0 C-N-CA 124.985 1.314 . . . . 0.0 112.558 -177.037 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 . . . . . 0 N--CA 1.473 0.682 0 CA-C-O 120.47 0.176 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 107.51 17.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.184 0.994 . . . . 0.0 110.435 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.02 128.7 37.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.382 165.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.23 124.81 53.4 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.592 1.557 . . . . 0.0 109.619 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 141' ' ' VAL . 14.5 pt -128.5 163.68 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 171.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.82 136.72 40.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 109.745 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.07 157.95 45.58 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.069 1.414 . . . . 0.0 114.783 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -139.13 141.25 38.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.462 3.105 . . . . 0.0 108.878 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.22 110.06 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.873 1.269 . . . . 0.0 110.429 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -123.69 168.85 12.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.539 1.536 . . . . 0.0 112.685 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -62.57 151.97 36.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.505 1.122 . . . . 0.0 111.147 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -20.28 63.24 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.42 25.35 1.53 Allowed Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.123 1.344 . . . . 0.0 114.959 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -141.16 161.41 37.93 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.917 1.358 . . . . 0.0 112.52 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -75.71 -17.72 59.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.783 1.633 . . . . 0.0 113.762 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -64.04 151.69 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.799 0.84 . . . . 0.0 112.456 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.46 117.25 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.787 1.635 . . . . 0.0 108.943 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.87 -44.05 56.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.721 0.808 . . . . 0.0 111.77 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.67 164.09 39.06 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.648 1.179 . . . . 0.0 111.581 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 m -165.87 159.6 16.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.384 1.874 . . . . 0.0 111.844 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -126.08 2.75 7.22 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 164.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.9 mm -47.46 -46.2 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.01 1.724 . . . . 0.0 113.965 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -93.42 -2.62 54.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.955 1.302 . . . . 0.0 113.581 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -98.05 -166.52 1.39 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.875 2.47 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.91 134.26 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.473 1.109 . . . . 0.0 111.775 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.55 159.01 55.18 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.27 2.647 . . . . 0.0 113.314 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.88 95.06 5.96 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.435 1.094 . . . . 0.0 110.268 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.34 125.46 31.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.159 1.783 . . . . 0.0 111.578 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.48 172.6 14.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.168 0.987 . . . . 0.0 113.399 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 142.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.601 1.56 . . . . 0.0 109.507 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mm -47.93 121.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.971 1.708 . . . . 0.0 112.462 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.41 76.85 1.09 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.995 1.283 . . . . 0.0 112.806 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -130.79 -26.69 2.18 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 53.48 21.96 2.7 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.518 1.927 . . . . 0.0 115.683 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -78.25 -28.6 47.82 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -170.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 pt -82.07 171.18 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.86 1.664 . . . . 0.0 112.196 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 pt -55.34 140.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.818 0.847 . . . . 0.0 111.169 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.67 78.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.543 0.737 . . . . 0.0 112.915 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.88 -30.41 72.98 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.327 0.965 . . . . 0.0 114.303 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.67 -43.9 13.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.337 1.055 . . . . 0.0 111.404 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -53.25 -48.02 68.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.595 1.158 . . . . 0.0 112.309 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.05 0.3 2.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.984 1.314 . . . . 0.0 114.468 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.54 -25.42 7.9 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.968 1.707 . . . . 0.0 114.04 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.3 t -58.31 -42.02 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.736 1.607 . . . . 0.0 112.114 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.92 -12.62 61.06 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.95 -36.9 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.995 1.718 . . . . 0.0 112.18 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 140.74 58.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.085 1.354 . . . . 0.0 112.385 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -86.28 154.28 21.37 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.009 0.924 . . . . 0.0 111.964 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.71 131.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.287 1.035 . . . . 0.0 111.346 171.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.25 12.63 76.43 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.289 0.947 . . . . 0.0 115.157 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.31 115.49 19.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.322 1.449 . . . . 0.0 111.246 -175.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -59.41 141.32 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.866 0.866 . . . . 0.0 112.151 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.17 142.68 42.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.147 1.379 . . . . 0.0 111.054 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.79 128.54 52.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.14 1.376 . . . . 0.0 110.156 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.55 110.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.706 2.002 . . . . 0.0 110.166 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.1 t -69.49 125.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.769 0.828 . . . . 0.0 109.94 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.29 140.1 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.308 1.443 . . . . 0.0 109.826 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.45 154.74 87.23 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.241 1.016 . . . . 0.0 111.731 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.18 -40.67 67.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.627 2.218 . . . . 0.0 113.462 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.28 -18.35 59.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.475 0.793 0 C-N-CA 124.737 1.215 . . . . 0.0 114.017 -178.841 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 p90 . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.8 103.59 10.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.252 1.021 . . . . 0.0 110.629 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -88.91 116.75 27.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.59 0.756 . . . . 0.0 110.35 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.11 112.22 7.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.25 1.02 . . . . 0.0 110.221 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 156.3 54.45 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 126.071 1.749 . . . . 0.0 110.812 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.08 149.64 46.8 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.047 1.831 . . . . 0.0 112.005 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -61.45 -17.31 53.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.04 1.336 . . . . 0.0 113.171 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.35 -33.9 22.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.184 2.194 . . . . 0.0 113.624 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -71.38 -10.8 60.35 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -135.19 14.48 3.53 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.612 1.565 . . . . 0.0 114.194 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.86 112.56 0.96 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.43 1.092 . . . . 0.0 112.441 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.11 3.86 58.81 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.21 1.386 . . . . 0.0 115.374 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mt -108.22 139.56 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.284 1.434 . . . . 0.0 110.378 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.0 55.87 1.86 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.378 1.871 . . . . 0.0 113.588 -173.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -55.04 130.04 40.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.283 1.833 . . . . 0.0 113.303 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.23 148.47 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.752 2.021 . . . . 0.0 110.345 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.36 135.76 57.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.489 1.116 . . . . 0.0 112.25 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 -9.37 75.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.136 1.35 . . . . 0.0 116.371 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 ptp -70.16 152.28 44.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.169 1.984 . . . . 0.0 112.416 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 p -78.38 102.01 7.53 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.606 1.163 . . . . 0.0 110.311 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.3 160.86 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.419 1.088 . . . . 0.0 110.551 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.32 162.21 30.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.06 1.344 . . . . 0.0 112.002 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.69 108.82 0.38 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.275 0.94 . . . . 0.0 112.891 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -66.4 147.13 53.74 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 122.05 -0.677 . . . . 0.0 111.299 174.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -128.88 157.39 41.7 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.729 1.612 . . . . 0.0 111.737 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -14.08 60.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.215 1.806 . . . . 0.0 113.736 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.35 13.13 0.62 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.285 1.834 . . . . 0.0 113.912 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.1 m120 57.25 40.14 28.12 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.13 2.172 . . . . 0.0 113.171 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -131.9 171.01 14.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.872 2.069 . . . . 0.0 111.253 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.6 m -141.93 111.75 6.73 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.683 1.593 . . . . 0.0 109.634 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.62 166.94 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 118.497 0.59 . . . . 0.0 111.067 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.33 154.77 34.55 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.623 1.169 . . . . 0.0 111.17 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.8 176.7 12.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.629 1.572 . . . . 0.0 110.966 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.37 128.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.385 1.074 . . . . 0.0 110.476 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.0 mm -68.65 125.97 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.062 0.945 . . . . 0.0 110.693 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.08 -38.68 5.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.773 1.229 . . . . 0.0 113.381 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -151.93 156.17 39.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.468 1.107 . . . . 0.0 111.243 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -147.19 149.85 33.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.186 -0.946 . . . . 0.0 113.395 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -143.2 170.17 16.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.841 2.057 . . . . 0.0 110.804 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.264 -0.897 . . . . 0.0 113.251 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.3 p -78.92 -66.71 0.83 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.676 1.99 . . . . 0.0 112.021 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -135.73 171.0 15.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.098 2.159 . . . . 0.0 111.367 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.21 144.03 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.567 1.547 . . . . 0.0 110.429 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.6 mtp -116.41 113.66 23.19 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.781 1.632 . . . . 0.0 110.651 -170.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.48 135.43 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.187 1.395 . . . . 0.0 110.264 -166.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.32 83.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.287 1.435 . . . . 0.0 112.17 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 126.035 1.734 . . . . 0.0 112.29 173.335 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.3 p -64.72 147.63 52.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.879 0.872 . . . . 0.0 112.125 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.58 154.21 51.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.81 1.244 . . . . 0.0 111.425 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.23 104.43 14.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 110.728 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -80.07 109.83 14.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.639 0.776 . . . . 0.0 109.726 167.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.24 120.64 43.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.858 1.663 . . . . 0.0 108.941 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -143.4 169.78 17.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 113.087 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.85 144.97 28.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.634 1.174 . . . . 0.0 111.899 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 15' ' ' ILE . 45.3 t -83.18 102.9 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.918 1.287 . . . . 0.0 109.003 165.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.35 -36.03 78.63 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.201 0.6 . . . . 0.0 111.698 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.68 -165.93 27.47 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.367 0.984 . . . . 0.0 114.211 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.21 133.2 54.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.818 1.647 . . . . 0.0 110.223 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.062 1.345 . . . . 0.0 112.015 175.933 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.43 105.7 8.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.708 1.203 . . . . 0.0 111.172 172.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.58 125.51 28.16 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.046 1.339 . . . . 0.0 110.227 163.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.37 123.88 50.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.34 1.456 . . . . 0.0 110.083 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 pt -131.22 161.3 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.219 1.007 . . . . 0.0 112.129 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -135.89 146.94 47.93 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.841 1.656 . . . . 0.0 110.397 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.51 154.31 43.5 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -146.03 129.06 16.51 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.766 2.426 . . . . 0.0 110.571 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.88 110.39 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.969 1.708 . . . . 0.0 110.062 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -116.5 151.74 35.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.855 1.662 . . . . 0.0 111.259 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.42 126.34 29.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.931 0.893 . . . . 0.0 109.79 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -72.73 75.65 1.12 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.316 -0.865 . . . . 0.0 111.352 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 -5.28 2.64 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.117 1.818 . . . . 0.0 116.135 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.0 t -133.45 144.29 49.39 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.981 1.891 . . . . 0.0 112.776 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 p -76.59 31.55 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.616 2.766 . . . . 0.0 115.599 -171.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.35 176.57 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.184 1.394 . . . . 0.0 112.216 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.45 117.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.434 1.494 . . . . 0.0 108.987 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.47 -53.3 6.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.912 0.885 . . . . 0.0 111.494 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -144.42 150.64 38.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.557 1.943 . . . . 0.0 109.865 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 p -157.64 151.58 24.29 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.295 -0.878 . . . . 0.0 112.703 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.3 -6.58 8.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.217 1.407 . . . . 0.0 113.135 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -62.5 -37.5 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.287 1.435 . . . . 0.0 112.094 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -73.38 -10.62 59.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.7 1.2 . . . . 0.0 113.506 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -114.7 -170.43 1.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 127.504 2.321 . . . . 0.0 111.164 -171.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.69 125.75 83.51 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 124.378 1.071 . . . . 0.0 111.835 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.68 152.21 82.34 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.029 2.486 . . . . 0.0 112.554 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.0 tp -75.91 108.91 9.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.119 1.368 . . . . 0.0 110.897 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -93.71 131.9 38.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.532 1.533 . . . . 0.0 111.78 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -146.78 167.86 22.81 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.478 1.111 . . . . 0.0 112.88 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.0 mm -101.48 146.88 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 109.715 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.3 mm -46.46 118.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.362 1.865 . . . . 0.0 111.792 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.19 77.5 1.05 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.993 1.282 . . . . 0.0 112.886 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -123.13 -36.84 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.002 1.321 . . . . 0.0 114.426 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.47 23.27 2.45 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 126.846 2.058 . . . . 0.0 115.175 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -80.15 -24.79 40.18 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.2 pt -78.42 167.07 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.989 1.316 . . . . 0.0 112.475 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.9 pt -59.53 141.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.242 1.017 . . . . 0.0 111.692 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.34 73.43 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.91 68.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.347 0.975 . . . . 0.0 114.296 176.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.58 -35.17 13.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.307 1.443 . . . . 0.0 111.844 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -59.4 -40.74 87.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.223 1.409 . . . . 0.0 112.678 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -73.69 -8.34 55.6 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.47 -47.89 5.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.978 1.311 . . . . 0.0 112.631 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.95 -28.54 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.996 1.318 . . . . 0.0 114.134 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 -19.71 63.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -108.46 -11.48 15.15 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.722 1.609 . . . . 0.0 113.843 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.94 113.09 4.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.35 1.46 . . . . 0.0 112.138 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.97 147.14 50.54 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.763 0.825 . . . . 0.0 111.891 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.49 131.65 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.432 1.093 . . . . 0.0 111.429 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.91 12.88 79.04 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.61 1.1 . . . . 0.0 115.334 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -116.65 118.53 32.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.229 1.412 . . . . 0.0 111.678 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -61.09 133.65 56.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.223 1.009 . . . . 0.0 111.947 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -136.97 136.45 38.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 110.956 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -126.63 105.93 9.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.678 1.191 . . . . 0.0 110.526 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 m -109.8 114.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.554 1.542 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.7 t -73.81 126.91 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.74 130.98 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.718 1.607 . . . . 0.0 108.989 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 154.45 87.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.65 1.18 . . . . 0.0 111.675 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.48 -45.06 15.64 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.201 1.934 . . . . 0.0 111.646 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -62.11 -21.07 64.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.116 178.435 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.2 p90 . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.55 137.82 31.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 112.002 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -126.8 124.29 39.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -88.04 82.5 7.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.9 1.68 . . . . 0.0 110.255 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.69 136.04 45.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.144 1.378 . . . . 0.0 109.722 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.77 156.01 57.63 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.475 2.117 . . . . 0.0 112.24 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -65.85 -9.28 27.54 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -56.31 -31.5 63.74 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.327 1.051 . . . . 0.0 113.582 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -82.17 -6.61 59.33 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -130.04 15.58 5.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.44 1.896 . . . . 0.0 113.403 -169.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.62 107.93 0.34 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.996 1.718 . . . . 0.0 112.289 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.84 11.05 57.13 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.88 1.229 . . . . 0.0 115.784 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.42 132.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.368 1.584 . . . . 0.0 110.557 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.67 79.45 9.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.915 1.686 . . . . 0.0 112.696 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.01 155.76 35.68 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.59 1.156 . . . . 0.0 112.819 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.91 157.64 45.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -73.96 25.69 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.113 1.765 . . . . 0.0 114.999 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.4 56.22 0.06 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.988 1.28 . . . . 0.0 112.663 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.4 ptp -132.18 149.25 52.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.699 1.2 . . . . 0.0 112.208 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -67.49 125.35 25.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.363 1.465 . . . . 0.0 110.629 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.14 160.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.627 1.571 . . . . 0.0 111.146 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -119.5 149.84 41.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.498 1.519 . . . . 0.0 111.578 -177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.89 108.53 0.64 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.651 1.119 . . . . 0.0 113.047 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -71.82 112.63 8.09 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.817 -0.814 . . . . 0.0 111.464 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 t -89.03 159.93 17.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.618 1.167 . . . . 0.0 111.967 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -13.56 60.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.623 1.569 . . . . 0.0 113.959 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.65 11.15 0.68 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.754 1.622 . . . . 0.0 113.941 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 53.41 47.86 23.17 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.844 2.058 . . . . 0.0 111.908 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.49 168.17 20.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.776 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 m -140.78 105.56 4.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.138 -0.976 . . . . 0.0 111.045 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.35 170.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.941 -0.474 . . . . 0.0 111.494 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 139.06 54.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.088 1.755 . . . . 0.0 111.564 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.06 179.48 7.71 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.419 1.888 . . . . 0.0 111.872 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.67 128.65 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.729 1.212 . . . . 0.0 110.722 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -72.7 131.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.865 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -95.38 -42.31 8.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.988 1.715 . . . . 0.0 112.0 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -155.09 167.36 30.63 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.625 1.17 . . . . 0.0 112.006 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -140.29 144.84 36.61 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.096 1.358 . . . . 0.0 111.536 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.4 m -117.94 174.08 6.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.776 2.03 . . . . 0.0 110.613 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.05 -19.79 63.27 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.1 p -133.45 -18.31 2.22 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.846 1.658 . . . . 0.0 115.173 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -143.03 172.06 13.22 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.045 1.738 . . . . 0.0 112.145 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.2 t -137.85 126.33 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 127.13 2.172 . . . . 0.0 110.591 -172.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 76.9 mmm -94.15 111.57 23.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.695 1.598 . . . . 0.0 111.078 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.13 151.27 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.131 1.772 . . . . 0.0 112.249 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -91.71 115.57 28.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.105 1.362 . . . . 0.0 111.166 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.344 1.858 . . . . 0.0 111.234 -179.419 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.1 p -64.48 137.78 58.05 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.923 1.689 . . . . 0.0 112.351 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.25 144.78 51.56 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.795 1.238 . . . . 0.0 112.001 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.09 99.1 10.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.676 1.59 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.39 93.37 5.96 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.704 1.202 . . . . 0.0 109.837 168.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 -76.93 141.37 40.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.928 -1.108 . . . . 0.0 109.784 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -152.72 170.48 20.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.905 0.882 . . . . 0.0 113.0 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -149.55 142.28 24.6 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.14 1.376 . . . . 0.0 111.132 169.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.29 107.8 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.154 1.382 . . . . 0.0 109.025 169.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.7 mp -69.95 -33.9 72.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 111.184 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.62 -175.13 22.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.438 1.494 . . . . 0.0 114.008 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.15 139.38 42.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.0 110.455 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 124.354 1.062 . . . . 0.0 113.28 177.004 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 120.65 0.262 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.89 106.37 8.53 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.354 1.062 . . . . 0.0 110.323 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 125.17 29.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.067 1.347 . . . . 0.0 110.63 169.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.88 125.63 51.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.475 1.51 . . . . 0.0 110.388 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 pt -133.61 163.26 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.314 1.046 . . . . 0.0 112.042 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -140.59 138.05 34.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.056 1.342 . . . . 0.0 110.559 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.47 160.56 38.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.141 1.376 . . . . 0.0 113.728 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -143.33 161.39 38.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.001 1.72 . . . . 0.0 111.396 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.03 107.41 11.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.735 1.614 . . . . 0.0 110.038 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -113.92 157.41 22.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.908 1.683 . . . . 0.0 110.31 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -63.81 152.18 40.24 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.689 -0.632 . . . . 0.0 110.933 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -25.79 60.11 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.38 57.38 0.3 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.47 1.033 . . . . 0.0 113.743 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 t -144.57 163.7 33.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.604 1.162 . . . . 0.0 112.441 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -80.36 -21.96 41.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 113.466 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 pp -69.35 157.06 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.811 0.732 . . . . 0.0 111.36 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.36 144.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.508 1.523 . . . . 0.0 110.697 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.91 -48.08 6.43 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.544 0.738 . . . . 0.0 111.038 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 157.21 36.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.704 1.602 . . . . 0.0 111.735 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.5 p -162.98 163.79 25.96 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.532 1.133 . . . . 0.0 113.615 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.86 8.28 4.11 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 167.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.43 -53.58 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 p -76.32 -18.92 58.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 0.0 113.892 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.02 -171.35 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.006 2.123 . . . . 0.0 111.035 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -64.17 142.59 98.28 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 121.147 -0.97 . . . . 0.0 111.77 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.14 159.43 53.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.374 2.716 . . . . 0.0 112.597 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.86 109.06 15.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 110.363 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.59 127.14 32.12 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.438 1.895 . . . . 0.0 111.452 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.14 175.1 10.74 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.7 137.77 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.051 1.74 . . . . 0.0 109.078 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 mm -48.14 109.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.27 1.828 . . . . 0.0 111.804 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.05 87.27 1.24 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.415 1.483 . . . . 0.0 112.936 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.1 t -146.35 -33.47 0.31 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.2 m120 53.45 60.64 3.58 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.852 2.061 . . . . 0.0 113.789 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -111.04 -26.28 9.33 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.8 pt -81.04 174.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.436 1.495 . . . . 0.0 112.177 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.8 pt -58.2 141.18 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.797 0.839 . . . . 0.0 111.469 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.08 91.75 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.81 -33.45 73.28 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.052 0.834 . . . . 0.0 113.95 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 tp -81.73 -45.38 15.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.436 1.094 . . . . 0.0 111.342 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -49.36 -47.7 47.26 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.71 1.604 . . . . 0.0 113.287 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.43 -18.22 63.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 113.276 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.05 -43.92 10.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.914 1.286 . . . . 0.0 112.69 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.62 -43.06 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 119.941 1.246 . . . . 0.0 112.525 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.58 -20.79 65.94 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -102.69 -11.34 18.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.399 1.88 . . . . 0.0 113.801 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.03 126.63 31.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.408 1.483 . . . . 0.0 112.392 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -77.8 155.04 31.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.754 0.822 . . . . 0.0 112.01 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.62 134.29 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.897 1.279 . . . . 0.0 111.473 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.54 13.83 74.58 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.75 100.23 7.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.964 1.306 . . . . 0.0 111.63 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -58.18 131.86 51.83 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.287 1.035 . . . . 0.0 111.469 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.41 157.84 44.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.907 0.883 . . . . 0.0 112.79 171.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -128.79 96.78 4.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.994 1.318 . . . . 0.0 110.91 -170.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -97.94 106.23 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.394 1.478 . . . . 0.0 110.119 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 t -74.26 123.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.351 -0.843 . . . . 0.0 109.807 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.41 140.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.451 1.9 . . . . 0.0 109.383 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.15 158.91 69.34 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.416 1.087 . . . . 0.0 112.214 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.93 -46.79 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.32 2.013 . . . . 0.0 112.082 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.89 -14.42 61.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.198 1.399 . . . . 0.0 114.656 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.38 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.221 0.534 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.7 mt -121.16 146.78 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.729 1.611 . . . . 0.0 111.69 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -131.54 111.45 11.77 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.685 1.594 . . . . 0.0 111.253 167.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -69.58 115.17 8.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.715 0.806 . . . . 0.0 110.087 160.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.36 156.85 69.53 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 125.942 1.697 . . . . 0.0 109.898 176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.34 153.52 61.4 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.025 1.817 . . . . 0.0 111.881 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -61.26 -19.37 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 0.0 113.245 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -53.95 -30.51 47.06 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.49 1.516 . . . . 0.0 114.589 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -19.73 65.05 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 175.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -137.68 20.98 2.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.032 1.733 . . . . 0.0 112.556 -168.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.93 -24.8 55.26 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.168 1.787 . . . . 0.0 114.168 -171.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.18 16.07 46.29 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.059 1.79 . . . . 0.0 115.338 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.32 132.62 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.281 1.54 . . . . 0.0 111.023 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -81.34 89.2 6.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.685 1.194 . . . . 0.0 111.108 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.2 160.28 32.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 112.326 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.1 152.29 27.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.019 1.328 . . . . 0.0 111.81 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -72.88 84.25 1.23 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.685 1.194 . . . . 0.0 110.878 168.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.69 43.71 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.765 1.174 . . . . 0.0 114.699 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.4 ptm -129.38 150.69 50.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.149 1.38 . . . . 0.0 111.149 170.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 p -67.99 133.83 49.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.041 0.937 . . . . 0.0 110.955 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.24 152.82 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.35 1.86 . . . . 0.0 110.166 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.59 143.95 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.572 1.149 . . . . 0.0 110.958 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.12 99.92 0.44 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 124.802 1.191 . . . . 0.0 112.109 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -66.87 140.31 57.79 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 117.604 0.702 . . . . 0.0 111.203 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -119.07 154.54 33.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.036 1.735 . . . . 0.0 111.656 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -62.0 -17.66 57.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.988 1.715 . . . . 0.0 113.439 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.99 15.46 0.16 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 127.23 2.212 . . . . 0.0 113.999 173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.6 m120 52.66 48.12 23.21 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.134 2.174 . . . . 0.0 112.617 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -144.77 177.36 8.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.798 1.639 . . . . 0.0 111.969 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.0 m -145.2 128.94 17.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.905 1.282 . . . . 0.0 110.538 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -84.66 165.72 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.73 0.812 . . . . 0.0 111.81 172.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -133.36 126.57 31.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.465 1.506 . . . . 0.0 110.209 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.77 -172.88 4.37 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.677 1.191 . . . . 0.0 112.486 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mp -113.67 140.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.629 1.572 . . . . 0.0 109.804 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.43 134.57 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.797 1.239 . . . . 0.0 110.831 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -107.96 -32.96 7.36 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.42 1.088 . . . . 0.0 113.57 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -152.83 153.92 34.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.231 1.412 . . . . 0.0 111.173 164.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -142.63 134.12 26.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 111.715 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 160.74 39.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.567 1.547 . . . . 0.0 110.517 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.24 -23.26 67.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.1 p -77.28 -62.59 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.021 1.728 . . . . 0.0 111.68 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -138.87 160.95 38.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.007 2.123 . . . . 0.0 112.109 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.41 147.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.703 1.601 . . . . 0.0 110.396 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -121.84 105.69 10.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.69 1.596 . . . . 0.0 110.288 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -106.31 146.59 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.555 1.542 . . . . 0.0 111.072 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 141.94 49.84 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.841 -0.537 . . . . 0.0 111.112 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 125.389 1.476 . . . . 0.0 111.474 176.797 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.19 142.85 57.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.738 1.615 . . . . 0.0 111.764 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.3 mt -126.71 143.1 51.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 112.002 -174.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.85 98.53 11.83 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.949 1.3 . . . . 0.0 111.457 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -79.62 92.57 5.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.848 0.832 . . . . 0.0 110.77 168.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.12 128.77 34.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.256 1.422 . . . . 0.0 109.417 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.47 169.39 21.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -149.55 147.96 28.79 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 112.055 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.9 108.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.42 1.488 . . . . 0.0 109.167 166.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.84 -29.43 68.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.51 0.724 . . . . 0.0 111.302 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.67 172.07 14.22 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.534 2.016 . . . . 0.0 112.422 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.15 156.34 17.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.451 0.7 . . . . 0.0 112.717 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 178.652 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.19 96.95 5.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.487 1.115 . . . . 0.0 111.176 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.83 118.99 22.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.752 2.021 . . . . 0.0 111.734 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.88 130.5 48.37 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.185 1.394 . . . . 0.0 111.313 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.52 158.74 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.173 1.389 . . . . 0.0 111.734 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -138.94 141.24 38.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 110.972 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.44 154.2 49.98 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 123.123 1.44 . . . . 0.0 114.069 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -142.56 113.03 7.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.18 2.592 . . . . 0.0 109.068 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.29 115.73 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.69 1.196 . . . . 0.0 109.602 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -124.54 151.87 44.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.132 1.773 . . . . 0.0 110.547 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.66 146.76 48.06 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.606 -0.683 . . . . 0.0 111.251 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.84 -33.35 61.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -170.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.2 45.33 0.84 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.368 0.985 . . . . 0.0 114.141 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 t -142.28 156.48 45.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 112.579 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.2 p -82.52 -11.9 58.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.97 1.708 . . . . 0.0 114.331 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.03 178.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.966 1.306 . . . . 0.0 112.196 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 p -133.77 137.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.736 1.215 . . . . 0.0 110.197 168.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.7 mt -81.27 -51.39 8.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.635 0.774 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.31 163.33 30.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.925 1.29 . . . . 0.0 112.544 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.9 p -157.11 165.27 36.51 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.003 -1.061 . . . . 0.0 112.812 171.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.68 -4.29 10.27 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 164.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.62 -48.57 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.762 1.625 . . . . 0.0 112.215 -171.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -75.93 -17.24 59.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -86.93 -73.93 0.45 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.061 1.745 . . . . 0.0 111.715 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -166.93 134.18 1.99 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.665 1.986 . . . . 0.0 110.335 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.95 154.33 74.98 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.11 2.54 . . . . 0.0 112.882 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tt -95.0 111.89 23.65 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 109.796 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -93.27 131.89 37.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.868 1.267 . . . . 0.0 111.519 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -145.6 179.38 7.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 112.097 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.81 135.5 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.758 1.223 . . . . 0.0 109.251 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.8 mm -49.8 109.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.14 1.376 . . . . 0.0 111.038 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.71 53.31 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.617 1.58 . . . . 0.0 114.634 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 m -122.79 -32.23 3.57 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.591 1.156 . . . . 0.0 113.296 175.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 54.3 33.45 18.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.327 1.851 . . . . 0.0 114.888 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -79.45 -24.1 42.66 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.0 pt -69.56 166.95 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.636 1.174 . . . . 0.0 112.589 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.6 pt -57.58 141.76 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.019 0.927 . . . . 0.0 111.428 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.18 76.81 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -173.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.11 68.53 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.002 0.81 . . . . 0.0 114.17 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -90.19 -29.72 18.05 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.177 1.391 . . . . 0.0 112.213 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -60.47 -42.88 97.16 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.844 -1.16 . . . . 0.0 112.504 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.53 -10.14 53.73 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.08 -49.94 4.56 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.625 1.57 . . . . 0.0 112.821 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.87 -31.71 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.565 1.146 . . . . 0.0 114.038 -174.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.64 -21.04 66.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.74 -13.78 16.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.678 1.991 . . . . 0.0 113.536 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.5 116.84 16.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.492 1.517 . . . . 0.0 112.07 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -73.7 157.48 36.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.813 0.816 . . . . 0.0 112.46 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.14 133.96 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.086 1.355 . . . . 0.0 111.639 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.47 72.52 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.758 1.171 . . . . 0.0 114.938 176.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -120.14 108.34 14.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.173 1.389 . . . . 0.0 111.201 -170.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -54.93 129.94 39.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.993 0.917 . . . . 0.0 111.456 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.84 141.26 51.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.072 1.349 . . . . 0.0 111.169 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -127.11 112.71 15.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.415 1.486 . . . . 0.0 109.572 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.81 124.03 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.627 1.171 . . . . 0.0 111.556 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.08 127.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.726 0.811 . . . . 0.0 109.646 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.34 135.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.251 1.82 . . . . 0.0 108.964 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.2 155.02 67.79 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.921 0.888 . . . . 0.0 112.329 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.15 -41.76 15.67 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.109 1.873 . . . . 0.0 111.379 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.71 -23.67 64.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.911 1.684 . . . . 0.0 114.51 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 N--CA 1.474 0.757 0 O-C-N 121.429 -0.794 . . . . 0.0 112.561 172.592 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.1 mt -153.46 132.57 12.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 129.32 3.048 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -139.93 117.01 11.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.09 1.356 . . . . 0.0 110.159 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.16 112.65 6.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 110.547 168.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.5 m -119.59 157.42 51.92 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.729 1.612 . . . . 0.0 110.634 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.43 163.04 40.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.008 1.805 . . . . 0.0 111.38 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -67.21 0.53 2.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.234 1.814 . . . . 0.0 114.667 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.31 -38.04 81.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.547 1.939 . . . . 0.0 113.907 -175.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -67.48 -15.89 63.91 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -127.38 21.18 6.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.514 1.526 . . . . 0.0 113.005 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.49 99.06 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.761 1.624 . . . . 0.0 112.171 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.95 56.93 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.599 1.571 . . . . 0.0 115.596 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.77 127.56 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.567 1.547 . . . . 0.0 109.763 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.87 124.13 21.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.828 0.851 . . . . 0.0 111.529 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.1 mt -115.11 139.27 50.03 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.335 1.454 . . . . 0.0 110.589 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -150.35 150.68 31.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.887 1.275 . . . . 0.0 111.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -76.66 89.59 3.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.83 -1.169 . . . . 0.0 111.052 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.72 43.11 0.27 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.482 1.515 . . . . 0.0 114.6 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 ptm -133.13 152.1 51.96 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.196 1.398 . . . . 0.0 111.365 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p -68.57 133.53 48.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.88 1.272 . . . . 0.0 111.32 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.73 156.94 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.481 1.913 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.86 139.54 53.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.634 1.174 . . . . 0.0 111.037 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.02 100.2 0.55 Allowed Glycine 0 N--CA 1.469 0.879 0 C-N-CA 124.878 1.228 . . . . 0.0 112.282 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -64.15 144.79 56.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.72 0.76 . . . . 0.0 111.383 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -128.93 155.44 45.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.576 1.55 . . . . 0.0 111.578 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -65.46 -14.95 62.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.836 1.654 . . . . 0.0 113.221 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -73.46 17.29 0.15 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.457 1.903 . . . . 0.0 113.934 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 54.15 44.72 28.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.144 2.178 . . . . 0.0 112.425 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.26 173.49 11.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.966 2.107 . . . . 0.0 111.48 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.4 m -146.14 118.33 8.35 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.66 1.184 . . . . 0.0 110.179 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -73.66 162.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.312 0.506 . . . . 0.0 110.976 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -137.26 119.76 15.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.348 1.459 . . . . 0.0 110.652 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.04 -170.75 3.59 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.456 1.103 . . . . 0.0 112.543 -172.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.71 142.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.393 1.477 . . . . 0.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.3 mt -73.46 126.3 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.066 -1.021 . . . . 0.0 110.303 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -101.41 -33.82 9.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.357 1.063 . . . . 0.0 113.174 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.41 154.93 36.55 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.372 1.469 . . . . 0.0 111.31 170.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -144.98 146.86 32.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.273 1.029 . . . . 0.0 112.078 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.3 t -146.47 170.46 16.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.438 1.895 . . . . 0.0 110.471 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.11 61.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.021 0.929 . . . . 0.0 113.463 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -79.91 -61.77 1.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.641 1.576 . . . . 0.0 111.706 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -138.45 166.92 23.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.029 2.132 . . . . 0.0 111.517 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.36 144.16 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.576 1.551 . . . . 0.0 110.6 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.8 mtp -118.42 93.36 4.09 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.018 1.727 . . . . 0.0 110.883 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.59 149.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.555 1.542 . . . . 0.0 109.904 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.8 114.25 4.92 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.363 -0.836 . . . . 0.0 111.508 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 125.668 1.587 . . . . 0.0 109.146 172.065 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 111.204 0.076 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.39 140.41 56.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.315 1.046 . . . . 0.0 111.701 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.62 134.15 55.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.819 2.047 . . . . 0.0 110.915 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.95 101.86 14.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.041 1.336 . . . . 0.0 111.347 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -81.68 96.96 7.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.893 0.877 . . . . 0.0 110.169 167.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -84.0 120.1 25.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.274 1.43 . . . . 0.0 108.87 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.72 168.84 18.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.69 0.677 . . . . 0.0 112.825 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -147.83 137.33 22.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.054 0.942 . . . . 0.0 111.699 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.8 t -80.63 102.77 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.211 1.004 . . . . 0.0 108.386 166.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.5 mt -65.52 -31.99 73.35 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.026 0.53 . . . . 0.0 111.549 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.31 174.32 13.45 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 126.928 2.204 . . . . 0.0 112.333 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -108.03 140.82 40.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.057 0.943 . . . . 0.0 111.113 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 125.533 1.533 . . . . 0.0 109.659 173.348 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 120.356 0.122 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.56 99.81 3.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.225 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.46 41.09 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.786 0.834 . . . . 0.0 111.051 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.62 131.55 49.89 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.721 1.608 . . . . 0.0 110.262 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -127.7 161.85 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.435 1.094 . . . . 0.0 111.791 171.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -137.27 127.12 25.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.605 1.562 . . . . 0.0 110.162 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -131.48 149.13 52.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.951 1.3 . . . . 0.0 112.888 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -137.89 148.66 45.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.631 2.372 . . . . 0.0 109.934 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.97 121.37 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.066 0.946 . . . . 0.0 112.054 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -124.26 142.82 50.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.336 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -66.29 128.64 36.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.106 0.962 . . . . 0.0 111.001 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.53 106.27 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.474 -0.767 . . . . 0.0 112.407 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.39 -13.97 47.43 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 126.445 1.974 . . . . 0.0 115.327 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -119.78 125.19 47.99 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.259 1.53 . . . . 0.0 111.582 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 m -66.43 18.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.812 2.445 . . . . 0.0 116.088 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -82.68 172.58 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.3 1.84 . . . . 0.0 112.44 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.84 89.02 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.044 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.55 -23.72 61.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.27 156.86 31.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.86 1.664 . . . . 0.0 110.389 165.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.7 p -155.66 159.68 39.78 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.435 -0.791 . . . . 0.0 111.986 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -114.33 -27.4 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.71 1.204 . . . . 0.0 112.08 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -55.43 -49.67 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.889 1.675 . . . . 0.0 112.252 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -65.47 -26.2 67.83 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.928 0.891 . . . . 0.0 113.122 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -85.81 -74.4 0.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.658 1.583 . . . . 0.0 111.351 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -169.35 149.56 3.87 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.915 2.086 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.49 144.69 74.16 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.528 2.152 . . . . 0.0 111.872 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.57 112.17 19.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 110.221 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -100.05 124.94 45.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.927 0.891 . . . . 0.0 112.199 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.04 168.86 23.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.313 1.045 . . . . 0.0 113.425 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.07 126.72 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.692 1.197 . . . . 0.0 109.137 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.0 mm -49.41 113.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.527 1.531 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.16 69.09 0.66 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.668 1.604 . . . . 0.0 112.368 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -140.04 -33.76 0.57 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.158 1.383 . . . . 0.0 113.616 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.98 28.46 14.8 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.433 1.893 . . . . 0.0 114.821 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -81.36 -21.62 38.97 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.8 pt -73.8 169.22 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.853 1.661 . . . . 0.0 112.923 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -56.63 144.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.15 0.98 . . . . 0.0 112.083 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.06 73.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.007 0.923 . . . . 0.0 113.262 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.82 70.02 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 123.731 0.681 . . . . 0.0 114.349 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -93.22 -30.43 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.773 1.229 . . . . 0.0 112.353 173.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.23 -43.14 82.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 112.321 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.92 -41.96 9.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.155 1.382 . . . . 0.0 113.024 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.05 -23.81 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.708 -1.245 . . . . 0.0 113.633 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.81 -26.86 62.57 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -83.65 -44.2 14.79 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.216 1.806 . . . . 0.0 111.394 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 122.28 13.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.846 1.258 . . . . 0.0 111.987 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 159.46 15.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.452 1.501 . . . . 0.0 111.916 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -55.67 129.95 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.128 1.371 . . . . 0.0 112.464 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.9 13.68 82.29 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.43 1.014 . . . . 0.0 115.21 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -126.26 115.77 20.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.05 1.34 . . . . 0.0 111.814 -172.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -60.2 141.16 56.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.717 0.807 . . . . 0.0 112.309 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -136.98 115.1 11.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.256 1.422 . . . . 0.0 111.382 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -90.18 114.29 26.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.227 1.411 . . . . 0.0 110.594 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.39 106.56 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.249 1.42 . . . . 0.0 110.593 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.26 131.87 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.235 -0.916 . . . . 0.0 109.593 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.6 mt -121.81 139.62 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.691 1.596 . . . . 0.0 109.228 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.6 155.46 81.46 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.226 1.01 . . . . 0.0 111.969 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.65 -29.96 84.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.604 2.203 . . . . 0.0 113.308 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.66 -23.86 45.47 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 . . . . . 0 N--CA 1.477 0.877 0 C-N-CA 125.093 1.357 . . . . 0.0 113.758 -172.61 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.27 148.97 27.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.027 0.931 . . . . 0.0 110.853 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -140.07 108.52 5.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.656 1.182 . . . . 0.0 110.838 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.35 122.92 18.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.351 1.061 . . . . 0.0 111.148 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 p -136.05 137.96 26.32 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.492 1.917 . . . . 0.0 109.949 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.3 168.32 25.09 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.739 2.292 . . . . 0.0 112.428 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -69.46 21.19 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.412 2.285 . . . . 0.0 115.003 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.89 -19.91 19.19 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.429 1.891 . . . . 0.0 113.888 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -98.61 -9.65 24.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.818 1.247 . . . . 0.0 113.814 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.24 26.62 6.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.299 1.84 . . . . 0.0 112.647 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.29 105.43 0.23 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 111.174 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.78 -0.02 39.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.647 1.594 . . . . 0.0 115.75 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.8 mt -100.51 136.85 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.321 1.56 . . . . 0.0 110.387 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.06 76.61 10.05 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.08 1.752 . . . . 0.0 112.971 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 140.52 57.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.137 -0.977 . . . . 0.0 112.334 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.38 152.95 32.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.397 1.879 . . . . 0.0 110.869 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -72.83 108.41 5.78 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.461 170.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.19 57.56 1.29 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.492 1.044 . . . . 0.0 113.54 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.7 ptm -135.05 154.72 51.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.768 1.627 . . . . 0.0 111.319 167.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 p -79.74 119.03 22.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.148 0.979 . . . . 0.0 110.64 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.95 158.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.823 1.649 . . . . 0.0 110.34 173.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -125.82 153.84 43.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.168 1.387 . . . . 0.0 111.465 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.49 101.47 0.28 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.382 0.991 . . . . 0.0 112.608 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -65.14 128.54 36.2 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.939 -0.742 . . . . 0.0 110.985 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -105.78 155.67 19.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.453 1.501 . . . . 0.0 111.399 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.03 -20.07 65.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.301 1.44 . . . . 0.0 113.126 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -71.65 19.83 0.06 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.983 2.113 . . . . 0.0 114.192 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.5 m120 52.02 47.63 24.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.316 2.246 . . . . 0.0 112.915 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -142.12 177.78 7.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.719 1.607 . . . . 0.0 112.109 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.8 m -145.99 113.85 6.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.361 1.064 . . . . 0.0 111.373 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.41 164.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.338 0.655 . . . . 0.0 111.406 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -136.57 136.8 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.358 1.463 . . . . 0.0 111.346 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.11 -178.99 7.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.455 1.102 . . . . 0.0 113.361 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.08 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.411 1.484 . . . . 0.0 110.538 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.2 mt -76.99 120.2 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.13 0.972 . . . . 0.0 110.661 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.96 -31.06 16.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.169 1.388 . . . . 0.0 113.531 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -153.7 150.0 28.1 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.878 1.671 . . . . 0.0 110.673 171.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -141.18 155.01 46.12 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.926 0.89 . . . . 0.0 112.661 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -153.34 174.26 14.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.172 1.789 . . . . 0.0 111.135 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 -29.44 66.88 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.47 1.108 . . . . 0.0 113.187 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.1 p -80.57 -62.76 1.58 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.017 1.727 . . . . 0.0 111.944 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -135.53 166.64 22.73 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.226 2.21 . . . . 0.0 111.405 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.83 147.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.915 1.686 . . . . 0.0 109.319 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 28.4 mtm -121.11 101.57 7.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.177 1.391 . . . . 0.0 110.15 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.3 t -97.17 150.12 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.394 1.077 . . . . 0.0 110.131 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.35 130.68 47.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.653 0.781 . . . . 0.0 111.033 166.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 CA--C 1.539 0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 111.571 176.65 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 120.432 0.158 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -65.72 143.75 57.34 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.766 1.226 . . . . 0.0 112.808 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.9 mt -125.01 123.06 39.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.13 1.372 . . . . 0.0 111.356 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.74 99.51 5.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.967 1.307 . . . . 0.0 111.159 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -79.68 99.46 7.41 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.757 0.789 . . . . 0.0 110.186 165.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -91.74 120.55 32.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.114 1.365 . . . . 0.0 109.034 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -140.94 168.7 19.15 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -148.33 140.49 24.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.079 1.351 . . . . 0.0 111.43 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.09 102.4 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 163.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.29 -33.73 71.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 111.701 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.76 -139.07 10.63 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.265 1.888 . . . . 0.0 110.675 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -150.31 165.2 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.461 1.105 . . . . 0.0 112.374 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.468 0.458 0 C-N-CA 126.221 1.809 . . . . 0.0 110.813 171.678 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.767 0.317 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.22 101.16 7.83 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 109.593 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.28 144.13 31.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.096 1.358 . . . . 0.0 111.033 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.74 126.53 47.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.503 1.521 . . . . 0.0 109.932 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.15 156.83 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.323 1.049 . . . . 0.0 110.969 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -139.16 135.68 34.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.68 1.192 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -138.3 157.2 46.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.781 1.232 . . . . 0.0 113.574 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -139.62 152.85 47.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.439 1.896 . . . . 0.0 110.763 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.85 119.13 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.583 1.553 . . . . 0.0 109.693 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -139.13 145.66 39.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.764 1.625 . . . . 0.0 111.176 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.22 133.18 45.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.454 0.702 . . . . 0.0 111.215 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -57.74 111.33 1.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.155 0.982 . . . . 0.0 111.752 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 23.24 33.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.64 1.114 . . . . 0.0 115.634 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -128.21 165.48 20.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.119 1.46 . . . . 0.0 113.579 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.2 m -99.15 -8.35 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.428 1.891 . . . . 0.0 113.865 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 166.98 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.643 0.777 . . . . 0.0 111.704 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.35 116.04 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.404 1.482 . . . . 0.0 108.751 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.58 -48.73 37.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.588 0.755 . . . . 0.0 111.026 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.27 162.04 36.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.16 1.384 . . . . 0.0 112.025 170.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -161.52 168.4 23.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.141 . . . . 0.0 112.494 168.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -123.82 -1.71 8.37 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 164.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.54 -60.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.733 1.613 . . . . 0.0 112.156 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -73.67 -22.98 59.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -74.5 -72.94 0.26 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.934 1.693 . . . . 0.0 112.067 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -169.7 118.65 0.55 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.083 2.153 . . . . 0.0 109.846 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -62.76 152.04 80.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.862 2.374 . . . . 0.0 112.706 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.8 tp -83.6 98.56 9.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.629 1.572 . . . . 0.0 110.873 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -71.11 117.51 12.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.357 1.463 . . . . 0.0 110.98 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -144.76 175.43 10.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.441 1.096 . . . . 0.0 113.129 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -113.48 137.52 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.456 1.502 . . . . 0.0 110.138 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -51.65 110.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.166 1.386 . . . . 0.0 111.086 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.94 -1.61 24.31 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.723 1.63 . . . . 0.0 115.677 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 m -70.69 -44.88 66.04 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.338 1.569 . . . . 0.0 112.531 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.3 m120 50.59 31.5 5.76 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.16 2.184 . . . . 0.0 116.013 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -13.81 61.19 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -69.63 168.31 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.843 1.657 . . . . 0.0 113.363 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -58.73 144.62 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.403 1.081 . . . . 0.0 111.953 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.7 -37.01 77.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.39 -29.11 73.56 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.672 -0.643 . . . . 0.0 113.82 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.03 -32.47 17.57 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 111.963 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -54.56 -47.31 73.41 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.061 1.344 . . . . 0.0 111.992 172.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -71.43 -10.81 60.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.67 -50.99 5.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.104 1.362 . . . . 0.0 112.485 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.04 -24.89 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -66.09 -19.99 66.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -106.0 -17.89 14.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.128 1.371 . . . . 0.0 114.187 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.97 118.65 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.667 1.187 . . . . 0.0 112.554 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -83.96 158.62 21.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 112.4 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -56.89 130.17 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.079 1.352 . . . . 0.0 111.595 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.97 11.81 78.88 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.977 1.275 . . . . 0.0 115.271 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -116.43 112.37 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.901 1.351 . . . . 0.0 111.763 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -60.33 143.21 53.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.189 0.995 . . . . 0.0 112.165 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -142.23 145.27 33.91 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.768 1.227 . . . . 0.0 111.476 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -126.08 113.16 16.72 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.869 1.668 . . . . 0.0 109.864 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -118.69 111.34 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.678 1.191 . . . . 0.0 110.533 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 t -76.45 128.39 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.919 0.888 . . . . 0.0 109.512 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 mt -124.83 139.4 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.461 1.505 . . . . 0.0 109.822 -174.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.09 151.66 97.03 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 112.133 173.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.6 -36.24 43.44 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.587 2.191 . . . . 0.0 112.508 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -67.31 -21.08 65.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.869 1.268 . . . . 0.0 114.166 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.761 1.224 . . . . 0.0 113.216 177.877 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.9 p90 . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.26 115.05 21.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.078 -1.014 . . . . 0.0 110.533 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -102.44 118.85 37.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.664 1.186 . . . . 0.0 110.814 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.47 128.83 36.79 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.82 0.848 . . . . 0.0 110.676 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 139.86 17.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.31 1.844 . . . . 0.0 109.613 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.09 154.95 62.17 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.458 2.105 . . . . 0.0 112.684 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -68.95 -4.56 17.16 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.39 -35.18 37.73 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 112.963 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -88.48 -2.97 58.89 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.323 1.449 . . . . 0.0 113.797 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -131.79 25.52 4.68 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.314 2.246 . . . . 0.0 112.326 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.64 105.49 1.24 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.793 1.637 . . . . 0.0 111.426 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.72 -9.14 56.83 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.725 1.631 . . . . 0.0 115.048 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.5 mt -88.38 126.13 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 109.634 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.36 130.92 45.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.609 0.763 . . . . 0.0 112.058 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.2 mt -124.77 138.57 54.27 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.723 1.609 . . . . 0.0 110.521 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -154.15 158.04 39.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.202 1.401 . . . . 0.0 111.01 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.13 119.32 10.61 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.949 -1.095 . . . . 0.0 111.16 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.94 43.11 5.16 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.09 0.852 . . . . 0.0 115.2 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 ptm -132.89 152.13 51.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.84 1.256 . . . . 0.0 111.889 168.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -74.03 134.09 42.98 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.351 1.06 . . . . 0.0 111.327 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.62 146.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.003 2.121 . . . . 0.0 110.592 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 133.89 41.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.94 1.296 . . . . 0.0 111.425 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.17 93.34 0.55 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.216 1.388 . . . . 0.0 112.196 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -63.74 144.46 57.01 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.961 0.88 . . . . 0.0 111.237 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 t -129.26 156.52 43.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.063 1.345 . . . . 0.0 112.435 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.14 -17.16 64.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.503 1.921 . . . . 0.0 113.474 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -74.81 16.63 0.27 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.34 1.856 . . . . 0.0 113.714 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.86 48.75 17.42 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.108 2.163 . . . . 0.0 112.511 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -143.36 176.32 9.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.96 1.704 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -146.62 113.53 6.12 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.674 1.189 . . . . 0.0 111.642 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.0 169.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.403 0.681 . . . . 0.0 111.717 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -135.72 124.83 24.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.426 1.49 . . . . 0.0 110.595 172.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.25 175.42 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.669 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -110.84 131.98 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 111.534 -171.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 56.7 mt -67.81 134.27 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.854 1.662 . . . . 0.0 111.304 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -112.39 -34.35 5.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.393 1.877 . . . . 0.0 113.299 -174.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -151.82 162.49 40.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.147 1.379 . . . . 0.0 110.855 169.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.81 158.36 43.74 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.9 m -140.0 176.6 8.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.159 2.184 . . . . 0.0 111.081 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.94 76.09 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 67.4 p -128.73 -3.57 5.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.842 1.657 . . . . 0.0 114.419 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -140.98 166.38 24.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.974 1.709 . . . . 0.0 111.679 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.71 157.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.602 1.561 . . . . 0.0 110.419 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.1 mtp -120.22 123.02 42.22 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.79 1.636 . . . . 0.0 109.771 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.69 143.46 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.35 1.46 . . . . 0.0 109.357 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -69.84 110.89 5.21 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.75 -0.594 . . . . 0.0 111.366 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 126.733 2.013 . . . . 0.0 111.779 178.951 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -66.6 145.33 55.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.89 1.676 . . . . 0.0 112.43 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.9 mt -133.92 147.75 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.294 1.437 . . . . 0.0 111.728 -174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.47 103.25 15.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 111.196 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -79.81 97.6 6.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.288 0.635 . . . . 0.0 109.405 161.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -89.63 140.42 29.57 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 170.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -150.34 169.39 21.51 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -146.25 150.5 35.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.391 1.476 . . . . 0.0 111.237 169.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.54 109.2 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 108.548 167.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.72 -36.85 84.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.184 0.593 . . . . 0.0 111.114 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.2 -164.07 25.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.114 1.816 . . . . 0.0 111.963 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.31 157.7 45.43 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.663 1.585 . . . . 0.0 111.291 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 C-N-CA 124.971 1.309 . . . . 0.0 111.269 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.051 0.453 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -144.32 129.11 18.31 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.101 0.961 . . . . 0.0 111.011 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -88.37 76.97 8.24 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.079 1.351 . . . . 0.0 111.247 175.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -137.72 171.26 14.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.264 1.825 . . . . 0.0 111.876 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -63.99 162.94 13.06 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.199 1.399 . . . . 0.0 113.433 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.77 94.55 3.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.968 1.307 . . . . 0.0 110.968 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -70.51 13.62 0.17 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.893 1.677 . . . . 0.0 114.52 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.9 m -71.25 -18.02 62.46 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.984 1.714 . . . . 0.0 114.494 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -86.12 131.02 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.686 1.195 . . . . 0.0 110.212 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -61.38 152.04 30.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.315 1.846 . . . . 0.0 113.689 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -139.85 152.72 46.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.61 1.564 . . . . 0.0 111.331 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.19 99.58 12.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.173 1.389 . . . . 0.0 110.679 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.08 106.04 13.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.546 1.539 . . . . 0.0 111.273 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.63 134.86 35.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 pt -132.46 167.16 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.48 1.512 . . . . 0.0 111.731 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -143.5 136.0 27.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.446 1.899 . . . . 0.0 110.394 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.3 153.04 51.29 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.419 1.488 . . . . 0.0 113.89 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -141.03 121.73 14.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.476 2.31 . . . . 0.0 109.483 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.12 103.46 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.498 1.119 . . . . 0.0 110.186 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -113.92 159.32 20.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.694 1.598 . . . . 0.0 110.623 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.55 147.2 29.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.002 -1.061 . . . . 0.0 111.506 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -64.14 125.57 24.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.389 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.01 -52.91 4.69 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.47 1.51 . . . . 0.0 114.201 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -61.16 143.79 54.87 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.52 1.528 . . . . 0.0 112.818 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -79.27 -13.91 59.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.87 155.98 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.708 1.203 . . . . 0.0 111.362 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.3 144.12 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.407 1.483 . . . . 0.0 110.664 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.58 -52.87 4.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.256 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.9 157.83 36.97 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.626 1.57 . . . . 0.0 111.048 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.3 p -151.05 144.7 25.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.295 1.038 . . . . 0.0 111.828 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.47 -17.85 15.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 167.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -56.49 -46.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.636 1.574 . . . . 0.0 112.019 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 t -68.54 -29.81 68.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -78.09 -72.97 0.34 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.777 1.631 . . . . 0.0 111.748 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -175.48 151.91 1.32 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 128.171 2.588 . . . . 0.0 110.016 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.92 170.86 15.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.66 2.906 . . . . 0.0 113.428 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 tt -124.0 108.55 12.51 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.251 1.42 . . . . 0.0 110.556 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.8 141.65 32.15 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.728 1.211 . . . . 0.0 112.968 170.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -144.12 164.74 29.8 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.256 1.423 . . . . 0.0 111.364 166.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.7 mm -84.1 138.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.702 0.801 . . . . 0.0 110.139 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 mm -47.86 109.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.523 1.529 . . . . 0.0 111.3 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -27.79 6.68 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.244 1.878 . . . . 0.0 114.315 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.6 m -85.25 72.77 10.69 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.922 1.361 . . . . 0.0 111.466 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 72.58 4.83 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.76 -1.213 . . . . 0.0 111.854 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -72.38 -11.84 60.86 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.0 pt -66.76 169.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 127.186 2.194 . . . . 0.0 113.188 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -58.84 147.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.909 1.284 . . . . 0.0 112.46 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.6 74.25 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.53 -36.84 93.66 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 121.194 -0.941 . . . . 0.0 113.109 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 tp -80.87 -28.11 36.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.744 1.218 . . . . 0.0 112.595 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -57.39 -42.78 82.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.431 1.092 . . . . 0.0 112.64 173.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -75.23 -14.93 60.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.67 -47.83 8.36 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.969 1.308 . . . . 0.0 112.645 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.02 -30.71 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.403 1.081 . . . . 0.0 113.615 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.09 -21.98 64.02 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -97.23 -23.04 16.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.811 1.645 . . . . 0.0 113.453 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.38 127.23 32.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.979 1.311 . . . . 0.0 112.28 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -83.62 162.81 20.68 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.925 0.89 . . . . 0.0 111.966 172.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.5 133.19 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.06 1.344 . . . . 0.0 111.692 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.42 13.37 81.71 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.44 1.019 . . . . 0.0 115.307 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -121.48 112.73 18.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.089 1.356 . . . . 0.0 111.832 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -59.92 141.01 56.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.046 0.938 . . . . 0.0 112.029 172.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -141.9 144.03 33.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.95 1.3 . . . . 0.0 111.042 174.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.29 110.96 13.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.672 1.189 . . . . 0.0 110.287 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -113.84 107.97 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.884 1.274 . . . . 0.0 110.839 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.08 126.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.201 1.0 . . . . 0.0 109.657 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.0 mt -124.69 138.56 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.694 1.597 . . . . 0.0 109.065 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 160.32 82.68 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.14 0.976 . . . . 0.0 112.178 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.05 -38.89 14.93 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.5 2.133 . . . . 0.0 111.786 -175.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.46 -12.48 61.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.117 1.767 . . . . 0.0 114.468 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.65 -1.02 26.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.956 1.702 . . . . 0.0 113.046 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.34 -65.28 1.21 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.525 1.53 . . . . 0.0 112.09 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -127.91 -20.33 3.87 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.2 25.18 68.0 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 t -64.22 -41.94 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.445 1.098 . . . . 0.0 112.38 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.97 92.04 2.69 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.478 1.111 . . . . 0.0 110.837 -172.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.89 163.45 7.61 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.385 1.474 . . . . 0.0 113.379 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.9 p -113.77 34.92 4.31 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.641 1.976 . . . . 0.0 112.782 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 t -123.48 106.42 10.6 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.283 1.833 . . . . 0.0 110.715 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -137.04 139.43 41.35 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.243 1.817 . . . . 0.0 110.863 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.395 -0.816 . . . . 0.0 111.342 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -134.99 125.22 26.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.994 1.718 . . . . 0.0 110.24 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -74.43 119.05 18.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.024 0.93 . . . . 0.0 110.611 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.34 134.52 25.57 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 109.189 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.22 144.11 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.245 1.963 . . . . 0.0 111.582 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -62.07 -14.17 33.61 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.26 -31.34 61.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.58 1.552 . . . . 0.0 113.267 169.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -70.56 -11.58 61.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.415 1.086 . . . . 0.0 113.901 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -132.63 16.88 4.35 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.883 1.673 . . . . 0.0 113.317 -167.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.76 -18.83 14.05 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -172.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.99 6.7 12.09 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.823 1.678 . . . . 0.0 115.426 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.6 pt -137.6 114.86 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.837 1.655 . . . . 0.0 111.31 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -66.39 154.03 41.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.523 1.129 . . . . 0.0 113.39 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.4 mt -132.74 162.85 30.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.823 . . . . 0.0 111.121 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -155.74 162.75 40.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.194 1.398 . . . . 0.0 110.599 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -69.88 129.49 39.67 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.431 -1.418 . . . . 0.0 110.436 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.99 65.47 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.724 1.05 . . . . 0.0 115.724 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp -97.26 150.2 21.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.282 1.541 . . . . 0.0 112.682 171.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 p -72.47 108.44 5.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 111.039 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.73 161.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.717 1.607 . . . . 0.0 110.934 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.52 154.55 40.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.12 1.368 . . . . 0.0 111.484 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.73 108.71 0.47 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.353 0.978 . . . . 0.0 113.084 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -73.33 111.4 8.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 111.575 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.3 t -80.83 158.19 25.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.563 1.145 . . . . 0.0 111.924 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.98 -17.36 63.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.386 1.474 . . . . 0.0 113.682 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.08 20.41 0.14 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.845 1.658 . . . . 0.0 113.911 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 50.22 48.0 22.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.346 2.259 . . . . 0.0 113.073 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -142.36 173.41 11.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.926 1.69 . . . . 0.0 111.736 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.0 m -141.07 107.84 5.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.629 1.171 . . . . 0.0 110.643 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.2 166.44 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.753 -0.592 . . . . 0.0 111.419 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -128.04 137.48 52.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.526 1.53 . . . . 0.0 110.879 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.8 178.98 9.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 113.206 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -126.82 125.65 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.186 0.994 . . . . 0.0 111.394 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.2 mt -72.78 129.02 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.475 1.11 . . . . 0.0 111.128 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -98.06 -35.89 10.28 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.692 1.597 . . . . 0.0 113.305 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -150.7 147.98 28.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.141 1.376 . . . . 0.0 110.164 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -140.01 136.93 34.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.169 0.987 . . . . 0.0 111.704 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.8 t -137.07 168.7 19.09 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.189 1.796 . . . . 0.0 110.154 172.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.33 63.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.099 0.96 . . . . 0.0 113.528 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 p -83.82 -62.05 1.67 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.233 1.813 . . . . 0.0 111.75 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -136.0 165.03 26.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.007 2.123 . . . . 0.0 111.707 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.634 1.573 . . . . 0.0 110.328 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mmm -120.64 105.28 10.64 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.727 2.011 . . . . 0.0 109.332 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 t -112.02 133.76 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 0.0 110.237 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.48 129.99 41.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.722 0.809 . . . . 0.0 111.32 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -136.34 163.81 29.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.656 1.582 . . . . 0.0 111.17 170.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -79.98 169.55 17.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.324 1.05 . . . . 0.0 112.701 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 144.6 17.51 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.571 1.148 . . . . 0.0 110.497 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.38 -9.19 24.84 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.147 2.565 . . . . 0.0 114.195 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.6 -17.93 62.89 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.53 1.532 . . . . 0.0 112.967 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.76 -176.33 0.64 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.483 1.513 . . . . 0.0 113.429 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.1 176.75 9.34 Favored Glycine 0 CA--C 1.543 1.81 0 O-C-N 121.334 -0.854 . . . . 0.0 114.184 166.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 168.65 19.12 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.158 2.183 . . . . 0.0 111.331 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -69.75 141.95 53.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.865 1.266 . . . . 0.0 112.369 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.64 147.97 49.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.534 1.534 . . . . 0.0 110.974 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.77 96.9 9.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.965 1.706 . . . . 0.0 111.074 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -76.86 95.72 4.15 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.799 0.84 . . . . 0.0 109.801 164.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -86.35 143.23 27.96 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.554 -0.716 . . . . 0.0 110.216 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -151.69 170.33 19.99 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -145.92 142.68 28.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.12 1.368 . . . . 0.0 111.306 168.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.25 101.97 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.438 1.095 . . . . 0.0 108.445 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.82 -37.4 86.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.243 1.017 . . . . 0.0 111.574 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 133.78 166.15 11.23 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.049 1.785 . . . . 0.0 113.29 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -98.54 146.92 25.3 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.492 1.117 . . . . 0.0 111.815 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -142.08 147.85 37.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.662 1.585 . . . . 0.0 111.31 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -74.51 136.58 42.2 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.983 0.513 . . . . 0.0 110.379 170.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.8 m -133.89 160.3 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.777 1.631 . . . . 0.0 111.062 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.6 m -135.86 156.66 48.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.995 1.318 . . . . 0.0 112.087 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -90.94 55.48 2.93 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.16 1.384 . . . . 0.0 111.567 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -138.19 -73.19 0.41 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.77 1.228 . . . . 0.0 111.43 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.187 1.395 . . . . 0.0 113.399 173.977 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 44.15 47.43 7.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.031 2.132 . . . . 0.0 113.98 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -126.92 22.37 6.75 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.403 1.881 . . . . 0.0 113.724 -169.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -98.16 70.3 2.05 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.771 1.628 . . . . 0.0 110.978 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.29 150.27 36.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.549 1.14 . . . . 0.0 111.985 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -120.39 148.18 44.11 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.954 1.702 . . . . 0.0 111.551 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -77.67 5.35 9.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.719 1.608 . . . . 0.0 114.083 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.1 m -69.36 8.27 0.64 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.473 1.909 . . . . 0.0 114.741 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.2 mm -55.4 144.34 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.561 1.944 . . . . 0.0 111.261 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -111.65 167.32 10.43 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.117 1.767 . . . . 0.0 111.812 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -146.03 153.04 40.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.062 1.345 . . . . 0.0 111.863 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 102.77 10.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.817 1.247 . . . . 0.0 110.618 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.68 118.88 24.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.038 1.335 . . . . 0.0 111.132 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.83 129.46 45.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.775 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.23 165.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.182 . . . . 0.0 111.896 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.46 136.27 34.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.913 1.685 . . . . 0.0 110.121 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.58 154.08 50.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 113.723 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.75 121.11 12.34 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 109.403 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.95 111.47 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 110.472 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -121.27 134.67 55.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.849 1.659 . . . . 0.0 109.229 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -63.67 152.77 38.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.984 -1.072 . . . . 0.0 111.103 165.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -71.46 151.63 43.8 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.394 -0.816 . . . . 0.0 110.832 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.6 -66.29 3.95 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.826 1.203 . . . . 0.0 113.987 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -65.29 141.58 58.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.01 0.905 . . . . 0.0 113.096 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 m -82.06 -15.33 53.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.69 176.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.284 1.033 . . . . 0.0 111.356 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.74 143.22 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.134 1.374 . . . . 0.0 111.274 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 mt -75.84 -57.15 4.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.126 0.971 . . . . 0.0 111.011 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -155.18 157.6 37.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.876 1.27 . . . . 0.0 111.746 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.3 p -155.02 137.06 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.777 1.231 . . . . 0.0 112.179 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.67 -18.06 19.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 166.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -56.94 -43.66 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.643 1.577 . . . . 0.0 112.047 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 t -72.25 -8.82 56.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.088 1.355 . . . . 0.0 113.976 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -107.87 -73.32 0.69 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.364 1.866 . . . . 0.0 110.889 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.52 152.53 6.82 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.966 2.507 . . . . 0.0 110.357 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.79 159.71 52.64 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.78 2.32 . . . . 0.0 112.553 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 tt -104.2 108.93 20.55 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.62 1.568 . . . . 0.0 109.544 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.97 130.76 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.489 1.516 . . . . 0.0 112.158 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.6 162.88 37.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.185 0.994 . . . . 0.0 111.963 167.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.0 mm -81.62 137.91 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.68 0.792 . . . . 0.0 109.033 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.69 104.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.507 1.123 . . . . 0.0 110.879 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.05 39.41 0.23 Allowed Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.508 1.528 . . . . 0.0 116.116 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.6 m -122.79 -31.66 3.65 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.141 1.47 . . . . 0.0 114.256 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 57.59 31.06 19.77 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.668 1.587 . . . . 0.0 114.425 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -69.74 -19.79 63.53 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.6 pt -75.84 168.0 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.298 1.439 . . . . 0.0 112.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.7 pt -59.16 148.14 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.556 1.143 . . . . 0.0 111.96 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.04 84.2 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.94 0.896 . . . . 0.0 113.298 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.88 68.84 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.051 0.834 . . . . 0.0 114.656 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.12 -36.62 11.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.382 1.473 . . . . 0.0 111.555 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -56.17 -44.25 79.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.401 1.081 . . . . 0.0 111.921 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -76.67 12.31 1.35 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.886 1.274 . . . . 0.0 113.802 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.52 -45.24 2.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.973 1.709 . . . . 0.0 113.121 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.5 m -55.5 -28.19 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -62.76 -16.45 57.9 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -110.92 -5.35 14.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.142 1.377 . . . . 0.0 113.627 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.95 114.02 18.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.012 1.325 . . . . 0.0 112.331 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -71.57 157.18 38.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.833 0.825 . . . . 0.0 112.369 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.18 135.65 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.53 1.532 . . . . 0.0 112.027 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.71 16.34 74.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.63 1.11 . . . . 0.0 115.094 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -122.19 111.7 17.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.318 1.447 . . . . 0.0 111.178 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -58.5 142.77 47.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.78 0.832 . . . . 0.0 112.163 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -142.46 141.21 32.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.777 1.231 . . . . 0.0 111.19 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -125.79 105.23 8.81 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.272 1.429 . . . . 0.0 110.329 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.67 106.8 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.865 1.266 . . . . 0.0 111.109 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.58 128.99 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.371 1.069 . . . . 0.0 109.783 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.96 145.79 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.939 1.696 . . . . 0.0 109.664 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.63 156.96 81.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.364 1.466 . . . . 0.0 113.283 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.15 -3.14 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.036 3.157 . . . . 0.0 116.634 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.83 -4.06 12.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.602 1.161 . . . . 0.0 113.502 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -111.49 -6.45 14.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.503 1.521 . . . . 0.0 113.637 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.04 91.06 2.54 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.87 1.668 . . . . 0.0 111.352 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 40.21 67.46 0.49 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.716 2.006 . . . . 0.0 112.547 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.71 100.99 0.48 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.742 1.163 . . . . 0.0 114.172 -170.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.3 m -126.06 139.6 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.83 1.652 . . . . 0.0 111.181 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -71.09 154.44 41.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.18 1.392 . . . . 0.0 111.363 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.93 131.25 47.11 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.176 -0.952 . . . . 0.0 110.343 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -61.61 -20.81 63.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 73.9 m -144.97 82.14 1.66 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.826 2.05 . . . . 0.0 111.22 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -76.78 156.42 32.36 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.11 -0.994 . . . . 0.0 111.991 171.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.53 138.78 45.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.132 1.773 . . . . 0.0 110.456 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -134.02 113.35 12.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 111.238 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -79.17 96.42 5.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.931 1.292 . . . . 0.0 111.33 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -94.74 137.33 22.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.319 1.847 . . . . 0.0 109.799 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.7 158.51 50.38 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.901 2.401 . . . . 0.0 112.13 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -76.27 65.24 2.18 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.371 1.068 . . . . 0.0 111.813 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -133.3 -36.43 0.99 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.421 1.889 . . . . 0.0 112.599 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -74.02 -12.37 60.61 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 171.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.14 28.54 6.04 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.977 1.711 . . . . 0.0 112.631 -171.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -11.94 60.77 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.95 5.42 6.46 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.772 1.653 . . . . 0.0 115.33 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 pt -138.21 122.29 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.509 1.924 . . . . 0.0 110.463 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -68.33 154.87 40.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.1 0.96 . . . . 0.0 113.34 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -133.16 159.4 40.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.482 1.913 . . . . 0.0 110.832 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -155.53 164.36 38.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 110.574 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -67.12 132.39 47.73 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.626 -1.296 . . . . 0.0 110.599 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.85 43.59 65.68 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.188 0.899 . . . . 0.0 114.655 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.38 145.3 47.31 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.55 1.14 . . . . 0.0 111.952 170.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -68.96 123.93 22.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.656 1.182 . . . . 0.0 110.679 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.33 155.58 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.514 1.526 . . . . 0.0 111.398 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -90.37 144.72 25.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.455 1.102 . . . . 0.0 111.608 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.03 96.94 0.49 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -65.31 144.31 57.21 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.267 1.034 . . . . 0.0 111.261 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.1 t -125.27 154.61 41.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.244 1.418 . . . . 0.0 112.151 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.4 -15.65 60.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.618 1.967 . . . . 0.0 113.65 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.38 15.71 0.43 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.44 1.896 . . . . 0.0 113.777 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.53 48.53 20.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 112.564 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -142.7 179.96 6.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.764 1.626 . . . . 0.0 112.202 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.6 m -145.73 127.91 15.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.563 1.145 . . . . 0.0 111.766 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -98.52 172.8 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.998 1.319 . . . . 0.0 112.104 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -121.19 119.98 33.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.183 1.793 . . . . 0.0 109.924 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -136.25 177.99 7.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.262 1.825 . . . . 0.0 112.415 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.23 131.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.165 1.386 . . . . 0.0 110.001 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -72.47 129.02 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.199 1.0 . . . . 0.0 110.663 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -93.98 -43.33 8.59 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.83 1.252 . . . . 0.0 112.359 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -144.45 152.74 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.004 1.322 . . . . 0.0 111.1 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.97 148.65 34.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.805 1.242 . . . . 0.0 112.431 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.7 t -152.34 171.51 17.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.724 2.01 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.28 -24.5 64.88 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.562 1.145 . . . . 0.0 113.352 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.2 p -84.31 -61.43 1.81 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.456 1.903 . . . . 0.0 112.571 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.27 166.02 24.78 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.277 2.231 . . . . 0.0 111.764 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.21 137.23 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 110.562 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 26.3 mmm -109.85 99.44 8.58 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.737 2.015 . . . . 0.0 109.601 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -98.2 149.89 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.346 1.059 . . . . 0.0 111.328 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.97 141.76 45.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 111.694 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -137.78 165.54 26.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.264 1.425 . . . . 0.0 111.697 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -147.19 92.43 2.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.278 1.431 . . . . 0.0 110.521 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -86.26 131.1 47.33 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.478 0.711 . . . . 0.0 110.565 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.07 -16.99 32.05 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.855 2.37 . . . . 0.0 114.084 -174.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.5 mt -111.31 77.07 1.01 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.995 1.718 . . . . 0.0 109.968 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.96 173.46 16.76 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.606 1.163 . . . . 0.0 113.34 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.06 -179.45 31.08 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.857 2.17 . . . . 0.0 113.321 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -139.36 165.98 25.78 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.032 1.733 . . . . 0.0 112.868 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.4 p -63.97 137.21 57.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.99 1.316 . . . . 0.0 113.227 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 mt -123.12 125.51 45.3 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.339 1.456 . . . . 0.0 111.842 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.97 96.39 6.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.177 1.391 . . . . 0.0 111.157 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.79 97.47 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.636 0.774 . . . . 0.0 109.233 162.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.34 142.75 27.65 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.111 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -150.97 170.75 18.58 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -148.72 137.8 21.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.167 1.387 . . . . 0.0 111.183 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.6 t -80.95 103.02 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.46 1.104 . . . . 0.0 108.341 166.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.9 mt -66.89 -28.3 68.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.906 0.482 . . . . 0.0 112.139 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.13 -179.01 16.6 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.612 2.053 . . . . 0.0 112.254 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -115.49 154.76 28.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.049 0.94 . . . . 0.0 112.03 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -132.71 124.79 28.84 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.691 1.596 . . . . 0.0 111.108 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -70.72 127.07 31.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.72 1.208 . . . . 0.0 110.337 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.88 130.77 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.597 1.159 . . . . 0.0 111.342 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.2 m -146.23 157.38 43.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.296 1.439 . . . . 0.0 111.966 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -88.17 -9.55 52.76 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.671 1.188 . . . . 0.0 113.601 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.79 -46.49 65.63 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.062 1.345 . . . . 0.0 112.753 -174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 125.721 1.608 . . . . 0.0 113.179 172.326 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtm . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -154.45 175.38 13.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.12 1.768 . . . . 0.0 110.954 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -60.53 147.79 40.16 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.795 0.838 . . . . 0.0 112.141 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -74.26 -83.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.468 1.107 . . . . 0.0 111.458 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -160.04 165.33 32.09 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.263 1.425 . . . . 0.0 111.24 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 mt -76.52 152.33 36.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.881 0.872 . . . . 0.0 111.925 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -140.69 109.55 6.04 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.831 1.652 . . . . 0.0 110.034 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 m -68.65 -27.65 66.19 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.1 mm -73.76 145.18 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.467 1.507 . . . . 0.0 109.621 172.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.29 160.91 14.84 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.492 -0.755 . . . . 0.0 112.745 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -146.76 145.0 29.8 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.013 1.325 . . . . 0.0 110.483 168.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.88 104.16 7.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.923 . . . . 0.0 110.136 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.63 143.12 29.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.772 1.229 . . . . 0.0 111.123 172.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.92 139.48 53.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.511 1.524 . . . . 0.0 110.767 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.82 159.32 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.488 1.115 . . . . 0.0 111.386 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -133.28 134.42 43.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.902 1.681 . . . . 0.0 109.133 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -138.43 152.09 48.04 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -134.67 128.11 32.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.702 2.801 . . . . 0.0 108.828 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.19 119.28 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.294 1.038 . . . . 0.0 111.004 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -132.22 147.45 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.788 1.635 . . . . 0.0 112.166 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -66.71 136.5 55.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.628 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -72.85 78.26 1.14 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.23 1.014 . . . . 0.0 113.313 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.66 -53.29 0.52 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.966 1.746 . . . . 0.0 112.33 172.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -68.55 147.43 51.97 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.924 1.29 . . . . 0.0 112.261 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.0 p -79.05 -6.77 57.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.43 162.35 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.186 1.394 . . . . 0.0 112.086 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.17 108.42 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.851 1.26 . . . . 0.0 109.272 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.44 -46.25 77.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.537 1.135 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.38 168.58 26.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.006 1.322 . . . . 0.0 111.233 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -155.55 157.51 36.95 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 112.902 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.45 -16.08 8.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.064 1.346 . . . . 0.0 112.782 168.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -55.39 -60.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 126.155 1.782 . . . . 0.0 111.912 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -69.03 -22.4 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.485 1.114 . . . . 0.0 113.035 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.48 -74.02 0.31 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.744 1.617 . . . . 0.0 111.711 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -168.64 125.98 0.86 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.174 1.79 . . . . 0.0 110.64 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.29 142.36 85.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.65 2.233 . . . . 0.0 112.027 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.01 101.56 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 0.0 110.387 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 130.3 34.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.202 1.401 . . . . 0.0 112.035 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.41 169.46 23.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.085 1.354 . . . . 0.0 112.47 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -94.49 139.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.334 1.053 . . . . 0.0 108.706 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.4 111.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.814 1.646 . . . . 0.0 112.14 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.38 74.31 0.69 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.962 1.744 . . . . 0.0 113.708 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.4 m -131.05 -37.79 1.26 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.039 1.336 . . . . 0.0 113.569 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.98 35.3 26.22 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 125.66 1.584 . . . . 0.0 114.523 172.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -99.58 -13.48 19.41 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 pt -68.92 167.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.614 1.166 . . . . 0.0 111.706 171.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 pt -55.71 142.34 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.619 -0.676 . . . . 0.0 110.893 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.17 72.68 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.292 -0.88 . . . . 0.0 112.868 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -45.07 87.02 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.142 0.877 . . . . 0.0 113.207 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.85 -31.1 59.17 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.355 1.062 . . . . 0.0 112.339 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.46 -48.31 82.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.616 1.166 . . . . 0.0 111.829 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -68.86 -5.44 21.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.63 -51.43 3.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.705 1.602 . . . . 0.0 112.852 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 p -54.95 -31.95 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.959 1.303 . . . . 0.0 114.079 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.99 -17.49 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -106.02 -7.95 17.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.736 2.014 . . . . 0.0 114.11 175.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.51 118.84 25.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.083 1.353 . . . . 0.0 112.337 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -77.33 160.21 28.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.914 0.886 . . . . 0.0 112.202 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -53.59 129.34 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.506 1.522 . . . . 0.0 111.647 170.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.95 -0.19 67.22 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.787 1.184 . . . . 0.0 115.866 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -97.04 113.07 24.58 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.411 1.606 . . . . 0.0 112.087 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -55.99 135.12 52.66 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.52 0.728 . . . . 0.0 111.103 164.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -137.79 113.18 9.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 0.0 110.93 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.83 98.45 11.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 110.242 172.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.27 153.11 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.824 0.85 . . . . 0.0 110.237 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.37 124.68 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.987 1.315 . . . . 0.0 109.988 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.94 134.12 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.115 1.766 . . . . 0.0 110.244 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.64 159.12 70.7 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.203 1.401 . . . . 0.0 112.936 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.83 50.56 2.5 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.682 3.588 . . . . 0.0 113.839 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.99 1.53 2.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.777 2.031 . . . . 0.0 113.15 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -147.04 -56.66 0.25 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.447 1.499 . . . . 0.0 111.761 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.64 74.51 1.08 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.502 1.121 . . . . 0.0 111.544 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 42.51 70.85 0.25 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.613 2.365 . . . . 0.0 112.989 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.08 78.19 0.29 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.01 1.766 . . . . 0.0 113.808 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.79 130.36 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.884 2.073 . . . . 0.0 109.504 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -65.61 166.92 9.82 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.685 1.194 . . . . 0.0 112.654 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -112.27 142.7 44.45 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.147 -0.971 . . . . 0.0 112.075 171.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -73.62 1.84 9.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.217 1.407 . . . . 0.0 113.846 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.8 p -145.14 52.51 1.21 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.776 2.031 . . . . 0.0 112.291 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -60.7 163.19 5.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.229 1.012 . . . . 0.0 112.173 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.14 146.1 47.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.074 1.35 . . . . 0.0 110.216 169.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -134.97 107.37 7.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.823 1.249 . . . . 0.0 110.121 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.4 121.47 18.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.049 0.54 . . . . 0.0 110.102 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.5 m -135.42 159.24 72.41 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.176 1.79 . . . . 0.0 110.724 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.21 165.21 31.46 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.325 2.016 . . . . 0.0 111.819 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -69.73 10.76 0.34 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.68 -43.48 97.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.451 1.5 . . . . 0.0 113.429 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -69.26 -21.92 63.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.049 0.94 . . . . 0.0 113.379 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -132.58 50.02 2.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.957 1.703 . . . . 0.0 111.391 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.07 -27.21 67.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.779 1.232 . . . . 0.0 113.0 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.43 34.02 1.64 Allowed Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.993 1.759 . . . . 0.0 114.094 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.64 128.82 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 126.643 1.977 . . . . 0.0 108.794 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -64.99 142.07 58.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.029 0.932 . . . . 0.0 111.762 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.41 146.02 51.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.736 1.614 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.45 145.06 20.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.622 1.169 . . . . 0.0 111.547 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.99 90.48 0.18 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.994 1.717 . . . . 0.0 110.579 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.51 -4.37 8.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.869 1.7 . . . . 0.0 116.58 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.5 159.41 32.27 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.482 2.141 . . . . 0.0 113.023 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -84.62 126.03 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 0.0 110.846 165.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.2 149.46 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.644 1.977 . . . . 0.0 110.723 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -97.78 155.72 16.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.74 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.82 95.52 0.19 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.17 1.367 . . . . 0.0 112.686 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.19 105.79 2.21 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.769 -0.842 . . . . 0.0 111.234 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -75.65 154.4 36.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.691 1.197 . . . . 0.0 112.169 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -65.11 -19.32 65.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.609 1.563 . . . . 0.0 112.661 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.3 13.21 0.13 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.663 1.985 . . . . 0.0 114.601 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 58.66 48.95 10.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.039 2.136 . . . . 0.0 112.597 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -146.57 176.82 9.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.533 1.933 . . . . 0.0 110.929 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 m -140.28 107.08 5.38 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 111.581 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.89 167.22 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.605 0.762 . . . . 0.0 111.8 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -128.34 132.3 48.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.977 1.711 . . . . 0.0 110.129 172.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.28 177.11 8.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.842 1.657 . . . . 0.0 112.509 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.413 ' H ' ' HB3' ' A' ' 125' ' ' ASP . 4.7 mp -115.75 137.99 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.46 1.504 . . . . 0.0 110.337 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.57 114.9 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.981 -1.074 . . . . 0.0 109.524 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -84.46 -33.18 23.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.195 1.398 . . . . 0.0 112.888 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -156.69 159.78 38.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.11 1.364 . . . . 0.0 111.445 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -149.06 151.06 33.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.956 1.302 . . . . 0.0 112.669 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -154.95 -176.55 5.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.737 1.615 . . . . 0.0 111.657 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.09 -27.95 54.34 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.301 1.441 . . . . 0.0 113.251 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.0 p -83.1 -65.3 1.03 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.904 1.682 . . . . 0.0 111.843 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -132.38 173.18 11.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.099 2.16 . . . . 0.0 111.71 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -143.51 148.83 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 127.148 2.179 . . . . 0.0 109.399 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.1 mtp -122.42 100.04 6.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.574 1.549 . . . . 0.0 110.263 -174.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.23 140.44 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.926 1.29 . . . . 0.0 111.67 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 113' ' ' ILE . 16.8 t70 -64.81 151.06 46.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.719 0.808 . . . . 0.0 111.347 168.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -146.95 169.88 18.25 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.252 1.421 . . . . 0.0 111.684 170.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -144.21 140.65 29.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.701 1.6 . . . . 0.0 110.209 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -152.06 129.78 5.9 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.934 0.894 . . . . 0.0 110.861 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.36 -19.81 21.74 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.726 2.284 . . . . 0.0 113.847 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 65.8 mt -104.4 76.78 1.34 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.529 1.532 . . . . 0.0 109.122 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -159.23 178.52 9.9 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.435 1.894 . . . . 0.0 112.043 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.39 166.77 36.92 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.061 1.791 . . . . 0.0 112.582 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -129.12 145.62 51.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.889 1.276 . . . . 0.0 112.582 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.97 145.0 55.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.853 1.661 . . . . 0.0 112.558 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.17 124.98 44.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.574 1.55 . . . . 0.0 111.446 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.38 139.53 32.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.655 0.782 . . . . 0.0 111.444 169.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.83 95.21 4.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.523 1.929 . . . . 0.0 108.78 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -81.83 112.32 18.85 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.437 1.095 . . . . 0.0 108.572 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.17 169.4 16.92 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -147.25 139.11 24.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.319 1.448 . . . . 0.0 110.579 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.59 100.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.23 -17.53 64.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.259 1.023 . . . . 0.0 112.568 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.57 -171.1 13.55 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.786 1.66 . . . . 0.0 112.735 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -125.93 151.44 46.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.128 0.971 . . . . 0.0 112.48 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -128.6 114.72 17.04 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.17 1.788 . . . . 0.0 111.04 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -77.22 92.66 3.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.857 1.663 . . . . 0.0 110.316 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.68 163.97 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.165 1.386 . . . . 0.0 112.672 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.2 t -60.31 156.3 15.96 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.23 1.012 . . . . 0.0 112.537 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.25 -16.24 43.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.371 1.469 . . . . 0.0 113.913 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -69.89 -16.15 63.19 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.721 1.608 . . . . 0.0 113.828 174.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 125.95 1.7 . . . . 0.0 114.19 -172.89 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 111.29 0.107 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -137.96 164.61 28.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.587 1.955 . . . . 0.0 110.592 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -145.54 174.48 11.13 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.748 1.619 . . . . 0.0 111.644 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -139.85 156.39 46.74 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.981 1.312 . . . . 0.0 111.403 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -149.13 165.79 30.73 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.986 1.715 . . . . 0.0 111.318 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.3 108.36 11.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.619 1.567 . . . . 0.0 111.03 -173.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -116.92 82.59 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.475 1.51 . . . . 0.0 110.559 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 p -67.54 -61.54 1.85 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.657 1.583 . . . . 0.0 112.414 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.0 mm -74.1 154.0 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 126.195 1.798 . . . . 0.0 110.181 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -95.15 160.5 14.53 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.391 1.476 . . . . 0.0 112.807 173.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.94 156.04 49.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.127 1.371 . . . . 0.0 110.469 165.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.41 112.23 17.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.332 0.653 . . . . 0.0 109.293 164.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.56 141.26 42.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.035 166.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.99 130.4 55.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.0 2.12 . . . . 0.0 109.991 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.3 pt -132.63 159.41 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.247 1.019 . . . . 0.0 112.392 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -138.47 134.75 34.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.192 1.797 . . . . 0.0 109.817 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -136.88 152.03 49.76 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.111 1.364 . . . . 0.0 114.027 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.42 115.99 9.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.614 2.365 . . . . 0.0 109.606 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.24 103.65 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 122.27 1.033 . . . . 0.0 110.634 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -102.77 152.15 21.58 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.593 2.357 . . . . 0.0 110.212 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -77.69 150.78 34.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.903 -1.123 . . . . 0.0 111.332 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -70.54 85.83 0.63 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.86 -1.15 . . . . 0.0 111.88 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.5 -44.78 1.26 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.467 1.984 . . . . 0.0 114.39 170.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -70.64 151.44 44.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.18 0.99 . . . . 0.0 112.971 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.4 m -79.87 -15.85 56.55 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.975 1.31 . . . . 0.0 114.072 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.83 159.57 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.777 0.831 . . . . 0.0 111.944 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.41 128.78 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.159 1.383 . . . . 0.0 109.517 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.43 -51.58 10.54 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.936 0.495 . . . . 0.0 111.423 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -159.89 163.84 34.0 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.393 1.877 . . . . 0.0 111.112 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.8 p -154.35 159.93 41.43 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.882 -1.136 . . . . 0.0 112.482 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -114.38 -12.52 12.37 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 165.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.19 -48.36 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.784 1.633 . . . . 0.0 111.826 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -76.0 -6.89 53.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.716 1.206 . . . . 0.0 113.984 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -107.47 -73.58 0.68 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.943 1.697 . . . . 0.0 111.354 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -163.54 131.68 2.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.301 1.84 . . . . 0.0 109.774 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.5 160.06 37.52 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.173 2.582 . . . . 0.0 112.891 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 tt -95.11 126.28 40.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 109.863 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -106.27 127.44 53.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.102 1.761 . . . . 0.0 111.558 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -147.57 162.98 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.508 1.123 . . . . 0.0 111.966 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.2 mm -88.38 149.48 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.717 -1.24 . . . . 0.0 109.366 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -50.7 106.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 110.971 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.03 59.63 1.75 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.547 1.546 . . . . 0.0 114.492 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -113.5 -28.68 7.44 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.966 1.306 . . . . 0.0 113.243 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.67 32.9 18.19 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.74 2.016 . . . . 0.0 114.711 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -83.5 -17.94 40.19 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -76.75 171.05 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.974 1.31 . . . . 0.0 112.791 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.4 pt -57.18 142.48 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.966 0.906 . . . . 0.0 111.46 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.78 77.57 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.48 -21.8 65.03 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.086 0.85 . . . . 0.0 114.518 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -96.52 -35.49 11.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.466 1.507 . . . . 0.0 111.804 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -56.77 -45.75 81.9 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.887 1.675 . . . . 0.0 112.188 174.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -75.69 -2.0 27.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.917 0.887 . . . . 0.0 113.393 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.5 -42.27 4.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.601 1.56 . . . . 0.0 113.18 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.02 -25.73 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.522 1.129 . . . . 0.0 113.893 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.3 -24.96 67.84 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -37.24 15.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.133 1.373 . . . . 0.0 112.498 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.91 131.3 46.77 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.63 1.572 . . . . 0.0 113.377 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -92.51 151.51 20.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.2 1.0 . . . . 0.0 111.833 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.16 125.06 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.904 0.882 . . . . 0.0 110.061 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.19 86.19 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.454 1.026 . . . . 0.0 115.454 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -122.58 116.38 23.76 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.992 1.396 . . . . 0.0 111.259 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -58.26 143.07 45.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.157 0.983 . . . . 0.0 112.008 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.49 142.5 41.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.633 1.573 . . . . 0.0 110.173 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -129.99 81.8 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.181 0.993 . . . . 0.0 110.583 -167.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -88.06 117.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.921 1.289 . . . . 0.0 111.554 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.44 118.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.889 0.876 . . . . 0.0 109.465 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -115.62 138.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 126.604 1.961 . . . . 0.0 108.812 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.08 155.52 90.15 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.475 1.11 . . . . 0.0 112.042 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.7 -46.28 5.38 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.601 2.201 . . . . 0.0 112.473 -172.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -64.69 -23.17 67.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.536 1.534 . . . . 0.0 113.309 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.45 -8.18 59.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.229 1.412 . . . . 0.0 113.502 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.62 -67.44 0.99 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.204 1.401 . . . . 0.0 111.733 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -139.39 -22.62 0.9 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.46 92.19 0.19 Allowed Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.337 1.446 . . . . 0.0 114.232 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.74 160.3 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.806 1.643 . . . . 0.0 112.515 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -142.4 175.66 9.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.195 1.798 . . . . 0.0 112.211 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -133.77 170.4 15.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.864 1.666 . . . . 0.0 112.229 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 t -111.28 11.53 21.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.798 1.639 . . . . 0.0 113.162 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.0 p -158.83 114.69 2.62 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.731 1.612 . . . . 0.0 111.384 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -149.66 157.34 43.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.53 1.132 . . . . 0.0 113.275 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.03 132.98 41.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 111.386 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.7 120.09 28.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.74 1.216 . . . . 0.0 110.847 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.12 101.47 5.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.345 1.458 . . . . 0.0 111.453 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 t -99.72 136.88 20.16 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.32 1.848 . . . . 0.0 109.476 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.87 152.58 68.78 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.502 2.134 . . . . 0.0 111.676 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -76.88 57.45 1.32 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.127 1.371 . . . . 0.0 111.447 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.63 -50.52 1.06 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.205 1.802 . . . . 0.0 112.812 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -66.43 -15.01 63.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -98.45 17.83 18.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.717 2.007 . . . . 0.0 113.484 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 112.3 1.47 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.717 -1.239 . . . . 0.0 111.341 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.22 2.43 59.13 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.869 1.223 . . . . 0.0 115.446 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.68 130.48 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.919 1.36 . . . . 0.0 111.368 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.76 147.64 39.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.532 1.133 . . . . 0.0 111.173 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.09 152.4 47.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.98 1.712 . . . . 0.0 109.689 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -155.8 162.05 40.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 111.604 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.25 123.6 20.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.829 -1.169 . . . . 0.0 110.92 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.96 30.68 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.167 0.889 . . . . 0.0 114.786 173.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.4 ptp -109.1 144.96 36.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.195 0.997 . . . . 0.0 111.421 165.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.1 p -70.26 136.67 50.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.883 0.873 . . . . 0.0 110.812 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.9 p -140.66 164.61 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.573 1.549 . . . . 0.0 111.046 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.21 148.39 34.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.212 1.405 . . . . 0.0 111.858 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.85 94.72 0.31 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.463 1.506 . . . . 0.0 111.936 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -68.66 104.96 2.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.855 0.862 . . . . 0.0 111.063 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -77.93 158.38 29.38 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.678 1.191 . . . . 0.0 112.21 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -66.48 -16.95 64.51 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.443 1.497 . . . . 0.0 113.264 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -72.16 13.86 0.28 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.575 1.95 . . . . 0.0 114.212 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 57.13 47.23 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.883 2.073 . . . . 0.0 112.301 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.06 170.43 15.95 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.037 2.135 . . . . 0.0 109.637 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 34.6 m -136.95 115.51 11.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.56 1.144 . . . . 0.0 111.585 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.64 164.5 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 111.406 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -121.23 133.14 55.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.677 1.591 . . . . 0.0 110.624 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 177.15 9.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.683 1.593 . . . . 0.0 112.474 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.94 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.428 1.491 . . . . 0.0 109.362 173.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.9 mt -74.93 116.42 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.706 1.202 . . . . 0.0 109.629 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -92.98 -33.12 14.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.131 0.972 . . . . 0.0 112.611 -175.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -148.41 148.09 29.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.946 1.698 . . . . 0.0 110.78 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -142.58 157.93 44.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.221 1.008 . . . . 0.0 112.51 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 t -157.01 176.21 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.861 1.664 . . . . 0.0 111.167 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.17 -25.85 62.72 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.531 1.132 . . . . 0.0 113.184 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.6 p -82.74 -64.18 1.22 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.747 1.619 . . . . 0.0 112.044 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -135.08 168.47 19.07 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.592 2.357 . . . . 0.0 111.159 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -137.58 150.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.498 1.519 . . . . 0.0 110.617 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.2 mmm -127.76 103.08 7.09 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.798 2.039 . . . . 0.0 110.288 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.76 143.47 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.398 1.479 . . . . 0.0 110.246 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.23 96.8 2.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.206 1.002 . . . . 0.0 111.861 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -94.56 168.92 10.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.063 1.345 . . . . 0.0 112.392 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -135.04 115.17 13.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.529 1.932 . . . . 0.0 110.263 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.87 135.94 10.68 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.634 0.774 . . . . 0.0 111.204 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -72.49 4.13 3.69 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.858 3.038 . . . . 0.0 114.941 -173.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.8 mt -112.79 12.44 19.57 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.602 1.961 . . . . 0.0 112.952 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -44.75 -62.13 1.32 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.278 2.231 . . . . 0.0 115.514 -167.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 58.5 81.06 0.08 OUTLIER Glycine 0 CA--C 1.542 1.75 0 C-N-CA 126.272 1.891 . . . . 0.0 116.999 169.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -74.43 154.61 38.69 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.787 1.235 . . . . 0.0 112.912 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.3 p -91.24 150.31 21.39 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.957 1.303 . . . . 0.0 113.208 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.3 120.94 32.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.742 2.017 . . . . 0.0 110.911 -170.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 101.08 10.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -79.59 92.43 5.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.633 0.773 . . . . 0.0 110.08 167.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -73.12 124.03 24.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 165.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -144.18 169.39 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -148.4 147.97 29.8 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.789 1.236 . . . . 0.0 111.511 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.95 108.0 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.614 1.166 . . . . 0.0 108.444 167.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.7 -12.76 60.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.007 1.323 . . . . 0.0 112.768 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.57 -150.51 18.66 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 126.009 1.766 . . . . 0.0 111.475 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.77 163.7 31.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.492 1.117 . . . . 0.0 112.681 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -144.91 155.26 43.34 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.397 1.479 . . . . 0.0 113.125 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.39 87.72 7.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.505 1.522 . . . . 0.0 111.187 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.7 160.87 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.368 1.067 . . . . 0.0 112.713 175.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 74.6 m -140.86 161.54 37.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.282 1.833 . . . . 0.0 111.787 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -84.49 -71.75 0.5 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.34 1.056 . . . . 0.0 112.395 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.64 -0.44 6.13 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -175.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 128.083 2.553 . . . . 0.0 114.919 -179.686 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -60.55 150.06 32.71 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.812 1.245 . . . . 0.0 111.411 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -129.02 94.82 3.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.722 1.209 . . . . 0.0 111.229 -173.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -119.33 144.12 47.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.087 1.355 . . . . 0.0 111.667 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -140.71 -171.69 3.29 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.534 2.333 . . . . 0.0 110.376 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.45 106.03 0.86 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.992 1.317 . . . . 0.0 110.968 172.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -120.03 54.16 1.04 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.283 1.833 . . . . 0.0 111.307 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 t -85.33 -25.98 26.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.55 1.14 . . . . 0.0 113.655 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.45 133.21 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.669 1.588 . . . . 0.0 109.723 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -61.09 146.39 47.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.926 0.89 . . . . 0.0 112.67 175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -145.94 149.05 33.48 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.111 1.364 . . . . 0.0 111.151 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.31 8.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.39 123.63 23.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.065 1.346 . . . . 0.0 110.566 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.72 117.44 34.08 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.6 1.96 . . . . 0.0 109.707 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.34 160.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.363 1.065 . . . . 0.0 111.524 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.13 165.36 28.05 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.076 -1.015 . . . . 0.0 112.445 169.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -147.69 157.8 43.72 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.7 1.6 . . . . 0.0 113.858 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -134.01 123.79 25.17 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.873 3.269 . . . . 0.0 108.148 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.21 112.58 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.263 1.025 . . . . 0.0 109.372 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -115.84 143.72 45.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.753 1.621 . . . . 0.0 110.172 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -70.04 132.92 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.516 -0.74 . . . . 0.0 110.4 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -59.16 123.84 18.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.305 0.642 . . . . 0.0 111.943 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.82 -45.86 2.31 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.019 1.771 . . . . 0.0 114.306 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -74.72 154.7 38.3 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.664 1.186 . . . . 0.0 113.514 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 m -83.8 -14.94 50.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.18 163.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.049 0.94 . . . . 0.0 111.983 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.66 122.74 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.367 1.467 . . . . 0.0 109.299 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.69 -51.09 24.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.102 0.961 . . . . 0.0 111.058 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.52 156.54 28.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.006 1.323 . . . . 0.0 112.554 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 57.5 m -149.84 151.97 34.37 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.679 1.591 . . . . 0.0 111.76 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.49 -6.13 11.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.3 mt -50.88 -58.14 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.908 1.683 . . . . 0.0 112.196 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -75.1 -19.83 59.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.504 1.121 . . . . 0.0 113.389 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -78.59 -72.47 0.38 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.048 1.739 . . . . 0.0 111.109 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -168.34 125.87 0.9 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 127.074 2.15 . . . . 0.0 109.392 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.29 147.05 87.43 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.444 2.096 . . . . 0.0 111.403 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.5 tp -72.83 142.89 48.0 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.316 1.047 . . . . 0.0 110.172 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -120.68 111.79 18.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 0.0 109.685 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -131.77 169.54 16.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.078 0.951 . . . . 0.0 112.262 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.2 mm -105.94 137.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.234 1.014 . . . . 0.0 108.9 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -46.37 106.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.634 1.574 . . . . 0.0 111.345 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.88 15.03 17.63 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.25 1.405 . . . . 0.0 116.397 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.6 m -73.8 -43.54 58.55 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.859 1.829 . . . . 0.0 113.001 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m120 57.17 21.52 6.61 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.161 2.185 . . . . 0.0 116.538 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -74.61 -16.0 60.81 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.4 pt -66.6 168.86 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.434 1.494 . . . . 0.0 112.96 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 pt -56.1 144.43 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.228 1.011 . . . . 0.0 111.775 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -38.41 75.23 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -171.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.81 -33.16 86.17 Favored Glycine 0 CA--C 1.539 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 113.962 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.52 -29.64 22.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.251 1.42 . . . . 0.0 112.144 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -59.65 -43.29 93.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.738 1.615 . . . . 0.0 112.091 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -70.47 -13.91 62.31 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.38 -46.81 7.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.817 1.247 . . . . 0.0 112.723 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.33 -27.77 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.8 -24.47 66.93 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.94 -36.65 10.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.107 1.763 . . . . 0.0 112.684 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.96 112.15 0.89 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.963 1.705 . . . . 0.0 113.142 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.08 151.4 41.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.448 0.699 . . . . 0.0 112.053 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 tt -57.33 127.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.426 1.09 . . . . 0.0 111.494 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.96 9.23 85.28 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.094 1.33 . . . . 0.0 115.3 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.1 119.07 30.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.088 1.444 . . . . 0.0 111.763 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -59.25 142.36 52.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.059 0.944 . . . . 0.0 112.082 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -136.51 138.82 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.598 1.159 . . . . 0.0 110.481 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -130.02 89.3 2.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.433 1.093 . . . . 0.0 110.534 -167.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -101.09 118.15 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.879 1.272 . . . . 0.0 111.507 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.9 t -78.82 111.18 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.434 1.094 . . . . 0.0 109.536 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.17 133.81 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.3 1.44 . . . . 0.0 109.53 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.51 153.45 93.1 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.09 0.956 . . . . 0.0 111.743 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.04 -43.53 35.69 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.563 2.175 . . . . 0.0 112.521 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.92 -15.6 63.53 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.833 1.653 . . . . 0.0 114.838 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -99.74 -26.88 13.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.769 1.227 . . . . 0.0 113.035 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.33 -70.57 0.33 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.852 1.261 . . . . 0.0 111.331 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -138.61 -18.36 1.09 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.67 7.69 58.91 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.795 1.188 . . . . 0.0 115.494 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.68 150.23 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 127.182 2.193 . . . . 0.0 109.584 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -135.59 166.16 23.85 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.657 1.583 . . . . 0.0 111.452 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -65.34 151.26 46.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.49 1.116 . . . . 0.0 113.474 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.7 p -83.02 15.13 2.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.334 1.854 . . . . 0.0 114.793 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m -108.41 79.26 1.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.178 1.391 . . . . 0.0 112.946 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -118.39 166.2 12.95 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.58 1.552 . . . . 0.0 110.936 166.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.36 147.85 44.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.199 1.4 . . . . 0.0 110.316 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -129.51 115.92 18.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.191 1.396 . . . . 0.0 110.653 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.8 115.43 6.58 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.498 0.719 . . . . 0.0 110.121 164.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.32 133.93 25.49 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 126.633 1.973 . . . . 0.0 109.463 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.2 155.96 60.08 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.201 1.934 . . . . 0.0 111.673 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -64.06 -17.62 63.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.91 -38.89 58.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.332 2.653 . . . . 0.0 114.316 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -71.58 -15.95 62.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.27 -45.41 3.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.635 1.174 . . . . 0.0 112.947 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 21.28 66.97 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 129.611 3.164 . . . . 0.0 115.043 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.41 -22.42 3.94 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.041 1.305 . . . . 0.0 115.601 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.55 132.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.247 1.523 . . . . 0.0 109.621 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.24 67.76 3.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.777 1.631 . . . . 0.0 112.613 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.66 148.05 17.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.713 1.605 . . . . 0.0 112.131 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -151.34 155.75 39.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.198 1.399 . . . . 0.0 111.189 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -71.81 21.94 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 54.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 120.95 -1.094 . . . . 0.0 113.578 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.8 ptm -132.29 151.58 51.77 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.991 1.317 . . . . 0.0 111.874 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 p -70.25 133.05 46.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.354 1.061 . . . . 0.0 111.245 167.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -135.72 156.95 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.149 1.78 . . . . 0.0 110.689 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -95.66 145.82 24.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.446 1.098 . . . . 0.0 111.902 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.18 95.44 0.37 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.692 1.615 . . . . 0.0 111.855 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -65.68 137.96 57.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 117.85 0.825 . . . . 0.0 111.123 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 t -116.93 155.15 29.6 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.942 1.697 . . . . 0.0 111.75 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.85 -15.44 58.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.177 1.791 . . . . 0.0 113.345 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.23 15.17 0.35 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.419 1.888 . . . . 0.0 113.769 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 55.54 46.74 22.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.368 2.267 . . . . 0.0 112.543 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -144.74 177.45 8.7 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.174 1.79 . . . . 0.0 112.218 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.7 m -145.37 120.32 10.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.667 1.187 . . . . 0.0 111.796 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -88.9 173.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.584 1.153 . . . . 0.0 112.053 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.7 133.97 46.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.219 1.408 . . . . 0.0 111.441 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.81 11.22 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.464 1.506 . . . . 0.0 112.052 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.95 131.95 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.639 1.176 . . . . 0.0 110.618 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.7 mt -70.55 134.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 120.821 -1.174 . . . . 0.0 111.059 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -94.73 -46.38 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.825 1.25 . . . . 0.0 112.065 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -146.81 156.87 43.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.284 1.434 . . . . 0.0 111.258 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.26 146.84 29.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.727 1.211 . . . . 0.0 112.331 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.3 t -152.97 169.41 22.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.272 1.829 . . . . 0.0 110.547 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.93 -27.26 67.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.192 0.997 . . . . 0.0 113.493 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -80.67 -66.42 0.89 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.789 2.036 . . . . 0.0 111.714 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -132.3 157.49 44.29 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.619 1.968 . . . . 0.0 111.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.41 150.32 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.95 2.1 . . . . 0.0 108.233 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.6 mtp -126.18 100.56 6.37 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.822 1.249 . . . . 0.0 109.992 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.3 m -99.29 151.72 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.287 1.035 . . . . 0.0 111.075 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.68 148.79 46.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.339 0.656 . . . . 0.0 111.187 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -145.05 152.82 40.7 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.264 1.426 . . . . 0.0 112.326 172.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -69.14 -28.63 66.62 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.614 1.166 . . . . 0.0 113.504 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 48.46 83.77 0.21 Allowed Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 127.609 2.364 . . . . 0.0 113.378 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -65.48 -13.71 41.18 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.021 2.48 . . . . 0.0 115.333 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.4 mp -85.0 6.24 25.97 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 125.894 1.678 . . . . 0.0 113.099 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.68 167.3 2.78 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.883 1.673 . . . . 0.0 115.119 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.17 128.0 3.25 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 126.635 2.065 . . . . 0.0 112.002 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -139.74 167.53 21.89 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.57 1.548 . . . . 0.0 112.756 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.2 p -73.06 136.88 45.03 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 112.47 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.81 136.48 53.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.618 1.967 . . . . 0.0 110.736 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.31 105.25 17.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.685 1.194 . . . . 0.0 111.345 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.88 92.09 8.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 109.913 167.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -74.84 122.5 23.46 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 163.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -143.24 166.35 24.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.454 0.702 . . . . 0.0 112.03 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -151.2 145.67 25.56 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.462 0.705 . . . . 0.0 112.503 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.1 t -91.25 102.87 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.475 1.51 . . . . 0.0 108.715 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.17 -27.36 69.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.85 0.86 . . . . 0.0 111.6 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.41 -133.04 7.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 125.992 1.758 . . . . 0.0 110.899 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -150.37 162.89 39.67 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.842 1.257 . . . . 0.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -130.71 132.38 45.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.201 1.4 . . . . 0.0 111.269 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.11 130.96 42.85 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.998 0.919 . . . . 0.0 110.127 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.4 m -131.98 171.13 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.407 1.883 . . . . 0.0 110.581 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.9 p -60.16 145.47 46.87 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.646 0.736 . . . . 0.0 112.429 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.72 -0.3 10.78 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.201 1.4 . . . . 0.0 113.794 -175.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.97 -35.39 74.4 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.192 1.397 . . . . 0.0 112.715 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 128.65 2.78 . . . . 0.0 114.729 -178.138 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -141.02 97.39 3.17 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.274 1.43 . . . . 0.0 110.701 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -137.85 147.61 44.66 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.337 1.455 . . . . 0.0 111.805 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -142.69 130.58 21.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.409 1.884 . . . . 0.0 110.442 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -73.06 167.18 21.65 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.331 1.052 . . . . 0.0 112.262 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.05 101.28 1.38 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.774 1.23 . . . . 0.0 111.984 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.6 9.96 3.61 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 99.6 p -64.76 -22.58 67.02 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.9 mp -73.5 152.53 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.483 1.513 . . . . 0.0 110.928 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -55.14 156.45 4.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.642 1.977 . . . . 0.0 112.775 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -140.98 151.74 44.38 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.171 1.389 . . . . 0.0 111.628 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.96 113.31 21.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.383 1.073 . . . . 0.0 111.573 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.2 101.43 7.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 110.483 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.53 111.19 11.75 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.01 1.724 . . . . 0.0 110.043 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 pp -133.6 158.3 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.944 0.897 . . . . 0.0 111.968 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -137.65 138.34 39.36 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.501 1.521 . . . . 0.0 109.852 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -136.4 162.19 33.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.854 1.262 . . . . 0.0 113.796 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -144.83 160.24 41.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.074 2.149 . . . . 0.0 111.678 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.47 112.59 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.36 1.464 . . . . 0.0 110.451 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -114.62 154.52 28.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.995 2.118 . . . . 0.0 110.054 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.91 148.28 26.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.323 1.449 . . . . 0.0 111.567 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -70.68 94.03 0.98 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.831 -1.168 . . . . 0.0 111.253 166.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 -39.22 2.97 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.233 1.873 . . . . 0.0 114.894 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -73.44 149.84 42.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.502 1.151 . . . . 0.0 112.046 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m -69.37 -23.06 63.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.923 1.289 . . . . 0.0 113.776 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.65 153.47 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 113.296 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.94 128.14 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.838 1.655 . . . . 0.0 108.982 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.24 -51.95 7.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.144 0.578 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.09 160.07 43.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.185 1.794 . . . . 0.0 111.488 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -162.38 167.14 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.923 1.289 . . . . 0.0 113.138 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -130.72 13.77 5.37 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 164.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.0 mm -53.15 -59.99 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.578 1.551 . . . . 0.0 112.358 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -78.68 -16.17 57.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -172.6 3.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.063 2.145 . . . . 0.0 111.722 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.94 126.36 83.24 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.208 1.003 . . . . 0.0 110.97 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.31 162.75 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.135 2.557 . . . . 0.0 112.335 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.95 149.1 37.73 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.823 168.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -130.81 48.26 2.44 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.297 1.439 . . . . 0.0 110.939 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -69.33 163.11 25.84 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.357 -0.84 . . . . 0.0 113.14 -175.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 mm -116.61 137.34 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.672 1.589 . . . . 0.0 109.244 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.73 107.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.799 1.64 . . . . 0.0 111.908 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.63 -28.03 8.43 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.24 1.876 . . . . 0.0 114.311 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -58.35 -24.52 60.06 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.593 1.697 . . . . 0.0 113.735 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 40.55 60.43 1.88 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.422 2.689 . . . . 0.0 114.137 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -89.41 -17.44 28.79 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.72 170.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.933 1.293 . . . . 0.0 112.218 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 pt -63.26 147.1 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.459 -0.776 . . . . 0.0 111.863 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.93 -25.92 68.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.26 -40.69 98.16 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.859 -1.151 . . . . 0.0 112.991 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 tp -81.63 -25.45 35.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.717 1.607 . . . . 0.0 112.804 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -51.25 -49.39 61.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.779 1.632 . . . . 0.0 112.476 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -13.89 62.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.256 1.022 . . . . 0.0 113.708 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.54 -43.36 7.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.793 1.237 . . . . 0.0 112.968 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.46 -27.25 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.34 -17.43 63.7 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -103.79 -40.44 6.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.907 1.683 . . . . 0.0 113.328 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.58 134.36 56.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.183 0.993 . . . . 0.0 112.5 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.7 161.6 13.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.05 0.94 . . . . 0.0 112.282 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -54.49 124.49 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.394 1.078 . . . . 0.0 111.575 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.63 -0.28 77.2 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.234 1.397 . . . . 0.0 115.604 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -105.96 112.6 25.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.415 1.607 . . . . 0.0 111.551 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -57.49 144.73 35.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.54 0.736 . . . . 0.0 111.824 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -138.12 139.81 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.155 1.782 . . . . 0.0 109.96 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -130.45 110.39 11.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.208 1.403 . . . . 0.0 110.571 -173.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -118.17 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.611 1.564 . . . . 0.0 110.778 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.81 123.05 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.898 0.879 . . . . 0.0 109.118 173.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.3 mt -127.87 130.4 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 109.294 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.2 145.3 97.47 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.785 0.834 . . . . 0.0 110.984 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.09 -32.55 91.71 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.884 1.722 . . . . 0.0 112.971 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -63.08 -20.7 65.59 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -87.74 -0.04 56.37 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.206 1.402 . . . . 0.0 113.163 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.35 -67.53 0.65 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.606 1.562 . . . . 0.0 112.395 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -142.23 88.47 2.09 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.499 2.32 . . . . 0.0 110.1 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.34 91.71 0.65 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.044 1.307 . . . . 0.0 113.255 -175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.53 148.55 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.836 1.654 . . . . 0.0 111.262 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -149.57 165.79 31.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.109 1.764 . . . . 0.0 111.691 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.3 138.36 32.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.431 1.092 . . . . 0.0 111.896 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.3 p -84.96 3.58 37.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.116 1.766 . . . . 0.0 114.24 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.8 t -154.72 100.48 2.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.624 1.569 . . . . 0.0 110.711 -170.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -148.82 161.44 41.82 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.166 0.987 . . . . 0.0 113.595 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.01 129.11 38.15 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 111.481 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -120.74 118.11 29.21 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.222 1.409 . . . . 0.0 110.153 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.95 130.27 42.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.163 0.985 . . . . 0.0 110.746 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.1 t -135.75 136.66 23.91 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.034 1.733 . . . . 0.0 109.15 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.63 157.83 54.93 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.637 2.225 . . . . 0.0 112.211 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -75.94 66.18 2.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.31 1.444 . . . . 0.0 111.876 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.38 -50.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.151 1.781 . . . . 0.0 112.245 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.84 -11.68 48.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -120.1 10.48 11.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.43 1.892 . . . . 0.0 113.718 -171.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -56.16 -27.99 56.4 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.371 1.468 . . . . 0.0 114.145 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.42 10.21 22.03 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.676 1.608 . . . . 0.0 116.367 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.8 pt -134.91 131.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.555 1.678 . . . . 0.0 112.893 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -75.92 137.64 40.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.168 1.387 . . . . 0.0 112.256 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.72 165.17 15.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.829 1.651 . . . . 0.0 112.655 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.21 155.5 30.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.017 1.727 . . . . 0.0 110.764 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -73.38 107.54 5.73 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.464 -1.397 . . . . 0.0 111.05 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.88 26.94 11.79 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.501 0.961 . . . . 0.0 115.501 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.1 ptm -99.73 153.26 19.25 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.883 1.342 . . . . 0.0 112.263 168.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 p -70.46 113.96 8.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.249 1.42 . . . . 0.0 111.157 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.15 161.19 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.896 1.678 . . . . 0.0 111.035 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -123.25 155.44 37.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.813 1.645 . . . . 0.0 111.878 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.58 105.51 0.29 Allowed Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.361 0.982 . . . . 0.0 113.341 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.0 111.57 7.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.926 1.29 . . . . 0.0 111.894 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.9 t -80.55 159.7 25.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.102 1.361 . . . . 0.0 111.897 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.04 -15.52 62.43 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.048 1.339 . . . . 0.0 113.366 173.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.44 18.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.757 1.623 . . . . 0.0 113.966 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 51.83 44.01 29.68 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.474 2.31 . . . . 0.0 113.077 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -140.98 172.33 12.83 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.286 1.834 . . . . 0.0 111.533 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.0 m -141.53 107.62 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.04 1.336 . . . . 0.0 110.521 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.59 167.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.972 -0.455 . . . . 0.0 111.41 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -132.41 136.22 46.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.082 1.353 . . . . 0.0 111.284 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.4 -179.53 8.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.816 1.246 . . . . 0.0 112.798 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.81 132.72 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.204 1.401 . . . . 0.0 110.61 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.63 122.46 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.9 1.28 . . . . 0.0 110.571 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -90.27 -38.02 13.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.705 1.202 . . . . 0.0 113.08 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -153.35 154.67 34.98 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.337 1.455 . . . . 0.0 111.571 170.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.07 145.83 30.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 113.388 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.4 m -148.3 173.68 12.79 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.771 2.028 . . . . 0.0 111.379 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.82 -21.99 61.62 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.9 p -83.52 -61.62 1.79 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.075 1.75 . . . . 0.0 111.924 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -136.62 169.31 17.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.628 2.371 . . . . 0.0 111.056 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.76 154.91 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.148 1.779 . . . . 0.0 109.888 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.0 mtp -130.22 101.27 5.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.518 1.527 . . . . 0.0 109.969 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.9 t -109.66 147.78 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.209 1.404 . . . . 0.0 109.371 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.89 134.01 54.36 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.758 -0.589 . . . . 0.0 111.158 168.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -143.71 173.76 11.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.365 1.466 . . . . 0.0 111.754 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -128.45 133.74 48.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.241 1.816 . . . . 0.0 110.143 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -156.63 128.45 3.91 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.79 0.836 . . . . 0.0 111.321 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.4 -15.9 34.79 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.771 2.314 . . . . 0.0 114.965 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.27 12.68 15.36 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.072 1.349 . . . . 0.0 113.506 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.1 -16.17 4.71 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.24 96.93 2.21 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 126.348 1.928 . . . . 0.0 113.328 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -64.85 166.98 8.18 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.887 1.275 . . . . 0.0 113.046 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 147.09 53.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.363 1.865 . . . . 0.0 113.597 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.8 mp -122.56 160.84 24.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.59 103.36 13.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.999 1.72 . . . . 0.0 111.161 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -82.41 109.99 17.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.601 0.76 . . . . 0.0 109.576 166.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -110.49 138.9 46.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.216 1.006 . . . . 0.0 110.129 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.94 170.0 20.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.417 0.687 . . . . 0.0 112.756 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -146.04 146.65 31.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 111.237 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.5 105.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.696 1.198 . . . . 0.0 108.742 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.17 -26.41 56.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.487 1.115 . . . . 0.0 112.453 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.89 -168.0 33.84 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -132.8 130.5 39.96 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.762 1.625 . . . . 0.0 110.225 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -117.18 93.89 4.35 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.938 1.295 . . . . 0.0 110.149 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.34 122.99 17.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.961 1.704 . . . . 0.0 111.134 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.27 164.41 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.652 1.581 . . . . 0.0 111.802 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 73.7 m -77.72 166.9 22.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.95 0.9 . . . . 0.0 111.79 168.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.93 -3.85 12.11 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.796 1.239 . . . . 0.0 114.046 174.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.28 -61.39 1.91 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.251 1.42 . . . . 0.0 111.939 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.962 1.705 . . . . 0.0 113.482 178.109 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.51 165.68 32.49 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.785 1.634 . . . . 0.0 112.474 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -149.38 175.65 11.27 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.779 2.031 . . . . 0.0 111.297 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -132.5 149.69 52.28 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.088 1.355 . . . . 0.0 112.378 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.41 167.9 17.07 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.761 2.024 . . . . 0.0 113.277 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.41 160.34 14.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.571 1.549 . . . . 0.0 111.426 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.97 20.84 0.18 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.257 1.823 . . . . 0.0 113.811 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t 65.94 21.56 11.35 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.03 2.132 . . . . 0.0 114.467 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mm -88.97 123.74 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.846 1.658 . . . . 0.0 111.305 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -73.44 131.03 41.35 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.217 1.407 . . . . 0.0 111.326 173.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -160.03 151.47 19.71 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.48 1.512 . . . . 0.0 111.654 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.09 98.72 9.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.019 1.328 . . . . 0.0 110.859 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.68 128.59 34.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.3 1.44 . . . . 0.0 111.327 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.72 134.7 43.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.166 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 pt -127.98 162.6 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.887 1.275 . . . . 0.0 112.247 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -138.64 131.45 29.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.509 1.924 . . . . 0.0 109.458 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -137.05 153.94 50.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.728 1.211 . . . . 0.0 113.784 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -143.68 133.93 24.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.907 2.483 . . . . 0.0 110.144 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.2 103.14 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -110.53 147.32 34.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.961 2.104 . . . . 0.0 110.906 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -76.68 141.64 40.87 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.409 -0.807 . . . . 0.0 111.872 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.6 93.45 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.779 0.832 . . . . 0.0 111.549 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.06 -54.65 0.7 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.247 1.88 . . . . 0.0 113.713 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 t -68.48 154.68 41.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -79.06 -20.67 48.27 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.258 1.423 . . . . 0.0 113.308 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.98 155.72 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.439 -0.788 . . . . 0.0 111.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.52 131.13 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.498 1.519 . . . . 0.0 110.082 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.8 mt -73.18 -55.1 6.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.503 0.721 . . . . 0.0 111.409 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.28 155.87 34.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.319 1.448 . . . . 0.0 110.922 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.4 p -148.26 126.03 11.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.266 1.026 . . . . 0.0 111.926 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -88.09 -29.65 20.47 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.199 0.6 . . . . 0.0 112.363 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -51.8 -51.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.013 1.725 . . . . 0.0 112.296 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -69.7 -14.99 63.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.497 1.119 . . . . 0.0 113.754 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -92.01 -72.17 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.812 1.645 . . . . 0.0 110.6 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -167.1 154.43 8.43 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.679 1.992 . . . . 0.0 111.623 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.31 146.38 69.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.439 2.092 . . . . 0.0 111.478 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 tp -87.52 130.55 34.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.857 1.263 . . . . 0.0 109.723 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.02 138.18 49.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.922 0.889 . . . . 0.0 112.649 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -153.04 163.02 40.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.189 1.396 . . . . 0.0 111.86 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.24 141.2 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -47.57 109.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.549 1.54 . . . . 0.0 111.163 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.4 -5.02 31.4 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.698 1.618 . . . . 0.0 115.916 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.9 m -57.04 -32.17 65.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.122 1.961 . . . . 0.0 113.665 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 47.31 62.5 2.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.589 1.956 . . . . 0.0 113.55 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.07 -20.83 13.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 pt -74.53 170.79 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.177 1.791 . . . . 0.0 112.611 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.9 pt -59.73 145.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.966 0.906 . . . . 0.0 111.781 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.69 75.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.6 98.75 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 121.552 -0.718 . . . . 0.0 113.029 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.5 tp -77.33 -34.19 55.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.616 1.166 . . . . 0.0 112.24 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.0 tp10 -56.74 -38.67 72.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.452 1.101 . . . . 0.0 112.668 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -78.82 -14.27 59.35 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.26 9.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.171 . . . . 0.0 112.501 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -59.3 -27.53 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.87 -20.41 66.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.63 -13.27 16.02 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.74 . . . . 0.0 113.121 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.44 132.58 50.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.598 1.159 . . . . 0.0 112.76 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -91.85 130.47 37.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 111.195 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.76 126.74 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.8 1.24 . . . . 0.0 111.674 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.64 9.03 87.26 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.13 119.03 29.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.383 1.591 . . . . 0.0 111.773 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -62.72 139.64 58.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.572 0.749 . . . . 0.0 111.465 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -141.93 160.49 40.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.457 1.103 . . . . 0.0 112.282 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.1 107.91 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 109.951 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -110.69 116.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.83 1.252 . . . . 0.0 110.097 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.8 110.77 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.449 -0.782 . . . . 0.0 109.376 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.9 139.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.089 1.756 . . . . 0.0 109.47 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.63 151.24 88.83 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.859 0.864 . . . . 0.0 112.244 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.73 -39.22 75.23 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.357 2.704 . . . . 0.0 112.472 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.64 -9.16 40.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.425 1.89 . . . . 0.0 114.205 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -113.07 5.07 16.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.828 1.651 . . . . 0.0 113.191 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.51 -67.45 0.89 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.541 1.536 . . . . 0.0 112.635 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -124.46 -12.18 7.28 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.02 29.9 72.28 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.057 -1.027 . . . . 0.0 115.374 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.0 p -65.01 151.25 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.861 1.264 . . . . 0.0 111.905 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -147.34 172.23 14.21 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.627 1.571 . . . . 0.0 112.427 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -118.06 142.07 47.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.713 1.605 . . . . 0.0 111.83 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.3 p -89.49 16.48 7.58 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.037 2.135 . . . . 0.0 114.49 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.3 t -41.88 -60.7 1.3 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.563 2.345 . . . . 0.0 114.806 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 56.55 8.03 0.41 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.3 mt -145.7 137.91 25.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.63 1.972 . . . . 0.0 110.991 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -144.2 127.99 17.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.15 0.58 . . . . 0.0 111.872 169.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -76.37 98.34 4.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.74 1.216 . . . . 0.0 110.425 167.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.31 156.6 38.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.424 1.889 . . . . 0.0 110.849 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 152.12 59.88 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.177 1.918 . . . . 0.0 111.771 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.4 -23.39 65.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.972 . . . . 0.0 113.15 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -51.01 -36.42 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.376 1.87 . . . . 0.0 113.789 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -66.49 -19.47 65.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.5 1.12 . . . . 0.0 113.564 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -133.28 17.84 4.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.307 1.843 . . . . 0.0 113.008 -172.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -57.43 -24.9 58.38 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.889 1.676 . . . . 0.0 114.438 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -113.57 17.43 20.94 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 126.24 1.876 . . . . 0.0 115.342 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.6 mt -123.49 123.55 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.316 1.558 . . . . 0.0 111.242 -170.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.74 77.34 2.06 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.055 1.742 . . . . 0.0 113.182 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.91 153.51 40.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.232 1.013 . . . . 0.0 112.759 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.99 137.29 18.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.105 1.362 . . . . 0.0 111.11 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -58.27 114.52 2.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.158 0.983 . . . . 0.0 110.93 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.54 20.94 11.05 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -108.93 161.3 15.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.277 1.538 . . . . 0.0 112.149 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.6 t -88.97 116.14 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.399 1.08 . . . . 0.0 110.967 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.0 160.92 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.896 1.678 . . . . 0.0 110.936 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -115.75 140.73 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.85 1.26 . . . . 0.0 111.823 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.75 93.34 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.575 1.559 . . . . 0.0 112.164 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -65.95 147.1 53.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.793 -0.828 . . . . 0.0 111.506 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -130.69 157.48 42.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.819 1.648 . . . . 0.0 112.302 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.35 -15.83 61.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.402 1.881 . . . . 0.0 113.689 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.38 14.75 0.41 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.162 1.785 . . . . 0.0 113.825 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 54.62 46.91 23.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.164 2.186 . . . . 0.0 112.556 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -140.94 173.21 11.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.987 1.715 . . . . 0.0 112.192 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 m -145.03 112.98 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 111.273 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -76.57 165.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.15 0.58 . . . . 0.0 111.482 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -123.18 139.96 53.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.274 1.43 . . . . 0.0 110.396 170.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.55 173.57 15.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.313 1.045 . . . . 0.0 113.144 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.81 135.97 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.076 1.351 . . . . 0.0 110.166 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 mm -67.06 117.96 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.974 1.309 . . . . 0.0 109.585 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -101.01 -36.11 9.13 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.699 1.2 . . . . 0.0 112.222 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.14 163.61 39.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.756 1.622 . . . . 0.0 111.8 166.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.08 158.46 43.59 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.329 1.052 . . . . 0.0 111.928 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 t -144.26 175.4 10.12 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.413 1.885 . . . . 0.0 111.202 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.61 69.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.144 1.377 . . . . 0.0 113.893 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -130.57 -9.69 4.06 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.184 1.394 . . . . 0.0 114.748 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -143.92 164.71 29.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.134 1.774 . . . . 0.0 111.821 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.4 t -140.24 141.96 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.657 1.583 . . . . 0.0 109.893 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.7 mtp -113.43 114.12 26.14 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.232 1.413 . . . . 0.0 111.104 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 t -121.46 153.05 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 109.964 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.73 107.25 0.67 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.824 1.249 . . . . 0.0 112.071 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -134.76 105.02 6.25 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.863 1.265 . . . . 0.0 111.323 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -59.88 144.35 49.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.568 0.747 . . . . 0.0 110.646 164.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -67.72 108.87 3.01 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.554 1.142 . . . . 0.0 111.074 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.46 -42.78 2.44 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.569 2.18 . . . . 0.0 112.872 -165.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.06 94.53 7.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.054 1.342 . . . . 0.0 108.179 168.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.5 96.49 0.52 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.287 1.035 . . . . 0.0 111.419 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.07 -166.55 33.75 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.374 0.988 . . . . 0.0 114.271 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -123.91 159.88 28.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.272 1.829 . . . . 0.0 111.98 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.98 141.95 45.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.26 1.424 . . . . 0.0 112.628 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.14 146.57 49.89 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.182 1.393 . . . . 0.0 111.886 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.01 103.68 16.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.512 1.525 . . . . 0.0 111.506 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.42 98.41 9.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.998 0.904 . . . . 0.0 109.851 167.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.51 123.5 32.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.461 1.504 . . . . 0.0 109.483 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.45 171.81 14.92 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -152.11 150.32 29.77 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.015 1.726 . . . . 0.0 111.576 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.9 112.54 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.357 1.463 . . . . 0.0 108.506 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.34 -33.58 76.06 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.133 0.973 . . . . 0.0 111.514 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 132.38 -168.79 22.51 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 126.358 1.933 . . . . 0.0 111.09 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -136.05 153.62 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.678 1.191 . . . . 0.0 111.982 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.49 129.87 51.42 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.096 1.358 . . . . 0.0 110.682 175.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.09 96.48 2.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.977 0.911 . . . . 0.0 109.978 172.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.97 164.18 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.821 1.648 . . . . 0.0 111.759 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 42.6 m -140.07 160.2 40.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.296 1.438 . . . . 0.0 111.58 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.57 25.91 8.56 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.957 1.703 . . . . 0.0 111.651 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 60.36 24.48 13.98 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 127.273 2.229 . . . . 0.0 114.268 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.926 2.09 . . . . 0.0 114.025 178.445 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.8 mmt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.133 0.492 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -88.51 164.53 15.39 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.759 -1.213 . . . . 0.0 112.074 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -126.83 128.49 46.63 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.942 1.697 . . . . 0.0 110.145 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -145.06 156.67 44.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.253 1.421 . . . . 0.0 110.457 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -66.63 155.0 39.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.604 0.762 . . . . 0.0 111.751 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.53 168.27 19.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.179 1.392 . . . . 0.0 112.935 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.08 52.72 0.81 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.648 1.579 . . . . 0.0 112.555 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 p -69.7 2.46 3.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.339 1.856 . . . . 0.0 114.974 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.6 mm -56.74 140.36 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 127.254 2.221 . . . . 0.0 111.589 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -65.77 138.32 57.85 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.997 1.319 . . . . 0.0 111.473 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.73 170.45 16.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.911 2.084 . . . . 0.0 111.031 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.24 118.99 38.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.122 0.969 . . . . 0.0 110.902 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.7 118.92 23.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.881 1.672 . . . . 0.0 110.902 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.44 131.3 37.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.072 0.949 . . . . 0.0 111.32 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -130.52 167.91 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.695 1.198 . . . . 0.0 112.303 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.35 133.5 33.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.43 1.892 . . . . 0.0 110.52 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -139.16 150.3 45.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 123.002 1.382 . . . . 0.0 113.934 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.32 136.96 26.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.927 2.091 . . . . 0.0 109.708 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.24 105.15 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.09 1.356 . . . . 0.0 110.397 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -113.23 147.47 37.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.342 1.857 . . . . 0.0 110.533 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.84 140.57 53.26 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.65 -0.656 . . . . 0.0 111.293 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.71 -34.87 78.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.864 -1.148 . . . . 0.0 113.846 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.85 55.72 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.992 1.282 . . . . 0.0 115.426 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.4 t -145.91 144.53 30.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.783 1.233 . . . . 0.0 111.283 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -73.38 -11.83 60.61 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.69 159.46 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.139 0.976 . . . . 0.0 111.991 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.1 p -108.79 145.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.185 1.394 . . . . 0.0 110.898 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.88 -44.11 7.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.325 1.05 . . . . 0.0 111.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.5 157.57 38.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 112.423 170.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -161.21 128.21 4.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.882 1.273 . . . . 0.0 111.341 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -16.44 40.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 167.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.07 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.897 1.279 . . . . 0.0 111.827 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -70.98 -9.64 58.34 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.81 1.244 . . . . 0.0 113.606 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -104.27 -75.8 0.61 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.409 1.883 . . . . 0.0 110.909 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -168.1 148.98 4.63 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.637 2.375 . . . . 0.0 110.579 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.47 149.28 74.52 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.892 2.394 . . . . 0.0 112.9 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.9 tp -80.52 123.97 28.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.162 0.985 . . . . 0.0 109.806 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.99 131.69 56.02 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.696 1.198 . . . . 0.0 112.253 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.93 165.12 35.58 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.435 1.094 . . . . 0.0 112.657 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -96.42 143.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.125 1.37 . . . . 0.0 109.12 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.05 113.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.643 1.577 . . . . 0.0 111.608 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 62.91 0.63 Allowed Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.788 1.661 . . . . 0.0 113.114 -174.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.9 m -134.27 -49.61 0.79 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.691 1.596 . . . . 0.0 111.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.5 m120 58.89 29.37 18.77 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.232 1.813 . . . . 0.0 115.287 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -70.79 -19.88 62.65 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.25 166.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 112.751 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 pt -62.48 157.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.075 0.95 . . . . 0.0 113.389 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.22 80.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.655 1.182 . . . . 0.0 113.716 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.33 -46.59 93.57 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.033 0.825 . . . . 0.0 112.841 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -69.04 -34.91 75.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 111.772 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -56.02 -35.38 66.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.105 1.362 . . . . 0.0 113.449 171.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -80.37 3.24 21.84 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.1 -33.69 3.87 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.348 1.459 . . . . 0.0 113.392 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -58.47 -28.63 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.872 -1.143 . . . . 0.0 113.929 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -71.11 -23.06 62.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -94.84 -27.58 15.67 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.344 1.858 . . . . 0.0 112.478 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.25 118.9 4.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.717 2.007 . . . . 0.0 113.474 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -80.11 145.62 32.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 111.483 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.24 132.4 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.879 0.872 . . . . 0.0 111.195 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.53 6.49 86.74 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.194 1.237 . . . . 0.0 116.194 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -118.62 114.26 22.5 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.881 1.672 . . . . 0.0 111.403 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -62.4 140.67 58.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.076 0.551 . . . . 0.0 111.305 169.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -142.42 162.11 36.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.49 1.116 . . . . 0.0 112.447 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -130.46 112.78 13.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.778 1.631 . . . . 0.0 109.844 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.92 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.341 1.456 . . . . 0.0 109.82 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 t -73.9 120.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.055 0.942 . . . . 0.0 110.046 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.3 mm -105.15 142.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.401 1.481 . . . . 0.0 110.061 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.87 156.94 85.93 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.693 1.197 . . . . 0.0 112.789 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.27 -11.92 27.77 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.461 2.774 . . . . 0.0 114.97 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -106.58 -9.35 16.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.094 1.358 . . . . 0.0 113.809 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -108.58 -18.9 13.61 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.983 1.313 . . . . 0.0 113.081 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.12 -167.95 1.63 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.532 1.933 . . . . 0.0 111.968 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -56.7 -22.13 32.75 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 169.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.74 72.77 1.23 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.411 1.481 . . . . 0.0 114.142 168.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.57 64.84 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.222 1.409 . . . . 0.0 112.785 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -69.73 169.27 13.24 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 121.221 -0.924 . . . . 0.0 112.481 170.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -139.33 154.15 47.84 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.186 1.394 . . . . 0.0 112.661 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -84.94 -6.18 59.34 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -172.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.0 p -153.65 123.47 6.81 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.384 1.473 . . . . 0.0 112.064 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.34 158.07 43.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.947 1.299 . . . . 0.0 112.379 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.06 107.08 9.16 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.849 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -85.12 131.99 34.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.838 1.255 . . . . 0.0 111.014 171.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -84.76 100.51 11.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.504 1.522 . . . . 0.0 110.238 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.1 137.3 20.83 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 124.932 1.293 . . . . 0.0 109.569 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.79 157.73 51.4 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 0.0 112.638 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.69 72.99 2.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.338 1.055 . . . . 0.0 111.454 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.42 -50.14 0.92 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.434 1.894 . . . . 0.0 111.452 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -65.26 -13.7 58.99 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.75 19.7 5.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.405 1.482 . . . . 0.0 114.461 -166.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.82 -25.48 63.78 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.86 9.04 37.02 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.126 1.346 . . . . 0.0 115.613 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.67 129.67 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.156 1.783 . . . . 0.0 111.04 -173.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -77.03 58.03 1.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.573 1.949 . . . . 0.0 112.556 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -61.29 157.21 16.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.991 1.317 . . . . 0.0 113.098 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -153.25 155.28 36.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.761 0.824 . . . . 0.0 112.524 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -60.05 113.56 2.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.937 1.295 . . . . 0.0 111.037 174.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.74 4.8 24.47 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.921 1.528 . . . . 0.0 116.921 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.4 ptm -101.63 154.26 19.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.97 1.885 . . . . 0.0 113.034 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 p -72.17 94.86 1.59 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.15 1.78 . . . . 0.0 111.657 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -82.2 156.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.443 1.497 . . . . 0.0 111.618 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.86 143.38 49.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.585 1.554 . . . . 0.0 110.694 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.05 99.14 0.36 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.772 1.177 . . . . 0.0 112.17 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -67.52 143.54 56.1 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.114 -0.639 . . . . 0.0 111.195 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -123.1 154.35 38.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.867 1.667 . . . . 0.0 111.457 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.44 -20.83 65.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.552 1.541 . . . . 0.0 113.164 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.67 19.88 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.097 2.159 . . . . 0.0 114.22 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.7 m120 52.52 47.97 23.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.391 2.276 . . . . 0.0 113.04 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -140.6 172.28 12.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.959 1.703 . . . . 0.0 112.108 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.4 m -143.48 118.47 10.02 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.94 1.296 . . . . 0.0 111.012 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.82 162.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.727 0.811 . . . . 0.0 111.259 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -134.06 128.36 34.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.572 1.549 . . . . 0.0 111.147 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.28 -175.65 5.54 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.34 1.456 . . . . 0.0 112.564 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.15 136.84 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 110.034 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.1 mt -68.11 133.08 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.396 1.478 . . . . 0.0 111.005 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -108.22 -37.99 5.87 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.146 1.379 . . . . 0.0 112.886 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.55 157.89 42.83 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.399 1.08 . . . . 0.0 111.482 166.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.24 143.44 28.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.241 -0.912 . . . . 0.0 113.204 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 70.3 m -141.04 168.69 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.876 2.07 . . . . 0.0 110.584 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.15 -25.87 67.17 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 121.203 -0.935 . . . . 0.0 113.211 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -81.18 -60.18 2.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.952 2.101 . . . . 0.0 112.988 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -140.65 168.88 18.75 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.288 2.235 . . . . 0.0 111.781 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.69 132.96 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.54 1.536 . . . . 0.0 111.553 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.7 mtp -101.82 115.25 30.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.185 1.794 . . . . 0.0 110.803 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.57 136.41 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.738 1.615 . . . . 0.0 110.872 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.94 111.81 5.91 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.344 0.658 . . . . 0.0 111.484 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -123.62 172.43 8.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.778 2.031 . . . . 0.0 111.467 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -132.61 127.55 35.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.827 1.651 . . . . 0.0 110.203 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.96 144.51 19.09 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.859 1.264 . . . . 0.0 110.395 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.83 -13.97 29.55 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.945 2.43 . . . . 0.0 113.491 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.22 14.37 9.49 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.47 1.908 . . . . 0.0 113.436 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.61 178.08 7.57 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.621 1.568 . . . . 0.0 113.465 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.93 -178.28 18.67 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.073 1.796 . . . . 0.0 113.347 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -139.3 169.41 17.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.538 1.535 . . . . 0.0 113.307 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.2 p -65.27 146.64 54.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.124 1.369 . . . . 0.0 113.039 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.17 131.57 44.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.687 -170.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.42 98.97 12.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.149 0.98 . . . . 0.0 111.652 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.23 103.14 10.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.758 0.79 . . . . 0.0 110.328 166.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -94.68 124.18 38.56 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.445 1.898 . . . . 0.0 109.336 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -148.82 170.65 17.78 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -154.33 147.43 24.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.98 1.712 . . . . 0.0 112.14 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 9.8 t -83.79 108.09 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.819 1.248 . . . . 0.0 108.727 163.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.1 mt -65.67 -39.48 91.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.888 -0.508 . . . . 0.0 111.492 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.76 -179.22 18.45 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.579 1.561 . . . . 0.0 113.496 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -96.57 147.68 23.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.968 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -128.65 144.66 51.2 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.979 1.312 . . . . 0.0 112.438 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -92.5 92.52 8.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.055 1.342 . . . . 0.0 110.427 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.51 156.08 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.879 0.872 . . . . 0.0 111.842 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.3 p -70.77 158.85 35.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.665 0.786 . . . . 0.0 112.323 172.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -125.29 25.94 7.0 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.714 1.605 . . . . 0.0 112.046 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 63.32 24.12 14.09 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.614 1.966 . . . . 0.0 113.911 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.465 1.906 . . . . 0.0 114.115 177.266 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -141.81 162.76 34.69 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.771 1.629 . . . . 0.0 110.85 -176.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -91.17 -2.97 57.42 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.306 1.442 . . . . 0.0 114.481 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -74.98 174.79 8.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.674 1.59 . . . . 0.0 113.437 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -133.03 172.72 12.26 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.557 1.943 . . . . 0.0 112.581 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.71 43.76 1.96 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.371 1.468 . . . . 0.0 111.668 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -128.92 60.95 1.53 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.895 1.278 . . . . 0.0 113.505 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -67.46 -8.73 35.72 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.641 1.576 . . . . 0.0 114.803 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.1 mp -66.26 121.51 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.827 2.051 . . . . 0.0 110.514 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 152.94 40.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.453 1.101 . . . . 0.0 112.286 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -152.73 155.56 37.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.205 1.802 . . . . 0.0 111.094 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 103.94 11.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.917 0.887 . . . . 0.0 110.893 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.53 120.81 18.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.539 1.536 . . . . 0.0 110.573 168.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.18 124.2 47.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.2 pt -131.35 163.62 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.661 1.184 . . . . 0.0 112.289 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -136.79 138.66 41.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.601 1.96 . . . . 0.0 109.831 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.77 151.93 44.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.066 1.346 . . . . 0.0 114.272 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -146.87 120.65 9.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.615 2.366 . . . . 0.0 110.315 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -99.94 110.28 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.858 1.663 . . . . 0.0 110.429 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 ttm105 -113.78 144.84 42.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.297 1.839 . . . . 0.0 110.694 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.79 117.33 11.25 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -61.84 105.33 0.55 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.571 0.748 . . . . 0.0 110.667 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.01 23.64 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 126.173 1.844 . . . . 0.0 115.169 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -137.05 165.84 25.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.332 1.566 . . . . 0.0 113.271 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.1 p -89.5 -13.47 37.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.737 2.015 . . . . 0.0 114.755 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.23 177.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 113.661 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.85 145.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.209 1.404 . . . . 0.0 110.121 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mp -106.57 -53.45 2.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.649 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.29 150.22 35.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.406 1.483 . . . . 0.0 110.381 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.6 p -163.01 169.61 19.31 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.158 -0.964 . . . . 0.0 111.694 173.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -122.72 -12.74 8.04 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -36.8 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 124.281 1.032 . . . . 0.0 112.217 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -73.1 -5.7 40.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.591 1.156 . . . . 0.0 113.601 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -117.59 -87.97 0.61 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.902 2.081 . . . . 0.0 110.367 -171.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -153.38 154.09 30.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 127.419 2.288 . . . . 0.0 111.272 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.35 150.69 86.89 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.596 2.864 . . . . 0.0 113.269 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -87.6 123.7 32.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.432 1.493 . . . . 0.0 109.774 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.15 134.58 50.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 111.533 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -150.12 172.58 15.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.499 1.119 . . . . 0.0 112.918 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.21 151.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.339 1.455 . . . . 0.0 109.195 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.85 109.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.509 1.124 . . . . 0.0 111.009 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.08 27.06 6.38 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.526 1.37 . . . . 0.0 116.526 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.3 m -97.06 -24.1 15.94 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 119.39 1.595 . . . . 0.0 114.355 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.3 t30 45.73 43.13 9.37 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.915 2.086 . . . . 0.0 115.092 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -71.77 -31.14 66.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.4 1.88 . . . . 0.0 114.155 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -72.41 166.87 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.866 1.267 . . . . 0.0 111.517 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 pt -63.15 146.36 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 0.0 111.413 172.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.9 75.76 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.07 -31.06 67.94 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.005 0.812 . . . . 0.0 113.913 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.25 -29.66 24.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.836 1.255 . . . . 0.0 112.307 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.09 -38.23 82.32 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.01 -1.056 . . . . 0.0 112.021 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -68.03 0.24 3.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.835 1.254 . . . . 0.0 114.312 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.39 -41.82 3.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.617 1.567 . . . . 0.0 113.167 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.71 -29.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.64 -10.39 55.85 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -118.96 -17.95 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.925 1.69 . . . . 0.0 114.549 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.95 141.62 49.43 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.309 0.959 . . . . 0.0 112.345 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -90.28 158.22 17.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.719 1.207 . . . . 0.0 111.779 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.03 129.75 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.179 0.992 . . . . 0.0 111.307 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.68 3.88 74.21 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.831 1.205 . . . . 0.0 115.692 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.63 111.95 24.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.181 1.491 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -55.93 139.66 45.48 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.766 0.826 . . . . 0.0 111.723 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -137.11 149.15 47.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.57 1.548 . . . . 0.0 110.275 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -134.71 104.74 6.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.449 1.099 . . . . 0.0 110.348 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.19 118.66 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.083 1.353 . . . . 0.0 110.359 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.0 t -75.83 121.32 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 109.59 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.55 144.46 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.953 1.701 . . . . 0.0 109.822 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.02 92.83 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.814 1.246 . . . . 0.0 112.55 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.81 -33.9 41.92 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.538 2.159 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -31.64 72.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.923 0.889 . . . . 0.0 113.265 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.67 -18.46 44.43 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.322 1.449 . . . . 0.0 113.177 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.92 -42.12 5.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.988 1.315 . . . . 0.0 113.767 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -134.79 -27.1 1.31 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.632 1.573 . . . . 0.0 114.83 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.2 -144.96 19.52 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 119.27 0.941 . . . . 0.0 112.273 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.5 m -50.97 96.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 127.158 2.183 . . . . 0.0 113.778 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -71.55 163.33 27.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.998 1.319 . . . . 0.0 112.466 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.9 -21.2 65.85 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.6 -1.313 . . . . 0.0 114.232 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 m -75.42 -0.36 19.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.265 1.826 . . . . 0.0 114.194 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t -69.15 -173.6 0.54 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 112.424 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 69.05 14.6 8.8 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.723 2.009 . . . . 0.0 113.458 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.66 147.23 30.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.149 2.58 . . . . 0.0 109.563 166.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -145.53 117.45 8.24 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.172 1.389 . . . . 0.0 110.416 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.11 118.45 15.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.955 0.902 . . . . 0.0 111.133 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.56 158.73 69.02 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 127.243 2.217 . . . . 0.0 110.978 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 149.3 64.43 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.154 1.902 . . . . 0.0 110.958 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -62.26 -20.31 64.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.533 0.733 . . . . 0.0 112.958 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -52.07 -32.19 33.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.997 1.719 . . . . 0.0 113.72 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -64.76 -18.16 64.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.517 1.127 . . . . 0.0 113.344 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.88 18.32 6.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.045 2.138 . . . . 0.0 112.915 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -53.34 108.61 0.35 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.61 1.564 . . . . 0.0 112.164 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.66 -5.11 34.82 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.826 1.679 . . . . 0.0 115.434 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mt -101.5 130.98 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.44 1.496 . . . . 0.0 110.375 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.76 89.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.489 1.116 . . . . 0.0 111.468 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.5 158.28 36.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.279 1.032 . . . . 0.0 111.777 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -155.33 145.81 22.05 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.732 1.213 . . . . 0.0 111.288 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -73.21 83.02 1.35 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.165 0.986 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.77 46.25 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.362 1.458 . . . . 0.0 113.87 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ppp? -129.01 148.7 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.199 1.4 . . . . 0.0 111.109 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 p -76.68 108.35 9.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.872 1.669 . . . . 0.0 111.479 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.1 156.79 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.668 1.587 . . . . 0.0 110.679 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -121.24 154.63 36.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.662 1.185 . . . . 0.0 111.068 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.68 106.23 0.41 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.344 0.973 . . . . 0.0 113.217 -173.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -74.55 114.05 12.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.462 1.105 . . . . 0.0 111.932 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -84.95 159.2 20.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.166 1.386 . . . . 0.0 112.122 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.46 -18.46 63.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.225 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.19 10.71 0.28 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 113.897 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 55.41 46.35 23.47 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.155 2.182 . . . . 0.0 111.956 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -141.22 171.13 14.48 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.795 2.038 . . . . 0.0 111.167 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 m -140.74 108.06 5.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.497 1.119 . . . . 0.0 110.697 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.42 165.88 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.832 -0.543 . . . . 0.0 111.29 176.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -129.16 131.11 47.11 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.971 1.308 . . . . 0.0 110.592 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.36 177.91 9.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.803 1.241 . . . . 0.0 113.59 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.89 135.59 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.628 1.571 . . . . 0.0 109.903 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.93 120.94 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.313 1.045 . . . . 0.0 110.22 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -87.69 -38.07 16.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.878 1.271 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.54 152.74 37.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.932 1.293 . . . . 0.0 111.63 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -146.78 142.56 27.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.094 0.957 . . . . 0.0 112.601 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.0 t -153.51 169.42 23.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.137 2.175 . . . . 0.0 110.125 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.71 -28.29 68.32 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.123 0.969 . . . . 0.0 113.408 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.6 p -79.56 -60.66 2.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.135 1.774 . . . . 0.0 111.852 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -134.16 156.94 47.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.371 1.868 . . . . 0.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.6 142.0 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.622 1.969 . . . . 0.0 108.566 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.9 mtp -121.94 98.87 6.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.997 1.319 . . . . 0.0 110.161 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.62 148.0 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.642 1.177 . . . . 0.0 109.849 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -62.99 110.4 1.78 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.36 0.664 . . . . 0.0 111.669 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -130.94 119.09 21.61 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.181 1.393 . . . . 0.0 109.422 171.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -71.75 37.34 0.06 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 126.75 2.02 . . . . 0.0 113.186 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.52 140.97 96.8 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.197 1.399 . . . . 0.0 111.991 -172.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.05 -29.16 12.14 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.832 2.355 . . . . 0.0 114.097 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.99 46.0 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.46 1.504 . . . . 0.0 111.632 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.99 -41.49 42.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.603 1.561 . . . . 0.0 114.095 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.44 -164.92 33.78 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.079 1.324 . . . . 0.0 113.11 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.87 168.31 9.58 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.703 1.201 . . . . 0.0 112.037 167.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.01 146.6 37.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.39 1.876 . . . . 0.0 113.13 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.9 mt -128.36 140.32 51.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.685 1.594 . . . . 0.0 110.941 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.88 94.31 5.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.023 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.48 92.68 3.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.503 1.121 . . . . 0.0 109.697 167.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 -75.48 139.46 42.24 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.86 171.06 17.82 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -150.23 146.2 26.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.028 1.331 . . . . 0.0 111.36 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.21 104.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.536 1.134 . . . . 0.0 109.119 167.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.71 -24.52 58.77 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 112.338 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.29 -167.43 25.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.047 1.308 . . . . 0.0 113.907 171.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.43 145.96 49.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 110.626 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -134.85 151.63 51.08 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 113.132 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.93 109.85 13.6 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.059 1.344 . . . . 0.0 110.586 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.3 m -66.53 153.6 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.578 0.751 . . . . 0.0 111.778 170.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.6 p -78.77 170.28 16.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.798 0.839 . . . . 0.0 111.635 164.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.36 8.24 7.13 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.702 1.601 . . . . 0.0 113.146 175.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.28 -51.53 36.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.797 1.639 . . . . 0.0 112.872 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 127.066 2.147 . . . . 0.0 112.32 178.439 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.96 166.51 19.91 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.912 1.285 . . . . 0.0 111.831 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -66.72 172.37 4.34 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.484 1.514 . . . . 0.0 112.697 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -121.92 153.55 38.32 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.244 1.418 . . . . 0.0 111.333 170.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -154.51 170.49 21.31 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.511 1.924 . . . . 0.0 110.368 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.81 98.73 1.26 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.375 1.47 . . . . 0.0 112.19 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -105.63 81.83 1.73 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.581 1.552 . . . . 0.0 110.749 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.4 t -70.12 -46.71 64.22 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.029 0.931 . . . . 0.0 112.346 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.7 mm -113.85 141.58 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.44 1.896 . . . . 0.0 109.235 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.51 173.09 11.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.168 1.787 . . . . 0.0 111.193 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 -132.6 143.71 49.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.585 1.554 . . . . 0.0 111.269 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.3 104.89 7.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.253 1.021 . . . . 0.0 109.63 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.08 141.21 37.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.657 1.183 . . . . 0.0 110.671 169.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.25 133.49 47.54 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.391 1.476 . . . . 0.0 110.599 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 pt -134.35 163.98 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.869 1.268 . . . . 0.0 111.544 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -137.84 135.81 36.57 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.168 1.387 . . . . 0.0 109.699 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -134.09 158.99 42.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 123.067 1.413 . . . . 0.0 114.368 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -141.04 120.83 13.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.961 2.904 . . . . 0.0 108.259 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -100.71 105.69 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.446 1.117 . . . . 0.0 109.93 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 ttp85 -118.57 153.16 34.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.202 2.201 . . . . 0.0 109.717 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.5 146.33 50.32 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.316 -0.865 . . . . 0.0 110.836 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -70.52 -33.11 70.81 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.881 -1.137 . . . . 0.0 112.434 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.45 -35.67 7.84 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.352 0.977 . . . . 0.0 115.017 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -116.92 151.07 37.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.319 1.448 . . . . 0.0 112.604 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 t -73.1 -7.52 51.71 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.95 151.11 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 120.892 -1.13 . . . . 0.0 112.372 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.43 126.97 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.226 1.41 . . . . 0.0 109.843 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -84.58 -42.89 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.777 0.831 . . . . 0.0 110.818 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -158.49 163.4 37.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.3 1.84 . . . . 0.0 110.767 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -166.65 150.57 7.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.071 1.348 . . . . 0.0 112.131 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -124.55 4.26 8.29 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -47.98 -64.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.234 1.414 . . . . 0.0 112.079 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 t -79.9 -23.67 41.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.256 1.023 . . . . 0.0 113.368 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -69.64 -71.61 0.22 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.884 1.674 . . . . 0.0 112.056 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -165.63 140.0 3.88 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.099 1.759 . . . . 0.0 110.876 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.41 152.48 75.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.666 2.244 . . . . 0.0 112.698 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.8 tp -83.07 97.68 8.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.222 1.809 . . . . 0.0 110.294 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -74.08 129.85 38.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.368 1.467 . . . . 0.0 111.923 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -149.43 176.49 10.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.967 1.307 . . . . 0.0 112.846 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.0 mm -112.43 134.87 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.469 1.508 . . . . 0.0 109.385 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.0 mm -50.09 117.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.332 1.453 . . . . 0.0 110.956 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.26 71.6 1.12 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.014 1.293 . . . . 0.0 112.044 -169.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -134.6 -43.9 0.75 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.049 1.34 . . . . 0.0 113.344 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 54.09 21.14 2.82 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 126.721 2.008 . . . . 0.0 115.097 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 pt -71.66 165.75 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 112.469 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.29 142.65 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.729 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.8 82.4 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.4 -28.72 69.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.48 -0.763 . . . . 0.0 113.992 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 tp -87.15 -35.39 18.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.044 1.338 . . . . 0.0 111.898 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.36 -46.42 69.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.718 1.207 . . . . 0.0 111.415 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -77.91 13.63 1.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.011 1.324 . . . . 0.0 114.143 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.59 -39.92 2.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.714 1.606 . . . . 0.0 113.616 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.22 -29.1 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -67.26 -14.32 62.81 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -118.69 -9.5 10.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.416 1.486 . . . . 0.0 114.112 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.85 8.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.212 1.405 . . . . 0.0 111.61 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -62.47 145.73 53.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.705 0.802 . . . . 0.0 112.117 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.75 133.41 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.664 0.786 . . . . 0.0 110.691 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 10.39 56.55 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 115.709 1.044 . . . . 0.0 115.709 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.91 128.13 54.13 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.448 1.499 . . . . 0.0 111.281 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -57.93 140.91 51.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.021 0.928 . . . . 0.0 112.243 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -134.12 141.51 47.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.795 2.038 . . . . 0.0 109.864 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.17 106.75 6.9 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.55 113.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.757 1.223 . . . . 0.0 111.711 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.96 123.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 109.554 173.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.4 mt -128.73 135.71 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.92 1.288 . . . . 0.0 109.489 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.6 161.46 59.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 125.703 1.601 . . . . 0.0 112.623 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 42.41 0.76 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 125.18 3.92 . . . . 0.0 113.872 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.42 -35.77 1.94 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.877 2.071 . . . . 0.0 113.057 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -110.93 -15.59 13.73 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.317 1.047 . . . . 0.0 113.617 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.83 99.92 5.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.403 1.481 . . . . 0.0 111.125 -171.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 43.19 47.97 5.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.684 1.594 . . . . 0.0 112.512 -163.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.27 -160.27 30.98 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.808 1.671 . . . . 0.0 114.139 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 t 61.7 34.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.146 1.378 . . . . 0.0 110.909 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -64.2 149.99 46.74 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.837 1.655 . . . . 0.0 112.342 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.05 107.26 8.13 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.799 1.24 . . . . 0.0 113.866 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.9 m -94.68 21.47 7.34 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.67 1.588 . . . . 0.0 113.102 171.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.4 m 55.76 63.34 2.08 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.119 2.167 . . . . 0.0 113.989 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -85.97 177.54 7.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.863 1.265 . . . . 0.0 112.135 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.53 166.75 24.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.674 1.589 . . . . 0.0 111.903 172.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -144.86 131.14 19.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.502 1.121 . . . . 0.0 110.983 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -70.04 128.57 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.794 0.838 . . . . 0.0 110.923 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.05 137.73 18.55 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.299 1.84 . . . . 0.0 109.903 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.73 172.66 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.017 2.478 . . . . 0.0 113.122 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -69.5 70.26 0.28 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.471 1.908 . . . . 0.0 111.901 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -129.19 -64.39 0.91 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.591 1.956 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -64.12 -16.39 61.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.906 1.283 . . . . 0.0 113.653 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.407 ' CG ' HD11 ' A' ' 94' ' ' LEU . 42.5 m-85 -131.69 13.88 4.9 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.968 1.707 . . . . 0.0 113.422 -172.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.61 -28.59 65.76 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.699 -1.251 . . . . 0.0 113.435 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.89 12.55 56.21 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.844 1.688 . . . . 0.0 115.047 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.75 115.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.509 1.524 . . . . 0.0 110.257 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.3 108.48 4.22 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.297 -0.877 . . . . 0.0 111.629 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.407 HD11 ' CG ' ' A' ' 89' ' ' PHE . 80.0 mt -101.63 156.99 17.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.368 1.467 . . . . 0.0 111.814 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.17 145.23 17.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.019 1.728 . . . . 0.0 109.863 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -51.87 128.35 23.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.772 0.829 . . . . 0.0 111.943 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 56.12 3.47 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.27 0.938 . . . . 0.0 114.327 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.1 ptp -132.27 172.45 12.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.116 1.766 . . . . 0.0 110.931 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 t -101.94 103.91 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.022 0.929 . . . . 0.0 110.452 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.28 154.44 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.153 1.381 . . . . 0.0 110.331 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -120.27 153.58 36.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.49 1.116 . . . . 0.0 111.944 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 97.52 0.23 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.73 1.157 . . . . 0.0 112.742 -175.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.71 142.67 58.35 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.874 -0.78 . . . . 0.0 111.38 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.0 t -126.09 157.12 38.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.909 1.683 . . . . 0.0 111.607 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.95 -15.15 61.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.071 1.748 . . . . 0.0 113.509 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -76.41 15.63 0.58 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.609 1.963 . . . . 0.0 113.721 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.6 m120 56.73 39.95 29.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.878 2.071 . . . . 0.0 113.136 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -133.67 172.56 12.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.686 1.995 . . . . 0.0 111.409 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.6 m -142.44 114.73 8.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.351 1.46 . . . . 0.0 110.427 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -72.57 163.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.015 0.526 . . . . 0.0 111.166 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -133.49 132.95 41.62 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.046 1.338 . . . . 0.0 110.901 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.96 175.33 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.613 1.565 . . . . 0.0 112.814 -166.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.438 ' H ' ' HB3' ' A' ' 125' ' ' ASP . 4.8 mp -121.46 142.76 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.705 1.602 . . . . 0.0 110.625 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.76 113.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.575 1.15 . . . . 0.0 109.856 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.96 -30.41 15.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.915 1.286 . . . . 0.0 113.429 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -155.38 155.55 33.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.947 1.699 . . . . 0.0 110.581 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -147.26 147.72 30.71 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.21 0.914 . . . . 0.0 113.253 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.0 t -153.17 171.91 17.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.737 2.015 . . . . 0.0 110.975 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.31 -21.98 61.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.63 1.172 . . . . 0.0 113.558 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.4 p -82.55 -63.6 1.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 111.724 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -135.22 165.17 26.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.325 2.25 . . . . 0.0 111.339 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.48 154.13 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.179 1.792 . . . . 0.0 109.798 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 80.2 mtp -125.77 103.98 8.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.159 1.384 . . . . 0.0 110.421 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -99.54 141.62 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.134 1.373 . . . . 0.0 109.627 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 113' ' ' ILE . 13.9 t70 -62.08 140.04 58.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.946 1.298 . . . . 0.0 111.436 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -143.43 173.74 11.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.686 1.194 . . . . 0.0 111.946 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -121.5 176.0 5.9 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.211 1.804 . . . . 0.0 111.578 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.77 133.59 10.48 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.556 1.142 . . . . 0.0 110.367 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.38 -35.22 51.34 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.214 1.943 . . . . 0.0 112.3 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.94 3.8 9.5 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.53 -26.79 65.61 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.46 -160.38 31.49 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.41 1.481 . . . . 0.0 113.588 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -132.73 165.55 24.26 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.232 1.413 . . . . 0.0 112.618 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -63.34 139.47 58.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.489 1.516 . . . . 0.0 112.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.4 148.04 46.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.279 1.432 . . . . 0.0 111.15 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -98.49 102.6 14.39 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.991 2.117 . . . . 0.0 110.262 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -80.12 95.29 6.18 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.607 0.717 . . . . 0.0 109.734 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -86.55 112.7 21.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.689 1.596 . . . . 0.0 108.776 171.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -136.12 170.31 16.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.833 0.853 . . . . 0.0 112.865 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -147.36 137.61 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.639 1.176 . . . . 0.0 111.005 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.7 t -87.45 94.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.03 -28.63 69.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.779 1.231 . . . . 0.0 112.686 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.68 177.87 15.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.968 1.746 . . . . 0.0 112.582 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -112.29 156.06 23.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.779 0.832 . . . . 0.0 111.688 169.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -135.19 130.62 35.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.637 1.575 . . . . 0.0 111.332 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -73.03 117.69 15.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.907 0.883 . . . . 0.0 109.513 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.8 m -110.17 170.56 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.37 1.468 . . . . 0.0 110.746 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 88.1 p -130.93 156.82 44.44 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.259 1.024 . . . . 0.0 112.315 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.82 9.04 3.57 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.947 1.699 . . . . 0.0 112.92 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -73.06 -44.61 60.39 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.585 1.554 . . . . 0.0 112.871 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.008 1.723 . . . . 0.0 114.475 -178.694 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -61.98 156.0 22.25 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.753 1.221 . . . . 0.0 112.401 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -84.02 175.46 9.52 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.972 1.309 . . . . 0.0 112.815 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -132.15 142.75 49.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.706 1.602 . . . . 0.0 111.589 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -85.53 168.66 14.31 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.295 1.438 . . . . 0.0 112.461 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.14 112.62 9.36 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.455 1.102 . . . . 0.0 110.588 166.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -129.43 27.57 5.29 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.696 1.598 . . . . 0.0 113.319 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -66.81 -35.03 79.13 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.298 1.439 . . . . 0.0 113.992 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -74.16 132.58 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.307 1.443 . . . . 0.0 110.546 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -61.36 159.18 12.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.15 1.38 . . . . 0.0 113.6 176.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -137.14 156.23 48.61 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.193 1.397 . . . . 0.0 111.152 170.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.94 115.03 22.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.824 0.85 . . . . 0.0 110.127 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.11 114.68 11.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.999 1.32 . . . . 0.0 109.908 162.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.48 119.84 33.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.798 1.239 . . . . 0.0 109.111 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.94 163.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.207 1.003 . . . . 0.0 111.859 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -143.1 140.22 30.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.565 1.546 . . . . 0.0 110.635 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -136.74 158.08 45.27 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.385 1.474 . . . . 0.0 114.055 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -144.16 107.92 4.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.643 1.977 . . . . 0.0 110.614 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.68 117.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 0.0 111.076 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -131.31 156.48 45.4 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.899 1.68 . . . . 0.0 111.104 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.3 146.46 40.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.297 -0.877 . . . . 0.0 111.055 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.16 133.51 48.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.075 0.95 . . . . 0.0 110.927 169.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.49 -57.13 3.76 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.991 1.281 . . . . 0.0 114.177 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -62.87 147.55 49.87 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.497 1.119 . . . . 0.0 112.598 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.5 m -83.44 -7.74 59.5 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.25 161.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.0 0.818 . . . . 0.0 111.876 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.71 124.75 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.351 1.46 . . . . 0.0 109.504 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 mt -71.7 -53.57 13.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.012 0.525 . . . . 0.0 112.016 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -157.88 162.09 38.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.761 1.224 . . . . 0.0 111.686 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 p -154.63 130.25 9.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.945 1.298 . . . . 0.0 112.466 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.64 -2.02 19.06 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.7 mm -51.67 -52.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.987 1.715 . . . . 0.0 111.884 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 m -82.6 -6.27 59.26 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 mmpp? -92.17 -172.07 3.02 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.56 1.944 . . . . 0.0 110.657 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.5 137.2 97.06 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 121.469 -0.77 . . . . 0.0 110.799 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.81 163.52 35.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.221 2.614 . . . . 0.0 113.204 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -92.91 110.24 21.7 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.76 1.224 . . . . 0.0 110.754 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.85 131.16 35.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.766 1.626 . . . . 0.0 111.499 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -143.06 157.04 44.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.256 1.022 . . . . 0.0 111.722 164.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.59 148.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.024 -1.047 . . . . 0.0 109.711 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.0 mm -48.19 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.316 1.446 . . . . 0.0 111.335 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.03 11.48 49.33 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -69.44 -35.0 75.25 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.926 1.863 . . . . 0.0 113.557 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.3 m120 57.72 37.74 27.33 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.527 1.931 . . . . 0.0 115.281 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -79.25 -23.65 43.52 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -72.76 167.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.367 1.067 . . . . 0.0 112.84 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.3 pt -59.11 136.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.95 0.9 . . . . 0.0 111.202 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.24 70.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.287 -0.883 . . . . 0.0 112.606 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.94 -13.97 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.111 173.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.94 -36.68 6.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.349 1.86 . . . . 0.0 111.595 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.28 -32.79 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -4.01 0.86 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 174.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.79 -29.9 4.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.387 1.875 . . . . 0.0 113.965 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.41 -24.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.849 1.204 . . . . 0.0 113.373 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -66.4 -13.85 61.29 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.34 -21.24 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.755 1.622 . . . . 0.0 113.859 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.29 111.58 2.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.662 1.185 . . . . 0.0 112.15 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.67 159.69 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.116 0.96 . . . . 0.0 113.2 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -56.64 131.99 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.194 1.398 . . . . 0.0 111.617 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.93 8.53 68.95 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.967 1.27 . . . . 0.0 115.064 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.53 112.7 24.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.032 1.333 . . . . 0.0 111.471 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -59.0 134.52 57.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.428 0.691 . . . . 0.0 111.363 171.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.61 112.97 12.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.121 1.768 . . . . 0.0 110.032 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.94 92.73 4.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.927 1.291 . . . . 0.0 110.508 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.06 165.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.592 0.757 . . . . 0.0 111.485 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.86 130.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.331 1.452 . . . . 0.0 108.461 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.4 mt -127.78 130.42 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 126.615 1.966 . . . . 0.0 109.135 -165.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.32 147.25 82.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.608 0.763 . . . . 0.0 111.264 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.22 -43.16 9.05 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -166.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.28 -21.86 66.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.822 1.649 . . . . 0.0 114.068 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -81.75 -13.53 57.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.698 1.199 . . . . 0.0 112.508 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.31 -73.39 0.64 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.126 1.77 . . . . 0.0 111.586 173.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -141.94 -12.32 0.86 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.66 78.15 0.84 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.406 1.003 . . . . 0.0 113.267 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.3 m -126.03 132.63 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.798 1.639 . . . . 0.0 110.767 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -134.21 172.51 12.76 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.893 1.277 . . . . 0.0 111.583 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -137.46 165.85 25.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.128 1.371 . . . . 0.0 111.868 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -122.68 8.46 9.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.129 1.772 . . . . 0.0 113.429 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.7 p -124.93 96.13 4.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.933 2.093 . . . . 0.0 111.786 -170.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -121.47 178.51 4.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.506 2.322 . . . . 0.0 109.848 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.34 143.96 50.72 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.069 -1.02 . . . . 0.0 110.635 174.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -126.39 124.65 40.68 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.666 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -83.89 78.34 9.74 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.366 1.079 . . . . 0.0 111.186 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.54 136.49 59.73 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.097 1.759 . . . . 0.0 109.903 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 159.44 52.91 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.71 2.273 . . . . 0.0 112.701 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -17.8 47.7 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.25 -31.26 63.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.902 1.681 . . . . 0.0 113.575 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -81.09 -6.16 58.49 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.155 0.982 . . . . 0.0 113.636 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -133.41 45.74 2.66 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.009 2.124 . . . . 0.0 110.996 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.66 111.82 19.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.54 1.136 . . . . 0.0 111.6 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.85 55.46 4.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.457 1.027 . . . . 0.0 114.319 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.428 HD13 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -137.46 -179.6 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.731 2.412 . . . . 0.0 111.786 -178.076 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -131.99 88.3 2.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.588 1.555 . . . . 0.0 110.601 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.428 ' HG ' HD13 ' A' ' 92' ' ' ILE . 26.0 mt -75.24 151.69 38.38 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.454 0.702 . . . . 0.0 111.398 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.84 135.09 19.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.217 1.007 . . . . 0.0 111.388 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.56 102.74 0.35 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.481 1.513 . . . . 0.0 110.563 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.97 21.15 5.75 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.994 1.283 . . . . 0.0 115.797 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -112.92 158.01 20.74 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.26 1.53 . . . . 0.0 112.555 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 p -82.46 97.8 8.58 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.113 1.365 . . . . 0.0 111.771 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 p -83.7 162.2 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.962 0.905 . . . . 0.0 111.015 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -123.32 152.89 40.98 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.276 1.431 . . . . 0.0 111.37 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.42 108.08 0.47 Allowed Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.369 0.985 . . . . 0.0 112.692 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -66.71 145.46 55.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.157 -0.614 . . . . 0.0 111.359 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -125.14 156.45 38.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.109 1.764 . . . . 0.0 111.533 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.16 -16.02 49.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.202 1.801 . . . . 0.0 114.294 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -74.68 12.82 0.73 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.428 1.891 . . . . 0.0 113.89 173.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 m120 54.27 48.66 20.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.942 2.097 . . . . 0.0 112.221 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -140.12 173.81 11.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.191 1.797 . . . . 0.0 111.792 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.4 m -145.67 110.96 5.32 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.05 1.34 . . . . 0.0 110.529 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.07 167.36 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.74 -0.6 . . . . 0.0 111.43 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -121.54 139.45 53.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.641 1.576 . . . . 0.0 110.725 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.8 173.96 14.65 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.465 1.106 . . . . 0.0 112.65 -168.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.85 128.53 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.0 mm -63.22 125.48 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.413 1.485 . . . . 0.0 110.279 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -111.84 -34.93 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.647 1.179 . . . . 0.0 113.041 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -157.62 167.5 29.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.491 1.116 . . . . 0.0 112.039 165.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.72 140.38 33.12 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.201 1.001 . . . . 0.0 112.168 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.9 m -111.76 174.07 6.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.152 2.181 . . . . 0.0 110.739 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.02 68.58 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 70.9 p -130.19 -7.57 4.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.788 1.635 . . . . 0.0 114.809 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -145.0 165.37 28.36 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.256 1.822 . . . . 0.0 111.278 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.69 144.42 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.706 1.603 . . . . 0.0 109.712 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 37.7 mmm -116.14 109.5 17.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 110.051 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.31 148.1 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.35 1.46 . . . . 0.0 109.933 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 120.52 13.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.241 1.417 . . . . 0.0 111.867 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -134.59 164.45 27.45 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.886 1.674 . . . . 0.0 111.873 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -83.03 171.09 14.16 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.518 1.127 . . . . 0.0 112.102 167.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -145.69 131.82 9.61 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.619 1.167 . . . . 0.0 110.769 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.52 -39.76 3.42 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.811 2.341 . . . . 0.0 112.968 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.67 78.75 7.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.444 1.098 . . . . 0.0 108.595 169.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.37 162.72 22.09 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.419 1.088 . . . . 0.0 112.692 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.12 102.21 2.34 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.71 1.148 . . . . 0.0 113.859 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -77.67 155.26 31.45 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.231 1.812 . . . . 0.0 112.693 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.87 144.21 43.49 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.185 1.394 . . . . 0.0 111.3 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.2 143.95 46.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.065 1.346 . . . . 0.0 111.262 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.75 144.38 37.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.659 0.784 . . . . 0.0 111.357 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -128.79 92.13 3.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.074 1.75 . . . . 0.0 108.652 170.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -79.01 110.37 14.17 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.901 1.28 . . . . 0.0 108.802 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -131.88 166.97 20.42 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.349 0.66 . . . . 0.0 112.773 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -149.92 142.74 24.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.658 1.183 . . . . 0.0 111.673 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.14 106.69 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.997 1.319 . . . . 0.0 108.826 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.61 -38.19 77.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 111.63 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.55 158.88 7.73 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.296 1.427 . . . . 0.0 114.749 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -82.9 125.38 31.3 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.803 1.641 . . . . 0.0 111.506 -176.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -142.83 120.42 11.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.276 1.43 . . . . 0.0 111.225 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.38 145.86 47.43 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.988 -1.07 . . . . 0.0 111.526 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.76 146.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.55 1.54 . . . . 0.0 110.85 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.4 m -70.13 126.88 30.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.218 1.007 . . . . 0.0 111.61 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -103.71 1.64 32.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.421 1.489 . . . . 0.0 113.656 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.44 -58.67 2.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.979 1.712 . . . . 0.0 113.166 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.744 1.618 . . . . 0.0 113.925 -177.817 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -129.38 125.55 36.84 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.125 1.37 . . . . 0.0 111.052 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -137.79 171.01 15.07 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.671 1.988 . . . . 0.0 110.945 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -145.18 172.91 12.44 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.643 1.177 . . . . 0.0 111.93 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -126.0 170.69 11.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.167 1.787 . . . . 0.0 112.022 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tt -118.99 107.23 13.28 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.625 1.57 . . . . 0.0 110.576 -173.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -132.87 85.29 2.21 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.552 1.541 . . . . 0.0 111.261 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 m -74.39 -12.13 60.43 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.8 mm -78.83 170.03 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 126.799 2.04 . . . . 0.0 110.538 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.55 145.62 47.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.407 1.083 . . . . 0.0 112.39 164.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -159.48 160.1 34.3 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.899 2.079 . . . . 0.0 109.621 167.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.19 108.44 6.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.093 0.557 . . . . 0.0 110.602 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.27 120.05 14.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.265 1.826 . . . . 0.0 110.456 165.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.28 113.86 27.69 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.244 2.218 . . . . 0.0 108.952 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 159.35 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 112.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -135.09 129.67 34.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.885 1.274 . . . . 0.0 110.38 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -135.68 155.0 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.607 1.163 . . . . 0.0 113.034 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -140.17 166.09 25.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.097 1.759 . . . . 0.0 111.424 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.37 101.2 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.84 1.256 . . . . 0.0 111.194 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -90.51 154.03 19.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 110.219 170.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -61.54 135.4 57.64 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.894 161.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -71.21 91.72 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.23 -0.919 . . . . 0.0 110.776 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.93 -68.91 0.54 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.185 1.85 . . . . 0.0 112.302 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -67.11 158.67 30.58 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.7 m -79.02 -13.09 59.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.46 151.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.074 0.852 . . . . 0.0 112.063 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.6 114.91 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.364 1.466 . . . . 0.0 109.182 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.0 mt -68.29 -48.57 64.62 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.619 1.168 . . . . 0.0 111.66 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -154.02 158.19 40.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.638 1.575 . . . . 0.0 110.362 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 p -151.2 125.68 9.49 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.472 1.109 . . . . 0.0 111.52 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -90.13 -30.89 17.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.29 0.636 . . . . 0.0 111.912 170.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.85 -50.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.613 1.565 . . . . 0.0 111.815 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -70.53 -5.54 29.72 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.21 1.404 . . . . 0.0 114.548 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -100.85 -83.61 0.44 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.772 1.629 . . . . 0.0 109.702 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.71 156.78 31.09 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 127.45 2.3 . . . . 0.0 110.451 171.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.82 141.35 78.01 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.679 2.253 . . . . 0.0 111.733 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.82 136.83 43.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.959 1.303 . . . . 0.0 109.971 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.64 119.71 34.52 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.05 1.34 . . . . 0.0 111.208 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -148.49 172.68 14.1 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -109.99 142.85 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.302 1.441 . . . . 0.0 109.839 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mm -47.32 115.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 111.864 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.52 64.76 1.49 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.171 1.367 . . . . 0.0 113.425 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -115.67 -22.37 9.21 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.044 1.338 . . . . 0.0 114.529 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m120 52.05 28.57 5.45 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 127.489 2.316 . . . . 0.0 116.107 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -86.75 -32.14 20.56 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 pt -81.26 170.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.975 1.31 . . . . 0.0 112.168 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.1 pt -59.57 140.01 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.189 0.996 . . . . 0.0 111.723 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.39 78.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -28.75 70.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.115 0.864 . . . . 0.0 114.295 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.19 -38.7 14.08 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.676 1.19 . . . . 0.0 111.588 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -53.42 -46.28 69.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.229 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.04 1.72 3.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.948 1.699 . . . . 0.0 114.667 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.55 -35.72 5.15 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.72 1.608 . . . . 0.0 113.498 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.74 -41.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.339 1.427 . . . . 0.0 112.253 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.29 -10.46 32.62 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -112.33 -9.43 13.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.205 1.802 . . . . 0.0 113.927 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.86 145.87 28.4 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.818 1.247 . . . . 0.0 111.842 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -98.37 157.01 16.46 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.925 1.29 . . . . 0.0 111.566 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 tt -57.39 129.36 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 111.829 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.14 78.88 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.035 1.302 . . . . 0.0 115.368 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.28 114.13 20.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.09 1.445 . . . . 0.0 111.65 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -56.0 142.06 37.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.536 1.135 . . . . 0.0 112.717 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -137.44 116.46 12.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.015 1.726 . . . . 0.0 110.728 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -101.4 107.05 18.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.012 1.325 . . . . 0.0 110.73 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -115.9 110.3 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.564 1.146 . . . . 0.0 110.907 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 t -73.89 130.19 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.73 141.64 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.157 1.383 . . . . 0.0 109.764 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.68 155.08 87.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.905 1.282 . . . . 0.0 112.789 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.62 -18.6 64.67 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.362 2.708 . . . . 0.0 114.457 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.49 -6.56 20.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.366 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -106.65 -21.41 13.06 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.19 1.396 . . . . 0.0 113.224 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.67 -168.3 1.36 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.899 1.68 . . . . 0.0 112.897 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -54.48 -21.36 9.75 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 164.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.84 72.16 1.1 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.307 1.432 . . . . 0.0 113.546 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.39 154.91 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.036 1.734 . . . . 0.0 110.876 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -137.72 144.83 41.91 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.769 1.227 . . . . 0.0 110.597 169.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -140.32 82.26 1.85 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.092 1.357 . . . . 0.0 109.771 167.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 p -62.11 -37.84 86.62 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.331 1.052 . . . . 0.0 111.952 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.1 m 47.39 48.46 16.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.366 1.466 . . . . 0.0 112.382 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 71.99 15.1 5.69 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.242 2.217 . . . . 0.0 114.402 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.7 mt -142.16 160.67 39.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.566 1.946 . . . . 0.0 112.974 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.39 133.23 11.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.297 1.439 . . . . 0.0 111.427 162.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -78.29 99.51 6.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.443 1.097 . . . . 0.0 110.407 167.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.67 137.1 21.46 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.714 1.606 . . . . 0.0 109.425 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.44 155.92 50.37 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 112.922 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -75.71 60.75 1.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.171 1.788 . . . . 0.0 112.24 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -122.38 -54.11 1.89 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.302 1.841 . . . . 0.0 111.038 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -63.78 -17.18 62.81 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.464 1.105 . . . . 0.0 113.453 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -126.59 12.05 7.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.822 1.649 . . . . 0.0 113.875 -170.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.417 1.087 . . . . 0.0 113.542 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.4 12.87 47.78 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.19 1.852 . . . . 0.0 115.355 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.6 mt -122.1 126.66 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.251 1.525 . . . . 0.0 110.725 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.93 78.38 0.64 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.22 1.408 . . . . 0.0 112.649 173.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.7 156.2 24.3 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.74 162.77 40.48 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.256 1.822 . . . . 0.0 110.028 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -71.32 136.05 47.66 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.698 -1.251 . . . . 0.0 110.816 166.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.68 18.15 76.05 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.5 ptm -100.53 148.64 24.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.944 1.372 . . . . 0.0 111.776 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -68.49 143.43 54.99 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.059 0.944 . . . . 0.0 111.765 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.37 163.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.757 1.623 . . . . 0.0 111.278 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.25 158.0 35.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.399 1.88 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.88 103.7 0.25 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 123.774 0.702 . . . . 0.0 113.229 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.38 111.03 8.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.323 1.049 . . . . 0.0 111.5 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 t -81.2 154.44 26.66 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.6 1.16 . . . . 0.0 111.744 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.86 -13.57 59.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.774 1.229 . . . . 0.0 113.515 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.06 18.85 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.165 1.786 . . . . 0.0 113.841 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 55.3 42.94 29.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.386 2.274 . . . . 0.0 113.037 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -143.02 169.75 16.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.794 1.638 . . . . 0.0 112.043 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.8 m -141.41 107.11 5.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 110.592 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.79 167.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.992 -0.442 . . . . 0.0 111.18 174.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.08 135.88 37.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.721 1.208 . . . . 0.0 111.587 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.41 -167.97 1.89 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.816 1.246 . . . . 0.0 112.732 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.55 140.29 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.296 1.838 . . . . 0.0 110.528 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.98 124.61 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.418 1.087 . . . . 0.0 111.317 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -91.57 -35.96 13.96 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.722 1.609 . . . . 0.0 113.352 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -154.8 160.21 41.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.223 1.409 . . . . 0.0 110.879 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -148.35 150.08 32.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.171 0.988 . . . . 0.0 113.038 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -143.95 175.69 9.84 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.179 1.791 . . . . 0.0 110.91 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.31 -20.77 58.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.51 1.124 . . . . 0.0 113.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -86.75 -57.49 2.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.68 1.592 . . . . 0.0 111.967 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -138.17 169.95 16.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.4 2.28 . . . . 0.0 111.308 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.45 148.28 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.496 1.518 . . . . 0.0 110.934 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.5 mtp -112.57 92.38 4.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.708 1.603 . . . . 0.0 110.436 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.7 143.37 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.526 1.53 . . . . 0.0 109.808 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -63.87 125.3 23.94 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.876 170.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -128.91 112.06 13.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.378 1.071 . . . . 0.0 110.132 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -125.11 24.71 7.42 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.912 1.685 . . . . 0.0 112.063 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.72 143.98 97.13 Favored Pre-proline 0 CA--C 1.549 0.939 0 O-C-N 120.997 -1.064 . . . . 0.0 111.357 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.31 -4.21 15.03 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.737 2.958 . . . . 0.0 114.207 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.15 92.26 1.69 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.44 2.296 . . . . 0.0 110.081 173.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.01 -64.32 1.21 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.636 0.774 . . . . 0.0 112.048 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.21 92.51 0.06 OUTLIER Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.767 1.651 . . . . 0.0 114.567 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -130.73 160.08 35.38 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.061 1.345 . . . . 0.0 113.507 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 p -65.6 144.54 56.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.198 1.399 . . . . 0.0 112.533 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.8 mt -126.84 142.76 51.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.125 1.37 . . . . 0.0 111.809 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.97 95.11 9.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.537 1.135 . . . . 0.0 111.292 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.76 88.82 5.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.261 1.029 . . . . 0.0 110.796 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.77 124.23 28.88 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.016 1.326 . . . . 0.0 109.45 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.57 171.76 13.73 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -150.94 144.86 25.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.405 1.482 . . . . 0.0 111.237 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.9 101.06 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.426 1.09 . . . . 0.0 108.233 165.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.71 -28.5 66.89 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.539 0.736 . . . . 0.0 112.258 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.74 -160.77 28.62 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.497 1.046 . . . . 0.0 113.539 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.73 149.42 51.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.49 1.116 . . . . 0.0 110.872 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -137.58 142.36 41.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.868 1.267 . . . . 0.0 112.048 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -71.86 131.86 43.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.537 0.735 . . . . 0.0 110.361 169.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.4 172.4 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.878 1.671 . . . . 0.0 111.561 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.6 t -126.76 167.39 15.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.844 1.658 . . . . 0.0 111.287 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.4 -0.68 8.71 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.899 1.68 . . . . 0.0 112.918 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -83.88 -55.18 4.38 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.175 1.39 . . . . 0.0 112.721 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 127.285 2.234 . . . . 0.0 112.414 -175.271 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.823 0.344 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -111.85 -12.16 13.83 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.592 1.157 . . . . 0.0 112.968 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -70.59 99.87 1.73 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.816 1.647 . . . . 0.0 111.174 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -61.57 119.76 9.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.193 1.397 . . . . 0.0 111.496 172.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -75.09 158.28 33.37 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.803 0.841 . . . . 0.0 112.451 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.06 19.25 15.87 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.36 1.864 . . . . 0.0 112.263 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 56.53 19.25 4.05 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.702 2.001 . . . . 0.0 114.812 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.0 m -77.3 12.74 1.38 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.465 1.906 . . . . 0.0 114.748 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.2 mm -60.98 139.94 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.994 1.718 . . . . 0.0 111.295 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -107.26 150.46 26.64 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.092 1.757 . . . . 0.0 111.06 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.55 153.88 34.3 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.658 1.583 . . . . 0.0 111.381 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.57 105.22 9.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.807 0.843 . . . . 0.0 110.678 174.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 129.99 41.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.295 1.038 . . . . 0.0 110.348 165.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -116.47 130.03 56.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.191 1.396 . . . . 0.0 110.39 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.91 163.64 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.511 1.124 . . . . 0.0 112.192 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.88 135.01 34.03 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.58 1.952 . . . . 0.0 110.453 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -139.06 149.61 44.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.111 1.434 . . . . 0.0 114.429 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.27 114.5 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.802 2.441 . . . . 0.0 109.253 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -92.87 96.59 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.409 1.084 . . . . 0.0 110.191 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -95.66 158.11 15.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.157 1.783 . . . . 0.0 110.362 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -72.35 156.8 38.71 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.125 -0.985 . . . . 0.0 110.98 166.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -65.65 -64.62 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 113.104 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.07 -47.76 5.4 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.018 0.818 . . . . 0.0 113.566 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -72.04 150.71 43.73 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 112.367 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 m -74.71 -12.39 60.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.813 1.245 . . . . 0.0 114.184 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 156.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.757 0.823 . . . . 0.0 113.091 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.39 128.13 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.886 1.674 . . . . 0.0 109.304 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -81.06 -49.35 11.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.178 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -154.87 160.51 41.25 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.171 1.388 . . . . 0.0 111.748 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.2 p -158.51 126.58 5.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.739 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.95 -17.15 31.94 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 170.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.12 -36.74 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.055 1.342 . . . . 0.0 112.553 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.1 p -75.57 -6.9 52.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.1 1.36 . . . . 0.0 114.64 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -107.93 -88.07 0.48 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.597 1.959 . . . . 0.0 110.133 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -151.44 152.71 31.24 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.937 2.095 . . . . 0.0 110.858 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.75 158.62 56.43 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.734 2.956 . . . . 0.0 113.526 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.38 112.61 23.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.657 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.97 129.49 40.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.716 1.607 . . . . 0.0 111.605 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -147.66 176.93 9.7 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 112.474 171.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.96 150.64 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.626 1.57 . . . . 0.0 108.856 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.6 mm -49.41 106.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.509 1.124 . . . . 0.0 111.892 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.73 80.21 1.5 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 125.887 1.708 . . . . 0.0 113.476 -171.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.3 m -132.61 -49.1 0.9 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.056 1.343 . . . . 0.0 112.897 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.25 32.84 22.3 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.596 1.558 . . . . 0.0 114.365 175.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -27.67 34.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.29 171.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.801 1.241 . . . . 0.0 112.317 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -56.25 144.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.533 1.133 . . . . 0.0 112.179 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.086 0.954 . . . . 0.0 113.216 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.37 93.85 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.45 1.024 . . . . 0.0 113.317 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.03 -42.38 38.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.626 0.77 . . . . 0.0 112.121 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -53.08 -48.19 67.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.756 1.162 . . . . 0.0 112.79 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.31 -21.59 66.73 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.98 27.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.114 0.966 . . . . 0.0 112.291 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -53.42 -44.31 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.749 1.159 . . . . 0.0 112.541 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.17 -18.25 65.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -102.84 -20.66 14.22 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.983 1.713 . . . . 0.0 113.971 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.63 134.19 48.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.917 1.287 . . . . 0.0 112.058 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.45 150.34 34.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.922 0.889 . . . . 0.0 111.665 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -56.61 129.62 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.689 1.196 . . . . 0.0 111.161 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.37 76.85 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -122.83 117.82 26.53 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.956 1.378 . . . . 0.0 111.429 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -60.65 141.2 57.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.007 0.923 . . . . 0.0 111.982 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -138.54 120.34 15.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.898 1.279 . . . . 0.0 111.019 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.58 101.51 11.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 110.376 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.26 116.72 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.101 1.36 . . . . 0.0 111.403 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 t -80.21 109.88 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.227 1.011 . . . . 0.0 109.7 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.8 mm -98.52 136.42 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.903 1.281 . . . . 0.0 109.808 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 152.35 89.41 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.336 1.055 . . . . 0.0 111.966 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.72 -46.05 22.16 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.682 2.255 . . . . 0.0 111.867 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 -14.09 46.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 0.0 114.976 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.36 -27.13 9.66 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.572 1.549 . . . . 0.0 112.714 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.08 -69.73 0.62 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.043 1.337 . . . . 0.0 112.151 171.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -101.08 -17.9 16.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.02 1.328 . . . . 0.0 113.694 -173.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.36 -174.42 41.71 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.725 1.155 . . . . 0.0 112.925 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -56.33 110.47 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.199 1.4 . . . . 0.0 112.014 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.63 155.4 39.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.022 0.929 . . . . 0.0 112.907 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.76 60.52 5.97 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.088 1.355 . . . . 0.0 113.016 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 81.6 p -74.18 5.52 4.36 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 71.0 m -63.32 109.28 1.53 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.832 1.253 . . . . 0.0 112.109 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -131.47 176.43 8.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.983 2.113 . . . . 0.0 111.329 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.04 143.26 33.13 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.976 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -116.37 117.5 30.14 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.925 1.29 . . . . 0.0 110.074 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -74.27 106.75 6.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.088 0.955 . . . . 0.0 110.18 171.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -121.44 131.58 24.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 126.8 2.04 . . . . 0.0 109.293 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.18 155.5 64.4 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.084 1.856 . . . . 0.0 112.557 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -58.72 -19.95 44.68 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 172.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.11 -30.97 62.84 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.936 1.294 . . . . 0.0 113.174 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -81.35 -3.32 52.3 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.204 1.002 . . . . 0.0 113.416 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.22 20.22 7.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.231 2.212 . . . . 0.0 112.432 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.94 104.28 0.28 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.461 1.505 . . . . 0.0 111.875 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.82 3.15 52.41 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.373 1.463 . . . . 0.0 115.68 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 pt -129.63 98.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.865 1.666 . . . . 0.0 111.209 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.28 144.34 54.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.698 1.199 . . . . 0.0 111.665 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -125.7 159.72 31.55 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.396 1.478 . . . . 0.0 111.1 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -150.86 145.19 25.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.244 1.418 . . . . 0.0 110.325 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -58.51 128.62 38.08 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.674 0.79 . . . . 0.0 111.349 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 43.08 12.93 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 123.741 0.686 . . . . 0.0 114.445 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.73 153.89 47.73 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.57 1.148 . . . . 0.0 111.705 168.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.9 t -82.83 98.75 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.233 1.413 . . . . 0.0 112.034 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.63 156.97 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 110.914 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -113.0 149.09 33.8 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.466 1.106 . . . . 0.0 111.353 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.42 97.58 0.22 Allowed Glycine 0 N--CA 1.469 0.862 0 C-N-CA 124.44 1.019 . . . . 0.0 112.516 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.1 110.79 4.69 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.999 0.919 . . . . 0.0 111.101 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -78.39 153.18 31.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.239 1.016 . . . . 0.0 111.659 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -66.21 -12.95 59.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.467 1.507 . . . . 0.0 113.245 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.98 16.39 0.16 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 126.339 1.855 . . . . 0.0 114.01 168.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.59 45.63 15.88 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.227 2.211 . . . . 0.0 112.649 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -145.29 170.03 17.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.358 1.863 . . . . 0.0 111.163 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.1 m -142.44 120.61 12.2 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.753 1.221 . . . . 0.0 110.82 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.57 167.14 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.104 0.561 . . . . 0.0 111.752 174.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -117.0 127.61 54.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.279 1.431 . . . . 0.0 109.052 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.5 171.84 13.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.975 1.31 . . . . 0.0 112.446 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.28 130.06 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.104 0.961 . . . . 0.0 110.57 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.4 mm -62.47 103.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 109.533 170.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -84.13 -38.29 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.061 0.945 . . . . 0.0 111.667 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -149.46 165.4 32.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.461 1.104 . . . . 0.0 112.373 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.01 159.0 44.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.765 1.226 . . . . 0.0 111.921 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.2 m -134.59 174.76 10.19 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.207 1.803 . . . . 0.0 110.835 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.24 -15.56 63.29 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.6 t -140.25 -17.93 0.91 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.92 1.688 . . . . 0.0 114.489 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -133.46 168.03 19.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.662 1.585 . . . . 0.0 112.282 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -136.48 148.65 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.817 2.047 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.0 mtp -129.82 99.57 5.17 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.978 1.311 . . . . 0.0 110.801 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.14 147.32 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 110.005 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.46 128.69 36.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.113 0.565 . . . . 0.0 111.143 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -134.07 162.78 31.15 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.552 . . . . 0.0 110.779 172.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -149.98 173.14 14.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.504 1.522 . . . . 0.0 110.61 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -108.22 129.81 23.59 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.545 0.738 . . . . 0.0 110.589 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.37 -34.16 35.76 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.582 2.188 . . . . 0.0 112.7 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.05 78.75 8.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.794 1.237 . . . . 0.0 108.596 167.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.34 98.83 6.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.524 1.53 . . . . 0.0 111.52 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.65 178.57 35.19 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.397 1.475 . . . . 0.0 113.595 -177.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -138.61 161.52 36.9 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.261 1.425 . . . . 0.0 113.393 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.85 140.66 58.89 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.963 1.705 . . . . 0.0 112.423 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -129.59 138.42 51.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.929 1.292 . . . . 0.0 112.009 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.41 96.68 10.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.486 1.514 . . . . 0.0 111.046 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -76.72 92.6 3.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.345 0.658 . . . . 0.0 109.585 166.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -77.09 119.5 20.88 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 164.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -138.25 169.83 17.09 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.378 0.671 . . . . 0.0 112.48 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -149.22 143.35 25.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.834 1.254 . . . . 0.0 111.584 171.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.5 t -82.24 104.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.772 1.229 . . . . 0.0 108.45 165.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.33 -35.49 75.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.366 0.666 . . . . 0.0 111.703 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.66 -149.95 18.86 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.449 1.499 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -129.29 151.16 50.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.262 1.025 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -129.07 136.2 49.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.382 1.473 . . . . 0.0 111.264 175.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.78 102.94 9.34 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.88 1.272 . . . . 0.0 110.264 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 30.5 m -133.06 169.48 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.573 1.549 . . . . 0.0 111.555 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.4 p -140.77 162.42 35.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.273 1.429 . . . . 0.0 111.966 174.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -124.84 18.71 8.58 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.792 1.637 . . . . 0.0 112.081 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 66.1 0.78 1.73 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.936 2.495 . . . . 0.0 114.653 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 128.726 2.81 . . . . 0.0 112.791 167.821 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -77.2 -64.66 1.09 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.31 1.044 . . . . 0.0 111.19 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -83.01 163.69 20.82 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.517 1.127 . . . . 0.0 111.376 174.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -83.78 -8.54 59.21 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -146.07 150.86 36.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.711 1.205 . . . . 0.0 112.6 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.0 130.98 35.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.691 2.396 . . . . 0.0 110.699 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 57.85 22.35 8.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.564 1.546 . . . . 0.0 114.314 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 t -71.08 -0.09 8.79 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.359 1.864 . . . . 0.0 114.899 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.568 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.6 mp -58.54 149.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 126.481 1.912 . . . . 0.0 110.313 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -89.89 135.76 33.44 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.329 1.452 . . . . 0.0 111.09 173.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -157.84 166.53 32.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.698 1.599 . . . . 0.0 111.844 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.01 118.1 18.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.101 0.96 . . . . 0.0 111.45 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.5 106.7 8.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.696 1.599 . . . . 0.0 110.001 164.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.66 115.46 24.13 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.392 1.877 . . . . 0.0 109.501 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -131.78 158.57 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.078 0.951 . . . . 0.0 111.892 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -138.87 134.6 33.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.901 1.28 . . . . 0.0 110.281 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -131.9 162.11 31.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.145 1.378 . . . . 0.0 112.803 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.17 171.03 15.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 111.357 166.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.77 106.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.454 1.102 . . . . 0.0 110.981 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -116.65 154.86 29.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.634 1.574 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.92 148.4 40.11 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.552 -0.717 . . . . 0.0 111.042 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -66.59 -25.84 66.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 -72.94 0.95 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.226 1.393 . . . . 0.0 112.647 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -59.89 140.18 56.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.221 1.408 . . . . 0.0 113.576 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -70.9 -21.28 62.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.812 1.245 . . . . 0.0 113.892 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.37 158.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.952 1.301 . . . . 0.0 112.562 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.0 129.04 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.478 1.511 . . . . 0.0 109.75 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mp -79.69 -45.67 18.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.392 0.677 . . . . 0.0 111.312 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.71 158.27 40.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.163 1.385 . . . . 0.0 111.383 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.3 t -156.93 141.63 16.86 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.278 -0.889 . . . . 0.0 112.666 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.17 3.7 15.29 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.398 1.879 . . . . 0.0 112.752 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.55 -55.9 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.469 1.107 . . . . 0.0 111.214 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 t -72.21 -21.64 61.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.458 1.103 . . . . 0.0 113.034 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -80.81 -178.18 6.69 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.954 2.102 . . . . 0.0 111.841 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.39 128.11 92.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.873 0.869 . . . . 0.0 111.069 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.48 151.85 83.91 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.851 2.367 . . . . 0.0 112.427 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 tt -81.9 134.87 35.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.318 1.047 . . . . 0.0 109.981 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -119.43 114.46 22.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.78 1.632 . . . . 0.0 110.564 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -130.13 172.71 11.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.255 1.022 . . . . 0.0 112.26 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.3 mm -115.8 150.73 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.263 1.425 . . . . 0.0 109.023 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.57 106.16 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.72 29.9 7.1 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.405 1.479 . . . . 0.0 116.369 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 m -98.23 -38.56 9.24 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.53 1.665 . . . . 0.0 113.795 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 55.28 33.02 19.8 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.114 1.766 . . . . 0.0 115.198 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -68.03 -21.42 65.02 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.8 pt -74.26 168.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.964 1.706 . . . . 0.0 113.082 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 pt -60.86 152.79 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.29 1.036 . . . . 0.0 112.518 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.64 -43.13 79.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.11 73.06 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 114.105 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -88.88 -30.5 18.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.999 1.32 . . . . 0.0 112.223 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.6 -44.27 72.92 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.777 1.631 . . . . 0.0 111.639 171.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.79 8.46 6.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.379 1.471 . . . . 0.0 113.817 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.41 -39.58 2.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.499 1.519 . . . . 0.0 113.671 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.27 -30.07 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.323 1.049 . . . . 0.0 113.572 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.17 -14.24 62.21 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.16 -34.46 7.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.511 1.525 . . . . 0.0 112.782 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.91 149.82 26.0 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.551 0.74 . . . . 0.0 111.808 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.07 161.06 22.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 111.409 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.52 125.49 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.81 0.844 . . . . 0.0 111.759 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.78 76.64 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.778 1.18 . . . . 0.0 115.038 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.08 108.76 17.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.957 1.378 . . . . 0.0 111.334 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -57.78 141.2 49.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.982 0.913 . . . . 0.0 112.223 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.33 116.98 12.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.179 1.791 . . . . 0.0 110.716 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.0 112.19 23.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.924 1.29 . . . . 0.0 110.871 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -123.05 112.51 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.132 0.973 . . . . 0.0 111.256 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.7 127.83 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 121.197 -0.939 . . . . 0.0 109.303 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.4 mt -120.56 135.95 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.699 1.6 . . . . 0.0 108.703 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.64 148.69 96.61 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.652 0.781 . . . . 0.0 111.494 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.56 -44.58 13.69 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.02 2.48 . . . . 0.0 112.405 -170.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.14 -30.69 71.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.229 1.811 . . . . 0.0 113.695 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -80.69 -29.31 36.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.758 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.53 -66.44 0.81 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.9 1.28 . . . . 0.0 111.791 168.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -143.51 -37.55 0.34 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.82 72.18 0.66 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.626 1.584 . . . . 0.0 115.667 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.17 -1.56 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -70.71 155.96 40.1 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.522 1.129 . . . . 0.0 113.425 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -87.78 89.92 8.18 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.476 1.91 . . . . 0.0 113.199 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 m -113.13 35.49 3.93 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.838 1.655 . . . . 0.0 113.839 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 p -55.0 112.18 1.0 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.996 1.718 . . . . 0.0 111.334 163.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -134.58 150.24 50.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.44 115.38 11.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.852 2.061 . . . . 0.0 111.349 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -116.98 119.22 34.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.259 1.423 . . . . 0.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.09 105.7 11.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.042 1.337 . . . . 0.0 111.06 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.85 131.56 21.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.673 1.989 . . . . 0.0 109.296 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.33 162.21 41.46 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.441 2.094 . . . . 0.0 112.52 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.95 -22.45 49.12 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.013 0.925 . . . . 0.0 113.417 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.42 -39.56 57.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.026 2.13 . . . . 0.0 114.031 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -69.77 -17.84 63.45 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -131.7 15.35 4.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.934 1.693 . . . . 0.0 114.161 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -57.33 -27.94 62.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.343 1.457 . . . . 0.0 114.143 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.76 6.69 33.29 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.823 1.678 . . . . 0.0 116.061 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.26 113.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.33 1.565 . . . . 0.0 111.881 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.92 139.65 58.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.102 0.961 . . . . 0.0 112.012 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -121.02 172.27 8.06 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.092 1.757 . . . . 0.0 111.609 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -148.29 161.15 42.1 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.222 1.009 . . . . 0.0 112.039 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -73.37 95.47 2.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.396 1.078 . . . . 0.0 111.026 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.41 64.24 0.73 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.9 ptp -133.95 152.0 51.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.129 1.372 . . . . 0.0 111.527 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.7 m -77.23 98.77 5.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.531 1.532 . . . . 0.0 110.652 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.09 154.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.366 1.466 . . . . 0.0 111.321 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.35 147.49 29.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.744 1.218 . . . . 0.0 111.589 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.99 96.98 0.28 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.949 1.261 . . . . 0.0 112.423 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -72.15 114.84 10.69 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.874 0.87 . . . . 0.0 111.13 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -82.42 154.84 24.97 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.507 1.123 . . . . 0.0 111.574 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.54 -13.21 39.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.024 1.329 . . . . 0.0 113.545 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -73.75 19.38 0.11 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.464 1.505 . . . . 0.0 113.781 171.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 58.4 33.85 23.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.346 2.259 . . . . 0.0 113.738 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -135.84 169.75 17.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.813 2.045 . . . . 0.0 111.493 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.1 m -137.68 138.28 39.24 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.543 1.537 . . . . 0.0 110.184 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.02 170.64 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.228 1.011 . . . . 0.0 111.372 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.23 133.74 55.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.919 1.688 . . . . 0.0 110.717 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.93 171.06 14.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.095 1.758 . . . . 0.0 111.228 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.7 126.97 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.862 0.865 . . . . 0.0 110.019 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.49 129.49 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 110.567 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -91.5 -49.27 6.41 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.061 1.344 . . . . 0.0 111.504 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -151.87 170.73 19.1 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.813 1.245 . . . . 0.0 112.208 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.72 155.61 45.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.432 1.093 . . . . 0.0 113.019 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.42 169.11 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.038 2.535 . . . . 0.0 110.049 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.41 67.96 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.129 -0.982 . . . . 0.0 113.167 171.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 63.9 p -131.22 -8.47 3.8 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.311 1.444 . . . . 0.0 114.811 -173.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -141.81 171.19 14.4 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.776 1.63 . . . . 0.0 111.047 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -138.65 150.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.514 1.926 . . . . 0.0 108.738 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 62.2 mtp -125.54 114.6 18.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.508 1.123 . . . . 0.0 111.035 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.2 163.83 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.811 1.244 . . . . 0.0 112.163 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -102.13 88.49 3.34 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.86 1.264 . . . . 0.0 112.182 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -81.28 171.97 14.18 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.647 1.179 . . . . 0.0 112.268 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -108.46 110.1 21.53 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.84 1.656 . . . . 0.0 110.148 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -66.35 134.62 94.64 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.554 0.742 . . . . 0.0 111.139 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.98 -31.85 23.14 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.54 2.16 . . . . 0.0 114.183 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.1 56.32 0.77 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.822 1.649 . . . . 0.0 111.022 175.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.5 103.49 14.41 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.747 1.619 . . . . 0.0 112.56 -173.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.25 -159.41 13.91 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.291 1.424 . . . . 0.0 113.495 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 159.71 35.91 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.378 1.871 . . . . 0.0 111.912 173.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.9 p -64.66 144.85 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.36 1.464 . . . . 0.0 113.14 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -130.31 136.42 49.12 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.275 . . . . 0.0 111.706 -173.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.68 97.41 7.9 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.73 1.612 . . . . 0.0 111.324 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.65 83.59 6.4 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.415 1.102 . . . . 0.0 110.613 166.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -76.58 131.67 39.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.14 169.89 19.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -145.41 145.63 31.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.971 1.309 . . . . 0.0 111.656 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 t -84.49 100.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.863 1.265 . . . . 0.0 108.693 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.23 -31.96 71.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.38 0.672 . . . . 0.0 111.837 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.88 -170.05 31.28 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.196 0.903 . . . . 0.0 114.883 170.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.55 118.93 27.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.616 1.567 . . . . 0.0 110.219 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -138.4 128.34 25.39 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.985 1.314 . . . . 0.0 112.558 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -75.45 115.69 15.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.407 0.683 . . . . 0.0 110.759 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.06 164.14 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.358 1.863 . . . . 0.0 111.094 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.1 m -135.06 146.89 49.38 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.623 1.169 . . . . 0.0 111.803 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -89.05 22.39 2.78 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.832 1.653 . . . . 0.0 112.973 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.16 13.96 6.24 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.666 1.986 . . . . 0.0 114.228 -172.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.985 2.114 . . . . 0.0 114.832 177.776 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -141.59 -63.49 0.45 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.836 -1.165 . . . . 0.0 111.751 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -75.85 171.92 13.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.409 1.084 . . . . 0.0 111.662 170.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -125.59 92.34 3.59 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.531 1.533 . . . . 0.0 111.618 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -78.02 170.46 16.57 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.149 1.38 . . . . 0.0 112.779 173.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.18 110.68 17.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.023 1.729 . . . . 0.0 110.163 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -134.42 75.93 1.61 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.777 1.631 . . . . 0.0 112.534 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 p -69.73 -20.92 63.51 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.6 mm -131.76 131.93 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.608 1.963 . . . . 0.0 110.665 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -73.93 137.48 43.65 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.3 1.44 . . . . 0.0 111.843 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -136.69 155.03 50.42 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.277 1.831 . . . . 0.0 110.656 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 107.51 17.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.184 0.994 . . . . 0.0 110.435 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.02 128.7 37.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.382 165.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.23 124.81 53.4 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.592 1.557 . . . . 0.0 109.619 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 141' ' ' VAL . 14.5 pt -128.5 163.68 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 171.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.82 136.72 40.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 109.745 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.07 157.95 45.58 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.069 1.414 . . . . 0.0 114.783 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -139.13 141.25 38.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.462 3.105 . . . . 0.0 108.878 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.22 110.06 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.873 1.269 . . . . 0.0 110.429 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -123.69 168.85 12.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.539 1.536 . . . . 0.0 112.685 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -62.57 151.97 36.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.505 1.122 . . . . 0.0 111.147 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -20.28 63.24 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.42 25.35 1.53 Allowed Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.123 1.344 . . . . 0.0 114.959 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -141.16 161.41 37.93 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.917 1.358 . . . . 0.0 112.52 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -75.71 -17.72 59.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.783 1.633 . . . . 0.0 113.762 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -64.04 151.69 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.799 0.84 . . . . 0.0 112.456 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.46 117.25 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.787 1.635 . . . . 0.0 108.943 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.87 -44.05 56.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.721 0.808 . . . . 0.0 111.77 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.67 164.09 39.06 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.648 1.179 . . . . 0.0 111.581 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 m -165.87 159.6 16.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.384 1.874 . . . . 0.0 111.844 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -126.08 2.75 7.22 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 164.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.9 mm -47.46 -46.2 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.01 1.724 . . . . 0.0 113.965 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -93.42 -2.62 54.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.955 1.302 . . . . 0.0 113.581 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -98.05 -166.52 1.39 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.875 2.47 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.91 134.26 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.473 1.109 . . . . 0.0 111.775 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.55 159.01 55.18 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.27 2.647 . . . . 0.0 113.314 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.88 95.06 5.96 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.435 1.094 . . . . 0.0 110.268 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.34 125.46 31.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.159 1.783 . . . . 0.0 111.578 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.48 172.6 14.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.168 0.987 . . . . 0.0 113.399 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 142.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.601 1.56 . . . . 0.0 109.507 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mm -47.93 121.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.971 1.708 . . . . 0.0 112.462 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.41 76.85 1.09 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.995 1.283 . . . . 0.0 112.806 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -130.79 -26.69 2.18 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 53.48 21.96 2.7 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.518 1.927 . . . . 0.0 115.683 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -78.25 -28.6 47.82 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -170.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 pt -82.07 171.18 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.86 1.664 . . . . 0.0 112.196 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 pt -55.34 140.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.818 0.847 . . . . 0.0 111.169 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.67 78.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.543 0.737 . . . . 0.0 112.915 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.88 -30.41 72.98 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.327 0.965 . . . . 0.0 114.303 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.67 -43.9 13.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.337 1.055 . . . . 0.0 111.404 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -53.25 -48.02 68.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.595 1.158 . . . . 0.0 112.309 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.05 0.3 2.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.984 1.314 . . . . 0.0 114.468 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.54 -25.42 7.9 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.968 1.707 . . . . 0.0 114.04 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.3 t -58.31 -42.02 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.736 1.607 . . . . 0.0 112.114 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.92 -12.62 61.06 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.95 -36.9 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.995 1.718 . . . . 0.0 112.18 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 140.74 58.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.085 1.354 . . . . 0.0 112.385 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -86.28 154.28 21.37 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.009 0.924 . . . . 0.0 111.964 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.71 131.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.287 1.035 . . . . 0.0 111.346 171.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.25 12.63 76.43 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.289 0.947 . . . . 0.0 115.157 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.31 115.49 19.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.322 1.449 . . . . 0.0 111.246 -175.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -59.41 141.32 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.866 0.866 . . . . 0.0 112.151 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.17 142.68 42.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.147 1.379 . . . . 0.0 111.054 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.79 128.54 52.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.14 1.376 . . . . 0.0 110.156 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.55 110.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.706 2.002 . . . . 0.0 110.166 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.1 t -69.49 125.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.769 0.828 . . . . 0.0 109.94 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.29 140.1 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.308 1.443 . . . . 0.0 109.826 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.45 154.74 87.23 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.241 1.016 . . . . 0.0 111.731 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.18 -40.67 67.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.627 2.218 . . . . 0.0 113.462 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.28 -18.35 59.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -90.31 -9.73 46.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.737 1.215 . . . . 0.0 114.017 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.46 78.32 1.84 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.346 1.458 . . . . 0.0 111.528 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 39.9 74.01 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.894 2.077 . . . . 0.0 113.335 -175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.53 101.35 0.33 Allowed Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.03 1.3 . . . . 0.0 113.641 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.53 61.35 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.223 1.809 . . . . 0.0 111.646 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -64.37 164.73 10.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.838 1.255 . . . . 0.0 113.155 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -123.06 8.39 9.25 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.047 1.739 . . . . 0.0 113.262 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.6 t -76.01 14.92 0.61 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.666 1.986 . . . . 0.0 114.071 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.91 114.4 2.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.252 2.221 . . . . 0.0 112.493 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -137.9 149.94 46.67 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.556 1.542 . . . . 0.0 113.039 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.8 103.59 10.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.252 1.021 . . . . 0.0 110.629 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -88.91 116.75 27.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.59 0.756 . . . . 0.0 110.35 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.11 112.22 7.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.25 1.02 . . . . 0.0 110.221 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 156.3 54.45 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 126.071 1.749 . . . . 0.0 110.812 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.08 149.64 46.8 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.047 1.831 . . . . 0.0 112.005 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -61.45 -17.31 53.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.04 1.336 . . . . 0.0 113.171 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.35 -33.9 22.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.184 2.194 . . . . 0.0 113.624 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -71.38 -10.8 60.35 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -135.19 14.48 3.53 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.612 1.565 . . . . 0.0 114.194 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.86 112.56 0.96 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.43 1.092 . . . . 0.0 112.441 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.11 3.86 58.81 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.21 1.386 . . . . 0.0 115.374 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mt -108.22 139.56 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.284 1.434 . . . . 0.0 110.378 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.0 55.87 1.86 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.378 1.871 . . . . 0.0 113.588 -173.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -55.04 130.04 40.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.283 1.833 . . . . 0.0 113.303 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.23 148.47 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.752 2.021 . . . . 0.0 110.345 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.36 135.76 57.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.489 1.116 . . . . 0.0 112.25 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 -9.37 75.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.136 1.35 . . . . 0.0 116.371 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 ptp -70.16 152.28 44.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.169 1.984 . . . . 0.0 112.416 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 p -78.38 102.01 7.53 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.606 1.163 . . . . 0.0 110.311 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.3 160.86 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.419 1.088 . . . . 0.0 110.551 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.32 162.21 30.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.06 1.344 . . . . 0.0 112.002 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.69 108.82 0.38 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.275 0.94 . . . . 0.0 112.891 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -66.4 147.13 53.74 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 122.05 -0.677 . . . . 0.0 111.299 174.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -128.88 157.39 41.7 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.729 1.612 . . . . 0.0 111.737 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -14.08 60.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.215 1.806 . . . . 0.0 113.736 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.35 13.13 0.62 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.285 1.834 . . . . 0.0 113.912 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.1 m120 57.25 40.14 28.12 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.13 2.172 . . . . 0.0 113.171 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -131.9 171.01 14.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.872 2.069 . . . . 0.0 111.253 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.6 m -141.93 111.75 6.73 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.683 1.593 . . . . 0.0 109.634 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.62 166.94 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 118.497 0.59 . . . . 0.0 111.067 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.33 154.77 34.55 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.623 1.169 . . . . 0.0 111.17 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.8 176.7 12.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.629 1.572 . . . . 0.0 110.966 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.37 128.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.385 1.074 . . . . 0.0 110.476 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.0 mm -68.65 125.97 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.062 0.945 . . . . 0.0 110.693 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.08 -38.68 5.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.773 1.229 . . . . 0.0 113.381 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -151.93 156.17 39.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.468 1.107 . . . . 0.0 111.243 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -147.19 149.85 33.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.186 -0.946 . . . . 0.0 113.395 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -143.2 170.17 16.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.841 2.057 . . . . 0.0 110.804 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.264 -0.897 . . . . 0.0 113.251 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.3 p -78.92 -66.71 0.83 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.676 1.99 . . . . 0.0 112.021 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -135.73 171.0 15.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.098 2.159 . . . . 0.0 111.367 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.21 144.03 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.567 1.547 . . . . 0.0 110.429 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.6 mtp -116.41 113.66 23.19 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.781 1.632 . . . . 0.0 110.651 -170.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.48 135.43 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.187 1.395 . . . . 0.0 110.264 -166.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.32 83.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.287 1.435 . . . . 0.0 112.17 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.14 170.28 11.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.035 1.734 . . . . 0.0 112.29 173.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -154.35 169.98 22.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.657 1.983 . . . . 0.0 110.676 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.92 138.22 95.07 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.586 172.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.97 -9.42 20.81 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.186 2.59 . . . . 0.0 114.456 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.91 32.79 4.02 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.861 2.065 . . . . 0.0 112.396 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.02 159.12 3.47 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.929 1.292 . . . . 0.0 113.766 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.84 -171.54 53.89 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.256 0.931 . . . . 0.0 113.45 -172.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.44 158.5 44.27 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.107 1.763 . . . . 0.0 112.152 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.3 p -64.72 147.63 52.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.879 0.872 . . . . 0.0 112.125 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.58 154.21 51.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.81 1.244 . . . . 0.0 111.425 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.23 104.43 14.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 110.728 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -80.07 109.83 14.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.639 0.776 . . . . 0.0 109.726 167.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.24 120.64 43.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.858 1.663 . . . . 0.0 108.941 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -143.4 169.78 17.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 113.087 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.85 144.97 28.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.634 1.174 . . . . 0.0 111.899 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 15' ' ' ILE . 45.3 t -83.18 102.9 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.918 1.287 . . . . 0.0 109.003 165.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.35 -36.03 78.63 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.201 0.6 . . . . 0.0 111.698 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.68 -165.93 27.47 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.367 0.984 . . . . 0.0 114.211 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.21 133.2 54.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.818 1.647 . . . . 0.0 110.223 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -124.31 159.11 31.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.062 1.345 . . . . 0.0 112.015 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.77 129.85 39.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.905 0.882 . . . . 0.0 111.385 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.01 170.18 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.202 1.401 . . . . 0.0 113.334 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 25.6 m 67.87 98.34 0.06 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.644 2.377 . . . . 0.0 113.904 173.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.4 53.36 0.4 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.646 1.978 . . . . 0.0 113.043 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 58.95 13.61 2.91 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.791 2.436 . . . . 0.0 115.258 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? . . . . . 0 C--O 1.253 1.245 0 C-N-CA 127.113 2.165 . . . . 0.0 115.167 -178.907 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.462 0.173 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -119.65 12.83 12.35 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.958 1.703 . . . . 0.0 113.229 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -63.73 148.03 50.19 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.961 -1.087 . . . . 0.0 112.353 173.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -154.5 167.96 28.31 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.746 1.618 . . . . 0.0 111.194 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -138.95 177.66 7.73 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.39 1.876 . . . . 0.0 111.482 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.87 101.07 3.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.851 1.261 . . . . 0.0 110.703 173.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -128.74 61.45 1.5 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.284 1.833 . . . . 0.0 111.856 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.6 t -58.53 -41.88 86.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.409 1.083 . . . . 0.0 113.424 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.1 mm -128.95 144.87 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.409 1.883 . . . . 0.0 109.87 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -65.31 141.11 58.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.365 1.466 . . . . 0.0 111.9 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -137.08 119.96 16.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.883 1.673 . . . . 0.0 110.492 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.43 105.7 8.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.708 1.203 . . . . 0.0 111.172 172.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.58 125.51 28.16 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.046 1.339 . . . . 0.0 110.227 163.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.37 123.88 50.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.34 1.456 . . . . 0.0 110.083 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 pt -131.22 161.3 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.219 1.007 . . . . 0.0 112.129 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -135.89 146.94 47.93 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.841 1.656 . . . . 0.0 110.397 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.51 154.31 43.5 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -146.03 129.06 16.51 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.766 2.426 . . . . 0.0 110.571 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.88 110.39 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.969 1.708 . . . . 0.0 110.062 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -116.5 151.74 35.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.855 1.662 . . . . 0.0 111.259 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.42 126.34 29.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.931 0.893 . . . . 0.0 109.79 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -72.73 75.65 1.12 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.316 -0.865 . . . . 0.0 111.352 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 -5.28 2.64 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.117 1.818 . . . . 0.0 116.135 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.0 t -133.45 144.29 49.39 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.981 1.891 . . . . 0.0 112.776 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 p -76.59 31.55 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.616 2.766 . . . . 0.0 115.599 -171.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.35 176.57 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.184 1.394 . . . . 0.0 112.216 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.45 117.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.434 1.494 . . . . 0.0 108.987 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.47 -53.3 6.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.912 0.885 . . . . 0.0 111.494 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -144.42 150.64 38.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.557 1.943 . . . . 0.0 109.865 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 p -157.64 151.58 24.29 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.295 -0.878 . . . . 0.0 112.703 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.3 -6.58 8.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.217 1.407 . . . . 0.0 113.135 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -62.5 -37.5 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.287 1.435 . . . . 0.0 112.094 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -73.38 -10.62 59.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.7 1.2 . . . . 0.0 113.506 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -114.7 -170.43 1.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 127.504 2.321 . . . . 0.0 111.164 -171.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.69 125.75 83.51 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 124.378 1.071 . . . . 0.0 111.835 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.68 152.21 82.34 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.029 2.486 . . . . 0.0 112.554 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.0 tp -75.91 108.91 9.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.119 1.368 . . . . 0.0 110.897 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -93.71 131.9 38.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.532 1.533 . . . . 0.0 111.78 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -146.78 167.86 22.81 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.478 1.111 . . . . 0.0 112.88 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.0 mm -101.48 146.88 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 109.715 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.3 mm -46.46 118.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.362 1.865 . . . . 0.0 111.792 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.19 77.5 1.05 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.993 1.282 . . . . 0.0 112.886 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -123.13 -36.84 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.002 1.321 . . . . 0.0 114.426 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.47 23.27 2.45 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 126.846 2.058 . . . . 0.0 115.175 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -80.15 -24.79 40.18 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.2 pt -78.42 167.07 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.989 1.316 . . . . 0.0 112.475 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.9 pt -59.53 141.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.242 1.017 . . . . 0.0 111.692 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.34 73.43 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.91 68.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.347 0.975 . . . . 0.0 114.296 176.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.58 -35.17 13.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.307 1.443 . . . . 0.0 111.844 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -59.4 -40.74 87.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.223 1.409 . . . . 0.0 112.678 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -73.69 -8.34 55.6 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.47 -47.89 5.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.978 1.311 . . . . 0.0 112.631 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.95 -28.54 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.996 1.318 . . . . 0.0 114.134 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 -19.71 63.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -108.46 -11.48 15.15 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.722 1.609 . . . . 0.0 113.843 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.94 113.09 4.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.35 1.46 . . . . 0.0 112.138 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.97 147.14 50.54 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.763 0.825 . . . . 0.0 111.891 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.49 131.65 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.432 1.093 . . . . 0.0 111.429 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.91 12.88 79.04 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.61 1.1 . . . . 0.0 115.334 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -116.65 118.53 32.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.229 1.412 . . . . 0.0 111.678 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -61.09 133.65 56.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.223 1.009 . . . . 0.0 111.947 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -136.97 136.45 38.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 110.956 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -126.63 105.93 9.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.678 1.191 . . . . 0.0 110.526 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 m -109.8 114.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.554 1.542 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.7 t -73.81 126.91 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.74 130.98 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.718 1.607 . . . . 0.0 108.989 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 154.45 87.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.65 1.18 . . . . 0.0 111.675 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.48 -45.06 15.64 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.201 1.934 . . . . 0.0 111.646 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -62.11 -21.07 64.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -85.79 -1.76 57.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.116 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.3 -67.8 0.6 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.497 1.519 . . . . 0.0 112.113 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -143.59 91.83 2.29 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.209 2.204 . . . . 0.0 109.826 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.85 -94.6 0.36 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.19 0.9 . . . . 0.0 112.357 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.8 m 42.42 42.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 127.578 2.351 . . . . 0.0 115.154 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -112.17 175.79 5.29 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.639 1.976 . . . . 0.0 113.596 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -106.42 47.01 0.89 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.02 1.728 . . . . 0.0 113.384 -171.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -66.38 -21.02 66.22 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.724 -1.235 . . . . 0.0 113.298 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.8 t -144.45 108.87 4.84 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.094 2.158 . . . . 0.0 109.164 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -141.39 160.22 40.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.829 1.252 . . . . 0.0 112.909 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.55 137.82 31.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 112.002 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -126.8 124.29 39.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -88.04 82.5 7.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.9 1.68 . . . . 0.0 110.255 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.69 136.04 45.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.144 1.378 . . . . 0.0 109.722 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.77 156.01 57.63 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.475 2.117 . . . . 0.0 112.24 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -65.85 -9.28 27.54 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -56.31 -31.5 63.74 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.327 1.051 . . . . 0.0 113.582 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -82.17 -6.61 59.33 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -130.04 15.58 5.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.44 1.896 . . . . 0.0 113.403 -169.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.62 107.93 0.34 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.996 1.718 . . . . 0.0 112.289 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.84 11.05 57.13 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.88 1.229 . . . . 0.0 115.784 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.42 132.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.368 1.584 . . . . 0.0 110.557 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.67 79.45 9.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.915 1.686 . . . . 0.0 112.696 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.01 155.76 35.68 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.59 1.156 . . . . 0.0 112.819 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.91 157.64 45.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -73.96 25.69 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.113 1.765 . . . . 0.0 114.999 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.4 56.22 0.06 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.988 1.28 . . . . 0.0 112.663 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.4 ptp -132.18 149.25 52.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.699 1.2 . . . . 0.0 112.208 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -67.49 125.35 25.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.363 1.465 . . . . 0.0 110.629 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.14 160.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.627 1.571 . . . . 0.0 111.146 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -119.5 149.84 41.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.498 1.519 . . . . 0.0 111.578 -177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.89 108.53 0.64 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.651 1.119 . . . . 0.0 113.047 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -71.82 112.63 8.09 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.817 -0.814 . . . . 0.0 111.464 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 t -89.03 159.93 17.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.618 1.167 . . . . 0.0 111.967 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -13.56 60.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.623 1.569 . . . . 0.0 113.959 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.65 11.15 0.68 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.754 1.622 . . . . 0.0 113.941 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 53.41 47.86 23.17 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.844 2.058 . . . . 0.0 111.908 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.49 168.17 20.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.776 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 m -140.78 105.56 4.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.138 -0.976 . . . . 0.0 111.045 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.35 170.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.941 -0.474 . . . . 0.0 111.494 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 139.06 54.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.088 1.755 . . . . 0.0 111.564 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.06 179.48 7.71 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.419 1.888 . . . . 0.0 111.872 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.67 128.65 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.729 1.212 . . . . 0.0 110.722 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -72.7 131.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.865 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -95.38 -42.31 8.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.988 1.715 . . . . 0.0 112.0 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -155.09 167.36 30.63 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.625 1.17 . . . . 0.0 112.006 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -140.29 144.84 36.61 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.096 1.358 . . . . 0.0 111.536 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.4 m -117.94 174.08 6.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.776 2.03 . . . . 0.0 110.613 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.05 -19.79 63.27 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.1 p -133.45 -18.31 2.22 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.846 1.658 . . . . 0.0 115.173 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -143.03 172.06 13.22 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.045 1.738 . . . . 0.0 112.145 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.2 t -137.85 126.33 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 127.13 2.172 . . . . 0.0 110.591 -172.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 76.9 mmm -94.15 111.57 23.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.695 1.598 . . . . 0.0 111.078 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.13 151.27 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.131 1.772 . . . . 0.0 112.249 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -91.71 115.57 28.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.105 1.362 . . . . 0.0 111.166 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -123.47 170.09 10.73 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.344 1.858 . . . . 0.0 111.234 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -112.17 142.63 44.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.595 1.558 . . . . 0.0 110.925 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -104.5 127.14 29.62 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.962 0.905 . . . . 0.0 110.956 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.2 -16.94 35.85 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.848 2.365 . . . . 0.0 114.849 -172.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.87 22.23 0.78 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.703 1.601 . . . . 0.0 112.982 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.07 174.93 6.43 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.955 1.702 . . . . 0.0 113.382 173.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.51 171.34 49.65 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 124.637 1.113 . . . . 0.0 114.367 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.25 168.17 22.39 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.923 1.689 . . . . 0.0 113.123 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.1 p -64.48 137.78 58.05 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.923 1.689 . . . . 0.0 112.351 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.25 144.78 51.56 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.795 1.238 . . . . 0.0 112.001 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.09 99.1 10.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.676 1.59 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.39 93.37 5.96 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.704 1.202 . . . . 0.0 109.837 168.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 -76.93 141.37 40.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.928 -1.108 . . . . 0.0 109.784 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -152.72 170.48 20.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.905 0.882 . . . . 0.0 113.0 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -149.55 142.28 24.6 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.14 1.376 . . . . 0.0 111.132 169.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.29 107.8 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.154 1.382 . . . . 0.0 109.025 169.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.7 mp -69.95 -33.9 72.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 111.184 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.62 -175.13 22.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.438 1.494 . . . . 0.0 114.008 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.15 139.38 42.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.0 110.455 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -138.97 157.36 46.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.354 1.062 . . . . 0.0 113.28 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.58 107.32 18.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.151 1.38 . . . . 0.0 110.808 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.61 159.36 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.108 0.963 . . . . 0.0 112.578 171.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.4 m -131.75 158.44 41.2 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.864 1.666 . . . . 0.0 111.027 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -122.02 60.28 0.98 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.151 1.38 . . . . 0.0 110.041 -176.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.59 14.56 5.02 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.412 2.285 . . . . 0.0 115.45 -174.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--O 1.255 1.347 0 C-N-CA 127.856 2.462 . . . . 0.0 114.131 175.886 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.7 tpp . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.68 168.39 21.43 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.166 1.386 . . . . 0.0 112.415 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -100.87 -63.57 1.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.881 1.272 . . . . 0.0 112.098 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.1 m170 45.05 44.12 7.99 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.156 1.782 . . . . 0.0 113.455 -171.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -68.92 156.21 38.93 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.682 1.593 . . . . 0.0 113.267 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt -107.83 93.99 4.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.382 1.473 . . . . 0.0 110.781 -168.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.08 63.85 0.66 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.775 1.63 . . . . 0.0 111.276 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.7 m -70.21 -27.82 64.8 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.373 -0.829 . . . . 0.0 113.196 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.7 mm -75.7 146.08 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.715 1.206 . . . . 0.0 110.051 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -102.2 147.75 26.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.029 1.732 . . . . 0.0 111.79 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.72 157.07 43.19 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.611 1.564 . . . . 0.0 111.023 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.89 106.37 8.53 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.354 1.062 . . . . 0.0 110.323 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 125.17 29.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.067 1.347 . . . . 0.0 110.63 169.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.88 125.63 51.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.475 1.51 . . . . 0.0 110.388 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 pt -133.61 163.26 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.314 1.046 . . . . 0.0 112.042 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -140.59 138.05 34.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.056 1.342 . . . . 0.0 110.559 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.47 160.56 38.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.141 1.376 . . . . 0.0 113.728 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -143.33 161.39 38.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.001 1.72 . . . . 0.0 111.396 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.03 107.41 11.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.735 1.614 . . . . 0.0 110.038 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -113.92 157.41 22.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.908 1.683 . . . . 0.0 110.31 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -63.81 152.18 40.24 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.689 -0.632 . . . . 0.0 110.933 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -25.79 60.11 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.38 57.38 0.3 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.47 1.033 . . . . 0.0 113.743 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 t -144.57 163.7 33.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.604 1.162 . . . . 0.0 112.441 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -80.36 -21.96 41.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 113.466 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 pp -69.35 157.06 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.811 0.732 . . . . 0.0 111.36 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.36 144.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.508 1.523 . . . . 0.0 110.697 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.91 -48.08 6.43 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.544 0.738 . . . . 0.0 111.038 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 157.21 36.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.704 1.602 . . . . 0.0 111.735 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.5 p -162.98 163.79 25.96 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.532 1.133 . . . . 0.0 113.615 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.86 8.28 4.11 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 167.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.43 -53.58 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 p -76.32 -18.92 58.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 0.0 113.892 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.02 -171.35 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.006 2.123 . . . . 0.0 111.035 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -64.17 142.59 98.28 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 121.147 -0.97 . . . . 0.0 111.77 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.14 159.43 53.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.374 2.716 . . . . 0.0 112.597 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.86 109.06 15.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 110.363 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.59 127.14 32.12 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.438 1.895 . . . . 0.0 111.452 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.14 175.1 10.74 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.7 137.77 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.051 1.74 . . . . 0.0 109.078 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 mm -48.14 109.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.27 1.828 . . . . 0.0 111.804 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.05 87.27 1.24 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.415 1.483 . . . . 0.0 112.936 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.1 t -146.35 -33.47 0.31 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.2 m120 53.45 60.64 3.58 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.852 2.061 . . . . 0.0 113.789 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -111.04 -26.28 9.33 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.8 pt -81.04 174.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.436 1.495 . . . . 0.0 112.177 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.8 pt -58.2 141.18 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.797 0.839 . . . . 0.0 111.469 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.08 91.75 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.81 -33.45 73.28 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.052 0.834 . . . . 0.0 113.95 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 tp -81.73 -45.38 15.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.436 1.094 . . . . 0.0 111.342 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -49.36 -47.7 47.26 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.71 1.604 . . . . 0.0 113.287 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.43 -18.22 63.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 113.276 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.05 -43.92 10.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.914 1.286 . . . . 0.0 112.69 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.62 -43.06 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 119.941 1.246 . . . . 0.0 112.525 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.58 -20.79 65.94 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -102.69 -11.34 18.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.399 1.88 . . . . 0.0 113.801 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.03 126.63 31.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.408 1.483 . . . . 0.0 112.392 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -77.8 155.04 31.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.754 0.822 . . . . 0.0 112.01 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.62 134.29 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.897 1.279 . . . . 0.0 111.473 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.54 13.83 74.58 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.75 100.23 7.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.964 1.306 . . . . 0.0 111.63 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -58.18 131.86 51.83 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.287 1.035 . . . . 0.0 111.469 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.41 157.84 44.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.907 0.883 . . . . 0.0 112.79 171.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -128.79 96.78 4.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.994 1.318 . . . . 0.0 110.91 -170.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -97.94 106.23 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.394 1.478 . . . . 0.0 110.119 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 t -74.26 123.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.351 -0.843 . . . . 0.0 109.807 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.41 140.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.451 1.9 . . . . 0.0 109.383 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.15 158.91 69.34 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.416 1.087 . . . . 0.0 112.214 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.93 -46.79 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.32 2.013 . . . . 0.0 112.082 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.89 -14.42 61.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.198 1.399 . . . . 0.0 114.656 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -79.43 -7.74 58.62 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.3 -82.59 0.52 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.051 1.34 . . . . 0.0 111.368 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -138.44 92.53 2.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.503 1.921 . . . . 0.0 109.574 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.03 81.08 1.71 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.754 1.168 . . . . 0.0 112.541 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.2 75.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.487 1.515 . . . . 0.0 111.832 -174.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -133.76 156.09 48.61 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.216 1.406 . . . . 0.0 111.738 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -138.34 110.24 7.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.447 1.899 . . . . 0.0 110.521 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 t -93.45 -8.03 42.76 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.72 56.59 7.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.328 1.851 . . . . 0.0 113.128 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -74.83 175.45 8.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.097 1.359 . . . . 0.0 112.39 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.7 mt -121.16 146.78 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.729 1.611 . . . . 0.0 111.69 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -131.54 111.45 11.77 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.685 1.594 . . . . 0.0 111.253 167.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -69.58 115.17 8.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.715 0.806 . . . . 0.0 110.087 160.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.36 156.85 69.53 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 125.942 1.697 . . . . 0.0 109.898 176.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.34 153.52 61.4 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.025 1.817 . . . . 0.0 111.881 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -61.26 -19.37 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 0.0 113.245 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -53.95 -30.51 47.06 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.49 1.516 . . . . 0.0 114.589 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -19.73 65.05 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 175.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -137.68 20.98 2.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.032 1.733 . . . . 0.0 112.556 -168.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.93 -24.8 55.26 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.168 1.787 . . . . 0.0 114.168 -171.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.18 16.07 46.29 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.059 1.79 . . . . 0.0 115.338 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.32 132.62 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.281 1.54 . . . . 0.0 111.023 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -81.34 89.2 6.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.685 1.194 . . . . 0.0 111.108 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.2 160.28 32.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 112.326 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.1 152.29 27.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.019 1.328 . . . . 0.0 111.81 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -72.88 84.25 1.23 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.685 1.194 . . . . 0.0 110.878 168.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.69 43.71 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.765 1.174 . . . . 0.0 114.699 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.4 ptm -129.38 150.69 50.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.149 1.38 . . . . 0.0 111.149 170.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 p -67.99 133.83 49.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.041 0.937 . . . . 0.0 110.955 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.24 152.82 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.35 1.86 . . . . 0.0 110.166 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.59 143.95 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.572 1.149 . . . . 0.0 110.958 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.12 99.92 0.44 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 124.802 1.191 . . . . 0.0 112.109 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -66.87 140.31 57.79 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 117.604 0.702 . . . . 0.0 111.203 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -119.07 154.54 33.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.036 1.735 . . . . 0.0 111.656 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -62.0 -17.66 57.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.988 1.715 . . . . 0.0 113.439 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.99 15.46 0.16 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 127.23 2.212 . . . . 0.0 113.999 173.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.6 m120 52.66 48.12 23.21 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.134 2.174 . . . . 0.0 112.617 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -144.77 177.36 8.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.798 1.639 . . . . 0.0 111.969 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.0 m -145.2 128.94 17.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.905 1.282 . . . . 0.0 110.538 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -84.66 165.72 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.73 0.812 . . . . 0.0 111.81 172.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -133.36 126.57 31.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.465 1.506 . . . . 0.0 110.209 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.77 -172.88 4.37 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.677 1.191 . . . . 0.0 112.486 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mp -113.67 140.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.629 1.572 . . . . 0.0 109.804 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.43 134.57 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.797 1.239 . . . . 0.0 110.831 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -107.96 -32.96 7.36 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.42 1.088 . . . . 0.0 113.57 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -152.83 153.92 34.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.231 1.412 . . . . 0.0 111.173 164.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -142.63 134.12 26.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 111.715 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 160.74 39.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.567 1.547 . . . . 0.0 110.517 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.24 -23.26 67.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.1 p -77.28 -62.59 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.021 1.728 . . . . 0.0 111.68 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -138.87 160.95 38.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.007 2.123 . . . . 0.0 112.109 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.41 147.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.703 1.601 . . . . 0.0 110.396 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -121.84 105.69 10.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.69 1.596 . . . . 0.0 110.288 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -106.31 146.59 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.555 1.542 . . . . 0.0 111.072 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 141.94 49.84 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.841 -0.537 . . . . 0.0 111.112 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -136.05 156.95 47.97 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.389 1.476 . . . . 0.0 111.474 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -126.04 109.23 12.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.675 1.59 . . . . 0.0 110.382 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -67.99 134.15 91.86 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.268 1.427 . . . . 0.0 110.755 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.52 -25.17 35.3 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.386 2.057 . . . . 0.0 113.447 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.1 mt -83.29 5.81 21.91 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.908 1.283 . . . . 0.0 113.591 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.67 169.48 3.95 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.729 1.612 . . . . 0.0 114.316 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.22 -173.87 29.3 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.411 1.481 . . . . 0.0 113.326 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -135.17 161.64 34.77 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.064 1.745 . . . . 0.0 112.043 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.19 142.85 57.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.738 1.615 . . . . 0.0 111.764 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.3 mt -126.71 143.1 51.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 112.002 -174.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.85 98.53 11.83 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.949 1.3 . . . . 0.0 111.457 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -79.62 92.57 5.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.848 0.832 . . . . 0.0 110.77 168.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.12 128.77 34.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.256 1.422 . . . . 0.0 109.417 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.47 169.39 21.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -149.55 147.96 28.79 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 112.055 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.9 108.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.42 1.488 . . . . 0.0 109.167 166.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.84 -29.43 68.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.51 0.724 . . . . 0.0 111.302 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.67 172.07 14.22 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.534 2.016 . . . . 0.0 112.422 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.15 156.34 17.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.451 0.7 . . . . 0.0 112.717 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -147.33 143.66 28.2 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -69.21 126.06 28.6 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.396 0.678 . . . . 0.0 110.428 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.6 m -122.0 162.9 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.84 1.656 . . . . 0.0 110.936 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.8 m -121.83 172.78 7.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.71 1.604 . . . . 0.0 112.002 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -96.77 -9.94 27.8 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.548 1.139 . . . . 0.0 113.61 171.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -77.65 -32.79 53.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.192 1.397 . . . . 0.0 113.144 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.335 1.854 . . . . 0.0 115.051 -178.461 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 mtt . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -138.5 146.59 42.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.703 1.601 . . . . 0.0 110.938 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.4 173.27 12.6 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.169 1.388 . . . . 0.0 111.769 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -70.48 81.53 0.57 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.288 1.035 . . . . 0.0 111.565 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -129.92 164.7 23.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.976 2.11 . . . . 0.0 110.809 172.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.88 -7.98 51.66 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.822 1.249 . . . . 0.0 113.382 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.13 32.06 2.03 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.723 2.009 . . . . 0.0 114.187 -177.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 t -54.52 -43.7 72.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.56 1.144 . . . . 0.0 113.355 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.2 mm -71.45 143.84 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.311 -0.868 . . . . 0.0 111.618 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -52.77 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 128.53 2.732 . . . . 0.0 113.071 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -72.7 122.63 21.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.017 1.327 . . . . 0.0 112.189 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.19 96.95 5.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.487 1.115 . . . . 0.0 111.176 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.83 118.99 22.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.752 2.021 . . . . 0.0 111.734 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.88 130.5 48.37 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.185 1.394 . . . . 0.0 111.313 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.52 158.74 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.173 1.389 . . . . 0.0 111.734 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -138.94 141.24 38.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 110.972 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.44 154.2 49.98 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 123.123 1.44 . . . . 0.0 114.069 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -142.56 113.03 7.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.18 2.592 . . . . 0.0 109.068 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.29 115.73 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.69 1.196 . . . . 0.0 109.602 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -124.54 151.87 44.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.132 1.773 . . . . 0.0 110.547 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.66 146.76 48.06 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.606 -0.683 . . . . 0.0 111.251 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.84 -33.35 61.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -170.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.2 45.33 0.84 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.368 0.985 . . . . 0.0 114.141 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 t -142.28 156.48 45.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 112.579 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.2 p -82.52 -11.9 58.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.97 1.708 . . . . 0.0 114.331 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.03 178.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.966 1.306 . . . . 0.0 112.196 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 p -133.77 137.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.736 1.215 . . . . 0.0 110.197 168.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.7 mt -81.27 -51.39 8.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.635 0.774 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.31 163.33 30.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.925 1.29 . . . . 0.0 112.544 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.9 p -157.11 165.27 36.51 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.003 -1.061 . . . . 0.0 112.812 171.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.68 -4.29 10.27 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 164.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.62 -48.57 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.762 1.625 . . . . 0.0 112.215 -171.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -75.93 -17.24 59.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -86.93 -73.93 0.45 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.061 1.745 . . . . 0.0 111.715 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -166.93 134.18 1.99 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.665 1.986 . . . . 0.0 110.335 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.95 154.33 74.98 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.11 2.54 . . . . 0.0 112.882 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tt -95.0 111.89 23.65 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 109.796 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -93.27 131.89 37.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.868 1.267 . . . . 0.0 111.519 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -145.6 179.38 7.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 112.097 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.81 135.5 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.758 1.223 . . . . 0.0 109.251 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.8 mm -49.8 109.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.14 1.376 . . . . 0.0 111.038 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.71 53.31 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.617 1.58 . . . . 0.0 114.634 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 m -122.79 -32.23 3.57 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.591 1.156 . . . . 0.0 113.296 175.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 54.3 33.45 18.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.327 1.851 . . . . 0.0 114.888 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -79.45 -24.1 42.66 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.0 pt -69.56 166.95 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.636 1.174 . . . . 0.0 112.589 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.6 pt -57.58 141.76 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.019 0.927 . . . . 0.0 111.428 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.18 76.81 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -173.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.11 68.53 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.002 0.81 . . . . 0.0 114.17 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -90.19 -29.72 18.05 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.177 1.391 . . . . 0.0 112.213 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -60.47 -42.88 97.16 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.844 -1.16 . . . . 0.0 112.504 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.53 -10.14 53.73 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.08 -49.94 4.56 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.625 1.57 . . . . 0.0 112.821 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.87 -31.71 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.565 1.146 . . . . 0.0 114.038 -174.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.64 -21.04 66.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.74 -13.78 16.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.678 1.991 . . . . 0.0 113.536 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.5 116.84 16.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.492 1.517 . . . . 0.0 112.07 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -73.7 157.48 36.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.813 0.816 . . . . 0.0 112.46 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.14 133.96 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.086 1.355 . . . . 0.0 111.639 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.47 72.52 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.758 1.171 . . . . 0.0 114.938 176.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -120.14 108.34 14.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.173 1.389 . . . . 0.0 111.201 -170.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -54.93 129.94 39.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.993 0.917 . . . . 0.0 111.456 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.84 141.26 51.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.072 1.349 . . . . 0.0 111.169 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -127.11 112.71 15.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.415 1.486 . . . . 0.0 109.572 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.81 124.03 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.627 1.171 . . . . 0.0 111.556 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.08 127.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.726 0.811 . . . . 0.0 109.646 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.34 135.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.251 1.82 . . . . 0.0 108.964 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.2 155.02 67.79 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.921 0.888 . . . . 0.0 112.329 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.15 -41.76 15.67 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.109 1.873 . . . . 0.0 111.379 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.71 -23.67 64.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.911 1.684 . . . . 0.0 114.51 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.24 -23.46 51.31 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.429 -0.794 . . . . 0.0 112.561 172.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.33 -72.6 0.49 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.645 1.178 . . . . 0.0 111.774 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -142.28 -22.21 0.69 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -173.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.37 80.43 0.5 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.314 1.435 . . . . 0.0 114.296 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.9 m -103.58 8.57 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.28 1.432 . . . . 0.0 113.749 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -63.82 170.96 3.02 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.074 1.35 . . . . 0.0 113.355 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.25 171.94 13.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.866 1.667 . . . . 0.0 112.073 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 m -70.11 29.84 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.479 2.312 . . . . 0.0 115.554 -173.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.7 m -64.74 -166.58 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.232 2.213 . . . . 0.0 112.063 164.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 68.15 16.35 9.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.893 1.677 . . . . 0.0 112.636 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.1 mt -153.46 132.57 12.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 129.32 3.048 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -139.93 117.01 11.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.09 1.356 . . . . 0.0 110.159 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.16 112.65 6.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 110.547 168.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.5 m -119.59 157.42 51.92 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.729 1.612 . . . . 0.0 110.634 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.43 163.04 40.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.008 1.805 . . . . 0.0 111.38 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -67.21 0.53 2.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.234 1.814 . . . . 0.0 114.667 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.31 -38.04 81.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.547 1.939 . . . . 0.0 113.907 -175.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -67.48 -15.89 63.91 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -127.38 21.18 6.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.514 1.526 . . . . 0.0 113.005 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.49 99.06 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.761 1.624 . . . . 0.0 112.171 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.95 56.93 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.599 1.571 . . . . 0.0 115.596 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.77 127.56 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.567 1.547 . . . . 0.0 109.763 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.87 124.13 21.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.828 0.851 . . . . 0.0 111.529 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.1 mt -115.11 139.27 50.03 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.335 1.454 . . . . 0.0 110.589 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -150.35 150.68 31.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.887 1.275 . . . . 0.0 111.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -76.66 89.59 3.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.83 -1.169 . . . . 0.0 111.052 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.72 43.11 0.27 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.482 1.515 . . . . 0.0 114.6 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 ptm -133.13 152.1 51.96 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.196 1.398 . . . . 0.0 111.365 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p -68.57 133.53 48.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.88 1.272 . . . . 0.0 111.32 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.73 156.94 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.481 1.913 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.86 139.54 53.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.634 1.174 . . . . 0.0 111.037 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.02 100.2 0.55 Allowed Glycine 0 N--CA 1.469 0.879 0 C-N-CA 124.878 1.228 . . . . 0.0 112.282 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -64.15 144.79 56.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.72 0.76 . . . . 0.0 111.383 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -128.93 155.44 45.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.576 1.55 . . . . 0.0 111.578 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -65.46 -14.95 62.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.836 1.654 . . . . 0.0 113.221 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -73.46 17.29 0.15 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.457 1.903 . . . . 0.0 113.934 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 54.15 44.72 28.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.144 2.178 . . . . 0.0 112.425 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.26 173.49 11.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.966 2.107 . . . . 0.0 111.48 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.4 m -146.14 118.33 8.35 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.66 1.184 . . . . 0.0 110.179 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -73.66 162.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.312 0.506 . . . . 0.0 110.976 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -137.26 119.76 15.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.348 1.459 . . . . 0.0 110.652 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.04 -170.75 3.59 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.456 1.103 . . . . 0.0 112.543 -172.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.71 142.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.393 1.477 . . . . 0.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.3 mt -73.46 126.3 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.066 -1.021 . . . . 0.0 110.303 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -101.41 -33.82 9.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.357 1.063 . . . . 0.0 113.174 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.41 154.93 36.55 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.372 1.469 . . . . 0.0 111.31 170.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -144.98 146.86 32.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.273 1.029 . . . . 0.0 112.078 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.3 t -146.47 170.46 16.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.438 1.895 . . . . 0.0 110.471 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.11 61.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.021 0.929 . . . . 0.0 113.463 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -79.91 -61.77 1.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.641 1.576 . . . . 0.0 111.706 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -138.45 166.92 23.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.029 2.132 . . . . 0.0 111.517 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.36 144.16 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.576 1.551 . . . . 0.0 110.6 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.8 mtp -118.42 93.36 4.09 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.018 1.727 . . . . 0.0 110.883 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.59 149.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.555 1.542 . . . . 0.0 109.904 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.8 114.25 4.92 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.363 -0.836 . . . . 0.0 111.508 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -124.85 99.21 6.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.668 1.587 . . . . 0.0 109.146 172.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -62.16 164.6 6.67 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.325 0.65 . . . . 0.0 111.527 170.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.05 140.47 17.06 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.154 0.582 . . . . 0.0 111.433 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.56 -12.65 24.8 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.144 2.563 . . . . 0.0 113.781 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.6 mt -73.0 -27.14 61.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.846 1.259 . . . . 0.0 113.155 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.55 161.54 27.71 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.24 1.016 . . . . 0.0 112.414 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.64 160.2 44.59 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 121.685 -0.635 . . . . 0.0 113.304 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -141.14 178.76 7.16 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.58 1.952 . . . . 0.0 111.204 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.39 140.41 56.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.315 1.046 . . . . 0.0 111.701 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.62 134.15 55.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.819 2.047 . . . . 0.0 110.915 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.95 101.86 14.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.041 1.336 . . . . 0.0 111.347 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -81.68 96.96 7.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.893 0.877 . . . . 0.0 110.169 167.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -84.0 120.1 25.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.274 1.43 . . . . 0.0 108.87 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.72 168.84 18.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.69 0.677 . . . . 0.0 112.825 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -147.83 137.33 22.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.054 0.942 . . . . 0.0 111.699 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.8 t -80.63 102.77 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.211 1.004 . . . . 0.0 108.386 166.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.5 mt -65.52 -31.99 73.35 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.026 0.53 . . . . 0.0 111.549 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.31 174.32 13.45 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 126.928 2.204 . . . . 0.0 112.333 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -108.03 140.82 40.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.057 0.943 . . . . 0.0 111.113 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -110.55 107.76 17.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.533 1.533 . . . . 0.0 109.659 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.85 128.44 36.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.85 0.86 . . . . 0.0 109.962 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.31 157.63 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.763 1.225 . . . . 0.0 110.998 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 65.6 m -145.25 153.38 41.24 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.42 1.488 . . . . 0.0 110.909 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -134.82 15.19 3.61 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.499 1.52 . . . . 0.0 113.083 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -130.0 -61.08 1.0 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.28 1.832 . . . . 0.0 111.468 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.718 1.607 . . . . 0.0 113.487 173.659 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -147.87 155.0 41.14 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.056 1.342 . . . . 0.0 112.237 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -157.19 -179.0 7.78 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.037 2.135 . . . . 0.0 111.188 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -136.66 107.99 6.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.805 1.242 . . . . 0.0 111.243 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -78.9 168.45 19.68 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.128 0.971 . . . . 0.0 112.447 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -81.16 -2.87 50.21 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.185 1.394 . . . . 0.0 114.484 171.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -113.26 65.43 0.65 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.571 1.948 . . . . 0.0 112.31 -172.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.5 m -73.63 -5.13 38.47 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.3 mp -65.56 146.75 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 126.387 1.875 . . . . 0.0 110.382 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -59.26 159.39 7.78 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.373 1.469 . . . . 0.0 112.489 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -148.9 149.36 31.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.062 1.345 . . . . 0.0 111.188 170.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.56 99.81 3.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.225 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.46 41.09 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.786 0.834 . . . . 0.0 111.051 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.62 131.55 49.89 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.721 1.608 . . . . 0.0 110.262 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -127.7 161.85 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.435 1.094 . . . . 0.0 111.791 171.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -137.27 127.12 25.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.605 1.562 . . . . 0.0 110.162 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -131.48 149.13 52.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.951 1.3 . . . . 0.0 112.888 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -137.89 148.66 45.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.631 2.372 . . . . 0.0 109.934 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.97 121.37 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.066 0.946 . . . . 0.0 112.054 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -124.26 142.82 50.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.336 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -66.29 128.64 36.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.106 0.962 . . . . 0.0 111.001 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.53 106.27 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.474 -0.767 . . . . 0.0 112.407 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.39 -13.97 47.43 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 126.445 1.974 . . . . 0.0 115.327 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -119.78 125.19 47.99 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.259 1.53 . . . . 0.0 111.582 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 m -66.43 18.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.812 2.445 . . . . 0.0 116.088 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -82.68 172.58 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.3 1.84 . . . . 0.0 112.44 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.84 89.02 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.044 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.55 -23.72 61.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.27 156.86 31.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.86 1.664 . . . . 0.0 110.389 165.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.7 p -155.66 159.68 39.78 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.435 -0.791 . . . . 0.0 111.986 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -114.33 -27.4 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.71 1.204 . . . . 0.0 112.08 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -55.43 -49.67 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.889 1.675 . . . . 0.0 112.252 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -65.47 -26.2 67.83 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.928 0.891 . . . . 0.0 113.122 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -85.81 -74.4 0.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.658 1.583 . . . . 0.0 111.351 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -169.35 149.56 3.87 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.915 2.086 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.49 144.69 74.16 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.528 2.152 . . . . 0.0 111.872 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.57 112.17 19.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 110.221 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -100.05 124.94 45.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.927 0.891 . . . . 0.0 112.199 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.04 168.86 23.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.313 1.045 . . . . 0.0 113.425 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.07 126.72 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.692 1.197 . . . . 0.0 109.137 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.0 mm -49.41 113.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.527 1.531 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.16 69.09 0.66 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.668 1.604 . . . . 0.0 112.368 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -140.04 -33.76 0.57 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.158 1.383 . . . . 0.0 113.616 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.98 28.46 14.8 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.433 1.893 . . . . 0.0 114.821 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -81.36 -21.62 38.97 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.8 pt -73.8 169.22 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.853 1.661 . . . . 0.0 112.923 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -56.63 144.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.15 0.98 . . . . 0.0 112.083 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.06 73.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.007 0.923 . . . . 0.0 113.262 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.82 70.02 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 123.731 0.681 . . . . 0.0 114.349 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -93.22 -30.43 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.773 1.229 . . . . 0.0 112.353 173.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.23 -43.14 82.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 112.321 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.92 -41.96 9.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.155 1.382 . . . . 0.0 113.024 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.05 -23.81 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.708 -1.245 . . . . 0.0 113.633 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.81 -26.86 62.57 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -83.65 -44.2 14.79 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.216 1.806 . . . . 0.0 111.394 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 122.28 13.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.846 1.258 . . . . 0.0 111.987 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 159.46 15.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.452 1.501 . . . . 0.0 111.916 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -55.67 129.95 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.128 1.371 . . . . 0.0 112.464 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.9 13.68 82.29 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.43 1.014 . . . . 0.0 115.21 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -126.26 115.77 20.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.05 1.34 . . . . 0.0 111.814 -172.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -60.2 141.16 56.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.717 0.807 . . . . 0.0 112.309 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -136.98 115.1 11.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.256 1.422 . . . . 0.0 111.382 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -90.18 114.29 26.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.227 1.411 . . . . 0.0 110.594 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.39 106.56 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.249 1.42 . . . . 0.0 110.593 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.26 131.87 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.235 -0.916 . . . . 0.0 109.593 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.6 mt -121.81 139.62 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.691 1.596 . . . . 0.0 109.228 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.6 155.46 81.46 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.226 1.01 . . . . 0.0 111.969 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.65 -29.96 84.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.604 2.203 . . . . 0.0 113.308 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.66 -23.86 45.47 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.69 -9.22 52.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.093 1.357 . . . . 0.0 113.758 -172.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.54 78.49 1.85 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.109 1.764 . . . . 0.0 110.597 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 43.02 76.06 0.08 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.393 2.277 . . . . 0.0 113.895 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 87.85 0.12 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.605 1.574 . . . . 0.0 113.951 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.35 19.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 127.059 2.143 . . . . 0.0 113.251 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -60.95 170.83 1.4 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.34 1.856 . . . . 0.0 114.346 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -73.1 179.27 3.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.871 1.668 . . . . 0.0 113.796 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 76.1 p -110.86 7.5 21.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.642 1.577 . . . . 0.0 113.604 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 p -153.52 137.57 16.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.742 1.617 . . . . 0.0 112.824 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -141.67 169.34 17.78 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.834 2.054 . . . . 0.0 110.67 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.27 148.97 27.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.027 0.931 . . . . 0.0 110.853 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -140.07 108.52 5.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.656 1.182 . . . . 0.0 110.838 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.35 122.92 18.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.351 1.061 . . . . 0.0 111.148 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 p -136.05 137.96 26.32 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.492 1.917 . . . . 0.0 109.949 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.3 168.32 25.09 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.739 2.292 . . . . 0.0 112.428 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -69.46 21.19 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.412 2.285 . . . . 0.0 115.003 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.89 -19.91 19.19 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.429 1.891 . . . . 0.0 113.888 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -98.61 -9.65 24.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.818 1.247 . . . . 0.0 113.814 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.24 26.62 6.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.299 1.84 . . . . 0.0 112.647 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.29 105.43 0.23 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 111.174 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.78 -0.02 39.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.647 1.594 . . . . 0.0 115.75 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.8 mt -100.51 136.85 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.321 1.56 . . . . 0.0 110.387 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.06 76.61 10.05 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.08 1.752 . . . . 0.0 112.971 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 140.52 57.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.137 -0.977 . . . . 0.0 112.334 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.38 152.95 32.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.397 1.879 . . . . 0.0 110.869 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -72.83 108.41 5.78 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.461 170.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.19 57.56 1.29 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.492 1.044 . . . . 0.0 113.54 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.7 ptm -135.05 154.72 51.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.768 1.627 . . . . 0.0 111.319 167.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 p -79.74 119.03 22.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.148 0.979 . . . . 0.0 110.64 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.95 158.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.823 1.649 . . . . 0.0 110.34 173.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -125.82 153.84 43.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.168 1.387 . . . . 0.0 111.465 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.49 101.47 0.28 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.382 0.991 . . . . 0.0 112.608 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -65.14 128.54 36.2 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.939 -0.742 . . . . 0.0 110.985 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -105.78 155.67 19.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.453 1.501 . . . . 0.0 111.399 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.03 -20.07 65.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.301 1.44 . . . . 0.0 113.126 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -71.65 19.83 0.06 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.983 2.113 . . . . 0.0 114.192 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.5 m120 52.02 47.63 24.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.316 2.246 . . . . 0.0 112.915 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -142.12 177.78 7.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.719 1.607 . . . . 0.0 112.109 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.8 m -145.99 113.85 6.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.361 1.064 . . . . 0.0 111.373 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.41 164.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.338 0.655 . . . . 0.0 111.406 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -136.57 136.8 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.358 1.463 . . . . 0.0 111.346 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.11 -178.99 7.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.455 1.102 . . . . 0.0 113.361 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.08 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.411 1.484 . . . . 0.0 110.538 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.2 mt -76.99 120.2 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.13 0.972 . . . . 0.0 110.661 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.96 -31.06 16.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.169 1.388 . . . . 0.0 113.531 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -153.7 150.0 28.1 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.878 1.671 . . . . 0.0 110.673 171.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -141.18 155.01 46.12 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.926 0.89 . . . . 0.0 112.661 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -153.34 174.26 14.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.172 1.789 . . . . 0.0 111.135 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 -29.44 66.88 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.47 1.108 . . . . 0.0 113.187 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.1 p -80.57 -62.76 1.58 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.017 1.727 . . . . 0.0 111.944 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -135.53 166.64 22.73 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.226 2.21 . . . . 0.0 111.405 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.83 147.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.915 1.686 . . . . 0.0 109.319 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 28.4 mtm -121.11 101.57 7.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.177 1.391 . . . . 0.0 110.15 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.3 t -97.17 150.12 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.394 1.077 . . . . 0.0 110.131 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.35 130.68 47.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.653 0.781 . . . . 0.0 111.033 166.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -142.38 169.75 17.0 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 111.571 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -117.6 133.97 55.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.063 1.745 . . . . 0.0 109.813 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -145.42 132.47 10.08 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.128 0.971 . . . . 0.0 111.312 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.28 -38.06 5.17 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.917 2.411 . . . . 0.0 112.831 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.43 80.06 6.93 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.212 1.005 . . . . 0.0 108.882 170.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -98.69 -42.12 7.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.924 1.69 . . . . 0.0 112.63 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.82 -161.07 33.19 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.874 1.702 . . . . 0.0 113.61 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.82 151.54 38.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.48 1.912 . . . . 0.0 111.098 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -65.72 143.75 57.34 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.766 1.226 . . . . 0.0 112.808 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.9 mt -125.01 123.06 39.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.13 1.372 . . . . 0.0 111.356 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.74 99.51 5.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.967 1.307 . . . . 0.0 111.159 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -79.68 99.46 7.41 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.757 0.789 . . . . 0.0 110.186 165.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -91.74 120.55 32.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.114 1.365 . . . . 0.0 109.034 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -140.94 168.7 19.15 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -148.33 140.49 24.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.079 1.351 . . . . 0.0 111.43 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.09 102.4 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 163.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.29 -33.73 71.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 111.701 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.76 -139.07 10.63 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.265 1.888 . . . . 0.0 110.675 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -150.31 165.2 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.461 1.105 . . . . 0.0 112.374 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -132.6 140.72 48.36 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.221 1.809 . . . . 0.0 110.813 171.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.72 141.08 49.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.419 0.688 . . . . 0.0 110.463 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 30.8 m -137.37 170.7 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.055 1.742 . . . . 0.0 111.277 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.2 p -59.84 148.14 35.76 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.669 1.188 . . . . 0.0 112.958 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -103.49 -0.71 29.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.003 1.321 . . . . 0.0 113.993 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -139.82 -58.52 0.56 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.642 1.577 . . . . 0.0 111.207 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.706 1.602 . . . . 0.0 113.318 170.875 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.405 0.621 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -69.36 143.66 53.66 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.484 -1.385 . . . . 0.0 110.976 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -124.81 170.13 11.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.787 1.635 . . . . 0.0 111.306 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -134.82 169.52 17.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.698 1.599 . . . . 0.0 112.072 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -71.97 90.24 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.234 1.413 . . . . 0.0 112.073 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.17 130.26 45.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.314 1.446 . . . . 0.0 111.113 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 52.98 33.61 15.09 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.781 1.632 . . . . 0.0 113.858 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.8 t -56.23 -47.55 78.23 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.828 1.251 . . . . 0.0 112.786 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.0 mm -93.71 147.71 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.288 1.435 . . . . 0.0 109.574 174.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -54.64 155.7 3.98 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.806 1.642 . . . . 0.0 113.031 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -119.28 134.44 55.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.723 1.209 . . . . 0.0 110.989 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.22 101.16 7.83 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 109.593 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.28 144.13 31.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.096 1.358 . . . . 0.0 111.033 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.74 126.53 47.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.503 1.521 . . . . 0.0 109.932 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.15 156.83 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.323 1.049 . . . . 0.0 110.969 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -139.16 135.68 34.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.68 1.192 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -138.3 157.2 46.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.781 1.232 . . . . 0.0 113.574 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -139.62 152.85 47.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.439 1.896 . . . . 0.0 110.763 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.85 119.13 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.583 1.553 . . . . 0.0 109.693 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -139.13 145.66 39.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.764 1.625 . . . . 0.0 111.176 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.22 133.18 45.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.454 0.702 . . . . 0.0 111.215 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -57.74 111.33 1.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.155 0.982 . . . . 0.0 111.752 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 23.24 33.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.64 1.114 . . . . 0.0 115.634 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -128.21 165.48 20.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.119 1.46 . . . . 0.0 113.579 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.2 m -99.15 -8.35 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.428 1.891 . . . . 0.0 113.865 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 166.98 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.643 0.777 . . . . 0.0 111.704 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.35 116.04 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.404 1.482 . . . . 0.0 108.751 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.58 -48.73 37.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.588 0.755 . . . . 0.0 111.026 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.27 162.04 36.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.16 1.384 . . . . 0.0 112.025 170.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -161.52 168.4 23.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.141 . . . . 0.0 112.494 168.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -123.82 -1.71 8.37 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 164.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.54 -60.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.733 1.613 . . . . 0.0 112.156 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -73.67 -22.98 59.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -74.5 -72.94 0.26 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.934 1.693 . . . . 0.0 112.067 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -169.7 118.65 0.55 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.083 2.153 . . . . 0.0 109.846 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -62.76 152.04 80.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.862 2.374 . . . . 0.0 112.706 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.8 tp -83.6 98.56 9.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.629 1.572 . . . . 0.0 110.873 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -71.11 117.51 12.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.357 1.463 . . . . 0.0 110.98 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -144.76 175.43 10.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.441 1.096 . . . . 0.0 113.129 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -113.48 137.52 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.456 1.502 . . . . 0.0 110.138 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -51.65 110.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.166 1.386 . . . . 0.0 111.086 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.94 -1.61 24.31 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.723 1.63 . . . . 0.0 115.677 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 m -70.69 -44.88 66.04 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.338 1.569 . . . . 0.0 112.531 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.3 m120 50.59 31.5 5.76 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.16 2.184 . . . . 0.0 116.013 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -13.81 61.19 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -69.63 168.31 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.843 1.657 . . . . 0.0 113.363 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -58.73 144.62 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.403 1.081 . . . . 0.0 111.953 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.7 -37.01 77.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.39 -29.11 73.56 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.672 -0.643 . . . . 0.0 113.82 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.03 -32.47 17.57 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 111.963 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -54.56 -47.31 73.41 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.061 1.344 . . . . 0.0 111.992 172.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -71.43 -10.81 60.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.67 -50.99 5.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.104 1.362 . . . . 0.0 112.485 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.04 -24.89 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -66.09 -19.99 66.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -106.0 -17.89 14.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.128 1.371 . . . . 0.0 114.187 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.97 118.65 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.667 1.187 . . . . 0.0 112.554 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -83.96 158.62 21.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 112.4 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -56.89 130.17 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.079 1.352 . . . . 0.0 111.595 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.97 11.81 78.88 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.977 1.275 . . . . 0.0 115.271 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -116.43 112.37 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.901 1.351 . . . . 0.0 111.763 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -60.33 143.21 53.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.189 0.995 . . . . 0.0 112.165 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -142.23 145.27 33.91 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.768 1.227 . . . . 0.0 111.476 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -126.08 113.16 16.72 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.869 1.668 . . . . 0.0 109.864 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -118.69 111.34 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.678 1.191 . . . . 0.0 110.533 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 t -76.45 128.39 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.919 0.888 . . . . 0.0 109.512 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 mt -124.83 139.4 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.461 1.505 . . . . 0.0 109.822 -174.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.09 151.66 97.03 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 112.133 173.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.6 -36.24 43.44 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.587 2.191 . . . . 0.0 112.508 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -67.31 -21.08 65.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.869 1.268 . . . . 0.0 114.166 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -93.73 -17.66 22.94 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.761 1.224 . . . . 0.0 113.216 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.34 -59.19 2.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.585 1.154 . . . . 0.0 112.408 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -128.35 -20.66 3.65 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.76 26.34 68.55 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-N 119.776 1.171 . . . . 0.0 115.352 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.56 29.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.335 1.854 . . . . 0.0 112.548 -168.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -60.23 155.43 17.56 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.406 1.482 . . . . 0.0 113.883 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.59 101.48 13.65 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.199 1.4 . . . . 0.0 111.663 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 t -71.74 18.7 0.07 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.701 1.6 . . . . 0.0 114.318 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 p -154.6 108.96 2.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.514 1.925 . . . . 0.0 111.2 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -146.76 157.37 43.66 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.046 1.338 . . . . 0.0 112.236 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.26 115.05 21.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.078 -1.014 . . . . 0.0 110.533 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -102.44 118.85 37.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.664 1.186 . . . . 0.0 110.814 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.47 128.83 36.79 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.82 0.848 . . . . 0.0 110.676 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 139.86 17.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.31 1.844 . . . . 0.0 109.613 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.09 154.95 62.17 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.458 2.105 . . . . 0.0 112.684 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -68.95 -4.56 17.16 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.39 -35.18 37.73 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 112.963 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -88.48 -2.97 58.89 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.323 1.449 . . . . 0.0 113.797 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -131.79 25.52 4.68 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.314 2.246 . . . . 0.0 112.326 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.64 105.49 1.24 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.793 1.637 . . . . 0.0 111.426 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.72 -9.14 56.83 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.725 1.631 . . . . 0.0 115.048 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.5 mt -88.38 126.13 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 109.634 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.36 130.92 45.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.609 0.763 . . . . 0.0 112.058 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.2 mt -124.77 138.57 54.27 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.723 1.609 . . . . 0.0 110.521 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -154.15 158.04 39.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.202 1.401 . . . . 0.0 111.01 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.13 119.32 10.61 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.949 -1.095 . . . . 0.0 111.16 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.94 43.11 5.16 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.09 0.852 . . . . 0.0 115.2 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 ptm -132.89 152.13 51.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.84 1.256 . . . . 0.0 111.889 168.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -74.03 134.09 42.98 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.351 1.06 . . . . 0.0 111.327 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.62 146.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.003 2.121 . . . . 0.0 110.592 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 133.89 41.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.94 1.296 . . . . 0.0 111.425 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.17 93.34 0.55 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.216 1.388 . . . . 0.0 112.196 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -63.74 144.46 57.01 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.961 0.88 . . . . 0.0 111.237 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 t -129.26 156.52 43.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.063 1.345 . . . . 0.0 112.435 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.14 -17.16 64.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.503 1.921 . . . . 0.0 113.474 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -74.81 16.63 0.27 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.34 1.856 . . . . 0.0 113.714 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.86 48.75 17.42 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.108 2.163 . . . . 0.0 112.511 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -143.36 176.32 9.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.96 1.704 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -146.62 113.53 6.12 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.674 1.189 . . . . 0.0 111.642 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.0 169.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.403 0.681 . . . . 0.0 111.717 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -135.72 124.83 24.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.426 1.49 . . . . 0.0 110.595 172.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.25 175.42 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.669 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -110.84 131.98 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 111.534 -171.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 56.7 mt -67.81 134.27 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.854 1.662 . . . . 0.0 111.304 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -112.39 -34.35 5.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.393 1.877 . . . . 0.0 113.299 -174.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -151.82 162.49 40.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.147 1.379 . . . . 0.0 110.855 169.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.81 158.36 43.74 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.9 m -140.0 176.6 8.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.159 2.184 . . . . 0.0 111.081 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.94 76.09 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 67.4 p -128.73 -3.57 5.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.842 1.657 . . . . 0.0 114.419 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -140.98 166.38 24.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.974 1.709 . . . . 0.0 111.679 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.71 157.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.602 1.561 . . . . 0.0 110.419 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.1 mtp -120.22 123.02 42.22 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.79 1.636 . . . . 0.0 109.771 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.69 143.46 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.35 1.46 . . . . 0.0 109.357 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -69.84 110.89 5.21 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.75 -0.594 . . . . 0.0 111.366 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -116.85 172.79 7.02 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.733 2.013 . . . . 0.0 111.779 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -129.86 137.91 50.68 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.911 1.684 . . . . 0.0 110.896 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -151.9 134.09 8.51 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.076 0.95 . . . . 0.0 110.889 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.92 -31.94 18.84 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.544 2.163 . . . . 0.0 112.716 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.09 75.35 8.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.963 0.905 . . . . 0.0 109.172 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.35 -26.84 26.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.483 1.113 . . . . 0.0 112.611 169.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.41 -168.16 37.06 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.406 1.955 . . . . 0.0 113.601 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.63 160.38 35.54 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.253 1.821 . . . . 0.0 112.199 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -66.6 145.33 55.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.89 1.676 . . . . 0.0 112.43 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.9 mt -133.92 147.75 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.294 1.437 . . . . 0.0 111.728 -174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.47 103.25 15.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 111.196 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -79.81 97.6 6.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.288 0.635 . . . . 0.0 109.405 161.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -89.63 140.42 29.57 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 170.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -150.34 169.39 21.51 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -146.25 150.5 35.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.391 1.476 . . . . 0.0 111.237 169.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.54 109.2 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 108.548 167.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.72 -36.85 84.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.184 0.593 . . . . 0.0 111.114 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.2 -164.07 25.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.114 1.816 . . . . 0.0 111.963 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.31 157.7 45.43 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.663 1.585 . . . . 0.0 111.291 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.7 121.32 31.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.971 1.309 . . . . 0.0 111.269 172.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.23 105.83 8.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.813 1.245 . . . . 0.0 109.776 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.3 m -63.29 161.85 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.601 0.76 . . . . 0.0 112.032 172.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.3 p -138.26 155.53 48.54 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.97 1.308 . . . . 0.0 112.195 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -136.6 49.83 2.06 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.628 1.571 . . . . 0.0 110.855 -173.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 61.0 9.16 2.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.655 1.982 . . . . 0.0 115.61 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 C--O 1.253 1.256 0 C-N-CA 127.005 2.122 . . . . 0.0 113.774 172.367 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.584 0.231 . . . . 0.0 111.331 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.19 99.58 12.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.173 1.389 . . . . 0.0 110.679 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.08 106.04 13.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.546 1.539 . . . . 0.0 111.273 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.63 134.86 35.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 pt -132.46 167.16 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.48 1.512 . . . . 0.0 111.731 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -143.5 136.0 27.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.446 1.899 . . . . 0.0 110.394 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.3 153.04 51.29 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.419 1.488 . . . . 0.0 113.89 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -141.03 121.73 14.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.476 2.31 . . . . 0.0 109.483 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.12 103.46 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.498 1.119 . . . . 0.0 110.186 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -113.92 159.32 20.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.694 1.598 . . . . 0.0 110.623 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.55 147.2 29.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.002 -1.061 . . . . 0.0 111.506 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -64.14 125.57 24.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.389 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.01 -52.91 4.69 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.47 1.51 . . . . 0.0 114.201 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -61.16 143.79 54.87 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.52 1.528 . . . . 0.0 112.818 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -79.27 -13.91 59.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.87 155.98 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.708 1.203 . . . . 0.0 111.362 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.3 144.12 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.407 1.483 . . . . 0.0 110.664 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.58 -52.87 4.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.256 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.9 157.83 36.97 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.626 1.57 . . . . 0.0 111.048 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.3 p -151.05 144.7 25.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.295 1.038 . . . . 0.0 111.828 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.47 -17.85 15.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 167.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -56.49 -46.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.636 1.574 . . . . 0.0 112.019 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 t -68.54 -29.81 68.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -78.09 -72.97 0.34 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.777 1.631 . . . . 0.0 111.748 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -175.48 151.91 1.32 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 128.171 2.588 . . . . 0.0 110.016 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.92 170.86 15.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.66 2.906 . . . . 0.0 113.428 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 tt -124.0 108.55 12.51 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.251 1.42 . . . . 0.0 110.556 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.8 141.65 32.15 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.728 1.211 . . . . 0.0 112.968 170.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -144.12 164.74 29.8 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.256 1.423 . . . . 0.0 111.364 166.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.7 mm -84.1 138.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.702 0.801 . . . . 0.0 110.139 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 mm -47.86 109.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.523 1.529 . . . . 0.0 111.3 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -27.79 6.68 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.244 1.878 . . . . 0.0 114.315 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.6 m -85.25 72.77 10.69 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.922 1.361 . . . . 0.0 111.466 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 72.58 4.83 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.76 -1.213 . . . . 0.0 111.854 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -72.38 -11.84 60.86 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.0 pt -66.76 169.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 127.186 2.194 . . . . 0.0 113.188 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -58.84 147.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.909 1.284 . . . . 0.0 112.46 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.6 74.25 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.53 -36.84 93.66 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 121.194 -0.941 . . . . 0.0 113.109 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 tp -80.87 -28.11 36.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.744 1.218 . . . . 0.0 112.595 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -57.39 -42.78 82.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.431 1.092 . . . . 0.0 112.64 173.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -75.23 -14.93 60.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.67 -47.83 8.36 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.969 1.308 . . . . 0.0 112.645 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.02 -30.71 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.403 1.081 . . . . 0.0 113.615 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.09 -21.98 64.02 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -97.23 -23.04 16.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.811 1.645 . . . . 0.0 113.453 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.38 127.23 32.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.979 1.311 . . . . 0.0 112.28 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -83.62 162.81 20.68 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.925 0.89 . . . . 0.0 111.966 172.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.5 133.19 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.06 1.344 . . . . 0.0 111.692 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.42 13.37 81.71 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.44 1.019 . . . . 0.0 115.307 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -121.48 112.73 18.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.089 1.356 . . . . 0.0 111.832 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -59.92 141.01 56.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.046 0.938 . . . . 0.0 112.029 172.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -141.9 144.03 33.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.95 1.3 . . . . 0.0 111.042 174.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.29 110.96 13.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.672 1.189 . . . . 0.0 110.287 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -113.84 107.97 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.884 1.274 . . . . 0.0 110.839 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.08 126.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.201 1.0 . . . . 0.0 109.657 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.0 mt -124.69 138.56 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.694 1.597 . . . . 0.0 109.065 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 160.32 82.68 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.14 0.976 . . . . 0.0 112.178 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.05 -38.89 14.93 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.5 2.133 . . . . 0.0 111.786 -175.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.46 -12.48 61.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.117 1.767 . . . . 0.0 114.468 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 CA--C 1.545 0.77 0 C-N-CA 125.956 1.702 . . . . 0.0 113.046 179.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 . . . . . 0 N--CA 1.469 0.499 0 CA-C-O 120.235 0.065 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.395 -0.816 . . . . 0.0 111.342 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -134.99 125.22 26.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.994 1.718 . . . . 0.0 110.24 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -74.43 119.05 18.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.024 0.93 . . . . 0.0 110.611 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.34 134.52 25.57 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 109.189 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.22 144.11 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.245 1.963 . . . . 0.0 111.582 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -62.07 -14.17 33.61 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.26 -31.34 61.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.58 1.552 . . . . 0.0 113.267 169.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -70.56 -11.58 61.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.415 1.086 . . . . 0.0 113.901 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -132.63 16.88 4.35 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.883 1.673 . . . . 0.0 113.317 -167.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.76 -18.83 14.05 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -172.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.99 6.7 12.09 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.823 1.678 . . . . 0.0 115.426 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.6 pt -137.6 114.86 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.837 1.655 . . . . 0.0 111.31 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -66.39 154.03 41.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.523 1.129 . . . . 0.0 113.39 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.4 mt -132.74 162.85 30.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.823 . . . . 0.0 111.121 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -155.74 162.75 40.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.194 1.398 . . . . 0.0 110.599 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -69.88 129.49 39.67 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.431 -1.418 . . . . 0.0 110.436 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.99 65.47 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.724 1.05 . . . . 0.0 115.724 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp -97.26 150.2 21.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.282 1.541 . . . . 0.0 112.682 171.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 p -72.47 108.44 5.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 111.039 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.73 161.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.717 1.607 . . . . 0.0 110.934 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.52 154.55 40.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.12 1.368 . . . . 0.0 111.484 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.73 108.71 0.47 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.353 0.978 . . . . 0.0 113.084 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -73.33 111.4 8.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 111.575 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.3 t -80.83 158.19 25.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.563 1.145 . . . . 0.0 111.924 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.98 -17.36 63.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.386 1.474 . . . . 0.0 113.682 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.08 20.41 0.14 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.845 1.658 . . . . 0.0 113.911 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 50.22 48.0 22.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.346 2.259 . . . . 0.0 113.073 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -142.36 173.41 11.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.926 1.69 . . . . 0.0 111.736 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.0 m -141.07 107.84 5.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.629 1.171 . . . . 0.0 110.643 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.2 166.44 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.753 -0.592 . . . . 0.0 111.419 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -128.04 137.48 52.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.526 1.53 . . . . 0.0 110.879 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.8 178.98 9.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 113.206 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -126.82 125.65 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.186 0.994 . . . . 0.0 111.394 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.2 mt -72.78 129.02 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.475 1.11 . . . . 0.0 111.128 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -98.06 -35.89 10.28 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.692 1.597 . . . . 0.0 113.305 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -150.7 147.98 28.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.141 1.376 . . . . 0.0 110.164 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -140.01 136.93 34.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.169 0.987 . . . . 0.0 111.704 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.8 t -137.07 168.7 19.09 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.189 1.796 . . . . 0.0 110.154 172.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.33 63.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.099 0.96 . . . . 0.0 113.528 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 p -83.82 -62.05 1.67 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.233 1.813 . . . . 0.0 111.75 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -136.0 165.03 26.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.007 2.123 . . . . 0.0 111.707 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.634 1.573 . . . . 0.0 110.328 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mmm -120.64 105.28 10.64 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.727 2.011 . . . . 0.0 109.332 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 t -112.02 133.76 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 0.0 110.237 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.48 129.99 41.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.722 0.809 . . . . 0.0 111.32 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 CA--C 1.537 0.45 0 C-N-CA 125.656 1.582 . . . . 0.0 111.17 170.258 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 111.331 0.123 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -69.75 141.95 53.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.865 1.266 . . . . 0.0 112.369 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.64 147.97 49.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.534 1.534 . . . . 0.0 110.974 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.77 96.9 9.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.965 1.706 . . . . 0.0 111.074 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -76.86 95.72 4.15 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.799 0.84 . . . . 0.0 109.801 164.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -86.35 143.23 27.96 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.554 -0.716 . . . . 0.0 110.216 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -151.69 170.33 19.99 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -145.92 142.68 28.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.12 1.368 . . . . 0.0 111.306 168.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.25 101.97 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.438 1.095 . . . . 0.0 108.445 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.82 -37.4 86.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.243 1.017 . . . . 0.0 111.574 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 133.78 166.15 11.23 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.049 1.785 . . . . 0.0 113.29 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -98.54 146.92 25.3 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.492 1.117 . . . . 0.0 111.815 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 125.662 1.585 . . . . 0.0 111.31 177.04 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 102.77 10.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.817 1.247 . . . . 0.0 110.618 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.68 118.88 24.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.038 1.335 . . . . 0.0 111.132 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.83 129.46 45.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.775 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.23 165.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.182 . . . . 0.0 111.896 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.46 136.27 34.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.913 1.685 . . . . 0.0 110.121 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.58 154.08 50.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 113.723 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.75 121.11 12.34 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 109.403 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.95 111.47 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 110.472 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -121.27 134.67 55.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.849 1.659 . . . . 0.0 109.229 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -63.67 152.77 38.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.984 -1.072 . . . . 0.0 111.103 165.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -71.46 151.63 43.8 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.394 -0.816 . . . . 0.0 110.832 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.6 -66.29 3.95 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.826 1.203 . . . . 0.0 113.987 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -65.29 141.58 58.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.01 0.905 . . . . 0.0 113.096 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 m -82.06 -15.33 53.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.69 176.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.284 1.033 . . . . 0.0 111.356 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.74 143.22 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.134 1.374 . . . . 0.0 111.274 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 mt -75.84 -57.15 4.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.126 0.971 . . . . 0.0 111.011 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -155.18 157.6 37.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.876 1.27 . . . . 0.0 111.746 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.3 p -155.02 137.06 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.777 1.231 . . . . 0.0 112.179 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.67 -18.06 19.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 166.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -56.94 -43.66 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.643 1.577 . . . . 0.0 112.047 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 t -72.25 -8.82 56.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.088 1.355 . . . . 0.0 113.976 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -107.87 -73.32 0.69 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.364 1.866 . . . . 0.0 110.889 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.52 152.53 6.82 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.966 2.507 . . . . 0.0 110.357 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.79 159.71 52.64 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.78 2.32 . . . . 0.0 112.553 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 tt -104.2 108.93 20.55 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.62 1.568 . . . . 0.0 109.544 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.97 130.76 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.489 1.516 . . . . 0.0 112.158 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.6 162.88 37.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.185 0.994 . . . . 0.0 111.963 167.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.0 mm -81.62 137.91 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.68 0.792 . . . . 0.0 109.033 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.69 104.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.507 1.123 . . . . 0.0 110.879 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.05 39.41 0.23 Allowed Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.508 1.528 . . . . 0.0 116.116 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.6 m -122.79 -31.66 3.65 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.141 1.47 . . . . 0.0 114.256 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 57.59 31.06 19.77 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.668 1.587 . . . . 0.0 114.425 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -69.74 -19.79 63.53 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.6 pt -75.84 168.0 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.298 1.439 . . . . 0.0 112.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.7 pt -59.16 148.14 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.556 1.143 . . . . 0.0 111.96 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.04 84.2 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.94 0.896 . . . . 0.0 113.298 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.88 68.84 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.051 0.834 . . . . 0.0 114.656 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.12 -36.62 11.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.382 1.473 . . . . 0.0 111.555 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -56.17 -44.25 79.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.401 1.081 . . . . 0.0 111.921 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -76.67 12.31 1.35 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.886 1.274 . . . . 0.0 113.802 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.52 -45.24 2.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.973 1.709 . . . . 0.0 113.121 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.5 m -55.5 -28.19 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -62.76 -16.45 57.9 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -110.92 -5.35 14.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.142 1.377 . . . . 0.0 113.627 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.95 114.02 18.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.012 1.325 . . . . 0.0 112.331 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -71.57 157.18 38.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.833 0.825 . . . . 0.0 112.369 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.18 135.65 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.53 1.532 . . . . 0.0 112.027 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.71 16.34 74.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.63 1.11 . . . . 0.0 115.094 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -122.19 111.7 17.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.318 1.447 . . . . 0.0 111.178 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -58.5 142.77 47.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.78 0.832 . . . . 0.0 112.163 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -142.46 141.21 32.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.777 1.231 . . . . 0.0 111.19 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -125.79 105.23 8.81 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.272 1.429 . . . . 0.0 110.329 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.67 106.8 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.865 1.266 . . . . 0.0 111.109 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.58 128.99 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.371 1.069 . . . . 0.0 109.783 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.96 145.79 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.939 1.696 . . . . 0.0 109.664 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.63 156.96 81.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.364 1.466 . . . . 0.0 113.283 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.15 -3.14 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.036 3.157 . . . . 0.0 116.634 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.83 -4.06 12.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.602 1.161 . . . . 0.0 113.502 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 . . . . . 0 N--CA 1.478 0.933 0 C-N-CA 125.503 1.521 . . . . 0.0 113.637 -177.755 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 . . . . . 0 N--CA 1.474 0.772 0 CA-C-O 121.264 0.554 . . . . 0.0 111.991 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.53 138.78 45.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.132 1.773 . . . . 0.0 110.456 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -134.02 113.35 12.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 111.238 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -79.17 96.42 5.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.931 1.292 . . . . 0.0 111.33 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -94.74 137.33 22.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.319 1.847 . . . . 0.0 109.799 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.7 158.51 50.38 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.901 2.401 . . . . 0.0 112.13 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -76.27 65.24 2.18 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.371 1.068 . . . . 0.0 111.813 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -133.3 -36.43 0.99 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.421 1.889 . . . . 0.0 112.599 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -74.02 -12.37 60.61 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 171.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.14 28.54 6.04 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.977 1.711 . . . . 0.0 112.631 -171.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -11.94 60.77 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.95 5.42 6.46 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.772 1.653 . . . . 0.0 115.33 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 pt -138.21 122.29 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.509 1.924 . . . . 0.0 110.463 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -68.33 154.87 40.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.1 0.96 . . . . 0.0 113.34 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -133.16 159.4 40.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.482 1.913 . . . . 0.0 110.832 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -155.53 164.36 38.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 110.574 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -67.12 132.39 47.73 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.626 -1.296 . . . . 0.0 110.599 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.85 43.59 65.68 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.188 0.899 . . . . 0.0 114.655 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.38 145.3 47.31 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.55 1.14 . . . . 0.0 111.952 170.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -68.96 123.93 22.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.656 1.182 . . . . 0.0 110.679 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.33 155.58 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.514 1.526 . . . . 0.0 111.398 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -90.37 144.72 25.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.455 1.102 . . . . 0.0 111.608 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.03 96.94 0.49 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -65.31 144.31 57.21 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.267 1.034 . . . . 0.0 111.261 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.1 t -125.27 154.61 41.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.244 1.418 . . . . 0.0 112.151 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.4 -15.65 60.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.618 1.967 . . . . 0.0 113.65 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.38 15.71 0.43 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.44 1.896 . . . . 0.0 113.777 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.53 48.53 20.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 112.564 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -142.7 179.96 6.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.764 1.626 . . . . 0.0 112.202 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.6 m -145.73 127.91 15.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.563 1.145 . . . . 0.0 111.766 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -98.52 172.8 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.998 1.319 . . . . 0.0 112.104 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -121.19 119.98 33.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.183 1.793 . . . . 0.0 109.924 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -136.25 177.99 7.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.262 1.825 . . . . 0.0 112.415 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.23 131.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.165 1.386 . . . . 0.0 110.001 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -72.47 129.02 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.199 1.0 . . . . 0.0 110.663 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -93.98 -43.33 8.59 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.83 1.252 . . . . 0.0 112.359 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -144.45 152.74 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.004 1.322 . . . . 0.0 111.1 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.97 148.65 34.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.805 1.242 . . . . 0.0 112.431 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.7 t -152.34 171.51 17.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.724 2.01 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.28 -24.5 64.88 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.562 1.145 . . . . 0.0 113.352 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.2 p -84.31 -61.43 1.81 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.456 1.903 . . . . 0.0 112.571 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.27 166.02 24.78 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.277 2.231 . . . . 0.0 111.764 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.21 137.23 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 110.562 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 26.3 mmm -109.85 99.44 8.58 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.737 2.015 . . . . 0.0 109.601 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -98.2 149.89 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.346 1.059 . . . . 0.0 111.328 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.97 141.76 45.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 111.694 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 CA--C 1.54 0.588 0 C-N-CA 125.264 1.425 . . . . 0.0 111.697 170.147 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt . . . . . 0 N--CA 1.483 1.206 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.4 p -63.97 137.21 57.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.99 1.316 . . . . 0.0 113.227 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 mt -123.12 125.51 45.3 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.339 1.456 . . . . 0.0 111.842 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.97 96.39 6.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.177 1.391 . . . . 0.0 111.157 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.79 97.47 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.636 0.774 . . . . 0.0 109.233 162.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.34 142.75 27.65 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.111 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -150.97 170.75 18.58 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -148.72 137.8 21.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.167 1.387 . . . . 0.0 111.183 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.6 t -80.95 103.02 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.46 1.104 . . . . 0.0 108.341 166.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.9 mt -66.89 -28.3 68.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.906 0.482 . . . . 0.0 112.139 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.13 -179.01 16.6 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.612 2.053 . . . . 0.0 112.254 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -115.49 154.76 28.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.049 0.94 . . . . 0.0 112.03 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 . . . . . 0 N--CA 1.471 0.589 0 C-N-CA 125.691 1.596 . . . . 0.0 111.108 178.358 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 CA--C 1.535 0.397 0 CA-C-O 120.537 0.208 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.88 104.16 7.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.923 . . . . 0.0 110.136 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.63 143.12 29.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.772 1.229 . . . . 0.0 111.123 172.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.92 139.48 53.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.511 1.524 . . . . 0.0 110.767 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.82 159.32 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.488 1.115 . . . . 0.0 111.386 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -133.28 134.42 43.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.902 1.681 . . . . 0.0 109.133 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -138.43 152.09 48.04 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -134.67 128.11 32.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.702 2.801 . . . . 0.0 108.828 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.19 119.28 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.294 1.038 . . . . 0.0 111.004 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -132.22 147.45 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.788 1.635 . . . . 0.0 112.166 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -66.71 136.5 55.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.628 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -72.85 78.26 1.14 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.23 1.014 . . . . 0.0 113.313 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.66 -53.29 0.52 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.966 1.746 . . . . 0.0 112.33 172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -68.55 147.43 51.97 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.924 1.29 . . . . 0.0 112.261 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.0 p -79.05 -6.77 57.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.43 162.35 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.186 1.394 . . . . 0.0 112.086 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.17 108.42 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.851 1.26 . . . . 0.0 109.272 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.44 -46.25 77.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.537 1.135 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.38 168.58 26.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.006 1.322 . . . . 0.0 111.233 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -155.55 157.51 36.95 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 112.902 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.45 -16.08 8.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.064 1.346 . . . . 0.0 112.782 168.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -55.39 -60.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 126.155 1.782 . . . . 0.0 111.912 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -69.03 -22.4 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.485 1.114 . . . . 0.0 113.035 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.48 -74.02 0.31 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.744 1.617 . . . . 0.0 111.711 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -168.64 125.98 0.86 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.174 1.79 . . . . 0.0 110.64 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.29 142.36 85.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.65 2.233 . . . . 0.0 112.027 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.01 101.56 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 0.0 110.387 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 130.3 34.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.202 1.401 . . . . 0.0 112.035 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.41 169.46 23.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.085 1.354 . . . . 0.0 112.47 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -94.49 139.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.334 1.053 . . . . 0.0 108.706 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.4 111.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.814 1.646 . . . . 0.0 112.14 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.38 74.31 0.69 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.962 1.744 . . . . 0.0 113.708 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.4 m -131.05 -37.79 1.26 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.039 1.336 . . . . 0.0 113.569 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.98 35.3 26.22 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 125.66 1.584 . . . . 0.0 114.523 172.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -99.58 -13.48 19.41 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 pt -68.92 167.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.614 1.166 . . . . 0.0 111.706 171.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 pt -55.71 142.34 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.619 -0.676 . . . . 0.0 110.893 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.17 72.68 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.292 -0.88 . . . . 0.0 112.868 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -45.07 87.02 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.142 0.877 . . . . 0.0 113.207 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.85 -31.1 59.17 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.355 1.062 . . . . 0.0 112.339 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.46 -48.31 82.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.616 1.166 . . . . 0.0 111.829 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -68.86 -5.44 21.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.63 -51.43 3.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.705 1.602 . . . . 0.0 112.852 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 p -54.95 -31.95 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.959 1.303 . . . . 0.0 114.079 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.99 -17.49 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -106.02 -7.95 17.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.736 2.014 . . . . 0.0 114.11 175.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.51 118.84 25.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.083 1.353 . . . . 0.0 112.337 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -77.33 160.21 28.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.914 0.886 . . . . 0.0 112.202 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -53.59 129.34 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.506 1.522 . . . . 0.0 111.647 170.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.95 -0.19 67.22 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.787 1.184 . . . . 0.0 115.866 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -97.04 113.07 24.58 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.411 1.606 . . . . 0.0 112.087 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -55.99 135.12 52.66 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.52 0.728 . . . . 0.0 111.103 164.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -137.79 113.18 9.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 0.0 110.93 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.83 98.45 11.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 110.242 172.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.27 153.11 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.824 0.85 . . . . 0.0 110.237 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.37 124.68 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.987 1.315 . . . . 0.0 109.988 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.94 134.12 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.115 1.766 . . . . 0.0 110.244 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.64 159.12 70.7 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.203 1.401 . . . . 0.0 112.936 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.83 50.56 2.5 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.682 3.588 . . . . 0.0 113.839 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.99 1.53 2.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.777 2.031 . . . . 0.0 113.15 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 125.447 1.499 . . . . 0.0 111.761 -179.849 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.14 146.1 47.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.074 1.35 . . . . 0.0 110.216 169.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -134.97 107.37 7.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.823 1.249 . . . . 0.0 110.121 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.4 121.47 18.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.049 0.54 . . . . 0.0 110.102 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.5 m -135.42 159.24 72.41 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.176 1.79 . . . . 0.0 110.724 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.21 165.21 31.46 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.325 2.016 . . . . 0.0 111.819 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -69.73 10.76 0.34 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.68 -43.48 97.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.451 1.5 . . . . 0.0 113.429 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -69.26 -21.92 63.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.049 0.94 . . . . 0.0 113.379 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -132.58 50.02 2.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.957 1.703 . . . . 0.0 111.391 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.07 -27.21 67.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.779 1.232 . . . . 0.0 113.0 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.43 34.02 1.64 Allowed Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.993 1.759 . . . . 0.0 114.094 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.64 128.82 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 126.643 1.977 . . . . 0.0 108.794 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -64.99 142.07 58.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.029 0.932 . . . . 0.0 111.762 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.41 146.02 51.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.736 1.614 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.45 145.06 20.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.622 1.169 . . . . 0.0 111.547 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.99 90.48 0.18 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.994 1.717 . . . . 0.0 110.579 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.51 -4.37 8.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.869 1.7 . . . . 0.0 116.58 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.5 159.41 32.27 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.482 2.141 . . . . 0.0 113.023 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -84.62 126.03 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 0.0 110.846 165.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.2 149.46 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.644 1.977 . . . . 0.0 110.723 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -97.78 155.72 16.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.74 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.82 95.52 0.19 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.17 1.367 . . . . 0.0 112.686 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.19 105.79 2.21 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.769 -0.842 . . . . 0.0 111.234 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -75.65 154.4 36.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.691 1.197 . . . . 0.0 112.169 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -65.11 -19.32 65.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.609 1.563 . . . . 0.0 112.661 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.3 13.21 0.13 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.663 1.985 . . . . 0.0 114.601 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 58.66 48.95 10.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.039 2.136 . . . . 0.0 112.597 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -146.57 176.82 9.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.533 1.933 . . . . 0.0 110.929 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 m -140.28 107.08 5.38 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 111.581 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.89 167.22 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.605 0.762 . . . . 0.0 111.8 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -128.34 132.3 48.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.977 1.711 . . . . 0.0 110.129 172.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.28 177.11 8.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.842 1.657 . . . . 0.0 112.509 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.413 ' H ' ' HB3' ' A' ' 125' ' ' ASP . 4.7 mp -115.75 137.99 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.46 1.504 . . . . 0.0 110.337 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.57 114.9 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.981 -1.074 . . . . 0.0 109.524 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -84.46 -33.18 23.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.195 1.398 . . . . 0.0 112.888 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -156.69 159.78 38.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.11 1.364 . . . . 0.0 111.445 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -149.06 151.06 33.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.956 1.302 . . . . 0.0 112.669 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -154.95 -176.55 5.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.737 1.615 . . . . 0.0 111.657 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.09 -27.95 54.34 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.301 1.441 . . . . 0.0 113.251 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.0 p -83.1 -65.3 1.03 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.904 1.682 . . . . 0.0 111.843 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -132.38 173.18 11.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.099 2.16 . . . . 0.0 111.71 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -143.51 148.83 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 127.148 2.179 . . . . 0.0 109.399 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.1 mtp -122.42 100.04 6.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.574 1.549 . . . . 0.0 110.263 -174.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.23 140.44 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.926 1.29 . . . . 0.0 111.67 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 113' ' ' ILE . 16.8 t70 -64.81 151.06 46.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.719 0.808 . . . . 0.0 111.347 168.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 . . . . . 0 CA--C 1.542 0.643 0 C-N-CA 125.252 1.421 . . . . 0.0 111.684 170.132 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.9 pttt . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.97 145.0 55.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.853 1.661 . . . . 0.0 112.558 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.17 124.98 44.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.574 1.55 . . . . 0.0 111.446 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.38 139.53 32.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.655 0.782 . . . . 0.0 111.444 169.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.83 95.21 4.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.523 1.929 . . . . 0.0 108.78 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -81.83 112.32 18.85 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.437 1.095 . . . . 0.0 108.572 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.17 169.4 16.92 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -147.25 139.11 24.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.319 1.448 . . . . 0.0 110.579 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.59 100.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.23 -17.53 64.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.259 1.023 . . . . 0.0 112.568 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.57 -171.1 13.55 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.786 1.66 . . . . 0.0 112.735 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -125.93 151.44 46.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.128 0.971 . . . . 0.0 112.48 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 . . . . . 0 N--CA 1.472 0.641 0 C-N-CA 126.17 1.788 . . . . 0.0 111.04 -177.108 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 110.469 -0.196 . . . . 0.0 110.469 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.41 112.23 17.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.332 0.653 . . . . 0.0 109.293 164.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.56 141.26 42.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.035 166.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.99 130.4 55.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.0 2.12 . . . . 0.0 109.991 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.3 pt -132.63 159.41 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.247 1.019 . . . . 0.0 112.392 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -138.47 134.75 34.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.192 1.797 . . . . 0.0 109.817 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -136.88 152.03 49.76 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.111 1.364 . . . . 0.0 114.027 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.42 115.99 9.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.614 2.365 . . . . 0.0 109.606 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.24 103.65 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 122.27 1.033 . . . . 0.0 110.634 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -102.77 152.15 21.58 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.593 2.357 . . . . 0.0 110.212 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -77.69 150.78 34.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.903 -1.123 . . . . 0.0 111.332 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -70.54 85.83 0.63 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.86 -1.15 . . . . 0.0 111.88 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.5 -44.78 1.26 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.467 1.984 . . . . 0.0 114.39 170.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -70.64 151.44 44.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.18 0.99 . . . . 0.0 112.971 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.4 m -79.87 -15.85 56.55 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.975 1.31 . . . . 0.0 114.072 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.83 159.57 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.777 0.831 . . . . 0.0 111.944 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.41 128.78 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.159 1.383 . . . . 0.0 109.517 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.43 -51.58 10.54 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.936 0.495 . . . . 0.0 111.423 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -159.89 163.84 34.0 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.393 1.877 . . . . 0.0 111.112 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.8 p -154.35 159.93 41.43 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.882 -1.136 . . . . 0.0 112.482 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -114.38 -12.52 12.37 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 165.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.19 -48.36 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.784 1.633 . . . . 0.0 111.826 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -76.0 -6.89 53.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.716 1.206 . . . . 0.0 113.984 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -107.47 -73.58 0.68 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.943 1.697 . . . . 0.0 111.354 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -163.54 131.68 2.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.301 1.84 . . . . 0.0 109.774 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.5 160.06 37.52 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.173 2.582 . . . . 0.0 112.891 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 tt -95.11 126.28 40.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 109.863 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -106.27 127.44 53.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.102 1.761 . . . . 0.0 111.558 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -147.57 162.98 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.508 1.123 . . . . 0.0 111.966 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.2 mm -88.38 149.48 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.717 -1.24 . . . . 0.0 109.366 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -50.7 106.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 110.971 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.03 59.63 1.75 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.547 1.546 . . . . 0.0 114.492 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -113.5 -28.68 7.44 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.966 1.306 . . . . 0.0 113.243 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.67 32.9 18.19 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.74 2.016 . . . . 0.0 114.711 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -83.5 -17.94 40.19 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -76.75 171.05 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.974 1.31 . . . . 0.0 112.791 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.4 pt -57.18 142.48 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.966 0.906 . . . . 0.0 111.46 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.78 77.57 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.48 -21.8 65.03 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.086 0.85 . . . . 0.0 114.518 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -96.52 -35.49 11.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.466 1.507 . . . . 0.0 111.804 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -56.77 -45.75 81.9 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.887 1.675 . . . . 0.0 112.188 174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -75.69 -2.0 27.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.917 0.887 . . . . 0.0 113.393 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.5 -42.27 4.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.601 1.56 . . . . 0.0 113.18 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.02 -25.73 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.522 1.129 . . . . 0.0 113.893 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.3 -24.96 67.84 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -37.24 15.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.133 1.373 . . . . 0.0 112.498 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.91 131.3 46.77 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.63 1.572 . . . . 0.0 113.377 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -92.51 151.51 20.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.2 1.0 . . . . 0.0 111.833 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.16 125.06 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.904 0.882 . . . . 0.0 110.061 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.19 86.19 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.454 1.026 . . . . 0.0 115.454 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -122.58 116.38 23.76 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.992 1.396 . . . . 0.0 111.259 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -58.26 143.07 45.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.157 0.983 . . . . 0.0 112.008 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.49 142.5 41.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.633 1.573 . . . . 0.0 110.173 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -129.99 81.8 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.181 0.993 . . . . 0.0 110.583 -167.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -88.06 117.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.921 1.289 . . . . 0.0 111.554 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.44 118.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.889 0.876 . . . . 0.0 109.465 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -115.62 138.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 126.604 1.961 . . . . 0.0 108.812 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.08 155.52 90.15 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.475 1.11 . . . . 0.0 112.042 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.7 -46.28 5.38 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.601 2.201 . . . . 0.0 112.473 -172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -64.69 -23.17 67.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.536 1.534 . . . . 0.0 113.309 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.545 0.765 0 C-N-CA 125.229 1.412 . . . . 0.0 113.502 176.54 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 p90 . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.03 132.98 41.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 111.386 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.7 120.09 28.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.74 1.216 . . . . 0.0 110.847 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.12 101.47 5.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.345 1.458 . . . . 0.0 111.453 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 t -99.72 136.88 20.16 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.32 1.848 . . . . 0.0 109.476 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.87 152.58 68.78 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.502 2.134 . . . . 0.0 111.676 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -76.88 57.45 1.32 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.127 1.371 . . . . 0.0 111.447 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.63 -50.52 1.06 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.205 1.802 . . . . 0.0 112.812 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -66.43 -15.01 63.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -98.45 17.83 18.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.717 2.007 . . . . 0.0 113.484 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 112.3 1.47 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.717 -1.239 . . . . 0.0 111.341 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.22 2.43 59.13 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.869 1.223 . . . . 0.0 115.446 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.68 130.48 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.919 1.36 . . . . 0.0 111.368 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.76 147.64 39.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.532 1.133 . . . . 0.0 111.173 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.09 152.4 47.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.98 1.712 . . . . 0.0 109.689 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -155.8 162.05 40.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 111.604 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.25 123.6 20.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.829 -1.169 . . . . 0.0 110.92 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.96 30.68 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.167 0.889 . . . . 0.0 114.786 173.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.4 ptp -109.1 144.96 36.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.195 0.997 . . . . 0.0 111.421 165.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.1 p -70.26 136.67 50.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.883 0.873 . . . . 0.0 110.812 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.9 p -140.66 164.61 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.573 1.549 . . . . 0.0 111.046 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.21 148.39 34.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.212 1.405 . . . . 0.0 111.858 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.85 94.72 0.31 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.463 1.506 . . . . 0.0 111.936 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -68.66 104.96 2.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.855 0.862 . . . . 0.0 111.063 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -77.93 158.38 29.38 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.678 1.191 . . . . 0.0 112.21 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -66.48 -16.95 64.51 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.443 1.497 . . . . 0.0 113.264 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -72.16 13.86 0.28 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.575 1.95 . . . . 0.0 114.212 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 57.13 47.23 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.883 2.073 . . . . 0.0 112.301 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.06 170.43 15.95 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.037 2.135 . . . . 0.0 109.637 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 34.6 m -136.95 115.51 11.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.56 1.144 . . . . 0.0 111.585 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.64 164.5 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 111.406 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -121.23 133.14 55.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.677 1.591 . . . . 0.0 110.624 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 177.15 9.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.683 1.593 . . . . 0.0 112.474 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.94 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.428 1.491 . . . . 0.0 109.362 173.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.9 mt -74.93 116.42 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.706 1.202 . . . . 0.0 109.629 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -92.98 -33.12 14.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.131 0.972 . . . . 0.0 112.611 -175.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -148.41 148.09 29.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.946 1.698 . . . . 0.0 110.78 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -142.58 157.93 44.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.221 1.008 . . . . 0.0 112.51 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 t -157.01 176.21 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.861 1.664 . . . . 0.0 111.167 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.17 -25.85 62.72 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.531 1.132 . . . . 0.0 113.184 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.6 p -82.74 -64.18 1.22 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.747 1.619 . . . . 0.0 112.044 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -135.08 168.47 19.07 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.592 2.357 . . . . 0.0 111.159 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -137.58 150.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.498 1.519 . . . . 0.0 110.617 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.2 mmm -127.76 103.08 7.09 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.798 2.039 . . . . 0.0 110.288 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.76 143.47 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.398 1.479 . . . . 0.0 110.246 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.23 96.8 2.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.206 1.002 . . . . 0.0 111.861 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 . . . . . 0 CA--C 1.54 0.562 0 C-N-CA 125.063 1.345 . . . . 0.0 112.392 173.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.3 p -91.24 150.31 21.39 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.957 1.303 . . . . 0.0 113.208 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.3 120.94 32.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.742 2.017 . . . . 0.0 110.911 -170.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 101.08 10.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -79.59 92.43 5.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.633 0.773 . . . . 0.0 110.08 167.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -73.12 124.03 24.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 165.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -144.18 169.39 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -148.4 147.97 29.8 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.789 1.236 . . . . 0.0 111.511 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.95 108.0 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.614 1.166 . . . . 0.0 108.444 167.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.7 -12.76 60.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.007 1.323 . . . . 0.0 112.768 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.57 -150.51 18.66 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 126.009 1.766 . . . . 0.0 111.475 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.77 163.7 31.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.492 1.117 . . . . 0.0 112.681 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 . . . . . 0 N--CA 1.478 0.94 0 C-N-CA 125.397 1.479 . . . . 0.0 113.125 176.087 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 120.477 0.18 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.31 8.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.39 123.63 23.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.065 1.346 . . . . 0.0 110.566 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.72 117.44 34.08 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.6 1.96 . . . . 0.0 109.707 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.34 160.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.363 1.065 . . . . 0.0 111.524 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.13 165.36 28.05 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.076 -1.015 . . . . 0.0 112.445 169.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -147.69 157.8 43.72 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.7 1.6 . . . . 0.0 113.858 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -134.01 123.79 25.17 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.873 3.269 . . . . 0.0 108.148 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.21 112.58 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.263 1.025 . . . . 0.0 109.372 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -115.84 143.72 45.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.753 1.621 . . . . 0.0 110.172 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -70.04 132.92 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.516 -0.74 . . . . 0.0 110.4 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -59.16 123.84 18.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.305 0.642 . . . . 0.0 111.943 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.82 -45.86 2.31 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.019 1.771 . . . . 0.0 114.306 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -74.72 154.7 38.3 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.664 1.186 . . . . 0.0 113.514 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 m -83.8 -14.94 50.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.18 163.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.049 0.94 . . . . 0.0 111.983 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.66 122.74 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.367 1.467 . . . . 0.0 109.299 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.69 -51.09 24.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.102 0.961 . . . . 0.0 111.058 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.52 156.54 28.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.006 1.323 . . . . 0.0 112.554 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 57.5 m -149.84 151.97 34.37 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.679 1.591 . . . . 0.0 111.76 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.49 -6.13 11.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.3 mt -50.88 -58.14 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.908 1.683 . . . . 0.0 112.196 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -75.1 -19.83 59.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.504 1.121 . . . . 0.0 113.389 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -78.59 -72.47 0.38 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.048 1.739 . . . . 0.0 111.109 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -168.34 125.87 0.9 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 127.074 2.15 . . . . 0.0 109.392 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.29 147.05 87.43 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.444 2.096 . . . . 0.0 111.403 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.5 tp -72.83 142.89 48.0 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.316 1.047 . . . . 0.0 110.172 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -120.68 111.79 18.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 0.0 109.685 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -131.77 169.54 16.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.078 0.951 . . . . 0.0 112.262 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.2 mm -105.94 137.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.234 1.014 . . . . 0.0 108.9 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -46.37 106.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.634 1.574 . . . . 0.0 111.345 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.88 15.03 17.63 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.25 1.405 . . . . 0.0 116.397 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.6 m -73.8 -43.54 58.55 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.859 1.829 . . . . 0.0 113.001 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m120 57.17 21.52 6.61 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.161 2.185 . . . . 0.0 116.538 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -74.61 -16.0 60.81 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.4 pt -66.6 168.86 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.434 1.494 . . . . 0.0 112.96 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 pt -56.1 144.43 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.228 1.011 . . . . 0.0 111.775 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -38.41 75.23 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -171.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.81 -33.16 86.17 Favored Glycine 0 CA--C 1.539 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 113.962 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.52 -29.64 22.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.251 1.42 . . . . 0.0 112.144 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -59.65 -43.29 93.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.738 1.615 . . . . 0.0 112.091 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -70.47 -13.91 62.31 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.38 -46.81 7.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.817 1.247 . . . . 0.0 112.723 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.33 -27.77 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.8 -24.47 66.93 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.94 -36.65 10.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.107 1.763 . . . . 0.0 112.684 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.96 112.15 0.89 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.963 1.705 . . . . 0.0 113.142 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.08 151.4 41.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.448 0.699 . . . . 0.0 112.053 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 tt -57.33 127.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.426 1.09 . . . . 0.0 111.494 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.96 9.23 85.28 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.094 1.33 . . . . 0.0 115.3 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.1 119.07 30.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.088 1.444 . . . . 0.0 111.763 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -59.25 142.36 52.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.059 0.944 . . . . 0.0 112.082 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -136.51 138.82 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.598 1.159 . . . . 0.0 110.481 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -130.02 89.3 2.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.433 1.093 . . . . 0.0 110.534 -167.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -101.09 118.15 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.879 1.272 . . . . 0.0 111.507 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.9 t -78.82 111.18 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.434 1.094 . . . . 0.0 109.536 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.17 133.81 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.3 1.44 . . . . 0.0 109.53 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.51 153.45 93.1 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.09 0.956 . . . . 0.0 111.743 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.04 -43.53 35.69 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.563 2.175 . . . . 0.0 112.521 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.92 -15.6 63.53 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.833 1.653 . . . . 0.0 114.838 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 124.769 1.227 . . . . 0.0 113.035 176.488 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 120.688 0.28 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.36 147.85 44.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.199 1.4 . . . . 0.0 110.316 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -129.51 115.92 18.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.191 1.396 . . . . 0.0 110.653 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.8 115.43 6.58 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.498 0.719 . . . . 0.0 110.121 164.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.32 133.93 25.49 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 126.633 1.973 . . . . 0.0 109.463 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.2 155.96 60.08 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.201 1.934 . . . . 0.0 111.673 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -64.06 -17.62 63.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.91 -38.89 58.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.332 2.653 . . . . 0.0 114.316 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -71.58 -15.95 62.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.27 -45.41 3.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.635 1.174 . . . . 0.0 112.947 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 21.28 66.97 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 129.611 3.164 . . . . 0.0 115.043 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.41 -22.42 3.94 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.041 1.305 . . . . 0.0 115.601 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.55 132.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.247 1.523 . . . . 0.0 109.621 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.24 67.76 3.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.777 1.631 . . . . 0.0 112.613 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.66 148.05 17.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.713 1.605 . . . . 0.0 112.131 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -151.34 155.75 39.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.198 1.399 . . . . 0.0 111.189 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -71.81 21.94 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 54.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 120.95 -1.094 . . . . 0.0 113.578 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.8 ptm -132.29 151.58 51.77 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.991 1.317 . . . . 0.0 111.874 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 p -70.25 133.05 46.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.354 1.061 . . . . 0.0 111.245 167.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -135.72 156.95 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.149 1.78 . . . . 0.0 110.689 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -95.66 145.82 24.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.446 1.098 . . . . 0.0 111.902 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.18 95.44 0.37 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.692 1.615 . . . . 0.0 111.855 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -65.68 137.96 57.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 117.85 0.825 . . . . 0.0 111.123 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 t -116.93 155.15 29.6 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.942 1.697 . . . . 0.0 111.75 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.85 -15.44 58.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.177 1.791 . . . . 0.0 113.345 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.23 15.17 0.35 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.419 1.888 . . . . 0.0 113.769 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 55.54 46.74 22.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.368 2.267 . . . . 0.0 112.543 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -144.74 177.45 8.7 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.174 1.79 . . . . 0.0 112.218 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.7 m -145.37 120.32 10.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.667 1.187 . . . . 0.0 111.796 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -88.9 173.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.584 1.153 . . . . 0.0 112.053 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.7 133.97 46.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.219 1.408 . . . . 0.0 111.441 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.81 11.22 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.464 1.506 . . . . 0.0 112.052 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.95 131.95 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.639 1.176 . . . . 0.0 110.618 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.7 mt -70.55 134.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 120.821 -1.174 . . . . 0.0 111.059 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -94.73 -46.38 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.825 1.25 . . . . 0.0 112.065 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -146.81 156.87 43.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.284 1.434 . . . . 0.0 111.258 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.26 146.84 29.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.727 1.211 . . . . 0.0 112.331 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.3 t -152.97 169.41 22.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.272 1.829 . . . . 0.0 110.547 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.93 -27.26 67.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.192 0.997 . . . . 0.0 113.493 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -80.67 -66.42 0.89 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.789 2.036 . . . . 0.0 111.714 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -132.3 157.49 44.29 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.619 1.968 . . . . 0.0 111.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.41 150.32 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.95 2.1 . . . . 0.0 108.233 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.6 mtp -126.18 100.56 6.37 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.822 1.249 . . . . 0.0 109.992 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.3 m -99.29 151.72 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.287 1.035 . . . . 0.0 111.075 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.68 148.79 46.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.339 0.656 . . . . 0.0 111.187 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 . . . . . 0 N--CA 1.47 0.572 0 C-N-CA 125.264 1.426 . . . . 0.0 112.326 172.873 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.2 p -73.06 136.88 45.03 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 112.47 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.81 136.48 53.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.618 1.967 . . . . 0.0 110.736 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.31 105.25 17.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.685 1.194 . . . . 0.0 111.345 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.88 92.09 8.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 109.913 167.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -74.84 122.5 23.46 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 163.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -143.24 166.35 24.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.454 0.702 . . . . 0.0 112.03 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -151.2 145.67 25.56 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.462 0.705 . . . . 0.0 112.503 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.1 t -91.25 102.87 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.475 1.51 . . . . 0.0 108.715 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.17 -27.36 69.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.85 0.86 . . . . 0.0 111.6 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.41 -133.04 7.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 125.992 1.758 . . . . 0.0 110.899 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -150.37 162.89 39.67 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.842 1.257 . . . . 0.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 . . . . . 0 N--CA 1.472 0.641 0 C-N-CA 125.201 1.4 . . . . 0.0 111.269 171.021 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 111.628 0.232 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.96 113.31 21.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.383 1.073 . . . . 0.0 111.573 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.2 101.43 7.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 110.483 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.53 111.19 11.75 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.01 1.724 . . . . 0.0 110.043 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 pp -133.6 158.3 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.944 0.897 . . . . 0.0 111.968 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -137.65 138.34 39.36 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.501 1.521 . . . . 0.0 109.852 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -136.4 162.19 33.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.854 1.262 . . . . 0.0 113.796 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -144.83 160.24 41.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.074 2.149 . . . . 0.0 111.678 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.47 112.59 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.36 1.464 . . . . 0.0 110.451 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -114.62 154.52 28.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.995 2.118 . . . . 0.0 110.054 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.91 148.28 26.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.323 1.449 . . . . 0.0 111.567 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -70.68 94.03 0.98 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.831 -1.168 . . . . 0.0 111.253 166.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 -39.22 2.97 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.233 1.873 . . . . 0.0 114.894 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -73.44 149.84 42.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.502 1.151 . . . . 0.0 112.046 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m -69.37 -23.06 63.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.923 1.289 . . . . 0.0 113.776 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.65 153.47 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 113.296 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.94 128.14 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.838 1.655 . . . . 0.0 108.982 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.24 -51.95 7.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.144 0.578 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.09 160.07 43.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.185 1.794 . . . . 0.0 111.488 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -162.38 167.14 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.923 1.289 . . . . 0.0 113.138 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -130.72 13.77 5.37 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 164.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.0 mm -53.15 -59.99 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.578 1.551 . . . . 0.0 112.358 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -78.68 -16.17 57.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -172.6 3.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.063 2.145 . . . . 0.0 111.722 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.94 126.36 83.24 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.208 1.003 . . . . 0.0 110.97 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.31 162.75 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.135 2.557 . . . . 0.0 112.335 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.95 149.1 37.73 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.823 168.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -130.81 48.26 2.44 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.297 1.439 . . . . 0.0 110.939 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -69.33 163.11 25.84 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.357 -0.84 . . . . 0.0 113.14 -175.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 mm -116.61 137.34 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.672 1.589 . . . . 0.0 109.244 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.73 107.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.799 1.64 . . . . 0.0 111.908 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.63 -28.03 8.43 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.24 1.876 . . . . 0.0 114.311 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -58.35 -24.52 60.06 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.593 1.697 . . . . 0.0 113.735 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 40.55 60.43 1.88 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.422 2.689 . . . . 0.0 114.137 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -89.41 -17.44 28.79 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.72 170.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.933 1.293 . . . . 0.0 112.218 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 pt -63.26 147.1 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.459 -0.776 . . . . 0.0 111.863 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.93 -25.92 68.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.26 -40.69 98.16 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.859 -1.151 . . . . 0.0 112.991 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 tp -81.63 -25.45 35.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.717 1.607 . . . . 0.0 112.804 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -51.25 -49.39 61.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.779 1.632 . . . . 0.0 112.476 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -13.89 62.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.256 1.022 . . . . 0.0 113.708 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.54 -43.36 7.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.793 1.237 . . . . 0.0 112.968 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.46 -27.25 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.34 -17.43 63.7 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -103.79 -40.44 6.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.907 1.683 . . . . 0.0 113.328 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.58 134.36 56.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.183 0.993 . . . . 0.0 112.5 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.7 161.6 13.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.05 0.94 . . . . 0.0 112.282 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -54.49 124.49 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.394 1.078 . . . . 0.0 111.575 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.63 -0.28 77.2 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.234 1.397 . . . . 0.0 115.604 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -105.96 112.6 25.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.415 1.607 . . . . 0.0 111.551 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -57.49 144.73 35.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.54 0.736 . . . . 0.0 111.824 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -138.12 139.81 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.155 1.782 . . . . 0.0 109.96 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -130.45 110.39 11.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.208 1.403 . . . . 0.0 110.571 -173.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -118.17 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.611 1.564 . . . . 0.0 110.778 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.81 123.05 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.898 0.879 . . . . 0.0 109.118 173.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.3 mt -127.87 130.4 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 109.294 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.2 145.3 97.47 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.785 0.834 . . . . 0.0 110.984 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.09 -32.55 91.71 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.884 1.722 . . . . 0.0 112.971 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -63.08 -20.7 65.59 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 . . . . . 0 CA--C 1.549 0.914 0 C-N-CA 125.206 1.402 . . . . 0.0 113.163 175.343 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 p90 . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.01 129.11 38.15 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 111.481 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -120.74 118.11 29.21 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.222 1.409 . . . . 0.0 110.153 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.95 130.27 42.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.163 0.985 . . . . 0.0 110.746 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.1 t -135.75 136.66 23.91 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.034 1.733 . . . . 0.0 109.15 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.63 157.83 54.93 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.637 2.225 . . . . 0.0 112.211 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -75.94 66.18 2.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.31 1.444 . . . . 0.0 111.876 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.38 -50.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.151 1.781 . . . . 0.0 112.245 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.84 -11.68 48.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -120.1 10.48 11.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.43 1.892 . . . . 0.0 113.718 -171.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -56.16 -27.99 56.4 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.371 1.468 . . . . 0.0 114.145 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.42 10.21 22.03 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.676 1.608 . . . . 0.0 116.367 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.8 pt -134.91 131.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.555 1.678 . . . . 0.0 112.893 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -75.92 137.64 40.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.168 1.387 . . . . 0.0 112.256 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.72 165.17 15.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.829 1.651 . . . . 0.0 112.655 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.21 155.5 30.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.017 1.727 . . . . 0.0 110.764 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -73.38 107.54 5.73 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.464 -1.397 . . . . 0.0 111.05 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.88 26.94 11.79 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.501 0.961 . . . . 0.0 115.501 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.1 ptm -99.73 153.26 19.25 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.883 1.342 . . . . 0.0 112.263 168.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 p -70.46 113.96 8.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.249 1.42 . . . . 0.0 111.157 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.15 161.19 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.896 1.678 . . . . 0.0 111.035 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -123.25 155.44 37.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.813 1.645 . . . . 0.0 111.878 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.58 105.51 0.29 Allowed Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.361 0.982 . . . . 0.0 113.341 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.0 111.57 7.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.926 1.29 . . . . 0.0 111.894 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.9 t -80.55 159.7 25.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.102 1.361 . . . . 0.0 111.897 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.04 -15.52 62.43 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.048 1.339 . . . . 0.0 113.366 173.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.44 18.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.757 1.623 . . . . 0.0 113.966 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 51.83 44.01 29.68 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.474 2.31 . . . . 0.0 113.077 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -140.98 172.33 12.83 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.286 1.834 . . . . 0.0 111.533 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.0 m -141.53 107.62 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.04 1.336 . . . . 0.0 110.521 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.59 167.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.972 -0.455 . . . . 0.0 111.41 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -132.41 136.22 46.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.082 1.353 . . . . 0.0 111.284 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.4 -179.53 8.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.816 1.246 . . . . 0.0 112.798 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.81 132.72 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.204 1.401 . . . . 0.0 110.61 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.63 122.46 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.9 1.28 . . . . 0.0 110.571 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -90.27 -38.02 13.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.705 1.202 . . . . 0.0 113.08 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -153.35 154.67 34.98 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.337 1.455 . . . . 0.0 111.571 170.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.07 145.83 30.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 113.388 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.4 m -148.3 173.68 12.79 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.771 2.028 . . . . 0.0 111.379 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.82 -21.99 61.62 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.9 p -83.52 -61.62 1.79 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.075 1.75 . . . . 0.0 111.924 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -136.62 169.31 17.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.628 2.371 . . . . 0.0 111.056 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.76 154.91 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.148 1.779 . . . . 0.0 109.888 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.0 mtp -130.22 101.27 5.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.518 1.527 . . . . 0.0 109.969 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.9 t -109.66 147.78 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.209 1.404 . . . . 0.0 109.371 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.89 134.01 54.36 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.758 -0.589 . . . . 0.0 111.158 168.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 . . . . . 0 CA--C 1.541 0.627 0 C-N-CA 125.365 1.466 . . . . 0.0 111.754 178.477 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.4 pttm . . . . . 0 N--CA 1.484 1.247 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 147.09 53.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.363 1.865 . . . . 0.0 113.597 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.8 mp -122.56 160.84 24.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.59 103.36 13.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.999 1.72 . . . . 0.0 111.161 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -82.41 109.99 17.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.601 0.76 . . . . 0.0 109.576 166.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -110.49 138.9 46.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.216 1.006 . . . . 0.0 110.129 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.94 170.0 20.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.417 0.687 . . . . 0.0 112.756 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -146.04 146.65 31.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 111.237 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.5 105.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.696 1.198 . . . . 0.0 108.742 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.17 -26.41 56.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.487 1.115 . . . . 0.0 112.453 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.89 -168.0 33.84 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -132.8 130.5 39.96 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.762 1.625 . . . . 0.0 110.225 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 124.938 1.295 . . . . 0.0 110.149 -177.331 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.09 98.72 9.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.019 1.328 . . . . 0.0 110.859 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.68 128.59 34.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.3 1.44 . . . . 0.0 111.327 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.72 134.7 43.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.166 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 pt -127.98 162.6 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.887 1.275 . . . . 0.0 112.247 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -138.64 131.45 29.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.509 1.924 . . . . 0.0 109.458 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -137.05 153.94 50.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.728 1.211 . . . . 0.0 113.784 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -143.68 133.93 24.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.907 2.483 . . . . 0.0 110.144 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.2 103.14 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -110.53 147.32 34.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.961 2.104 . . . . 0.0 110.906 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -76.68 141.64 40.87 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.409 -0.807 . . . . 0.0 111.872 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.6 93.45 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.779 0.832 . . . . 0.0 111.549 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.06 -54.65 0.7 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.247 1.88 . . . . 0.0 113.713 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 t -68.48 154.68 41.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -79.06 -20.67 48.27 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.258 1.423 . . . . 0.0 113.308 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.98 155.72 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.439 -0.788 . . . . 0.0 111.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.52 131.13 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.498 1.519 . . . . 0.0 110.082 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.8 mt -73.18 -55.1 6.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.503 0.721 . . . . 0.0 111.409 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.28 155.87 34.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.319 1.448 . . . . 0.0 110.922 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.4 p -148.26 126.03 11.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.266 1.026 . . . . 0.0 111.926 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -88.09 -29.65 20.47 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.199 0.6 . . . . 0.0 112.363 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -51.8 -51.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.013 1.725 . . . . 0.0 112.296 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -69.7 -14.99 63.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.497 1.119 . . . . 0.0 113.754 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -92.01 -72.17 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.812 1.645 . . . . 0.0 110.6 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -167.1 154.43 8.43 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.679 1.992 . . . . 0.0 111.623 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.31 146.38 69.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.439 2.092 . . . . 0.0 111.478 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 tp -87.52 130.55 34.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.857 1.263 . . . . 0.0 109.723 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.02 138.18 49.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.922 0.889 . . . . 0.0 112.649 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -153.04 163.02 40.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.189 1.396 . . . . 0.0 111.86 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.24 141.2 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -47.57 109.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.549 1.54 . . . . 0.0 111.163 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.4 -5.02 31.4 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.698 1.618 . . . . 0.0 115.916 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.9 m -57.04 -32.17 65.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.122 1.961 . . . . 0.0 113.665 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 47.31 62.5 2.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.589 1.956 . . . . 0.0 113.55 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.07 -20.83 13.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 pt -74.53 170.79 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.177 1.791 . . . . 0.0 112.611 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.9 pt -59.73 145.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.966 0.906 . . . . 0.0 111.781 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.69 75.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.6 98.75 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 121.552 -0.718 . . . . 0.0 113.029 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.5 tp -77.33 -34.19 55.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.616 1.166 . . . . 0.0 112.24 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.0 tp10 -56.74 -38.67 72.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.452 1.101 . . . . 0.0 112.668 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -78.82 -14.27 59.35 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.26 9.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.171 . . . . 0.0 112.501 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -59.3 -27.53 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.87 -20.41 66.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.63 -13.27 16.02 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.74 . . . . 0.0 113.121 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.44 132.58 50.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.598 1.159 . . . . 0.0 112.76 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -91.85 130.47 37.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 111.195 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.76 126.74 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.8 1.24 . . . . 0.0 111.674 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.64 9.03 87.26 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.13 119.03 29.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.383 1.591 . . . . 0.0 111.773 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -62.72 139.64 58.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.572 0.749 . . . . 0.0 111.465 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -141.93 160.49 40.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.457 1.103 . . . . 0.0 112.282 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.1 107.91 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 109.951 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -110.69 116.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.83 1.252 . . . . 0.0 110.097 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.8 110.77 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.449 -0.782 . . . . 0.0 109.376 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.9 139.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.089 1.756 . . . . 0.0 109.47 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.63 151.24 88.83 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.859 0.864 . . . . 0.0 112.244 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.73 -39.22 75.23 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.357 2.704 . . . . 0.0 112.472 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.64 -9.16 40.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.425 1.89 . . . . 0.0 114.205 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 CA--C 1.546 0.806 0 C-N-CA 125.828 1.651 . . . . 0.0 113.191 -179.09 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 CA--C 1.549 0.923 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.3 mt -145.7 137.91 25.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.63 1.972 . . . . 0.0 110.991 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -144.2 127.99 17.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.15 0.58 . . . . 0.0 111.872 169.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -76.37 98.34 4.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.74 1.216 . . . . 0.0 110.425 167.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.31 156.6 38.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.424 1.889 . . . . 0.0 110.849 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 152.12 59.88 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.177 1.918 . . . . 0.0 111.771 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.4 -23.39 65.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.972 . . . . 0.0 113.15 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -51.01 -36.42 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.376 1.87 . . . . 0.0 113.789 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -66.49 -19.47 65.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.5 1.12 . . . . 0.0 113.564 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -133.28 17.84 4.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.307 1.843 . . . . 0.0 113.008 -172.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -57.43 -24.9 58.38 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.889 1.676 . . . . 0.0 114.438 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -113.57 17.43 20.94 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 126.24 1.876 . . . . 0.0 115.342 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.6 mt -123.49 123.55 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.316 1.558 . . . . 0.0 111.242 -170.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.74 77.34 2.06 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.055 1.742 . . . . 0.0 113.182 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.91 153.51 40.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.232 1.013 . . . . 0.0 112.759 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.99 137.29 18.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.105 1.362 . . . . 0.0 111.11 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -58.27 114.52 2.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.158 0.983 . . . . 0.0 110.93 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.54 20.94 11.05 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -108.93 161.3 15.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.277 1.538 . . . . 0.0 112.149 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.6 t -88.97 116.14 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.399 1.08 . . . . 0.0 110.967 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.0 160.92 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.896 1.678 . . . . 0.0 110.936 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -115.75 140.73 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.85 1.26 . . . . 0.0 111.823 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.75 93.34 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.575 1.559 . . . . 0.0 112.164 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -65.95 147.1 53.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.793 -0.828 . . . . 0.0 111.506 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -130.69 157.48 42.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.819 1.648 . . . . 0.0 112.302 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.35 -15.83 61.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.402 1.881 . . . . 0.0 113.689 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.38 14.75 0.41 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.162 1.785 . . . . 0.0 113.825 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 54.62 46.91 23.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.164 2.186 . . . . 0.0 112.556 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -140.94 173.21 11.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.987 1.715 . . . . 0.0 112.192 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 m -145.03 112.98 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 111.273 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -76.57 165.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.15 0.58 . . . . 0.0 111.482 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -123.18 139.96 53.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.274 1.43 . . . . 0.0 110.396 170.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.55 173.57 15.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.313 1.045 . . . . 0.0 113.144 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.81 135.97 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.076 1.351 . . . . 0.0 110.166 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 mm -67.06 117.96 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.974 1.309 . . . . 0.0 109.585 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -101.01 -36.11 9.13 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.699 1.2 . . . . 0.0 112.222 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.14 163.61 39.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.756 1.622 . . . . 0.0 111.8 166.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.08 158.46 43.59 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.329 1.052 . . . . 0.0 111.928 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 t -144.26 175.4 10.12 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.413 1.885 . . . . 0.0 111.202 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.61 69.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.144 1.377 . . . . 0.0 113.893 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -130.57 -9.69 4.06 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.184 1.394 . . . . 0.0 114.748 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -143.92 164.71 29.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.134 1.774 . . . . 0.0 111.821 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.4 t -140.24 141.96 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.657 1.583 . . . . 0.0 109.893 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.7 mtp -113.43 114.12 26.14 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.232 1.413 . . . . 0.0 111.104 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 t -121.46 153.05 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 109.964 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.73 107.25 0.67 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.824 1.249 . . . . 0.0 112.071 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 . . . . . 0 N--CA 1.47 0.539 0 C-N-CA 124.863 1.265 . . . . 0.0 111.323 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.98 141.95 45.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.26 1.424 . . . . 0.0 112.628 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.14 146.57 49.89 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.182 1.393 . . . . 0.0 111.886 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.01 103.68 16.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.512 1.525 . . . . 0.0 111.506 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.42 98.41 9.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.998 0.904 . . . . 0.0 109.851 167.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.51 123.5 32.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.461 1.504 . . . . 0.0 109.483 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.45 171.81 14.92 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -152.11 150.32 29.77 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.015 1.726 . . . . 0.0 111.576 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.9 112.54 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.357 1.463 . . . . 0.0 108.506 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.34 -33.58 76.06 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.133 0.973 . . . . 0.0 111.514 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 132.38 -168.79 22.51 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 126.358 1.933 . . . . 0.0 111.09 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -136.05 153.62 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.678 1.191 . . . . 0.0 111.982 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 125.096 1.358 . . . . 0.0 110.682 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.623 0 CA-C-O 120.297 0.094 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.24 118.99 38.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.122 0.969 . . . . 0.0 110.902 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.7 118.92 23.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.881 1.672 . . . . 0.0 110.902 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.44 131.3 37.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.072 0.949 . . . . 0.0 111.32 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -130.52 167.91 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.695 1.198 . . . . 0.0 112.303 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.35 133.5 33.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.43 1.892 . . . . 0.0 110.52 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -139.16 150.3 45.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 123.002 1.382 . . . . 0.0 113.934 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.32 136.96 26.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.927 2.091 . . . . 0.0 109.708 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.24 105.15 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.09 1.356 . . . . 0.0 110.397 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -113.23 147.47 37.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.342 1.857 . . . . 0.0 110.533 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.84 140.57 53.26 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.65 -0.656 . . . . 0.0 111.293 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.71 -34.87 78.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.864 -1.148 . . . . 0.0 113.846 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.85 55.72 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.992 1.282 . . . . 0.0 115.426 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.4 t -145.91 144.53 30.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.783 1.233 . . . . 0.0 111.283 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -73.38 -11.83 60.61 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.69 159.46 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.139 0.976 . . . . 0.0 111.991 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.1 p -108.79 145.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.185 1.394 . . . . 0.0 110.898 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.88 -44.11 7.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.325 1.05 . . . . 0.0 111.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.5 157.57 38.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 112.423 170.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -161.21 128.21 4.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.882 1.273 . . . . 0.0 111.341 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -16.44 40.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 167.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.07 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.897 1.279 . . . . 0.0 111.827 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -70.98 -9.64 58.34 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.81 1.244 . . . . 0.0 113.606 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -104.27 -75.8 0.61 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.409 1.883 . . . . 0.0 110.909 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -168.1 148.98 4.63 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.637 2.375 . . . . 0.0 110.579 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.47 149.28 74.52 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.892 2.394 . . . . 0.0 112.9 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.9 tp -80.52 123.97 28.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.162 0.985 . . . . 0.0 109.806 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.99 131.69 56.02 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.696 1.198 . . . . 0.0 112.253 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.93 165.12 35.58 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.435 1.094 . . . . 0.0 112.657 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -96.42 143.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.125 1.37 . . . . 0.0 109.12 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.05 113.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.643 1.577 . . . . 0.0 111.608 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 62.91 0.63 Allowed Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.788 1.661 . . . . 0.0 113.114 -174.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.9 m -134.27 -49.61 0.79 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.691 1.596 . . . . 0.0 111.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.5 m120 58.89 29.37 18.77 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.232 1.813 . . . . 0.0 115.287 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -70.79 -19.88 62.65 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.25 166.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 112.751 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 pt -62.48 157.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.075 0.95 . . . . 0.0 113.389 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.22 80.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.655 1.182 . . . . 0.0 113.716 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.33 -46.59 93.57 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.033 0.825 . . . . 0.0 112.841 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -69.04 -34.91 75.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 111.772 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -56.02 -35.38 66.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.105 1.362 . . . . 0.0 113.449 171.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -80.37 3.24 21.84 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.1 -33.69 3.87 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.348 1.459 . . . . 0.0 113.392 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -58.47 -28.63 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.872 -1.143 . . . . 0.0 113.929 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -71.11 -23.06 62.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -94.84 -27.58 15.67 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.344 1.858 . . . . 0.0 112.478 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.25 118.9 4.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.717 2.007 . . . . 0.0 113.474 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -80.11 145.62 32.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 111.483 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.24 132.4 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.879 0.872 . . . . 0.0 111.195 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.53 6.49 86.74 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.194 1.237 . . . . 0.0 116.194 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -118.62 114.26 22.5 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.881 1.672 . . . . 0.0 111.403 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -62.4 140.67 58.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.076 0.551 . . . . 0.0 111.305 169.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -142.42 162.11 36.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.49 1.116 . . . . 0.0 112.447 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -130.46 112.78 13.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.778 1.631 . . . . 0.0 109.844 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.92 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.341 1.456 . . . . 0.0 109.82 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 t -73.9 120.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.055 0.942 . . . . 0.0 110.046 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.3 mm -105.15 142.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.401 1.481 . . . . 0.0 110.061 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.87 156.94 85.93 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.693 1.197 . . . . 0.0 112.789 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.27 -11.92 27.77 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.461 2.774 . . . . 0.0 114.97 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -106.58 -9.35 16.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.094 1.358 . . . . 0.0 113.809 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 . . . . . 0 N--CA 1.479 0.986 0 C-N-CA 124.983 1.313 . . . . 0.0 113.081 -176.633 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 p90 . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.06 107.08 9.16 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.849 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -85.12 131.99 34.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.838 1.255 . . . . 0.0 111.014 171.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -84.76 100.51 11.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.504 1.522 . . . . 0.0 110.238 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.1 137.3 20.83 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 124.932 1.293 . . . . 0.0 109.569 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.79 157.73 51.4 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 0.0 112.638 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.69 72.99 2.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.338 1.055 . . . . 0.0 111.454 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.42 -50.14 0.92 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.434 1.894 . . . . 0.0 111.452 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -65.26 -13.7 58.99 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.75 19.7 5.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.405 1.482 . . . . 0.0 114.461 -166.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.82 -25.48 63.78 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.86 9.04 37.02 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.126 1.346 . . . . 0.0 115.613 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.67 129.67 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.156 1.783 . . . . 0.0 111.04 -173.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -77.03 58.03 1.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.573 1.949 . . . . 0.0 112.556 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -61.29 157.21 16.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.991 1.317 . . . . 0.0 113.098 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -153.25 155.28 36.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.761 0.824 . . . . 0.0 112.524 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -60.05 113.56 2.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.937 1.295 . . . . 0.0 111.037 174.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.74 4.8 24.47 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.921 1.528 . . . . 0.0 116.921 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.4 ptm -101.63 154.26 19.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.97 1.885 . . . . 0.0 113.034 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 p -72.17 94.86 1.59 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.15 1.78 . . . . 0.0 111.657 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -82.2 156.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.443 1.497 . . . . 0.0 111.618 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.86 143.38 49.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.585 1.554 . . . . 0.0 110.694 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.05 99.14 0.36 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.772 1.177 . . . . 0.0 112.17 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -67.52 143.54 56.1 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.114 -0.639 . . . . 0.0 111.195 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -123.1 154.35 38.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.867 1.667 . . . . 0.0 111.457 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.44 -20.83 65.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.552 1.541 . . . . 0.0 113.164 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.67 19.88 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.097 2.159 . . . . 0.0 114.22 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.7 m120 52.52 47.97 23.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.391 2.276 . . . . 0.0 113.04 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -140.6 172.28 12.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.959 1.703 . . . . 0.0 112.108 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.4 m -143.48 118.47 10.02 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.94 1.296 . . . . 0.0 111.012 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.82 162.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.727 0.811 . . . . 0.0 111.259 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -134.06 128.36 34.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.572 1.549 . . . . 0.0 111.147 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.28 -175.65 5.54 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.34 1.456 . . . . 0.0 112.564 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.15 136.84 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 110.034 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.1 mt -68.11 133.08 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.396 1.478 . . . . 0.0 111.005 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -108.22 -37.99 5.87 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.146 1.379 . . . . 0.0 112.886 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.55 157.89 42.83 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.399 1.08 . . . . 0.0 111.482 166.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.24 143.44 28.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.241 -0.912 . . . . 0.0 113.204 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 70.3 m -141.04 168.69 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.876 2.07 . . . . 0.0 110.584 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.15 -25.87 67.17 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 121.203 -0.935 . . . . 0.0 113.211 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -81.18 -60.18 2.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.952 2.101 . . . . 0.0 112.988 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -140.65 168.88 18.75 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.288 2.235 . . . . 0.0 111.781 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.69 132.96 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.54 1.536 . . . . 0.0 111.553 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.7 mtp -101.82 115.25 30.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.185 1.794 . . . . 0.0 110.803 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.57 136.41 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.738 1.615 . . . . 0.0 110.872 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.94 111.81 5.91 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.344 0.658 . . . . 0.0 111.484 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 126.778 2.031 . . . . 0.0 111.467 -174.61 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.2 p -65.27 146.64 54.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.124 1.369 . . . . 0.0 113.039 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.17 131.57 44.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.687 -170.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.42 98.97 12.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.149 0.98 . . . . 0.0 111.652 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.23 103.14 10.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.758 0.79 . . . . 0.0 110.328 166.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -94.68 124.18 38.56 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.445 1.898 . . . . 0.0 109.336 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -148.82 170.65 17.78 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -154.33 147.43 24.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.98 1.712 . . . . 0.0 112.14 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 9.8 t -83.79 108.09 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.819 1.248 . . . . 0.0 108.727 163.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.1 mt -65.67 -39.48 91.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.888 -0.508 . . . . 0.0 111.492 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.76 -179.22 18.45 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.579 1.561 . . . . 0.0 113.496 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -96.57 147.68 23.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.968 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 . . . . . 0 N--CA 1.477 0.925 0 C-N-CA 124.979 1.312 . . . . 0.0 112.438 172.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.177 0.037 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 103.94 11.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.917 0.887 . . . . 0.0 110.893 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.53 120.81 18.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.539 1.536 . . . . 0.0 110.573 168.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.18 124.2 47.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.2 pt -131.35 163.62 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.661 1.184 . . . . 0.0 112.289 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -136.79 138.66 41.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.601 1.96 . . . . 0.0 109.831 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.77 151.93 44.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.066 1.346 . . . . 0.0 114.272 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -146.87 120.65 9.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.615 2.366 . . . . 0.0 110.315 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -99.94 110.28 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.858 1.663 . . . . 0.0 110.429 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 ttm105 -113.78 144.84 42.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.297 1.839 . . . . 0.0 110.694 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.79 117.33 11.25 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.84 105.33 0.55 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.571 0.748 . . . . 0.0 110.667 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.01 23.64 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 126.173 1.844 . . . . 0.0 115.169 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -137.05 165.84 25.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.332 1.566 . . . . 0.0 113.271 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.1 p -89.5 -13.47 37.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.737 2.015 . . . . 0.0 114.755 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.23 177.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 113.661 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.85 145.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.209 1.404 . . . . 0.0 110.121 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mp -106.57 -53.45 2.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.649 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.29 150.22 35.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.406 1.483 . . . . 0.0 110.381 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.6 p -163.01 169.61 19.31 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.158 -0.964 . . . . 0.0 111.694 173.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -122.72 -12.74 8.04 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -36.8 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 124.281 1.032 . . . . 0.0 112.217 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -73.1 -5.7 40.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.591 1.156 . . . . 0.0 113.601 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -117.59 -87.97 0.61 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.902 2.081 . . . . 0.0 110.367 -171.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -153.38 154.09 30.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 127.419 2.288 . . . . 0.0 111.272 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.35 150.69 86.89 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.596 2.864 . . . . 0.0 113.269 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -87.6 123.7 32.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.432 1.493 . . . . 0.0 109.774 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.15 134.58 50.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 111.533 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -150.12 172.58 15.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.499 1.119 . . . . 0.0 112.918 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.21 151.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.339 1.455 . . . . 0.0 109.195 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.85 109.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.509 1.124 . . . . 0.0 111.009 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.08 27.06 6.38 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.526 1.37 . . . . 0.0 116.526 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.3 m -97.06 -24.1 15.94 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 119.39 1.595 . . . . 0.0 114.355 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.3 t30 45.73 43.13 9.37 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.915 2.086 . . . . 0.0 115.092 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -71.77 -31.14 66.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.4 1.88 . . . . 0.0 114.155 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -72.41 166.87 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.866 1.267 . . . . 0.0 111.517 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 pt -63.15 146.36 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 0.0 111.413 172.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.9 75.76 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.07 -31.06 67.94 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.005 0.812 . . . . 0.0 113.913 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.25 -29.66 24.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.836 1.255 . . . . 0.0 112.307 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.09 -38.23 82.32 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.01 -1.056 . . . . 0.0 112.021 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -68.03 0.24 3.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.835 1.254 . . . . 0.0 114.312 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.39 -41.82 3.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.617 1.567 . . . . 0.0 113.167 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.71 -29.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.64 -10.39 55.85 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -118.96 -17.95 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.925 1.69 . . . . 0.0 114.549 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.95 141.62 49.43 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.309 0.959 . . . . 0.0 112.345 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -90.28 158.22 17.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.719 1.207 . . . . 0.0 111.779 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.03 129.75 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.179 0.992 . . . . 0.0 111.307 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.68 3.88 74.21 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.831 1.205 . . . . 0.0 115.692 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.63 111.95 24.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.181 1.491 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -55.93 139.66 45.48 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.766 0.826 . . . . 0.0 111.723 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -137.11 149.15 47.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.57 1.548 . . . . 0.0 110.275 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -134.71 104.74 6.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.449 1.099 . . . . 0.0 110.348 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.19 118.66 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.083 1.353 . . . . 0.0 110.359 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.0 t -75.83 121.32 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 109.59 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.55 144.46 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.953 1.701 . . . . 0.0 109.822 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.02 92.83 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.814 1.246 . . . . 0.0 112.55 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.81 -33.9 41.92 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.538 2.159 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -31.64 72.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.923 0.889 . . . . 0.0 113.265 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 125.322 1.449 . . . . 0.0 113.177 177.559 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.66 147.23 30.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.149 2.58 . . . . 0.0 109.563 166.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -145.53 117.45 8.24 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.172 1.389 . . . . 0.0 110.416 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.11 118.45 15.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.955 0.902 . . . . 0.0 111.133 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.56 158.73 69.02 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 127.243 2.217 . . . . 0.0 110.978 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 149.3 64.43 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.154 1.902 . . . . 0.0 110.958 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -62.26 -20.31 64.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.533 0.733 . . . . 0.0 112.958 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -52.07 -32.19 33.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.997 1.719 . . . . 0.0 113.72 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -64.76 -18.16 64.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.517 1.127 . . . . 0.0 113.344 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.88 18.32 6.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.045 2.138 . . . . 0.0 112.915 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -53.34 108.61 0.35 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.61 1.564 . . . . 0.0 112.164 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.66 -5.11 34.82 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.826 1.679 . . . . 0.0 115.434 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mt -101.5 130.98 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.44 1.496 . . . . 0.0 110.375 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.76 89.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.489 1.116 . . . . 0.0 111.468 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.5 158.28 36.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.279 1.032 . . . . 0.0 111.777 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -155.33 145.81 22.05 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.732 1.213 . . . . 0.0 111.288 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -73.21 83.02 1.35 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.165 0.986 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.77 46.25 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.362 1.458 . . . . 0.0 113.87 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ppp? -129.01 148.7 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.199 1.4 . . . . 0.0 111.109 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 p -76.68 108.35 9.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.872 1.669 . . . . 0.0 111.479 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.1 156.79 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.668 1.587 . . . . 0.0 110.679 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -121.24 154.63 36.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.662 1.185 . . . . 0.0 111.068 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.68 106.23 0.41 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.344 0.973 . . . . 0.0 113.217 -173.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -74.55 114.05 12.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.462 1.105 . . . . 0.0 111.932 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -84.95 159.2 20.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.166 1.386 . . . . 0.0 112.122 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.46 -18.46 63.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.225 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.19 10.71 0.28 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 113.897 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 55.41 46.35 23.47 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.155 2.182 . . . . 0.0 111.956 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -141.22 171.13 14.48 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.795 2.038 . . . . 0.0 111.167 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 m -140.74 108.06 5.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.497 1.119 . . . . 0.0 110.697 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.42 165.88 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.832 -0.543 . . . . 0.0 111.29 176.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -129.16 131.11 47.11 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.971 1.308 . . . . 0.0 110.592 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.36 177.91 9.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.803 1.241 . . . . 0.0 113.59 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.89 135.59 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.628 1.571 . . . . 0.0 109.903 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.93 120.94 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.313 1.045 . . . . 0.0 110.22 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -87.69 -38.07 16.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.878 1.271 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.54 152.74 37.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.932 1.293 . . . . 0.0 111.63 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -146.78 142.56 27.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.094 0.957 . . . . 0.0 112.601 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.0 t -153.51 169.42 23.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.137 2.175 . . . . 0.0 110.125 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.71 -28.29 68.32 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.123 0.969 . . . . 0.0 113.408 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.6 p -79.56 -60.66 2.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.135 1.774 . . . . 0.0 111.852 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -134.16 156.94 47.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.371 1.868 . . . . 0.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.6 142.0 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.622 1.969 . . . . 0.0 108.566 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.9 mtp -121.94 98.87 6.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.997 1.319 . . . . 0.0 110.161 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.62 148.0 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.642 1.177 . . . . 0.0 109.849 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -62.99 110.4 1.78 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.36 0.664 . . . . 0.0 111.669 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 . . . . . 0 N--CA 1.465 0.285 0 C-N-CA 125.181 1.393 . . . . 0.0 109.422 171.222 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 121.162 0.506 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.01 146.6 37.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.39 1.876 . . . . 0.0 113.13 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.9 mt -128.36 140.32 51.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.685 1.594 . . . . 0.0 110.941 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.88 94.31 5.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.023 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.48 92.68 3.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.503 1.121 . . . . 0.0 109.697 167.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 -75.48 139.46 42.24 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.86 171.06 17.82 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -150.23 146.2 26.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.028 1.331 . . . . 0.0 111.36 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.21 104.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.536 1.134 . . . . 0.0 109.119 167.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.71 -24.52 58.77 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 112.338 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.29 -167.43 25.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.047 1.308 . . . . 0.0 113.907 171.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.43 145.96 49.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 110.626 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 . . . . . 0 N--CA 1.478 0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 113.132 175.825 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 120.888 0.375 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.3 104.89 7.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.253 1.021 . . . . 0.0 109.63 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.08 141.21 37.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.657 1.183 . . . . 0.0 110.671 169.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.25 133.49 47.54 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.391 1.476 . . . . 0.0 110.599 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 pt -134.35 163.98 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.869 1.268 . . . . 0.0 111.544 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -137.84 135.81 36.57 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.168 1.387 . . . . 0.0 109.699 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -134.09 158.99 42.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 123.067 1.413 . . . . 0.0 114.368 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -141.04 120.83 13.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.961 2.904 . . . . 0.0 108.259 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -100.71 105.69 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.446 1.117 . . . . 0.0 109.93 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 ttp85 -118.57 153.16 34.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.202 2.201 . . . . 0.0 109.717 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.5 146.33 50.32 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.316 -0.865 . . . . 0.0 110.836 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -70.52 -33.11 70.81 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.881 -1.137 . . . . 0.0 112.434 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.45 -35.67 7.84 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.352 0.977 . . . . 0.0 115.017 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -116.92 151.07 37.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.319 1.448 . . . . 0.0 112.604 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 t -73.1 -7.52 51.71 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.95 151.11 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 120.892 -1.13 . . . . 0.0 112.372 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.43 126.97 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.226 1.41 . . . . 0.0 109.843 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -84.58 -42.89 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.777 0.831 . . . . 0.0 110.818 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -158.49 163.4 37.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.3 1.84 . . . . 0.0 110.767 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -166.65 150.57 7.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.071 1.348 . . . . 0.0 112.131 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -124.55 4.26 8.29 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -47.98 -64.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.234 1.414 . . . . 0.0 112.079 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 t -79.9 -23.67 41.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.256 1.023 . . . . 0.0 113.368 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -69.64 -71.61 0.22 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.884 1.674 . . . . 0.0 112.056 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -165.63 140.0 3.88 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.099 1.759 . . . . 0.0 110.876 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.41 152.48 75.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.666 2.244 . . . . 0.0 112.698 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.8 tp -83.07 97.68 8.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.222 1.809 . . . . 0.0 110.294 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -74.08 129.85 38.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.368 1.467 . . . . 0.0 111.923 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -149.43 176.49 10.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.967 1.307 . . . . 0.0 112.846 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.0 mm -112.43 134.87 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.469 1.508 . . . . 0.0 109.385 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.0 mm -50.09 117.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.332 1.453 . . . . 0.0 110.956 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.26 71.6 1.12 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.014 1.293 . . . . 0.0 112.044 -169.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -134.6 -43.9 0.75 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.049 1.34 . . . . 0.0 113.344 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 54.09 21.14 2.82 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 126.721 2.008 . . . . 0.0 115.097 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 pt -71.66 165.75 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 112.469 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.29 142.65 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.729 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.8 82.4 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.4 -28.72 69.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.48 -0.763 . . . . 0.0 113.992 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 tp -87.15 -35.39 18.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.044 1.338 . . . . 0.0 111.898 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.36 -46.42 69.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.718 1.207 . . . . 0.0 111.415 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -77.91 13.63 1.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.011 1.324 . . . . 0.0 114.143 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.59 -39.92 2.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.714 1.606 . . . . 0.0 113.616 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.22 -29.1 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -67.26 -14.32 62.81 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -118.69 -9.5 10.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.416 1.486 . . . . 0.0 114.112 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.85 8.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.212 1.405 . . . . 0.0 111.61 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -62.47 145.73 53.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.705 0.802 . . . . 0.0 112.117 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.75 133.41 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.664 0.786 . . . . 0.0 110.691 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 10.39 56.55 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 115.709 1.044 . . . . 0.0 115.709 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.91 128.13 54.13 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.448 1.499 . . . . 0.0 111.281 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -57.93 140.91 51.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.021 0.928 . . . . 0.0 112.243 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -134.12 141.51 47.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.795 2.038 . . . . 0.0 109.864 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.17 106.75 6.9 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.55 113.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.757 1.223 . . . . 0.0 111.711 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.96 123.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 109.554 173.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.4 mt -128.73 135.71 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.92 1.288 . . . . 0.0 109.489 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.6 161.46 59.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 125.703 1.601 . . . . 0.0 112.623 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 42.41 0.76 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 125.18 3.92 . . . . 0.0 113.872 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.42 -35.77 1.94 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.877 2.071 . . . . 0.0 113.057 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 . . . . . 0 N--CA 1.477 0.89 0 C-N-CA 124.317 1.047 . . . . 0.0 113.617 174.658 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 . . . . . 0 CA--C 1.541 0.631 0 CA-C-O 121.345 0.593 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.53 166.75 24.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.674 1.589 . . . . 0.0 111.903 172.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -144.86 131.14 19.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.502 1.121 . . . . 0.0 110.983 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -70.04 128.57 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.794 0.838 . . . . 0.0 110.923 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.05 137.73 18.55 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.299 1.84 . . . . 0.0 109.903 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.73 172.66 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.017 2.478 . . . . 0.0 113.122 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -69.5 70.26 0.28 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.471 1.908 . . . . 0.0 111.901 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -129.19 -64.39 0.91 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.591 1.956 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -64.12 -16.39 61.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.906 1.283 . . . . 0.0 113.653 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.407 ' CG ' HD11 ' A' ' 94' ' ' LEU . 42.5 m-85 -131.69 13.88 4.9 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.968 1.707 . . . . 0.0 113.422 -172.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.61 -28.59 65.76 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.699 -1.251 . . . . 0.0 113.435 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.89 12.55 56.21 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.844 1.688 . . . . 0.0 115.047 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.75 115.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.509 1.524 . . . . 0.0 110.257 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.3 108.48 4.22 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.297 -0.877 . . . . 0.0 111.629 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.407 HD11 ' CG ' ' A' ' 89' ' ' PHE . 80.0 mt -101.63 156.99 17.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.368 1.467 . . . . 0.0 111.814 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.17 145.23 17.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.019 1.728 . . . . 0.0 109.863 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -51.87 128.35 23.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.772 0.829 . . . . 0.0 111.943 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 56.12 3.47 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.27 0.938 . . . . 0.0 114.327 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.1 ptp -132.27 172.45 12.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.116 1.766 . . . . 0.0 110.931 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 t -101.94 103.91 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.022 0.929 . . . . 0.0 110.452 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.28 154.44 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.153 1.381 . . . . 0.0 110.331 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -120.27 153.58 36.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.49 1.116 . . . . 0.0 111.944 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 97.52 0.23 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.73 1.157 . . . . 0.0 112.742 -175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.71 142.67 58.35 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.874 -0.78 . . . . 0.0 111.38 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.0 t -126.09 157.12 38.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.909 1.683 . . . . 0.0 111.607 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.95 -15.15 61.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.071 1.748 . . . . 0.0 113.509 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -76.41 15.63 0.58 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.609 1.963 . . . . 0.0 113.721 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.6 m120 56.73 39.95 29.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.878 2.071 . . . . 0.0 113.136 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -133.67 172.56 12.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.686 1.995 . . . . 0.0 111.409 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.6 m -142.44 114.73 8.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.351 1.46 . . . . 0.0 110.427 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -72.57 163.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.015 0.526 . . . . 0.0 111.166 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -133.49 132.95 41.62 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.046 1.338 . . . . 0.0 110.901 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.96 175.33 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.613 1.565 . . . . 0.0 112.814 -166.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.438 ' H ' ' HB3' ' A' ' 125' ' ' ASP . 4.8 mp -121.46 142.76 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.705 1.602 . . . . 0.0 110.625 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.76 113.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.575 1.15 . . . . 0.0 109.856 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.96 -30.41 15.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.915 1.286 . . . . 0.0 113.429 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -155.38 155.55 33.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.947 1.699 . . . . 0.0 110.581 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -147.26 147.72 30.71 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.21 0.914 . . . . 0.0 113.253 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.0 t -153.17 171.91 17.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.737 2.015 . . . . 0.0 110.975 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.31 -21.98 61.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.63 1.172 . . . . 0.0 113.558 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.4 p -82.55 -63.6 1.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 111.724 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -135.22 165.17 26.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.325 2.25 . . . . 0.0 111.339 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.48 154.13 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.179 1.792 . . . . 0.0 109.798 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 80.2 mtp -125.77 103.98 8.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.159 1.384 . . . . 0.0 110.421 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -99.54 141.62 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.134 1.373 . . . . 0.0 109.627 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 113' ' ' ILE . 13.9 t70 -62.08 140.04 58.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.946 1.298 . . . . 0.0 111.436 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 124.686 1.194 . . . . 0.0 111.946 175.536 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -63.34 139.47 58.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.489 1.516 . . . . 0.0 112.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.4 148.04 46.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.279 1.432 . . . . 0.0 111.15 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -98.49 102.6 14.39 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.991 2.117 . . . . 0.0 110.262 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -80.12 95.29 6.18 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.607 0.717 . . . . 0.0 109.734 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -86.55 112.7 21.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.689 1.596 . . . . 0.0 108.776 171.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -136.12 170.31 16.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.833 0.853 . . . . 0.0 112.865 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -147.36 137.61 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.639 1.176 . . . . 0.0 111.005 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.7 t -87.45 94.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.03 -28.63 69.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.779 1.231 . . . . 0.0 112.686 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.68 177.87 15.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.968 1.746 . . . . 0.0 112.582 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -112.29 156.06 23.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.779 0.832 . . . . 0.0 111.688 169.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 . . . . . 0 N--CA 1.469 0.505 0 C-N-CA 125.637 1.575 . . . . 0.0 111.332 178.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 111.152 0.056 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.94 115.03 22.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.824 0.85 . . . . 0.0 110.127 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.11 114.68 11.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.999 1.32 . . . . 0.0 109.908 162.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.48 119.84 33.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.798 1.239 . . . . 0.0 109.111 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.94 163.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.207 1.003 . . . . 0.0 111.859 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -143.1 140.22 30.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.565 1.546 . . . . 0.0 110.635 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -136.74 158.08 45.27 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.385 1.474 . . . . 0.0 114.055 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -144.16 107.92 4.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.643 1.977 . . . . 0.0 110.614 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.68 117.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 0.0 111.076 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -131.31 156.48 45.4 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.899 1.68 . . . . 0.0 111.104 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.3 146.46 40.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.297 -0.877 . . . . 0.0 111.055 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.16 133.51 48.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.075 0.95 . . . . 0.0 110.927 169.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.49 -57.13 3.76 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.991 1.281 . . . . 0.0 114.177 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -62.87 147.55 49.87 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.497 1.119 . . . . 0.0 112.598 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.5 m -83.44 -7.74 59.5 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.25 161.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.0 0.818 . . . . 0.0 111.876 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.71 124.75 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.351 1.46 . . . . 0.0 109.504 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 mt -71.7 -53.57 13.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.012 0.525 . . . . 0.0 112.016 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -157.88 162.09 38.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.761 1.224 . . . . 0.0 111.686 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 p -154.63 130.25 9.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.945 1.298 . . . . 0.0 112.466 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.64 -2.02 19.06 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.7 mm -51.67 -52.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.987 1.715 . . . . 0.0 111.884 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 m -82.6 -6.27 59.26 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 mmpp? -92.17 -172.07 3.02 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.56 1.944 . . . . 0.0 110.657 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.5 137.2 97.06 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 121.469 -0.77 . . . . 0.0 110.799 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.81 163.52 35.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.221 2.614 . . . . 0.0 113.204 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -92.91 110.24 21.7 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.76 1.224 . . . . 0.0 110.754 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.85 131.16 35.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.766 1.626 . . . . 0.0 111.499 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -143.06 157.04 44.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.256 1.022 . . . . 0.0 111.722 164.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.59 148.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.024 -1.047 . . . . 0.0 109.711 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.0 mm -48.19 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.316 1.446 . . . . 0.0 111.335 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.03 11.48 49.33 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -69.44 -35.0 75.25 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.926 1.863 . . . . 0.0 113.557 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.3 m120 57.72 37.74 27.33 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.527 1.931 . . . . 0.0 115.281 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -79.25 -23.65 43.52 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -72.76 167.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.367 1.067 . . . . 0.0 112.84 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.3 pt -59.11 136.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.95 0.9 . . . . 0.0 111.202 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.24 70.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.287 -0.883 . . . . 0.0 112.606 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.94 -13.97 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.111 173.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.94 -36.68 6.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.349 1.86 . . . . 0.0 111.595 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.28 -32.79 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -4.01 0.86 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 174.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.79 -29.9 4.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.387 1.875 . . . . 0.0 113.965 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.41 -24.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.849 1.204 . . . . 0.0 113.373 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -66.4 -13.85 61.29 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.34 -21.24 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.755 1.622 . . . . 0.0 113.859 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.29 111.58 2.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.662 1.185 . . . . 0.0 112.15 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.67 159.69 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.116 0.96 . . . . 0.0 113.2 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -56.64 131.99 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.194 1.398 . . . . 0.0 111.617 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.93 8.53 68.95 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.967 1.27 . . . . 0.0 115.064 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.53 112.7 24.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.032 1.333 . . . . 0.0 111.471 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -59.0 134.52 57.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.428 0.691 . . . . 0.0 111.363 171.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.61 112.97 12.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.121 1.768 . . . . 0.0 110.032 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.94 92.73 4.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.927 1.291 . . . . 0.0 110.508 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.06 165.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.592 0.757 . . . . 0.0 111.485 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.86 130.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.331 1.452 . . . . 0.0 108.461 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.4 mt -127.78 130.42 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 126.615 1.966 . . . . 0.0 109.135 -165.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.32 147.25 82.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.608 0.763 . . . . 0.0 111.264 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.22 -43.16 9.05 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -166.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.28 -21.86 66.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.822 1.649 . . . . 0.0 114.068 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 CA--C 1.545 0.769 0 C-N-CA 124.698 1.199 . . . . 0.0 112.508 175.572 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.34 143.96 50.72 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.069 -1.02 . . . . 0.0 110.635 174.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -126.39 124.65 40.68 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.666 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -83.89 78.34 9.74 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.366 1.079 . . . . 0.0 111.186 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.54 136.49 59.73 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.097 1.759 . . . . 0.0 109.903 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 159.44 52.91 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.71 2.273 . . . . 0.0 112.701 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -17.8 47.7 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.25 -31.26 63.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.902 1.681 . . . . 0.0 113.575 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -81.09 -6.16 58.49 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.155 0.982 . . . . 0.0 113.636 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -133.41 45.74 2.66 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.009 2.124 . . . . 0.0 110.996 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.66 111.82 19.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.54 1.136 . . . . 0.0 111.6 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.85 55.46 4.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.457 1.027 . . . . 0.0 114.319 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.428 HD13 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -137.46 -179.6 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.731 2.412 . . . . 0.0 111.786 -178.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -131.99 88.3 2.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.588 1.555 . . . . 0.0 110.601 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.428 ' HG ' HD13 ' A' ' 92' ' ' ILE . 26.0 mt -75.24 151.69 38.38 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.454 0.702 . . . . 0.0 111.398 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.84 135.09 19.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.217 1.007 . . . . 0.0 111.388 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.56 102.74 0.35 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.481 1.513 . . . . 0.0 110.563 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.97 21.15 5.75 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.994 1.283 . . . . 0.0 115.797 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -112.92 158.01 20.74 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.26 1.53 . . . . 0.0 112.555 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 p -82.46 97.8 8.58 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.113 1.365 . . . . 0.0 111.771 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 p -83.7 162.2 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.962 0.905 . . . . 0.0 111.015 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -123.32 152.89 40.98 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.276 1.431 . . . . 0.0 111.37 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.42 108.08 0.47 Allowed Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.369 0.985 . . . . 0.0 112.692 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -66.71 145.46 55.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.157 -0.614 . . . . 0.0 111.359 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -125.14 156.45 38.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.109 1.764 . . . . 0.0 111.533 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.16 -16.02 49.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.202 1.801 . . . . 0.0 114.294 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -74.68 12.82 0.73 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.428 1.891 . . . . 0.0 113.89 173.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 m120 54.27 48.66 20.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.942 2.097 . . . . 0.0 112.221 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -140.12 173.81 11.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.191 1.797 . . . . 0.0 111.792 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.4 m -145.67 110.96 5.32 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.05 1.34 . . . . 0.0 110.529 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.07 167.36 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.74 -0.6 . . . . 0.0 111.43 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -121.54 139.45 53.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.641 1.576 . . . . 0.0 110.725 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.8 173.96 14.65 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.465 1.106 . . . . 0.0 112.65 -168.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.85 128.53 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.0 mm -63.22 125.48 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.413 1.485 . . . . 0.0 110.279 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -111.84 -34.93 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.647 1.179 . . . . 0.0 113.041 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -157.62 167.5 29.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.491 1.116 . . . . 0.0 112.039 165.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.72 140.38 33.12 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.201 1.001 . . . . 0.0 112.168 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.9 m -111.76 174.07 6.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.152 2.181 . . . . 0.0 110.739 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.02 68.58 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 70.9 p -130.19 -7.57 4.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.788 1.635 . . . . 0.0 114.809 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -145.0 165.37 28.36 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.256 1.822 . . . . 0.0 111.278 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.69 144.42 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.706 1.603 . . . . 0.0 109.712 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 37.7 mmm -116.14 109.5 17.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 110.051 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.31 148.1 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.35 1.46 . . . . 0.0 109.933 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 120.52 13.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.241 1.417 . . . . 0.0 111.867 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 . . . . . 0 N--CA 1.472 0.672 0 C-N-CA 125.886 1.674 . . . . 0.0 111.873 -179.746 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.87 144.21 43.49 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.185 1.394 . . . . 0.0 111.3 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.2 143.95 46.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.065 1.346 . . . . 0.0 111.262 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.75 144.38 37.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.659 0.784 . . . . 0.0 111.357 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -128.79 92.13 3.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.074 1.75 . . . . 0.0 108.652 170.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -79.01 110.37 14.17 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.901 1.28 . . . . 0.0 108.802 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -131.88 166.97 20.42 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.349 0.66 . . . . 0.0 112.773 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -149.92 142.74 24.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.658 1.183 . . . . 0.0 111.673 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.14 106.69 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.997 1.319 . . . . 0.0 108.826 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.61 -38.19 77.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 111.63 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.55 158.88 7.73 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.296 1.427 . . . . 0.0 114.749 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -82.9 125.38 31.3 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.803 1.641 . . . . 0.0 111.506 -176.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 . . . . . 0 N--CA 1.476 0.84 0 C-N-CA 125.276 1.43 . . . . 0.0 111.225 179.888 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.19 108.44 6.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.093 0.557 . . . . 0.0 110.602 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.27 120.05 14.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.265 1.826 . . . . 0.0 110.456 165.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.28 113.86 27.69 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.244 2.218 . . . . 0.0 108.952 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 159.35 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 112.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -135.09 129.67 34.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.885 1.274 . . . . 0.0 110.38 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -135.68 155.0 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.607 1.163 . . . . 0.0 113.034 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -140.17 166.09 25.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.097 1.759 . . . . 0.0 111.424 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.37 101.2 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.84 1.256 . . . . 0.0 111.194 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -90.51 154.03 19.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 110.219 170.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -61.54 135.4 57.64 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.894 161.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -71.21 91.72 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.23 -0.919 . . . . 0.0 110.776 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.93 -68.91 0.54 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.185 1.85 . . . . 0.0 112.302 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -67.11 158.67 30.58 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.7 m -79.02 -13.09 59.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.46 151.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.074 0.852 . . . . 0.0 112.063 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.6 114.91 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.364 1.466 . . . . 0.0 109.182 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.0 mt -68.29 -48.57 64.62 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.619 1.168 . . . . 0.0 111.66 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -154.02 158.19 40.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.638 1.575 . . . . 0.0 110.362 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 p -151.2 125.68 9.49 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.472 1.109 . . . . 0.0 111.52 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -90.13 -30.89 17.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.29 0.636 . . . . 0.0 111.912 170.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.85 -50.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.613 1.565 . . . . 0.0 111.815 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -70.53 -5.54 29.72 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.21 1.404 . . . . 0.0 114.548 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -100.85 -83.61 0.44 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.772 1.629 . . . . 0.0 109.702 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.71 156.78 31.09 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 127.45 2.3 . . . . 0.0 110.451 171.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.82 141.35 78.01 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.679 2.253 . . . . 0.0 111.733 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.82 136.83 43.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.959 1.303 . . . . 0.0 109.971 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.64 119.71 34.52 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.05 1.34 . . . . 0.0 111.208 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -148.49 172.68 14.1 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -109.99 142.85 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.302 1.441 . . . . 0.0 109.839 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mm -47.32 115.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 111.864 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.52 64.76 1.49 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.171 1.367 . . . . 0.0 113.425 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -115.67 -22.37 9.21 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.044 1.338 . . . . 0.0 114.529 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m120 52.05 28.57 5.45 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 127.489 2.316 . . . . 0.0 116.107 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -86.75 -32.14 20.56 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 pt -81.26 170.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.975 1.31 . . . . 0.0 112.168 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.1 pt -59.57 140.01 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.189 0.996 . . . . 0.0 111.723 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.39 78.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -28.75 70.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.115 0.864 . . . . 0.0 114.295 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.19 -38.7 14.08 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.676 1.19 . . . . 0.0 111.588 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -53.42 -46.28 69.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.229 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.04 1.72 3.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.948 1.699 . . . . 0.0 114.667 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.55 -35.72 5.15 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.72 1.608 . . . . 0.0 113.498 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.74 -41.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.339 1.427 . . . . 0.0 112.253 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.29 -10.46 32.62 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -112.33 -9.43 13.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.205 1.802 . . . . 0.0 113.927 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.86 145.87 28.4 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.818 1.247 . . . . 0.0 111.842 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -98.37 157.01 16.46 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.925 1.29 . . . . 0.0 111.566 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 tt -57.39 129.36 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 111.829 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.14 78.88 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.035 1.302 . . . . 0.0 115.368 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.28 114.13 20.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.09 1.445 . . . . 0.0 111.65 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -56.0 142.06 37.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.536 1.135 . . . . 0.0 112.717 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -137.44 116.46 12.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.015 1.726 . . . . 0.0 110.728 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -101.4 107.05 18.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.012 1.325 . . . . 0.0 110.73 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -115.9 110.3 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.564 1.146 . . . . 0.0 110.907 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 t -73.89 130.19 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.73 141.64 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.157 1.383 . . . . 0.0 109.764 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.68 155.08 87.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.905 1.282 . . . . 0.0 112.789 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.62 -18.6 64.67 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.362 2.708 . . . . 0.0 114.457 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.49 -6.56 20.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.366 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 . . . . . 0 N--CA 1.477 0.91 0 C-N-CA 125.19 1.396 . . . . 0.0 113.224 179.225 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 . . . . . 0 CA--C 1.546 0.806 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.7 mt -142.16 160.67 39.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.566 1.946 . . . . 0.0 112.974 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.39 133.23 11.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.297 1.439 . . . . 0.0 111.427 162.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -78.29 99.51 6.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.443 1.097 . . . . 0.0 110.407 167.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.67 137.1 21.46 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.714 1.606 . . . . 0.0 109.425 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.44 155.92 50.37 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 112.922 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -75.71 60.75 1.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.171 1.788 . . . . 0.0 112.24 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -122.38 -54.11 1.89 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.302 1.841 . . . . 0.0 111.038 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -63.78 -17.18 62.81 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.464 1.105 . . . . 0.0 113.453 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -126.59 12.05 7.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.822 1.649 . . . . 0.0 113.875 -170.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.417 1.087 . . . . 0.0 113.542 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.4 12.87 47.78 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.19 1.852 . . . . 0.0 115.355 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.6 mt -122.1 126.66 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.251 1.525 . . . . 0.0 110.725 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.93 78.38 0.64 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.22 1.408 . . . . 0.0 112.649 173.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.7 156.2 24.3 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.74 162.77 40.48 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.256 1.822 . . . . 0.0 110.028 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -71.32 136.05 47.66 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.698 -1.251 . . . . 0.0 110.816 166.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.68 18.15 76.05 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.5 ptm -100.53 148.64 24.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.944 1.372 . . . . 0.0 111.776 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -68.49 143.43 54.99 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.059 0.944 . . . . 0.0 111.765 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.37 163.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.757 1.623 . . . . 0.0 111.278 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.25 158.0 35.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.399 1.88 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.88 103.7 0.25 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 123.774 0.702 . . . . 0.0 113.229 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.38 111.03 8.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.323 1.049 . . . . 0.0 111.5 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 t -81.2 154.44 26.66 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.6 1.16 . . . . 0.0 111.744 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.86 -13.57 59.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.774 1.229 . . . . 0.0 113.515 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.06 18.85 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.165 1.786 . . . . 0.0 113.841 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 55.3 42.94 29.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.386 2.274 . . . . 0.0 113.037 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -143.02 169.75 16.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.794 1.638 . . . . 0.0 112.043 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.8 m -141.41 107.11 5.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 110.592 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.79 167.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.992 -0.442 . . . . 0.0 111.18 174.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.08 135.88 37.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.721 1.208 . . . . 0.0 111.587 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.41 -167.97 1.89 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.816 1.246 . . . . 0.0 112.732 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.55 140.29 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.296 1.838 . . . . 0.0 110.528 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.98 124.61 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.418 1.087 . . . . 0.0 111.317 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -91.57 -35.96 13.96 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.722 1.609 . . . . 0.0 113.352 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -154.8 160.21 41.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.223 1.409 . . . . 0.0 110.879 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -148.35 150.08 32.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.171 0.988 . . . . 0.0 113.038 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -143.95 175.69 9.84 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.179 1.791 . . . . 0.0 110.91 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.31 -20.77 58.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.51 1.124 . . . . 0.0 113.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -86.75 -57.49 2.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.68 1.592 . . . . 0.0 111.967 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -138.17 169.95 16.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.4 2.28 . . . . 0.0 111.308 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.45 148.28 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.496 1.518 . . . . 0.0 110.934 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.5 mtp -112.57 92.38 4.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.708 1.603 . . . . 0.0 110.436 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.7 143.37 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.526 1.53 . . . . 0.0 109.808 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -63.87 125.3 23.94 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.876 170.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 . . . . . 0 N--CA 1.471 0.619 0 C-N-CA 124.378 1.071 . . . . 0.0 110.132 173.097 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 p -65.6 144.54 56.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.198 1.399 . . . . 0.0 112.533 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.8 mt -126.84 142.76 51.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.125 1.37 . . . . 0.0 111.809 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.97 95.11 9.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.537 1.135 . . . . 0.0 111.292 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.76 88.82 5.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.261 1.029 . . . . 0.0 110.796 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.77 124.23 28.88 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.016 1.326 . . . . 0.0 109.45 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.57 171.76 13.73 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -150.94 144.86 25.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.405 1.482 . . . . 0.0 111.237 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.9 101.06 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.426 1.09 . . . . 0.0 108.233 165.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.71 -28.5 66.89 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.539 0.736 . . . . 0.0 112.258 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.74 -160.77 28.62 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.497 1.046 . . . . 0.0 113.539 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.73 149.42 51.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.49 1.116 . . . . 0.0 110.872 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 124.868 1.267 . . . . 0.0 112.048 174.956 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 120.408 0.147 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.57 105.22 9.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.807 0.843 . . . . 0.0 110.678 174.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 129.99 41.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.295 1.038 . . . . 0.0 110.348 165.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -116.47 130.03 56.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.191 1.396 . . . . 0.0 110.39 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.91 163.64 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.511 1.124 . . . . 0.0 112.192 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.88 135.01 34.03 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.58 1.952 . . . . 0.0 110.453 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -139.06 149.61 44.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.111 1.434 . . . . 0.0 114.429 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.27 114.5 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.802 2.441 . . . . 0.0 109.253 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -92.87 96.59 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.409 1.084 . . . . 0.0 110.191 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -95.66 158.11 15.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.157 1.783 . . . . 0.0 110.362 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -72.35 156.8 38.71 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.125 -0.985 . . . . 0.0 110.98 166.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -65.65 -64.62 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 113.104 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.07 -47.76 5.4 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.018 0.818 . . . . 0.0 113.566 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -72.04 150.71 43.73 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 112.367 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 m -74.71 -12.39 60.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.813 1.245 . . . . 0.0 114.184 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 156.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.757 0.823 . . . . 0.0 113.091 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.39 128.13 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.886 1.674 . . . . 0.0 109.304 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -81.06 -49.35 11.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.178 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -154.87 160.51 41.25 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.171 1.388 . . . . 0.0 111.748 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.2 p -158.51 126.58 5.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.739 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.95 -17.15 31.94 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 170.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.12 -36.74 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.055 1.342 . . . . 0.0 112.553 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.1 p -75.57 -6.9 52.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.1 1.36 . . . . 0.0 114.64 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -107.93 -88.07 0.48 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.597 1.959 . . . . 0.0 110.133 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -151.44 152.71 31.24 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.937 2.095 . . . . 0.0 110.858 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.75 158.62 56.43 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.734 2.956 . . . . 0.0 113.526 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.38 112.61 23.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.657 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.97 129.49 40.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.716 1.607 . . . . 0.0 111.605 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -147.66 176.93 9.7 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 112.474 171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.96 150.64 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.626 1.57 . . . . 0.0 108.856 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.6 mm -49.41 106.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.509 1.124 . . . . 0.0 111.892 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.73 80.21 1.5 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 125.887 1.708 . . . . 0.0 113.476 -171.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.3 m -132.61 -49.1 0.9 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.056 1.343 . . . . 0.0 112.897 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.25 32.84 22.3 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.596 1.558 . . . . 0.0 114.365 175.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -27.67 34.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.29 171.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.801 1.241 . . . . 0.0 112.317 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -56.25 144.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.533 1.133 . . . . 0.0 112.179 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.086 0.954 . . . . 0.0 113.216 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.37 93.85 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.45 1.024 . . . . 0.0 113.317 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.03 -42.38 38.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.626 0.77 . . . . 0.0 112.121 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -53.08 -48.19 67.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.756 1.162 . . . . 0.0 112.79 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.31 -21.59 66.73 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.98 27.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.114 0.966 . . . . 0.0 112.291 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -53.42 -44.31 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.749 1.159 . . . . 0.0 112.541 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.17 -18.25 65.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -102.84 -20.66 14.22 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.983 1.713 . . . . 0.0 113.971 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.63 134.19 48.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.917 1.287 . . . . 0.0 112.058 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.45 150.34 34.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.922 0.889 . . . . 0.0 111.665 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -56.61 129.62 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.689 1.196 . . . . 0.0 111.161 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.37 76.85 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -122.83 117.82 26.53 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.956 1.378 . . . . 0.0 111.429 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -60.65 141.2 57.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.007 0.923 . . . . 0.0 111.982 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -138.54 120.34 15.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.898 1.279 . . . . 0.0 111.019 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.58 101.51 11.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 110.376 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.26 116.72 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.101 1.36 . . . . 0.0 111.403 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 t -80.21 109.88 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.227 1.011 . . . . 0.0 109.7 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.8 mm -98.52 136.42 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.903 1.281 . . . . 0.0 109.808 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 152.35 89.41 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.336 1.055 . . . . 0.0 111.966 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.72 -46.05 22.16 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.682 2.255 . . . . 0.0 111.867 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 -14.09 46.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 0.0 114.976 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 . . . . . 0 CA--C 1.543 0.71 0 C-N-CA 125.572 1.549 . . . . 0.0 112.714 -178.239 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.997 0.427 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.04 143.26 33.13 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.976 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -116.37 117.5 30.14 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.925 1.29 . . . . 0.0 110.074 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -74.27 106.75 6.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.088 0.955 . . . . 0.0 110.18 171.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -121.44 131.58 24.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 126.8 2.04 . . . . 0.0 109.293 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.18 155.5 64.4 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.084 1.856 . . . . 0.0 112.557 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -58.72 -19.95 44.68 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 172.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.11 -30.97 62.84 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.936 1.294 . . . . 0.0 113.174 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -81.35 -3.32 52.3 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.204 1.002 . . . . 0.0 113.416 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.22 20.22 7.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.231 2.212 . . . . 0.0 112.432 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.94 104.28 0.28 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.461 1.505 . . . . 0.0 111.875 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.82 3.15 52.41 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.373 1.463 . . . . 0.0 115.68 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 pt -129.63 98.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.865 1.666 . . . . 0.0 111.209 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.28 144.34 54.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.698 1.199 . . . . 0.0 111.665 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -125.7 159.72 31.55 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.396 1.478 . . . . 0.0 111.1 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -150.86 145.19 25.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.244 1.418 . . . . 0.0 110.325 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -58.51 128.62 38.08 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.674 0.79 . . . . 0.0 111.349 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 43.08 12.93 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 123.741 0.686 . . . . 0.0 114.445 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.73 153.89 47.73 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.57 1.148 . . . . 0.0 111.705 168.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.9 t -82.83 98.75 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.233 1.413 . . . . 0.0 112.034 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.63 156.97 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 110.914 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -113.0 149.09 33.8 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.466 1.106 . . . . 0.0 111.353 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.42 97.58 0.22 Allowed Glycine 0 N--CA 1.469 0.862 0 C-N-CA 124.44 1.019 . . . . 0.0 112.516 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.1 110.79 4.69 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.999 0.919 . . . . 0.0 111.101 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -78.39 153.18 31.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.239 1.016 . . . . 0.0 111.659 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -66.21 -12.95 59.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.467 1.507 . . . . 0.0 113.245 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.98 16.39 0.16 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 126.339 1.855 . . . . 0.0 114.01 168.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.59 45.63 15.88 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.227 2.211 . . . . 0.0 112.649 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -145.29 170.03 17.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.358 1.863 . . . . 0.0 111.163 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.1 m -142.44 120.61 12.2 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.753 1.221 . . . . 0.0 110.82 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.57 167.14 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.104 0.561 . . . . 0.0 111.752 174.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -117.0 127.61 54.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.279 1.431 . . . . 0.0 109.052 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.5 171.84 13.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.975 1.31 . . . . 0.0 112.446 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.28 130.06 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.104 0.961 . . . . 0.0 110.57 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.4 mm -62.47 103.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 109.533 170.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -84.13 -38.29 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.061 0.945 . . . . 0.0 111.667 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -149.46 165.4 32.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.461 1.104 . . . . 0.0 112.373 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.01 159.0 44.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.765 1.226 . . . . 0.0 111.921 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.2 m -134.59 174.76 10.19 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.207 1.803 . . . . 0.0 110.835 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.24 -15.56 63.29 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.6 t -140.25 -17.93 0.91 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.92 1.688 . . . . 0.0 114.489 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -133.46 168.03 19.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.662 1.585 . . . . 0.0 112.282 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -136.48 148.65 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.817 2.047 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.0 mtp -129.82 99.57 5.17 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.978 1.311 . . . . 0.0 110.801 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.14 147.32 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 110.005 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.46 128.69 36.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.113 0.565 . . . . 0.0 111.143 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 . . . . . 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.552 . . . . 0.0 110.779 172.324 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.85 140.66 58.89 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.963 1.705 . . . . 0.0 112.423 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -129.59 138.42 51.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.929 1.292 . . . . 0.0 112.009 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.41 96.68 10.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.486 1.514 . . . . 0.0 111.046 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -76.72 92.6 3.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.345 0.658 . . . . 0.0 109.585 166.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -77.09 119.5 20.88 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 164.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -138.25 169.83 17.09 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.378 0.671 . . . . 0.0 112.48 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -149.22 143.35 25.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.834 1.254 . . . . 0.0 111.584 171.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.5 t -82.24 104.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.772 1.229 . . . . 0.0 108.45 165.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.33 -35.49 75.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.366 0.666 . . . . 0.0 111.703 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.66 -149.95 18.86 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.449 1.499 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -129.29 151.16 50.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.262 1.025 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 . . . . . 0 N--CA 1.475 0.778 0 C-N-CA 125.382 1.473 . . . . 0.0 111.264 175.348 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.01 118.1 18.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.101 0.96 . . . . 0.0 111.45 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.5 106.7 8.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.696 1.599 . . . . 0.0 110.001 164.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.66 115.46 24.13 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.392 1.877 . . . . 0.0 109.501 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -131.78 158.57 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.078 0.951 . . . . 0.0 111.892 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -138.87 134.6 33.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.901 1.28 . . . . 0.0 110.281 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -131.9 162.11 31.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.145 1.378 . . . . 0.0 112.803 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.17 171.03 15.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 111.357 166.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.77 106.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.454 1.102 . . . . 0.0 110.981 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -116.65 154.86 29.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.634 1.574 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.92 148.4 40.11 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.552 -0.717 . . . . 0.0 111.042 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -66.59 -25.84 66.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 -72.94 0.95 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.226 1.393 . . . . 0.0 112.647 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -59.89 140.18 56.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.221 1.408 . . . . 0.0 113.576 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -70.9 -21.28 62.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.812 1.245 . . . . 0.0 113.892 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.37 158.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.952 1.301 . . . . 0.0 112.562 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.0 129.04 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.478 1.511 . . . . 0.0 109.75 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mp -79.69 -45.67 18.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.392 0.677 . . . . 0.0 111.312 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.71 158.27 40.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.163 1.385 . . . . 0.0 111.383 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.3 t -156.93 141.63 16.86 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.278 -0.889 . . . . 0.0 112.666 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.17 3.7 15.29 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.398 1.879 . . . . 0.0 112.752 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.55 -55.9 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.469 1.107 . . . . 0.0 111.214 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 t -72.21 -21.64 61.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.458 1.103 . . . . 0.0 113.034 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -80.81 -178.18 6.69 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.954 2.102 . . . . 0.0 111.841 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.39 128.11 92.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.873 0.869 . . . . 0.0 111.069 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.48 151.85 83.91 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.851 2.367 . . . . 0.0 112.427 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 tt -81.9 134.87 35.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.318 1.047 . . . . 0.0 109.981 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -119.43 114.46 22.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.78 1.632 . . . . 0.0 110.564 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -130.13 172.71 11.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.255 1.022 . . . . 0.0 112.26 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.3 mm -115.8 150.73 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.263 1.425 . . . . 0.0 109.023 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.57 106.16 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.72 29.9 7.1 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.405 1.479 . . . . 0.0 116.369 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 m -98.23 -38.56 9.24 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.53 1.665 . . . . 0.0 113.795 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 55.28 33.02 19.8 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.114 1.766 . . . . 0.0 115.198 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -68.03 -21.42 65.02 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.8 pt -74.26 168.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.964 1.706 . . . . 0.0 113.082 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 pt -60.86 152.79 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.29 1.036 . . . . 0.0 112.518 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.64 -43.13 79.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.11 73.06 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 114.105 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -88.88 -30.5 18.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.999 1.32 . . . . 0.0 112.223 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.6 -44.27 72.92 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.777 1.631 . . . . 0.0 111.639 171.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.79 8.46 6.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.379 1.471 . . . . 0.0 113.817 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.41 -39.58 2.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.499 1.519 . . . . 0.0 113.671 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.27 -30.07 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.323 1.049 . . . . 0.0 113.572 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.17 -14.24 62.21 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.16 -34.46 7.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.511 1.525 . . . . 0.0 112.782 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.91 149.82 26.0 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.551 0.74 . . . . 0.0 111.808 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.07 161.06 22.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 111.409 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.52 125.49 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.81 0.844 . . . . 0.0 111.759 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.78 76.64 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.778 1.18 . . . . 0.0 115.038 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.08 108.76 17.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.957 1.378 . . . . 0.0 111.334 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -57.78 141.2 49.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.982 0.913 . . . . 0.0 112.223 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.33 116.98 12.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.179 1.791 . . . . 0.0 110.716 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.0 112.19 23.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.924 1.29 . . . . 0.0 110.871 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -123.05 112.51 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.132 0.973 . . . . 0.0 111.256 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.7 127.83 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 121.197 -0.939 . . . . 0.0 109.303 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.4 mt -120.56 135.95 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.699 1.6 . . . . 0.0 108.703 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.64 148.69 96.61 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.652 0.781 . . . . 0.0 111.494 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.56 -44.58 13.69 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.02 2.48 . . . . 0.0 112.405 -170.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.14 -30.69 71.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.229 1.811 . . . . 0.0 113.695 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.758 -176.297 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.44 115.38 11.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.852 2.061 . . . . 0.0 111.349 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -116.98 119.22 34.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.259 1.423 . . . . 0.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.09 105.7 11.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.042 1.337 . . . . 0.0 111.06 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.85 131.56 21.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.673 1.989 . . . . 0.0 109.296 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.33 162.21 41.46 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.441 2.094 . . . . 0.0 112.52 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.95 -22.45 49.12 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.013 0.925 . . . . 0.0 113.417 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.42 -39.56 57.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.026 2.13 . . . . 0.0 114.031 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -69.77 -17.84 63.45 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -131.7 15.35 4.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.934 1.693 . . . . 0.0 114.161 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -57.33 -27.94 62.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.343 1.457 . . . . 0.0 114.143 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.76 6.69 33.29 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.823 1.678 . . . . 0.0 116.061 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.26 113.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.33 1.565 . . . . 0.0 111.881 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.92 139.65 58.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.102 0.961 . . . . 0.0 112.012 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -121.02 172.27 8.06 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.092 1.757 . . . . 0.0 111.609 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -148.29 161.15 42.1 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.222 1.009 . . . . 0.0 112.039 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -73.37 95.47 2.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.396 1.078 . . . . 0.0 111.026 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.41 64.24 0.73 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.9 ptp -133.95 152.0 51.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.129 1.372 . . . . 0.0 111.527 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.7 m -77.23 98.77 5.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.531 1.532 . . . . 0.0 110.652 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.09 154.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.366 1.466 . . . . 0.0 111.321 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.35 147.49 29.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.744 1.218 . . . . 0.0 111.589 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.99 96.98 0.28 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.949 1.261 . . . . 0.0 112.423 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -72.15 114.84 10.69 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.874 0.87 . . . . 0.0 111.13 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -82.42 154.84 24.97 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.507 1.123 . . . . 0.0 111.574 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.54 -13.21 39.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.024 1.329 . . . . 0.0 113.545 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -73.75 19.38 0.11 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.464 1.505 . . . . 0.0 113.781 171.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 58.4 33.85 23.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.346 2.259 . . . . 0.0 113.738 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -135.84 169.75 17.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.813 2.045 . . . . 0.0 111.493 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.1 m -137.68 138.28 39.24 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.543 1.537 . . . . 0.0 110.184 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.02 170.64 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.228 1.011 . . . . 0.0 111.372 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.23 133.74 55.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.919 1.688 . . . . 0.0 110.717 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.93 171.06 14.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.095 1.758 . . . . 0.0 111.228 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.7 126.97 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.862 0.865 . . . . 0.0 110.019 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.49 129.49 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 110.567 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -91.5 -49.27 6.41 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.061 1.344 . . . . 0.0 111.504 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -151.87 170.73 19.1 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.813 1.245 . . . . 0.0 112.208 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.72 155.61 45.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.432 1.093 . . . . 0.0 113.019 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.42 169.11 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.038 2.535 . . . . 0.0 110.049 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.41 67.96 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.129 -0.982 . . . . 0.0 113.167 171.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 63.9 p -131.22 -8.47 3.8 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.311 1.444 . . . . 0.0 114.811 -173.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -141.81 171.19 14.4 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.776 1.63 . . . . 0.0 111.047 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -138.65 150.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.514 1.926 . . . . 0.0 108.738 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 62.2 mtp -125.54 114.6 18.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.508 1.123 . . . . 0.0 111.035 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.2 163.83 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.811 1.244 . . . . 0.0 112.163 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -102.13 88.49 3.34 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.86 1.264 . . . . 0.0 112.182 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 . . . . . 0 N--CA 1.475 0.801 0 C-N-CA 124.647 1.179 . . . . 0.0 112.268 171.863 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.9 p -64.66 144.85 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.36 1.464 . . . . 0.0 113.14 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -130.31 136.42 49.12 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.275 . . . . 0.0 111.706 -173.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.68 97.41 7.9 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.73 1.612 . . . . 0.0 111.324 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.65 83.59 6.4 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.415 1.102 . . . . 0.0 110.613 166.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -76.58 131.67 39.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.14 169.89 19.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -145.41 145.63 31.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.971 1.309 . . . . 0.0 111.656 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 t -84.49 100.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.863 1.265 . . . . 0.0 108.693 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.23 -31.96 71.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.38 0.672 . . . . 0.0 111.837 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.88 -170.05 31.28 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.196 0.903 . . . . 0.0 114.883 170.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.55 118.93 27.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.616 1.567 . . . . 0.0 110.219 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 . . . . . 0 N--CA 1.48 1.045 0 C-N-CA 124.985 1.314 . . . . 0.0 112.558 -177.037 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 . . . . . 0 N--CA 1.473 0.682 0 CA-C-O 120.47 0.176 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 107.51 17.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.184 0.994 . . . . 0.0 110.435 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.02 128.7 37.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.382 165.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.23 124.81 53.4 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.592 1.557 . . . . 0.0 109.619 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 141' ' ' VAL . 14.5 pt -128.5 163.68 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 171.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.82 136.72 40.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 109.745 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.07 157.95 45.58 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.069 1.414 . . . . 0.0 114.783 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -139.13 141.25 38.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.462 3.105 . . . . 0.0 108.878 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.22 110.06 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.873 1.269 . . . . 0.0 110.429 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -123.69 168.85 12.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.539 1.536 . . . . 0.0 112.685 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -62.57 151.97 36.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.505 1.122 . . . . 0.0 111.147 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -20.28 63.24 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.42 25.35 1.53 Allowed Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.123 1.344 . . . . 0.0 114.959 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -141.16 161.41 37.93 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.917 1.358 . . . . 0.0 112.52 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -75.71 -17.72 59.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.783 1.633 . . . . 0.0 113.762 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -64.04 151.69 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.799 0.84 . . . . 0.0 112.456 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.46 117.25 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.787 1.635 . . . . 0.0 108.943 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.87 -44.05 56.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.721 0.808 . . . . 0.0 111.77 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.67 164.09 39.06 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.648 1.179 . . . . 0.0 111.581 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 m -165.87 159.6 16.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.384 1.874 . . . . 0.0 111.844 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -126.08 2.75 7.22 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 164.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.9 mm -47.46 -46.2 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.01 1.724 . . . . 0.0 113.965 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -93.42 -2.62 54.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.955 1.302 . . . . 0.0 113.581 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -98.05 -166.52 1.39 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.875 2.47 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.91 134.26 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.473 1.109 . . . . 0.0 111.775 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.55 159.01 55.18 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.27 2.647 . . . . 0.0 113.314 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.88 95.06 5.96 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.435 1.094 . . . . 0.0 110.268 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.34 125.46 31.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.159 1.783 . . . . 0.0 111.578 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.48 172.6 14.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.168 0.987 . . . . 0.0 113.399 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 142.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.601 1.56 . . . . 0.0 109.507 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mm -47.93 121.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.971 1.708 . . . . 0.0 112.462 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.41 76.85 1.09 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.995 1.283 . . . . 0.0 112.806 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -130.79 -26.69 2.18 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 53.48 21.96 2.7 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.518 1.927 . . . . 0.0 115.683 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -78.25 -28.6 47.82 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -170.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 pt -82.07 171.18 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.86 1.664 . . . . 0.0 112.196 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 pt -55.34 140.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.818 0.847 . . . . 0.0 111.169 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.67 78.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.543 0.737 . . . . 0.0 112.915 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.88 -30.41 72.98 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.327 0.965 . . . . 0.0 114.303 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.67 -43.9 13.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.337 1.055 . . . . 0.0 111.404 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -53.25 -48.02 68.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.595 1.158 . . . . 0.0 112.309 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.05 0.3 2.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.984 1.314 . . . . 0.0 114.468 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.54 -25.42 7.9 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.968 1.707 . . . . 0.0 114.04 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.3 t -58.31 -42.02 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.736 1.607 . . . . 0.0 112.114 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.92 -12.62 61.06 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.95 -36.9 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.995 1.718 . . . . 0.0 112.18 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 140.74 58.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.085 1.354 . . . . 0.0 112.385 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -86.28 154.28 21.37 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.009 0.924 . . . . 0.0 111.964 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.71 131.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.287 1.035 . . . . 0.0 111.346 171.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.25 12.63 76.43 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.289 0.947 . . . . 0.0 115.157 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.31 115.49 19.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.322 1.449 . . . . 0.0 111.246 -175.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -59.41 141.32 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.866 0.866 . . . . 0.0 112.151 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.17 142.68 42.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.147 1.379 . . . . 0.0 111.054 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.79 128.54 52.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.14 1.376 . . . . 0.0 110.156 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.55 110.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.706 2.002 . . . . 0.0 110.166 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.1 t -69.49 125.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.769 0.828 . . . . 0.0 109.94 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.29 140.1 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.308 1.443 . . . . 0.0 109.826 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.45 154.74 87.23 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.241 1.016 . . . . 0.0 111.731 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.18 -40.67 67.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.627 2.218 . . . . 0.0 113.462 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.28 -18.35 59.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.475 0.793 0 C-N-CA 124.737 1.215 . . . . 0.0 114.017 -178.841 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 p90 . . . . . 0 N--CA 1.472 0.667 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.8 103.59 10.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.252 1.021 . . . . 0.0 110.629 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -88.91 116.75 27.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.59 0.756 . . . . 0.0 110.35 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.11 112.22 7.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.25 1.02 . . . . 0.0 110.221 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 156.3 54.45 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 126.071 1.749 . . . . 0.0 110.812 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.08 149.64 46.8 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.047 1.831 . . . . 0.0 112.005 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -61.45 -17.31 53.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.04 1.336 . . . . 0.0 113.171 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.35 -33.9 22.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.184 2.194 . . . . 0.0 113.624 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -71.38 -10.8 60.35 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -135.19 14.48 3.53 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.612 1.565 . . . . 0.0 114.194 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.86 112.56 0.96 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.43 1.092 . . . . 0.0 112.441 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.11 3.86 58.81 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.21 1.386 . . . . 0.0 115.374 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mt -108.22 139.56 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.284 1.434 . . . . 0.0 110.378 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.0 55.87 1.86 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.378 1.871 . . . . 0.0 113.588 -173.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -55.04 130.04 40.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.283 1.833 . . . . 0.0 113.303 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.23 148.47 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.752 2.021 . . . . 0.0 110.345 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.36 135.76 57.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.489 1.116 . . . . 0.0 112.25 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 -9.37 75.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.136 1.35 . . . . 0.0 116.371 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 ptp -70.16 152.28 44.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.169 1.984 . . . . 0.0 112.416 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 p -78.38 102.01 7.53 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.606 1.163 . . . . 0.0 110.311 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.3 160.86 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.419 1.088 . . . . 0.0 110.551 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.32 162.21 30.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.06 1.344 . . . . 0.0 112.002 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.69 108.82 0.38 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.275 0.94 . . . . 0.0 112.891 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -66.4 147.13 53.74 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 122.05 -0.677 . . . . 0.0 111.299 174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -128.88 157.39 41.7 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.729 1.612 . . . . 0.0 111.737 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -14.08 60.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.215 1.806 . . . . 0.0 113.736 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.35 13.13 0.62 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.285 1.834 . . . . 0.0 113.912 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.1 m120 57.25 40.14 28.12 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.13 2.172 . . . . 0.0 113.171 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -131.9 171.01 14.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.872 2.069 . . . . 0.0 111.253 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.6 m -141.93 111.75 6.73 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.683 1.593 . . . . 0.0 109.634 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.62 166.94 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 118.497 0.59 . . . . 0.0 111.067 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.33 154.77 34.55 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.623 1.169 . . . . 0.0 111.17 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.8 176.7 12.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.629 1.572 . . . . 0.0 110.966 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.37 128.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.385 1.074 . . . . 0.0 110.476 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.0 mm -68.65 125.97 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.062 0.945 . . . . 0.0 110.693 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.08 -38.68 5.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.773 1.229 . . . . 0.0 113.381 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -151.93 156.17 39.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.468 1.107 . . . . 0.0 111.243 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -147.19 149.85 33.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.186 -0.946 . . . . 0.0 113.395 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -143.2 170.17 16.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.841 2.057 . . . . 0.0 110.804 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.264 -0.897 . . . . 0.0 113.251 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.3 p -78.92 -66.71 0.83 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.676 1.99 . . . . 0.0 112.021 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -135.73 171.0 15.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.098 2.159 . . . . 0.0 111.367 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.21 144.03 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.567 1.547 . . . . 0.0 110.429 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.6 mtp -116.41 113.66 23.19 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.781 1.632 . . . . 0.0 110.651 -170.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.48 135.43 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.187 1.395 . . . . 0.0 110.264 -166.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.32 83.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.287 1.435 . . . . 0.0 112.17 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 126.035 1.734 . . . . 0.0 112.29 173.335 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.3 p -64.72 147.63 52.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.879 0.872 . . . . 0.0 112.125 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.58 154.21 51.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.81 1.244 . . . . 0.0 111.425 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.23 104.43 14.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 110.728 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -80.07 109.83 14.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.639 0.776 . . . . 0.0 109.726 167.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.24 120.64 43.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.858 1.663 . . . . 0.0 108.941 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -143.4 169.78 17.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 113.087 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.85 144.97 28.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.634 1.174 . . . . 0.0 111.899 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 15' ' ' ILE . 45.3 t -83.18 102.9 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.918 1.287 . . . . 0.0 109.003 165.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.35 -36.03 78.63 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.201 0.6 . . . . 0.0 111.698 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.68 -165.93 27.47 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.367 0.984 . . . . 0.0 114.211 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.21 133.2 54.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.818 1.647 . . . . 0.0 110.223 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 125.062 1.345 . . . . 0.0 112.015 175.933 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 110.492 -0.188 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.43 105.7 8.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.708 1.203 . . . . 0.0 111.172 172.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.58 125.51 28.16 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.046 1.339 . . . . 0.0 110.227 163.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.37 123.88 50.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.34 1.456 . . . . 0.0 110.083 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 pt -131.22 161.3 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.219 1.007 . . . . 0.0 112.129 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -135.89 146.94 47.93 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.841 1.656 . . . . 0.0 110.397 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.51 154.31 43.5 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -146.03 129.06 16.51 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.766 2.426 . . . . 0.0 110.571 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.88 110.39 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.969 1.708 . . . . 0.0 110.062 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -116.5 151.74 35.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.855 1.662 . . . . 0.0 111.259 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.42 126.34 29.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.931 0.893 . . . . 0.0 109.79 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.73 75.65 1.12 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.316 -0.865 . . . . 0.0 111.352 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 -5.28 2.64 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.117 1.818 . . . . 0.0 116.135 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.0 t -133.45 144.29 49.39 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.981 1.891 . . . . 0.0 112.776 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 p -76.59 31.55 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.616 2.766 . . . . 0.0 115.599 -171.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.35 176.57 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.184 1.394 . . . . 0.0 112.216 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.45 117.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.434 1.494 . . . . 0.0 108.987 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.47 -53.3 6.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.912 0.885 . . . . 0.0 111.494 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -144.42 150.64 38.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.557 1.943 . . . . 0.0 109.865 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 p -157.64 151.58 24.29 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.295 -0.878 . . . . 0.0 112.703 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.3 -6.58 8.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.217 1.407 . . . . 0.0 113.135 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -62.5 -37.5 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.287 1.435 . . . . 0.0 112.094 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -73.38 -10.62 59.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.7 1.2 . . . . 0.0 113.506 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -114.7 -170.43 1.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 127.504 2.321 . . . . 0.0 111.164 -171.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.69 125.75 83.51 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 124.378 1.071 . . . . 0.0 111.835 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.68 152.21 82.34 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.029 2.486 . . . . 0.0 112.554 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.0 tp -75.91 108.91 9.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.119 1.368 . . . . 0.0 110.897 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -93.71 131.9 38.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.532 1.533 . . . . 0.0 111.78 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -146.78 167.86 22.81 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.478 1.111 . . . . 0.0 112.88 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.0 mm -101.48 146.88 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 109.715 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.3 mm -46.46 118.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.362 1.865 . . . . 0.0 111.792 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.19 77.5 1.05 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.993 1.282 . . . . 0.0 112.886 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -123.13 -36.84 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.002 1.321 . . . . 0.0 114.426 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.47 23.27 2.45 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 126.846 2.058 . . . . 0.0 115.175 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -80.15 -24.79 40.18 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.2 pt -78.42 167.07 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.989 1.316 . . . . 0.0 112.475 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.9 pt -59.53 141.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.242 1.017 . . . . 0.0 111.692 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.34 73.43 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.91 68.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.347 0.975 . . . . 0.0 114.296 176.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.58 -35.17 13.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.307 1.443 . . . . 0.0 111.844 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -59.4 -40.74 87.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.223 1.409 . . . . 0.0 112.678 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -73.69 -8.34 55.6 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.47 -47.89 5.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.978 1.311 . . . . 0.0 112.631 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.95 -28.54 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.996 1.318 . . . . 0.0 114.134 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 -19.71 63.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -108.46 -11.48 15.15 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.722 1.609 . . . . 0.0 113.843 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.94 113.09 4.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.35 1.46 . . . . 0.0 112.138 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.97 147.14 50.54 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.763 0.825 . . . . 0.0 111.891 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.49 131.65 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.432 1.093 . . . . 0.0 111.429 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.91 12.88 79.04 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.61 1.1 . . . . 0.0 115.334 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -116.65 118.53 32.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.229 1.412 . . . . 0.0 111.678 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -61.09 133.65 56.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.223 1.009 . . . . 0.0 111.947 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -136.97 136.45 38.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 110.956 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -126.63 105.93 9.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.678 1.191 . . . . 0.0 110.526 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 m -109.8 114.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.554 1.542 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.7 t -73.81 126.91 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.74 130.98 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.718 1.607 . . . . 0.0 108.989 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 154.45 87.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.65 1.18 . . . . 0.0 111.675 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.48 -45.06 15.64 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.201 1.934 . . . . 0.0 111.646 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -62.11 -21.07 64.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 . . . . . 0 CA--C 1.546 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.116 178.435 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.2 p90 . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.55 137.82 31.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 112.002 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -126.8 124.29 39.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -88.04 82.5 7.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.9 1.68 . . . . 0.0 110.255 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.69 136.04 45.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.144 1.378 . . . . 0.0 109.722 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.77 156.01 57.63 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.475 2.117 . . . . 0.0 112.24 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -65.85 -9.28 27.54 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -56.31 -31.5 63.74 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.327 1.051 . . . . 0.0 113.582 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -82.17 -6.61 59.33 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -130.04 15.58 5.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.44 1.896 . . . . 0.0 113.403 -169.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.62 107.93 0.34 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.996 1.718 . . . . 0.0 112.289 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.84 11.05 57.13 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.88 1.229 . . . . 0.0 115.784 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.42 132.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.368 1.584 . . . . 0.0 110.557 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.67 79.45 9.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.915 1.686 . . . . 0.0 112.696 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.01 155.76 35.68 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.59 1.156 . . . . 0.0 112.819 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.91 157.64 45.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -73.96 25.69 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.113 1.765 . . . . 0.0 114.999 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.4 56.22 0.06 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.988 1.28 . . . . 0.0 112.663 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.4 ptp -132.18 149.25 52.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.699 1.2 . . . . 0.0 112.208 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -67.49 125.35 25.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.363 1.465 . . . . 0.0 110.629 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.14 160.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.627 1.571 . . . . 0.0 111.146 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -119.5 149.84 41.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.498 1.519 . . . . 0.0 111.578 -177.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.89 108.53 0.64 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.651 1.119 . . . . 0.0 113.047 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -71.82 112.63 8.09 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.817 -0.814 . . . . 0.0 111.464 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 t -89.03 159.93 17.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.618 1.167 . . . . 0.0 111.967 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -13.56 60.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.623 1.569 . . . . 0.0 113.959 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.65 11.15 0.68 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.754 1.622 . . . . 0.0 113.941 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 53.41 47.86 23.17 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.844 2.058 . . . . 0.0 111.908 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.49 168.17 20.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.776 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 m -140.78 105.56 4.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.138 -0.976 . . . . 0.0 111.045 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.35 170.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.941 -0.474 . . . . 0.0 111.494 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 139.06 54.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.088 1.755 . . . . 0.0 111.564 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.06 179.48 7.71 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.419 1.888 . . . . 0.0 111.872 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.67 128.65 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.729 1.212 . . . . 0.0 110.722 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -72.7 131.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.865 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -95.38 -42.31 8.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.988 1.715 . . . . 0.0 112.0 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -155.09 167.36 30.63 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.625 1.17 . . . . 0.0 112.006 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -140.29 144.84 36.61 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.096 1.358 . . . . 0.0 111.536 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.4 m -117.94 174.08 6.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.776 2.03 . . . . 0.0 110.613 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.05 -19.79 63.27 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.1 p -133.45 -18.31 2.22 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.846 1.658 . . . . 0.0 115.173 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -143.03 172.06 13.22 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.045 1.738 . . . . 0.0 112.145 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.2 t -137.85 126.33 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 127.13 2.172 . . . . 0.0 110.591 -172.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 76.9 mmm -94.15 111.57 23.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.695 1.598 . . . . 0.0 111.078 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.13 151.27 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.131 1.772 . . . . 0.0 112.249 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -91.71 115.57 28.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.105 1.362 . . . . 0.0 111.166 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 . . . . . 0 CA--C 1.543 0.7 0 C-N-CA 126.344 1.858 . . . . 0.0 111.234 -179.419 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.1 p -64.48 137.78 58.05 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.923 1.689 . . . . 0.0 112.351 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.25 144.78 51.56 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.795 1.238 . . . . 0.0 112.001 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.09 99.1 10.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.676 1.59 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.39 93.37 5.96 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.704 1.202 . . . . 0.0 109.837 168.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 -76.93 141.37 40.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.928 -1.108 . . . . 0.0 109.784 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -152.72 170.48 20.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.905 0.882 . . . . 0.0 113.0 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -149.55 142.28 24.6 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.14 1.376 . . . . 0.0 111.132 169.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.29 107.8 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.154 1.382 . . . . 0.0 109.025 169.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.7 mp -69.95 -33.9 72.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 111.184 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.62 -175.13 22.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.438 1.494 . . . . 0.0 114.008 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.15 139.38 42.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.0 110.455 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 124.354 1.062 . . . . 0.0 113.28 177.004 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 120.65 0.262 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.89 106.37 8.53 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.354 1.062 . . . . 0.0 110.323 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 125.17 29.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.067 1.347 . . . . 0.0 110.63 169.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.88 125.63 51.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.475 1.51 . . . . 0.0 110.388 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 pt -133.61 163.26 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.314 1.046 . . . . 0.0 112.042 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -140.59 138.05 34.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.056 1.342 . . . . 0.0 110.559 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.47 160.56 38.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.141 1.376 . . . . 0.0 113.728 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -143.33 161.39 38.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.001 1.72 . . . . 0.0 111.396 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.03 107.41 11.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.735 1.614 . . . . 0.0 110.038 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -113.92 157.41 22.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.908 1.683 . . . . 0.0 110.31 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -63.81 152.18 40.24 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.689 -0.632 . . . . 0.0 110.933 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -25.79 60.11 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.38 57.38 0.3 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.47 1.033 . . . . 0.0 113.743 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 t -144.57 163.7 33.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.604 1.162 . . . . 0.0 112.441 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -80.36 -21.96 41.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 113.466 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 pp -69.35 157.06 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.811 0.732 . . . . 0.0 111.36 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.36 144.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.508 1.523 . . . . 0.0 110.697 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.91 -48.08 6.43 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.544 0.738 . . . . 0.0 111.038 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 157.21 36.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.704 1.602 . . . . 0.0 111.735 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.5 p -162.98 163.79 25.96 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.532 1.133 . . . . 0.0 113.615 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.86 8.28 4.11 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 167.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.43 -53.58 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 p -76.32 -18.92 58.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 0.0 113.892 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.02 -171.35 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.006 2.123 . . . . 0.0 111.035 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -64.17 142.59 98.28 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 121.147 -0.97 . . . . 0.0 111.77 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.14 159.43 53.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.374 2.716 . . . . 0.0 112.597 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.86 109.06 15.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 110.363 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.59 127.14 32.12 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.438 1.895 . . . . 0.0 111.452 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.14 175.1 10.74 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.7 137.77 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.051 1.74 . . . . 0.0 109.078 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 mm -48.14 109.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.27 1.828 . . . . 0.0 111.804 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.05 87.27 1.24 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.415 1.483 . . . . 0.0 112.936 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.1 t -146.35 -33.47 0.31 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.2 m120 53.45 60.64 3.58 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.852 2.061 . . . . 0.0 113.789 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -111.04 -26.28 9.33 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.8 pt -81.04 174.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.436 1.495 . . . . 0.0 112.177 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.8 pt -58.2 141.18 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.797 0.839 . . . . 0.0 111.469 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.08 91.75 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.81 -33.45 73.28 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.052 0.834 . . . . 0.0 113.95 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 tp -81.73 -45.38 15.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.436 1.094 . . . . 0.0 111.342 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -49.36 -47.7 47.26 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.71 1.604 . . . . 0.0 113.287 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.43 -18.22 63.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 113.276 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.05 -43.92 10.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.914 1.286 . . . . 0.0 112.69 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.62 -43.06 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 119.941 1.246 . . . . 0.0 112.525 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.58 -20.79 65.94 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -102.69 -11.34 18.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.399 1.88 . . . . 0.0 113.801 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.03 126.63 31.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.408 1.483 . . . . 0.0 112.392 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -77.8 155.04 31.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.754 0.822 . . . . 0.0 112.01 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.62 134.29 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.897 1.279 . . . . 0.0 111.473 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.54 13.83 74.58 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.75 100.23 7.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.964 1.306 . . . . 0.0 111.63 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -58.18 131.86 51.83 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.287 1.035 . . . . 0.0 111.469 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.41 157.84 44.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.907 0.883 . . . . 0.0 112.79 171.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -128.79 96.78 4.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.994 1.318 . . . . 0.0 110.91 -170.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -97.94 106.23 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.394 1.478 . . . . 0.0 110.119 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 t -74.26 123.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.351 -0.843 . . . . 0.0 109.807 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.41 140.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.451 1.9 . . . . 0.0 109.383 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.15 158.91 69.34 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.416 1.087 . . . . 0.0 112.214 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.93 -46.79 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.32 2.013 . . . . 0.0 112.082 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.89 -14.42 61.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.198 1.399 . . . . 0.0 114.656 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.38 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 121.221 0.534 . . . . 0.0 112.39 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.7 mt -121.16 146.78 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.729 1.611 . . . . 0.0 111.69 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -131.54 111.45 11.77 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.685 1.594 . . . . 0.0 111.253 167.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -69.58 115.17 8.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.715 0.806 . . . . 0.0 110.087 160.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.36 156.85 69.53 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 125.942 1.697 . . . . 0.0 109.898 176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.34 153.52 61.4 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.025 1.817 . . . . 0.0 111.881 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -61.26 -19.37 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 0.0 113.245 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -53.95 -30.51 47.06 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.49 1.516 . . . . 0.0 114.589 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -19.73 65.05 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 175.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -137.68 20.98 2.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.032 1.733 . . . . 0.0 112.556 -168.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.93 -24.8 55.26 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.168 1.787 . . . . 0.0 114.168 -171.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.18 16.07 46.29 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.059 1.79 . . . . 0.0 115.338 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.32 132.62 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.281 1.54 . . . . 0.0 111.023 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -81.34 89.2 6.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.685 1.194 . . . . 0.0 111.108 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.2 160.28 32.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 112.326 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.1 152.29 27.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.019 1.328 . . . . 0.0 111.81 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -72.88 84.25 1.23 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.685 1.194 . . . . 0.0 110.878 168.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.69 43.71 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.765 1.174 . . . . 0.0 114.699 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.4 ptm -129.38 150.69 50.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.149 1.38 . . . . 0.0 111.149 170.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 p -67.99 133.83 49.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.041 0.937 . . . . 0.0 110.955 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.24 152.82 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.35 1.86 . . . . 0.0 110.166 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.59 143.95 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.572 1.149 . . . . 0.0 110.958 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.12 99.92 0.44 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 124.802 1.191 . . . . 0.0 112.109 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -66.87 140.31 57.79 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 117.604 0.702 . . . . 0.0 111.203 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -119.07 154.54 33.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.036 1.735 . . . . 0.0 111.656 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -62.0 -17.66 57.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.988 1.715 . . . . 0.0 113.439 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.99 15.46 0.16 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 127.23 2.212 . . . . 0.0 113.999 173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.6 m120 52.66 48.12 23.21 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.134 2.174 . . . . 0.0 112.617 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -144.77 177.36 8.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.798 1.639 . . . . 0.0 111.969 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.0 m -145.2 128.94 17.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.905 1.282 . . . . 0.0 110.538 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -84.66 165.72 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.73 0.812 . . . . 0.0 111.81 172.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -133.36 126.57 31.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.465 1.506 . . . . 0.0 110.209 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.77 -172.88 4.37 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.677 1.191 . . . . 0.0 112.486 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mp -113.67 140.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.629 1.572 . . . . 0.0 109.804 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.43 134.57 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.797 1.239 . . . . 0.0 110.831 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -107.96 -32.96 7.36 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.42 1.088 . . . . 0.0 113.57 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -152.83 153.92 34.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.231 1.412 . . . . 0.0 111.173 164.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -142.63 134.12 26.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 111.715 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 160.74 39.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.567 1.547 . . . . 0.0 110.517 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.24 -23.26 67.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.1 p -77.28 -62.59 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.021 1.728 . . . . 0.0 111.68 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -138.87 160.95 38.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.007 2.123 . . . . 0.0 112.109 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.41 147.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.703 1.601 . . . . 0.0 110.396 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -121.84 105.69 10.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.69 1.596 . . . . 0.0 110.288 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -106.31 146.59 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.555 1.542 . . . . 0.0 111.072 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 141.94 49.84 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.841 -0.537 . . . . 0.0 111.112 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 CA--C 1.54 0.577 0 C-N-CA 125.389 1.476 . . . . 0.0 111.474 176.797 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.19 142.85 57.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.738 1.615 . . . . 0.0 111.764 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.3 mt -126.71 143.1 51.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 112.002 -174.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.85 98.53 11.83 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.949 1.3 . . . . 0.0 111.457 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -79.62 92.57 5.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.848 0.832 . . . . 0.0 110.77 168.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.12 128.77 34.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.256 1.422 . . . . 0.0 109.417 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.47 169.39 21.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -149.55 147.96 28.79 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 112.055 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.9 108.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.42 1.488 . . . . 0.0 109.167 166.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.84 -29.43 68.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.51 0.724 . . . . 0.0 111.302 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.67 172.07 14.22 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.534 2.016 . . . . 0.0 112.422 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.15 156.34 17.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.451 0.7 . . . . 0.0 112.717 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 . . . . . 0 N--CA 1.473 0.69 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 178.652 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 . . . . . 0 CA--C 1.542 0.659 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.19 96.95 5.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.487 1.115 . . . . 0.0 111.176 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.83 118.99 22.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.752 2.021 . . . . 0.0 111.734 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.88 130.5 48.37 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.185 1.394 . . . . 0.0 111.313 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.52 158.74 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.173 1.389 . . . . 0.0 111.734 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -138.94 141.24 38.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 110.972 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.44 154.2 49.98 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 123.123 1.44 . . . . 0.0 114.069 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -142.56 113.03 7.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.18 2.592 . . . . 0.0 109.068 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.29 115.73 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.69 1.196 . . . . 0.0 109.602 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -124.54 151.87 44.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.132 1.773 . . . . 0.0 110.547 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.66 146.76 48.06 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.606 -0.683 . . . . 0.0 111.251 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.84 -33.35 61.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -170.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.2 45.33 0.84 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.368 0.985 . . . . 0.0 114.141 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 t -142.28 156.48 45.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 112.579 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.2 p -82.52 -11.9 58.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.97 1.708 . . . . 0.0 114.331 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.03 178.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.966 1.306 . . . . 0.0 112.196 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 p -133.77 137.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.736 1.215 . . . . 0.0 110.197 168.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.7 mt -81.27 -51.39 8.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.635 0.774 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.31 163.33 30.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.925 1.29 . . . . 0.0 112.544 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.9 p -157.11 165.27 36.51 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.003 -1.061 . . . . 0.0 112.812 171.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.68 -4.29 10.27 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 164.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.62 -48.57 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.762 1.625 . . . . 0.0 112.215 -171.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -75.93 -17.24 59.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -86.93 -73.93 0.45 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.061 1.745 . . . . 0.0 111.715 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -166.93 134.18 1.99 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.665 1.986 . . . . 0.0 110.335 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.95 154.33 74.98 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.11 2.54 . . . . 0.0 112.882 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tt -95.0 111.89 23.65 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 109.796 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -93.27 131.89 37.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.868 1.267 . . . . 0.0 111.519 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -145.6 179.38 7.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 112.097 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.81 135.5 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.758 1.223 . . . . 0.0 109.251 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.8 mm -49.8 109.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.14 1.376 . . . . 0.0 111.038 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.71 53.31 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.617 1.58 . . . . 0.0 114.634 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 m -122.79 -32.23 3.57 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.591 1.156 . . . . 0.0 113.296 175.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 54.3 33.45 18.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.327 1.851 . . . . 0.0 114.888 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -79.45 -24.1 42.66 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.0 pt -69.56 166.95 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.636 1.174 . . . . 0.0 112.589 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.6 pt -57.58 141.76 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.019 0.927 . . . . 0.0 111.428 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.18 76.81 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -173.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.11 68.53 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.002 0.81 . . . . 0.0 114.17 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -90.19 -29.72 18.05 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.177 1.391 . . . . 0.0 112.213 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -60.47 -42.88 97.16 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.844 -1.16 . . . . 0.0 112.504 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.53 -10.14 53.73 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.08 -49.94 4.56 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.625 1.57 . . . . 0.0 112.821 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.87 -31.71 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.565 1.146 . . . . 0.0 114.038 -174.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.64 -21.04 66.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.74 -13.78 16.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.678 1.991 . . . . 0.0 113.536 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.5 116.84 16.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.492 1.517 . . . . 0.0 112.07 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -73.7 157.48 36.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.813 0.816 . . . . 0.0 112.46 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.14 133.96 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.086 1.355 . . . . 0.0 111.639 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.47 72.52 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.758 1.171 . . . . 0.0 114.938 176.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -120.14 108.34 14.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.173 1.389 . . . . 0.0 111.201 -170.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -54.93 129.94 39.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.993 0.917 . . . . 0.0 111.456 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.84 141.26 51.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.072 1.349 . . . . 0.0 111.169 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -127.11 112.71 15.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.415 1.486 . . . . 0.0 109.572 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.81 124.03 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.627 1.171 . . . . 0.0 111.556 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.08 127.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.726 0.811 . . . . 0.0 109.646 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.34 135.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.251 1.82 . . . . 0.0 108.964 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.2 155.02 67.79 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.921 0.888 . . . . 0.0 112.329 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.15 -41.76 15.67 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.109 1.873 . . . . 0.0 111.379 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.71 -23.67 64.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.911 1.684 . . . . 0.0 114.51 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 N--CA 1.474 0.757 0 O-C-N 121.429 -0.794 . . . . 0.0 112.561 172.592 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 N--CA 1.476 0.86 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.1 mt -153.46 132.57 12.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 129.32 3.048 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -139.93 117.01 11.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.09 1.356 . . . . 0.0 110.159 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.16 112.65 6.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 110.547 168.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.5 m -119.59 157.42 51.92 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.729 1.612 . . . . 0.0 110.634 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.43 163.04 40.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.008 1.805 . . . . 0.0 111.38 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -67.21 0.53 2.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.234 1.814 . . . . 0.0 114.667 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.31 -38.04 81.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.547 1.939 . . . . 0.0 113.907 -175.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -67.48 -15.89 63.91 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -127.38 21.18 6.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.514 1.526 . . . . 0.0 113.005 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.49 99.06 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.761 1.624 . . . . 0.0 112.171 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.95 56.93 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.599 1.571 . . . . 0.0 115.596 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.77 127.56 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.567 1.547 . . . . 0.0 109.763 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.87 124.13 21.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.828 0.851 . . . . 0.0 111.529 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.1 mt -115.11 139.27 50.03 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.335 1.454 . . . . 0.0 110.589 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -150.35 150.68 31.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.887 1.275 . . . . 0.0 111.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -76.66 89.59 3.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.83 -1.169 . . . . 0.0 111.052 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.72 43.11 0.27 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.482 1.515 . . . . 0.0 114.6 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 ptm -133.13 152.1 51.96 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.196 1.398 . . . . 0.0 111.365 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p -68.57 133.53 48.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.88 1.272 . . . . 0.0 111.32 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.73 156.94 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.481 1.913 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.86 139.54 53.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.634 1.174 . . . . 0.0 111.037 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.02 100.2 0.55 Allowed Glycine 0 N--CA 1.469 0.879 0 C-N-CA 124.878 1.228 . . . . 0.0 112.282 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -64.15 144.79 56.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.72 0.76 . . . . 0.0 111.383 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -128.93 155.44 45.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.576 1.55 . . . . 0.0 111.578 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -65.46 -14.95 62.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.836 1.654 . . . . 0.0 113.221 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -73.46 17.29 0.15 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.457 1.903 . . . . 0.0 113.934 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 54.15 44.72 28.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.144 2.178 . . . . 0.0 112.425 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.26 173.49 11.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.966 2.107 . . . . 0.0 111.48 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.4 m -146.14 118.33 8.35 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.66 1.184 . . . . 0.0 110.179 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -73.66 162.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.312 0.506 . . . . 0.0 110.976 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -137.26 119.76 15.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.348 1.459 . . . . 0.0 110.652 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.04 -170.75 3.59 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.456 1.103 . . . . 0.0 112.543 -172.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.71 142.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.393 1.477 . . . . 0.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.3 mt -73.46 126.3 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.066 -1.021 . . . . 0.0 110.303 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -101.41 -33.82 9.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.357 1.063 . . . . 0.0 113.174 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.41 154.93 36.55 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.372 1.469 . . . . 0.0 111.31 170.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -144.98 146.86 32.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.273 1.029 . . . . 0.0 112.078 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.3 t -146.47 170.46 16.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.438 1.895 . . . . 0.0 110.471 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.11 61.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.021 0.929 . . . . 0.0 113.463 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -79.91 -61.77 1.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.641 1.576 . . . . 0.0 111.706 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -138.45 166.92 23.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.029 2.132 . . . . 0.0 111.517 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.36 144.16 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.576 1.551 . . . . 0.0 110.6 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.8 mtp -118.42 93.36 4.09 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.018 1.727 . . . . 0.0 110.883 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.59 149.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.555 1.542 . . . . 0.0 109.904 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.8 114.25 4.92 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.363 -0.836 . . . . 0.0 111.508 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 125.668 1.587 . . . . 0.0 109.146 172.065 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 111.204 0.076 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.39 140.41 56.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.315 1.046 . . . . 0.0 111.701 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.62 134.15 55.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.819 2.047 . . . . 0.0 110.915 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.95 101.86 14.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.041 1.336 . . . . 0.0 111.347 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -81.68 96.96 7.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.893 0.877 . . . . 0.0 110.169 167.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -84.0 120.1 25.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.274 1.43 . . . . 0.0 108.87 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.72 168.84 18.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.69 0.677 . . . . 0.0 112.825 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -147.83 137.33 22.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.054 0.942 . . . . 0.0 111.699 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.8 t -80.63 102.77 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.211 1.004 . . . . 0.0 108.386 166.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.5 mt -65.52 -31.99 73.35 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.026 0.53 . . . . 0.0 111.549 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.31 174.32 13.45 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 126.928 2.204 . . . . 0.0 112.333 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -108.03 140.82 40.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.057 0.943 . . . . 0.0 111.113 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 125.533 1.533 . . . . 0.0 109.659 173.348 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 N--CA 1.468 0.434 0 CA-C-O 120.356 0.122 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.56 99.81 3.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.225 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.46 41.09 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.786 0.834 . . . . 0.0 111.051 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.62 131.55 49.89 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.721 1.608 . . . . 0.0 110.262 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -127.7 161.85 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.435 1.094 . . . . 0.0 111.791 171.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -137.27 127.12 25.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.605 1.562 . . . . 0.0 110.162 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -131.48 149.13 52.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.951 1.3 . . . . 0.0 112.888 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -137.89 148.66 45.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.631 2.372 . . . . 0.0 109.934 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.97 121.37 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.066 0.946 . . . . 0.0 112.054 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -124.26 142.82 50.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.336 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -66.29 128.64 36.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.106 0.962 . . . . 0.0 111.001 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.53 106.27 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.474 -0.767 . . . . 0.0 112.407 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.39 -13.97 47.43 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 126.445 1.974 . . . . 0.0 115.327 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -119.78 125.19 47.99 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.259 1.53 . . . . 0.0 111.582 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 m -66.43 18.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.812 2.445 . . . . 0.0 116.088 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -82.68 172.58 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.3 1.84 . . . . 0.0 112.44 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.84 89.02 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.044 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.55 -23.72 61.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.27 156.86 31.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.86 1.664 . . . . 0.0 110.389 165.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.7 p -155.66 159.68 39.78 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.435 -0.791 . . . . 0.0 111.986 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -114.33 -27.4 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.71 1.204 . . . . 0.0 112.08 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -55.43 -49.67 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.889 1.675 . . . . 0.0 112.252 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -65.47 -26.2 67.83 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.928 0.891 . . . . 0.0 113.122 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -85.81 -74.4 0.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.658 1.583 . . . . 0.0 111.351 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -169.35 149.56 3.87 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.915 2.086 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.49 144.69 74.16 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.528 2.152 . . . . 0.0 111.872 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.57 112.17 19.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 110.221 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -100.05 124.94 45.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.927 0.891 . . . . 0.0 112.199 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.04 168.86 23.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.313 1.045 . . . . 0.0 113.425 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.07 126.72 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.692 1.197 . . . . 0.0 109.137 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.0 mm -49.41 113.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.527 1.531 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.16 69.09 0.66 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.668 1.604 . . . . 0.0 112.368 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -140.04 -33.76 0.57 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.158 1.383 . . . . 0.0 113.616 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.98 28.46 14.8 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.433 1.893 . . . . 0.0 114.821 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -81.36 -21.62 38.97 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.8 pt -73.8 169.22 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.853 1.661 . . . . 0.0 112.923 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -56.63 144.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.15 0.98 . . . . 0.0 112.083 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.06 73.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.007 0.923 . . . . 0.0 113.262 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.82 70.02 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 123.731 0.681 . . . . 0.0 114.349 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -93.22 -30.43 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.773 1.229 . . . . 0.0 112.353 173.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.23 -43.14 82.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 112.321 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.92 -41.96 9.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.155 1.382 . . . . 0.0 113.024 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.05 -23.81 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.708 -1.245 . . . . 0.0 113.633 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.81 -26.86 62.57 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -83.65 -44.2 14.79 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.216 1.806 . . . . 0.0 111.394 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 122.28 13.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.846 1.258 . . . . 0.0 111.987 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 159.46 15.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.452 1.501 . . . . 0.0 111.916 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -55.67 129.95 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.128 1.371 . . . . 0.0 112.464 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.9 13.68 82.29 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.43 1.014 . . . . 0.0 115.21 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -126.26 115.77 20.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.05 1.34 . . . . 0.0 111.814 -172.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -60.2 141.16 56.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.717 0.807 . . . . 0.0 112.309 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -136.98 115.1 11.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.256 1.422 . . . . 0.0 111.382 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -90.18 114.29 26.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.227 1.411 . . . . 0.0 110.594 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.39 106.56 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.249 1.42 . . . . 0.0 110.593 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.26 131.87 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.235 -0.916 . . . . 0.0 109.593 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.6 mt -121.81 139.62 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.691 1.596 . . . . 0.0 109.228 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.6 155.46 81.46 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.226 1.01 . . . . 0.0 111.969 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.65 -29.96 84.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.604 2.203 . . . . 0.0 113.308 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.66 -23.86 45.47 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 . . . . . 0 N--CA 1.477 0.877 0 C-N-CA 125.093 1.357 . . . . 0.0 113.758 -172.61 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 110.67 -0.122 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.27 148.97 27.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.027 0.931 . . . . 0.0 110.853 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -140.07 108.52 5.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.656 1.182 . . . . 0.0 110.838 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.35 122.92 18.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.351 1.061 . . . . 0.0 111.148 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 p -136.05 137.96 26.32 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.492 1.917 . . . . 0.0 109.949 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.3 168.32 25.09 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.739 2.292 . . . . 0.0 112.428 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -69.46 21.19 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.412 2.285 . . . . 0.0 115.003 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.89 -19.91 19.19 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.429 1.891 . . . . 0.0 113.888 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -98.61 -9.65 24.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.818 1.247 . . . . 0.0 113.814 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.24 26.62 6.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.299 1.84 . . . . 0.0 112.647 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.29 105.43 0.23 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 111.174 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.78 -0.02 39.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.647 1.594 . . . . 0.0 115.75 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.8 mt -100.51 136.85 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.321 1.56 . . . . 0.0 110.387 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.06 76.61 10.05 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.08 1.752 . . . . 0.0 112.971 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 140.52 57.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.137 -0.977 . . . . 0.0 112.334 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.38 152.95 32.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.397 1.879 . . . . 0.0 110.869 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -72.83 108.41 5.78 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.461 170.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.19 57.56 1.29 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.492 1.044 . . . . 0.0 113.54 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.7 ptm -135.05 154.72 51.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.768 1.627 . . . . 0.0 111.319 167.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 p -79.74 119.03 22.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.148 0.979 . . . . 0.0 110.64 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.95 158.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.823 1.649 . . . . 0.0 110.34 173.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -125.82 153.84 43.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.168 1.387 . . . . 0.0 111.465 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.49 101.47 0.28 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.382 0.991 . . . . 0.0 112.608 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -65.14 128.54 36.2 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.939 -0.742 . . . . 0.0 110.985 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -105.78 155.67 19.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.453 1.501 . . . . 0.0 111.399 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.03 -20.07 65.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.301 1.44 . . . . 0.0 113.126 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -71.65 19.83 0.06 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.983 2.113 . . . . 0.0 114.192 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.5 m120 52.02 47.63 24.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.316 2.246 . . . . 0.0 112.915 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -142.12 177.78 7.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.719 1.607 . . . . 0.0 112.109 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.8 m -145.99 113.85 6.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.361 1.064 . . . . 0.0 111.373 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.41 164.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.338 0.655 . . . . 0.0 111.406 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -136.57 136.8 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.358 1.463 . . . . 0.0 111.346 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.11 -178.99 7.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.455 1.102 . . . . 0.0 113.361 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.08 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.411 1.484 . . . . 0.0 110.538 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.2 mt -76.99 120.2 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.13 0.972 . . . . 0.0 110.661 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.96 -31.06 16.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.169 1.388 . . . . 0.0 113.531 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -153.7 150.0 28.1 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.878 1.671 . . . . 0.0 110.673 171.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -141.18 155.01 46.12 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.926 0.89 . . . . 0.0 112.661 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -153.34 174.26 14.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.172 1.789 . . . . 0.0 111.135 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 -29.44 66.88 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.47 1.108 . . . . 0.0 113.187 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.1 p -80.57 -62.76 1.58 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.017 1.727 . . . . 0.0 111.944 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -135.53 166.64 22.73 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.226 2.21 . . . . 0.0 111.405 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.83 147.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.915 1.686 . . . . 0.0 109.319 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 28.4 mtm -121.11 101.57 7.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.177 1.391 . . . . 0.0 110.15 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.3 t -97.17 150.12 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.394 1.077 . . . . 0.0 110.131 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.35 130.68 47.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.653 0.781 . . . . 0.0 111.033 166.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 . . . . . 0 CA--C 1.539 0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 111.571 176.65 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.714 0 CA-C-O 120.432 0.158 . . . . 0.0 111.098 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -65.72 143.75 57.34 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.766 1.226 . . . . 0.0 112.808 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.9 mt -125.01 123.06 39.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.13 1.372 . . . . 0.0 111.356 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.74 99.51 5.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.967 1.307 . . . . 0.0 111.159 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -79.68 99.46 7.41 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.757 0.789 . . . . 0.0 110.186 165.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -91.74 120.55 32.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.114 1.365 . . . . 0.0 109.034 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -140.94 168.7 19.15 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -148.33 140.49 24.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.079 1.351 . . . . 0.0 111.43 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.09 102.4 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 163.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.29 -33.73 71.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 111.701 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.76 -139.07 10.63 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.265 1.888 . . . . 0.0 110.675 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -150.31 165.2 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.461 1.105 . . . . 0.0 112.374 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.468 0.458 0 C-N-CA 126.221 1.809 . . . . 0.0 110.813 171.678 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.469 0.522 0 CA-C-O 120.767 0.317 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.22 101.16 7.83 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 109.593 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.28 144.13 31.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.096 1.358 . . . . 0.0 111.033 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.74 126.53 47.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.503 1.521 . . . . 0.0 109.932 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.15 156.83 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.323 1.049 . . . . 0.0 110.969 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -139.16 135.68 34.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.68 1.192 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -138.3 157.2 46.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.781 1.232 . . . . 0.0 113.574 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -139.62 152.85 47.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.439 1.896 . . . . 0.0 110.763 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.85 119.13 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.583 1.553 . . . . 0.0 109.693 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -139.13 145.66 39.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.764 1.625 . . . . 0.0 111.176 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.22 133.18 45.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.454 0.702 . . . . 0.0 111.215 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -57.74 111.33 1.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.155 0.982 . . . . 0.0 111.752 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 23.24 33.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.64 1.114 . . . . 0.0 115.634 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -128.21 165.48 20.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.119 1.46 . . . . 0.0 113.579 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.2 m -99.15 -8.35 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.428 1.891 . . . . 0.0 113.865 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 166.98 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.643 0.777 . . . . 0.0 111.704 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.35 116.04 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.404 1.482 . . . . 0.0 108.751 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.58 -48.73 37.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.588 0.755 . . . . 0.0 111.026 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.27 162.04 36.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.16 1.384 . . . . 0.0 112.025 170.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -161.52 168.4 23.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.141 . . . . 0.0 112.494 168.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -123.82 -1.71 8.37 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 164.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.54 -60.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.733 1.613 . . . . 0.0 112.156 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -73.67 -22.98 59.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -74.5 -72.94 0.26 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.934 1.693 . . . . 0.0 112.067 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -169.7 118.65 0.55 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.083 2.153 . . . . 0.0 109.846 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -62.76 152.04 80.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.862 2.374 . . . . 0.0 112.706 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.8 tp -83.6 98.56 9.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.629 1.572 . . . . 0.0 110.873 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -71.11 117.51 12.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.357 1.463 . . . . 0.0 110.98 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -144.76 175.43 10.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.441 1.096 . . . . 0.0 113.129 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -113.48 137.52 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.456 1.502 . . . . 0.0 110.138 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -51.65 110.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.166 1.386 . . . . 0.0 111.086 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.94 -1.61 24.31 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.723 1.63 . . . . 0.0 115.677 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 m -70.69 -44.88 66.04 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.338 1.569 . . . . 0.0 112.531 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.3 m120 50.59 31.5 5.76 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.16 2.184 . . . . 0.0 116.013 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -13.81 61.19 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -69.63 168.31 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.843 1.657 . . . . 0.0 113.363 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -58.73 144.62 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.403 1.081 . . . . 0.0 111.953 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.7 -37.01 77.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.39 -29.11 73.56 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.672 -0.643 . . . . 0.0 113.82 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.03 -32.47 17.57 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 111.963 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -54.56 -47.31 73.41 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.061 1.344 . . . . 0.0 111.992 172.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -71.43 -10.81 60.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.67 -50.99 5.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.104 1.362 . . . . 0.0 112.485 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.04 -24.89 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -66.09 -19.99 66.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -106.0 -17.89 14.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.128 1.371 . . . . 0.0 114.187 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.97 118.65 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.667 1.187 . . . . 0.0 112.554 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -83.96 158.62 21.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 112.4 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -56.89 130.17 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.079 1.352 . . . . 0.0 111.595 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.97 11.81 78.88 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.977 1.275 . . . . 0.0 115.271 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -116.43 112.37 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.901 1.351 . . . . 0.0 111.763 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -60.33 143.21 53.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.189 0.995 . . . . 0.0 112.165 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -142.23 145.27 33.91 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.768 1.227 . . . . 0.0 111.476 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -126.08 113.16 16.72 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.869 1.668 . . . . 0.0 109.864 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -118.69 111.34 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.678 1.191 . . . . 0.0 110.533 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 t -76.45 128.39 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.919 0.888 . . . . 0.0 109.512 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 mt -124.83 139.4 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.461 1.505 . . . . 0.0 109.822 -174.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.09 151.66 97.03 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 112.133 173.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.6 -36.24 43.44 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.587 2.191 . . . . 0.0 112.508 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -67.31 -21.08 65.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.869 1.268 . . . . 0.0 114.166 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 124.761 1.224 . . . . 0.0 113.216 177.877 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.9 p90 . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.26 115.05 21.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.078 -1.014 . . . . 0.0 110.533 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -102.44 118.85 37.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.664 1.186 . . . . 0.0 110.814 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.47 128.83 36.79 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.82 0.848 . . . . 0.0 110.676 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 139.86 17.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.31 1.844 . . . . 0.0 109.613 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.09 154.95 62.17 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.458 2.105 . . . . 0.0 112.684 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -68.95 -4.56 17.16 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.39 -35.18 37.73 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 112.963 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -88.48 -2.97 58.89 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.323 1.449 . . . . 0.0 113.797 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -131.79 25.52 4.68 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.314 2.246 . . . . 0.0 112.326 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.64 105.49 1.24 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.793 1.637 . . . . 0.0 111.426 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.72 -9.14 56.83 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.725 1.631 . . . . 0.0 115.048 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.5 mt -88.38 126.13 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 109.634 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.36 130.92 45.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.609 0.763 . . . . 0.0 112.058 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.2 mt -124.77 138.57 54.27 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.723 1.609 . . . . 0.0 110.521 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -154.15 158.04 39.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.202 1.401 . . . . 0.0 111.01 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.13 119.32 10.61 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.949 -1.095 . . . . 0.0 111.16 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.94 43.11 5.16 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.09 0.852 . . . . 0.0 115.2 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 ptm -132.89 152.13 51.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.84 1.256 . . . . 0.0 111.889 168.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -74.03 134.09 42.98 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.351 1.06 . . . . 0.0 111.327 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.62 146.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.003 2.121 . . . . 0.0 110.592 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 133.89 41.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.94 1.296 . . . . 0.0 111.425 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.17 93.34 0.55 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.216 1.388 . . . . 0.0 112.196 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -63.74 144.46 57.01 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.961 0.88 . . . . 0.0 111.237 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 t -129.26 156.52 43.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.063 1.345 . . . . 0.0 112.435 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.14 -17.16 64.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.503 1.921 . . . . 0.0 113.474 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -74.81 16.63 0.27 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.34 1.856 . . . . 0.0 113.714 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.86 48.75 17.42 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.108 2.163 . . . . 0.0 112.511 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -143.36 176.32 9.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.96 1.704 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -146.62 113.53 6.12 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.674 1.189 . . . . 0.0 111.642 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.0 169.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.403 0.681 . . . . 0.0 111.717 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -135.72 124.83 24.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.426 1.49 . . . . 0.0 110.595 172.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.25 175.42 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.669 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -110.84 131.98 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 111.534 -171.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 56.7 mt -67.81 134.27 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.854 1.662 . . . . 0.0 111.304 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -112.39 -34.35 5.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.393 1.877 . . . . 0.0 113.299 -174.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -151.82 162.49 40.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.147 1.379 . . . . 0.0 110.855 169.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.81 158.36 43.74 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.9 m -140.0 176.6 8.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.159 2.184 . . . . 0.0 111.081 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.94 76.09 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 67.4 p -128.73 -3.57 5.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.842 1.657 . . . . 0.0 114.419 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -140.98 166.38 24.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.974 1.709 . . . . 0.0 111.679 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.71 157.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.602 1.561 . . . . 0.0 110.419 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.1 mtp -120.22 123.02 42.22 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.79 1.636 . . . . 0.0 109.771 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.69 143.46 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.35 1.46 . . . . 0.0 109.357 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -69.84 110.89 5.21 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.75 -0.594 . . . . 0.0 111.366 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 CA--C 1.541 0.616 0 C-N-CA 126.733 2.013 . . . . 0.0 111.779 178.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.868 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -66.6 145.33 55.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.89 1.676 . . . . 0.0 112.43 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.9 mt -133.92 147.75 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.294 1.437 . . . . 0.0 111.728 -174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.47 103.25 15.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 111.196 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -79.81 97.6 6.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.288 0.635 . . . . 0.0 109.405 161.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -89.63 140.42 29.57 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 170.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -150.34 169.39 21.51 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -146.25 150.5 35.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.391 1.476 . . . . 0.0 111.237 169.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.54 109.2 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 108.548 167.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.72 -36.85 84.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.184 0.593 . . . . 0.0 111.114 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.2 -164.07 25.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.114 1.816 . . . . 0.0 111.963 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.31 157.7 45.43 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.663 1.585 . . . . 0.0 111.291 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.724 0 C-N-CA 124.971 1.309 . . . . 0.0 111.269 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.051 0.453 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -144.32 129.11 18.31 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.101 0.961 . . . . 0.0 111.011 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -88.37 76.97 8.24 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.079 1.351 . . . . 0.0 111.247 175.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -137.72 171.26 14.71 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.264 1.825 . . . . 0.0 111.876 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -63.99 162.94 13.06 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.199 1.399 . . . . 0.0 113.433 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.77 94.55 3.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.968 1.307 . . . . 0.0 110.968 174.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -70.51 13.62 0.17 Allowed 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.893 1.677 . . . . 0.0 114.52 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.9 m -71.25 -18.02 62.46 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.984 1.714 . . . . 0.0 114.494 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -86.12 131.02 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.686 1.195 . . . . 0.0 110.212 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -61.38 152.04 30.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.315 1.846 . . . . 0.0 113.689 177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -139.85 152.72 46.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.61 1.564 . . . . 0.0 111.331 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.19 99.58 12.31 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.173 1.389 . . . . 0.0 110.679 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.08 106.04 13.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.546 1.539 . . . . 0.0 111.273 174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.9 mp -81.63 134.86 35.53 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.09 0.956 . . . . 0.0 110.671 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.4 pt -132.46 167.16 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 C-N-CA 125.48 1.512 . . . . 0.0 111.731 170.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -143.5 136.0 27.21 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.446 1.899 . . . . 0.0 110.394 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -136.3 153.04 51.29 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.419 1.488 . . . . 0.0 113.89 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -141.03 121.73 14.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.476 2.31 . . . . 0.0 109.483 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -102.12 103.46 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.498 1.119 . . . . 0.0 110.186 178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -113.92 159.32 20.02 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.694 1.598 . . . . 0.0 110.623 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.55 147.2 29.76 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.002 -1.061 . . . . 0.0 111.506 171.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -64.14 125.57 24.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.817 0.847 . . . . 0.0 111.389 173.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.01 -52.91 4.69 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.47 1.51 . . . . 0.0 114.201 177.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.8 m -61.16 143.79 54.87 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.52 1.528 . . . . 0.0 112.818 178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.2 m -79.27 -13.91 59.36 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -65.87 155.98 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.708 1.203 . . . . 0.0 111.362 177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.3 144.12 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.407 1.483 . . . . 0.0 110.664 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.58 -52.87 4.68 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.641 0.776 . . . . 0.0 110.256 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -155.9 157.83 36.97 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.626 1.57 . . . . 0.0 111.048 174.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.3 p -151.05 144.7 25.02 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.295 1.038 . . . . 0.0 111.828 172.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -102.47 -17.85 15.6 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 167.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -56.49 -46.36 82.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.636 1.574 . . . . 0.0 112.019 -176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 t -68.54 -29.81 68.46 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.334 0.865 . . . . 0.0 113.334 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -78.09 -72.97 0.34 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.777 1.631 . . . . 0.0 111.748 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -175.48 151.91 1.32 Allowed Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 128.171 2.588 . . . . 0.0 110.016 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.92 170.86 15.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.66 2.906 . . . . 0.0 113.428 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.3 tt -124.0 108.55 12.51 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.251 1.42 . . . . 0.0 110.556 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.8 141.65 32.15 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.728 1.211 . . . . 0.0 112.968 170.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -144.12 164.74 29.8 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.256 1.423 . . . . 0.0 111.364 166.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.7 mm -84.1 138.68 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.702 0.801 . . . . 0.0 110.139 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.3 mm -47.86 109.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.523 1.529 . . . . 0.0 111.3 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 119.81 -27.79 6.68 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.244 1.878 . . . . 0.0 114.315 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.6 m -85.25 72.77 10.69 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 118.922 1.361 . . . . 0.0 111.466 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -78.3 72.58 4.83 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 120.76 -1.213 . . . . 0.0 111.854 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -72.38 -11.84 60.86 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.0 pt -66.76 169.32 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 127.186 2.194 . . . . 0.0 113.188 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.3 pt -58.84 147.44 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 124.909 1.284 . . . . 0.0 112.46 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.65 -33.6 74.25 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -173.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.53 -36.84 93.66 Favored Glycine 0 CA--C 1.536 1.355 0 O-C-N 121.194 -0.941 . . . . 0.0 113.109 174.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 tp -80.87 -28.11 36.11 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.744 1.218 . . . . 0.0 112.595 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -57.39 -42.78 82.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.431 1.092 . . . . 0.0 112.64 173.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -75.23 -14.93 60.56 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.67 -47.83 8.36 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.969 1.308 . . . . 0.0 112.645 176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.02 -30.71 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.403 1.081 . . . . 0.0 113.615 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -69.09 -21.98 64.02 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -97.23 -23.04 16.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.811 1.645 . . . . 0.0 113.453 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.38 127.23 32.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.979 1.311 . . . . 0.0 112.28 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.3 mp0 -83.62 162.81 20.68 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.925 0.89 . . . . 0.0 111.966 172.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.7 tt -54.5 133.19 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 C-N-CA 125.06 1.344 . . . . 0.0 111.692 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.42 13.37 81.71 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.44 1.019 . . . . 0.0 115.307 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -121.48 112.73 18.88 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.089 1.356 . . . . 0.0 111.832 -174.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -59.92 141.01 56.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.046 0.938 . . . . 0.0 112.029 172.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -141.9 144.03 33.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.95 1.3 . . . . 0.0 111.042 174.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -126.29 110.96 13.99 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.672 1.189 . . . . 0.0 110.287 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.4 m -113.84 107.97 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 C-N-CA 124.884 1.274 . . . . 0.0 110.839 -178.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 41.0 t -72.08 126.64 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 124.201 1.0 . . . . 0.0 109.657 173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 82.0 mt -124.69 138.56 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 125.694 1.597 . . . . 0.0 109.065 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -70.93 160.32 82.68 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.14 0.976 . . . . 0.0 112.178 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -67.05 -38.89 14.93 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.5 2.133 . . . . 0.0 111.786 -175.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -68.46 -12.48 61.25 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.117 1.767 . . . . 0.0 114.468 174.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.65 -1.02 26.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.956 1.702 . . . . 0.0 113.046 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -115.34 -65.28 1.21 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.525 1.53 . . . . 0.0 112.09 177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -127.91 -20.33 3.87 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -176.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.2 25.18 68.0 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.436 1.334 . . . . 0.0 116.436 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 t -64.22 -41.94 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 124.445 1.098 . . . . 0.0 112.38 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.97 92.04 2.69 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.478 1.111 . . . . 0.0 110.837 -172.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.89 163.45 7.61 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.385 1.474 . . . . 0.0 113.379 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.9 p -113.77 34.92 4.31 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.641 1.976 . . . . 0.0 112.782 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.1 t -123.48 106.42 10.6 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.283 1.833 . . . . 0.0 110.715 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -137.04 139.43 41.35 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.243 1.817 . . . . 0.0 110.863 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.7 mp -80.84 149.7 29.43 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 121.395 -0.816 . . . . 0.0 111.342 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -134.99 125.22 26.15 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.994 1.718 . . . . 0.0 110.24 177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -74.43 119.05 18.1 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.024 0.93 . . . . 0.0 110.611 173.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.34 134.52 25.57 Favored Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 126.082 1.753 . . . . 0.0 109.189 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.22 144.11 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.245 1.963 . . . . 0.0 111.582 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 23.3 mmm-85 -62.07 -14.17 33.61 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 174.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.26 -31.34 61.48 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.58 1.552 . . . . 0.0 113.267 169.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -70.56 -11.58 61.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.415 1.086 . . . . 0.0 113.901 173.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -132.63 16.88 4.35 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.883 1.673 . . . . 0.0 113.317 -167.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -56.76 -18.83 14.05 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.977 1.843 . . . . 0.0 115.977 -172.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -119.99 6.7 12.09 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 125.823 1.678 . . . . 0.0 115.426 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.6 pt -137.6 114.86 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.837 1.655 . . . . 0.0 111.31 -174.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -66.39 154.03 41.21 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.523 1.129 . . . . 0.0 113.39 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.4 mt -132.74 162.85 30.37 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.256 1.823 . . . . 0.0 111.121 -171.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -155.74 162.75 40.47 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.194 1.398 . . . . 0.0 110.599 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -69.88 129.49 39.67 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 120.431 -1.418 . . . . 0.0 110.436 166.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.99 65.47 Favored Glycine 0 CA--C 1.538 1.504 0 N-CA-C 115.724 1.05 . . . . 0.0 115.724 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.5 ptp -97.26 150.2 21.19 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.282 1.541 . . . . 0.0 112.682 171.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.2 p -72.47 108.44 5.55 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.308 1.443 . . . . 0.0 111.039 167.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -105.73 161.63 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.717 1.607 . . . . 0.0 110.934 175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.52 154.55 40.4 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.12 1.368 . . . . 0.0 111.484 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -145.73 108.71 0.47 Allowed Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.353 0.978 . . . . 0.0 113.084 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -73.33 111.4 8.42 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.026 0.93 . . . . 0.0 111.575 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.3 t -80.83 158.19 25.47 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.563 1.145 . . . . 0.0 111.924 174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -63.98 -17.36 63.22 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.386 1.474 . . . . 0.0 113.682 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -75.08 20.41 0.14 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 125.845 1.658 . . . . 0.0 113.911 175.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 50.22 48.0 22.82 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 127.346 2.259 . . . . 0.0 113.073 -174.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -142.36 173.41 11.55 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.926 1.69 . . . . 0.0 111.736 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.0 m -141.07 107.84 5.38 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.629 1.171 . . . . 0.0 110.643 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.2 166.44 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 O-C-N 121.753 -0.592 . . . . 0.0 111.419 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -128.04 137.48 52.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.526 1.53 . . . . 0.0 110.879 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.8 178.98 9.29 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.38 1.072 . . . . 0.0 113.206 -170.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -126.82 125.65 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.186 0.994 . . . . 0.0 111.394 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 27.2 mt -72.78 129.02 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.475 1.11 . . . . 0.0 111.128 178.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.4 mmpt? -98.06 -35.89 10.28 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.692 1.597 . . . . 0.0 113.305 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -150.7 147.98 28.01 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.141 1.376 . . . . 0.0 110.164 172.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -140.01 136.93 34.22 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.169 0.987 . . . . 0.0 111.704 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.8 t -137.07 168.7 19.09 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.189 1.796 . . . . 0.0 110.154 172.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.19 -20.33 63.12 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.099 0.96 . . . . 0.0 113.528 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.3 p -83.82 -62.05 1.67 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.233 1.813 . . . . 0.0 111.75 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -136.0 165.03 26.63 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.007 2.123 . . . . 0.0 111.707 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.2 p -131.44 148.45 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.634 1.573 . . . . 0.0 110.328 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 89.1 mmm -120.64 105.28 10.64 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 126.727 2.011 . . . . 0.0 109.332 -172.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 t -112.02 133.76 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.545 1.138 . . . . 0.0 110.237 -172.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.48 129.99 41.26 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.722 0.809 . . . . 0.0 111.32 172.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -136.34 163.81 29.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.656 1.582 . . . . 0.0 111.17 170.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -79.98 169.55 17.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.324 1.05 . . . . 0.0 112.701 167.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.59 144.6 17.51 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.571 1.148 . . . . 0.0 110.497 177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.38 -9.19 24.84 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.147 2.565 . . . . 0.0 114.195 -175.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.8 mp -70.6 -17.93 62.89 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.53 1.532 . . . . 0.0 112.967 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.76 -176.33 0.64 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.483 1.513 . . . . 0.0 113.429 173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -64.1 176.75 9.34 Favored Glycine 0 CA--C 1.543 1.81 0 O-C-N 121.334 -0.854 . . . . 0.0 114.184 166.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.71 168.65 19.12 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 127.158 2.183 . . . . 0.0 111.331 177.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -69.75 141.95 53.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.865 1.266 . . . . 0.0 112.369 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -125.64 147.97 49.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.534 1.534 . . . . 0.0 110.974 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -94.77 96.9 9.68 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.965 1.706 . . . . 0.0 111.074 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -76.86 95.72 4.15 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.799 0.84 . . . . 0.0 109.801 164.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -86.35 143.23 27.96 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.554 -0.716 . . . . 0.0 110.216 169.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -151.69 170.33 19.99 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 113.232 0.826 . . . . 0.0 113.232 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 25.2 ttpp -145.92 142.68 28.97 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.12 1.368 . . . . 0.0 111.306 168.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.25 101.97 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.438 1.095 . . . . 0.0 108.445 167.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 79.4 mt -62.82 -37.4 86.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.243 1.017 . . . . 0.0 111.574 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 133.78 166.15 11.23 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.049 1.785 . . . . 0.0 113.29 172.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -98.54 146.92 25.3 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.492 1.117 . . . . 0.0 111.815 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -142.08 147.85 37.44 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.662 1.585 . . . . 0.0 111.31 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -74.51 136.58 42.2 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 122.983 0.513 . . . . 0.0 110.379 170.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.8 m -133.89 160.3 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.777 1.631 . . . . 0.0 111.062 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.6 m -135.86 156.66 48.45 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.995 1.318 . . . . 0.0 112.087 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -90.94 55.48 2.93 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.16 1.384 . . . . 0.0 111.567 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -138.19 -73.19 0.41 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.77 1.228 . . . . 0.0 111.43 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 . . . . . 0 C--O 1.253 1.24 0 C-N-CA 125.187 1.395 . . . . 0.0 113.399 173.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 44.15 47.43 7.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 127.031 2.132 . . . . 0.0 113.98 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.6 p-10 -126.92 22.37 6.75 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.403 1.881 . . . . 0.0 113.724 -169.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.5 t-160 -98.16 70.3 2.05 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.771 1.628 . . . . 0.0 110.978 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -76.29 150.27 36.98 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.549 1.14 . . . . 0.0 111.985 174.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -120.39 148.18 44.11 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.954 1.702 . . . . 0.0 111.551 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -77.67 5.35 9.43 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.719 1.608 . . . . 0.0 114.083 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.1 m -69.36 8.27 0.64 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 126.473 1.909 . . . . 0.0 114.741 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.2 mm -55.4 144.34 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.561 1.944 . . . . 0.0 111.261 176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -111.65 167.32 10.43 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.117 1.767 . . . . 0.0 111.812 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -146.03 153.04 40.3 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.062 1.345 . . . . 0.0 111.863 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 102.77 10.35 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.817 1.247 . . . . 0.0 110.618 178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.68 118.88 24.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.038 1.335 . . . . 0.0 111.132 175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.1 mp -98.83 129.46 45.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.252 1.421 . . . . 0.0 110.775 177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.4 pt -128.23 165.46 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.654 1.182 . . . . 0.0 111.896 171.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -139.46 136.27 34.43 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.913 1.685 . . . . 0.0 110.121 174.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -136.58 154.08 50.79 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 113.723 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.75 121.11 12.34 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 109.403 -177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.95 111.47 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 110.472 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -121.27 134.67 55.17 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.849 1.659 . . . . 0.0 109.229 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -63.67 152.77 38.11 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 120.984 -1.072 . . . . 0.0 111.103 165.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -71.46 151.63 43.8 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.394 -0.816 . . . . 0.0 110.832 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.6 -66.29 3.95 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 124.826 1.203 . . . . 0.0 113.987 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.2 t -65.29 141.58 58.56 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 118.01 0.905 . . . . 0.0 113.096 -176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.5 m -82.06 -15.33 53.9 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -73.69 176.18 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.284 1.033 . . . . 0.0 111.356 173.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.74 143.22 41.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.134 1.374 . . . . 0.0 111.274 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.2 mt -75.84 -57.15 4.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.126 0.971 . . . . 0.0 111.011 178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -155.18 157.6 37.64 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.876 1.27 . . . . 0.0 111.746 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 81.3 p -155.02 137.06 14.67 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.777 1.231 . . . . 0.0 112.179 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.67 -18.06 19.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 166.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -56.94 -43.66 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.643 1.577 . . . . 0.0 112.047 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.9 t -72.25 -8.82 56.89 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.088 1.355 . . . . 0.0 113.976 176.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -107.87 -73.32 0.69 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.364 1.866 . . . . 0.0 110.889 -170.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -167.52 152.53 6.82 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 127.966 2.507 . . . . 0.0 110.357 176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -68.79 159.71 52.64 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.78 2.32 . . . . 0.0 112.553 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.8 tt -104.2 108.93 20.55 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.62 1.568 . . . . 0.0 109.544 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.97 130.76 38.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.489 1.516 . . . . 0.0 112.158 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -146.6 162.88 37.46 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.185 0.994 . . . . 0.0 111.963 167.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 52.0 mm -81.62 137.91 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.68 0.792 . . . . 0.0 109.033 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.9 mm -56.69 104.58 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.507 1.123 . . . . 0.0 110.879 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.05 39.41 0.23 Allowed Glycine 0 CA--C 1.541 1.681 0 C-N-CA 125.508 1.528 . . . . 0.0 116.116 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.6 m -122.79 -31.66 3.65 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 119.141 1.47 . . . . 0.0 114.256 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 57.59 31.06 19.77 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 125.668 1.587 . . . . 0.0 114.425 174.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -69.74 -19.79 63.53 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.6 pt -75.84 168.0 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.298 1.439 . . . . 0.0 112.76 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.7 pt -59.16 148.14 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.556 1.143 . . . . 0.0 111.96 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.13 -40.04 84.2 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.94 0.896 . . . . 0.0 113.298 -177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.88 68.84 Favored Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.051 0.834 . . . . 0.0 114.656 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 28.3 tp -94.12 -36.62 11.99 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.382 1.473 . . . . 0.0 111.555 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -56.17 -44.25 79.15 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.401 1.081 . . . . 0.0 111.921 172.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -76.67 12.31 1.35 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.886 1.274 . . . . 0.0 113.802 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.52 -45.24 2.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.973 1.709 . . . . 0.0 113.121 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.5 m -55.5 -28.19 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -177.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -62.76 -16.45 57.9 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.007 1.484 . . . . 0.0 115.007 178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -110.92 -5.35 14.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.142 1.377 . . . . 0.0 113.627 176.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.95 114.02 18.55 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.012 1.325 . . . . 0.0 112.331 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -71.57 157.18 38.45 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.833 0.825 . . . . 0.0 112.369 173.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.18 135.65 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.53 1.532 . . . . 0.0 112.027 173.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.71 16.34 74.15 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.63 1.11 . . . . 0.0 115.094 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -122.19 111.7 17.28 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.318 1.447 . . . . 0.0 111.178 -173.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -58.5 142.77 47.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.78 0.832 . . . . 0.0 112.163 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -142.46 141.21 32.13 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.777 1.231 . . . . 0.0 111.19 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -125.79 105.23 8.81 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.272 1.429 . . . . 0.0 110.329 -175.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.0 m -110.67 106.8 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.865 1.266 . . . . 0.0 111.109 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.8 t -73.58 128.99 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.371 1.069 . . . . 0.0 109.783 174.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.96 145.79 31.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.939 1.696 . . . . 0.0 109.664 -177.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.63 156.96 81.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 C-N-CA 125.364 1.466 . . . . 0.0 113.283 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -65.15 -3.14 6.77 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.036 3.157 . . . . 0.0 116.634 -176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -115.83 -4.06 12.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.602 1.161 . . . . 0.0 113.502 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -111.49 -6.45 14.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.503 1.521 . . . . 0.0 113.637 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -138.04 91.06 2.54 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.87 1.668 . . . . 0.0 111.352 178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 40.21 67.46 0.49 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.716 2.006 . . . . 0.0 112.547 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.71 100.99 0.48 Allowed Glycine 0 CA--C 1.531 1.04 0 C-N-CA 124.742 1.163 . . . . 0.0 114.172 -170.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.3 m -126.06 139.6 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.83 1.652 . . . . 0.0 111.181 175.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -71.09 154.44 41.75 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.18 1.392 . . . . 0.0 111.363 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.93 131.25 47.11 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.176 -0.952 . . . . 0.0 110.343 169.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -61.61 -20.81 63.75 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 73.9 m -144.97 82.14 1.66 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.826 2.05 . . . . 0.0 111.22 -176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -76.78 156.42 32.36 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.11 -0.994 . . . . 0.0 111.991 171.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.53 138.78 45.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.132 1.773 . . . . 0.0 110.456 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -134.02 113.35 12.03 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.501 1.12 . . . . 0.0 111.238 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -79.17 96.42 5.87 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.931 1.292 . . . . 0.0 111.33 177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 73.4 t -94.74 137.33 22.47 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.319 1.847 . . . . 0.0 109.799 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.7 158.51 50.38 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.901 2.401 . . . . 0.0 112.13 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -76.27 65.24 2.18 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.371 1.068 . . . . 0.0 111.813 176.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -133.3 -36.43 0.99 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.421 1.889 . . . . 0.0 112.599 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -74.02 -12.37 60.61 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 171.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -126.14 28.54 6.04 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.977 1.711 . . . . 0.0 112.631 -171.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.93 -11.94 60.77 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -128.95 5.42 6.46 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.772 1.653 . . . . 0.0 115.33 -178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 pt -138.21 122.29 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.509 1.924 . . . . 0.0 110.463 -177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? -68.33 154.87 40.92 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.1 0.96 . . . . 0.0 113.34 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.3 mt -133.16 159.4 40.26 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.482 1.913 . . . . 0.0 110.832 -172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -155.53 164.36 38.77 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 110.574 175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -67.12 132.39 47.73 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.626 -1.296 . . . . 0.0 110.599 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 69.85 43.59 65.68 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.188 0.899 . . . . 0.0 114.655 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.38 145.3 47.31 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.55 1.14 . . . . 0.0 111.952 170.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 50.4 m -68.96 123.93 22.35 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.656 1.182 . . . . 0.0 110.679 171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.33 155.58 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.514 1.526 . . . . 0.0 111.398 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -90.37 144.72 25.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.455 1.102 . . . . 0.0 111.608 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.03 96.94 0.49 Allowed Glycine 0 CA--C 1.527 0.838 0 C-N-CA 125.439 1.495 . . . . 0.0 111.762 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -65.31 144.31 57.21 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 118.267 1.034 . . . . 0.0 111.261 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.1 t -125.27 154.61 41.42 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.244 1.418 . . . . 0.0 112.151 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.4 -15.65 60.9 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.618 1.967 . . . . 0.0 113.65 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -75.38 15.71 0.43 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 126.44 1.896 . . . . 0.0 113.777 170.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.0 m120 54.53 48.53 20.27 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 127.113 2.165 . . . . 0.0 112.564 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -142.7 179.96 6.68 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.764 1.626 . . . . 0.0 112.202 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.6 m -145.73 127.91 15.71 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.563 1.145 . . . . 0.0 111.766 -176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -98.52 172.8 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 124.998 1.319 . . . . 0.0 112.104 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -121.19 119.98 33.88 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.183 1.793 . . . . 0.0 109.924 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -136.25 177.99 7.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.262 1.825 . . . . 0.0 112.415 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -128.23 131.15 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.165 1.386 . . . . 0.0 110.001 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 11.9 mt -72.47 129.02 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.199 1.0 . . . . 0.0 110.663 178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -93.98 -43.33 8.59 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.83 1.252 . . . . 0.0 112.359 177.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -144.45 152.74 41.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.004 1.322 . . . . 0.0 111.1 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.97 148.65 34.02 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.805 1.242 . . . . 0.0 112.431 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.7 t -152.34 171.51 17.89 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.724 2.01 . . . . 0.0 110.592 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.28 -24.5 64.88 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.562 1.145 . . . . 0.0 113.352 171.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.2 p -84.31 -61.43 1.81 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.456 1.903 . . . . 0.0 112.571 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -137.27 166.02 24.78 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.277 2.231 . . . . 0.0 111.764 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.5 p -137.21 137.23 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.693 1.597 . . . . 0.0 110.562 177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 26.3 mmm -109.85 99.44 8.58 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 126.737 2.015 . . . . 0.0 109.601 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.0 m -98.2 149.89 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.346 1.059 . . . . 0.0 111.328 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -73.97 141.76 45.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.495 0.718 . . . . 0.0 111.694 174.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -137.78 165.54 26.19 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.264 1.425 . . . . 0.0 111.697 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -147.19 92.43 2.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.278 1.431 . . . . 0.0 110.521 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -86.26 131.1 47.33 Favored Pre-proline 0 CA--C 1.545 0.771 0 C-N-CA 123.478 0.711 . . . . 0.0 110.565 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.07 -16.99 32.05 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.855 2.37 . . . . 0.0 114.084 -174.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 52.5 mt -111.31 77.07 1.01 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.995 1.718 . . . . 0.0 109.968 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.96 173.46 16.76 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.606 1.163 . . . . 0.0 113.34 -177.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 155.06 -179.45 31.08 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.857 2.17 . . . . 0.0 113.321 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 8.3 ptmt -139.36 165.98 25.78 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 126.032 1.733 . . . . 0.0 112.868 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.4 p -63.97 137.21 57.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.99 1.316 . . . . 0.0 113.227 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 mt -123.12 125.51 45.3 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.339 1.456 . . . . 0.0 111.842 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.97 96.39 6.41 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.177 1.391 . . . . 0.0 111.157 170.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -76.79 97.47 4.53 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.636 0.774 . . . . 0.0 109.233 162.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -87.34 142.75 27.65 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.285 -0.884 . . . . 0.0 110.111 171.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -150.97 170.75 18.58 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -148.72 137.8 21.62 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.167 1.387 . . . . 0.0 111.183 169.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 56.6 t -80.95 103.02 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.46 1.104 . . . . 0.0 108.341 166.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 30.9 mt -66.89 -28.3 68.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.906 0.482 . . . . 0.0 112.139 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.13 -179.01 16.6 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 126.612 2.053 . . . . 0.0 112.254 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -115.49 154.76 28.74 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.049 0.94 . . . . 0.0 112.03 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -132.71 124.79 28.84 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.691 1.596 . . . . 0.0 111.108 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -70.72 127.07 31.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.72 1.208 . . . . 0.0 110.337 175.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.5 m -105.88 130.77 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.597 1.159 . . . . 0.0 111.342 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.2 m -146.23 157.38 43.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.296 1.439 . . . . 0.0 111.966 -176.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -88.17 -9.55 52.76 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.671 1.188 . . . . 0.0 113.601 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -69.79 -46.49 65.63 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.062 1.345 . . . . 0.0 112.753 -174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--O 1.253 1.289 0 C-N-CA 125.721 1.608 . . . . 0.0 113.179 172.326 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtm . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -154.45 175.38 13.66 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.12 1.768 . . . . 0.0 110.954 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -60.53 147.79 40.16 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.795 0.838 . . . . 0.0 112.141 174.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -74.26 -83.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.468 1.107 . . . . 0.0 111.458 175.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -160.04 165.33 32.09 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.263 1.425 . . . . 0.0 111.24 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 53.4 mt -76.52 152.33 36.08 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.881 0.872 . . . . 0.0 111.925 168.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -140.69 109.55 6.04 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.831 1.652 . . . . 0.0 110.034 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.8 m -68.65 -27.65 66.19 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 113.529 0.937 . . . . 0.0 113.529 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 22.1 mm -73.76 145.18 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.467 1.507 . . . . 0.0 109.621 172.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -63.29 160.91 14.84 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 121.492 -0.755 . . . . 0.0 112.745 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -146.76 145.0 29.8 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.013 1.325 . . . . 0.0 110.483 168.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.88 104.16 7.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.006 0.923 . . . . 0.0 110.136 176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.63 143.12 29.45 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.772 1.229 . . . . 0.0 111.123 172.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -124.92 139.48 53.79 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.511 1.524 . . . . 0.0 110.767 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 29.1 pt -129.82 159.32 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.488 1.115 . . . . 0.0 111.386 170.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -133.28 134.42 43.88 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.902 1.681 . . . . 0.0 109.133 173.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -138.43 152.09 48.04 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -134.67 128.11 32.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.702 2.801 . . . . 0.0 108.828 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.6 p -107.19 119.28 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 124.294 1.038 . . . . 0.0 111.004 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.9 ttp85 -132.22 147.45 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.788 1.635 . . . . 0.0 112.166 -169.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -66.71 136.5 55.62 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.541 1.536 . . . . 0.0 110.628 174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -72.85 78.26 1.14 Allowed 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.23 1.014 . . . . 0.0 113.313 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 148.66 -53.29 0.52 Allowed Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.966 1.746 . . . . 0.0 112.33 172.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 9.3 m -68.55 147.43 51.97 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.924 1.29 . . . . 0.0 112.261 179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 55.0 p -79.05 -6.77 57.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.43 162.35 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.186 1.394 . . . . 0.0 112.086 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.9 t -126.17 108.42 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.851 1.26 . . . . 0.0 109.272 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.6 mt -66.44 -46.25 77.1 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.537 1.135 . . . . 0.0 111.839 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.38 168.58 26.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.006 1.322 . . . . 0.0 111.233 171.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -155.55 157.51 36.95 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.119 -0.988 . . . . 0.0 112.902 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -120.45 -16.08 8.43 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.064 1.346 . . . . 0.0 112.782 168.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -55.39 -60.6 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 C-N-CA 126.155 1.782 . . . . 0.0 111.912 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.1 t -69.03 -22.4 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.485 1.114 . . . . 0.0 113.035 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -79.48 -74.02 0.31 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.744 1.617 . . . . 0.0 111.711 -176.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -168.64 125.98 0.86 Allowed Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.174 1.79 . . . . 0.0 110.64 -176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.29 142.36 85.68 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.65 2.233 . . . . 0.0 112.027 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.01 101.56 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.91 1.284 . . . . 0.0 110.387 -175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.15 130.3 34.59 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.202 1.401 . . . . 0.0 112.035 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -153.41 169.46 23.08 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.085 1.354 . . . . 0.0 112.47 173.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 33.5 mm -94.49 139.02 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.334 1.053 . . . . 0.0 108.706 169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.4 111.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 125.814 1.646 . . . . 0.0 112.14 -176.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.38 74.31 0.69 Allowed Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.962 1.744 . . . . 0.0 113.708 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 53.4 m -131.05 -37.79 1.26 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.039 1.336 . . . . 0.0 113.569 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 56.98 35.3 26.22 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 125.66 1.584 . . . . 0.0 114.523 172.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? -99.58 -13.48 19.41 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 -176.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.5 pt -68.92 167.24 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 124.614 1.166 . . . . 0.0 111.706 171.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.2 pt -55.71 142.34 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.619 -0.676 . . . . 0.0 110.893 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.08 -32.17 72.68 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.292 -0.88 . . . . 0.0 112.868 -173.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -55.84 -45.07 87.02 Favored Glycine 0 CA--C 1.536 1.394 0 C-N-CA 124.142 0.877 . . . . 0.0 113.207 172.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 tp -75.85 -31.1 59.17 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.355 1.062 . . . . 0.0 112.339 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -59.46 -48.31 82.12 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.616 1.166 . . . . 0.0 111.829 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -68.86 -5.44 21.13 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.63 -51.43 3.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.705 1.602 . . . . 0.0 112.852 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 10.9 p -54.95 -31.95 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.959 1.303 . . . . 0.0 114.079 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.99 -17.49 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -106.02 -7.95 17.81 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 126.736 2.014 . . . . 0.0 114.11 175.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -85.51 118.84 25.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.083 1.353 . . . . 0.0 112.337 -178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -77.33 160.21 28.97 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.914 0.886 . . . . 0.0 112.202 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.3 tt -53.59 129.34 14.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 125.506 1.522 . . . . 0.0 111.647 170.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.95 -0.19 67.22 Favored Glycine 0 CA--C 1.538 1.473 0 C-N-CA 124.787 1.184 . . . . 0.0 115.866 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -97.04 113.07 24.58 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.411 1.606 . . . . 0.0 112.087 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -55.99 135.12 52.66 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.52 0.728 . . . . 0.0 111.103 164.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -137.79 113.18 9.39 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 0.0 110.93 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.83 98.45 11.79 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.717 1.207 . . . . 0.0 110.242 172.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.3 p -99.27 153.11 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.824 0.85 . . . . 0.0 110.237 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 66.6 t -131.37 124.68 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.987 1.315 . . . . 0.0 109.988 -176.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.5 mm -116.94 134.12 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 126.115 1.766 . . . . 0.0 110.244 -169.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.64 159.12 70.7 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 125.203 1.401 . . . . 0.0 112.936 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.83 50.56 2.5 Favored 'Trans proline' 0 CA--C 1.547 1.131 0 C-N-CA 124.682 3.588 . . . . 0.0 113.839 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -137.99 1.53 2.27 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.777 2.031 . . . . 0.0 113.15 177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 25.5 tp10 -147.04 -56.66 0.25 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.447 1.499 . . . . 0.0 111.761 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.64 74.51 1.08 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.502 1.121 . . . . 0.0 111.544 173.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 42.51 70.85 0.25 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.613 2.365 . . . . 0.0 112.989 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.08 78.19 0.29 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.01 1.766 . . . . 0.0 113.808 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -132.79 130.36 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 126.884 2.073 . . . . 0.0 109.504 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -65.61 166.92 9.82 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.685 1.194 . . . . 0.0 112.654 175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -112.27 142.7 44.45 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.147 -0.971 . . . . 0.0 112.075 171.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -73.62 1.84 9.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.217 1.407 . . . . 0.0 113.846 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.8 p -145.14 52.51 1.21 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.776 2.031 . . . . 0.0 112.291 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -60.7 163.19 5.77 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.229 1.012 . . . . 0.0 112.173 169.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.7 mp -122.14 146.1 47.55 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.074 1.35 . . . . 0.0 110.216 169.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 51.8 tp60 -134.97 107.37 7.29 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.823 1.249 . . . . 0.0 110.121 173.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -71.4 121.47 18.63 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.049 0.54 . . . . 0.0 110.102 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 25.5 m -135.42 159.24 72.41 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.176 1.79 . . . . 0.0 110.724 -178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -75.21 165.21 31.46 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.325 2.016 . . . . 0.0 111.819 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -69.73 10.76 0.34 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -60.68 -43.48 97.67 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.451 1.5 . . . . 0.0 113.429 172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -69.26 -21.92 63.87 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.049 0.94 . . . . 0.0 113.379 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -132.58 50.02 2.27 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.957 1.703 . . . . 0.0 111.391 -175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.07 -27.21 67.91 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.779 1.232 . . . . 0.0 113.0 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -144.43 34.02 1.64 Allowed Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.993 1.759 . . . . 0.0 114.094 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 97.4 mt -126.64 128.82 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 126.643 1.977 . . . . 0.0 108.794 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -64.99 142.07 58.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.029 0.932 . . . . 0.0 111.762 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.8 mt -130.41 146.02 51.91 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.736 1.614 . . . . 0.0 110.403 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -156.45 145.06 20.01 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.622 1.169 . . . . 0.0 111.547 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -66.99 90.48 0.18 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.994 1.717 . . . . 0.0 110.579 174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.51 -4.37 8.15 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.869 1.7 . . . . 0.0 116.58 177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptp -74.5 159.41 32.27 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 120.482 2.141 . . . . 0.0 113.023 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.1 t -84.62 126.03 32.99 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 0.0 110.846 165.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -121.2 149.46 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.644 1.977 . . . . 0.0 110.723 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -97.78 155.72 16.9 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.499 1.12 . . . . 0.0 112.74 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.82 95.52 0.19 Allowed Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.17 1.367 . . . . 0.0 112.686 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -68.19 105.79 2.21 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.769 -0.842 . . . . 0.0 111.234 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -75.65 154.4 36.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.691 1.197 . . . . 0.0 112.169 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -65.11 -19.32 65.93 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.609 1.563 . . . . 0.0 112.661 176.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.3 13.21 0.13 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.663 1.985 . . . . 0.0 114.601 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 58.66 48.95 10.94 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.039 2.136 . . . . 0.0 112.597 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -146.57 176.82 9.54 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.533 1.933 . . . . 0.0 110.929 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 48.7 m -140.28 107.08 5.38 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.692 1.197 . . . . 0.0 111.581 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.5 pp -72.89 167.22 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 123.605 0.762 . . . . 0.0 111.8 172.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -128.34 132.3 48.6 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.977 1.711 . . . . 0.0 110.129 172.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.28 177.11 8.85 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.842 1.657 . . . . 0.0 112.509 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.413 ' H ' ' HB3' ' A' ' 125' ' ' ASP . 4.7 mp -115.75 137.99 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 125.46 1.504 . . . . 0.0 110.337 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.1 mt -79.57 114.9 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 O-C-N 120.981 -1.074 . . . . 0.0 109.524 173.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -84.46 -33.18 23.68 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.195 1.398 . . . . 0.0 112.888 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -156.69 159.78 38.7 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.11 1.364 . . . . 0.0 111.445 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -149.06 151.06 33.82 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.956 1.302 . . . . 0.0 112.669 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.1 t -154.95 -176.55 5.99 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.737 1.615 . . . . 0.0 111.657 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.09 -27.95 54.34 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.301 1.441 . . . . 0.0 113.251 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.0 p -83.1 -65.3 1.03 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.904 1.682 . . . . 0.0 111.843 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -132.38 173.18 11.55 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.099 2.16 . . . . 0.0 111.71 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -143.51 148.83 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 127.148 2.179 . . . . 0.0 109.399 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.1 mtp -122.42 100.04 6.73 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.574 1.549 . . . . 0.0 110.263 -174.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.23 140.44 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.926 1.29 . . . . 0.0 111.67 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 113' ' ' ILE . 16.8 t70 -64.81 151.06 46.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.719 0.808 . . . . 0.0 111.347 168.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -146.95 169.88 18.25 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.252 1.421 . . . . 0.0 111.684 170.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -144.21 140.65 29.43 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.701 1.6 . . . . 0.0 110.209 168.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -152.06 129.78 5.9 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 123.934 0.894 . . . . 0.0 110.861 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -73.36 -19.81 21.74 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.726 2.284 . . . . 0.0 113.847 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 65.8 mt -104.4 76.78 1.34 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.529 1.532 . . . . 0.0 109.122 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -159.23 178.52 9.9 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 126.435 1.894 . . . . 0.0 112.043 -177.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.39 166.77 36.92 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.061 1.791 . . . . 0.0 112.582 170.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -129.12 145.62 51.25 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.889 1.276 . . . . 0.0 112.582 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -66.97 145.0 55.88 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.853 1.661 . . . . 0.0 112.558 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -123.17 124.98 44.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.574 1.55 . . . . 0.0 111.446 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -83.38 139.53 32.94 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.655 0.782 . . . . 0.0 111.444 169.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.83 95.21 4.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.523 1.929 . . . . 0.0 108.78 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -81.83 112.32 18.85 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.437 1.095 . . . . 0.0 108.572 171.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -133.17 169.4 16.92 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 7.7 ttpm? -147.25 139.11 24.25 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 125.319 1.448 . . . . 0.0 110.579 173.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 67.5 t -82.59 100.9 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 165.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.23 -17.53 64.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.259 1.023 . . . . 0.0 112.568 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 115.57 -171.1 13.55 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 125.786 1.66 . . . . 0.0 112.735 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -125.93 151.44 46.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.128 0.971 . . . . 0.0 112.48 176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -128.6 114.72 17.04 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.17 1.788 . . . . 0.0 111.04 -177.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -77.22 92.66 3.86 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.857 1.663 . . . . 0.0 110.316 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.5 m -80.68 163.97 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 125.165 1.386 . . . . 0.0 112.672 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.2 t -60.31 156.3 15.96 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.23 1.012 . . . . 0.0 112.537 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.25 -16.24 43.26 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.371 1.469 . . . . 0.0 113.913 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -69.89 -16.15 63.19 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.721 1.608 . . . . 0.0 113.828 174.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 125.95 1.7 . . . . 0.0 114.19 -172.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptm . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 111.29 0.107 . . . . 0.0 111.29 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.9 mm100 -137.96 164.61 28.61 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.587 1.955 . . . . 0.0 110.592 172.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -145.54 174.48 11.13 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.748 1.619 . . . . 0.0 111.644 173.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -139.85 156.39 46.74 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.981 1.312 . . . . 0.0 111.403 172.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -149.13 165.79 30.73 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.986 1.715 . . . . 0.0 111.318 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.3 108.36 11.19 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.619 1.567 . . . . 0.0 111.03 -173.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -116.92 82.59 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.475 1.51 . . . . 0.0 110.559 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 p -67.54 -61.54 1.85 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.657 1.583 . . . . 0.0 112.414 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.0 mm -74.1 154.0 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 C-N-CA 126.195 1.798 . . . . 0.0 110.181 173.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -95.15 160.5 14.53 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 125.391 1.476 . . . . 0.0 112.807 173.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -134.94 156.04 49.68 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.127 1.371 . . . . 0.0 110.469 165.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.41 112.23 17.56 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.332 0.653 . . . . 0.0 109.293 164.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.56 141.26 42.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.682 1.193 . . . . 0.0 111.035 166.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.99 130.4 55.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.0 2.12 . . . . 0.0 109.991 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 34.3 pt -132.63 159.41 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.247 1.019 . . . . 0.0 112.392 172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -138.47 134.75 34.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.192 1.797 . . . . 0.0 109.817 176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -136.88 152.03 49.76 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.111 1.364 . . . . 0.0 114.027 -178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -141.42 115.99 9.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.614 2.365 . . . . 0.0 109.606 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.9 p -91.24 103.65 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 122.27 1.033 . . . . 0.0 110.634 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpp85 -102.77 152.15 21.58 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.593 2.357 . . . . 0.0 110.212 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -77.69 150.78 34.46 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 120.903 -1.123 . . . . 0.0 111.332 174.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -70.54 85.83 0.63 Allowed 'General case' 0 CA--C 1.545 0.768 0 O-C-N 120.86 -1.15 . . . . 0.0 111.88 171.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.5 -44.78 1.26 Allowed Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.467 1.984 . . . . 0.0 114.39 170.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.5 t -70.64 151.44 44.96 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.18 0.99 . . . . 0.0 112.971 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.4 m -79.87 -15.85 56.55 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.975 1.31 . . . . 0.0 114.072 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -70.83 159.57 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.777 0.831 . . . . 0.0 111.944 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.41 128.78 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.159 1.383 . . . . 0.0 109.517 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.2 mp -77.43 -51.58 10.54 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.936 0.495 . . . . 0.0 111.423 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -159.89 163.84 34.0 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.393 1.877 . . . . 0.0 111.112 176.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 96.8 p -154.35 159.93 41.43 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.882 -1.136 . . . . 0.0 112.482 171.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -114.38 -12.52 12.37 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 165.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.9 mt -55.19 -48.36 76.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.784 1.633 . . . . 0.0 111.826 -174.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -76.0 -6.89 53.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.716 1.206 . . . . 0.0 113.984 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -107.47 -73.58 0.68 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.943 1.697 . . . . 0.0 111.354 -172.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -163.54 131.68 2.73 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.301 1.84 . . . . 0.0 109.774 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.5 160.06 37.52 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.173 2.582 . . . . 0.0 112.891 175.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.1 tt -95.11 126.28 40.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.127 1.371 . . . . 0.0 109.863 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -106.27 127.44 53.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.102 1.761 . . . . 0.0 111.558 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -147.57 162.98 38.0 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.508 1.123 . . . . 0.0 111.966 171.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.2 mm -88.38 149.48 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 120.717 -1.24 . . . . 0.0 109.366 174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mm -50.7 106.09 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.708 1.203 . . . . 0.0 110.971 176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.03 59.63 1.75 Allowed Glycine 0 CA--C 1.539 1.543 0 C-N-CA 125.547 1.546 . . . . 0.0 114.492 -174.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 54.2 m -113.5 -28.68 7.44 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.966 1.306 . . . . 0.0 113.243 174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.7 m120 54.67 32.9 18.19 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 126.74 2.016 . . . . 0.0 114.711 171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -83.5 -17.94 40.19 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -76.75 171.05 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.974 1.31 . . . . 0.0 112.791 -178.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.4 pt -57.18 142.48 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 123.966 0.906 . . . . 0.0 111.46 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -41.78 77.57 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -171.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.48 -21.8 65.03 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 124.086 0.85 . . . . 0.0 114.518 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -96.52 -35.49 11.09 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.466 1.507 . . . . 0.0 111.804 174.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -56.77 -45.75 81.9 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.887 1.675 . . . . 0.0 112.188 174.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -75.69 -2.0 27.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.917 0.887 . . . . 0.0 113.393 177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.5 -42.27 4.84 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.601 1.56 . . . . 0.0 113.18 176.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -58.02 -25.73 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.522 1.129 . . . . 0.0 113.893 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.3 -24.96 67.84 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 174.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.26 -37.24 15.11 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.133 1.373 . . . . 0.0 112.498 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.91 131.3 46.77 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.63 1.572 . . . . 0.0 113.377 -171.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -92.51 151.51 20.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.2 1.0 . . . . 0.0 111.833 -175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 85.8 mt -65.16 125.06 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.904 0.882 . . . . 0.0 110.061 175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.4 9.19 86.19 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 124.454 1.026 . . . . 0.0 115.454 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -122.58 116.38 23.76 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.992 1.396 . . . . 0.0 111.259 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -58.26 143.07 45.79 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.157 0.983 . . . . 0.0 112.008 174.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -137.49 142.5 41.5 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.633 1.573 . . . . 0.0 110.173 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -129.99 81.8 2.03 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.181 0.993 . . . . 0.0 110.583 -167.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.5 m -88.06 117.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.921 1.289 . . . . 0.0 111.554 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.8 t -75.44 118.53 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.889 0.876 . . . . 0.0 109.465 171.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 66.2 mt -115.62 138.03 47.34 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 126.604 1.961 . . . . 0.0 108.812 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.08 155.52 90.15 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.475 1.11 . . . . 0.0 112.042 175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.7 -46.28 5.38 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.601 2.201 . . . . 0.0 112.473 -172.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -64.69 -23.17 67.17 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.536 1.534 . . . . 0.0 113.309 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.45 -8.18 59.69 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.229 1.412 . . . . 0.0 113.502 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -110.62 -67.44 0.99 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.204 1.401 . . . . 0.0 111.733 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -139.39 -22.62 0.9 Allowed 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.019 1.489 . . . . 0.0 115.019 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.46 92.19 0.19 Allowed Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.337 1.446 . . . . 0.0 114.232 178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.2 m -133.74 160.3 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 125.806 1.643 . . . . 0.0 112.515 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -142.4 175.66 9.61 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.195 1.798 . . . . 0.0 112.211 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -133.77 170.4 15.63 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.864 1.666 . . . . 0.0 112.229 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.8 t -111.28 11.53 21.7 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.798 1.639 . . . . 0.0 113.162 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 17.0 p -158.83 114.69 2.62 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.731 1.612 . . . . 0.0 111.384 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -149.66 157.34 43.15 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.53 1.132 . . . . 0.0 113.275 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 92.8 mt -75.03 132.98 41.72 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.668 1.187 . . . . 0.0 111.386 175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -126.7 120.09 28.57 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.74 1.216 . . . . 0.0 110.847 178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.12 101.47 5.35 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.345 1.458 . . . . 0.0 111.453 177.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 t -99.72 136.88 20.16 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.32 1.848 . . . . 0.0 109.476 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.87 152.58 68.78 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.502 2.134 . . . . 0.0 111.676 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -76.88 57.45 1.32 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.127 1.371 . . . . 0.0 111.447 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -130.63 -50.52 1.06 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.205 1.802 . . . . 0.0 112.812 -170.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -66.43 -15.01 63.0 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 172.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -98.45 17.83 18.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.717 2.007 . . . . 0.0 113.484 -178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.05 112.3 1.47 Allowed 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.717 -1.239 . . . . 0.0 111.341 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.22 2.43 59.13 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.869 1.223 . . . . 0.0 115.446 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -124.68 130.48 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.919 1.36 . . . . 0.0 111.368 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -75.76 147.64 39.11 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.532 1.133 . . . . 0.0 111.173 172.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.4 mt -127.09 152.4 47.35 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.98 1.712 . . . . 0.0 109.689 -174.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -155.8 162.05 40.55 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 111.604 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -66.25 123.6 20.38 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 120.829 -1.169 . . . . 0.0 110.92 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.44 34.96 30.68 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.167 0.889 . . . . 0.0 114.786 173.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 5.4 ptp -109.1 144.96 36.45 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.195 0.997 . . . . 0.0 111.421 165.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.1 p -70.26 136.67 50.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.883 0.873 . . . . 0.0 110.812 167.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.9 p -140.66 164.61 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.573 1.549 . . . . 0.0 111.046 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -112.21 148.39 34.17 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.212 1.405 . . . . 0.0 111.858 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.85 94.72 0.31 Allowed Glycine 0 CA--C 1.528 0.884 0 C-N-CA 125.463 1.506 . . . . 0.0 111.936 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -68.66 104.96 2.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.855 0.862 . . . . 0.0 111.063 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.8 t -77.93 158.38 29.38 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.678 1.191 . . . . 0.0 112.21 177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -66.48 -16.95 64.51 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.443 1.497 . . . . 0.0 113.264 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -72.16 13.86 0.28 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 126.575 1.95 . . . . 0.0 114.212 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 57.13 47.23 17.63 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.883 2.073 . . . . 0.0 112.301 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.06 170.43 15.95 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.037 2.135 . . . . 0.0 109.637 -177.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 34.6 m -136.95 115.51 11.97 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.56 1.144 . . . . 0.0 111.585 -175.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -79.64 164.5 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.997 0.919 . . . . 0.0 111.406 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -121.23 133.14 55.15 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.677 1.591 . . . . 0.0 110.624 173.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.26 177.15 9.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.683 1.593 . . . . 0.0 112.474 -171.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -123.94 131.58 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.428 1.491 . . . . 0.0 109.362 173.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.9 mt -74.93 116.42 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.706 1.202 . . . . 0.0 109.629 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -92.98 -33.12 14.27 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.131 0.972 . . . . 0.0 112.611 -175.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -148.41 148.09 29.93 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.946 1.698 . . . . 0.0 110.78 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -142.58 157.93 44.2 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.221 1.008 . . . . 0.0 112.51 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.5 t -157.01 176.21 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.861 1.664 . . . . 0.0 111.167 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.17 -25.85 62.72 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.531 1.132 . . . . 0.0 113.184 171.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.6 p -82.74 -64.18 1.22 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.747 1.619 . . . . 0.0 112.044 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -135.08 168.47 19.07 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.592 2.357 . . . . 0.0 111.159 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.9 p -137.58 150.36 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.498 1.519 . . . . 0.0 110.617 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 40.2 mmm -127.76 103.08 7.09 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.798 2.039 . . . . 0.0 110.288 -167.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.2 t -112.76 143.47 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.398 1.479 . . . . 0.0 110.246 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -74.23 96.8 2.84 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.206 1.002 . . . . 0.0 111.861 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -94.56 168.92 10.55 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.063 1.345 . . . . 0.0 112.392 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -135.04 115.17 13.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.529 1.932 . . . . 0.0 110.263 179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -148.87 135.94 10.68 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 123.634 0.774 . . . . 0.0 111.204 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -72.49 4.13 3.69 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.858 3.038 . . . . 0.0 114.941 -173.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 41.8 mt -112.79 12.44 19.57 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.602 1.961 . . . . 0.0 112.952 -176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -44.75 -62.13 1.32 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.278 2.231 . . . . 0.0 115.514 -167.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 58.5 81.06 0.08 OUTLIER Glycine 0 CA--C 1.542 1.75 0 C-N-CA 126.272 1.891 . . . . 0.0 116.999 169.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.9 ptpt -74.43 154.61 38.69 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.787 1.235 . . . . 0.0 112.912 171.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.3 p -91.24 150.31 21.39 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.957 1.303 . . . . 0.0 113.208 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.8 mp -125.3 120.94 32.56 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.742 2.017 . . . . 0.0 110.911 -170.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -82.08 101.08 10.15 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.194 1.398 . . . . 0.0 111.376 173.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -79.59 92.43 5.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.633 0.773 . . . . 0.0 110.08 167.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 tpp85 -73.12 124.03 24.77 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 165.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -144.18 169.39 17.97 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -148.4 147.97 29.8 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.789 1.236 . . . . 0.0 111.511 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.95 108.0 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.614 1.166 . . . . 0.0 108.444 167.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.7 -12.76 60.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.007 1.323 . . . . 0.0 112.768 -178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 114.57 -150.51 18.66 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 126.009 1.766 . . . . 0.0 111.475 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.77 163.7 31.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.492 1.117 . . . . 0.0 112.681 176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.8 ptp180 -144.91 155.26 43.34 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.397 1.479 . . . . 0.0 113.125 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -87.39 87.72 7.49 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.505 1.522 . . . . 0.0 111.187 -178.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.7 m -74.7 160.87 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.368 1.067 . . . . 0.0 112.713 175.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 74.6 m -140.86 161.54 37.58 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 126.282 1.833 . . . . 0.0 111.787 177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -84.49 -71.75 0.5 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.34 1.056 . . . . 0.0 112.395 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.64 -0.44 6.13 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 115.247 1.573 . . . . 0.0 115.247 -175.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--O 1.254 1.313 0 C-N-CA 128.083 2.553 . . . . 0.0 114.919 -179.686 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 mtt . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 119.555 -0.26 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -60.55 150.06 32.71 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.812 1.245 . . . . 0.0 111.411 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -129.02 94.82 3.91 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.722 1.209 . . . . 0.0 111.229 -173.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -119.33 144.12 47.02 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.087 1.355 . . . . 0.0 111.667 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -140.71 -171.69 3.29 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.534 2.333 . . . . 0.0 110.376 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -63.45 106.03 0.86 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.992 1.317 . . . . 0.0 110.968 172.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -120.03 54.16 1.04 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.283 1.833 . . . . 0.0 111.307 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.5 t -85.33 -25.98 26.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.55 1.14 . . . . 0.0 113.655 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.1 mp -79.45 133.21 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.669 1.588 . . . . 0.0 109.723 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? -61.09 146.39 47.5 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.926 0.89 . . . . 0.0 112.67 175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -145.94 149.05 33.48 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.111 1.364 . . . . 0.0 111.151 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.57 105.31 8.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.39 123.63 23.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.065 1.346 . . . . 0.0 110.566 169.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.72 117.44 34.08 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.6 1.96 . . . . 0.0 109.707 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.34 160.05 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.363 1.065 . . . . 0.0 111.524 177.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.13 165.36 28.05 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.076 -1.015 . . . . 0.0 112.445 169.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 51.7 p90 -147.69 157.8 43.72 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.7 1.6 . . . . 0.0 113.858 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -134.01 123.79 25.17 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.873 3.269 . . . . 0.0 108.148 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.2 p -100.21 112.58 33.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.263 1.025 . . . . 0.0 109.372 170.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -115.84 143.72 45.01 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.753 1.621 . . . . 0.0 110.172 -178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -70.04 132.92 46.63 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.516 -0.74 . . . . 0.0 110.4 172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 -59.16 123.84 18.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.305 0.642 . . . . 0.0 111.943 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.82 -45.86 2.31 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.019 1.771 . . . . 0.0 114.306 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 30.4 m -74.72 154.7 38.3 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.664 1.186 . . . . 0.0 113.514 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 20.4 m -83.8 -14.94 50.16 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -68.18 163.21 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.049 0.94 . . . . 0.0 111.983 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.66 122.74 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.367 1.467 . . . . 0.0 109.299 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.4 mt -71.69 -51.09 24.8 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.102 0.961 . . . . 0.0 111.058 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -159.52 156.54 28.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.006 1.323 . . . . 0.0 112.554 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 57.5 m -149.84 151.97 34.37 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.679 1.591 . . . . 0.0 111.76 174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -116.49 -6.13 11.71 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 165.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 8.3 mt -50.88 -58.14 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.908 1.683 . . . . 0.0 112.196 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -75.1 -19.83 59.76 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.504 1.121 . . . . 0.0 113.389 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -78.59 -72.47 0.38 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.048 1.739 . . . . 0.0 111.109 -177.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -168.34 125.87 0.9 Allowed Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 127.074 2.15 . . . . 0.0 109.392 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.29 147.05 87.43 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.444 2.096 . . . . 0.0 111.403 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 11.5 tp -72.83 142.89 48.0 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.316 1.047 . . . . 0.0 110.172 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -120.68 111.79 18.06 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.869 1.668 . . . . 0.0 109.685 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -131.77 169.54 16.08 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.078 0.951 . . . . 0.0 112.262 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.2 mm -105.94 137.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.234 1.014 . . . . 0.0 108.9 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.8 mm -46.37 106.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.634 1.574 . . . . 0.0 111.345 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.88 15.03 17.63 Favored Glycine 0 CA--C 1.544 1.861 0 C-N-CA 125.25 1.405 . . . . 0.0 116.397 -175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 62.6 m -73.8 -43.54 58.55 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.859 1.829 . . . . 0.0 113.001 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 15.8 m120 57.17 21.52 6.61 Favored 'General case' 0 CA--C 1.558 1.267 0 C-N-CA 127.161 2.185 . . . . 0.0 116.538 174.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -74.61 -16.0 60.81 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -172.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.4 pt -66.6 168.86 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.434 1.494 . . . . 0.0 112.96 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.3 pt -56.1 144.43 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.228 1.011 . . . . 0.0 111.775 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -38.41 75.23 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -171.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.81 -33.16 86.17 Favored Glycine 0 CA--C 1.539 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 113.962 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.2 tp -86.52 -29.64 22.55 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.251 1.42 . . . . 0.0 112.144 176.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -59.65 -43.29 93.95 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.738 1.615 . . . . 0.0 112.091 173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -70.47 -13.91 62.31 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.38 -46.81 7.82 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.817 1.247 . . . . 0.0 112.723 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -58.33 -27.77 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.5 pp -65.8 -24.47 66.93 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.715 1.006 . . . . 0.0 113.715 173.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -96.94 -36.65 10.49 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.107 1.763 . . . . 0.0 112.684 177.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.96 112.15 0.89 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.963 1.705 . . . . 0.0 113.142 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -73.08 151.4 41.67 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.448 0.699 . . . . 0.0 112.053 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.4 tt -57.33 127.59 16.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.426 1.09 . . . . 0.0 111.494 172.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.96 9.23 85.28 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.094 1.33 . . . . 0.0 115.3 177.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -122.1 119.07 30.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.088 1.444 . . . . 0.0 111.763 -174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -59.25 142.36 52.07 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.059 0.944 . . . . 0.0 112.082 175.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -136.51 138.82 41.76 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.598 1.159 . . . . 0.0 110.481 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -130.02 89.3 2.78 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.433 1.093 . . . . 0.0 110.534 -167.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.6 m -101.09 118.15 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.879 1.272 . . . . 0.0 111.507 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.9 t -78.82 111.18 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 124.434 1.094 . . . . 0.0 109.536 175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.1 mm -97.17 133.81 37.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 125.3 1.44 . . . . 0.0 109.53 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.51 153.45 93.1 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.09 0.956 . . . . 0.0 111.743 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -60.04 -43.53 35.69 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.563 2.175 . . . . 0.0 112.521 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.92 -15.6 63.53 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.833 1.653 . . . . 0.0 114.838 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -99.74 -26.88 13.9 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.769 1.227 . . . . 0.0 113.035 176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -72.33 -70.57 0.33 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.852 1.261 . . . . 0.0 111.331 173.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -138.61 -18.36 1.09 Allowed 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.67 7.69 58.91 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 124.795 1.188 . . . . 0.0 115.494 -175.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.4 t -137.68 150.23 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 127.182 2.193 . . . . 0.0 109.584 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -135.59 166.16 23.85 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.657 1.583 . . . . 0.0 111.452 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 21.3 mm-40 -65.34 151.26 46.69 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.49 1.116 . . . . 0.0 113.474 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.7 p -83.02 15.13 2.91 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.334 1.854 . . . . 0.0 114.793 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 50.6 m -108.41 79.26 1.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.178 1.391 . . . . 0.0 112.946 -170.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 -118.39 166.2 12.95 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.58 1.552 . . . . 0.0 110.936 166.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.8 mp -120.36 147.85 44.51 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.199 1.4 . . . . 0.0 110.316 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -129.51 115.92 18.17 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 125.191 1.396 . . . . 0.0 110.653 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -66.8 115.43 6.58 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.498 0.719 . . . . 0.0 110.121 164.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.2 p -130.32 133.93 25.49 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 126.633 1.973 . . . . 0.0 109.463 -175.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.2 155.96 60.08 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.201 1.934 . . . . 0.0 111.673 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -64.06 -17.62 63.57 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -51.91 -38.89 58.0 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 128.332 2.653 . . . . 0.0 114.316 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -71.58 -15.95 62.29 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -110.27 -45.41 3.58 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.635 1.174 . . . . 0.0 112.947 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 21.28 66.97 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 129.611 3.164 . . . . 0.0 115.043 177.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.41 -22.42 3.94 Favored Glycine 0 CA--C 1.536 1.37 0 C-N-CA 125.041 1.305 . . . . 0.0 115.601 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.55 132.83 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.247 1.523 . . . . 0.0 109.621 172.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -77.24 67.76 3.25 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.777 1.631 . . . . 0.0 112.613 176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 39.5 mt -55.66 148.05 17.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.713 1.605 . . . . 0.0 112.131 178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -151.34 155.75 39.35 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.198 1.399 . . . . 0.0 111.189 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -71.81 21.94 0.05 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 -175.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 54.97 0.08 OUTLIER Glycine 0 CA--C 1.53 1.0 0 O-C-N 120.95 -1.094 . . . . 0.0 113.578 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.8 ptm -132.29 151.58 51.77 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.991 1.317 . . . . 0.0 111.874 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.0 p -70.25 133.05 46.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.354 1.061 . . . . 0.0 111.245 167.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -135.72 156.95 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.149 1.78 . . . . 0.0 110.689 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -95.66 145.82 24.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.446 1.098 . . . . 0.0 111.902 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.18 95.44 0.37 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 125.692 1.615 . . . . 0.0 111.855 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -65.68 137.96 57.66 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 117.85 0.825 . . . . 0.0 111.123 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.9 t -116.93 155.15 29.6 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.942 1.697 . . . . 0.0 111.75 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -63.85 -15.44 58.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.177 1.791 . . . . 0.0 113.345 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.23 15.17 0.35 Allowed 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.419 1.888 . . . . 0.0 113.769 171.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 55.54 46.74 22.37 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.368 2.267 . . . . 0.0 112.543 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -144.74 177.45 8.7 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.174 1.79 . . . . 0.0 112.218 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 32.7 m -145.37 120.32 10.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.667 1.187 . . . . 0.0 111.796 -174.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -88.9 173.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 124.584 1.153 . . . . 0.0 112.053 174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -130.7 133.97 46.52 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.219 1.408 . . . . 0.0 111.441 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.31 176.81 11.22 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.464 1.506 . . . . 0.0 112.052 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.5 mp -106.95 131.95 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.639 1.176 . . . . 0.0 110.618 -177.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.7 mt -70.55 134.65 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 O-C-N 120.821 -1.174 . . . . 0.0 111.059 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -94.73 -46.38 6.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.825 1.25 . . . . 0.0 112.065 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -146.81 156.87 43.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.284 1.434 . . . . 0.0 111.258 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -147.26 146.84 29.9 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.727 1.211 . . . . 0.0 112.331 177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 11.3 t -152.97 169.41 22.95 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 126.272 1.829 . . . . 0.0 110.547 170.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.93 -27.26 67.33 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.192 0.997 . . . . 0.0 113.493 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -80.67 -66.42 0.89 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 126.789 2.036 . . . . 0.0 111.714 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.5 m80 -132.3 157.49 44.29 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.619 1.968 . . . . 0.0 111.843 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.5 t -126.41 150.32 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.95 2.1 . . . . 0.0 108.233 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 96.6 mtp -126.18 100.56 6.37 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.822 1.249 . . . . 0.0 109.992 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.3 m -99.29 151.72 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.287 1.035 . . . . 0.0 111.075 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -71.68 148.79 46.12 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.339 0.656 . . . . 0.0 111.187 171.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -145.05 152.82 40.7 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.264 1.426 . . . . 0.0 112.326 172.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -69.14 -28.63 66.62 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.614 1.166 . . . . 0.0 113.504 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 48.46 83.77 0.21 Allowed Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 127.609 2.364 . . . . 0.0 113.378 -175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -65.48 -13.71 41.18 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.021 2.48 . . . . 0.0 115.333 -169.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.4 mp -85.0 6.24 25.97 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 125.894 1.678 . . . . 0.0 113.099 173.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.68 167.3 2.78 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.883 1.673 . . . . 0.0 115.119 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 124.17 128.0 3.25 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 126.635 2.065 . . . . 0.0 112.002 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -139.74 167.53 21.89 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.57 1.548 . . . . 0.0 112.756 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 11.2 p -73.06 136.88 45.03 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.042 1.337 . . . . 0.0 112.47 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.81 136.48 53.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.618 1.967 . . . . 0.0 110.736 -172.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -93.31 105.25 17.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.685 1.194 . . . . 0.0 111.345 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -84.88 92.09 8.19 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.892 0.877 . . . . 0.0 109.913 167.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -74.84 122.5 23.46 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 163.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -143.24 166.35 24.96 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.454 0.702 . . . . 0.0 112.03 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -151.2 145.67 25.56 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.462 0.705 . . . . 0.0 112.503 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.1 t -91.25 102.87 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 C-N-CA 125.475 1.51 . . . . 0.0 108.715 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.17 -27.36 69.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.85 0.86 . . . . 0.0 111.6 174.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 130.41 -133.04 7.18 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 125.992 1.758 . . . . 0.0 110.899 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -150.37 162.89 39.67 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.842 1.257 . . . . 0.0 111.542 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -130.71 132.38 45.33 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.201 1.4 . . . . 0.0 111.269 171.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.11 130.96 42.85 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.998 0.919 . . . . 0.0 110.127 169.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.4 m -131.98 171.13 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 126.407 1.883 . . . . 0.0 110.581 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 34.9 p -60.16 145.47 46.87 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.646 0.736 . . . . 0.0 112.429 176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.72 -0.3 10.78 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.201 1.4 . . . . 0.0 113.794 -175.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -69.97 -35.39 74.4 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.192 1.397 . . . . 0.0 112.715 175.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 128.65 2.78 . . . . 0.0 114.729 -178.138 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -141.02 97.39 3.17 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.274 1.43 . . . . 0.0 110.701 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -137.85 147.61 44.66 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.337 1.455 . . . . 0.0 111.805 178.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 72.6 m-70 -142.69 130.58 21.67 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.409 1.884 . . . . 0.0 110.442 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -73.06 167.18 21.65 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.331 1.052 . . . . 0.0 112.262 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 47.7 tp -69.05 101.28 1.38 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.774 1.23 . . . . 0.0 111.984 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -78.6 9.96 3.61 Favored 'General case' 0 CA--C 1.55 0.948 0 N-CA-C 115.632 1.715 . . . . 0.0 115.632 -175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 99.6 p -64.76 -22.58 67.02 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.881 1.437 . . . . 0.0 114.881 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.436 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.9 mp -73.5 152.53 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.835 0 C-N-CA 125.483 1.513 . . . . 0.0 110.928 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -55.14 156.45 4.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.642 1.977 . . . . 0.0 112.775 174.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.1 pp0? -140.98 151.74 44.38 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.171 1.389 . . . . 0.0 111.628 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.96 113.31 21.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.383 1.073 . . . . 0.0 111.573 177.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.2 101.43 7.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.3 1.44 . . . . 0.0 110.483 171.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.53 111.19 11.75 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.01 1.724 . . . . 0.0 110.043 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.3 pp -133.6 158.3 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.944 0.897 . . . . 0.0 111.968 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -137.65 138.34 39.36 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.501 1.521 . . . . 0.0 109.852 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -136.4 162.19 33.73 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.854 1.262 . . . . 0.0 113.796 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -144.83 160.24 41.59 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.074 2.149 . . . . 0.0 111.678 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -131.47 112.59 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 125.36 1.464 . . . . 0.0 110.451 175.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -114.62 154.52 28.22 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.995 2.118 . . . . 0.0 110.054 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -57.91 148.28 26.13 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.323 1.449 . . . . 0.0 111.567 167.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.5 mm100 -70.68 94.03 0.98 Allowed 'General case' 0 N--CA 1.474 0.731 0 O-C-N 120.831 -1.168 . . . . 0.0 111.253 166.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.27 -39.22 2.97 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.233 1.873 . . . . 0.0 114.894 168.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -73.44 149.84 42.11 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.502 1.151 . . . . 0.0 112.046 175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 25.0 m -69.37 -23.06 63.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.923 1.289 . . . . 0.0 113.776 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -64.65 153.47 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.629 1.172 . . . . 0.0 113.296 -173.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.3 t -119.94 128.14 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.838 1.655 . . . . 0.0 108.982 -176.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.3 mp -81.24 -51.95 7.85 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.144 0.578 . . . . 0.0 111.276 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.09 160.07 43.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.185 1.794 . . . . 0.0 111.488 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.7 p -162.38 167.14 24.2 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.923 1.289 . . . . 0.0 113.138 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -130.72 13.77 5.37 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.201 1.186 . . . . 0.0 114.201 164.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.0 mm -53.15 -59.99 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.578 1.551 . . . . 0.0 112.358 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.5 t -78.68 -16.17 57.61 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -80.83 -172.6 3.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 127.063 2.145 . . . . 0.0 111.722 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.94 126.36 83.24 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 124.208 1.003 . . . . 0.0 110.97 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.31 162.75 32.06 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.135 2.557 . . . . 0.0 112.335 175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 tp -75.95 149.1 37.73 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.706 -0.621 . . . . 0.0 109.823 168.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -130.81 48.26 2.44 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.297 1.439 . . . . 0.0 110.939 -175.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -69.33 163.11 25.84 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.357 -0.84 . . . . 0.0 113.14 -175.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.9 mm -116.61 137.34 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.672 1.589 . . . . 0.0 109.244 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.5 mm -50.73 107.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.799 1.64 . . . . 0.0 111.908 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.63 -28.03 8.43 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.24 1.876 . . . . 0.0 114.311 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.2 t -58.35 -24.52 60.06 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 119.593 1.697 . . . . 0.0 113.735 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.4 t30 40.55 60.43 1.88 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.422 2.689 . . . . 0.0 114.137 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -89.41 -17.44 28.79 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -177.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -79.72 170.04 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 124.933 1.293 . . . . 0.0 112.218 175.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.8 pt -63.26 147.1 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.459 -0.776 . . . . 0.0 111.863 175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.93 -25.92 68.56 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -64.26 -40.69 98.16 Favored Glycine 0 CA--C 1.537 1.407 0 O-C-N 120.859 -1.151 . . . . 0.0 112.991 171.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.8 tp -81.63 -25.45 35.63 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.717 1.607 . . . . 0.0 112.804 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -51.25 -49.39 61.25 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.779 1.632 . . . . 0.0 112.476 173.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -13.89 62.5 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.256 1.022 . . . . 0.0 113.708 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.54 -43.36 7.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.793 1.237 . . . . 0.0 112.968 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 p -61.46 -27.25 41.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -69.34 -17.43 63.7 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 173.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 59.0 mtmt -103.79 -40.44 6.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.907 1.683 . . . . 0.0 113.328 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.58 134.36 56.67 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.183 0.993 . . . . 0.0 112.5 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -96.7 161.6 13.81 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.05 0.94 . . . . 0.0 112.282 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.5 tt -54.49 124.49 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 C-N-CA 124.394 1.078 . . . . 0.0 111.575 172.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.63 -0.28 77.2 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.234 1.397 . . . . 0.0 115.604 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -105.96 112.6 25.72 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.415 1.607 . . . . 0.0 111.551 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -57.49 144.73 35.7 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.54 0.736 . . . . 0.0 111.824 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -138.12 139.81 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.155 1.782 . . . . 0.0 109.96 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -130.45 110.39 11.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.208 1.403 . . . . 0.0 110.571 -173.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -118.17 117.87 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.611 1.564 . . . . 0.0 110.778 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 47.5 t -75.81 123.05 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.898 0.879 . . . . 0.0 109.118 173.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.3 mt -127.87 130.4 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 125.558 1.543 . . . . 0.0 109.294 -174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.2 145.3 97.47 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 123.785 0.834 . . . . 0.0 110.984 173.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.09 -32.55 91.71 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 121.884 1.722 . . . . 0.0 112.971 -176.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -63.08 -20.7 65.59 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.166 1.173 . . . . 0.0 114.166 175.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -87.74 -0.04 56.37 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.206 1.402 . . . . 0.0 113.163 175.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -132.35 -67.53 0.65 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.606 1.562 . . . . 0.0 112.395 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -142.23 88.47 2.09 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.499 2.32 . . . . 0.0 110.1 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.34 91.71 0.65 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.044 1.307 . . . . 0.0 113.255 -175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.3 p -134.53 148.55 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.836 1.654 . . . . 0.0 111.262 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -149.57 165.79 31.17 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.109 1.764 . . . . 0.0 111.691 177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -94.3 138.36 32.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.431 1.092 . . . . 0.0 111.896 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.3 p -84.96 3.58 37.69 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.116 1.766 . . . . 0.0 114.24 176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.8 t -154.72 100.48 2.24 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.624 1.569 . . . . 0.0 110.711 -170.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -148.82 161.44 41.82 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.166 0.987 . . . . 0.0 113.595 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.4 mp -71.01 129.11 38.15 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.625 1.17 . . . . 0.0 111.481 175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -120.74 118.11 29.21 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.222 1.409 . . . . 0.0 110.153 172.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.95 130.27 42.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.163 0.985 . . . . 0.0 110.746 169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 55.1 t -135.75 136.66 23.91 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 126.034 1.733 . . . . 0.0 109.15 -177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -71.63 157.83 54.93 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.637 2.225 . . . . 0.0 112.211 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -75.94 66.18 2.12 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.31 1.444 . . . . 0.0 111.876 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.38 -50.36 0.93 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.151 1.781 . . . . 0.0 112.245 -176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -65.84 -11.68 48.42 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -120.1 10.48 11.42 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.43 1.892 . . . . 0.0 113.718 -171.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.5 tm-20 -56.16 -27.99 56.4 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 125.371 1.468 . . . . 0.0 114.145 -173.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -114.42 10.21 22.03 Favored Glycine 0 CA--C 1.54 1.599 0 C-N-CA 125.676 1.608 . . . . 0.0 116.367 -177.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.8 pt -134.91 131.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.555 1.678 . . . . 0.0 112.893 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.9 mp0 -75.92 137.64 40.5 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.168 1.387 . . . . 0.0 112.256 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.5 mt -120.72 165.17 15.47 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.829 1.651 . . . . 0.0 112.655 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -157.21 155.5 30.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 126.017 1.727 . . . . 0.0 110.764 -177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -73.38 107.54 5.73 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 120.464 -1.397 . . . . 0.0 111.05 173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.88 26.94 11.79 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.501 0.961 . . . . 0.0 115.501 175.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.1 ptm -99.73 153.26 19.25 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 118.883 1.342 . . . . 0.0 112.263 168.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 p -70.46 113.96 8.1 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.249 1.42 . . . . 0.0 111.157 167.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.15 161.19 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.896 1.678 . . . . 0.0 111.035 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -123.25 155.44 37.16 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.813 1.645 . . . . 0.0 111.878 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.58 105.51 0.29 Allowed Glycine 0 N--CA 1.473 1.152 0 C-N-CA 124.361 0.982 . . . . 0.0 113.341 -174.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -72.0 111.57 7.36 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.926 1.29 . . . . 0.0 111.894 179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.9 t -80.55 159.7 25.39 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.102 1.361 . . . . 0.0 111.897 172.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.04 -15.52 62.43 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.048 1.339 . . . . 0.0 113.366 173.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -73.44 18.12 0.13 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.757 1.623 . . . . 0.0 113.966 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 51.83 44.01 29.68 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.474 2.31 . . . . 0.0 113.077 -175.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -140.98 172.33 12.83 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.286 1.834 . . . . 0.0 111.533 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 62.0 m -141.53 107.62 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.04 1.336 . . . . 0.0 110.521 -173.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.59 167.21 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 O-C-N 121.972 -0.455 . . . . 0.0 111.41 176.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -132.41 136.22 46.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.082 1.353 . . . . 0.0 111.284 174.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.4 -179.53 8.18 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.816 1.246 . . . . 0.0 112.798 -174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.8 mp -113.81 132.72 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.204 1.401 . . . . 0.0 110.61 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.63 122.46 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.9 1.28 . . . . 0.0 110.571 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -90.27 -38.02 13.69 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.705 1.202 . . . . 0.0 113.08 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -153.35 154.67 34.98 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.337 1.455 . . . . 0.0 111.571 170.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.07 145.83 30.7 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.189 0.996 . . . . 0.0 113.388 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 49.4 m -148.3 173.68 12.79 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.771 2.028 . . . . 0.0 111.379 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.82 -21.99 61.62 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.9 p -83.52 -61.62 1.79 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 126.075 1.75 . . . . 0.0 111.924 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.4 m80 -136.62 169.31 17.93 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.628 2.371 . . . . 0.0 111.056 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 6.1 p -133.76 154.91 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 126.148 1.779 . . . . 0.0 109.888 173.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.0 mtp -130.22 101.27 5.71 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.518 1.527 . . . . 0.0 109.969 -176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.9 t -109.66 147.78 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.209 1.404 . . . . 0.0 109.371 -175.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -63.89 134.01 54.36 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.758 -0.589 . . . . 0.0 111.158 168.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -143.71 173.76 11.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.365 1.466 . . . . 0.0 111.754 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -128.45 133.74 48.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.241 1.816 . . . . 0.0 110.143 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -156.63 128.45 3.91 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.79 0.836 . . . . 0.0 111.321 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.4 -15.9 34.79 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.771 2.314 . . . . 0.0 114.965 -173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.27 12.68 15.36 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.072 1.349 . . . . 0.0 113.506 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.1 -16.17 4.71 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -92.24 96.93 2.21 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 126.348 1.928 . . . . 0.0 113.328 174.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -64.85 166.98 8.18 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.887 1.275 . . . . 0.0 113.046 169.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.77 147.09 53.95 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.363 1.865 . . . . 0.0 113.597 176.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.8 mp -122.56 160.84 24.84 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.999 2.119 . . . . 0.0 110.714 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.59 103.36 13.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.999 1.72 . . . . 0.0 111.161 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -82.41 109.99 17.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.601 0.76 . . . . 0.0 109.576 166.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -110.49 138.9 46.26 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.216 1.006 . . . . 0.0 110.129 175.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -150.94 170.0 20.38 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.417 0.687 . . . . 0.0 112.756 -177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -146.04 146.65 31.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.111 1.364 . . . . 0.0 111.237 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 98.9 t -84.5 105.14 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.696 1.198 . . . . 0.0 108.742 166.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.17 -26.41 56.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.487 1.115 . . . . 0.0 112.453 -178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 156.89 -168.0 33.84 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 115.439 0.936 . . . . 0.0 115.439 173.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -132.8 130.5 39.96 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 125.762 1.625 . . . . 0.0 110.225 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -117.18 93.89 4.35 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.938 1.295 . . . . 0.0 110.149 -177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -63.34 122.99 17.55 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.961 1.704 . . . . 0.0 111.134 174.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.27 164.41 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.652 1.581 . . . . 0.0 111.802 -175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 73.7 m -77.72 166.9 22.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.95 0.9 . . . . 0.0 111.79 168.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.93 -3.85 12.11 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.796 1.239 . . . . 0.0 114.046 174.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -82.28 -61.39 1.91 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.251 1.42 . . . . 0.0 111.939 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 . . . . . 0 C--O 1.253 1.263 0 C-N-CA 125.962 1.705 . . . . 0.0 113.482 178.109 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.3 mtm . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -150.51 165.68 32.49 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.785 1.634 . . . . 0.0 112.474 -178.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -149.38 175.65 11.27 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.779 2.031 . . . . 0.0 111.297 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -132.5 149.69 52.28 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.088 1.355 . . . . 0.0 112.378 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.41 167.9 17.07 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.761 2.024 . . . . 0.0 113.277 174.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.41 160.34 14.79 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.571 1.549 . . . . 0.0 111.426 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.97 20.84 0.18 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 126.257 1.823 . . . . 0.0 113.811 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t 65.94 21.56 11.35 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.03 2.132 . . . . 0.0 114.467 -178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.5 mm -88.97 123.74 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.846 1.658 . . . . 0.0 111.305 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -73.44 131.03 41.35 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.217 1.407 . . . . 0.0 111.326 173.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -160.03 151.47 19.71 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.48 1.512 . . . . 0.0 111.654 -178.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -83.09 98.72 9.46 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.019 1.328 . . . . 0.0 110.859 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -77.68 128.59 34.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.3 1.44 . . . . 0.0 111.327 173.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.7 mp -100.72 134.7 43.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.095 1.358 . . . . 0.0 111.166 175.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.8 pt -127.98 162.6 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.887 1.275 . . . . 0.0 112.247 170.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.9 mt-10 -138.64 131.45 29.38 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.509 1.924 . . . . 0.0 109.458 173.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -137.05 153.94 50.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.728 1.211 . . . . 0.0 113.784 -178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -143.68 133.93 24.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 127.907 2.483 . . . . 0.0 110.144 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.7 p -107.2 103.14 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.7 tpp85 -110.53 147.32 34.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.961 2.104 . . . . 0.0 110.906 -176.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -76.68 141.64 40.87 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.409 -0.807 . . . . 0.0 111.872 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -67.6 93.45 0.37 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.779 0.832 . . . . 0.0 111.549 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 123.06 -54.65 0.7 Allowed Glycine 0 CA--C 1.533 1.167 0 C-N-CA 126.247 1.88 . . . . 0.0 113.713 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 t -68.48 154.68 41.38 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.7 t -79.06 -20.67 48.27 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.258 1.423 . . . . 0.0 113.308 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.98 155.72 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 O-C-N 121.439 -0.788 . . . . 0.0 111.744 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.52 131.13 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.498 1.519 . . . . 0.0 110.082 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.8 mt -73.18 -55.1 6.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.503 0.721 . . . . 0.0 111.409 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -155.28 155.87 34.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.319 1.448 . . . . 0.0 110.922 176.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.4 p -148.26 126.03 11.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.266 1.026 . . . . 0.0 111.926 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -88.09 -29.65 20.47 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.199 0.6 . . . . 0.0 112.363 171.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.8 mt -51.8 -51.52 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.013 1.725 . . . . 0.0 112.296 -176.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.5 t -69.7 -14.99 63.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.497 1.119 . . . . 0.0 113.754 -178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -92.01 -72.17 0.6 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.812 1.645 . . . . 0.0 110.6 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -167.1 154.43 8.43 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.679 1.992 . . . . 0.0 111.623 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.31 146.38 69.02 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 122.439 2.092 . . . . 0.0 111.478 172.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.0 tp -87.52 130.55 34.68 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.857 1.263 . . . . 0.0 109.723 171.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -112.02 138.18 49.01 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.922 0.889 . . . . 0.0 112.649 172.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -153.04 163.02 40.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.189 1.396 . . . . 0.0 111.86 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.7 mm -83.24 141.2 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 O-C-N 121.279 -0.888 . . . . 0.0 109.645 173.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -47.57 109.3 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.549 1.54 . . . . 0.0 111.163 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.4 -5.02 31.4 Favored Glycine 0 CA--C 1.54 1.643 0 C-N-CA 125.698 1.618 . . . . 0.0 115.916 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 41.9 m -57.04 -32.17 65.92 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.122 1.961 . . . . 0.0 113.665 -176.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 47.31 62.5 2.38 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.589 1.956 . . . . 0.0 113.55 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.07 -20.83 13.71 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.4 pt -74.53 170.79 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.177 1.791 . . . . 0.0 112.611 177.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.9 pt -59.73 145.28 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.966 0.906 . . . . 0.0 111.781 175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.4 -34.69 75.78 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.6 98.75 Favored Glycine 0 CA--C 1.536 1.39 0 O-C-N 121.552 -0.718 . . . . 0.0 113.029 174.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.5 tp -77.33 -34.19 55.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.616 1.166 . . . . 0.0 112.24 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.0 tp10 -56.74 -38.67 72.71 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.452 1.101 . . . . 0.0 112.668 174.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -78.82 -14.27 59.35 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 176.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -87.81 -46.26 9.6 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.626 1.171 . . . . 0.0 112.501 173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.2 p -59.3 -27.53 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 113.977 1.102 . . . . 0.0 113.977 -173.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pp -64.87 -20.41 66.41 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -104.63 -13.27 16.02 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.74 . . . . 0.0 113.121 174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.44 132.58 50.42 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.598 1.159 . . . . 0.0 112.76 -174.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -91.85 130.47 37.61 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.297 1.039 . . . . 0.0 111.195 -178.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.5 tt -53.76 126.74 10.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 124.8 1.24 . . . . 0.0 111.674 175.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.64 9.03 87.26 Favored Glycine 0 CA--C 1.538 1.479 0 N-CA-C 116.011 1.165 . . . . 0.0 116.011 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -123.13 119.03 29.07 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 119.383 1.591 . . . . 0.0 111.773 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -62.72 139.64 58.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.572 0.749 . . . . 0.0 111.465 171.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -141.93 160.49 40.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.457 1.103 . . . . 0.0 112.282 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -127.1 107.91 10.45 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.832 1.653 . . . . 0.0 109.951 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.7 m -110.69 116.28 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.83 1.252 . . . . 0.0 110.097 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.8 110.77 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 121.449 -0.782 . . . . 0.0 109.376 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 58.8 mt -103.9 139.3 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 126.089 1.756 . . . . 0.0 109.47 -175.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.63 151.24 88.83 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.859 0.864 . . . . 0.0 112.244 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -59.73 -39.22 75.23 Favored 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.357 2.704 . . . . 0.0 112.472 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.64 -9.16 40.68 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.425 1.89 . . . . 0.0 114.205 177.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -113.07 5.07 16.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.828 1.651 . . . . 0.0 113.191 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -125.51 -67.45 0.89 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.541 1.536 . . . . 0.0 112.635 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -124.46 -12.18 7.28 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.02 29.9 72.28 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.057 -1.027 . . . . 0.0 115.374 173.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.0 p -65.01 151.25 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.861 1.264 . . . . 0.0 111.905 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -147.34 172.23 14.21 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.627 1.571 . . . . 0.0 112.427 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -118.06 142.07 47.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.713 1.605 . . . . 0.0 111.83 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.3 p -89.49 16.48 7.58 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.037 2.135 . . . . 0.0 114.49 -177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 43.3 t -41.88 -60.7 1.3 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.563 2.345 . . . . 0.0 114.806 -169.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 56.55 8.03 0.41 Allowed 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 116.407 2.003 . . . . 0.0 116.407 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 84.3 mt -145.7 137.91 25.51 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.63 1.972 . . . . 0.0 110.991 -177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -144.2 127.99 17.28 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.15 0.58 . . . . 0.0 111.872 169.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -76.37 98.34 4.51 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.74 1.216 . . . . 0.0 110.425 167.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.3 m -94.31 156.6 38.61 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.424 1.889 . . . . 0.0 110.849 175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.47 152.12 59.88 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 122.177 1.918 . . . . 0.0 111.771 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 25.0 tpt180 -61.4 -23.39 65.77 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.129 0.972 . . . . 0.0 113.15 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -51.01 -36.42 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.376 1.87 . . . . 0.0 113.789 175.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -66.49 -19.47 65.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.5 1.12 . . . . 0.0 113.564 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -133.28 17.84 4.04 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.307 1.843 . . . . 0.0 113.008 -172.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -57.43 -24.9 58.38 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.889 1.676 . . . . 0.0 114.438 -167.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -113.57 17.43 20.94 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 126.24 1.876 . . . . 0.0 115.342 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.6 mt -123.49 123.55 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 119.316 1.558 . . . . 0.0 111.242 -170.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -74.74 77.34 2.06 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.055 1.742 . . . . 0.0 113.182 178.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.0 mt -64.91 153.51 40.14 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.232 1.013 . . . . 0.0 112.759 177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -150.99 137.29 18.5 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.105 1.362 . . . . 0.0 111.11 173.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -58.27 114.52 2.45 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.158 0.983 . . . . 0.0 110.93 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.54 20.94 11.05 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 -177.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -108.93 161.3 15.27 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.277 1.538 . . . . 0.0 112.149 170.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.6 t -88.97 116.14 27.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.399 1.08 . . . . 0.0 110.967 169.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.1 p -107.0 160.92 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.896 1.678 . . . . 0.0 110.936 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -115.75 140.73 48.93 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.85 1.26 . . . . 0.0 111.823 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.75 93.34 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.575 1.559 . . . . 0.0 112.164 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 -65.95 147.1 53.89 Favored 'General case' 0 CA--C 1.545 0.775 0 O-C-N 121.793 -0.828 . . . . 0.0 111.506 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.4 t -130.69 157.48 42.66 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.819 1.648 . . . . 0.0 112.302 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -64.35 -15.83 61.12 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.402 1.881 . . . . 0.0 113.689 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -74.38 14.75 0.41 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.162 1.785 . . . . 0.0 113.825 170.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.8 m120 54.62 46.91 23.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.164 2.186 . . . . 0.0 112.556 -175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -140.94 173.21 11.7 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.987 1.715 . . . . 0.0 112.192 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 45.4 m -145.03 112.98 6.39 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.01 1.324 . . . . 0.0 111.273 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -76.57 165.26 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.15 0.58 . . . . 0.0 111.482 172.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -123.18 139.96 53.52 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.274 1.43 . . . . 0.0 110.396 170.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.55 173.57 15.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.313 1.045 . . . . 0.0 113.144 -170.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -115.81 135.97 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.076 1.351 . . . . 0.0 110.166 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 mm -67.06 117.96 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.974 1.309 . . . . 0.0 109.585 170.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -101.01 -36.11 9.13 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.699 1.2 . . . . 0.0 112.222 -177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -153.14 163.61 39.56 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.756 1.622 . . . . 0.0 111.8 166.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -143.08 158.46 43.59 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.329 1.052 . . . . 0.0 111.928 172.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 22.8 t -144.26 175.4 10.12 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.413 1.885 . . . . 0.0 111.202 -177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.67 -27.61 69.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.144 1.377 . . . . 0.0 113.893 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 71.9 p -130.57 -9.69 4.06 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.184 1.394 . . . . 0.0 114.748 -173.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -143.92 164.71 29.79 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.134 1.774 . . . . 0.0 111.821 -177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.4 t -140.24 141.96 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.657 1.583 . . . . 0.0 109.893 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 83.7 mtp -113.43 114.12 26.14 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.232 1.413 . . . . 0.0 111.104 175.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 t -121.46 153.05 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.075 1.35 . . . . 0.0 109.964 -175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -60.73 107.25 0.67 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.824 1.249 . . . . 0.0 112.071 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -134.76 105.02 6.25 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.863 1.265 . . . . 0.0 111.323 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -59.88 144.35 49.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.568 0.747 . . . . 0.0 110.646 164.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -67.72 108.87 3.01 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.554 1.142 . . . . 0.0 111.074 -176.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.46 -42.78 2.44 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.569 2.18 . . . . 0.0 112.872 -165.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.06 94.53 7.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.054 1.342 . . . . 0.0 108.179 168.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -67.5 96.49 0.52 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.287 1.035 . . . . 0.0 111.419 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 89.07 -166.55 33.75 Favored Glycine 0 CA--C 1.54 1.61 0 C-N-CA 124.374 0.988 . . . . 0.0 114.271 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 12.6 ptpt -123.91 159.88 28.73 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 126.272 1.829 . . . . 0.0 111.98 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.98 141.95 45.85 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.26 1.424 . . . . 0.0 112.628 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -126.14 146.57 49.89 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.182 1.393 . . . . 0.0 111.886 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -90.01 103.68 16.32 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.512 1.525 . . . . 0.0 111.506 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -83.42 98.41 9.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.998 0.904 . . . . 0.0 109.851 167.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.51 123.5 32.48 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.461 1.504 . . . . 0.0 109.483 173.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -147.45 171.81 14.92 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -176.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -152.11 150.32 29.77 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.015 1.726 . . . . 0.0 111.576 173.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 24.6 t -91.9 112.54 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.357 1.463 . . . . 0.0 108.506 164.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 8.5 mp -66.34 -33.58 76.06 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.133 0.973 . . . . 0.0 111.514 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 132.38 -168.79 22.51 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 126.358 1.933 . . . . 0.0 111.09 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -136.05 153.62 51.29 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.678 1.191 . . . . 0.0 111.982 -176.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.49 129.87 51.42 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.096 1.358 . . . . 0.0 110.682 175.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -73.09 96.48 2.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.977 0.911 . . . . 0.0 109.978 172.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.97 164.18 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.821 1.648 . . . . 0.0 111.759 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 42.6 m -140.07 160.2 40.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.296 1.438 . . . . 0.0 111.58 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.57 25.91 8.56 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.957 1.703 . . . . 0.0 111.651 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 60.36 24.48 13.98 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 127.273 2.229 . . . . 0.0 114.268 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.926 2.09 . . . . 0.0 114.025 178.445 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.8 mmt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.133 0.492 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 mm-40 -88.51 164.53 15.39 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.759 -1.213 . . . . 0.0 112.074 176.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -126.83 128.49 46.63 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.942 1.697 . . . . 0.0 110.145 175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -145.06 156.67 44.06 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.253 1.421 . . . . 0.0 110.457 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -66.63 155.0 39.08 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.604 0.762 . . . . 0.0 111.751 171.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -137.53 168.27 19.99 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.179 1.392 . . . . 0.0 112.935 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -102.08 52.72 0.81 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.648 1.579 . . . . 0.0 112.555 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 p -69.7 2.46 3.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.339 1.856 . . . . 0.0 114.974 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 26.6 mm -56.74 140.36 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 127.254 2.221 . . . . 0.0 111.589 -177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.1 mmmm -65.77 138.32 57.85 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.997 1.319 . . . . 0.0 111.473 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.73 170.45 16.95 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.911 2.084 . . . . 0.0 111.031 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -102.24 118.99 38.06 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.122 0.969 . . . . 0.0 110.902 174.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.7 118.92 23.22 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.881 1.672 . . . . 0.0 110.902 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.44 131.3 37.71 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.072 0.949 . . . . 0.0 111.32 169.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -130.52 167.91 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.695 1.198 . . . . 0.0 112.303 168.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.35 133.5 33.04 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.43 1.892 . . . . 0.0 110.52 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.8 p90 -139.16 150.3 45.45 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 123.002 1.382 . . . . 0.0 113.934 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -144.32 136.96 26.84 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.927 2.091 . . . . 0.0 109.708 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.6 p -120.24 105.15 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.09 1.356 . . . . 0.0 110.397 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -113.23 147.47 37.43 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 126.342 1.857 . . . . 0.0 110.533 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -69.84 140.57 53.26 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.65 -0.656 . . . . 0.0 111.293 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -66.71 -34.87 78.81 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 120.864 -1.148 . . . . 0.0 113.846 175.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -100.32 -0.85 55.72 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.992 1.282 . . . . 0.0 115.426 -170.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 21.4 t -145.91 144.53 30.24 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.783 1.233 . . . . 0.0 111.283 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -73.38 -11.83 60.61 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.69 159.46 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.139 0.976 . . . . 0.0 111.991 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.1 p -108.79 145.45 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 125.185 1.394 . . . . 0.0 110.898 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.3 mt -95.88 -44.11 7.53 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.325 1.05 . . . . 0.0 111.656 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.5 157.57 38.56 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.18 0.992 . . . . 0.0 112.423 170.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.3 t -161.21 128.21 4.06 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.882 1.273 . . . . 0.0 111.341 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.02 -16.44 40.78 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 167.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 4.2 mt -64.07 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.897 1.279 . . . . 0.0 111.827 -170.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.1 t -70.98 -9.64 58.34 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.81 1.244 . . . . 0.0 113.606 174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -104.27 -75.8 0.61 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.409 1.883 . . . . 0.0 110.909 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -168.1 148.98 4.63 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 127.637 2.375 . . . . 0.0 110.579 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.47 149.28 74.52 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.892 2.394 . . . . 0.0 112.9 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 25.9 tp -80.52 123.97 28.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.162 0.985 . . . . 0.0 109.806 172.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.99 131.69 56.02 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.696 1.198 . . . . 0.0 112.253 175.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.3 p90 -151.93 165.12 35.58 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.435 1.094 . . . . 0.0 112.657 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mm -96.42 143.59 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.125 1.37 . . . . 0.0 109.12 173.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.2 mm -48.05 113.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.643 1.577 . . . . 0.0 111.608 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.59 62.91 0.63 Allowed Glycine 0 CA--C 1.536 1.398 0 C-N-CA 125.788 1.661 . . . . 0.0 113.114 -174.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 86.9 m -134.27 -49.61 0.79 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.691 1.596 . . . . 0.0 111.827 177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.5 m120 58.89 29.37 18.77 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 126.232 1.813 . . . . 0.0 115.287 167.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -70.79 -19.88 62.65 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 115.544 1.683 . . . . 0.0 115.544 -174.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.1 pt -69.25 166.44 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.807 1.643 . . . . 0.0 112.751 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 14.5 pt -62.48 157.39 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.075 0.95 . . . . 0.0 113.389 -177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.44 -38.22 80.15 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.655 1.182 . . . . 0.0 113.716 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -62.33 -46.59 93.57 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 124.033 0.825 . . . . 0.0 112.841 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -69.04 -34.91 75.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 111.772 178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -56.02 -35.38 66.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.105 1.362 . . . . 0.0 113.449 171.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -80.37 3.24 21.84 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 175.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.1 -33.69 3.87 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.348 1.459 . . . . 0.0 113.392 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -58.47 -28.63 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 O-C-N 120.872 -1.143 . . . . 0.0 113.929 -176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -71.11 -23.06 62.02 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 173.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -94.84 -27.58 15.67 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.344 1.858 . . . . 0.0 112.478 174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.25 118.9 4.46 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.717 2.007 . . . . 0.0 113.474 -173.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -80.11 145.62 32.29 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 111.483 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 tt -62.24 132.4 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 123.879 0.872 . . . . 0.0 111.195 171.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.53 6.49 86.74 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.194 1.237 . . . . 0.0 116.194 173.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -118.62 114.26 22.5 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.881 1.672 . . . . 0.0 111.403 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -62.4 140.67 58.56 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.076 0.551 . . . . 0.0 111.305 169.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -142.42 162.11 36.33 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.49 1.116 . . . . 0.0 112.447 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -130.46 112.78 13.55 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.778 1.631 . . . . 0.0 109.844 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.6 m -115.92 104.34 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.341 1.456 . . . . 0.0 109.82 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.0 t -73.9 120.09 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.055 0.942 . . . . 0.0 110.046 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.3 mm -105.15 142.55 18.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 125.401 1.481 . . . . 0.0 110.061 -175.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.87 156.94 85.93 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.693 1.197 . . . . 0.0 112.789 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.27 -11.92 27.77 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.461 2.774 . . . . 0.0 114.97 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -106.58 -9.35 16.6 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.094 1.358 . . . . 0.0 113.809 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -108.58 -18.9 13.61 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.983 1.313 . . . . 0.0 113.081 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -81.12 -167.95 1.63 Allowed 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.532 1.933 . . . . 0.0 111.968 169.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -56.7 -22.13 32.75 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 169.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 81.74 72.77 1.23 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.411 1.481 . . . . 0.0 114.142 168.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.57 64.84 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.222 1.409 . . . . 0.0 112.785 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -69.73 169.27 13.24 Favored 'General case' 0 CA--C 1.547 0.849 0 O-C-N 121.221 -0.924 . . . . 0.0 112.481 170.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -139.33 154.15 47.84 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.186 1.394 . . . . 0.0 112.661 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -84.94 -6.18 59.34 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -172.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.0 p -153.65 123.47 6.81 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.384 1.473 . . . . 0.0 112.064 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -151.34 158.07 43.3 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.947 1.299 . . . . 0.0 112.379 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.1 mp -77.06 107.08 9.16 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.066 -1.021 . . . . 0.0 110.849 175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -85.12 131.99 34.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.838 1.255 . . . . 0.0 111.014 171.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -84.76 100.51 11.57 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.504 1.522 . . . . 0.0 110.238 172.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.1 t -98.1 137.3 20.83 Favored Pre-proline 0 N--CA 1.477 0.913 0 C-N-CA 124.932 1.293 . . . . 0.0 109.569 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -72.79 157.73 51.4 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 0.0 112.638 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -75.69 72.99 2.66 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.338 1.055 . . . . 0.0 111.454 175.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -132.42 -50.14 0.92 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.434 1.894 . . . . 0.0 111.452 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -65.26 -13.7 58.99 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -130.75 19.7 5.09 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.405 1.482 . . . . 0.0 114.461 -166.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.82 -25.48 63.78 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -107.86 9.04 37.02 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.126 1.346 . . . . 0.0 115.613 -172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.67 129.67 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.156 1.783 . . . . 0.0 111.04 -173.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -77.03 58.03 1.45 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.573 1.949 . . . . 0.0 112.556 176.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -61.29 157.21 16.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.991 1.317 . . . . 0.0 113.098 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -153.25 155.28 36.29 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.761 0.824 . . . . 0.0 112.524 -176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -60.05 113.56 2.39 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.937 1.295 . . . . 0.0 111.037 174.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.74 4.8 24.47 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.921 1.528 . . . . 0.0 116.921 174.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.4 ptm -101.63 154.26 19.03 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 119.97 1.885 . . . . 0.0 113.034 171.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.9 p -72.17 94.86 1.59 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.15 1.78 . . . . 0.0 111.657 172.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.3 p -82.2 156.85 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.443 1.497 . . . . 0.0 111.618 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -121.86 143.38 49.46 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.585 1.554 . . . . 0.0 110.694 176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.05 99.14 0.36 Allowed Glycine 0 CA--C 1.527 0.822 0 C-N-CA 124.772 1.177 . . . . 0.0 112.17 -174.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -67.52 143.54 56.1 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 122.114 -0.639 . . . . 0.0 111.195 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -123.1 154.35 38.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.867 1.667 . . . . 0.0 111.457 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -63.44 -20.83 65.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.552 1.541 . . . . 0.0 113.164 -176.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -71.67 19.88 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 127.097 2.159 . . . . 0.0 114.22 172.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.7 m120 52.52 47.97 23.57 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.391 2.276 . . . . 0.0 113.04 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 10.1 mm-40 -140.6 172.28 12.93 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.959 1.703 . . . . 0.0 112.108 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.4 m -143.48 118.47 10.02 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.94 1.296 . . . . 0.0 111.012 -177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.82 162.09 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.727 0.811 . . . . 0.0 111.259 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -134.06 128.36 34.09 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.572 1.549 . . . . 0.0 111.147 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.28 -175.65 5.54 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.34 1.456 . . . . 0.0 112.564 -175.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.7 mp -116.15 136.84 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.212 1.405 . . . . 0.0 110.034 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.1 mt -68.11 133.08 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 125.396 1.478 . . . . 0.0 111.005 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.0 mmtt -108.22 -37.99 5.87 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.146 1.379 . . . . 0.0 112.886 -176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -151.55 157.89 42.83 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.399 1.08 . . . . 0.0 111.482 166.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -147.24 143.44 28.14 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.241 -0.912 . . . . 0.0 113.204 177.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 70.3 m -141.04 168.69 19.17 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.876 2.07 . . . . 0.0 110.584 174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.15 -25.87 67.17 Favored 'General case' 0 CA--C 1.549 0.904 0 O-C-N 121.203 -0.935 . . . . 0.0 113.211 173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.3 p -81.18 -60.18 2.38 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 126.952 2.101 . . . . 0.0 112.988 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -140.65 168.88 18.75 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.288 2.235 . . . . 0.0 111.781 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.69 132.96 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.54 1.536 . . . . 0.0 111.553 -177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 75.7 mtp -101.82 115.25 30.12 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.185 1.794 . . . . 0.0 110.803 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 1.1 m -129.57 136.41 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.738 1.615 . . . . 0.0 110.872 -174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -69.94 111.81 5.91 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.344 0.658 . . . . 0.0 111.484 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -123.62 172.43 8.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.778 2.031 . . . . 0.0 111.467 -174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -132.61 127.55 35.2 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.827 1.651 . . . . 0.0 110.203 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.96 144.51 19.09 Favored Pre-proline 0 CA--C 1.545 0.786 0 C-N-CA 124.859 1.264 . . . . 0.0 110.395 175.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.83 -13.97 29.55 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.945 2.43 . . . . 0.0 113.491 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.9 mt -88.22 14.37 9.49 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.47 1.908 . . . . 0.0 113.436 -177.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.61 178.08 7.57 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 125.621 1.568 . . . . 0.0 113.465 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 112.93 -178.28 18.67 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 126.073 1.796 . . . . 0.0 113.347 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -139.3 169.41 17.82 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.538 1.535 . . . . 0.0 113.307 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 17.2 p -65.27 146.64 54.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.124 1.369 . . . . 0.0 113.039 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -131.17 131.57 44.14 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.194 1.798 . . . . 0.0 111.687 -170.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.42 98.97 12.07 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.149 0.98 . . . . 0.0 111.652 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -81.23 103.14 10.81 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.758 0.79 . . . . 0.0 110.328 166.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -94.68 124.18 38.56 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.445 1.898 . . . . 0.0 109.336 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -148.82 170.65 17.78 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -154.33 147.43 24.67 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.98 1.712 . . . . 0.0 112.14 174.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 9.8 t -83.79 108.09 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.819 1.248 . . . . 0.0 108.727 163.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 20.1 mt -65.67 -39.48 91.38 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.888 -0.508 . . . . 0.0 111.492 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 137.76 -179.22 18.45 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.579 1.561 . . . . 0.0 113.496 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -96.57 147.68 23.62 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.661 1.184 . . . . 0.0 110.968 177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -128.65 144.66 51.2 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.979 1.312 . . . . 0.0 112.438 172.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -92.5 92.52 8.11 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.055 1.342 . . . . 0.0 110.427 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.7 m -62.51 156.08 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.879 0.872 . . . . 0.0 111.842 173.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.3 p -70.77 158.85 35.59 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.665 0.786 . . . . 0.0 112.323 172.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -125.29 25.94 7.0 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.714 1.605 . . . . 0.0 112.046 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 63.32 24.12 14.09 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.614 1.966 . . . . 0.0 113.911 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.253 1.258 0 C-N-CA 126.465 1.906 . . . . 0.0 114.115 177.266 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.2 mp0 -141.81 162.76 34.69 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.771 1.629 . . . . 0.0 110.85 -176.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.8 p-10 -91.17 -2.97 57.42 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.306 1.442 . . . . 0.0 114.481 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -74.98 174.79 8.84 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.674 1.59 . . . . 0.0 113.437 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -133.03 172.72 12.26 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.557 1.943 . . . . 0.0 112.581 176.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.71 43.76 1.96 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.371 1.468 . . . . 0.0 111.668 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -128.92 60.95 1.53 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.895 1.278 . . . . 0.0 113.505 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.8 m -67.46 -8.73 35.72 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.641 1.576 . . . . 0.0 114.803 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.443 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.1 mp -66.26 121.51 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 126.827 2.051 . . . . 0.0 110.514 -177.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 152.94 40.87 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.453 1.101 . . . . 0.0 112.286 176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -152.73 155.56 37.45 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.205 1.802 . . . . 0.0 111.094 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.97 103.94 11.14 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.917 0.887 . . . . 0.0 110.893 175.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.53 120.81 18.66 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.539 1.536 . . . . 0.0 110.573 168.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.18 124.2 47.37 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.215 1.406 . . . . 0.0 110.169 172.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 45.2 pt -131.35 163.62 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.661 1.184 . . . . 0.0 112.289 174.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -136.79 138.66 41.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.601 1.96 . . . . 0.0 109.831 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -140.77 151.93 44.82 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.066 1.346 . . . . 0.0 114.272 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -146.87 120.65 9.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 127.615 2.366 . . . . 0.0 110.315 -175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 10.9 t -99.94 110.28 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.858 1.663 . . . . 0.0 110.429 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.5 ttm105 -113.78 144.84 42.32 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 126.297 1.839 . . . . 0.0 110.694 178.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -69.79 117.33 11.25 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.908 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.84 105.33 0.55 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.571 0.748 . . . . 0.0 110.667 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 114.35 0.01 23.64 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 126.173 1.844 . . . . 0.0 115.169 -174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.8 t -137.05 165.84 25.1 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.332 1.566 . . . . 0.0 113.271 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 65.1 p -89.5 -13.47 37.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.737 2.015 . . . . 0.0 114.755 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.23 177.46 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.507 1.523 . . . . 0.0 113.661 -175.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.85 145.29 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.209 1.404 . . . . 0.0 110.121 169.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.8 mp -106.57 -53.45 2.62 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.173 0.989 . . . . 0.0 111.649 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.29 150.22 35.34 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.406 1.483 . . . . 0.0 110.381 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.6 p -163.01 169.61 19.31 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 121.158 -0.964 . . . . 0.0 111.694 173.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -122.72 -12.74 8.04 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 164.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -61.82 -36.8 75.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 124.281 1.032 . . . . 0.0 112.217 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.5 t -73.1 -5.7 40.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.591 1.156 . . . . 0.0 113.601 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.9 mmmm -117.59 -87.97 0.61 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.902 2.081 . . . . 0.0 110.367 -171.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -153.38 154.09 30.15 Favored Pre-proline 0 N--CA 1.478 0.966 0 C-N-CA 127.419 2.288 . . . . 0.0 111.272 172.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -65.35 150.69 86.89 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.596 2.864 . . . . 0.0 113.269 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 10.2 tt -87.6 123.7 32.74 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.432 1.493 . . . . 0.0 109.774 174.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -107.15 134.58 50.04 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.807 1.243 . . . . 0.0 111.533 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -150.12 172.58 15.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.499 1.119 . . . . 0.0 112.918 175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 45.3 mm -106.21 151.05 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.339 1.455 . . . . 0.0 109.195 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.1 mm -54.85 109.22 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 124.509 1.124 . . . . 0.0 111.009 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 104.08 27.06 6.38 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 116.526 1.37 . . . . 0.0 116.526 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 98.3 m -97.06 -24.1 15.94 Favored 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 119.39 1.595 . . . . 0.0 114.355 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.3 t30 45.73 43.13 9.37 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 126.915 2.086 . . . . 0.0 115.092 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -71.77 -31.14 66.32 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.4 1.88 . . . . 0.0 114.155 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.7 pt -72.41 166.87 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.866 1.267 . . . . 0.0 111.517 170.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 pt -63.15 146.36 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 0.0 111.413 172.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.03 -36.9 75.76 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -59.07 -31.06 67.94 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 124.005 0.812 . . . . 0.0 113.913 175.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.25 -29.66 24.45 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.836 1.255 . . . . 0.0 112.307 176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.09 -38.23 82.32 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.01 -1.056 . . . . 0.0 112.021 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -68.03 0.24 3.77 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.835 1.254 . . . . 0.0 114.312 173.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.39 -41.82 3.23 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.617 1.567 . . . . 0.0 113.167 174.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.0 p -58.71 -29.12 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -68.64 -10.39 55.85 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 175.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -118.96 -17.95 8.93 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.925 1.69 . . . . 0.0 114.549 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.95 141.62 49.43 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 119.309 0.959 . . . . 0.0 112.345 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -90.28 158.22 17.28 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.719 1.207 . . . . 0.0 111.779 177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.0 tt -58.03 129.75 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 124.179 0.992 . . . . 0.0 111.307 169.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.68 3.88 74.21 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.831 1.205 . . . . 0.0 115.692 177.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -106.63 111.95 24.73 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.181 1.491 . . . . 0.0 111.642 -178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -55.93 139.66 45.48 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.766 0.826 . . . . 0.0 111.723 170.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -137.11 149.15 47.15 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.57 1.548 . . . . 0.0 110.275 177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -134.71 104.74 6.16 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.449 1.099 . . . . 0.0 110.348 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.5 m -111.19 118.66 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.083 1.353 . . . . 0.0 110.359 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 38.0 t -75.83 121.32 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.488 0.715 . . . . 0.0 109.59 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 73.6 mt -118.55 144.46 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.953 1.701 . . . . 0.0 109.822 -175.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.32 152.02 92.83 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.814 1.246 . . . . 0.0 112.55 176.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.81 -33.9 41.92 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 122.538 2.159 . . . . 0.0 112.042 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.18 -31.64 72.92 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.923 0.889 . . . . 0.0 113.265 176.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -81.67 -18.46 44.43 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.322 1.449 . . . . 0.0 113.177 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -102.92 -42.12 5.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.988 1.315 . . . . 0.0 113.767 -178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -134.79 -27.1 1.31 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.632 1.573 . . . . 0.0 114.83 -172.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.2 -144.96 19.52 Favored Glycine 0 CA--C 1.536 1.394 0 CA-C-N 119.27 0.941 . . . . 0.0 112.273 -172.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 5.5 m -50.97 96.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 127.158 2.183 . . . . 0.0 113.778 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -71.55 163.33 27.94 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.998 1.319 . . . . 0.0 112.466 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -62.9 -21.2 65.85 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 120.6 -1.313 . . . . 0.0 114.232 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 m -75.42 -0.36 19.76 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.265 1.826 . . . . 0.0 114.194 175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 4.6 t -69.15 -173.6 0.54 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.968 1.307 . . . . 0.0 112.424 178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 69.05 14.6 8.8 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.723 2.009 . . . . 0.0 113.458 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.5 mp -146.66 147.23 30.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.149 2.58 . . . . 0.0 109.563 166.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -145.53 117.45 8.24 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.172 1.389 . . . . 0.0 110.416 170.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -72.11 118.45 15.0 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.955 0.902 . . . . 0.0 111.133 171.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 m -127.56 158.73 69.02 Favored Pre-proline 0 N--CA 1.475 0.787 0 C-N-CA 127.243 2.217 . . . . 0.0 110.978 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.12 149.3 64.43 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 122.154 1.902 . . . . 0.0 110.958 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -62.26 -20.31 64.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.533 0.733 . . . . 0.0 112.958 175.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -52.07 -32.19 33.64 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.997 1.719 . . . . 0.0 113.72 174.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -64.76 -18.16 64.81 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.517 1.127 . . . . 0.0 113.344 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.88 18.32 6.15 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.045 2.138 . . . . 0.0 112.915 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -53.34 108.61 0.35 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.61 1.564 . . . . 0.0 112.164 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 107.66 -5.11 34.82 Favored Glycine 0 CA--C 1.54 1.625 0 C-N-CA 125.826 1.679 . . . . 0.0 115.434 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.7 mt -101.5 130.98 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.44 1.496 . . . . 0.0 110.375 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.76 89.88 1.83 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.489 1.116 . . . . 0.0 111.468 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 18.3 mt -70.5 158.28 36.35 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.279 1.032 . . . . 0.0 111.777 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -155.33 145.81 22.05 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.732 1.213 . . . . 0.0 111.288 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -73.21 83.02 1.35 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.165 0.986 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.77 46.25 0.29 Allowed Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.362 1.458 . . . . 0.0 113.87 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.7 ppp? -129.01 148.7 50.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.199 1.4 . . . . 0.0 111.109 173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 3.1 p -76.68 108.35 9.62 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.872 1.669 . . . . 0.0 111.479 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.2 p -109.1 156.79 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 125.668 1.587 . . . . 0.0 110.679 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -121.24 154.63 36.06 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.662 1.185 . . . . 0.0 111.068 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -143.68 106.23 0.41 Allowed Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.344 0.973 . . . . 0.0 113.217 -173.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -74.55 114.05 12.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.462 1.105 . . . . 0.0 111.932 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -84.95 159.2 20.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.166 1.386 . . . . 0.0 112.122 173.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -63.46 -18.46 63.78 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.225 174.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -69.19 10.71 0.28 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 125.993 1.717 . . . . 0.0 113.897 173.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 55.41 46.35 23.47 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 127.155 2.182 . . . . 0.0 111.956 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -141.22 171.13 14.48 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.795 2.038 . . . . 0.0 111.167 176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.5 m -140.74 108.06 5.53 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.497 1.119 . . . . 0.0 110.697 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.42 165.88 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.832 -0.543 . . . . 0.0 111.29 176.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -129.16 131.11 47.11 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.971 1.308 . . . . 0.0 110.592 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.36 177.91 9.52 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.803 1.241 . . . . 0.0 113.59 -169.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.89 135.59 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.628 1.571 . . . . 0.0 109.903 175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.3 mt -75.93 120.94 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.313 1.045 . . . . 0.0 110.22 174.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -87.69 -38.07 16.16 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.878 1.271 . . . . 0.0 112.477 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -148.54 152.74 37.36 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.932 1.293 . . . . 0.0 111.63 174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -146.78 142.56 27.87 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.094 0.957 . . . . 0.0 112.601 174.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 21.0 t -153.51 169.42 23.25 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.137 2.175 . . . . 0.0 110.125 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.71 -28.29 68.32 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.123 0.969 . . . . 0.0 113.408 177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.6 p -79.56 -60.66 2.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 126.135 1.774 . . . . 0.0 111.852 177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -134.16 156.94 47.43 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.371 1.868 . . . . 0.0 112.294 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 61.4 t -131.6 142.0 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.622 1.969 . . . . 0.0 108.566 177.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 85.9 mtp -121.94 98.87 6.14 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.997 1.319 . . . . 0.0 110.161 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.3 t -99.62 148.0 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.642 1.177 . . . . 0.0 109.849 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -62.99 110.4 1.78 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.36 0.664 . . . . 0.0 111.669 172.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -130.94 119.09 21.61 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.181 1.393 . . . . 0.0 109.422 171.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -71.75 37.34 0.06 Allowed 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 126.75 2.02 . . . . 0.0 113.186 173.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.52 140.97 96.8 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 125.197 1.399 . . . . 0.0 111.991 -172.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.05 -29.16 12.14 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.832 2.355 . . . . 0.0 114.097 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.0 mp -78.99 46.0 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.46 1.504 . . . . 0.0 111.632 175.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -76.99 -41.49 42.67 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.603 1.561 . . . . 0.0 114.095 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -81.44 -164.92 33.78 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.079 1.324 . . . . 0.0 113.11 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.87 168.31 9.58 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.703 1.201 . . . . 0.0 112.037 167.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -59.01 146.6 37.69 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.39 1.876 . . . . 0.0 113.13 174.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.9 mt -128.36 140.32 51.92 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.685 1.594 . . . . 0.0 110.941 -175.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -79.88 94.31 5.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.01 1.324 . . . . 0.0 111.023 177.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -76.48 92.68 3.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.503 1.121 . . . . 0.0 109.697 167.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 32.4 ttt85 -75.48 139.46 42.24 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 167.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -150.86 171.06 17.82 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 171.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -150.23 146.2 26.67 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.028 1.331 . . . . 0.0 111.36 171.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.21 104.19 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.536 1.134 . . . . 0.0 109.119 167.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.71 -24.52 58.77 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.45 0.7 . . . . 0.0 112.338 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.29 -167.43 25.48 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 125.047 1.308 . . . . 0.0 113.907 171.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -125.43 145.96 49.84 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.009 1.324 . . . . 0.0 110.626 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -134.85 151.63 51.08 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.21 1.004 . . . . 0.0 113.132 175.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.93 109.85 13.6 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.059 1.344 . . . . 0.0 110.586 173.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.3 m -66.53 153.6 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.578 0.751 . . . . 0.0 111.778 170.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.6 p -78.77 170.28 16.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.798 0.839 . . . . 0.0 111.635 164.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.36 8.24 7.13 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.702 1.601 . . . . 0.0 113.146 175.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.28 -51.53 36.49 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.797 1.639 . . . . 0.0 112.872 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 127.066 2.147 . . . . 0.0 112.32 178.439 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -129.96 166.51 19.91 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.912 1.285 . . . . 0.0 111.831 174.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -66.72 172.37 4.34 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.484 1.514 . . . . 0.0 112.697 168.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -121.92 153.55 38.32 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.244 1.418 . . . . 0.0 111.333 170.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -154.51 170.49 21.31 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.511 1.924 . . . . 0.0 110.368 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.81 98.73 1.26 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.375 1.47 . . . . 0.0 112.19 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -105.63 81.83 1.73 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.581 1.552 . . . . 0.0 110.749 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.4 t -70.12 -46.71 64.22 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.029 0.931 . . . . 0.0 112.346 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.7 mm -113.85 141.58 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.44 1.896 . . . . 0.0 109.235 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.51 173.09 11.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.168 1.787 . . . . 0.0 111.193 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 -132.6 143.71 49.88 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.585 1.554 . . . . 0.0 111.269 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.3 104.89 7.05 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.253 1.021 . . . . 0.0 109.63 174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.08 141.21 37.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.657 1.183 . . . . 0.0 110.671 169.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.7 mp -129.25 133.49 47.54 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.391 1.476 . . . . 0.0 110.599 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.2 pt -134.35 163.98 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.869 1.268 . . . . 0.0 111.544 173.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -137.84 135.81 36.57 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.168 1.387 . . . . 0.0 109.699 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -134.09 158.99 42.18 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 123.067 1.413 . . . . 0.0 114.368 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -141.04 120.83 13.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.961 2.904 . . . . 0.0 108.259 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -100.71 105.69 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.446 1.117 . . . . 0.0 109.93 174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 ttp85 -118.57 153.16 34.68 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 127.202 2.201 . . . . 0.0 109.717 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -70.5 146.33 50.32 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.316 -0.865 . . . . 0.0 110.836 175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -70.52 -33.11 70.81 Favored 'General case' 0 CA--C 1.545 0.779 0 O-C-N 120.881 -1.137 . . . . 0.0 112.434 176.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.45 -35.67 7.84 Favored Glycine 0 CA--C 1.537 1.443 0 C-N-CA 124.352 0.977 . . . . 0.0 115.017 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -116.92 151.07 37.42 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.319 1.448 . . . . 0.0 112.604 -175.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 t -73.1 -7.52 51.71 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.95 151.11 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 O-C-N 120.892 -1.13 . . . . 0.0 112.372 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.43 126.97 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.226 1.41 . . . . 0.0 109.843 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.1 mp -84.58 -42.89 15.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.777 0.831 . . . . 0.0 110.818 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -158.49 163.4 37.15 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 126.3 1.84 . . . . 0.0 110.767 171.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.3 t -166.65 150.57 7.2 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.071 1.348 . . . . 0.0 112.131 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -124.55 4.26 8.29 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 170.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.4 mm -47.98 -64.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.234 1.414 . . . . 0.0 112.079 -176.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.4 t -79.9 -23.67 41.66 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.256 1.023 . . . . 0.0 113.368 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.5 mmtp -69.64 -71.61 0.22 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.884 1.674 . . . . 0.0 112.056 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -165.63 140.0 3.88 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.099 1.759 . . . . 0.0 110.876 175.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.41 152.48 75.28 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.666 2.244 . . . . 0.0 112.698 176.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.8 tp -83.07 97.68 8.9 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.222 1.809 . . . . 0.0 110.294 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -74.08 129.85 38.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.368 1.467 . . . . 0.0 111.923 171.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -149.43 176.49 10.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.967 1.307 . . . . 0.0 112.846 168.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.0 mm -112.43 134.87 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.469 1.508 . . . . 0.0 109.385 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.0 mm -50.09 117.04 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.332 1.453 . . . . 0.0 110.956 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.26 71.6 1.12 Allowed Glycine 0 CA--C 1.533 1.194 0 C-N-CA 125.014 1.293 . . . . 0.0 112.044 -169.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.1 t -134.6 -43.9 0.75 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.049 1.34 . . . . 0.0 113.344 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 54.09 21.14 2.82 Favored 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 126.721 2.008 . . . . 0.0 115.097 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 pt -71.66 165.75 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.997 1.319 . . . . 0.0 112.469 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.29 142.65 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.289 1.036 . . . . 0.0 111.729 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.54 -37.8 82.4 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.369 0.878 . . . . 0.0 113.369 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.4 -28.72 69.91 Favored Glycine 0 CA--C 1.538 1.498 0 O-C-N 121.48 -0.763 . . . . 0.0 113.992 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 tp -87.15 -35.39 18.65 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.044 1.338 . . . . 0.0 111.898 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.36 -46.42 69.57 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.718 1.207 . . . . 0.0 111.415 171.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -77.91 13.63 1.33 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.011 1.324 . . . . 0.0 114.143 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.59 -39.92 2.39 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.714 1.606 . . . . 0.0 113.616 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.4 m -56.22 -29.1 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -67.26 -14.32 62.81 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -118.69 -9.5 10.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.416 1.486 . . . . 0.0 114.112 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.69 113.85 8.19 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.212 1.405 . . . . 0.0 111.61 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -62.47 145.73 53.41 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.705 0.802 . . . . 0.0 112.117 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.1 tp -64.75 133.41 30.26 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.664 0.786 . . . . 0.0 110.691 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.16 10.39 56.55 Favored Glycine 0 CA--C 1.539 1.531 0 N-CA-C 115.709 1.044 . . . . 0.0 115.709 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -118.91 128.13 54.13 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.448 1.499 . . . . 0.0 111.281 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -57.93 140.91 51.06 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.021 0.928 . . . . 0.0 112.243 175.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -134.12 141.51 47.15 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.795 2.038 . . . . 0.0 109.864 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.17 106.75 6.9 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.132 0.973 . . . . 0.0 110.265 -171.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.5 m -117.55 113.48 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 124.757 1.223 . . . . 0.0 111.711 -176.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 13.9 t -75.96 123.83 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.092 0.957 . . . . 0.0 109.554 173.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.4 mt -128.73 135.71 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.92 1.288 . . . . 0.0 109.489 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.6 161.46 59.62 Favored Pre-proline 0 CA--C 1.556 1.186 0 C-N-CA 125.703 1.601 . . . . 0.0 112.623 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.28 42.41 0.76 Allowed 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 125.18 3.92 . . . . 0.0 113.872 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -128.42 -35.77 1.94 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.877 2.071 . . . . 0.0 113.057 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -110.93 -15.59 13.73 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.317 1.047 . . . . 0.0 113.617 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -127.83 99.92 5.72 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.403 1.481 . . . . 0.0 111.125 -171.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 43.19 47.97 5.47 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.684 1.594 . . . . 0.0 112.512 -163.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.27 -160.27 30.98 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.808 1.671 . . . . 0.0 114.139 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 t 61.7 34.83 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 125.146 1.378 . . . . 0.0 110.909 -176.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -64.2 149.99 46.74 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.837 1.655 . . . . 0.0 112.342 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -133.05 107.26 8.13 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.799 1.24 . . . . 0.0 113.866 -176.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.9 m -94.68 21.47 7.34 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.67 1.588 . . . . 0.0 113.102 171.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.4 m 55.76 63.34 2.08 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 127.119 2.167 . . . . 0.0 113.989 178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -85.97 177.54 7.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.863 1.265 . . . . 0.0 112.135 172.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.53 166.75 24.8 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.674 1.589 . . . . 0.0 111.903 172.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -144.86 131.14 19.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.502 1.121 . . . . 0.0 110.983 176.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -70.04 128.57 36.78 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.794 0.838 . . . . 0.0 110.923 169.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.05 137.73 18.55 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.299 1.84 . . . . 0.0 109.903 -178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.73 172.66 15.36 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.017 2.478 . . . . 0.0 113.122 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -69.5 70.26 0.28 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.471 1.908 . . . . 0.0 111.901 172.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -129.19 -64.39 0.91 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.591 1.956 . . . . 0.0 110.494 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -64.12 -16.39 61.74 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.906 1.283 . . . . 0.0 113.653 176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.407 ' CG ' HD11 ' A' ' 94' ' ' LEU . 42.5 m-85 -131.69 13.88 4.9 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.968 1.707 . . . . 0.0 113.422 -172.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -58.61 -28.59 65.76 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 120.699 -1.251 . . . . 0.0 113.435 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -102.89 12.55 56.21 Favored Glycine 0 CA--C 1.54 1.635 0 C-N-CA 125.844 1.688 . . . . 0.0 115.047 175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.2 mt -129.75 115.19 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.509 1.524 . . . . 0.0 110.257 -170.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.3 108.48 4.22 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.297 -0.877 . . . . 0.0 111.629 174.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.407 HD11 ' CG ' ' A' ' 89' ' ' PHE . 80.0 mt -101.63 156.99 17.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.368 1.467 . . . . 0.0 111.814 176.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.17 145.23 17.88 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.019 1.728 . . . . 0.0 109.863 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -51.87 128.35 23.71 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.772 0.829 . . . . 0.0 111.943 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.52 56.12 3.47 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.27 0.938 . . . . 0.0 114.327 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.1 ptp -132.27 172.45 12.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.116 1.766 . . . . 0.0 110.931 165.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 t -101.94 103.91 14.58 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.022 0.929 . . . . 0.0 110.452 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.7 p -93.28 154.44 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.153 1.381 . . . . 0.0 110.331 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -120.27 153.58 36.15 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.49 1.116 . . . . 0.0 111.944 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 97.52 0.23 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 124.73 1.157 . . . . 0.0 112.742 -175.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -64.71 142.67 58.35 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.874 -0.78 . . . . 0.0 111.38 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.0 t -126.09 157.12 38.83 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.909 1.683 . . . . 0.0 111.607 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -64.95 -15.15 61.83 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.071 1.748 . . . . 0.0 113.509 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -76.41 15.63 0.58 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.609 1.963 . . . . 0.0 113.721 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 28.6 m120 56.73 39.95 29.41 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.878 2.071 . . . . 0.0 113.136 -175.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -133.67 172.56 12.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.686 1.995 . . . . 0.0 111.409 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.6 m -142.44 114.73 8.35 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.351 1.46 . . . . 0.0 110.427 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.4 pp -72.57 163.89 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.015 0.526 . . . . 0.0 111.166 173.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -133.49 132.95 41.62 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.046 1.338 . . . . 0.0 110.901 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -147.96 175.33 11.06 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.613 1.565 . . . . 0.0 112.814 -166.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.438 ' H ' ' HB3' ' A' ' 125' ' ' ASP . 4.8 mp -121.46 142.76 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.705 1.602 . . . . 0.0 110.625 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.76 113.71 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.575 1.15 . . . . 0.0 109.856 172.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.96 -30.41 15.37 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.915 1.286 . . . . 0.0 113.429 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -155.38 155.55 33.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.947 1.699 . . . . 0.0 110.581 166.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -147.26 147.72 30.71 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.21 0.914 . . . . 0.0 113.253 176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.0 t -153.17 171.91 17.75 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.737 2.015 . . . . 0.0 110.975 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.31 -21.98 61.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.63 1.172 . . . . 0.0 113.558 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.4 p -82.55 -63.6 1.34 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.675 1.59 . . . . 0.0 111.724 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -135.22 165.17 26.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.325 2.25 . . . . 0.0 111.339 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.8 p -133.48 154.13 38.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.179 1.792 . . . . 0.0 109.798 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 80.2 mtp -125.77 103.98 8.1 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.159 1.384 . . . . 0.0 110.421 -175.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.8 t -99.54 141.62 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.134 1.373 . . . . 0.0 109.627 -177.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 113' ' ' ILE . 13.9 t70 -62.08 140.04 58.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.946 1.298 . . . . 0.0 111.436 172.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -143.43 173.74 11.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.686 1.194 . . . . 0.0 111.946 175.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 56.0 p30 -121.5 176.0 5.9 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.211 1.804 . . . . 0.0 111.578 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -145.77 133.59 10.48 Favored Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 124.556 1.142 . . . . 0.0 110.367 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.38 -35.22 51.34 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.214 1.943 . . . . 0.0 112.3 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.94 3.8 9.5 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.53 -26.79 65.61 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.46 -160.38 31.49 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.41 1.481 . . . . 0.0 113.588 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -132.73 165.55 24.26 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.232 1.413 . . . . 0.0 112.618 170.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 3.0 p -63.34 139.47 58.77 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.489 1.516 . . . . 0.0 112.856 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.4 148.04 46.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.279 1.432 . . . . 0.0 111.15 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -98.49 102.6 14.39 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.991 2.117 . . . . 0.0 110.262 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -80.12 95.29 6.18 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.607 0.717 . . . . 0.0 109.734 168.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -86.55 112.7 21.8 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.689 1.596 . . . . 0.0 108.776 171.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -136.12 170.31 16.22 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.833 0.853 . . . . 0.0 112.865 -176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -147.36 137.61 23.21 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.639 1.176 . . . . 0.0 111.005 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 5.7 t -87.45 94.31 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 172.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.03 -28.63 69.72 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.779 1.231 . . . . 0.0 112.686 -175.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 127.68 177.87 15.07 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 125.968 1.746 . . . . 0.0 112.582 176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -112.29 156.06 23.04 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.779 0.832 . . . . 0.0 111.688 169.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.5 ptp180 -135.19 130.62 35.59 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.637 1.575 . . . . 0.0 111.332 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -73.03 117.69 15.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.907 0.883 . . . . 0.0 109.513 169.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.8 m -110.17 170.56 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.37 1.468 . . . . 0.0 110.746 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 88.1 p -130.93 156.82 44.44 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.259 1.024 . . . . 0.0 112.315 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -134.82 9.04 3.57 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.947 1.699 . . . . 0.0 112.92 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -73.06 -44.61 60.39 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.585 1.554 . . . . 0.0 112.871 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.008 1.723 . . . . 0.0 114.475 -178.694 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 119.431 -0.318 . . . . 0.0 110.882 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -61.98 156.0 22.25 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.753 1.221 . . . . 0.0 112.401 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.8 p30 -84.02 175.46 9.52 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.972 1.309 . . . . 0.0 112.815 173.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.5 m80 -132.15 142.75 49.58 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.706 1.602 . . . . 0.0 111.589 171.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -85.53 168.66 14.31 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.295 1.438 . . . . 0.0 112.461 174.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.14 112.62 9.36 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.455 1.102 . . . . 0.0 110.588 166.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -129.43 27.57 5.29 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.696 1.598 . . . . 0.0 113.319 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -66.81 -35.03 79.13 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.298 1.439 . . . . 0.0 113.992 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.4 mp -74.16 132.58 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.307 1.443 . . . . 0.0 110.546 -177.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -61.36 159.18 12.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.15 1.38 . . . . 0.0 113.6 176.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -137.14 156.23 48.61 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.193 1.397 . . . . 0.0 111.152 170.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.94 115.03 22.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.824 0.85 . . . . 0.0 110.127 165.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.11 114.68 11.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.999 1.32 . . . . 0.0 109.908 162.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.48 119.84 33.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.798 1.239 . . . . 0.0 109.111 173.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -131.94 163.1 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.207 1.003 . . . . 0.0 111.859 176.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -143.1 140.22 30.79 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.565 1.546 . . . . 0.0 110.635 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -136.74 158.08 45.27 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.385 1.474 . . . . 0.0 114.055 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -144.16 107.92 4.67 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.643 1.977 . . . . 0.0 110.614 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -87.68 117.6 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.276 1.031 . . . . 0.0 111.076 178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -131.31 156.48 45.4 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.899 1.68 . . . . 0.0 111.104 -174.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -75.3 146.46 40.97 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.297 -0.877 . . . . 0.0 111.055 169.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -69.16 133.51 48.1 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.075 0.95 . . . . 0.0 110.927 169.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 77.49 -57.13 3.76 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 124.991 1.281 . . . . 0.0 114.177 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.0 t -62.87 147.55 49.87 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.497 1.119 . . . . 0.0 112.598 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 68.5 m -83.44 -7.74 59.5 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -67.25 161.14 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 119.0 0.818 . . . . 0.0 111.876 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.8 t -129.71 124.75 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.351 1.46 . . . . 0.0 109.504 179.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 mt -71.7 -53.57 13.09 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.012 0.525 . . . . 0.0 112.016 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -157.88 162.09 38.33 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.761 1.224 . . . . 0.0 111.686 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 69.8 p -154.63 130.25 9.94 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.945 1.298 . . . . 0.0 112.466 -175.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -108.64 -2.02 19.06 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 168.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 26.7 mm -51.67 -52.29 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.987 1.715 . . . . 0.0 111.884 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 m -82.6 -6.27 59.26 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 mmpp? -92.17 -172.07 3.02 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.56 1.944 . . . . 0.0 110.657 175.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -64.5 137.2 97.06 Favored Pre-proline 0 CA--C 1.556 1.175 0 O-C-N 121.469 -0.77 . . . . 0.0 110.799 170.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -67.81 163.52 35.1 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.221 2.614 . . . . 0.0 113.204 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.2 tp -92.91 110.24 21.7 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.76 1.224 . . . . 0.0 110.754 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -88.85 131.16 35.22 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.766 1.626 . . . . 0.0 111.499 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -143.06 157.04 44.9 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.256 1.022 . . . . 0.0 111.722 164.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 40.1 mm -88.59 148.79 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 121.024 -1.047 . . . . 0.0 109.711 173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.0 mm -48.19 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.316 1.446 . . . . 0.0 111.335 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.03 11.48 49.33 Favored Glycine 0 CA--C 1.543 1.83 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -69.44 -35.0 75.25 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 119.926 1.863 . . . . 0.0 113.557 178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.3 m120 57.72 37.74 27.33 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 126.527 1.931 . . . . 0.0 115.281 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -79.25 -23.65 43.52 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 115.861 1.801 . . . . 0.0 115.861 -176.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.3 pt -72.76 167.91 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.367 1.067 . . . . 0.0 112.84 178.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.3 pt -59.11 136.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.95 0.9 . . . . 0.0 111.202 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.78 -29.24 70.01 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.287 -0.883 . . . . 0.0 112.606 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -65.94 -13.97 60.32 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.436 1.493 . . . . 0.0 115.111 173.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.5 tp -105.94 -36.68 6.9 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.349 1.86 . . . . 0.0 111.595 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -57.28 -32.79 66.98 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -4.01 0.86 Allowed 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 174.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.79 -29.9 4.56 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.387 1.875 . . . . 0.0 113.965 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.41 -24.95 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 CA-C-N 119.849 1.204 . . . . 0.0 113.373 -178.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -66.4 -13.85 61.29 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 173.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -116.34 -21.24 9.39 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.755 1.622 . . . . 0.0 113.859 176.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.29 111.58 2.68 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.662 1.185 . . . . 0.0 112.15 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.67 159.69 33.96 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 122.116 0.96 . . . . 0.0 113.2 176.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -56.64 131.99 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.194 1.398 . . . . 0.0 111.617 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.93 8.53 68.95 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.967 1.27 . . . . 0.0 115.064 178.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -110.53 112.7 24.79 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.032 1.333 . . . . 0.0 111.471 -172.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.0 m95 -59.0 134.52 57.06 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.428 0.691 . . . . 0.0 111.363 171.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -132.61 112.97 12.49 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.121 1.768 . . . . 0.0 110.032 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -101.94 92.73 4.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.927 1.291 . . . . 0.0 110.508 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 28.3 m -99.06 165.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.592 0.757 . . . . 0.0 111.485 170.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.86 130.13 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.331 1.452 . . . . 0.0 108.461 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.4 mt -127.78 130.42 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 126.615 1.966 . . . . 0.0 109.135 -165.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.32 147.25 82.34 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 123.608 0.763 . . . . 0.0 111.264 174.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -66.22 -43.16 9.05 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.45 2.1 . . . . 0.0 112.354 -166.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -66.28 -21.86 66.29 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.822 1.649 . . . . 0.0 114.068 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -81.75 -13.53 57.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.698 1.199 . . . . 0.0 112.508 175.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -100.31 -73.39 0.64 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.126 1.77 . . . . 0.0 111.586 173.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -141.94 -12.32 0.86 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -173.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.66 78.15 0.84 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.406 1.003 . . . . 0.0 113.267 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.3 m -126.03 132.63 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.798 1.639 . . . . 0.0 110.767 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -134.21 172.51 12.76 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.893 1.277 . . . . 0.0 111.583 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -137.46 165.85 25.26 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.128 1.371 . . . . 0.0 111.868 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.4 p -122.68 8.46 9.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.129 1.772 . . . . 0.0 113.429 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.7 p -124.93 96.13 4.76 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.933 2.093 . . . . 0.0 111.786 -170.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -121.47 178.51 4.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.506 2.322 . . . . 0.0 109.848 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -125.34 143.96 50.72 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.069 -1.02 . . . . 0.0 110.635 174.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -126.39 124.65 40.68 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.854 1.262 . . . . 0.0 110.666 -178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -83.89 78.34 9.74 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 122.366 1.079 . . . . 0.0 111.186 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 54.0 t -78.54 136.49 59.73 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.097 1.759 . . . . 0.0 109.903 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 159.44 52.91 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.71 2.273 . . . . 0.0 112.701 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -60.5 -17.8 47.7 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 178.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -56.25 -31.26 63.41 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.902 1.681 . . . . 0.0 113.575 175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -81.09 -6.16 58.49 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.155 0.982 . . . . 0.0 113.636 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -133.41 45.74 2.66 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.009 2.124 . . . . 0.0 110.996 -172.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -83.66 111.82 19.48 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.54 1.136 . . . . 0.0 111.6 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.85 55.46 4.14 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.457 1.027 . . . . 0.0 114.319 174.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.428 HD13 ' HG ' ' A' ' 94' ' ' LEU . 0.8 OUTLIER -137.46 -179.6 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 127.731 2.412 . . . . 0.0 111.786 -178.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -131.99 88.3 2.54 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.588 1.555 . . . . 0.0 110.601 172.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.428 ' HG ' HD13 ' A' ' 92' ' ' ILE . 26.0 mt -75.24 151.69 38.38 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.454 0.702 . . . . 0.0 111.398 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -148.84 135.09 19.32 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.217 1.007 . . . . 0.0 111.388 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -62.56 102.74 0.35 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.481 1.513 . . . . 0.0 110.563 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.97 21.15 5.75 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 124.994 1.283 . . . . 0.0 115.797 -175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 8.0 ptt? -112.92 158.01 20.74 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 119.26 1.53 . . . . 0.0 112.555 172.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.8 p -82.46 97.8 8.58 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.113 1.365 . . . . 0.0 111.771 169.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 p -83.7 162.2 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.962 0.905 . . . . 0.0 111.015 171.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -123.32 152.89 40.98 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.276 1.431 . . . . 0.0 111.37 174.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.42 108.08 0.47 Allowed Glycine 0 N--CA 1.471 0.983 0 C-N-CA 124.369 0.985 . . . . 0.0 112.692 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -66.71 145.46 55.52 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 122.157 -0.614 . . . . 0.0 111.359 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.2 t -125.14 156.45 38.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.109 1.764 . . . . 0.0 111.533 176.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -62.16 -16.02 49.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.202 1.801 . . . . 0.0 114.294 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -74.68 12.82 0.73 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.428 1.891 . . . . 0.0 113.89 173.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 31.5 m120 54.27 48.66 20.3 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.942 2.097 . . . . 0.0 112.221 -172.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -140.12 173.81 11.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.191 1.797 . . . . 0.0 111.792 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 25.4 m -145.67 110.96 5.32 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.05 1.34 . . . . 0.0 110.529 -176.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.07 167.36 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 O-C-N 121.74 -0.6 . . . . 0.0 111.43 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -121.54 139.45 53.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.641 1.576 . . . . 0.0 110.725 173.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.8 173.96 14.65 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.465 1.106 . . . . 0.0 112.65 -168.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.2 mp -122.85 128.53 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.702 1.201 . . . . 0.0 110.744 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.0 mm -63.22 125.48 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.413 1.485 . . . . 0.0 110.279 173.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.9 mmmm -111.84 -34.93 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.647 1.179 . . . . 0.0 113.041 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -157.62 167.5 29.96 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.491 1.116 . . . . 0.0 112.039 165.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -141.72 140.38 33.12 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.201 1.001 . . . . 0.0 112.168 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.9 m -111.76 174.07 6.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.152 2.181 . . . . 0.0 110.739 177.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.3 -26.02 68.58 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 70.9 p -130.19 -7.57 4.32 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.788 1.635 . . . . 0.0 114.809 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -145.0 165.37 28.36 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.256 1.822 . . . . 0.0 111.278 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -134.69 144.42 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.706 1.603 . . . . 0.0 109.712 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 37.7 mmm -116.14 109.5 17.56 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.04 1.736 . . . . 0.0 110.051 178.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.31 148.1 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.35 1.46 . . . . 0.0 109.933 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -67.03 120.52 13.79 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.241 1.417 . . . . 0.0 111.867 173.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -134.59 164.45 27.45 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.886 1.674 . . . . 0.0 111.873 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -83.03 171.09 14.16 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.518 1.127 . . . . 0.0 112.102 167.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -145.69 131.82 9.61 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 124.619 1.167 . . . . 0.0 110.769 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.52 -39.76 3.42 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.811 2.341 . . . . 0.0 112.968 -175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.67 78.75 7.4 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.444 1.098 . . . . 0.0 108.595 169.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.37 162.72 22.09 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.419 1.088 . . . . 0.0 112.692 177.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 99.12 102.21 2.34 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.71 1.148 . . . . 0.0 113.859 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -77.67 155.26 31.45 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.231 1.812 . . . . 0.0 112.693 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.87 144.21 43.49 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.185 1.394 . . . . 0.0 111.3 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.2 143.95 46.98 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.065 1.346 . . . . 0.0 111.262 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.75 144.38 37.25 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.659 0.784 . . . . 0.0 111.357 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -128.79 92.13 3.35 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.074 1.75 . . . . 0.0 108.652 170.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.2 tpt180 -79.01 110.37 14.17 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.901 1.28 . . . . 0.0 108.802 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -131.88 166.97 20.42 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.349 0.66 . . . . 0.0 112.773 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -149.92 142.74 24.73 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.658 1.183 . . . . 0.0 111.673 175.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.14 106.69 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.997 1.319 . . . . 0.0 108.826 168.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 32.4 mt -69.61 -38.19 77.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.499 1.12 . . . . 0.0 111.63 -178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.55 158.88 7.73 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.296 1.427 . . . . 0.0 114.749 167.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -82.9 125.38 31.3 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.803 1.641 . . . . 0.0 111.506 -176.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -142.83 120.42 11.77 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.276 1.43 . . . . 0.0 111.225 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.38 145.86 47.43 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 120.988 -1.07 . . . . 0.0 111.526 171.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.76 146.84 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.55 1.54 . . . . 0.0 110.85 177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 49.4 m -70.13 126.88 30.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.218 1.007 . . . . 0.0 111.61 177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -103.71 1.64 32.07 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.421 1.489 . . . . 0.0 113.656 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -84.44 -58.67 2.64 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.979 1.712 . . . . 0.0 113.166 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 C--O 1.253 1.254 0 C-N-CA 125.744 1.618 . . . . 0.0 113.925 -177.817 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -129.38 125.55 36.84 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.125 1.37 . . . . 0.0 111.052 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -137.79 171.01 15.07 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.671 1.988 . . . . 0.0 110.945 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -145.18 172.91 12.44 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.643 1.177 . . . . 0.0 111.93 172.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -126.0 170.69 11.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.167 1.787 . . . . 0.0 112.022 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 tt -118.99 107.23 13.28 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.625 1.57 . . . . 0.0 110.576 -173.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -132.87 85.29 2.21 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.552 1.541 . . . . 0.0 111.261 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.4 m -74.39 -12.13 60.43 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.8 mm -78.83 170.03 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.942 0 C-N-CA 126.799 2.04 . . . . 0.0 110.538 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -72.55 145.62 47.3 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.407 1.083 . . . . 0.0 112.39 164.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -159.48 160.1 34.3 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.899 2.079 . . . . 0.0 109.621 167.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.19 108.44 6.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.093 0.557 . . . . 0.0 110.602 175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.27 120.05 14.5 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.265 1.826 . . . . 0.0 110.456 165.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.28 113.86 27.69 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.244 2.218 . . . . 0.0 108.952 177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.9 pt -129.07 159.35 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.055 0.942 . . . . 0.0 112.177 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -135.09 129.67 34.32 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.885 1.274 . . . . 0.0 110.38 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -135.68 155.0 51.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.607 1.163 . . . . 0.0 113.034 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -140.17 166.09 25.61 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.097 1.759 . . . . 0.0 111.424 169.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.37 101.2 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 124.84 1.256 . . . . 0.0 111.194 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -90.51 154.03 19.92 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.137 1.375 . . . . 0.0 110.219 170.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -61.54 135.4 57.64 Favored 'General case' 0 CA--C 1.544 0.745 0 O-C-N 121.585 -0.697 . . . . 0.0 109.894 161.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -71.21 91.72 0.96 Allowed 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.23 -0.919 . . . . 0.0 110.776 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.93 -68.91 0.54 Allowed Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.185 1.85 . . . . 0.0 112.302 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.0 m -67.11 158.67 30.58 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.7 m -79.02 -13.09 59.99 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.9 pp -69.46 151.05 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.074 0.852 . . . . 0.0 112.063 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 t -120.6 114.91 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.364 1.466 . . . . 0.0 109.182 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 38.0 mt -68.29 -48.57 64.62 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.619 1.168 . . . . 0.0 111.66 -176.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -154.02 158.19 40.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.638 1.575 . . . . 0.0 110.362 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.5 p -151.2 125.68 9.49 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.472 1.109 . . . . 0.0 111.52 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -90.13 -30.89 17.36 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.29 0.636 . . . . 0.0 111.912 170.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.5 mt -50.85 -50.91 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 125.613 1.565 . . . . 0.0 111.815 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.4 m -70.53 -5.54 29.72 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.21 1.404 . . . . 0.0 114.548 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -100.85 -83.61 0.44 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.772 1.629 . . . . 0.0 109.702 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -155.71 156.78 31.09 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 127.45 2.3 . . . . 0.0 110.451 171.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -63.82 141.35 78.01 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.679 2.253 . . . . 0.0 111.733 173.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.82 136.83 43.54 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.959 1.303 . . . . 0.0 109.971 175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.64 119.71 34.52 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.05 1.34 . . . . 0.0 111.208 -177.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -148.49 172.68 14.1 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -109.99 142.85 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.302 1.441 . . . . 0.0 109.839 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 45.1 mm -47.32 115.7 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.598 . . . . 0.0 111.864 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.52 64.76 1.49 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.171 1.367 . . . . 0.0 113.425 -176.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.9 t -115.67 -22.37 9.21 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 125.044 1.338 . . . . 0.0 114.529 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.5 m120 52.05 28.57 5.45 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 127.489 2.316 . . . . 0.0 116.107 179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -86.75 -32.14 20.56 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 pt -81.26 170.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.975 1.31 . . . . 0.0 112.168 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 23.1 pt -59.57 140.01 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.189 0.996 . . . . 0.0 111.723 176.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.38 -40.39 78.06 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -174.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.88 -28.75 70.75 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 124.115 0.864 . . . . 0.0 114.295 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.0 tp -89.19 -38.7 14.08 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.676 1.19 . . . . 0.0 111.588 173.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -53.42 -46.28 69.7 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.217 1.407 . . . . 0.0 112.229 177.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -69.04 1.72 3.29 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.948 1.699 . . . . 0.0 114.667 173.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -113.55 -35.72 5.15 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.72 1.608 . . . . 0.0 113.498 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -56.74 -41.55 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 CA-C-N 120.339 1.427 . . . . 0.0 112.253 -178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -65.29 -10.46 32.62 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -112.33 -9.43 13.87 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 126.205 1.802 . . . . 0.0 113.927 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.86 145.87 28.4 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.818 1.247 . . . . 0.0 111.842 171.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -98.37 157.01 16.46 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.925 1.29 . . . . 0.0 111.566 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.8 tt -57.39 129.36 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.258 1.023 . . . . 0.0 111.829 173.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.14 78.88 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.035 1.302 . . . . 0.0 115.368 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.28 114.13 20.37 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 119.09 1.445 . . . . 0.0 111.65 -173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -56.0 142.06 37.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.536 1.135 . . . . 0.0 112.717 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -137.44 116.46 12.45 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.015 1.726 . . . . 0.0 110.728 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -101.4 107.05 18.28 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.012 1.325 . . . . 0.0 110.73 177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.4 m -115.9 110.3 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.564 1.146 . . . . 0.0 110.907 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 t -73.89 130.19 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.347 -0.845 . . . . 0.0 109.398 173.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.3 mt -121.73 141.64 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.157 1.383 . . . . 0.0 109.764 -177.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.68 155.08 87.08 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.905 1.282 . . . . 0.0 112.789 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.62 -18.6 64.67 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.362 2.708 . . . . 0.0 114.457 -179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -104.49 -6.56 20.52 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.991 1.317 . . . . 0.0 113.366 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -106.65 -21.41 13.06 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.19 1.396 . . . . 0.0 113.224 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -78.67 -168.3 1.36 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.899 1.68 . . . . 0.0 112.897 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -54.48 -21.36 9.75 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 164.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.84 72.16 1.1 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.307 1.432 . . . . 0.0 113.546 169.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.9 p -138.39 154.91 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.036 1.734 . . . . 0.0 110.876 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 9.8 p90 -137.72 144.83 41.91 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.769 1.227 . . . . 0.0 110.597 169.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -140.32 82.26 1.85 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.092 1.357 . . . . 0.0 109.771 167.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.8 p -62.11 -37.84 86.62 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.331 1.052 . . . . 0.0 111.952 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 51.1 m 47.39 48.46 16.46 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.366 1.466 . . . . 0.0 112.382 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 71.99 15.1 5.69 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 127.242 2.217 . . . . 0.0 114.402 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.7 mt -142.16 160.67 39.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.566 1.946 . . . . 0.0 112.974 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.39 133.23 11.34 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.297 1.439 . . . . 0.0 111.427 162.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -78.29 99.51 6.33 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.443 1.097 . . . . 0.0 110.407 167.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.67 137.1 21.46 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 125.714 1.606 . . . . 0.0 109.425 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.44 155.92 50.37 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 112.922 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -75.71 60.75 1.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.171 1.788 . . . . 0.0 112.24 174.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -122.38 -54.11 1.89 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.302 1.841 . . . . 0.0 111.038 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -63.78 -17.18 62.81 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.464 1.105 . . . . 0.0 113.453 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -126.59 12.05 7.4 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.822 1.649 . . . . 0.0 113.875 -170.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -57.61 -27.13 62.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.417 1.087 . . . . 0.0 113.542 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.4 12.87 47.78 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 126.19 1.852 . . . . 0.0 115.355 177.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 24.6 mt -122.1 126.66 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 119.251 1.525 . . . . 0.0 110.725 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.93 78.38 0.64 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.22 1.408 . . . . 0.0 112.649 173.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.7 156.2 24.3 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.832 0.853 . . . . 0.0 112.395 175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -151.74 162.77 40.48 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.256 1.822 . . . . 0.0 110.028 -176.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -71.32 136.05 47.66 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 120.698 -1.251 . . . . 0.0 110.816 166.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.68 18.15 76.05 Favored Glycine 0 CA--C 1.537 1.455 0 N-CA-C 115.842 1.097 . . . . 0.0 115.842 171.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.5 ptm -100.53 148.64 24.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.944 1.372 . . . . 0.0 111.776 170.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 p -68.49 143.43 54.99 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.059 0.944 . . . . 0.0 111.765 169.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.9 p -148.37 163.58 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.757 1.623 . . . . 0.0 111.278 -177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.25 158.0 35.17 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.399 1.88 . . . . 0.0 111.081 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -150.88 103.7 0.25 Allowed Glycine 0 N--CA 1.472 1.05 0 C-N-CA 123.774 0.702 . . . . 0.0 113.229 -175.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -73.38 111.03 8.13 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.323 1.049 . . . . 0.0 111.5 178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.0 t -81.2 154.44 26.66 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.6 1.16 . . . . 0.0 111.744 171.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -65.86 -13.57 59.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.774 1.229 . . . . 0.0 113.515 172.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -71.06 18.85 0.06 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 126.165 1.786 . . . . 0.0 113.841 168.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 55.3 42.94 29.83 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 127.386 2.274 . . . . 0.0 113.037 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -143.02 169.75 16.99 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.794 1.638 . . . . 0.0 112.043 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.8 m -141.41 107.11 5.1 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.29 1.436 . . . . 0.0 110.592 -177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.79 167.22 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.992 -0.442 . . . . 0.0 111.18 174.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -137.08 135.88 37.86 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.721 1.208 . . . . 0.0 111.587 173.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -161.41 -167.97 1.89 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.816 1.246 . . . . 0.0 112.732 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -121.55 140.29 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.296 1.838 . . . . 0.0 110.528 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.3 mt -74.98 124.61 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.418 1.087 . . . . 0.0 111.317 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -91.57 -35.96 13.96 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.722 1.609 . . . . 0.0 113.352 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -154.8 160.21 41.12 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.223 1.409 . . . . 0.0 110.879 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -148.35 150.08 32.94 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.171 0.988 . . . . 0.0 113.038 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.4 t -143.95 175.69 9.84 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 126.179 1.791 . . . . 0.0 110.91 175.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.31 -20.77 58.9 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.51 1.124 . . . . 0.0 113.605 177.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 32.6 p -86.75 -57.49 2.96 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.68 1.592 . . . . 0.0 111.967 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -138.17 169.95 16.9 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.4 2.28 . . . . 0.0 111.308 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 5.8 p -130.45 148.28 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.496 1.518 . . . . 0.0 110.934 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 66.5 mtp -112.57 92.38 4.0 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.708 1.603 . . . . 0.0 110.436 -175.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.1 t -89.7 143.37 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.526 1.53 . . . . 0.0 109.808 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -63.87 125.3 23.94 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.876 170.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -128.91 112.06 13.69 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.378 1.071 . . . . 0.0 110.132 173.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -125.11 24.71 7.42 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.912 1.685 . . . . 0.0 112.063 176.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.72 143.98 97.13 Favored Pre-proline 0 CA--C 1.549 0.939 0 O-C-N 120.997 -1.064 . . . . 0.0 111.357 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.31 -4.21 15.03 Favored 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 123.737 2.958 . . . . 0.0 114.207 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -152.15 92.26 1.69 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.44 2.296 . . . . 0.0 110.081 173.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.01 -64.32 1.21 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.636 0.774 . . . . 0.0 112.048 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 69.21 92.51 0.06 OUTLIER Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.767 1.651 . . . . 0.0 114.567 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -130.73 160.08 35.38 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 125.061 1.345 . . . . 0.0 113.507 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 9.4 p -65.6 144.54 56.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.198 1.399 . . . . 0.0 112.533 176.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 76.8 mt -126.84 142.76 51.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.125 1.37 . . . . 0.0 111.809 -172.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.97 95.11 9.28 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.537 1.135 . . . . 0.0 111.292 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -80.76 88.82 5.78 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.261 1.029 . . . . 0.0 110.796 169.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -80.77 124.23 28.88 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.016 1.326 . . . . 0.0 109.45 169.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -143.57 171.76 13.73 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -150.94 144.86 25.22 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.405 1.482 . . . . 0.0 111.237 173.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 57.5 t -83.9 101.06 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 124.426 1.09 . . . . 0.0 108.233 165.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.71 -28.5 66.89 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.539 0.736 . . . . 0.0 112.258 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 149.74 -160.77 28.62 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 124.497 1.046 . . . . 0.0 113.539 174.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -133.73 149.42 51.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.49 1.116 . . . . 0.0 110.872 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -137.58 142.36 41.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.868 1.267 . . . . 0.0 112.048 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -71.86 131.86 43.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.537 0.735 . . . . 0.0 110.361 169.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.4 172.4 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.878 1.671 . . . . 0.0 111.561 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 19.6 t -126.76 167.39 15.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.844 1.658 . . . . 0.0 111.287 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.4 -0.68 8.71 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.899 1.68 . . . . 0.0 112.918 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -83.88 -55.18 4.38 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.175 1.39 . . . . 0.0 112.721 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 127.285 2.234 . . . . 0.0 112.414 -175.271 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.823 0.344 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -111.85 -12.16 13.83 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.592 1.157 . . . . 0.0 112.968 178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -70.59 99.87 1.73 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.816 1.647 . . . . 0.0 111.174 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -61.57 119.76 9.26 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.193 1.397 . . . . 0.0 111.496 172.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -75.09 158.28 33.37 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.803 0.841 . . . . 0.0 112.451 175.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -115.06 19.25 15.87 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.36 1.864 . . . . 0.0 112.263 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 56.53 19.25 4.05 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.702 2.001 . . . . 0.0 114.812 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 69.0 m -77.3 12.74 1.38 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.465 1.906 . . . . 0.0 114.748 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 33.2 mm -60.98 139.94 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.994 1.718 . . . . 0.0 111.295 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.5 mtpp -107.26 150.46 26.64 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 126.092 1.757 . . . . 0.0 111.06 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -152.55 153.88 34.3 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.658 1.583 . . . . 0.0 111.381 -177.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.57 105.22 9.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.807 0.843 . . . . 0.0 110.678 174.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.85 129.99 41.05 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.295 1.038 . . . . 0.0 110.348 165.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -116.47 130.03 56.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.191 1.396 . . . . 0.0 110.39 175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 21.3 pt -132.91 163.64 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.511 1.124 . . . . 0.0 112.192 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -138.88 135.01 34.03 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.58 1.952 . . . . 0.0 110.453 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -139.06 149.61 44.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.111 1.434 . . . . 0.0 114.429 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.27 114.5 9.64 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.802 2.441 . . . . 0.0 109.253 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.4 p -92.87 96.59 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 124.409 1.084 . . . . 0.0 110.191 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -95.66 158.11 15.6 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.157 1.783 . . . . 0.0 110.362 175.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -72.35 156.8 38.71 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.125 -0.985 . . . . 0.0 110.98 166.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -65.65 -64.62 0.82 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.226 1.011 . . . . 0.0 113.104 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.07 -47.76 5.4 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.018 0.818 . . . . 0.0 113.566 -173.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.0 t -72.04 150.71 43.73 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.851 0.86 . . . . 0.0 112.367 176.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 m -74.71 -12.39 60.41 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.813 1.245 . . . . 0.0 114.184 176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.3 156.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.757 0.823 . . . . 0.0 113.091 -175.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -116.39 128.13 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.886 1.674 . . . . 0.0 109.304 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.5 mp -81.06 -49.35 11.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.289 0.635 . . . . 0.0 111.178 -177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -154.87 160.51 41.25 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.171 1.388 . . . . 0.0 111.748 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.2 p -158.51 126.58 5.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.324 1.45 . . . . 0.0 111.739 -178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.95 -17.15 31.94 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 170.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -61.12 -36.74 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 125.055 1.342 . . . . 0.0 112.553 -171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.1 p -75.57 -6.9 52.6 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.1 1.36 . . . . 0.0 114.64 174.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -107.93 -88.07 0.48 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 126.597 1.959 . . . . 0.0 110.133 -174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -151.44 152.71 31.24 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 126.937 2.095 . . . . 0.0 110.858 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.75 158.62 56.43 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.734 2.956 . . . . 0.0 113.526 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.0 tp -89.38 112.61 23.76 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.497 1.119 . . . . 0.0 110.657 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -93.97 129.49 40.43 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.716 1.607 . . . . 0.0 111.605 178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -147.66 176.93 9.7 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.781 1.232 . . . . 0.0 112.474 171.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mm -116.96 150.64 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 125.626 1.57 . . . . 0.0 108.856 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.6 mm -49.41 106.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.509 1.124 . . . . 0.0 111.892 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.73 80.21 1.5 Allowed Glycine 0 CA--C 1.541 1.658 0 C-N-CA 125.887 1.708 . . . . 0.0 113.476 -171.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 87.3 m -132.61 -49.1 0.9 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.056 1.343 . . . . 0.0 112.897 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.25 32.84 22.3 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 125.596 1.558 . . . . 0.0 114.365 175.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.47 -27.67 34.49 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -176.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 28.7 pt -76.29 171.67 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.801 1.241 . . . . 0.0 112.317 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.7 pt -56.25 144.14 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.533 1.133 . . . . 0.0 112.179 177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.45 -42.3 87.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.086 0.954 . . . . 0.0 113.216 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -57.48 -42.37 93.85 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 124.45 1.024 . . . . 0.0 113.317 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 tp -77.03 -42.38 38.72 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.626 0.77 . . . . 0.0 112.121 175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -53.08 -48.19 67.93 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.756 1.162 . . . . 0.0 112.79 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -65.31 -21.59 66.73 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.64 -42.98 27.31 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.114 0.966 . . . . 0.0 112.291 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -53.42 -44.31 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 CA-C-N 119.749 1.159 . . . . 0.0 112.541 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -67.17 -18.25 65.19 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -102.84 -20.66 14.22 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.983 1.713 . . . . 0.0 113.971 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.63 134.19 48.45 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.917 1.287 . . . . 0.0 112.058 172.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 10.7 mp0 -77.45 150.34 34.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.922 0.889 . . . . 0.0 111.665 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.0 tt -56.61 129.62 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 124.689 1.196 . . . . 0.0 111.161 170.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.28 14.37 76.85 Favored Glycine 0 CA--C 1.537 1.432 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 177.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -122.83 117.82 26.53 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.956 1.378 . . . . 0.0 111.429 -177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -60.65 141.2 57.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.007 0.923 . . . . 0.0 111.982 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -138.54 120.34 15.33 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.898 1.279 . . . . 0.0 111.019 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -103.58 101.51 11.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.504 1.522 . . . . 0.0 110.376 179.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 m -110.26 116.72 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.101 1.36 . . . . 0.0 111.403 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.2 t -80.21 109.88 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 124.227 1.011 . . . . 0.0 109.7 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.8 mm -98.52 136.42 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.903 1.281 . . . . 0.0 109.808 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 152.35 89.41 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.336 1.055 . . . . 0.0 111.966 175.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.72 -46.05 22.16 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.682 2.255 . . . . 0.0 111.867 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.33 -14.09 46.12 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.265 1.826 . . . . 0.0 114.976 176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -109.36 -27.13 9.66 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.572 1.549 . . . . 0.0 112.714 -178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -84.08 -69.73 0.62 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.043 1.337 . . . . 0.0 112.151 171.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -101.08 -17.9 16.48 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.02 1.328 . . . . 0.0 113.694 -173.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.36 -174.42 41.71 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.725 1.155 . . . . 0.0 112.925 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.2 m -56.33 110.47 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.199 1.4 . . . . 0.0 112.014 175.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -67.63 155.4 39.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.022 0.929 . . . . 0.0 112.907 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.76 60.52 5.97 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.088 1.355 . . . . 0.0 113.016 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 81.6 p -74.18 5.52 4.36 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 177.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 71.0 m -63.32 109.28 1.53 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.832 1.253 . . . . 0.0 112.109 175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -131.47 176.43 8.31 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.983 2.113 . . . . 0.0 111.329 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.3 mp -104.04 143.26 33.13 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.009 -1.057 . . . . 0.0 109.976 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -116.37 117.5 30.14 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.925 1.29 . . . . 0.0 110.074 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -74.27 106.75 6.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.088 0.955 . . . . 0.0 110.18 171.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.1 p -121.44 131.58 24.42 Favored Pre-proline 0 N--CA 1.474 0.733 0 C-N-CA 126.8 2.04 . . . . 0.0 109.293 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -70.18 155.5 64.4 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.084 1.856 . . . . 0.0 112.557 -176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -58.72 -19.95 44.68 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 172.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.11 -30.97 62.84 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.936 1.294 . . . . 0.0 113.174 174.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -81.35 -3.32 52.3 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.204 1.002 . . . . 0.0 113.416 176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -126.22 20.22 7.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.231 2.212 . . . . 0.0 112.432 -178.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -59.94 104.28 0.28 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.461 1.505 . . . . 0.0 111.875 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.82 3.15 52.41 Favored Glycine 0 CA--C 1.539 1.58 0 C-N-CA 125.373 1.463 . . . . 0.0 115.68 -177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 pt -129.63 98.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.865 1.666 . . . . 0.0 111.209 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -61.28 144.34 54.03 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.698 1.199 . . . . 0.0 111.665 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.6 mt -125.7 159.72 31.55 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.396 1.478 . . . . 0.0 111.1 -176.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -150.86 145.19 25.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.244 1.418 . . . . 0.0 110.325 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -58.51 128.62 38.08 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.674 0.79 . . . . 0.0 111.349 178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 78.51 43.08 12.93 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 123.741 0.686 . . . . 0.0 114.445 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.73 153.89 47.73 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.57 1.148 . . . . 0.0 111.705 168.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.9 t -82.83 98.75 9.31 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.233 1.413 . . . . 0.0 112.034 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.63 156.97 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.955 1.302 . . . . 0.0 110.914 174.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -113.0 149.09 33.8 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.466 1.106 . . . . 0.0 111.353 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.42 97.58 0.22 Allowed Glycine 0 N--CA 1.469 0.862 0 C-N-CA 124.44 1.019 . . . . 0.0 112.516 -175.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.1 110.79 4.69 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.999 0.919 . . . . 0.0 111.101 174.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.7 t -78.39 153.18 31.79 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.239 1.016 . . . . 0.0 111.659 170.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -66.21 -12.95 59.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.467 1.507 . . . . 0.0 113.245 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -72.98 16.39 0.16 Allowed 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 126.339 1.855 . . . . 0.0 114.01 168.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 58.59 45.63 15.88 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 127.227 2.211 . . . . 0.0 112.649 178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -145.29 170.03 17.09 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.358 1.863 . . . . 0.0 111.163 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 93.1 m -142.44 120.61 12.2 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.753 1.221 . . . . 0.0 110.82 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.57 167.14 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.104 0.561 . . . . 0.0 111.752 174.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -117.0 127.61 54.35 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.279 1.431 . . . . 0.0 109.052 170.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -139.5 171.84 13.66 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.975 1.31 . . . . 0.0 112.446 -170.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.28 130.06 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.104 0.961 . . . . 0.0 110.57 -177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 39.4 mm -62.47 103.59 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.86 1.664 . . . . 0.0 109.533 170.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -84.13 -38.29 20.9 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.061 0.945 . . . . 0.0 111.667 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -149.46 165.4 32.24 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.461 1.104 . . . . 0.0 112.373 169.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.01 159.0 44.35 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.765 1.226 . . . . 0.0 111.921 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 37.2 m -134.59 174.76 10.19 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.207 1.803 . . . . 0.0 110.835 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.24 -15.56 63.29 Favored 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.6 t -140.25 -17.93 0.91 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 125.92 1.688 . . . . 0.0 114.489 -173.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -133.46 168.03 19.36 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.662 1.585 . . . . 0.0 112.282 178.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 90.2 t -136.48 148.65 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.817 2.047 . . . . 0.0 109.386 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 93.0 mtp -129.82 99.57 5.17 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.978 1.311 . . . . 0.0 110.801 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.14 147.32 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.108 1.363 . . . . 0.0 110.005 -176.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -64.46 128.69 36.88 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.113 0.565 . . . . 0.0 111.143 167.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -134.07 162.78 31.15 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.581 1.552 . . . . 0.0 110.779 172.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -149.98 173.14 14.16 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.504 1.522 . . . . 0.0 110.61 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -108.22 129.81 23.59 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.545 0.738 . . . . 0.0 110.589 177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.37 -34.16 35.76 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.582 2.188 . . . . 0.0 112.7 -174.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.3 mp -87.05 78.75 8.88 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.794 1.237 . . . . 0.0 108.596 167.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.34 98.83 6.1 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.524 1.53 . . . . 0.0 111.52 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 96.65 178.57 35.19 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 125.397 1.475 . . . . 0.0 113.595 -177.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -138.61 161.52 36.9 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.261 1.425 . . . . 0.0 113.393 -177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.85 140.66 58.89 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.963 1.705 . . . . 0.0 112.423 178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.1 mt -129.59 138.42 51.27 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.929 1.292 . . . . 0.0 112.009 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.41 96.68 10.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.486 1.514 . . . . 0.0 111.046 178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -76.72 92.6 3.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.345 0.658 . . . . 0.0 109.585 166.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.5 tpp85 -77.09 119.5 20.88 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 164.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -138.25 169.83 17.09 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.378 0.671 . . . . 0.0 112.48 178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -149.22 143.35 25.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.834 1.254 . . . . 0.0 111.584 171.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 45.5 t -82.24 104.77 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 124.772 1.229 . . . . 0.0 108.45 165.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.9 mt -60.33 -35.49 75.76 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.366 0.666 . . . . 0.0 111.703 176.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 129.66 -149.95 18.86 Favored Glycine 0 CA--C 1.523 0.586 0 C-N-CA 125.449 1.499 . . . . 0.0 111.93 -176.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -129.29 151.16 50.25 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.262 1.025 . . . . 0.0 111.75 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -129.07 136.2 49.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.382 1.473 . . . . 0.0 111.264 175.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -79.78 102.94 9.34 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.88 1.272 . . . . 0.0 110.264 174.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 30.5 m -133.06 169.48 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 125.573 1.549 . . . . 0.0 111.555 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.4 p -140.77 162.42 35.47 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.273 1.429 . . . . 0.0 111.966 174.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -124.84 18.71 8.58 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.792 1.637 . . . . 0.0 112.081 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 66.1 0.78 1.73 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 127.936 2.495 . . . . 0.0 114.653 -173.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 128.726 2.81 . . . . 0.0 112.791 167.821 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tp60 -77.2 -64.66 1.09 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.31 1.044 . . . . 0.0 111.19 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -83.01 163.69 20.82 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.517 1.127 . . . . 0.0 111.376 174.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -83.78 -8.54 59.21 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -146.07 150.86 36.75 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.711 1.205 . . . . 0.0 112.6 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.0 130.98 35.69 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 127.691 2.396 . . . . 0.0 110.699 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 57.85 22.35 8.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.564 1.546 . . . . 0.0 114.314 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 t -71.08 -0.09 8.79 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.359 1.864 . . . . 0.0 114.899 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.568 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.6 mp -58.54 149.15 5.65 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 126.481 1.912 . . . . 0.0 110.313 176.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -89.89 135.76 33.44 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.329 1.452 . . . . 0.0 111.09 173.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -157.84 166.53 32.45 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.698 1.599 . . . . 0.0 111.844 176.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.01 118.1 18.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.101 0.96 . . . . 0.0 111.45 175.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.5 106.7 8.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.696 1.599 . . . . 0.0 110.001 164.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.66 115.46 24.13 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.392 1.877 . . . . 0.0 109.501 175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 pp -131.78 158.57 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.078 0.951 . . . . 0.0 111.892 177.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -138.87 134.6 33.51 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.901 1.28 . . . . 0.0 110.281 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -131.9 162.11 31.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.145 1.378 . . . . 0.0 112.803 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.17 171.03 15.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.11 1.764 . . . . 0.0 111.357 166.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.8 p -139.77 106.67 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.454 1.102 . . . . 0.0 110.981 173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -116.65 154.86 29.79 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.634 1.574 . . . . 0.0 111.062 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -74.92 148.4 40.11 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.552 -0.717 . . . . 0.0 111.042 174.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -66.59 -25.84 66.82 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.71 -72.94 0.95 Allowed Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.226 1.393 . . . . 0.0 112.647 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.0 m -59.89 140.18 56.84 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.221 1.408 . . . . 0.0 113.576 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.2 t -70.9 -21.28 62.4 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.812 1.245 . . . . 0.0 113.892 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 pp -63.37 158.83 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.952 1.301 . . . . 0.0 112.562 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.9 t -117.0 129.04 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.478 1.511 . . . . 0.0 109.75 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mp -79.69 -45.67 18.53 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.392 0.677 . . . . 0.0 111.312 -177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.71 158.27 40.75 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.163 1.385 . . . . 0.0 111.383 173.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 46.3 t -156.93 141.63 16.86 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.278 -0.889 . . . . 0.0 112.666 175.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -114.17 3.7 15.29 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.398 1.879 . . . . 0.0 112.752 173.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.7 mm -64.55 -55.9 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.469 1.107 . . . . 0.0 111.214 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.0 t -72.21 -21.64 61.38 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.458 1.103 . . . . 0.0 113.034 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.2 mmtp -80.81 -178.18 6.69 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.954 2.102 . . . . 0.0 111.841 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.39 128.11 92.08 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 123.873 0.869 . . . . 0.0 111.069 174.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -64.48 151.85 83.91 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.851 2.367 . . . . 0.0 112.427 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 tt -81.9 134.87 35.43 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.318 1.047 . . . . 0.0 109.981 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -119.43 114.46 22.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 125.78 1.632 . . . . 0.0 110.564 -174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 21.0 p90 -130.13 172.71 11.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.255 1.022 . . . . 0.0 112.26 174.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 34.3 mm -115.8 150.73 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.263 1.425 . . . . 0.0 109.023 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mm -55.57 106.16 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 O-C-N 121.114 -0.991 . . . . 0.0 110.61 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.72 29.9 7.1 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 125.405 1.479 . . . . 0.0 116.369 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 35.1 m -98.23 -38.56 9.24 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.53 1.665 . . . . 0.0 113.795 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 55.28 33.02 19.8 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 126.114 1.766 . . . . 0.0 115.198 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -68.03 -21.42 65.02 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.224 1.565 . . . . 0.0 115.224 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.8 pt -74.26 168.18 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.964 1.706 . . . . 0.0 113.082 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.3 pt -60.86 152.79 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.29 1.036 . . . . 0.0 112.518 178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.64 -43.13 79.98 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -173.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.11 73.06 Favored Glycine 0 CA--C 1.539 1.564 0 O-C-N 121.263 -0.898 . . . . 0.0 114.105 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 tp -88.88 -30.5 18.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.999 1.32 . . . . 0.0 112.223 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -54.6 -44.27 72.92 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.777 1.631 . . . . 0.0 111.639 171.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -79.79 8.46 6.71 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.379 1.471 . . . . 0.0 113.817 176.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -120.41 -39.58 2.76 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.499 1.519 . . . . 0.0 113.671 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.6 p -58.27 -30.07 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.323 1.049 . . . . 0.0 113.572 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -71.17 -14.24 62.21 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -106.16 -34.46 7.52 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.511 1.525 . . . . 0.0 112.782 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.91 149.82 26.0 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.551 0.74 . . . . 0.0 111.808 170.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -121.07 161.06 22.36 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 111.409 -176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -56.52 125.49 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 123.81 0.844 . . . . 0.0 111.759 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.78 76.64 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 124.778 1.18 . . . . 0.0 115.038 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -114.08 108.76 17.43 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 118.957 1.378 . . . . 0.0 111.334 -172.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -57.78 141.2 49.64 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.982 0.913 . . . . 0.0 112.223 173.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -137.33 116.98 12.99 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.179 1.791 . . . . 0.0 110.716 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -96.0 112.19 23.99 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.924 1.29 . . . . 0.0 110.871 176.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.5 m -123.05 112.51 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 124.132 0.973 . . . . 0.0 111.256 173.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.7 127.83 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 121.197 -0.939 . . . . 0.0 109.303 172.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 59.4 mt -120.56 135.95 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.699 1.6 . . . . 0.0 108.703 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.64 148.69 96.61 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.652 0.781 . . . . 0.0 111.494 174.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -63.56 -44.58 13.69 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.02 2.48 . . . . 0.0 112.405 -170.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -62.14 -30.69 71.22 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.229 1.811 . . . . 0.0 113.695 174.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -80.69 -29.31 36.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.225 1.41 . . . . 0.0 111.758 -176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -76.53 -66.44 0.81 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.9 1.28 . . . . 0.0 111.791 168.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -143.51 -37.55 0.34 Allowed 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 59.82 72.18 0.66 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.626 1.584 . . . . 0.0 115.667 175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.6 m -118.17 -1.56 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -70.71 155.96 40.1 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.522 1.129 . . . . 0.0 113.425 -176.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -87.78 89.92 8.18 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.476 1.91 . . . . 0.0 113.199 -177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.4 m -113.13 35.49 3.93 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.838 1.655 . . . . 0.0 113.839 -177.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 p -55.0 112.18 1.0 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.996 1.718 . . . . 0.0 111.334 163.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -134.58 150.24 50.69 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.097 1.147 . . . . 0.0 114.097 -177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.44 115.38 11.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.852 2.061 . . . . 0.0 111.349 176.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -116.98 119.22 34.65 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.259 1.423 . . . . 0.0 110.377 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -80.09 105.7 11.56 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.042 1.337 . . . . 0.0 111.06 174.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.4 p -106.85 131.56 21.6 Favored Pre-proline 0 N--CA 1.473 0.723 0 C-N-CA 126.673 1.989 . . . . 0.0 109.296 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.33 162.21 41.46 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.441 2.094 . . . . 0.0 112.52 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.95 -22.45 49.12 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.013 0.925 . . . . 0.0 113.417 176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -51.42 -39.56 57.57 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 127.026 2.13 . . . . 0.0 114.031 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -69.77 -17.84 63.45 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -131.7 15.35 4.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.934 1.693 . . . . 0.0 114.161 -167.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 tm-20 -57.33 -27.94 62.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.343 1.457 . . . . 0.0 114.143 -169.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -108.76 6.69 33.29 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.823 1.678 . . . . 0.0 116.061 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.26 113.26 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 CA-C-N 119.33 1.565 . . . . 0.0 111.881 -175.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -63.92 139.65 58.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.102 0.961 . . . . 0.0 112.012 175.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.2 mt -121.02 172.27 8.06 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.092 1.757 . . . . 0.0 111.609 -175.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -148.29 161.15 42.1 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.222 1.009 . . . . 0.0 112.039 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -73.37 95.47 2.19 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.396 1.078 . . . . 0.0 111.026 175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.41 64.24 0.73 Allowed Glycine 0 CA--C 1.531 1.059 0 C-N-CA 125.434 1.492 . . . . 0.0 113.228 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 6.9 ptp -133.95 152.0 51.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.129 1.372 . . . . 0.0 111.527 168.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 37.7 m -77.23 98.77 5.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.531 1.532 . . . . 0.0 110.652 173.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.6 p -96.09 154.37 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.366 1.466 . . . . 0.0 111.321 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -106.35 147.49 29.16 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.744 1.218 . . . . 0.0 111.589 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.99 96.98 0.28 Allowed Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.949 1.261 . . . . 0.0 112.423 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -72.15 114.84 10.69 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.874 0.87 . . . . 0.0 111.13 174.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 4.0 t -82.42 154.84 24.97 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.507 1.123 . . . . 0.0 111.574 171.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -63.54 -13.21 39.03 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.024 1.329 . . . . 0.0 113.545 169.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -73.75 19.38 0.11 Allowed 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 125.464 1.505 . . . . 0.0 113.781 171.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 58.4 33.85 23.48 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 127.346 2.259 . . . . 0.0 113.738 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -135.84 169.75 17.07 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.813 2.045 . . . . 0.0 111.493 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 94.1 m -137.68 138.28 39.24 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.543 1.537 . . . . 0.0 110.184 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -111.02 170.64 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.228 1.011 . . . . 0.0 111.372 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.23 133.74 55.17 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.919 1.688 . . . . 0.0 110.717 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.93 171.06 14.57 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.095 1.758 . . . . 0.0 111.228 -178.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.7 126.97 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.862 0.865 . . . . 0.0 110.019 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.49 129.49 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.225 1.01 . . . . 0.0 110.567 174.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -91.5 -49.27 6.41 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.061 1.344 . . . . 0.0 111.504 174.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -151.87 170.73 19.1 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.813 1.245 . . . . 0.0 112.208 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -141.72 155.61 45.64 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.432 1.093 . . . . 0.0 113.019 173.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.42 169.11 11.3 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 128.038 2.535 . . . . 0.0 110.049 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.6 -26.41 67.96 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.129 -0.982 . . . . 0.0 113.167 171.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 63.9 p -131.22 -8.47 3.8 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.311 1.444 . . . . 0.0 114.811 -173.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -141.81 171.19 14.4 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.776 1.63 . . . . 0.0 111.047 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -138.65 150.22 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.514 1.926 . . . . 0.0 108.738 177.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 62.2 mtp -125.54 114.6 18.98 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.508 1.123 . . . . 0.0 111.035 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 10.7 m -125.2 163.83 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.811 1.244 . . . . 0.0 112.163 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -102.13 88.49 3.34 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.86 1.264 . . . . 0.0 112.182 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -81.28 171.97 14.18 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.647 1.179 . . . . 0.0 112.268 171.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -108.46 110.1 21.53 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.84 1.656 . . . . 0.0 110.148 173.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -66.35 134.62 94.64 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.554 0.742 . . . . 0.0 111.139 -177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -68.98 -31.85 23.14 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.54 2.16 . . . . 0.0 114.183 -172.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.1 56.32 0.77 Allowed 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.822 1.649 . . . . 0.0 111.022 175.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.5 103.49 14.41 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.747 1.619 . . . . 0.0 112.56 -173.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 110.25 -159.41 13.91 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.291 1.424 . . . . 0.0 113.495 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 159.71 35.91 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.378 1.871 . . . . 0.0 111.912 173.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.9 p -64.66 144.85 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.36 1.464 . . . . 0.0 113.14 -176.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -130.31 136.42 49.12 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.889 1.275 . . . . 0.0 111.706 -173.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -81.68 97.41 7.9 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.73 1.612 . . . . 0.0 111.324 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -80.65 83.59 6.4 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 122.415 1.102 . . . . 0.0 110.613 166.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -76.58 131.67 39.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.526 1.13 . . . . 0.0 109.555 168.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -148.14 169.89 19.01 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -145.41 145.63 31.22 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.971 1.309 . . . . 0.0 111.656 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 32.8 t -84.49 100.84 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 124.863 1.265 . . . . 0.0 108.693 166.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.23 -31.96 71.82 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.38 0.672 . . . . 0.0 111.837 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.88 -170.05 31.28 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.196 0.903 . . . . 0.0 114.883 170.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -124.55 118.93 27.67 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.616 1.567 . . . . 0.0 110.219 -177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -138.4 128.34 25.39 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.985 1.314 . . . . 0.0 112.558 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -75.45 115.69 15.38 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.407 0.683 . . . . 0.0 110.759 175.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.06 164.14 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 126.358 1.863 . . . . 0.0 111.094 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 61.1 m -135.06 146.89 49.38 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.623 1.169 . . . . 0.0 111.803 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -89.05 22.39 2.78 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.832 1.653 . . . . 0.0 112.973 -178.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.16 13.96 6.24 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.666 1.986 . . . . 0.0 114.228 -172.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? . . . . . 0 C--O 1.252 1.222 0 C-N-CA 126.985 2.114 . . . . 0.0 114.832 177.776 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -141.59 -63.49 0.45 Allowed 'General case' 0 N--CA 1.477 0.879 0 O-C-N 120.836 -1.165 . . . . 0.0 111.751 -176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -75.85 171.92 13.58 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.409 1.084 . . . . 0.0 111.662 170.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -125.59 92.34 3.59 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.531 1.533 . . . . 0.0 111.618 -175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -78.02 170.46 16.57 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.149 1.38 . . . . 0.0 112.779 173.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.18 110.68 17.88 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.023 1.729 . . . . 0.0 110.163 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -134.42 75.93 1.61 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.777 1.631 . . . . 0.0 112.534 -175.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.0 p -69.73 -20.92 63.51 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.6 mm -131.76 131.93 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.608 1.963 . . . . 0.0 110.665 -177.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.6 mtpt -73.93 137.48 43.65 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.3 1.44 . . . . 0.0 111.843 177.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -136.69 155.03 50.42 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.277 1.831 . . . . 0.0 110.656 -177.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.06 107.51 17.2 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.184 0.994 . . . . 0.0 110.435 169.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.02 128.7 37.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.382 165.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -113.23 124.81 53.4 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.592 1.557 . . . . 0.0 109.619 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.42 HG22 ' HA ' ' A' ' 141' ' ' VAL . 14.5 pt -128.5 163.68 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.075 0.95 . . . . 0.0 111.412 171.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -135.82 136.72 40.88 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.899 1.68 . . . . 0.0 109.745 179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -136.07 157.95 45.58 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 123.069 1.414 . . . . 0.0 114.783 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -139.13 141.25 38.08 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 129.462 3.105 . . . . 0.0 108.878 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -124.22 110.06 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.873 1.269 . . . . 0.0 110.429 174.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -123.69 168.85 12.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.539 1.536 . . . . 0.0 112.685 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -62.57 151.97 36.24 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.505 1.122 . . . . 0.0 111.147 173.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.06 -20.28 63.24 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.42 25.35 1.53 Allowed Glycine 0 CA--C 1.539 1.532 0 C-N-CA 125.123 1.344 . . . . 0.0 114.959 -176.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.1 t -141.16 161.41 37.93 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 118.917 1.358 . . . . 0.0 112.52 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.3 t -75.71 -17.72 59.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.783 1.633 . . . . 0.0 113.762 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -64.04 151.69 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.799 0.84 . . . . 0.0 112.456 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.3 t -129.46 117.25 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.787 1.635 . . . . 0.0 108.943 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.87 -44.05 56.63 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.721 0.808 . . . . 0.0 111.77 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -155.67 164.09 39.06 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.648 1.179 . . . . 0.0 111.581 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 m -165.87 159.6 16.09 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.384 1.874 . . . . 0.0 111.844 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -126.08 2.75 7.22 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 164.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.9 mm -47.46 -46.2 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 126.01 1.724 . . . . 0.0 113.965 -173.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 t -93.42 -2.62 54.42 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.955 1.302 . . . . 0.0 113.581 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mmmt -98.05 -166.52 1.39 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 127.875 2.47 . . . . 0.0 110.758 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -61.91 134.26 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 124.473 1.109 . . . . 0.0 111.775 172.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.55 159.01 55.18 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.27 2.647 . . . . 0.0 113.314 179.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.9 tp -79.88 95.06 5.96 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.435 1.094 . . . . 0.0 110.268 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.34 125.46 31.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.159 1.783 . . . . 0.0 111.578 174.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -149.48 172.6 14.71 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.168 0.987 . . . . 0.0 113.399 172.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.9 mm -110.51 142.28 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.601 1.56 . . . . 0.0 109.507 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.2 mm -47.93 121.48 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 125.971 1.708 . . . . 0.0 112.462 -174.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.41 76.85 1.09 Allowed Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.995 1.283 . . . . 0.0 112.806 -178.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.8 t -130.79 -26.69 2.18 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 -174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 53.48 21.96 2.7 Favored 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 126.518 1.927 . . . . 0.0 115.683 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -78.25 -28.6 47.82 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -170.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 pt -82.07 171.18 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 125.86 1.664 . . . . 0.0 112.196 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.5 pt -55.34 140.77 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.818 0.847 . . . . 0.0 111.169 173.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.67 78.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.543 0.737 . . . . 0.0 112.915 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.88 -30.41 72.98 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 124.327 0.965 . . . . 0.0 114.303 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.67 -43.9 13.93 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.337 1.055 . . . . 0.0 111.404 172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -53.25 -48.02 68.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.595 1.158 . . . . 0.0 112.309 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -67.05 0.3 2.7 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.984 1.314 . . . . 0.0 114.468 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -115.54 -25.42 7.9 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.968 1.707 . . . . 0.0 114.04 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.3 t -58.31 -42.02 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 CA-C-N 120.736 1.607 . . . . 0.0 112.114 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -67.92 -12.62 61.06 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -98.95 -36.9 9.6 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.995 1.718 . . . . 0.0 112.18 -178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.89 140.74 58.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.085 1.354 . . . . 0.0 112.385 173.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -86.28 154.28 21.37 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.009 0.924 . . . . 0.0 111.964 176.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.7 tt -59.71 131.3 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 C-N-CA 124.287 1.035 . . . . 0.0 111.346 171.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.25 12.63 76.43 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.289 0.947 . . . . 0.0 115.157 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -126.31 115.49 19.76 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.322 1.449 . . . . 0.0 111.246 -175.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -59.41 141.32 54.91 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.866 0.866 . . . . 0.0 112.151 176.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -137.17 142.68 42.17 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.147 1.379 . . . . 0.0 111.054 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.79 128.54 52.97 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.14 1.376 . . . . 0.0 110.156 177.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.0 m -130.55 110.89 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 126.706 2.002 . . . . 0.0 110.166 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.1 t -69.49 125.47 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 123.769 0.828 . . . . 0.0 109.94 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.6 mm -115.29 140.1 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.308 1.443 . . . . 0.0 109.826 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.45 154.74 87.23 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 124.241 1.016 . . . . 0.0 111.731 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.18 -40.67 67.35 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.627 2.218 . . . . 0.0 113.462 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -76.28 -18.35 59.02 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -90.31 -9.73 46.71 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.737 1.215 . . . . 0.0 114.017 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -129.46 78.32 1.84 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.346 1.458 . . . . 0.0 111.528 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 39.9 74.01 0.11 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.894 2.077 . . . . 0.0 113.335 -175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.53 101.35 0.33 Allowed Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.03 1.3 . . . . 0.0 113.641 -178.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 m -119.53 61.35 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 126.223 1.809 . . . . 0.0 111.646 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -64.37 164.73 10.82 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.838 1.255 . . . . 0.0 113.155 173.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -123.06 8.39 9.25 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 126.047 1.739 . . . . 0.0 113.262 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.6 t -76.01 14.92 0.61 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.666 1.986 . . . . 0.0 114.071 179.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.91 114.4 2.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.252 2.221 . . . . 0.0 112.493 174.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -137.9 149.94 46.67 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.556 1.542 . . . . 0.0 113.039 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.8 103.59 10.74 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.252 1.021 . . . . 0.0 110.629 177.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -88.91 116.75 27.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.59 0.756 . . . . 0.0 110.35 170.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -71.11 112.22 7.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.25 1.02 . . . . 0.0 110.221 167.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.93 156.3 54.45 Favored Pre-proline 0 N--CA 1.475 0.809 0 C-N-CA 126.071 1.749 . . . . 0.0 110.812 178.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.08 149.64 46.8 Favored 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 122.047 1.831 . . . . 0.0 112.005 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -61.45 -17.31 53.79 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.04 1.336 . . . . 0.0 113.171 173.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -50.35 -33.9 22.0 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 127.184 2.194 . . . . 0.0 113.624 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -71.38 -10.8 60.35 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -135.19 14.48 3.53 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.612 1.565 . . . . 0.0 114.194 -168.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.86 112.56 0.96 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.43 1.092 . . . . 0.0 112.441 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 97.11 3.86 58.81 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.21 1.386 . . . . 0.0 115.374 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.7 mt -108.22 139.56 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.284 1.434 . . . . 0.0 110.378 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -79.0 55.87 1.86 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.378 1.871 . . . . 0.0 113.588 -173.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -55.04 130.04 40.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.283 1.833 . . . . 0.0 113.303 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -152.23 148.47 27.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.752 2.021 . . . . 0.0 110.345 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -59.36 135.76 57.76 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.489 1.116 . . . . 0.0 112.25 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 92.81 -9.37 75.64 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.136 1.35 . . . . 0.0 116.371 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 11.4 ptp -70.16 152.28 44.47 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 120.169 1.984 . . . . 0.0 112.416 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 5.0 p -78.38 102.01 7.53 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.606 1.163 . . . . 0.0 110.311 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.3 160.86 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.419 1.088 . . . . 0.0 110.551 173.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -131.32 162.21 30.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.06 1.344 . . . . 0.0 112.002 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.69 108.82 0.38 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.275 0.94 . . . . 0.0 112.891 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -66.4 147.13 53.74 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 122.05 -0.677 . . . . 0.0 111.299 174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -128.88 157.39 41.7 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.729 1.612 . . . . 0.0 111.737 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -65.45 -14.08 60.17 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.215 1.806 . . . . 0.0 113.736 -177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -74.35 13.13 0.62 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.285 1.834 . . . . 0.0 113.912 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.1 m120 57.25 40.14 28.12 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.13 2.172 . . . . 0.0 113.171 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -131.9 171.01 14.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.872 2.069 . . . . 0.0 111.253 177.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.6 m -141.93 111.75 6.73 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.683 1.593 . . . . 0.0 109.634 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.62 166.94 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-N 118.497 0.59 . . . . 0.0 111.067 174.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.33 154.77 34.55 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.623 1.169 . . . . 0.0 111.17 169.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.8 176.7 12.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.629 1.572 . . . . 0.0 110.966 179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.6 mp -130.37 128.84 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 124.385 1.074 . . . . 0.0 110.476 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.0 mm -68.65 125.97 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.062 0.945 . . . . 0.0 110.693 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -108.08 -38.68 5.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.773 1.229 . . . . 0.0 113.381 -178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -151.93 156.17 39.54 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.468 1.107 . . . . 0.0 111.243 171.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -147.19 149.85 33.76 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 121.186 -0.946 . . . . 0.0 113.395 177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.4 m -143.2 170.17 16.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.841 2.057 . . . . 0.0 110.804 175.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.2 -24.25 65.83 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 121.264 -0.897 . . . . 0.0 113.251 174.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.3 p -78.92 -66.71 0.83 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.676 1.99 . . . . 0.0 112.021 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -135.73 171.0 15.09 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.098 2.159 . . . . 0.0 111.367 -178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.7 p -135.21 144.03 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.567 1.547 . . . . 0.0 110.429 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 88.6 mtp -116.41 113.66 23.19 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.781 1.632 . . . . 0.0 110.651 -170.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.48 135.43 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.187 1.395 . . . . 0.0 110.264 -166.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -71.32 83.6 0.77 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.287 1.435 . . . . 0.0 112.17 178.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -87.14 170.28 11.64 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.035 1.734 . . . . 0.0 112.29 173.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -154.35 169.98 22.42 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.657 1.983 . . . . 0.0 110.676 178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.92 138.22 95.07 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-O 118.703 -0.665 . . . . 0.0 110.586 172.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.97 -9.42 20.81 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.186 2.59 . . . . 0.0 114.456 -173.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -131.91 32.79 4.02 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.861 2.065 . . . . 0.0 112.396 176.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -56.02 159.12 3.47 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.929 1.292 . . . . 0.0 113.766 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 80.84 -171.54 53.89 Favored Glycine 0 CA--C 1.539 1.573 0 C-N-CA 124.256 0.931 . . . . 0.0 113.45 -172.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -137.44 158.5 44.27 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 126.107 1.763 . . . . 0.0 112.152 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 40.3 p -64.72 147.63 52.7 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.879 0.872 . . . . 0.0 112.125 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -135.58 154.21 51.42 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.81 1.244 . . . . 0.0 111.425 -176.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -103.23 104.43 14.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.768 1.227 . . . . 0.0 110.728 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -80.07 109.83 14.89 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.639 0.776 . . . . 0.0 109.726 167.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.24 120.64 43.1 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.858 1.663 . . . . 0.0 108.941 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -143.4 169.78 17.03 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.938 0.895 . . . . 0.0 113.087 -170.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -147.85 144.97 28.51 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.634 1.174 . . . . 0.0 111.899 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.42 ' HA ' HG22 ' A' ' 15' ' ' ILE . 45.3 t -83.18 102.9 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 124.918 1.287 . . . . 0.0 109.003 165.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.35 -36.03 78.63 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.201 0.6 . . . . 0.0 111.698 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.68 -165.93 27.47 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.367 0.984 . . . . 0.0 114.211 175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -122.21 133.2 54.72 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.818 1.647 . . . . 0.0 110.223 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.8 ptp180 -124.31 159.11 31.01 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.062 1.345 . . . . 0.0 112.015 175.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -72.77 129.85 39.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.905 0.882 . . . . 0.0 111.385 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.6 m -70.01 170.18 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.202 1.401 . . . . 0.0 113.334 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 25.6 m 67.87 98.34 0.06 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 127.644 2.377 . . . . 0.0 113.904 173.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -73.4 53.36 0.4 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.646 1.978 . . . . 0.0 113.043 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 58.95 13.61 2.91 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 127.791 2.436 . . . . 0.0 115.258 -177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 pp20? . . . . . 0 C--O 1.253 1.245 0 C-N-CA 127.113 2.165 . . . . 0.0 115.167 -178.907 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.5 mmt . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 120.462 0.173 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 mm-40 -119.65 12.83 12.35 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 125.958 1.703 . . . . 0.0 113.229 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -63.73 148.03 50.19 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.961 -1.087 . . . . 0.0 112.353 173.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -154.5 167.96 28.31 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.746 1.618 . . . . 0.0 111.194 169.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -138.95 177.66 7.73 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 126.39 1.876 . . . . 0.0 111.482 -176.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 mp -72.87 101.07 3.07 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.851 1.261 . . . . 0.0 110.703 173.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -128.74 61.45 1.5 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 126.284 1.833 . . . . 0.0 111.856 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.6 t -58.53 -41.88 86.53 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.409 1.083 . . . . 0.0 113.424 -176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.1 mm -128.95 144.87 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 126.409 1.883 . . . . 0.0 109.87 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -65.31 141.11 58.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.365 1.466 . . . . 0.0 111.9 177.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -137.08 119.96 16.36 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.883 1.673 . . . . 0.0 110.492 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.43 105.7 8.73 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.708 1.203 . . . . 0.0 111.172 172.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.58 125.51 28.16 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.046 1.339 . . . . 0.0 110.227 163.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.37 123.88 50.67 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.34 1.456 . . . . 0.0 110.083 175.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 pt -131.22 161.3 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.219 1.007 . . . . 0.0 112.129 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -135.89 146.94 47.93 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.841 1.656 . . . . 0.0 110.397 176.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.51 154.31 43.5 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -146.03 129.06 16.51 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.766 2.426 . . . . 0.0 110.571 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.0 t -106.88 110.39 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.969 1.708 . . . . 0.0 110.062 -177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -116.5 151.74 35.5 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.855 1.662 . . . . 0.0 111.259 -178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.42 126.34 29.35 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.931 0.893 . . . . 0.0 109.79 173.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.73 75.65 1.12 Allowed 'General case' 0 CA--C 1.549 0.906 0 O-C-N 121.316 -0.865 . . . . 0.0 111.352 177.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.35 -5.28 2.64 Favored Glycine 0 CA--C 1.541 1.697 0 C-N-CA 126.117 1.818 . . . . 0.0 116.135 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.0 t -133.45 144.29 49.39 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.981 1.891 . . . . 0.0 112.776 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 66.5 p -76.59 31.55 0.13 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.616 2.766 . . . . 0.0 115.599 -171.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -110.35 176.57 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.184 1.394 . . . . 0.0 112.216 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.1 t -133.45 117.13 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.434 1.494 . . . . 0.0 108.987 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.0 mt -80.47 -53.3 6.71 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.912 0.885 . . . . 0.0 111.494 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -144.42 150.64 38.02 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.557 1.943 . . . . 0.0 109.865 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.3 p -157.64 151.58 24.29 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.295 -0.878 . . . . 0.0 112.703 173.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -123.3 -6.58 8.23 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.217 1.407 . . . . 0.0 113.135 175.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.1 mt -62.5 -37.5 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 125.287 1.435 . . . . 0.0 112.094 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.1 t -73.38 -10.62 59.93 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.7 1.2 . . . . 0.0 113.506 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -114.7 -170.43 1.74 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 127.504 2.321 . . . . 0.0 111.164 -171.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -60.69 125.75 83.51 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 124.378 1.071 . . . . 0.0 111.835 173.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.68 152.21 82.34 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.029 2.486 . . . . 0.0 112.554 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 33.0 tp -75.91 108.91 9.1 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.119 1.368 . . . . 0.0 110.897 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -93.71 131.9 38.58 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.532 1.533 . . . . 0.0 111.78 175.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -146.78 167.86 22.81 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.478 1.111 . . . . 0.0 112.88 169.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.0 mm -101.48 146.88 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.902 1.281 . . . . 0.0 109.715 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.3 mm -46.46 118.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.362 1.865 . . . . 0.0 111.792 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.19 77.5 1.05 Allowed Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.993 1.282 . . . . 0.0 112.886 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.0 t -123.13 -36.84 2.78 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.002 1.321 . . . . 0.0 114.426 -175.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 52.47 23.27 2.45 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 126.846 2.058 . . . . 0.0 115.175 -178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -80.15 -24.79 40.18 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.2 pt -78.42 167.07 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.989 1.316 . . . . 0.0 112.475 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.9 pt -59.53 141.58 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.242 1.017 . . . . 0.0 111.692 176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.34 73.43 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -174.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.0 -25.91 68.5 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.347 0.975 . . . . 0.0 114.296 176.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.58 -35.17 13.71 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.307 1.443 . . . . 0.0 111.844 173.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -59.4 -40.74 87.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.223 1.409 . . . . 0.0 112.678 177.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -73.69 -8.34 55.6 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 172.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.47 -47.89 5.22 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.978 1.311 . . . . 0.0 112.631 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.1 p -56.95 -28.54 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.996 1.318 . . . . 0.0 114.134 -172.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.01 -19.71 63.14 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -108.46 -11.48 15.15 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 125.722 1.609 . . . . 0.0 113.843 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.94 113.09 4.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.35 1.46 . . . . 0.0 112.138 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -69.97 147.14 50.54 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.763 0.825 . . . . 0.0 111.891 -179.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 tt -59.49 131.65 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 124.432 1.093 . . . . 0.0 111.429 174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.91 12.88 79.04 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.61 1.1 . . . . 0.0 115.334 176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -116.65 118.53 32.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.229 1.412 . . . . 0.0 111.678 -175.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -61.09 133.65 56.24 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.223 1.009 . . . . 0.0 111.947 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -136.97 136.45 38.55 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.652 1.181 . . . . 0.0 110.956 178.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -126.63 105.93 9.06 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.678 1.191 . . . . 0.0 110.526 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.0 m -109.8 114.74 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.554 1.542 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.7 t -73.81 126.91 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 121.337 -0.852 . . . . 0.0 109.552 175.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 56.1 mt -119.74 130.98 73.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.718 1.607 . . . . 0.0 108.989 -177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.4 154.45 87.71 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.65 1.18 . . . . 0.0 111.675 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.48 -45.06 15.64 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.201 1.934 . . . . 0.0 111.646 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -62.11 -21.07 64.7 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -85.79 -1.76 57.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.687 1.195 . . . . 0.0 113.116 178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -133.3 -67.8 0.6 Allowed 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.497 1.519 . . . . 0.0 112.113 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -143.59 91.83 2.29 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.209 2.204 . . . . 0.0 109.826 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.85 -94.6 0.36 Allowed Glycine 0 CA--C 1.533 1.176 0 C-N-CA 124.19 0.9 . . . . 0.0 112.357 -177.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.8 m 42.42 42.34 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 127.578 2.351 . . . . 0.0 115.154 175.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -112.17 175.79 5.29 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.639 1.976 . . . . 0.0 113.596 -174.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -106.42 47.01 0.89 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 126.02 1.728 . . . . 0.0 113.384 -171.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -66.38 -21.02 66.22 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 120.724 -1.235 . . . . 0.0 113.298 175.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.8 t -144.45 108.87 4.84 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.094 2.158 . . . . 0.0 109.164 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -141.39 160.22 40.59 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.829 1.252 . . . . 0.0 112.909 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.55 137.82 31.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 112.002 -177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -126.8 124.29 39.34 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -88.04 82.5 7.18 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.9 1.68 . . . . 0.0 110.255 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.69 136.04 45.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.144 1.378 . . . . 0.0 109.722 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -71.77 156.01 57.63 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.475 2.117 . . . . 0.0 112.24 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 29.6 mtm105 -65.85 -9.28 27.54 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -56.31 -31.5 63.74 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.327 1.051 . . . . 0.0 113.582 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -82.17 -6.61 59.33 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -130.04 15.58 5.72 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.44 1.896 . . . . 0.0 113.403 -169.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.62 107.93 0.34 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.996 1.718 . . . . 0.0 112.289 -177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.84 11.05 57.13 Favored Glycine 0 CA--C 1.539 1.559 0 C-N-CA 124.88 1.229 . . . . 0.0 115.784 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.9 mt -108.42 132.76 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-N 119.368 1.584 . . . . 0.0 110.557 -178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -82.67 79.45 9.07 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.915 1.686 . . . . 0.0 112.696 177.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 11.0 mp -66.01 155.76 35.68 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.59 1.156 . . . . 0.0 112.819 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -139.91 157.64 45.37 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.248 1.819 . . . . 0.0 111.248 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -73.96 25.69 0.07 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 126.113 1.765 . . . . 0.0 114.999 -177.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.4 56.22 0.06 OUTLIER Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.988 1.28 . . . . 0.0 112.663 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.4 ptp -132.18 149.25 52.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.699 1.2 . . . . 0.0 112.208 174.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.6 m -67.49 125.35 25.87 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.363 1.465 . . . . 0.0 110.629 169.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.14 160.31 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.627 1.571 . . . . 0.0 111.146 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -119.5 149.84 41.23 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.498 1.519 . . . . 0.0 111.578 -177.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -137.89 108.53 0.64 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.651 1.119 . . . . 0.0 113.047 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -71.82 112.63 8.09 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.817 -0.814 . . . . 0.0 111.464 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.2 t -89.03 159.93 17.34 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.618 1.167 . . . . 0.0 111.967 174.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -65.99 -13.56 60.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.623 1.569 . . . . 0.0 113.959 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -72.65 11.15 0.68 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.754 1.622 . . . . 0.0 113.941 171.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 30.3 m120 53.41 47.86 23.17 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.844 2.058 . . . . 0.0 111.908 -172.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.49 168.17 20.43 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.722 2.009 . . . . 0.0 109.776 -176.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.8 m -140.78 105.56 4.93 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.138 -0.976 . . . . 0.0 111.045 -177.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.35 170.11 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 O-C-N 121.941 -0.474 . . . . 0.0 111.494 174.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -123.8 139.06 54.35 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.088 1.755 . . . . 0.0 111.564 176.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.06 179.48 7.71 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.419 1.888 . . . . 0.0 111.872 -174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -128.67 128.65 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.729 1.212 . . . . 0.0 110.722 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.9 mt -72.7 131.13 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.5 1.52 . . . . 0.0 110.865 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -95.38 -42.31 8.56 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.988 1.715 . . . . 0.0 112.0 175.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -155.09 167.36 30.63 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.625 1.17 . . . . 0.0 112.006 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -140.29 144.84 36.61 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.096 1.358 . . . . 0.0 111.536 174.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 65.4 m -117.94 174.08 6.4 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.776 2.03 . . . . 0.0 110.613 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -62.05 -19.79 63.27 Favored 'General case' 0 CA--C 1.549 0.942 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 37.1 p -133.45 -18.31 2.22 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.846 1.658 . . . . 0.0 115.173 -173.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -143.03 172.06 13.22 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.045 1.738 . . . . 0.0 112.145 -174.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.2 t -137.85 126.33 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 127.13 2.172 . . . . 0.0 110.591 -172.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 76.9 mmm -94.15 111.57 23.31 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.695 1.598 . . . . 0.0 111.078 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -118.13 151.27 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 126.131 1.772 . . . . 0.0 112.249 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -91.71 115.57 28.16 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.105 1.362 . . . . 0.0 111.166 174.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -123.47 170.09 10.73 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.344 1.858 . . . . 0.0 111.234 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -112.17 142.63 44.4 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.595 1.558 . . . . 0.0 110.925 173.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -104.5 127.14 29.62 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.962 0.905 . . . . 0.0 110.956 -178.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.2 -16.94 35.85 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.848 2.365 . . . . 0.0 114.849 -172.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.87 22.23 0.78 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.703 1.601 . . . . 0.0 112.982 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.07 174.93 6.43 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.955 1.702 . . . . 0.0 113.382 173.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -72.51 171.34 49.65 Favored Glycine 0 CA--C 1.54 1.642 0 C-N-CA 124.637 1.113 . . . . 0.0 114.367 176.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -147.25 168.17 22.39 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.923 1.689 . . . . 0.0 113.123 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 7.1 p -64.48 137.78 58.05 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.923 1.689 . . . . 0.0 112.351 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.3 mt -131.25 144.78 51.56 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.795 1.238 . . . . 0.0 112.001 -177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -84.09 99.1 10.25 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.676 1.59 . . . . 0.0 111.277 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.39 93.37 5.96 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.704 1.202 . . . . 0.0 109.837 168.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.5 ttt85 -76.93 141.37 40.52 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 120.928 -1.108 . . . . 0.0 109.784 168.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -152.72 170.48 20.16 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.905 0.882 . . . . 0.0 113.0 170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -149.55 142.28 24.6 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.14 1.376 . . . . 0.0 111.132 169.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.29 107.8 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.154 1.382 . . . . 0.0 109.025 169.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.7 mp -69.95 -33.9 72.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.628 0.771 . . . . 0.0 111.184 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 140.62 -175.13 22.24 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 125.438 1.494 . . . . 0.0 114.008 174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 45.2 m-85 -108.15 139.38 42.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.475 1.51 . . . . 0.0 110.455 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -138.97 157.36 46.14 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.354 1.062 . . . . 0.0 113.28 177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.58 107.32 18.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.151 1.38 . . . . 0.0 110.808 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 14.6 m -64.61 159.36 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.108 0.963 . . . . 0.0 112.578 171.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 66.4 m -131.75 158.44 41.2 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.864 1.666 . . . . 0.0 111.027 174.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -122.02 60.28 0.98 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.151 1.38 . . . . 0.0 110.041 -176.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 60.59 14.56 5.02 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 127.412 2.285 . . . . 0.0 115.45 -174.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 . . . . . 0 C--O 1.255 1.347 0 C-N-CA 127.856 2.462 . . . . 0.0 114.131 175.886 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.7 tpp . . . . . 0 N--CA 1.487 1.399 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.68 168.39 21.43 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.166 1.386 . . . . 0.0 112.415 177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -100.87 -63.57 1.12 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.881 1.272 . . . . 0.0 112.098 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 49.1 m170 45.05 44.12 7.99 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.156 1.782 . . . . 0.0 113.455 -171.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -68.92 156.21 38.93 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.682 1.593 . . . . 0.0 113.267 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt -107.83 93.99 4.83 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.382 1.473 . . . . 0.0 110.781 -168.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.08 63.85 0.66 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.775 1.63 . . . . 0.0 111.276 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.7 m -70.21 -27.82 64.8 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 121.373 -0.829 . . . . 0.0 113.196 173.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 35.7 mm -75.7 146.08 9.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.715 1.206 . . . . 0.0 110.051 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -102.2 147.75 26.26 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.029 1.732 . . . . 0.0 111.79 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -148.72 157.07 43.19 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.611 1.564 . . . . 0.0 111.023 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.89 106.37 8.53 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.354 1.062 . . . . 0.0 110.323 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.18 125.17 29.1 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.067 1.347 . . . . 0.0 110.63 169.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -107.88 125.63 51.7 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.475 1.51 . . . . 0.0 110.388 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.7 pt -133.61 163.26 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.314 1.046 . . . . 0.0 112.042 174.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -140.59 138.05 34.14 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.056 1.342 . . . . 0.0 110.559 176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.47 160.56 38.39 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.141 1.376 . . . . 0.0 113.728 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -143.33 161.39 38.46 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.001 1.72 . . . . 0.0 111.396 167.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -133.03 107.41 11.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.735 1.614 . . . . 0.0 110.038 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -113.92 157.41 22.44 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.908 1.683 . . . . 0.0 110.31 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -63.81 152.18 40.24 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.689 -0.632 . . . . 0.0 110.933 174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.41 -25.79 60.11 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -174.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.38 57.38 0.3 Allowed Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.47 1.033 . . . . 0.0 113.743 177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.6 t -144.57 163.7 33.13 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.604 1.162 . . . . 0.0 112.441 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.8 t -80.36 -21.96 41.85 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 113.466 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 pp -69.35 157.06 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 118.811 0.732 . . . . 0.0 111.36 177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 p -125.36 144.71 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.508 1.523 . . . . 0.0 110.697 178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 mp -93.91 -48.08 6.43 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.544 0.738 . . . . 0.0 111.038 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.76 157.21 36.15 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.704 1.602 . . . . 0.0 111.735 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 99.5 p -162.98 163.79 25.96 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.532 1.133 . . . . 0.0 113.615 172.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -132.86 8.28 4.11 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 167.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 22.7 mm -55.43 -53.58 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.76 1.224 . . . . 0.0 112.504 -175.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.4 p -76.32 -18.92 58.7 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 0.0 113.892 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -84.02 -171.35 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.006 2.123 . . . . 0.0 111.035 174.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -64.17 142.59 98.28 Favored Pre-proline 0 CA--C 1.551 0.986 0 O-C-N 121.147 -0.97 . . . . 0.0 111.77 173.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.14 159.43 53.89 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.374 2.716 . . . . 0.0 112.597 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.86 109.06 15.07 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.86 1.664 . . . . 0.0 110.363 174.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -80.59 127.14 32.12 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.438 1.895 . . . . 0.0 111.452 171.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -146.14 175.1 10.74 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 166.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.8 mm -114.7 137.77 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.051 1.74 . . . . 0.0 109.078 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 41.0 mm -48.14 109.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.27 1.828 . . . . 0.0 111.804 -178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.05 87.27 1.24 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 125.415 1.483 . . . . 0.0 112.936 -175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.1 t -146.35 -33.47 0.31 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.2 m120 53.45 60.64 3.58 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.852 2.061 . . . . 0.0 113.789 176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -111.04 -26.28 9.33 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -172.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.8 pt -81.04 174.61 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.436 1.495 . . . . 0.0 112.177 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.8 pt -58.2 141.18 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 123.797 0.839 . . . . 0.0 111.469 175.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.08 -43.08 91.75 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -175.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.81 -33.45 73.28 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.052 0.834 . . . . 0.0 113.95 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.5 tp -81.73 -45.38 15.74 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.436 1.094 . . . . 0.0 111.342 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -49.36 -47.7 47.26 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.71 1.604 . . . . 0.0 113.287 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -63.43 -18.22 63.51 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.26 1.024 . . . . 0.0 113.276 178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.05 -43.92 10.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.914 1.286 . . . . 0.0 112.69 169.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.62 -43.06 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 CA-C-N 119.941 1.246 . . . . 0.0 112.525 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -63.58 -20.79 65.94 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -102.69 -11.34 18.48 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 126.399 1.88 . . . . 0.0 113.801 177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.03 126.63 31.42 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.408 1.483 . . . . 0.0 112.392 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.6 mp0 -77.8 155.04 31.35 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.754 0.822 . . . . 0.0 112.01 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 tt -57.62 134.29 22.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 124.897 1.279 . . . . 0.0 111.473 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.54 13.83 74.58 Favored Glycine 0 CA--C 1.538 1.481 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -118.75 100.23 7.27 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.964 1.306 . . . . 0.0 111.63 -173.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 70.6 m95 -58.18 131.86 51.83 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.287 1.035 . . . . 0.0 111.469 171.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -141.41 157.84 44.65 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.907 0.883 . . . . 0.0 112.79 171.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -128.79 96.78 4.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.994 1.318 . . . . 0.0 110.91 -170.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 m -97.94 106.23 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.394 1.478 . . . . 0.0 110.119 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 t -74.26 123.96 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.351 -0.843 . . . . 0.0 109.807 177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 89.1 mt -121.41 140.09 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.451 1.9 . . . . 0.0 109.383 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.15 158.91 69.34 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.416 1.087 . . . . 0.0 112.214 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.93 -46.79 7.81 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.32 2.013 . . . . 0.0 112.082 -178.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -71.89 -14.42 61.93 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.198 1.399 . . . . 0.0 114.656 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -79.43 -7.74 58.62 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -131.3 -82.59 0.52 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.051 1.34 . . . . 0.0 111.368 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -138.44 92.53 2.64 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.503 1.921 . . . . 0.0 109.574 178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.03 81.08 1.71 Allowed Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.754 1.168 . . . . 0.0 112.541 -176.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 16.0 m -116.2 75.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 125.487 1.515 . . . . 0.0 111.832 -174.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -133.76 156.09 48.61 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.216 1.406 . . . . 0.0 111.738 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -138.34 110.24 7.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.447 1.899 . . . . 0.0 110.521 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 t -93.45 -8.03 42.76 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 53.72 56.59 7.01 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.328 1.851 . . . . 0.0 113.128 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -74.83 175.45 8.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.097 1.359 . . . . 0.0 112.39 175.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 73.7 mt -121.16 146.78 46.41 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.729 1.611 . . . . 0.0 111.69 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -131.54 111.45 11.77 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.685 1.594 . . . . 0.0 111.253 167.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -69.58 115.17 8.52 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.715 0.806 . . . . 0.0 110.087 160.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.8 m -125.36 156.85 69.53 Favored Pre-proline 0 N--CA 1.477 0.923 0 C-N-CA 125.942 1.697 . . . . 0.0 109.898 176.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.34 153.52 61.4 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.025 1.817 . . . . 0.0 111.881 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.1 tpp85 -61.26 -19.37 61.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.373 1.069 . . . . 0.0 113.245 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -53.95 -30.51 47.06 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.49 1.516 . . . . 0.0 114.589 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.88 -19.73 65.05 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.573 0.953 . . . . 0.0 113.573 175.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -137.68 20.98 2.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.032 1.733 . . . . 0.0 112.556 -168.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 tm-20 -56.93 -24.8 55.26 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.168 1.787 . . . . 0.0 114.168 -171.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -105.18 16.07 46.29 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 126.059 1.79 . . . . 0.0 115.338 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 5.4 mt -127.32 132.62 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.281 1.54 . . . . 0.0 111.023 -173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.9 mp0 -81.34 89.2 6.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.685 1.194 . . . . 0.0 111.108 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -70.2 160.28 32.43 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.4 1.08 . . . . 0.0 112.326 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -156.1 152.29 27.8 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.019 1.328 . . . . 0.0 111.81 -179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -72.88 84.25 1.23 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.685 1.194 . . . . 0.0 110.878 168.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 130.69 43.71 0.18 Allowed Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.765 1.174 . . . . 0.0 114.699 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.4 ptm -129.38 150.69 50.63 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.149 1.38 . . . . 0.0 111.149 170.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.8 p -67.99 133.83 49.7 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.041 0.937 . . . . 0.0 110.955 168.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.2 p -132.24 152.82 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.35 1.86 . . . . 0.0 110.166 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -118.59 143.95 46.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.572 1.149 . . . . 0.0 110.958 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.12 99.92 0.44 Allowed Glycine 0 N--CA 1.47 0.912 0 C-N-CA 124.802 1.191 . . . . 0.0 112.109 -174.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -66.87 140.31 57.79 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 117.604 0.702 . . . . 0.0 111.203 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.2 t -119.07 154.54 33.01 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.036 1.735 . . . . 0.0 111.656 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -62.0 -17.66 57.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.988 1.715 . . . . 0.0 113.439 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -71.99 15.46 0.16 Allowed 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 127.23 2.212 . . . . 0.0 113.999 173.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.6 m120 52.66 48.12 23.21 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.134 2.174 . . . . 0.0 112.617 -173.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -144.77 177.36 8.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.798 1.639 . . . . 0.0 111.969 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.0 m -145.2 128.94 17.23 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.905 1.282 . . . . 0.0 110.538 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -84.66 165.72 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.73 0.812 . . . . 0.0 111.81 172.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.8 mp0 -133.36 126.57 31.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.465 1.506 . . . . 0.0 110.209 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -153.77 -172.88 4.37 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.677 1.191 . . . . 0.0 112.486 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.9 mp -113.67 140.7 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.629 1.572 . . . . 0.0 109.804 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.8 mt -70.43 134.57 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.797 1.239 . . . . 0.0 110.831 175.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -107.96 -32.96 7.36 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.42 1.088 . . . . 0.0 113.57 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -152.83 153.92 34.09 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.231 1.412 . . . . 0.0 111.173 164.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -142.63 134.12 26.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.659 1.184 . . . . 0.0 111.715 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 8.2 t -138.94 160.74 39.03 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.567 1.547 . . . . 0.0 110.517 171.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.24 -23.26 67.01 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -177.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.1 p -77.28 -62.59 1.61 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.021 1.728 . . . . 0.0 111.68 173.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -138.87 160.95 38.49 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.007 2.123 . . . . 0.0 112.109 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.41 147.98 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.703 1.601 . . . . 0.0 110.396 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.7 mtp -121.84 105.69 10.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.69 1.596 . . . . 0.0 110.288 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.6 m -106.31 146.59 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 125.555 1.542 . . . . 0.0 111.072 -177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 141.94 49.84 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.841 -0.537 . . . . 0.0 111.112 176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -136.05 156.95 47.97 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.389 1.476 . . . . 0.0 111.474 176.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -126.04 109.23 12.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.675 1.59 . . . . 0.0 110.382 177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -67.99 134.15 91.86 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.268 1.427 . . . . 0.0 110.755 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.52 -25.17 35.3 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.386 2.057 . . . . 0.0 113.447 -174.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 15.1 mt -83.29 5.81 21.91 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.908 1.283 . . . . 0.0 113.591 -177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.67 169.48 3.95 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.729 1.612 . . . . 0.0 114.316 -179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 97.22 -173.87 29.3 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 125.411 1.481 . . . . 0.0 113.326 -175.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -135.17 161.64 34.77 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.064 1.745 . . . . 0.0 112.043 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.19 142.85 57.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.738 1.615 . . . . 0.0 111.764 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 93.3 mt -126.71 143.1 51.34 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 112.002 -174.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.85 98.53 11.83 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.949 1.3 . . . . 0.0 111.457 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -79.62 92.57 5.36 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.848 0.832 . . . . 0.0 110.77 168.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -84.12 128.77 34.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.256 1.422 . . . . 0.0 109.417 171.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.47 169.39 21.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -149.55 147.96 28.79 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.109 1.364 . . . . 0.0 112.055 173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.5 t -87.9 108.59 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.42 1.488 . . . . 0.0 109.167 166.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.84 -29.43 68.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.51 0.724 . . . . 0.0 111.302 176.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 121.67 172.07 14.22 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 126.534 2.016 . . . . 0.0 112.422 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -101.15 156.34 17.48 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.451 0.7 . . . . 0.0 112.717 175.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -147.33 143.66 28.2 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.522 1.529 . . . . 0.0 111.903 178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -69.21 126.06 28.6 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.396 0.678 . . . . 0.0 110.428 172.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.6 m -122.0 162.9 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.84 1.656 . . . . 0.0 110.936 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 59.8 m -121.83 172.78 7.92 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.71 1.604 . . . . 0.0 112.002 -179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -96.77 -9.94 27.8 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.548 1.139 . . . . 0.0 113.61 171.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -77.65 -32.79 53.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.192 1.397 . . . . 0.0 113.144 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.253 1.244 0 C-N-CA 126.335 1.854 . . . . 0.0 115.051 -178.461 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 mtt . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -138.5 146.59 42.19 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.703 1.601 . . . . 0.0 110.938 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -81.4 173.27 12.6 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.169 1.388 . . . . 0.0 111.769 173.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -70.48 81.53 0.57 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.288 1.035 . . . . 0.0 111.565 169.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -129.92 164.7 23.63 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.976 2.11 . . . . 0.0 110.809 172.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.88 -7.98 51.66 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.822 1.249 . . . . 0.0 113.382 -178.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -96.13 32.06 2.03 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.723 2.009 . . . . 0.0 114.187 -177.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.6 t -54.52 -43.7 72.12 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.56 1.144 . . . . 0.0 113.355 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.2 mm -71.45 143.84 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.311 -0.868 . . . . 0.0 111.618 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -52.77 101.19 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 128.53 2.732 . . . . 0.0 113.071 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -72.7 122.63 21.78 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.017 1.327 . . . . 0.0 112.189 177.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.19 96.95 5.34 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.487 1.115 . . . . 0.0 111.176 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.83 118.99 22.11 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.752 2.021 . . . . 0.0 111.734 174.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.88 130.5 48.37 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.185 1.394 . . . . 0.0 111.313 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.7 pp -134.52 158.74 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.173 1.389 . . . . 0.0 111.734 176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -138.94 141.24 38.46 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.698 1.599 . . . . 0.0 110.972 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.44 154.2 49.98 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 123.123 1.44 . . . . 0.0 114.069 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -142.56 113.03 7.26 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 128.18 2.592 . . . . 0.0 109.068 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.1 p -91.29 115.73 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 124.69 1.196 . . . . 0.0 109.602 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -124.54 151.87 44.17 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.132 1.773 . . . . 0.0 110.547 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -71.66 146.76 48.06 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.606 -0.683 . . . . 0.0 111.251 175.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -54.84 -33.35 61.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -170.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.2 45.33 0.84 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.368 0.985 . . . . 0.0 114.141 -173.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.4 t -142.28 156.48 45.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.334 1.054 . . . . 0.0 112.579 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 63.2 p -82.52 -11.9 58.14 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.97 1.708 . . . . 0.0 114.331 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.03 178.18 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.966 1.306 . . . . 0.0 112.196 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.2 p -133.77 137.81 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.736 1.215 . . . . 0.0 110.197 168.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 53.7 mt -81.27 -51.39 8.44 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.635 0.774 . . . . 0.0 110.421 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.31 163.33 30.91 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.925 1.29 . . . . 0.0 112.544 173.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.9 p -157.11 165.27 36.51 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.003 -1.061 . . . . 0.0 112.812 171.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -119.68 -4.29 10.27 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 164.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.62 -48.57 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.762 1.625 . . . . 0.0 112.215 -171.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.3 t -75.93 -17.24 59.83 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -86.93 -73.93 0.45 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.061 1.745 . . . . 0.0 111.715 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -166.93 134.18 1.99 Allowed Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 126.665 1.986 . . . . 0.0 110.335 -178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -66.95 154.33 74.98 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.11 2.54 . . . . 0.0 112.882 177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.6 tt -95.0 111.89 23.65 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.025 1.33 . . . . 0.0 109.796 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -93.27 131.89 37.97 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.868 1.267 . . . . 0.0 111.519 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -145.6 179.38 7.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.476 1.51 . . . . 0.0 112.097 172.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.3 mm -110.81 135.5 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.758 1.223 . . . . 0.0 109.251 174.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.8 mm -49.8 109.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.14 1.376 . . . . 0.0 111.038 179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.71 53.31 0.72 Allowed Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.617 1.58 . . . . 0.0 114.634 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 m -122.79 -32.23 3.57 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.591 1.156 . . . . 0.0 113.296 175.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 54.3 33.45 18.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.327 1.851 . . . . 0.0 114.888 173.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -79.45 -24.1 42.66 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -177.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 39.0 pt -69.56 166.95 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.636 1.174 . . . . 0.0 112.589 177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.6 pt -57.58 141.76 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.019 0.927 . . . . 0.0 111.428 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.4 -38.18 76.81 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -173.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -61.18 -28.11 68.53 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 124.002 0.81 . . . . 0.0 114.17 175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.5 tp -90.19 -29.72 18.05 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.177 1.391 . . . . 0.0 112.213 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -60.47 -42.88 97.16 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 120.844 -1.16 . . . . 0.0 112.504 174.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -68.53 -10.14 53.73 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 173.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.08 -49.94 4.56 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.625 1.57 . . . . 0.0 112.821 177.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.0 p -54.87 -31.71 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.565 1.146 . . . . 0.0 114.038 -174.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 pp -64.64 -21.04 66.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -103.74 -13.78 16.33 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 126.678 1.991 . . . . 0.0 113.536 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -75.5 116.84 16.64 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.492 1.517 . . . . 0.0 112.07 176.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -73.7 157.48 36.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.813 0.816 . . . . 0.0 112.46 174.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 tt -57.14 133.96 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.086 1.355 . . . . 0.0 111.639 169.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.27 12.47 72.52 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.758 1.171 . . . . 0.0 114.938 176.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -120.14 108.34 14.12 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.173 1.389 . . . . 0.0 111.201 -170.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -54.93 129.94 39.52 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.993 0.917 . . . . 0.0 111.456 173.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -128.84 141.26 51.35 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.072 1.349 . . . . 0.0 111.169 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -127.11 112.71 15.48 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.415 1.486 . . . . 0.0 109.572 -174.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -123.81 124.03 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.627 1.171 . . . . 0.0 111.556 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.4 t -85.08 127.93 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.726 0.811 . . . . 0.0 109.646 176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 80.1 mt -126.34 135.72 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.251 1.82 . . . . 0.0 108.964 -175.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.2 155.02 67.79 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.921 0.888 . . . . 0.0 112.329 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -65.15 -41.76 15.67 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.109 1.873 . . . . 0.0 111.379 -176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -68.71 -23.67 64.39 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.911 1.684 . . . . 0.0 114.51 175.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.24 -23.46 51.31 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 121.429 -0.794 . . . . 0.0 112.561 172.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.33 -72.6 0.49 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.645 1.178 . . . . 0.0 111.774 172.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -142.28 -22.21 0.69 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.454 1.65 . . . . 0.0 115.454 -173.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.37 80.43 0.5 Allowed Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.314 1.435 . . . . 0.0 114.296 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 23.9 m -103.58 8.57 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.28 1.432 . . . . 0.0 113.749 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -63.82 170.96 3.02 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.074 1.35 . . . . 0.0 113.355 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -139.25 171.94 13.56 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.866 1.667 . . . . 0.0 112.073 -179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 m -70.11 29.84 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.479 2.312 . . . . 0.0 115.554 -173.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.7 m -64.74 -166.58 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.232 2.213 . . . . 0.0 112.063 164.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 68.15 16.35 9.42 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.893 1.677 . . . . 0.0 112.636 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 67.1 mt -153.46 132.57 12.61 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 129.32 3.048 . . . . 0.0 109.491 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -139.93 117.01 11.13 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.09 1.356 . . . . 0.0 110.159 168.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -70.16 112.65 6.67 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.01 0.924 . . . . 0.0 110.547 168.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 23.5 m -119.59 157.42 51.92 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 125.729 1.612 . . . . 0.0 110.634 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.43 163.04 40.38 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.008 1.805 . . . . 0.0 111.38 172.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -67.21 0.53 2.68 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.234 1.814 . . . . 0.0 114.667 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -68.31 -38.04 81.2 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.547 1.939 . . . . 0.0 113.907 -175.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -67.48 -15.89 63.91 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -127.38 21.18 6.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.514 1.526 . . . . 0.0 113.005 -168.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -56.49 99.06 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.761 1.624 . . . . 0.0 112.171 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 99.07 2.95 56.93 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.599 1.571 . . . . 0.0 115.596 -178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 23.5 mt -97.77 127.56 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.567 1.547 . . . . 0.0 109.763 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -64.87 124.13 21.21 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.828 0.851 . . . . 0.0 111.529 170.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.1 mt -115.11 139.27 50.03 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.335 1.454 . . . . 0.0 110.589 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -150.35 150.68 31.76 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.887 1.275 . . . . 0.0 111.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -76.66 89.59 3.36 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.83 -1.169 . . . . 0.0 111.052 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 126.72 43.11 0.27 Allowed Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.482 1.515 . . . . 0.0 114.6 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 17.9 ptm -133.13 152.1 51.96 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.196 1.398 . . . . 0.0 111.365 171.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.3 p -68.57 133.53 48.66 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.88 1.272 . . . . 0.0 111.32 167.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -135.73 156.94 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 126.481 1.913 . . . . 0.0 110.241 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -121.86 139.54 53.5 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.634 1.174 . . . . 0.0 111.037 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.02 100.2 0.55 Allowed Glycine 0 N--CA 1.469 0.879 0 C-N-CA 124.878 1.228 . . . . 0.0 112.282 -173.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -64.15 144.79 56.85 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.72 0.76 . . . . 0.0 111.383 177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.2 t -128.93 155.44 45.31 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.576 1.55 . . . . 0.0 111.578 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -65.46 -14.95 62.09 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.836 1.654 . . . . 0.0 113.221 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -73.46 17.29 0.15 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.457 1.903 . . . . 0.0 113.934 171.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 54.15 44.72 28.76 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 127.144 2.178 . . . . 0.0 112.425 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -139.26 173.49 11.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.966 2.107 . . . . 0.0 111.48 -174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.4 m -146.14 118.33 8.35 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.66 1.184 . . . . 0.0 110.179 -179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.6 pp -73.66 162.13 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 118.312 0.506 . . . . 0.0 110.976 172.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -137.26 119.76 15.95 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.348 1.459 . . . . 0.0 110.652 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.04 -170.75 3.59 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.456 1.103 . . . . 0.0 112.543 -172.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.71 142.21 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.393 1.477 . . . . 0.0 110.071 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.3 mt -73.46 126.3 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 O-C-N 121.066 -1.021 . . . . 0.0 110.303 174.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -101.41 -33.82 9.83 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.357 1.063 . . . . 0.0 113.174 -176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.41 154.93 36.55 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.372 1.469 . . . . 0.0 111.31 170.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -144.98 146.86 32.11 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.273 1.029 . . . . 0.0 112.078 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 12.3 t -146.47 170.46 16.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.438 1.895 . . . . 0.0 110.471 172.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -72.43 -24.11 61.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.021 0.929 . . . . 0.0 113.463 177.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 21.5 p -79.91 -61.77 1.89 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.641 1.576 . . . . 0.0 111.706 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -138.45 166.92 23.04 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.029 2.132 . . . . 0.0 111.517 178.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.36 144.16 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.576 1.551 . . . . 0.0 110.6 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 91.8 mtp -118.42 93.36 4.09 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.018 1.727 . . . . 0.0 110.883 -174.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.6 t -88.59 149.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.555 1.542 . . . . 0.0 109.904 176.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.8 114.25 4.92 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.363 -0.836 . . . . 0.0 111.508 171.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -124.85 99.21 6.04 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.668 1.587 . . . . 0.0 109.146 172.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -62.16 164.6 6.67 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.325 0.65 . . . . 0.0 111.527 170.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.05 140.47 17.06 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.154 0.582 . . . . 0.0 111.433 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.56 -12.65 24.8 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.144 2.563 . . . . 0.0 113.781 -175.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.6 mt -73.0 -27.14 61.61 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.846 1.259 . . . . 0.0 113.155 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.55 161.54 27.71 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.24 1.016 . . . . 0.0 112.414 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -65.64 160.2 44.59 Favored Glycine 0 CA--C 1.538 1.487 0 O-C-N 121.685 -0.635 . . . . 0.0 113.304 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -141.14 178.76 7.16 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.58 1.952 . . . . 0.0 111.204 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.39 140.41 56.16 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.315 1.046 . . . . 0.0 111.701 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.62 134.15 55.31 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.819 2.047 . . . . 0.0 110.915 -172.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -87.95 101.86 14.16 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.041 1.336 . . . . 0.0 111.347 178.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -81.68 96.96 7.69 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.893 0.877 . . . . 0.0 110.169 167.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -84.0 120.1 25.71 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.274 1.43 . . . . 0.0 108.87 168.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -140.72 168.84 18.85 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.69 0.677 . . . . 0.0 112.825 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -147.83 137.33 22.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.054 0.942 . . . . 0.0 111.699 174.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 35.8 t -80.63 102.77 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 124.211 1.004 . . . . 0.0 108.386 166.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 26.5 mt -65.52 -31.99 73.35 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.026 0.53 . . . . 0.0 111.549 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 134.31 174.32 13.45 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 126.928 2.204 . . . . 0.0 112.333 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -108.03 140.82 40.64 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.057 0.943 . . . . 0.0 111.113 171.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -110.55 107.76 17.5 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.533 1.533 . . . . 0.0 109.659 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -66.85 128.44 36.33 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.85 0.86 . . . . 0.0 109.962 172.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.31 157.63 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.763 1.225 . . . . 0.0 110.998 177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 65.6 m -145.25 153.38 41.24 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.42 1.488 . . . . 0.0 110.909 175.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -134.82 15.19 3.61 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.499 1.52 . . . . 0.0 113.083 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -130.0 -61.08 1.0 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.28 1.832 . . . . 0.0 111.468 -176.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 C--O 1.254 1.307 0 C-N-CA 125.718 1.607 . . . . 0.0 113.487 173.659 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -147.87 155.0 41.14 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.056 1.342 . . . . 0.0 112.237 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -157.19 -179.0 7.78 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 127.037 2.135 . . . . 0.0 111.188 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -136.66 107.99 6.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.805 1.242 . . . . 0.0 111.243 176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -78.9 168.45 19.68 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.128 0.971 . . . . 0.0 112.447 173.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -81.16 -2.87 50.21 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.185 1.394 . . . . 0.0 114.484 171.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -113.26 65.43 0.65 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 126.571 1.948 . . . . 0.0 112.31 -172.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.5 m -73.63 -5.13 38.47 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' H ' HD12 ' A' ' 9' ' ' ILE . 4.3 mp -65.56 146.75 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 126.387 1.875 . . . . 0.0 110.382 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 30.8 mtmm -59.26 159.39 7.78 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.373 1.469 . . . . 0.0 112.489 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -148.9 149.36 31.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.062 1.345 . . . . 0.0 111.188 170.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.56 99.81 3.72 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.93 0.892 . . . . 0.0 109.225 169.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.44 148.46 41.09 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.786 0.834 . . . . 0.0 111.051 170.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.62 131.55 49.89 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.721 1.608 . . . . 0.0 110.262 177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 23.5 pt -127.7 161.85 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.435 1.094 . . . . 0.0 111.791 171.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -137.27 127.12 25.63 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.605 1.562 . . . . 0.0 110.162 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -131.48 149.13 52.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.951 1.3 . . . . 0.0 112.888 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -137.89 148.66 45.56 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 127.631 2.372 . . . . 0.0 109.934 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.5 p -126.97 121.37 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.066 0.946 . . . . 0.0 112.054 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -124.26 142.82 50.94 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.325 1.85 . . . . 0.0 111.336 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -66.29 128.64 36.92 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.106 0.962 . . . . 0.0 111.001 173.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -59.53 106.27 0.45 Allowed 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.474 -0.767 . . . . 0.0 112.407 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.39 -13.97 47.43 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 126.445 1.974 . . . . 0.0 115.327 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.8 m -119.78 125.19 47.99 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.259 1.53 . . . . 0.0 111.582 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 16.3 m -66.43 18.35 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 127.812 2.445 . . . . 0.0 116.088 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.0 pp -82.68 172.58 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.3 1.84 . . . . 0.0 112.44 -176.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.84 89.02 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 120.879 -1.138 . . . . 0.0 110.044 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -71.55 -23.72 61.81 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.27 156.86 31.44 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.86 1.664 . . . . 0.0 110.389 165.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.7 p -155.66 159.68 39.78 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.435 -0.791 . . . . 0.0 111.986 166.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -114.33 -27.4 7.61 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.71 1.204 . . . . 0.0 112.08 169.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -55.43 -49.67 71.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 125.889 1.675 . . . . 0.0 112.252 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -65.47 -26.2 67.83 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.928 0.891 . . . . 0.0 113.122 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.1 mmmm -85.81 -74.4 0.41 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.658 1.583 . . . . 0.0 111.351 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -169.35 149.56 3.87 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.915 2.086 . . . . 0.0 111.131 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.49 144.69 74.16 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.528 2.152 . . . . 0.0 111.872 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 14.2 tp -83.57 112.17 19.76 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.813 1.245 . . . . 0.0 110.221 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -100.05 124.94 45.99 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.927 0.891 . . . . 0.0 112.199 -178.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -152.04 168.86 23.89 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.313 1.045 . . . . 0.0 113.425 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.5 mm -93.07 126.72 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 124.692 1.197 . . . . 0.0 109.137 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.0 mm -49.41 113.65 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 125.527 1.531 . . . . 0.0 111.141 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 108.16 69.09 0.66 Allowed Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.668 1.604 . . . . 0.0 112.368 -172.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.4 t -140.04 -33.76 0.57 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.158 1.383 . . . . 0.0 113.616 178.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.2 m120 56.98 28.46 14.8 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 126.433 1.893 . . . . 0.0 114.821 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -81.36 -21.62 38.97 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 29.8 pt -73.8 169.22 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.853 1.661 . . . . 0.0 112.923 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.5 pt -56.63 144.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.15 0.98 . . . . 0.0 112.083 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.0 -39.06 73.99 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.007 0.923 . . . . 0.0 113.262 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.5 -26.82 70.02 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 123.731 0.681 . . . . 0.0 114.349 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.0 tp -93.22 -30.43 15.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.773 1.229 . . . . 0.0 112.353 173.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -57.23 -43.14 82.61 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.597 1.559 . . . . 0.0 112.321 174.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.44 -12.67 60.08 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -93.92 -41.96 9.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.155 1.382 . . . . 0.0 113.024 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.05 -23.81 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 120.708 -1.245 . . . . 0.0 113.633 -176.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.81 -26.86 62.57 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -83.65 -44.2 14.79 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.216 1.806 . . . . 0.0 111.394 174.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.56 122.28 13.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.846 1.258 . . . . 0.0 111.987 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.98 159.46 15.07 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.452 1.501 . . . . 0.0 111.916 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 tt -55.67 129.95 17.6 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 125.128 1.371 . . . . 0.0 112.464 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.9 13.68 82.29 Favored Glycine 0 CA--C 1.536 1.387 0 C-N-CA 124.43 1.014 . . . . 0.0 115.21 174.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -126.26 115.77 20.24 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.05 1.34 . . . . 0.0 111.814 -172.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.5 m95 -60.2 141.16 56.4 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.717 0.807 . . . . 0.0 112.309 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -136.98 115.1 11.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.256 1.422 . . . . 0.0 111.382 178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -90.18 114.29 26.24 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.227 1.411 . . . . 0.0 110.594 172.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.39 106.56 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.249 1.42 . . . . 0.0 110.593 175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.9 t -71.26 131.87 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 O-C-N 121.235 -0.916 . . . . 0.0 109.593 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.6 mt -121.81 139.62 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.691 1.596 . . . . 0.0 109.228 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.6 155.46 81.46 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.226 1.01 . . . . 0.0 111.969 176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.65 -29.96 84.76 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.604 2.203 . . . . 0.0 113.308 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -78.66 -23.86 45.47 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.69 -9.22 52.81 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.093 1.357 . . . . 0.0 113.758 -172.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -128.54 78.49 1.85 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.109 1.764 . . . . 0.0 110.597 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 43.02 76.06 0.08 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 127.393 2.277 . . . . 0.0 113.895 -175.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.14 87.85 0.12 Allowed Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.605 1.574 . . . . 0.0 113.951 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.35 19.33 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 127.059 2.143 . . . . 0.0 113.251 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -60.95 170.83 1.4 Allowed 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 126.34 1.856 . . . . 0.0 114.346 177.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -73.1 179.27 3.9 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.871 1.668 . . . . 0.0 113.796 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 76.1 p -110.86 7.5 21.88 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.642 1.577 . . . . 0.0 113.604 173.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 12.0 p -153.52 137.57 16.39 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.742 1.617 . . . . 0.0 112.824 -178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -141.67 169.34 17.78 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.834 2.054 . . . . 0.0 110.67 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mp -106.27 148.97 27.36 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.027 0.931 . . . . 0.0 110.853 173.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -140.07 108.52 5.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.656 1.182 . . . . 0.0 110.838 178.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -66.35 122.92 18.6 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.351 1.061 . . . . 0.0 111.148 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 p -136.05 137.96 26.32 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 126.492 1.917 . . . . 0.0 109.949 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.3 168.32 25.09 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.739 2.292 . . . . 0.0 112.428 178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.2 mmm-85 -69.46 21.19 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.412 2.285 . . . . 0.0 115.003 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -95.89 -19.91 19.19 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.429 1.891 . . . . 0.0 113.888 -179.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -98.61 -9.65 24.49 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.818 1.247 . . . . 0.0 113.814 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -127.24 26.62 6.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.299 1.84 . . . . 0.0 112.647 -176.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.29 105.43 0.23 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.335 1.454 . . . . 0.0 111.174 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.78 -0.02 39.3 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.647 1.594 . . . . 0.0 115.75 -178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.8 mt -100.51 136.85 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 119.321 1.56 . . . . 0.0 110.387 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -84.06 76.61 10.05 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.08 1.752 . . . . 0.0 112.971 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.44 140.52 57.19 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.137 -0.977 . . . . 0.0 112.334 -177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -152.38 152.95 32.67 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 126.397 1.879 . . . . 0.0 110.869 -174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -72.83 108.41 5.78 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.764 -1.21 . . . . 0.0 110.461 170.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 94.19 57.56 1.29 Allowed Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.492 1.044 . . . . 0.0 113.54 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 14.7 ptm -135.05 154.72 51.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.768 1.627 . . . . 0.0 111.319 167.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.9 p -79.74 119.03 22.09 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.148 0.979 . . . . 0.0 110.64 168.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -113.95 158.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.823 1.649 . . . . 0.0 110.34 173.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -125.82 153.84 43.49 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.168 1.387 . . . . 0.0 111.465 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.49 101.47 0.28 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 124.382 0.991 . . . . 0.0 112.608 -175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -65.14 128.54 36.2 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.939 -0.742 . . . . 0.0 110.985 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.6 t -105.78 155.67 19.06 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.453 1.501 . . . . 0.0 111.399 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -64.03 -20.07 65.65 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.301 1.44 . . . . 0.0 113.126 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -71.65 19.83 0.06 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.983 2.113 . . . . 0.0 114.192 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 29.5 m120 52.02 47.63 24.37 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.316 2.246 . . . . 0.0 112.915 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -142.12 177.78 7.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.719 1.607 . . . . 0.0 112.109 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 9.8 m -145.99 113.85 6.48 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.361 1.064 . . . . 0.0 111.373 -175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.41 164.8 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.338 0.655 . . . . 0.0 111.406 173.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -136.57 136.8 39.58 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.358 1.463 . . . . 0.0 111.346 172.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -157.11 -178.99 7.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.455 1.102 . . . . 0.0 113.361 -175.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.1 mp -115.08 135.69 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.411 1.484 . . . . 0.0 110.538 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 20.2 mt -76.99 120.2 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.13 0.972 . . . . 0.0 110.661 175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -90.96 -31.06 16.5 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.169 1.388 . . . . 0.0 113.531 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -153.7 150.0 28.1 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 125.878 1.671 . . . . 0.0 110.673 171.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -141.18 155.01 46.12 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.926 0.89 . . . . 0.0 112.661 175.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.2 t -153.34 174.26 14.55 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.172 1.789 . . . . 0.0 111.135 173.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.68 -29.44 66.88 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.47 1.108 . . . . 0.0 113.187 174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 24.1 p -80.57 -62.76 1.58 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.017 1.727 . . . . 0.0 111.944 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -135.53 166.64 22.73 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.226 2.21 . . . . 0.0 111.405 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.1 p -135.83 147.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 125.915 1.686 . . . . 0.0 109.319 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 28.4 mtm -121.11 101.57 7.75 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.177 1.391 . . . . 0.0 110.15 -176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.3 t -97.17 150.12 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.394 1.077 . . . . 0.0 110.131 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -61.35 130.68 47.3 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.653 0.781 . . . . 0.0 111.033 166.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -142.38 169.75 17.0 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.763 1.225 . . . . 0.0 111.571 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -117.6 133.97 55.37 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.063 1.745 . . . . 0.0 109.813 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 11.0 t-80 -145.42 132.47 10.08 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.128 0.971 . . . . 0.0 111.312 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.28 -38.06 5.17 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.917 2.411 . . . . 0.0 112.831 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.43 80.06 6.93 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.212 1.005 . . . . 0.0 108.882 170.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -98.69 -42.12 7.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.924 1.69 . . . . 0.0 112.63 177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -84.82 -161.07 33.19 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.874 1.702 . . . . 0.0 113.61 177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.82 151.54 38.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.48 1.912 . . . . 0.0 111.098 177.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -65.72 143.75 57.34 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.766 1.226 . . . . 0.0 112.808 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 72.9 mt -125.01 123.06 39.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.13 1.372 . . . . 0.0 111.356 -171.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -76.74 99.51 5.12 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.967 1.307 . . . . 0.0 111.159 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -79.68 99.46 7.41 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.757 0.789 . . . . 0.0 110.186 165.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -91.74 120.55 32.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.114 1.365 . . . . 0.0 109.034 173.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -140.94 168.7 19.15 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -148.33 140.49 24.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.079 1.351 . . . . 0.0 111.43 174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.09 102.4 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 163.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 76.6 mt -59.29 -33.73 71.43 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.814 0.846 . . . . 0.0 111.701 176.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 131.76 -139.07 10.63 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 126.265 1.888 . . . . 0.0 110.675 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -150.31 165.2 33.72 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 124.461 1.105 . . . . 0.0 112.374 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -132.6 140.72 48.36 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 126.221 1.809 . . . . 0.0 110.813 171.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.72 141.08 49.81 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.419 0.688 . . . . 0.0 110.463 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 30.8 m -137.37 170.7 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.055 1.742 . . . . 0.0 111.277 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.2 p -59.84 148.14 35.76 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.669 1.188 . . . . 0.0 112.958 174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -103.49 -0.71 29.5 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.003 1.321 . . . . 0.0 113.993 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -139.82 -58.52 0.56 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.642 1.577 . . . . 0.0 111.207 -174.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 125.706 1.602 . . . . 0.0 113.318 170.875 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.405 0.621 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.6 mp0 -69.36 143.66 53.66 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 120.484 -1.385 . . . . 0.0 110.976 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -124.81 170.13 11.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.787 1.635 . . . . 0.0 111.306 179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -134.82 169.52 17.24 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.698 1.599 . . . . 0.0 112.072 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -71.97 90.24 1.14 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.234 1.413 . . . . 0.0 112.073 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.17 130.26 45.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.314 1.446 . . . . 0.0 111.113 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 52.98 33.61 15.09 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.781 1.632 . . . . 0.0 113.858 -179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.8 t -56.23 -47.55 78.23 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.828 1.251 . . . . 0.0 112.786 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 43.0 mm -93.71 147.71 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.288 1.435 . . . . 0.0 109.574 174.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -54.64 155.7 3.98 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.806 1.642 . . . . 0.0 113.031 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -119.28 134.44 55.21 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.723 1.209 . . . . 0.0 110.989 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -79.22 101.16 7.83 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.642 0.777 . . . . 0.0 109.593 173.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.28 144.13 31.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.096 1.358 . . . . 0.0 111.033 172.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.74 126.53 47.68 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.503 1.521 . . . . 0.0 109.932 178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.15 156.83 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.323 1.049 . . . . 0.0 110.969 172.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -139.16 135.68 34.29 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.68 1.192 . . . . 0.0 110.596 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -138.3 157.2 46.72 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.781 1.232 . . . . 0.0 113.574 -175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -139.62 152.85 47.12 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.439 1.896 . . . . 0.0 110.763 169.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.7 p -124.85 119.13 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.583 1.553 . . . . 0.0 109.693 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -139.13 145.66 39.7 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.764 1.625 . . . . 0.0 111.176 -170.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -71.22 133.18 45.93 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.454 0.702 . . . . 0.0 111.215 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -57.74 111.33 1.1 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.155 0.982 . . . . 0.0 111.752 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.89 23.24 33.43 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.64 1.114 . . . . 0.0 115.634 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.6 t -128.21 165.48 20.39 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 119.119 1.46 . . . . 0.0 113.579 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.2 m -99.15 -8.35 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.428 1.891 . . . . 0.0 113.865 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.3 pp -70.51 166.98 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.643 0.777 . . . . 0.0 111.704 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.35 116.04 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.404 1.482 . . . . 0.0 108.751 175.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 63.5 mt -72.58 -48.73 37.52 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.588 0.755 . . . . 0.0 111.026 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -159.27 162.04 36.05 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.16 1.384 . . . . 0.0 112.025 170.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 83.3 p -161.52 168.4 23.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.551 1.141 . . . . 0.0 112.494 168.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -123.82 -1.71 8.37 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 164.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 5.5 mt -55.54 -60.3 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.733 1.613 . . . . 0.0 112.156 -173.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.2 t -73.67 -22.98 59.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -74.5 -72.94 0.26 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.934 1.693 . . . . 0.0 112.067 -176.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -169.7 118.65 0.55 Allowed Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 127.083 2.153 . . . . 0.0 109.846 -175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -62.76 152.04 80.63 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.862 2.374 . . . . 0.0 112.706 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.8 tp -83.6 98.56 9.67 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.629 1.572 . . . . 0.0 110.873 -175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -71.11 117.51 12.71 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.357 1.463 . . . . 0.0 110.98 170.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -144.76 175.43 10.19 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.441 1.096 . . . . 0.0 113.129 175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 39.4 mm -113.48 137.52 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 125.456 1.502 . . . . 0.0 110.138 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -51.65 110.31 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 125.166 1.386 . . . . 0.0 111.086 178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.94 -1.61 24.31 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 125.723 1.63 . . . . 0.0 115.677 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.8 m -70.69 -44.88 66.04 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 119.338 1.569 . . . . 0.0 112.531 177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.3 m120 50.59 31.5 5.76 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.16 2.184 . . . . 0.0 116.013 176.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -13.81 61.19 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.5 pt -69.63 168.31 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.843 1.657 . . . . 0.0 113.363 177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -58.73 144.62 11.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.403 1.081 . . . . 0.0 111.953 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.7 -37.01 77.65 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.017 1.118 . . . . 0.0 114.017 -172.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.39 -29.11 73.56 Favored Glycine 0 CA--C 1.537 1.45 0 O-C-N 121.672 -0.643 . . . . 0.0 113.82 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.03 -32.47 17.57 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.229 1.412 . . . . 0.0 111.963 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -54.56 -47.31 73.41 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.061 1.344 . . . . 0.0 111.992 172.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -71.43 -10.81 60.35 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -89.67 -50.99 5.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.104 1.362 . . . . 0.0 112.485 174.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -57.04 -24.89 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 114.641 1.348 . . . . 0.0 114.641 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -66.09 -19.99 66.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -106.0 -17.89 14.2 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.128 1.371 . . . . 0.0 114.187 173.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.97 118.65 8.76 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.667 1.187 . . . . 0.0 112.554 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -83.96 158.62 21.48 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.072 0.949 . . . . 0.0 112.4 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.1 tt -56.89 130.17 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 125.079 1.352 . . . . 0.0 111.595 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.97 11.81 78.88 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.977 1.275 . . . . 0.0 115.271 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -116.43 112.37 21.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 118.901 1.351 . . . . 0.0 111.763 -172.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -60.33 143.21 53.5 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.189 0.995 . . . . 0.0 112.165 173.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -142.23 145.27 33.91 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.768 1.227 . . . . 0.0 111.476 176.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -126.08 113.16 16.72 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.869 1.668 . . . . 0.0 109.864 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.7 m -118.69 111.34 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.678 1.191 . . . . 0.0 110.533 177.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 t -76.45 128.39 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.919 0.888 . . . . 0.0 109.512 174.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 mt -124.83 139.4 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.461 1.505 . . . . 0.0 109.822 -174.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -68.09 151.66 97.03 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.942 1.297 . . . . 0.0 112.133 173.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -64.6 -36.24 43.44 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.587 2.191 . . . . 0.0 112.508 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -67.31 -21.08 65.69 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.869 1.268 . . . . 0.0 114.166 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -93.73 -17.66 22.94 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.761 1.224 . . . . 0.0 113.216 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -86.34 -59.19 2.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.585 1.154 . . . . 0.0 112.408 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -128.35 -20.66 3.65 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.76 26.34 68.55 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-N 119.776 1.171 . . . . 0.0 115.352 175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.8 p -109.56 29.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.335 1.854 . . . . 0.0 112.548 -168.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -60.23 155.43 17.56 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.406 1.482 . . . . 0.0 113.883 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -93.59 101.48 13.65 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.199 1.4 . . . . 0.0 111.663 -177.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.3 t -71.74 18.7 0.07 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.701 1.6 . . . . 0.0 114.318 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.3 p -154.6 108.96 2.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.514 1.925 . . . . 0.0 111.2 178.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -146.76 157.37 43.66 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.046 1.338 . . . . 0.0 112.236 177.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.26 115.05 21.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.078 -1.014 . . . . 0.0 110.533 176.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -102.44 118.85 37.74 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.664 1.186 . . . . 0.0 110.814 174.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.47 128.83 36.79 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.82 0.848 . . . . 0.0 110.676 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 139.86 17.23 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.31 1.844 . . . . 0.0 109.613 -175.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.09 154.95 62.17 Favored 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 122.458 2.105 . . . . 0.0 112.684 -177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -68.95 -4.56 17.16 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 171.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -51.39 -35.18 37.73 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.007 1.323 . . . . 0.0 112.963 170.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -88.48 -2.97 58.89 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.323 1.449 . . . . 0.0 113.797 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -131.79 25.52 4.68 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.314 2.246 . . . . 0.0 112.326 -176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.64 105.49 1.24 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.793 1.637 . . . . 0.0 111.426 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.72 -9.14 56.83 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.725 1.631 . . . . 0.0 115.048 -176.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.5 mt -88.38 126.13 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.211 1.404 . . . . 0.0 109.634 176.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -64.36 130.92 45.66 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.609 0.763 . . . . 0.0 112.058 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.2 mt -124.77 138.57 54.27 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.723 1.609 . . . . 0.0 110.521 -177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -154.15 158.04 39.79 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.202 1.401 . . . . 0.0 111.01 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.13 119.32 10.61 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 120.949 -1.095 . . . . 0.0 111.16 172.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.94 43.11 5.16 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.09 0.852 . . . . 0.0 115.2 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 10.4 ptm -132.89 152.13 51.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.84 1.256 . . . . 0.0 111.889 168.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 23.2 t -74.03 134.09 42.98 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.351 1.06 . . . . 0.0 111.327 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.62 146.47 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.003 2.121 . . . . 0.0 110.592 177.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -98.17 133.89 41.98 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.94 1.296 . . . . 0.0 111.425 -177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.17 93.34 0.55 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.216 1.388 . . . . 0.0 112.196 -175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -63.74 144.46 57.01 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 117.961 0.88 . . . . 0.0 111.237 175.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 10.9 t -129.26 156.52 43.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.063 1.345 . . . . 0.0 112.435 179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -65.14 -17.16 64.24 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.503 1.921 . . . . 0.0 113.474 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -74.81 16.63 0.27 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.34 1.856 . . . . 0.0 113.714 170.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 55.86 48.75 17.42 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.108 2.163 . . . . 0.0 112.511 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -143.36 176.32 9.25 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.96 1.704 . . . . 0.0 112.54 -178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 10.8 m -146.62 113.53 6.12 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.674 1.189 . . . . 0.0 111.642 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 1.3 pp -77.0 169.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.403 0.681 . . . . 0.0 111.717 172.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -135.72 124.83 24.4 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.426 1.49 . . . . 0.0 110.595 172.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.25 175.42 11.8 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.982 1.313 . . . . 0.0 112.669 -175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 5.3 mp -110.84 131.98 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 111.534 -171.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 56.7 mt -67.81 134.27 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.854 1.662 . . . . 0.0 111.304 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -112.39 -34.35 5.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.393 1.877 . . . . 0.0 113.299 -174.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -151.82 162.49 40.96 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.147 1.379 . . . . 0.0 110.855 169.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -143.81 158.36 43.74 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 44.9 m -140.0 176.6 8.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 127.159 2.184 . . . . 0.0 111.081 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.99 -35.94 76.09 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 67.4 p -128.73 -3.57 5.29 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.842 1.657 . . . . 0.0 114.419 -173.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -140.98 166.38 24.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.974 1.709 . . . . 0.0 111.679 -176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.7 p -143.71 157.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.602 1.561 . . . . 0.0 110.419 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' MET . . . . . . . . . . . . . 95.1 mtp -120.22 123.02 42.22 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.79 1.636 . . . . 0.0 109.771 174.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.2 t -130.69 143.46 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.35 1.46 . . . . 0.0 109.357 -172.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -69.84 110.89 5.21 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.75 -0.594 . . . . 0.0 111.366 172.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -116.85 172.79 7.02 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.733 2.013 . . . . 0.0 111.779 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 p-10 -129.86 137.91 50.68 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.911 1.684 . . . . 0.0 110.896 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -151.9 134.09 8.51 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 124.076 0.95 . . . . 0.0 110.889 178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.92 -31.94 18.84 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 122.544 2.163 . . . . 0.0 112.716 -179.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -88.09 75.35 8.71 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.963 0.905 . . . . 0.0 109.172 169.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.35 -26.84 26.27 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.483 1.113 . . . . 0.0 112.611 169.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -94.41 -168.16 37.06 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 126.406 1.955 . . . . 0.0 113.601 177.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.63 160.38 35.54 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.253 1.821 . . . . 0.0 112.199 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.0 p -66.6 145.33 55.71 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.89 1.676 . . . . 0.0 112.43 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.9 mt -133.92 147.75 51.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.294 1.437 . . . . 0.0 111.728 -174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -89.47 103.25 15.9 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.997 1.319 . . . . 0.0 111.196 177.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -79.81 97.6 6.71 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.288 0.635 . . . . 0.0 109.405 161.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 9.4 ttt85 -89.63 140.42 29.57 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.401 -0.812 . . . . 0.0 109.602 170.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -150.34 169.39 21.51 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -146.25 150.5 35.9 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.391 1.476 . . . . 0.0 111.237 169.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 61.7 t -91.54 109.2 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.512 1.525 . . . . 0.0 108.548 167.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.72 -36.85 84.3 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.184 0.593 . . . . 0.0 111.114 176.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 136.2 -164.07 25.08 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 126.114 1.816 . . . . 0.0 111.963 -174.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -139.31 157.7 45.43 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.663 1.585 . . . . 0.0 111.291 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.7 121.32 31.74 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.971 1.309 . . . . 0.0 111.269 172.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.23 105.83 8.58 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.813 1.245 . . . . 0.0 109.776 168.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.3 m -63.29 161.85 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 123.601 0.76 . . . . 0.0 112.032 172.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 78.3 p -138.26 155.53 48.54 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.97 1.308 . . . . 0.0 112.195 176.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -136.6 49.83 2.06 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.628 1.571 . . . . 0.0 110.855 -173.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 61.0 9.16 2.2 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.655 1.982 . . . . 0.0 115.61 -174.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 . . . . . 0 C--O 1.253 1.256 0 C-N-CA 127.005 2.122 . . . . 0.0 113.774 172.367 . . . . . . . . 0 0 . 1 stop_ save_